text,label
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.743;	OD280: 0.932;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 65;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
prostate from PB-NICD model,pert
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed",pert
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,pert
EB_0_5d_62_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
NME2 induced A549 cell,pert
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Non-lesional,ctrl
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: healthy,ctrl
peripheral blood cell,pert
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.17 uM (EC50).,pert
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
normal adult rat testis,ctrl
phenotype: alcoholic;	gender: female;	case_id: 304;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 58.5;	brain ph at time of freezing: 6.4;	labeling_batch: 1,pert
Colonic mucosal endoscopic pinch biopsy,pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp-tagged rhogdi2,pert
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
"n22, surgically resected from patient of gastric cancer.",ctrl
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 1",ctrl
"C57BL/6N, adult, male",pert
Lacrimal Gland,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 12h,pert
cell type: dermal fibroblast;	genotype: CCALD patient,pert
phenotype: alcoholic;	gender: male;	case_id: 256;	age: 37;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 17;	brain ph at time of freezing: 6.33;	labeling_batch: 2,pert
chip number: 21;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.8;	rin: 9.7;	transfection date: 2012-03-26,pert
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 218,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
A2CKO1,pert
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,ctrl
triplicate 2 of S. aureus infected HepG2 HIF-1-/- cells,pert
57A;pretreatment;female;breast tumor,ctrl
c-Met KO CD9+ trophoblasts,pert
tissue: Biceps muscle;	patient: C.b.5;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
HOX424 Control Day1,ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 4",ctrl
"whole-blood leukocytes, etanercept, 0hr",pert
A2CKO2,pert
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,pert
RNA from microdissected breast cancer cells from case 651 labeled with Cy5,pert
genotype: WT;	strain: C57BL/6;	treatment: regular diet,ctrl
liver_Wt_female_35wk_rep1,ctrl
heart,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: untreated,pert
PancreaticSample30-Normal,ctrl
Mouse otic vesicle at E10.5 wt,ctrl
C57BL/6J Mouse Male Kidney,ctrl
quadriceps muscle tissue of normal controls,ctrl
Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
Macro-dissected renal cystic epithelial tissue from Fh1 knockout mouse,pert
T178,pert
tissue: Lung Epithelium,pert
age_years: 55;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
untreated with TGF-beta,pert
PBMC of Rhesus Macaque Mnk_3133-S-7,pert
Zfx-flox TC1 ESC;	Cultured in 15% KO + LIF without feeders,ctrl
duration of untreated disease in month:8.5;	age at onset:4.5,pert
lymphoblast cell line,ctrl
"Lymphoblastoid cell lines derived from family 1743, member 2",pert
BM single-cell suspensions from bone fragments and aspirates were used to establish non-clonal BMSC cultures from normal donors (N-BMSCs),ctrl
gonadal WAT of five Fsp27 knockout mice,pert
"PDAC, sample 3",pert
tissue: white blood cells;	age: 9.84;	Sex: male,pert
Olfactory mucosa,pert
"amniocytes, euploid, 1565",ctrl
Patient: A;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
gender: F;	age at blood draw: 55;	tissue: whole blood,pert
Cervical cancer_1434T,pert
strain: C57BL6/J;	age: 12 weeks;	gender: female,ctrl
"affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker, ever drinker",ctrl
treatment: siRNA LMG2,pert
after 30 days intervention with resveratrol,pert
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",ctrl
Common Reference 2 round amplification 2 ug,pert
S25 NLS 142Q TG3	F4/34	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
Sample Group: HD patient; Gender: male; Age: 59; Tissue: lymphocytes (blood); IT15 CAG repeats: 21/45,pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
patient: 51292;	sample: tumor,pert
Gallbladder- leptin treated,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T165,pert
"PC-3 cells, 60μM gefitinib (Gef), 24h",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 78 years,ctrl
status: Slow;	age: 54;	gender: female;	tissue: cultured human fibroblasts,pert
"Rb null MEFs with cisplatin treatment (16microM, 24hrs)",pert
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD8+ T-cells,ctrl
Sex: male;	Age: adult (11-12 weeks),ctrl
phenotype: control;	gender: male;	case_id: 225;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.53;	labeling_batch: 1,ctrl
human preadipocytes+oligo1_day6_rep2,pert
chip number: 12;	transfection plate: 3B;	target gene: YY1;	kd level: 0.66;	rin: 9.6;	transfection date: 2012-03-26,pert
12_2 cells with Tetracycline-repressible WT1(-KTS) expression,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 4,pert
Cervical cancer tissue,pert
NOMO-1 acute myeloid leukemia cells,pert
"Lox control liver, ad lib, 4:00pm",ctrl
"Ishikawa cell line, BPA, 10nM, 8hr",pert
EB_0_8d_65_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
"Hippocampus, soman, 72h",pert
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
cell type: Peripheral blood leukocytes;	strain: DBA/2,ctrl
Kidney,ctrl
PDAC_T_123,pert
Tissue: normal thyroid; Gender: female; Age:31,ctrl
whole uterus,ctrl
"Frontal Cerebrocortex, permethrin (10mg/kg), 6 hours",pert
patient: 133;	current medication: Omeprazole 20mg;	birth date: 4/23/65;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/13/05;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"Tracheal explants, Dex, 2hr",pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Ing1 knockout embryo MEF cells,pert
strain: C57Bl/6;	genotype/variation: : ARR2PB-Cre;ROSA(N1IC) model (a.k.a. PB-NICD) that expresses the Notch1 intracellular domain (NICD or N1IC) in the prostate and develops prostatic intraepithelial neoplasia (PIN lesions).,pert
"Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: 100 ppb, 5wk",pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 4,pert
HEK293_ControlsiRNASparse_rep1,ctrl
A375P cells expressing PGC1a shRNA 65,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp2,pert
14-week-old WT liver_464WT,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 23.9589,ctrl
cell type: glioma stem cells;	treatment: DMSO,ctrl
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep3,pert
Healthy controls; individual=CM; time=2; beverage=alcohol,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 26;	gender: male,ctrl
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 29;	maternal age: 30,ctrl
"Brain tissue from Fisher 344 male rat, Animal #253, 200mg/kg D-Serine",pert
A375P cells expressing PGC1a shRNA 66,pert
knockdown: shControl;	cell line: MDA-MB-231,ctrl
CD8+ T cells derived by negative selection from leukopheresed blood sample,ctrl
NB60,ctrl
"Gender: female, Age: 37 years, Tissue: normal vulva,",ctrl
suppressed induction of AICD,ctrl
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
RNA from whole tissue section of case 662 labeled with Cy5,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,ctrl
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: streptozotocin,pert
"Brain tissue from Fisher 344 male rat, Animal #265, 20mg/kg D-Serine",pert
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
F1 ES Cells,pert
chip number: 11;	transfection plate: 4;	target gene: IRF7;	kd level: 0.7;	rin: 9.4;	transfection date: 2011-10-17,pert
"ID: MLL_00266;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
T3.02,pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with lupus arthritis",pert
P2C Progranulin-hippocampus,pert
"Undifferentiated Dicer -/- ES cell line, passage 18",pert
WT 3 Quadriceps,ctrl
treatment: Arid3a knockdown;	cell line: J1 ES cells,pert
"primary cortical neurons, MEF2A shRNA",pert
"DHL6, DMSO",ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: No2 -/-;	infection status: uninfected,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 172;	fata: 63;	eea: 1500;	wtkg: 70;	perfat: 21.2;	lbm: 51.4;	fat_mass: 1484,ctrl
"Patient  J, lesion, 12 week",pert
disease state: healthy control;	tissue: epidermis;	age: 46;	gender: female;	treatment: untreated;	time: control,ctrl
CD4+/CD25- T effector cells 72h after activation,pert
cell type: brown preadipocyte;	genotype: Ezh2 -/-,pert
sirna: control;	plate: collagen coated;	cell line: MCF10A,ctrl
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: +Dox,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
coMCF-7_2,ctrl
"DBA/2J Saline treated, biological replicate 2",ctrl
cell type: B-cell;	cell line: Pfeiffer DLBCL,ctrl
genotype/variation: TRPV4 knockdown,pert
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
"Cardiac, ventricular tissue",ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,pert
CD34+ cells from the patient (CML33),pert
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,ctrl
treatment: siRNA against ETS2;	cell line: H441,ctrl
first-episode bipolar patient,pert
"Male, 59 years old, HIV infection of 15 years",pert
Sodium arsenite added to food: None; Injection: IP 8hr 1 mg/kg sodium arsenite in saline; Diet: AIN-76A; Sodium arsenite added to drinking water: None,pert
P28 testes,ctrl
tissue: brain;	genotype: mutant Dcx ko/Y;	age: P0,pert
chip number: 22;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.63;	rin: 9.4;	transfection date: 2012-03-26,pert
patient id: 324;	tissue: Normal cortex;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
microdissected epithelial cells from IPMC 1,pert
MMA wild type,ctrl
Kidney from mice treated with 7 daily iv injections of vancomycin at 400 mg/kg,pert
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Sham;	experimetal group: Adult Sham,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.63562,pert
FoxO1 KO_VMH,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
HEK cell lines non-expressing mutant channel,pert
Gender:F;	Age:47;	Tissue: Mucosa,pert
"Normal Cervix, microdissected epithelium, Age 54",ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
tissue type: Bone Marrow;	cell type: Normal Plama Cells (NPC),ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 52;	Sex: male,pert
"spc-c-raf transgenic mice, age: 6 month old, Gender: male, Tissue: tumor",pert
Control 11 appendix,ctrl
Frozen disease-free lung tissue,ctrl
"Deltoid, FSHD, cohort 21, subject 21B",pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
chip number: 18;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.82;	rin: 9;	transfection date: 2011-10-17,pert
BV2_Curcumin_rep2,pert
Strain: Mix 129X1/SvJ and C57BL/6J and Sjl;	Gender: Mix;	Age: 4Wks;	Tissue: retina,pert
Vector Control Transfected 3T3 cells treated with DMSO for 24 h,ctrl
agent: resveratrol_250mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: MTDH knockdown",pert
background strain: C57Bl6;	genotype: Rsk2 knockout,pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
control KD mouse ES cells,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 3,pert
human CD14 positive monopcytes,ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 178-day-old male;	40 mg liver used for RNA extraction",pert
"Uninfected treated with 1,25D, replicate 1",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 205min;	race: White;	sex: Male,pert
"SWR/J Saline treated, biological replicate 3",ctrl
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 4h",ctrl
"SPC-c-raf transgenic mice, 5 month old, male, unaltered",pert
"Pool of two samples (n=2);;	cells: CD3+ T cells, bone marrow;;	healthy volunteers; gender: one male, one female; age: 58 and 42 years old",ctrl
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,pert
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 3 months;	tissue: liver;	disease status: steatosis,pert
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",pert
A VIS _B031,pert
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 6h;	gender: Male;	age: 63 years old,ctrl
myoblasts transduced with lentivirus carrying DUX4-s,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, M0, G4",pert
cell type: neuron progenitor cells (NPC);	disease group: healthy control,ctrl
"Mouse, ATF6bKO, colon, UT, rep1",pert
Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 6h,pert
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: VhlhKO",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
patient: 26;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
transfection: Control siRNA;	cell line: HeLa S3,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu2,pert
Patient: I;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
Mouse soleus,ctrl
Zmpste24+/+ mouse embryonic fibroblasts (P3),ctrl
strain/background: C57/B6x129 mixed background;	genotype/variation: Bptf KO;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: wildtype,ctrl
"Lung tissue of CD-1 wildtype mouse, smoke treated",ctrl
cell line: A549;	cell type: Lung adenocarcinoma,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 207;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
tissue: brain;	genotype: WT mix background A;	age: E14,ctrl
"Mouse embryonic stem cells, day 0, Alkb1-/-",pert
S4C Sporadic-hippocampus,ctrl
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
69A;pretreatment;female;breast tumor,ctrl
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb+/+;	progeny from cross: Cbfb+/- x Cbfb+/-,ctrl
Bladder cancer cells,ctrl
diagnosis: HP;	fvc-group: FVC3;	tissue: lung,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: D835 mutation,pert
CD46+/STAT1-KO hippo - Untreated-D,pert
monocytes_T14,pert
Knockout liver_saline-injected 12weeks repl1,pert
cell line: WM-266;	pir knock-down: no,ctrl
cell type: PBMC;	disease state: Acute,ctrl
genotype: ß-catenin gain-of-function mutant (ß-catGOF-UB);	tissue: kidney (uteric bud);	developmental stage: embryo;	age: 12.5 days,pert
"gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
tisue: cleared mammary fat pad;	genotype: Rarb -/-;	age: four weeks,pert
GIST882 Cell line,ctrl
skeletal muscle myoblast_WT_day0,ctrl
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 100 nM,pert
INS-1 cell line #2 with non-induced HNF6,ctrl
MPM tumor specimen 11,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 57,pert
"LCL GM19238, Kd E2F6, 72hrs",pert
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
"C57BL/6, Male, Contol",ctrl
"liver, Q10, 14 months",pert
liver_wildtype,ctrl
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
Patient: N;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"heart, 30 months of age, resveratrol diet",pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 3,ctrl
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
EPLM,pert
Huh7,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 28.0;	age of psoriasis onset: 13,pert
Dysf +/+ QF control mouse muscle,ctrl
"brain, motor cortex, layer 5 thick tufted pyramidal neurons, Mecp2 null",pert
E14.5 Tgfbr2fl/fl Wildtype Mouse Model Palate,ctrl
Igf1 +/+ mouse vestibular organs at embrionic stage E18.5,ctrl
fresh tissue: splenocytes;	strain: DBA/2,ctrl
untreated or induced,pert
genetic background: FVB;	cell type: DN2;	genotype: E2A deficient,pert
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, aneurysm;	agent: Ang II;	time: 14d",pert
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: Wild type,ctrl
disease state: healthy donor;	tissue: PBMC,ctrl
Cervical cancer_CC222,pert
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
erythroblast transduced with empty vector,ctrl
"NB4 cell line, TG2 knockout, ATRA, 48hr",pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,pert
Total RNA from WT ESCs,ctrl
Insm1 control #8_pituitary gland,ctrl
MPM tumor specimen 42,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 2,pert
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,ctrl
genetic modification: no modification;	tissue:  spleen: FACS sorted IgM+IgD+ cells,ctrl
A2CNT1,ctrl
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,ctrl
Gingiva tissue,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, non-treated",pert
Treg cells from Ptenfl/flFoxp3-Cre mouse,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 2,pert
patient id: T164;	tissue: Normal cortex;	gender: Male;	age: 75;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"Patient  N, lesion, 4 week",pert
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
Cervical cancer_CaCx54,pert
Monocyte human familial combined hyperlipidemia after treatment with atorvastatin (ATV) sample,pert
14 Day Mouse Diaphragm muscle,pert
SCLC cell line MS-1,pert
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
CSTB KO_cerebellum at P30,ctrl
"GI_canc, Col1",pert
C2C12 MYOTUBES,ctrl
Patient: G;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Knockout liver_saline-injected 12weeks repl3,pert
Sample ID: TP28;	Twin Pair ID: CCN5.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 26/47,pert
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 2, clone 1",pert
scram_hi_8,ctrl
"liver, Q10, 6 months",pert
"Amniocytes, trisomy 21, 1573",pert
T117,pert
T1alpha (-/-) lung at birth (term),pert
Mus musculus embryonic stem cells derived from HDAC1 knock out embryos,pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,pert
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
Mus musculus brain hemisphere,ctrl
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Non-lesional,ctrl
"C57BL/6 mice, thymus and spleen pooled",ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, non-treated",pert
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
HMEC culture,ctrl
SV589_NoKD,ctrl
"FACS-sorted cones, P60 C-DGCR8 KO mice",pert
tissue: testis;	genotype: WT;	genetic background: C57BL/6,pert
"wt-Gfp, Gfp+ photoreceptor cells",ctrl
disease: psoriasis;	skin: lesional,pert
Neurons overexpressing GFP,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate B,pert
patient id: 1393;	tissue: Normal cortex;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MeCP2 shRNA,pert
hair follicles from wild-type,ctrl
Mock-treated MDA-MB-231,ctrl
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Gadd45a-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
murine colon epithelium,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: control,ctrl
disease status: autism;	tissue (brain region): Frontal cortex,pert
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L014,pert
genotype/variation: Gsk-3a-/-;	cell type: embryonic stem cells,pert
Kidney tissue from obese rats on diet with rosiglitazone,pert
cell type: monocyte;	disease state: control participant,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.51233,pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Treg cell,ctrl
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 28;	gender: f;	treatment: -,ctrl
"Patient  E, lesion, 2 week",pert
patient: 41027;	sample: tumor,pert
human skin biopsy,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",ctrl
liver_Akt1+/-_female_8wk_rep2,pert
Murine Lung,pert
duration of untreated disease in month:4.9;	age at onset:8.3,pert
SV589_3DayKD_SerumStarved->1hr EGF,pert
RNA from microdissected breast cancer cells from case 1125 labeled with Cy5,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 58,pert
race: african america;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
Disease_status: Bipolar disorder;	Age (years): 59;	Gender: Male;	Age of onset (years): 25;	Duration of illness (years): 34;	Brain pH: 6.65;	Post mortem interval (hours): 84;	Side of brain: Right;	Fluphenazine mg. Equivalents: 500;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: Yes;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Fibroblasts isolated from wild type mouse mammary glands,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.64384,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.26575,ctrl
Tissue: brain (frontal cortex);	Disease State: HIVE-control,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: ;	fata: ;	eea: ;	wtkg: 69.9;	perfat: 10.4;	lbm: 61.2;	fat_mass: 726.96,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 3,pert
Cells: HCT116 colon cancer cell line,ctrl
"Right brain hemisphere ,C57BL male mouse,Clozapine treated,Orally,4 weeks",pert
"cerebellum,6weeks,KO",pert
genotype: WT;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,ctrl
scan batch: Batch 2;	group: control;	subject age: 3;	paternal age: 22;	maternal age: 22,ctrl
Whole testis RNA from Crem-/- mouse #144 at 0h,pert
HCT116-Neo124 human colon cancer cells with intact PTEN,pert
subject: 40;	disease: CP;	muscle: ST;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
mouse whole lung,pert
Y HID_B039,ctrl
RNA from whole tissue section of case 687 labeled with Cy5,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,pert
SCLC cell line Lu-134a,pert
"MCF7 cells stably transfected with XBP1, passage 3",pert
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,ctrl
HLA risk: Low;	Height: 134.6 cm;	Weight: 30.6 kg;	BMI: 16.7;	Age: 9.27 years;	Gender: Male;	Race: White;	Glucose: 245 mg/dl;	HbA1c: 7.5%,pert
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
chip number: 23;	transfection plate: 6;	target gene: RAD21;	kd level: 0.87;	rin: 9.6;	transfection date: 2012-03-26,pert
Patient: L;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: M;	age: 65,pert
MPM tumor specimen 18,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 21;	maternal age: 21,pert
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,pert
LSK cell from Gfi1 knockout mice,pert
Mouse otic vesicle at E10.5 mut,pert
affection: unaffected;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,ctrl
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Normal Pleura 4,ctrl
HCC_27T,pert
"Gift Prof Dr Olivier De Wever, Ghent University Hospital, Ghent, Belgium)",pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 5,ctrl
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
14 Day Mouse extraocular muscle,ctrl
Laser Capture Microdissected Serous Ovarian Cancer Epithelia,pert
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 1 hour",pert
patient: 51091;	sample: normal,ctrl
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24727,pert
"Cervical cancer cell line, C4-I",pert
treatment: before Rituximab (control),ctrl
gender: Male;	age: 58;	post-mortem delay: 15h;	ph: 6.5,ctrl
Vehicle-Control;	Vehicle-Control 30 hours set 1,ctrl
patient id: T127;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
"Whole blood - General population, Male",ctrl
RNA pool from untreated LCLs generated from ADHD patients,ctrl
MLL_00266,pert
P910,pert
PBMC GM T1,pert
"Lymphoblastoid cell lines derived from family 1734, member 1",ctrl
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",pert
WT Primary Hepatocytes - Pooled -Cy3,pert
"rat hippocampus (combined dorsal and ventral apsects), aged control, subject 8",ctrl
Aquaporin-11+/+_mouse P7 kidney #1-1,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 1",pert
"cell type: Primary chondrocytes;	genotype: Wt;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",ctrl
induction of AICD,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.674;	OD280: 0.969;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 293;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
gastrocnemus muscle,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.03;	OD280: 1.028;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 218;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
condition: Psoriasis;	patient: PS-A;	tissue: LS skin biopsy;	kit: Affy,pert
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
strain/background: mix of 129Sv and C57BL/6;	genotype: conditional keratinocyte-specific ADAM17 knockout;	tissue: back skin;	age: 10 days,pert
Group4: 6 days differentiated Flk1+ Runx1-/- ES cells,pert
"Prospectively purified bone marrow hematopoietic stem cells (LSK, defined as Lineage- Sca-1+ c-Kit+) and myeloid progenitors (defined as Lineage- Sca-1- c-Kit+) from Mx-Cre-; FoxO1/O3/O4LoxP/LoxP and Mx-Cre+; FoxO1/O3/O4LoxP/LoxP mice 4 weeks after induction of excision with polyinosine-polycyticylic acid (pIpC, 300ug)",ctrl
PancreaticSample53-Tumor,pert
MCF-7 cell line treated with FoxA1 siRNA and vehicle (control),pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
"disease group: Psoriasis;	Sex: m;	age: 30s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 360;	ige (kiu/l): normal (0-48.5 kIU/L): 224;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.80822,pert
fatty (fa/fa) adipose tissue (epididymal),ctrl
sample: #21;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
Colon 21 days old,ctrl
treatment: DMSO;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"C57BL/6, Male, CF",pert
E14 cells_Zfp322a RNAi,pert
PancreaticSample31-Tumor,pert
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type,ctrl
tissue: white blood cells;	age: 7;	Sex: female,ctrl
"HCT116 shCDK8, low glucose",pert
cell type: HeLa;	genotype/variation: nucleofacted with Dharmacon control siRNA,ctrl
individual: patient2;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Frontal Cerebrocortex, deltamethrin (0.3 mg/kg), 6 hours",pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: vehicle,pert
disease state: mPIN (mouse prostatic intraepithelial neoplasia);	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,pert
male;	CABG patient atrial tissue;	baseline before CABG surgery,ctrl
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 16;	Duration of illness (years): 32;	Brain pH: 5.8;	Post mortem interval (hours): 22;	Side of brain: Left;	Fluphenazine mg. Equivalents: 32000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
normal tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 53;	Sex: male,pert
gender: male;	age (years): 50;	evolution time (years): 6;	disease extension: Pancolitis;	treatment: Azathioprine,pert
Patient: H;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
race: hispanic;	age (years): 47;	stage: IB;	grade: 1;	histology: endometrioid,pert
sex: Male;	Age: 61 months;	additional patient information found in Series supplementary file,pert
Mixed_E18.5_Whole_Kidney,pert
Substantia nigra,ctrl
PancreaticSample15-Tumor,pert
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 8 hours,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 63 dpi,pert
cell line: TOM-1;	tissue: Human B cell precursor leukemia,pert
"sirna: Dhamracon negative siGENOME Non-Targeting siRNA;	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
tissue: skin;	individual: Patient P10;	condition: ANL;	eczema severity: SCORAD: 0,pert
cell line: HCT116;	shRNA: non-target;	treatment: low glucose,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: P,pert
24 weeks female,pert
Breast cancer,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 2,pert
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24714,ctrl
Squamous cell lung cancer patient 31,pert
cell line: prostate cancer cell line PC-3;	telomere status: Long;	exogenous htert: present,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 177;	colon ratio (mg/mm): 2.855;	myeloperoxidase activity (u/mg): 0.217;	tissue: colon;	treatment: 5% DSS,pert
disease status: controls;	tissue (brain region): Cerebellum,ctrl
"Cultured ovarian cancer cell line HeyC2, untreated",ctrl
tissue: LNCaP-LM NSG xenografts;	expression: vector control,ctrl
pLenti transduced cell lines overexpressing canonical CDH1,ctrl
IRAK4-KD-MEFs_unstimulated_4hours_rep1,pert
PancreaticSample36-Tumor,pert
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with no Cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),ctrl
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
WT striatum Veh,ctrl
WILDTYPE cerebrum at new born,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,ctrl
"Cultured ovarian cancer cell line OVCA433, Cisplatin treated",pert
Muscle_control,ctrl
cell type: breast cancer cells;	agent: none,ctrl
"Cell type: neuronal, age:45, gender:male, diagnostic group: schizophrenia, PMI:35h",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-13;	Primary Site:Floor of Mouth;	Age:54;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
Control AGS cells (transduced with non targetting shRNA) treated with 10 microM LPA for 4 hr,ctrl
"NB4 cell line, wild-type, ATRA, 48hr",pert
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
strain: mixed background;	age: 4 months;	genotype: hnf1alpha KO;	tissue: jejunum;	sample type: mutant,pert
"Human lung adenocarcinoma A549 cells treated without TNFα, in presence of control siRNA",ctrl
R1/E ESC,pert
Rb F19/F19;	age: newborn;	strain: FVB;	tissue: skin,ctrl
normal embryonic day 18 lungs,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: no mutation detected,ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P11;	clone: C18,pert
WT_48A_2,ctrl
ak 03,pert
age: 34;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 5;	Exposures: 3,ctrl
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 39;	gender: f;	treatment: -,ctrl
Wild-type retina at P15,ctrl
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Runx1-/- ES cells,pert
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,pert
7 Day Mouse Leg muscle,ctrl
cell line: KGN;	transfection: GC matched control,ctrl
chip number: 23;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.81;	rin: 9.7;	transfection date: 2012-03-26,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.651;	Ratio: 2.11,ctrl
"NALT infected with 90-226 deltaM, 24h, biological rep2",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 89;	Usage number: 5;	Exposures: 3,pert
Leukemic mice 2 months after ENU treatment,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 3,pert
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,ctrl
Temporal cortex of non-AD brain,ctrl
"SW480, stable line of treatment of ezrin RNAi. Incubate in L15 medium, 37.0°C, air 100%",pert
"rat, hepatocellular carcinoma (DEN 50mg), treated with erlotinib 2mg (week 18)",pert
Against CDK19-2 transfected HeLa S3 cell,pert
HeLa cells transiently transfected with SON siRNA,pert
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate A,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 3,pert
Brain from 67 days Npc1-/- mouse1,pert
Pcgf6_4_shRNA2-dox,ctrl
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #2,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 44;	maternal age: 40,pert
race: caucasian;	age (years): 49;	stage: IC;	grade: 3;	histology: endometrioid,pert
cell type: Endothelial cell;	agent: estradiol;	dose: 1 nM;	time: 24 h,pert
"primary mucosal tissue,  colon",pert
Mesenchymal derived mouse cell line,pert
Male mouse 120 day old,ctrl
HL60 cell line,ctrl
"BOEC, normal 10",ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical carcinoma, Separation Type: trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA,ctrl
"Ulcerative colitis patient, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",pert
"ID:12-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD4+ T-cells,ctrl
Gender:female,ctrl
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 0,ctrl
human liver,ctrl
left hippocampus of prenatal stressed mice,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-WT cells, expression induced with doxycycline for 24 h",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 28.105;	Ratio: 2.13,ctrl
Sprague-Dawley Rat retina (male); 4h post injury,pert
Normal male wistar rat,ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: n/a;	maternal age: n/a,pert
H157 siCTL2,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.57534,pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 5,ctrl
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24715,pert
INS-1 cell line #2 with non-induced HNF4a2,ctrl
sample 1:;	age: 32;	gender: female;	sample 2;	age: 47;	gender: male;	sample 3;	age: 75;	gender: female,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,pert
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Weight: 20-25g;	Wild type,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),ctrl
Human skeletal muscle biopsy sample;	Patient #57 with NORM,ctrl
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). Gata4 conditional knockout (mutant) sample.,pert
race: caucasian;	age (years): 49;	stage: IA;	grade: 2;	histology: endometrioid,pert
Patient: D;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"U937 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 9,pert
Neo6 cell line,pert
"Tibialis Anterior Muscle, Wildtype, Aged",ctrl
"neocortex, 30 months of age, resveratrol diet",pert
cell type: T cell;	disease state: homozygote FH,pert
tissue: dental pulp cells;	genotype: control;	passages: 7,ctrl
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: control shRNA",ctrl
"Wild type, pancreas",pert
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: Lkb1 knockout;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 50,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P30 postnatal stage,ctrl
CD8 T cells isolated from spleen,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
chip number: 20;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
skin derived melanocyte cell line,ctrl
female;	29 yr old;	Black,ctrl
Tendon;Quadriceps_Non-lesional,ctrl
treatment: naïve;	transgenic variant: FVB/N;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,ctrl
Sample: nontransgenic control (NTG);	Replicate: 1;	Pool: NP,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",pert
race: caucasian;	age (years): 48;	stage: IB;	grade: 2;	histology: endometrioid,pert
"BOEC, at_risk 5",pert
tissue: normal colonic mucosa,ctrl
CTRL_siRNA,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day2,pert
Mouse TCF-1-deficient memory CD8 T cells,pert
TTF=115min;	Race=Caucasian/White;	Sex=Male;	Group=C;	Prototype_N,pert
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
"ICR10 mouse strain (Nrf2-/-)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",pert
"brain, control, 6 months",ctrl
LNCaP-MED1 overexpressed,pert
Gastrocnemius muscle mRNA from old (24 month old) wild-type mice,ctrl
"-Rosi, +PPAR, 24hrs",pert
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
patient: 801B;	disease state: LGSC;	component: Invasive,pert
age: 46;	gender: female;	ejection fraction: 61;	left ventricular end diastolic diameter: 49;	inflammation/PVB19: negative,ctrl
"embryonic stem cells, KD replicate B",pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 1,ctrl
Karyotype: inv(14)(q11q32);	Age: 49 years;	Gender: male,pert
PBS Treated Cells 2,ctrl
WT J1 ESCs on day 3,ctrl
Extensor carpi radialis brevis muscle from cerebral palsy patient,ctrl
A549 NSCLC cell line,pert
normal mammary gland,ctrl
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
hOB695_shRB1383_2hr_IR,pert
WT fundus,ctrl
A YOKE_B062,pert
duration of untreated disease in month:7.7;	age at onset:1.6,pert
SK-MEL-2 melanoma cells,ctrl
"prostate cancer cell line, CBFbeta knockdown",pert
Disease_status: Bipolar disorder;	Age (years): 51;	Gender: Male;	Age of onset (years): 23;	Duration of illness (years): 28;	Brain pH: 6.67;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Male,pert
"C4_transgenic but unaltered, lung tissue",pert
cell type: Immortalized AR positive myofibroblast,pert
"patient 6, left arm treated with pimecrolimus until day 22",pert
HCC_20N,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 21 yr,pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Male mouse 60 day old,ctrl
human_hepatocyte_trovafloxacin_24hr,pert
sparse HUVECs stimulated with Angiopoietin for 1 hour,pert
human preadipocytes+oligo2_day6_rep2,pert
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24722,pert
"Tibialis anterior, healthy control",ctrl
patient: 40843;	sample: normal,ctrl
mammary gland,pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 22;	Brain pH: 6.65;	Post mortem interval (hours): 49;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
con-50,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD),pert
tissue: Hippocampus;	age: 72;	Sex: F,ctrl
Mouse_E14 ES cell_Undifferentialted,pert
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: control,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 13;	age of psoriasis onset: 25,pert
condition: Discoid Lupus;	patient: L4;	tissue: LS skin biopsy;	kit: Ovation,pert
SCLC cell line DMS79,pert
strain: C57BL/6;	genotype/variation: IkkβF/F,ctrl
Superior Frontal Gyrus from a 6 year-old girl suffering from Rett Syndrome.,pert
mouse E12.5 embryonic kidney isolated from Ret-knockout pregnant female,pert
PS-NA cerebellum at 18 weeks,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: WT,ctrl
Pool Ts1Cje_P15,pert
"HSCs from female mice treated with E2, replicate 2",pert
"Cells: U2OS, Treatment: infected with control shRNA_pLenti, blasticidin selection",ctrl
"Patient  D, lesion, 2 week",pert
triplicate 1 of S. aureus infected HepG2 HIF-1-/- cells,pert
"H1 hESCs, OCT4 shRNA",pert
Mouse C57/bl6,pert
"Male F344 rats, sacrificed at the age 18 weeks",pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 29;	maternal age: 29,ctrl
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,ctrl
patient: 235;	current medication: Asacol Predfoam Lanzoprazole;	birth date: 1/9/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/24/97;	diagnosis date: 8/26/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/11/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/11/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/97;	smoking amount: 15-24;	other illnesses: TURP;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Sh2b3 wild type NOTCH1 induced tumors,ctrl
"Control maternal diet, Cited2 -/-",pert
"Huh7 cells, JFH-1 Infected, 6 hours.",pert
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
strain: C57BL/6J;	genotype: Homozygous dumbo;	developmental stage: P15,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"Strain: C57BL/6, NOD-SCID;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6, NOD-SCID Eeyore T2996C",pert
BV2_rep1,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,ctrl
gender: Male;	tissue: liver;	genotype: Wild Type;	treatment: DMSO 3-day;	genetic background: C57BL/6,ctrl
WT mouse skin treated once with acetone and collected 24 hr later,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: male;	passage: P11;	clone: C29,ctrl
PS-NA cerebellum at 12 weeks,pert
NFIA E18WT1,ctrl
wild type control tissue  3,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: 33,pert
E18.5 control,ctrl
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,ctrl
HEK 293,ctrl
2-3 month old littermate control animal (IκBαfl/-),ctrl
MSI colorectal tumor,pert
Female - caucasian - E-03-G,pert
"whole-blood leukocytes, placebo, 4hr",ctrl
TAMs sorted from vehicle control tumors,ctrl
"SWR/J Acute morphine treated, biological replicate 1",pert
WT Primary Hepatocytes - Pooled -Cy5,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.8;	age of onset: 18 yr,pert
At Risk: -;	Age: 15;	Sex: M,pert
Sca+ SP (side population) bone marrow cells,ctrl
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,pert
"Patient  F, lesion, 2 week",pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 30 days;	tissue: retina,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 111min;	race: White;	sex: Male,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,ctrl
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Human-ApoD transgenic gain of function mutant,pert
"Mature proximal small intestine with intestinal epithelium-specific Pdx1 inactivation, first 5 cm immediately adjacent to the pylorus",pert
Osteoblasts_Lrp5_Knockout_Day7,pert
Mouse cardiac left ventricle,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 64 yr;	population: white;	dsm-iv: 295.7;	age of onset: 19 yr,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 2,ctrl
tissue: retina;	disease state: Control,ctrl
"SRF silenced, treated with EtOH, biological rep 3",pert
4T1.2 base vector expressing cell,ctrl
CD4+ T cells derived by negative selection from leukopheresed blood sample,ctrl
Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 6h,pert
KO_72_O3_1,pert
cell line: NALM1;	tissue: Human B cell precursor leukemia,ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: F,pert
strain: C57/Bl6;	genotype: Akt1+/+;	gender: PND70 female,ctrl
Celecoxib_#4866,pert
tissue: dental pulp cells;	genotype: control;	passages: 5,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 45,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,pert
14dpp Ubb knockout testis,pert
disease state: normal;	specimen: Ovarian Surface Epithelia,ctrl
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 7-9 wk;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
genotype/variation: wild type;	tissue: Brain Tissues,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 4 hours,ctrl
EmptyVector 2,ctrl
"12 weeks anterior prostates, wild-type",ctrl
PBMC,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: maxilla;	donor sex: female,pert
Brain from 55 days Npc1+/- mouse1,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr",ctrl
CD71+ bone marrow cells from Ifng-/- mouse 3,pert
"Human healthy male subjects, peripheral blood monocytes",ctrl
"gender: Male;	age: 76;	post-mortem delay: 6h;	ph: 6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
BMM,ctrl
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 9.1;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 10;	ige (kiu/l): normal (0-48.5 kIU/L): 49.3;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5,ctrl
treatment: empty vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,ctrl
"59B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Wistar rat liver tissue following animal exposure to orotic acid for 1 day,pert
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
age_years: 66;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Array Type: HG-U133A_2;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Stain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
"Biceps, control, cohort 18, subject 18U",ctrl
"seminoma specimen, pT3, patient age: 49y",pert
strain: c57/bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
HNF4loxp/+villin cre,ctrl
"BMMC, WT pLKO.1, nonactivated",ctrl
coc-53,pert
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: control,ctrl
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 31;	maternal age: 26,pert
strain: C57BL/6J;	gender: male,pert
"C57Bl/6, CD-1",pert
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing no insert,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 32 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
Laser-capture microdissected non-malignant FTE from BRCA1/2-mutation carrier,ctrl
Primary hepatocytes isolated from Donor 6 treated with DMSO for 6h,ctrl
UC Inflamed sigmoid colon,pert
Biopsy 1 from cystectomy 18,pert
CD4_T_cell_pool_melanoma_M09+M10,pert
NORMAL #99-1053,ctrl
"Liposarcoma culture from tumor 389, untreated",ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Epithelial Cell,pert
Lung; wild type; spontaneous breathing,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 38 yr;	population: white,pert
male;	34 yr old;	Black,ctrl
"Deltoid, FSHD, cohort 22, subject 22A",pert
"Heart, KO1",pert
HeLa cells;	(cervical cancer cells),pert
Patient: M;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
CA1 hippocampus,ctrl
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 35,ctrl
treated MCF-7 cells,pert
SCLC cells,pert
14-week-old Trim24-/- liver_648M,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: mid-UV,pert
"seminoma specimen, pT1, pN1, patient age: 34y",pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,ctrl
"cultured PBMC, nontreated",ctrl
Tobacco abuse,pert
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
genetic background: FVB;	cell type: DN2;	genotype: wild type,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 1",ctrl
"Tumor sample from patient with p53 wild type, replicate 1",ctrl
"Wild type, snap frozen, plantaris muscle, 7 month age animal",ctrl
tissue: white blood cells;	age: 15.6;	Sex: male,pert
AIRE ko CD80hi mTEC sample2,pert
genotype/variation: Gb5-deficient;	tissue: Brain Tissues,pert
cell line: REH E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
ID: MLL_00112;	cell type: PBMC;	disease state: control,ctrl
"MDA-MB231 cells, G9a knockdown",pert
"19B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
genotype: ILKR211A Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
p107-/-;	age: newborn;	strain: FVB;	tissue: skin,pert
CGR8 embryonic stem cells,pert
"Deltoid, FSHD, cohort 12, subject 12A",pert
treatment: vehicle;	genotype: wild type;	treatement time: 4 hours,ctrl
gender: Female;	age (y): 52;	tissue: prolactinoma,pert
HEK293_GFP,ctrl
explanted heart tissue at time of cardiac transplantation,pert
A YOKE_B063,pert
"Brown adipose tissue, KO",pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A;	cell line: GM00038,pert
At Risk: -;	Age: 11;	Sex: F,pert
RNA from whole tissue section of case 1093 labeled with Cy5,ctrl
cell: ES cells;	genotype/variation: UTX conditional knockout,ctrl
agent: ConA;	time point: 6 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,pert
"Liposarcoma culture from tumor 399, untreated",ctrl
lrrk2 genotype: WT / LRRK2 GS,pert
"liver, PPAR WT_ctr_53",ctrl
Disease_status: Healthy control;	Age (years): 41;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
CON - LV22,ctrl
ERA,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 3",ctrl
"DSS colon tissue, biological rep1",pert
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,ctrl
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Male,pert
chip number: 23;	transfection plate: 5;	target gene: TAF1;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
WILDTYPE cerebellum at new born,ctrl
Age: 38;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 A1959T;	Family History: Yes,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 0,pert
Clcn5 knockout,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 1,ctrl
RV16;	Age = 19;	Sex = M,pert
tissue: Temporal cortex;	age: 71;	Sex: F,ctrl
"treatment: control;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
cell line: COV434;	transfection: pFOXL2m,pert
"Tumor sample from patient with p53 wild type, replicate 3",ctrl
Epidermal keratinocytes treated with EFNA4 for 4h,pert
PBMC from T cell Large granular lymphocyte leukemia patient#133,pert
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,ctrl
tissue: breast;	normal/tumor: normal,ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,pert
Strain: mixed;	Tissue: liver;	Age: 28 days,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 1;	Exposures: 4,pert
"AZ521 dnSox2 cells, uninduced, 18h",ctrl
skin squamous cell carcinoma,pert
MPM tumor specimen 2,pert
age: 49;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 5;	Exposures: 3,ctrl
gender: male;	individual: patient 4;	treatment: paclitaxel-eluting stent,pert
Pre-Frontal contex of naïve FVB/N mice,ctrl
tissue: cerebellum;	strain: wild type;	age: 3 months;	genetic background: C57Bl/6,ctrl
Y HID_B040,ctrl
"heart, beta1-Gly389 transgenic mice at 90 days of age",pert
"BOEC, not_at_risk 1",pert
age	26;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.3;	leukocyte count (/nl)	25.7;	hemoglobin (g/dl)	13.9;	platelet count (/nl)	915,pert
28dpp wild type testis,ctrl
E14.5 WT 1,ctrl
No_drug_#4868,ctrl
diaphram muscle,pert
U2OS_siHic5_2_2h,pert
Strain: FVB;	Genotype: MMTV-iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated (0 hour),ctrl
"Brain tissue from Fisher 344 male rat, Animal #259, 50mg/kg D-Serine",pert
EA_Control_CD8,ctrl
B6_Pseudomonas_overexpressor_48,pert
chip number: 21;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.2;	transfection date: 2012-03-26,pert
protocol: NGN1 overexpression;	cells: Neural Neural Stem Cell Line F3,pert
cell line: SCOV3,pert
hippocampal tissue from heterozygous p300 mice,pert
"Gift Prof Dr Sandra Nuyts (University Hospital Leuven, Leuven, Belgium)",ctrl
T37,pert
"cerebellum,12weeks,KO",pert
NFIA E18KO1,pert
A YOKE_B027,pert
gender: Male;	cell type: hESC H1 cells;	genotype/variation: wt,ctrl
Mouse spleen at 1 month,pert
cultured skin fibroblasts from control subjects,ctrl
gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7,ctrl
"breast tumor, Cyp27b1 knockout",pert
MLL_00118,ctrl
subject id: 34;	infection: DENV;	status: DHF;	tissue: whole blood,pert
HeLa cells transiently transfected with a Stau1 siRNA.,pert
"Control #4, Untreated",ctrl
16A;pretreatment;female;breast tumor,ctrl
tissue: skin;	individual: Patient P1;	condition: AL;	eczema severity: SCORAD: 36,pert
age	55;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	25.8;	leukocyte count (/nl)	206;	hemoglobin (g/dl)	10.1;	platelet count (/nl)	331,pert
8 wk old male C57BL10 TA,ctrl
ventricular tissue,pert
PBMCs from normal control subject C,ctrl
"Sham NALT (PBS), biological replicate 3",ctrl
Heart left ventricle,pert
strain: C57BL/6;	tissue: Spleen;	genotype: WT,ctrl
HEK293 cell line #4 with uninduced HNF1alpha,ctrl
"25B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
sample: #11;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
"lymphoblastoid cell line from F6.06, one out of seven of sensitive group, 50*10e6 cells",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day4,pert
genotype/variation: Cbx2_KO_XX;	tissue: gonads;	age: E11.5,pert
CD4+/CD25- T effector cells 72h after activation,ctrl
transfected with pSuper-shMTDH,pert
con-9,ctrl
CTL made from PDK1fl/fl TamoxCre splenocytes and treated with 4OHT,pert
patient id: 42;	tissue: Normal cortex;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L003,pert
"CA2, SOX17 expressing HESC - clone1",pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: male,pert
HMEC_50,pert
cell line: HL60;	disease state: promyelocytic leukemia,pert
EE_IC_2_amind_lcm,pert
PDE1C siRNA treated for 10 days,pert
"8 weeks old sex age matched littermates, lung typeII cells",ctrl
Dorsal Skin_Lox_Control,ctrl
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",ctrl
disease state:NHM;,ctrl
tissue: Biceps muscle;	patient: C.b.6;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Peripheral blood mononuclear cells;	TTF=110min;	Race=White;	Sex=Male,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 59.3726,pert
PBMC from T cell Large granular lymphocyte leukemia patient#106,pert
Postmenopausal female. Estradiol treated. Patient 13.,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 39;	maternal age: 33,ctrl
Strain: 129Sv (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
chip number: 16;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.57;	rin: 9.5;	transfection date: 2012-03-26,pert
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: yes,ctrl
nasopharynx,ctrl
Gender: Male;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
Gender: male;	Source tissue: foreskin,ctrl
"Control #5, Untreated",ctrl
tissue: Peripheral blood;	disease status: patient with recurrent events,pert
Control liver sample 2,ctrl
myotubes from control subject,ctrl
KO PGC rep1,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 44;	Usage number: 1;	Exposures: 3,pert
A7,pert
cell line: A2058;	treatment: CT16 siRNA,pert
chip number: 16;	transfection plate: 5;	target gene: TAF1;	kd level: 0.68;	rin: 9.4;	transfection date: 2011-10-17,pert
"new born PS-NA mice, cerebellum",pert
Ovarian Cancer xenograft,pert
genotype: Villin-Claudin-2 transgenic (Cl-2TG);	cell type: colon epithelial cells;	gender: male;	treatment: water,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 7 (STAG2 deficient),pert
Murine Hippocampus,pert
braak stage: BR12;	rin: 71;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
RV64.02_CONTROL_day25,ctrl
Gata4LoxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
SUM149 cells transfected with siRNA targeting TIG1 (NM_002888),pert
CEM-C1 cells treated with 10 nM rapmycin for 3 hours,pert
"Patient  O, lesion, 4 week",pert
gender: Male;	tissue: Tendon;Biceps;	age: 50;	donor: 24;	disease state: Non-lesional,ctrl
"SBC-5 cells, siEGR4 (target), 72 hr after siRNA, duplicate sample 2",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 3,ctrl
T-ALL cell line,ctrl
"cirrhotic liver, antiangiogenic treatment",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 80min;	race: White;	sex: Female,ctrl
cell line: SKBR3 parental;	treatment: basal conditions,ctrl
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"genotype/variation: Brg1_cKO1;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",pert
chip number: 19;	transfection plate: 4;	target gene: IRF3;	kd level: 0.9;	rin: 9.2;	transfection date: 2011-10-17,pert
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,pert
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 0 h;	genetic background: C57BL\6",pert
Cav3 knockout,pert
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,pert
HepG2 cells,pert
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: LITAF-specific siRNA,pert
"twin pair: #12;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
knockdown: estrogen receptor alpha KD;	cell line: MCF7,pert
cell line: U251;	transduction: stably expressing shRNA against cyclophilin B,pert
Control liver sample 1,ctrl
Calf muscle complex,ctrl
strain: C57Bl/6;	genotype: AIRE ko;	treatment: Freshly isolated cells,pert
HepG2,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 132;	genotype/variation: WT;	age: 8 weeks,ctrl
Strain: C57BL/6: PGC1beta mutant; Tissue: liver,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 52;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
lung fibroblasts,ctrl
"white adipose tissue, KSR2-/-",pert
braak stage: BR56;	rin: 81;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 5,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#115,pert
Uninvolved lung tissue sample from lung cancer patient,ctrl
Directly ex vivo brain CD8 T cells,ctrl
HUVEC,ctrl
non-transgenic,ctrl
no_22,ctrl
sampleID: SAM630137;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
S1A Sporadic-frontal,ctrl
cell line: LICR HN1;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-2,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
Array Type: HG-U133A_2;	Ratio: 1.99;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Mouse liver (8 weeks),pert
"jejunum, GATA4 mutant, 1",pert
"45B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Human prostate tumor,pert
"Brain tissue from Fisher 344 male rat, Animal #248, 500mg/kg D-Serine",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,pert
chip number: 9;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.2;	transfection date: 2011-03-29,pert
cell line: LICR HN1;	treatment: PBS,ctrl
Diagnosis: AML M5;	Age: 69y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379004;	hybridization batch: V,ctrl
"Human Umbilical Vein Endothelial Cell, TSA (500nM, 24h, Sigma)",pert
"Fibroblasts from normal histology lung tissue, NL-7",ctrl
"HSCs from female mice treated with E2, replicate 1",pert
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	Wild type,ctrl
"PMVEC isolated from mice carrying TetO7-Bmpr2-R899X, immortomouse and Rosa26-rtTA transgenes",pert
aortic biopsy,ctrl
Mouse female ES cells PGK12.1 after double RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-2 in PGK12.1.,ctrl
Liver wildtype HFD,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 5",ctrl
CDK9 Knock Down,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 32.96164,ctrl
background mouse strain: C57BL/6;	source: liver;	genotype: wildtype,ctrl
Total RNA from bone marrow derived macrophage from C3H/ARC mice,ctrl
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 34;	maternal age: 37,pert
tissue: adipose tissue;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
Age: 45;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
Whole testis RNA from WT mouse #145 at 0h,ctrl
344SQ with PIK3CA shRNA,pert
cell type: embryonic stem cells [E14];	transfected with: siRNA targeting the pCIP proteins,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1957998117;	hybridization batch: I,pert
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: A;	experimental sample name: PC1-R,ctrl
"Male, 42 years old",ctrl
EPLM,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 214,pert
U2OS control shRNA_pLenti,ctrl
Patient 19 appendix,pert
"SR-A mutant, 6 weeks old",pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,pert
HEK293_hCdc73siRNASparse_rep1,pert
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
age: 14dpp;	genotype/variation: wild type;	tissue: testis,ctrl
TG mouse_left ventricle_tamoxifen treated_1,pert
control participant P302 (human CD3 positive T cells),ctrl
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Vehicle,ctrl
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,ctrl
Age: 49;	Sex: F;	Ancestry: European;	Smoking status: non-smoker,ctrl
"20B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Human CD34+ cord blood cells expressing ZMYM2/FGFR1,pert
tissue: lesional skin;	urticaria status: affected;	patient: 3,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 29;	maternal age: 33,pert
Wt,pert
A SIT_B098,pert
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg KO,pert
"Patient CV, stable renal transplant recipients, male, 58 years old, T1 (3 months after the switching of the therapy)",pert
Control 25 appendix,ctrl
mutant 14-3-3 ko/ko inbred,pert
agent: EFNA4-Fc conjugate;	time: 24h,pert
condition: Psoriasis;	patient: PS-K;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 3;	psoriasis duration: 8.89390828199863;	age of psoriasis onset: 38,pert
patient: 12;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
cell line: U87MG;	treatment: siRNA against CASP2,pert
ATP-treated AML blasts,pert
gender: Female;	tissue: Tendon;Teres minor;	age: 46;	donor: 32;	disease state: Non-lesional,ctrl
PancreaticSample15-Normal,ctrl
RV16;	Age = 18;	Sex = F,pert
"DHL6, R406, 24h",pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,pert
Synovium_SynoAcAr,pert
Mouse embryonic stem cell line E14,pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
"MaF pre-iPSC9P2, Vc treated, lysed on D5",pert
"Control, replicate 1",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 mins,pert
disease state: control;	patient: 32,ctrl
cell type: Endothelial cells,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: control,ctrl
MDA-MB-231 cells transfected with SDC1-siRNA,pert
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5+/+; Pten-/-;PB-Cre4,ctrl
64A;pretreatment;female;breast tumor,ctrl
rat distal colon,pert
PBMCs enriched for CD8+ cells from normal control subject C,ctrl
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,ctrl
tissue: skin;	individual: Patient P5;	condition: AL;	eczema severity: SCORAD: 57,pert
"SiRNA-scrambled, replicate 3",ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 102;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E14.5;	tissue: kidney,pert
"liver RNA, wt mouse",ctrl
X50 NLS 18Q TG1	F2/34	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
"BMDM, not treated, KO Vdr -/-",pert
age	52;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	4.4;	leukocyte count (/nl)	30.5;	hemoglobin (g/dl)	12.8;	platelet count (/nl)	359,pert
hRPE cells 24h post-infection with WNV,pert
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cell line: HEK293 cells WTX inducible clone F5;	agent: control,pert
Primary chondrocytes;Mir140 KO; total RNA,pert
disease state: Healthy;	cell type: CD4+T;	twin: T,ctrl
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
"HMEC-TR, SiRNA scramble",ctrl
"Embryonic stem cells, Vitamin C treated",pert
"jejunum, control, 3",ctrl
"t01, surgically resected from patient of gastric cancer.",pert
"A pool of RNA from lung from three male mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks; mice are 12 weeks old when sac'd.",pert
PBMC from T cell Large granular lymphocyte leukemia patient#116,pert
strain: C57BL/6;	genotype: wildtype;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,ctrl
cell line: prostate cancer cell line DU145;	genotype/variation: MYB siRNA,pert
"ONS76, mock control",ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 5;	peasi reduction [%]: 0,pert
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
"DMSO-treated, sham UV exposed",pert
LOX1_Untreated_2hr,pert
age: 13.5 day;	strain: 129;	genotype/variation: wild type,ctrl
"Age: 46;	Sex: M;	Ancestry: European;	Smoking status: smoker, 21 pack-years",pert
patient: 40656;	sample: tumor,pert
N5B Normal-cerebelum,ctrl
gender: Male;	tissue: Tendon;ECRL;	age: 52;	donor: 30;	disease state: Non-lesional,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 52;	gender: male;	tumor grade: IV,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 22;	maternal age: 23,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: White;	sex: Female,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.748;	OD280: 0.861;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 76;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Kidney HEK293 cells,pert
Age: 43;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
HEK293 cell line #1 with uninduced HNF1beta,ctrl
cultured human melanoma cancer cell BL,ctrl
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Gastrocnemius muscle from PPARalpha overexpressing mouse,pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
"mouse lung, tamoxifen-treated Tmem1002loxP/2loxp",ctrl
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 59;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 2,pert
Septic shock;	gender: Male;	Non survivor;	organism: Neisseria,pert
"fetal sex: female;	karyotype: 45,X",pert
wild-type naïve CD8 T cells,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 2",pert
infection: 2009 pandemic H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
patient skin sample-Normal Skin,ctrl
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.51;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 15000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
EB_6_5d_297_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Semitendinosus Muscle, Control",ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 I312R mutant,pert
"cell line: hgps-fib_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
cell line: MH1C1,ctrl
double mutant,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.98;	RNA Integrity Number: 8.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 48;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
N11A Normal-frontal,ctrl
primary chondrocytes treated,pert
Diagnosis: AML M5;	Age: 41y ;	Gender: Male;	Blast %: 90;	Source: BM;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.14;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
patient E1507,ctrl
"Ishikawa cell line, BPA, 10nM, 48hr",pert
gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1,pert
Genotype: Mdr2-KO homozygous mouse;	Age: 12 month,pert
RNA from whole tissue section of case 1419 labeled with Cy5,ctrl
Whole adrenal RNA from WT mouse #147 at 0h,ctrl
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,ctrl
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_2,pert
Pooled litter samples were collected 24 hrs after the final compound dose.,pert
adrenal gland,ctrl
WT Liver - Pooled -Cy5,pert
Age: 38;	Sex: M;	Ancestry: Hispanic;	Smoking status: non-smoker,ctrl
E2F3 Heterozygous,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,ctrl
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: EtOH,ctrl
Retina of 4 month old RPE65 -/- mouse,pert
pancreatic cancer cell line MiaPaCa2 stabley transfected with empty vector pCEP4,ctrl
age	29;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	7.3;	hemoglobin (g/dl)	12.9;	platelet count (/nl)	257,ctrl
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,ctrl
Strain: CBA,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
primary normal lung tissue 1473,ctrl
race: caucasian;	age (years): 59;	stage: IB;	grade: 2;	histology: endometrioid,pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
E18.5 Top2b+/+ brain,ctrl
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,ctrl
S2A Sporadic-frontal,ctrl
"Cultured ovarian cancer cell line OV90, Cisplatin treated",pert
quadriceps_muscle_Akt1+/-_female_8wk_rep1,pert
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
bone-marrow-derived macrophages,pert
N7B Normal-cerebellum,ctrl
Colo-205 cell line,ctrl
strain background: C57BL/6;	gender: female;	genotype/variation: Mut -/- ;TgINS-Alb-Mut (MMA mutant);	tissue: kidney;	diet: high protein diet for 2 months,pert
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
chip number: 19;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.87;	rin: 9.2;	transfection date: 2011-10-17,pert
cardiac syngraft,ctrl
strain background: C57BL/6J;	genotype/variation: WT;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days adipocyte differentiation,pert
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
PancreaticSample22-Tumor,pert
A549 cultured cell,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.04;	OD280: 1.071;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 131;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: Myc-depleted,pert
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 48h,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.450;	Ratio: 2.11,ctrl
disease state: healthy control;	tissue: epidermis;	age: 73;	gender: female;	treatment: untreated;	time: control,ctrl
HCC tumor,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: phenobarbitol,pert
cell line: SK-N-SH;	lentivirus isoform: e1;	lentivirus: WT,pert
"patient 16, right arm treated with pimecrolimus until day 22",pert
Liver_PXR KO_Vehicle,pert
112 Day Mouse leg muscle,ctrl
strain: C57/BL6;	genotype/variation: NEMO knockout (NemoΔhepa);	gender: male;	age: 8-9 weeks;	tissue: liver,pert
Healthy-1 baseline,ctrl
HLA risk: Medium;	Height: 167 cm;	Weight: 65 kg;	BMI: 23.3;	Age: 33.7 years;	Gender: Male;	Race: Asian;	Glucose: 85 mg/dl;	HbA1c: NA,ctrl
Time of Surgery:Pre;,pert
C5_CLP_overexpressor_12,pert
"Mdr2-KO homozygous mouse, 12 month old mouse, liver sample",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp3,pert
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,pert
"seminoma specimen, pT1, patient age: 38y",pert
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 8 months;	tissue: liver;	disease status: hepatocellular carcinoma,pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 65min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 242,pert
tissue: Temporal cortex;	age: 82;	Sex: M,ctrl
race: american indian;	age (years): 60;	stage: IC;	grade: 2;	histology: endometrioid,pert
INS-1 cell line #3b with non-induced HNF1b mutant A263insGG,ctrl
"Control at ZT6, retina",ctrl
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + morphine,pert
"5B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
B_cell_pool_melanoma_M09+M10,pert
WT 2 1509,ctrl
"HepG2 cells; (HB-8065; ATCC, Manassas, VA)",ctrl
231/ARF-4_2,pert
HEK293 cells + BAHD1 siRNA 72h,pert
cell line: Mc3T3-E1;	cell type: osteoblastic cells;	treated with: 50µg of Ascorbic Acid (AA) for 5 days,pert
Mouse heart at 6-weeks old,ctrl
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 overexpression,ctrl
Gender: Male;	Age: 32;	Ethnicity: Hispanic,pert
PDAC_T_105,pert
Tendon;ECRB_Non-lesional,ctrl
Strain: C57BL/6; PGC1beta mutant; Tissue: liver,pert
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: Wild type,ctrl
"Wild type,pancreas",ctrl
colon,ctrl
chip number: 11;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.6;	transfection date: 2012-03-26,pert
MCF10A 5days,ctrl
subject: 40;	disease: CP;	muscle: GR;	gender: M;	age: 10.1;	gmfcs: 2;	popliteal angle: 120,pert
"Adult mouse, C57black background, left ventricle of heart",pert
"Reh, transient expression of IKKb(EE)",pert
human thyroid,ctrl
treatment: 0.1 μM CDKI-73 for 4h;	cell type: CLL B-cells,pert
Total RNA from bone marrow derived macrophage from C3H/HeJ mice,ctrl
untrained plakoglobin (+/-),pert
EpiAdip GPR120KO ND,pert
Mouse embryonic fibroblasts (MEFs),ctrl
"Transgenic, snap frozen, extensor digitorum longus muscle, 7 month age animal",pert
patient: 19;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Human squamous cell lung cancer cells,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 8 weeks;	Tissue: whole brain,pert
ONH severe glaucoma,pert
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/+,ctrl
strain: 2nd Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Ptenloxp/loxp,pert
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with vehicle for 6h,ctrl
Total RNA from LM2 cells labeled with Cyanine-5 (red).,pert
RNA from whole tissue section of case 633 labeled with Cy5,pert
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA)",pert
gender: M;	age at blood draw: 48;	tissue: whole blood,pert
chip number: 22;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.84;	rin: 9.5;	transfection date: 2012-03-26,pert
3T3-L1 20uM pioglitazone,pert
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"ID:14-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
HOX424 Carbo Day1,pert
strain: 116;	Disorder: normal;	Condition: no hydrocortisone,ctrl
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: scrambled siRNA,ctrl
iFGFR1 mammary gland 24 hr solvent,pert
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",ctrl
"Quadricpes muscle, PGC1beta mutant mouse",pert
EB_6_24h_292_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Age: 46;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 1",ctrl
HGPS-iPSC_2,pert
LT-HSCs of control mouse,ctrl
"C3_transgenic but unaltered, lung tissue",pert
Total skin,ctrl
COV434,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 38;	Sex: male;	region: M1;	age: 47;	genotype: Y/X;G42/-,ctrl
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 53;	age-at-onset: 45;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"Gift Prof Dr Sandra Nuyts (University Hospital Leuven, Leuven, Belgium)",pert
"gender: Female;	age: 54;	post-mortem delay: 4h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 38;	gender: f;	treatment: -,pert
Mild asthma,pert
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of wild type mice brains,ctrl
INS-1 cell line #2 with induced HNF6,pert
age: 63;	gender: male,pert
Cbx2_KO_XX gonads at E11.5,ctrl
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 7;	Duration of illness (years): 23;	Brain pH: 5.8;	Post mortem interval (hours): 56;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
biopsy specimen,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shCHK1-3,pert
PBMC from Rhesus Macaque,ctrl
scc_14,pert
homozygous_TGFb_24hr_1,pert
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),pert
Brain hemisphere,ctrl
HL-60 cells treated for 24h with 10 nM TCDD,pert
Gender: Female;	AJCC Stage: I;	Pathological T: 1;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
Lacrimal Gland,ctrl
Tsc1-deficient CD4 naïve cells,pert
strain: C57BL/6;	genotype/variation: Zmpste24-/-;	cell type: mouse embryonic fibroblasts,pert
"twin pair: #8;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.999;	Ratio: 2.12,pert
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
"LCL GM19238, Kd IRF9, 72hrs",pert
Subconfluent RBP2-/- primary mouse embryonic fibroblasts at passage 3.,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Tip60,pert
RNA from microdissected breast cancer cells from case 648 labeled with Cy5,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: luciferase shRNA,ctrl
"Cell type: endothelial, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
RNA from whole tissue section of case 518 labeled with Cy5,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 21,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 25;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Age: 44;	Sex: F;	Ancestry: European;	Smoking status: smoker, 30 pack-years",pert
RNA from whole tissue section of case 25 labeled with Cy5,pert
condition: Normal;	patient: N_LJ_9;	tissue: Normal skin biopsy;	kit: Affy,ctrl
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 32;	maternal age: 33,pert
H1299,ctrl
Regulatory T-cells CD4+CD25+,pert
age: 67;	gender: male;	ejection fraction: 43;	left ventricular end diastolic diameter: 59;	inflammation/PVB19: positive,pert
"Diabetic mice, time point 3 week",pert
tissue: Hippocampus;	age: 80;	Sex: F,ctrl
DU145 + Medi5117,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.53;	age of onset: 25 yr,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 26;	gender: male,pert
Striatum of 8-10 week old SWR/J mice,ctrl
Prostate cancer cell line,ctrl
Post Transduction:24 hr; treatment:Mut;,pert
WHOLE BRAIN,pert
Olfactory mucosa,ctrl
Sex: male;	Age: 7;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",pert
KO PGC rep2,pert
Tet1 shRNA-transfected ES cells in ES cell culture,pert
male;	38 yr old;	White,ctrl
"EtOH treated, Vehicle",ctrl
"frontal cortex, healthy control",ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
INS-1 cell line (parental),ctrl
race: african american;	age (years): 72;	stage: IC;	grade: 2;	histology: endometrioid,pert
temporal lobe,ctrl
Retina RNA,pert
RNA from MLL1-KO MEF (18h after serum shock),pert
NL_cauc_lcm,ctrl
Human skeletal muscle biopsy sample;	Patient #176 with NORM,ctrl
JoMa1-MYCN-induced tumor,pert
wild type oocyte,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: other,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 50 yr;	population: white;	dsm-iv: 295.3;	age of onset: 31 yr,pert
cell line: A2780;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
112 Day Mouse Diaphragm muscle,ctrl
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 18;	dfs-event: 1;	distant metastasis: 1",pert
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,ctrl
"twin pair: #3;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
Treated with 25uM Zinc for 4 hrs -- replicate #2,pert
B-CLL PB P255,pert
chip number: 11;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
tissue: Frontal cortex;	age: 83;	Sex: M,pert
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD4+ T-cells,ctrl
"Whole blood - Autism no regression, Female",pert
"SKO-transduced MEFs, Vc treated, lysed on D4",pert
treatment: naïve;	transgenic variant: AChE-R;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
cell line: MCF-7;	expression: BP1-overexpressor,pert
microdissected epithelial cells from IPMC 4,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Asian;	sex: Male,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p30;	strain: E14,pert
race: caucasian;	age (years): 55;	stage: IB;	grade: 2;	histology: endometrioid,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 3",ctrl
liver_WT,ctrl
GC resistant clone C7H2-R19E7 treated for 6 hours with EtOH,ctrl
"46, XY",ctrl
Ada3FL/FL MEFs_control adenovirus,ctrl
T149,pert
"Epidermal keratinocytes untreated control, 48h",ctrl
Dumbo retina at P15,pert
agent: EFNA4-Fc conjugate;	time: 48h,pert
"liver, genetic control, Nrf1(dN/+)",ctrl
"liver, LDLr-KO",ctrl
DA rat stomach control,ctrl
"Lymphoblastoid cell lines derived from family 1736, member 2",pert
11_2_MOE_430A_HO,pert
A375P cells expressing Control shGFP,ctrl
Gadd45a knockout embryo MEF cells,pert
cell line: Normal bone cell line 1705;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
in vitro differentiated DCs,ctrl
"fetal testis sample 25, 20 weeks gestation",ctrl
CON-2-PLASTIC,pert
sampleID: SAM630138;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
PBMC CCo T1,pert
cell line: HCT116 Human colon cancer;	shRNA expressing: NFX1-91,pert
gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
murine total uterus,pert
"SWR/J Chronic morphine treated, biological replicate 3",pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: n/a,ctrl
tissue: bone marrow;	genotype: E2A-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
pooled reference mRNA from 4 harvests of ZR-75-1 cells,ctrl
strain: C57BL/6J;	cell type: MEP;	genotype/varation: wildtype,ctrl
Primary neonatal keratinocytes,ctrl
T38,pert
9_5_MOE_430A_HO,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 46;	sex: M,ctrl
3 h-apra-10 nM,pert
dental pulp cells obtained from milk teeth,ctrl
EB_6_6h_284_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
MCF7 cells that were transfected by siRNA targeting estrogen receptor alpha (ESR1).,pert
transfection: CDK19-1;	cell line: HeLa S3,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 1,ctrl
total RNA,ctrl
quadriceps_muscle_Wt_female_35wk_rep2,ctrl
tissue: sciatic nerve;	age: 2 months;	genotype: MPZ-Tfam KO,pert
transfection: CDK19-2;	cell line: HeLa S3,pert
CD4_T_cell_pool_healthy_H01+H02,ctrl
chip number: 19;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.59;	rin: 9.6;	transfection date: 2012-03-26,pert
condition: Psoriasis;	patient: PS-I;	tissue: LS skin biopsy;	kit: Affy,pert
Peripheral Mononuclear Blood Cells,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 6 hr,pert
RNA from microdissected breast cancer cells from case 638 labeled with Cy5,ctrl
"MCF7/BUS cells, human breast adenocarcinoma cell line, estrogen receptor-positive",ctrl
Cirrhotic_Liver_Kidney,pert
human_hepatocyte_vehicle_24hr,ctrl
"Cultured ovarian cancer cell line CH1, untreated",ctrl
"Total RNA, WT LSK",ctrl
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
strain: FVB/NHsd;	tissue type: back skin,ctrl
obtained from RIKEN CELL BANK,ctrl
Control;	Survivor;	gender: Female,ctrl
Oral Squamous cell Epithelium Tissue,pert
treatment: Vehicle;	time: 7,ctrl
"MaF pre-iPSC9P2, Vc treated, lysed on D4",pert
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: shJMJD3-expressing,pert
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate to poor;	Tumor Site: Descending;	Drug Treatment: YES,pert
"Patient  M, lesion, 2 week",pert
"Patient  I, lesion, time: 0",ctrl
wildtype murine HSCs,ctrl
"metastasis: none;	Stage: 2b;	tissue: normal, homogenized",ctrl
Insm1 control #7_pituitary gland,ctrl
RNA from whole tissue section of case 655 labeled with Cy5,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 28;	gender: male,pert
cell type: LSK;	tissue: hematopoietic stem cell enriched fraction from bone marrow,pert
231/ARF-4_3,pert
"DU145, Untreated",ctrl
Primary hepatocytes isolated from SV129 mouse strain treated with Wy14643 for 24h,pert
CML cell line: JURL-MK1,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 36;	maternal age: 30,pert
Embryoid body formation (10 days) of empty vector transduced embryonic stem cells (CCE ES cells).,ctrl
mouse intestine pLagl2 knockout 4,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 206,ctrl
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.6;	Post mortem interval (hours): 27;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
HCC_6N,ctrl
acne skin sample,pert
E8.5 embryo proper,pert
HCC_22T,pert
Lung Tissue,pert
race: caucasian;	age (years): 62;	stage: IB;	grade: 2;	histology: endometrioid,pert
P32_exPKO_pancreas,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 38 yr;	population: white,ctrl
RV16;	Age = 21;	Sex = M,pert
G with Cy5,ctrl
M AA S45P,pert
Mouse Megakaryocytes,ctrl
MLL_00116,ctrl
cell line: Calu-3;	cell type: airway epithelia cells,ctrl
patient: 26;	disease state: hypertension;	tissue: Atheroma plaque,pert
CON-3-PLASTIC,ctrl
H157 siCTL1,ctrl
"Ishikawa cell line, BPA, 1uM, 24hr",pert
Cortex,pert
tissue: freshly isolated human monocyte;	gender:male; age: 41 yr; weight: 92 kg,ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 knock-out;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
Gender: Male;	Age: 25;	Ethnicity: Black,ctrl
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO (PGC-1b expression is unaffected),ctrl
PancreaticSample14-Tumor,pert
Heart sample5,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",ctrl
At Risk: +;	Age: 9;	Sex: F,pert
"Spleen homogenate, infected, 4 weeks",pert
patient: 30057;	sample: tumor,pert
"cerebellum,12weeks,WT",ctrl
Lung tissue from male Ifitm1-deficient mice,pert
Cav1KO 1761,pert
race: unknown;	age (years): 64;	stage: IB;	grade: 2;	histology: endometrioid,pert
disease state: Chronic hepatitis B;	cell type: Peripheral blood mononuclear cells,pert
disease state: paediatric glioblastoma;	age: 14;	gender: M;	h3.3_status: wt,ctrl
A HID U_B049,pert
mouse hippocampus,pert
MDA-MB-231_TR30003,ctrl
status: Control;	gender: Female;	age: 51;	tissue: Blood,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 29;	gender: male,ctrl
wild type 2 cell embryo rep1,ctrl
tissue: Peripheral blood;	disease status: normal control,ctrl
strain: mixed C57BL6;	genotype/variation: TSC1flox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
tissue: retina;	age: postnatal day 6;	genotype: rd1,pert
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 4h",pert
Gender:F;	Age:42;	Tissue: Mucosa,ctrl
Scrambled 12 hours_1,ctrl
Diagnosis: AML M1;	Age: 64y ;	Gender: Male;	Blast %: 93;	Source: PB;	Cyto: t(2;12)del16;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
PC12 line PFR3K650E,pert
female,ctrl
T130,pert
RNA from whole tissue section of case 1085 labeled with Cy5,pert
genotype/variation: WT;	cell type: pancreatic cells,ctrl
"MCF7 cells, SIN3A silenced, LIF 1h",pert
WT BM LT-HSC,ctrl
Retina no or early glaucoma,pert
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 217,pert
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,ctrl
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
patient id: T163;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
HCC_24N,ctrl
cell line: HTB-58;	gender: male;	age: 65 years;	race: Caucasian;	disease: squamous cell carcinoma of the lung;	sirna: anti-Evi1,pert
Eed KO J1 ESCs on day 0,pert
"Tumor sample from patient with p53 mutant, replicate 2",pert
Primary hepatocytes isolated from DBA mouse strain treated with DMSO for 24h,ctrl
18A;pretreatment;female;breast tumor,ctrl
Gender:M;	Age:22;	Tissue: Mucosa,pert
MelJuSo cell line,pert
tissue: adipose tissue;	sample group: placebo;	treatment: before;	gender: Female,ctrl
subject id: c8;	infection: control;	status: control;	tissue: whole blood,ctrl
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,ctrl
Human skeletal muscle,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
A VIS _B067,pert
FoxO deficient LSK,pert
phenotype: control;	gender: male;	case_id: 282;	age: 82;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.24;	labeling_batch: 1,ctrl
genotype/variation: Cbx2_KO_XY;	tissue: gonads;	age: E11.5,pert
"MCF-10A cells, overexpression ΔNp63α",pert
sample type: HeLa-Ctrl-siRNA-3d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 50;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-2α knockdown;	cell subtype: 10 days old tumor spheroids,pert
Control subject,ctrl
HCC_26N,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 6 months,pert
disease state: control;	patient: 25,ctrl
"Trim28 conditional KO mice Treg cell, replicate 4",pert
CONTROL;	Age = 21;	Sex = M,ctrl
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 3 in vitro effector CD8+ T cells,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 50.98904,pert
E14Tg2a ES Cells,ctrl
Peripheral blood mononuclear cells;	TTF=90min;	Race=White;	Sex=Male,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
tissue: Temporal cortex;	age: 77;	Sex: F,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
Littermate Control,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 41;	maternal age: 40,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic",pert
patient: 6;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Intermediate-CORT (ADX),pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: C,pert
primary cell culture,pert
phenotype: alcoholic;	gender: female;	case_id: 285;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 68;	brain ph at time of freezing: 6.3;	labeling_batch: 2,pert
C with Cy5,ctrl
"C26, whole gastrocnemius",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
cell line: H1299;	agent: azacitidine;	dose: 1 uM,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,pert
Aorta from ApoE-/- RAGE -/- mouse with diabetes sacrificed at 9 weeks.,pert
"gender: Male;	age: 91;	post-mortem delay: 4.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Pooled litter samples were collected 24 hrs after the final compound dose.,ctrl
482 cells scrambledshRNA rep3,ctrl
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: liver",pert
cell type: monocyte;	disease state: heterozygote FH,pert
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24720,ctrl
"LCL GM19238, Kd TAF1, 72hrs",pert
HSF1+/+ T cells activated at 37oC,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 4 weeks post infection 20 cercariae,pert
sex: Female;	family: 1;	age: 41;	disease status: Control;	tissue: Muscle: Biceps,ctrl
"t04, surgically resected from patient of gastric cancer.",pert
genotype variation: Nrf-/-;	treatment: air;	developmental stage: neonate,pert
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-14;	Primary Site:Floor of mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",ctrl
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,ctrl
Genotype: HDAC1 knock out;	not differentiated,pert
ref,ctrl
Insm1 control #3_pituitary gland,ctrl
strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 8 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
"NeuroD1 cKO at ZT20, pineal gland",pert
HUVEC culture,ctrl
"Patient  M, lesion, 4 week",pert
MPM tumor specimen 38,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 4",ctrl
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",ctrl
cRNA;	postnatal day 16;	WT,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
visceral_fat_Wt_female_8wk_rep2,ctrl
short-hairpin rna: shControl;	cell line: HCT116,ctrl
lung,ctrl
uterus - Mid secretory endometrium from normal patient,ctrl
tissue: small intestine;	genotype/variation: wildtype,ctrl
"suprarenal aorta, control, saline treated 7d",ctrl
Whole testis RNA from Crem-/- mouse #77 at 0h,pert
"human whole blood, PAXgene",pert
Rat Hippocampus,ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2+dox,pert
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1mi;	er: 1;	pgr: NA;	dfs-month: 8;	dfs-event: 0;	distant metastasis: 0",pert
"cell line: prostate cancer, PPC1",pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
S6_Sham_wildtype_12,ctrl
cell line: MLL-AF9 AML cell line 10977 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
strain: Myd88 KO;	age: 4 month;	gender: N/A;	weight: 25-30g;	tissue: whole trachea,pert
mouse: 1;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
chip number: 8;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-03-29,pert
mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
KO_lung_PBS_control,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 3h,pert
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD  TYPE",ctrl
heart,pert
2i/LIF maintained Usp-22 depleted Embryonic Stem Cell,pert
tissue: prefrontal cortex from adult APLP2 knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
genotype/variation: wt;	age: P8;	tissue: Whole eye,ctrl
Synovial fluid macrophages,pert
"Wildtype mouse, liver",ctrl
18h fasted hearts,pert
"Fibroblasts from normal histology lung tissue, NL-5",ctrl
tissue: lung;	genotype: knock out,pert
cell line: HT29RC PLX4720 resistant cell line;	cell type: colon cancer,pert
"Patient  F, lesion, time: 0",ctrl
MMTV-neu mouse mammary tumor,pert
MCF-10A_shCHK2-1,pert
PancreaticSample30-Tumor,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.15;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
CTL made from wild type splenocytes and treated with AktI,pert
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Non-Down syndrome",ctrl
fetal liver with p38alpha knock out,pert
Strain: a mixed C57BL6/129 genetic background,pert
genotype: Tsc1-deficient;	cell type: CD4 naive cells;	genetic background: C57BL\6,pert
strain: Mixed;	genotype/variation: Nrf1 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
"Wild type, snap frozen, extensor digitorum longus muscle, 7month age animal",ctrl
"Mkl2-/-, embryonic stem cells",pert
Tissue:tumor; Gender:female; Age:48  Tumor stage:T3N1bMx,pert
"genotype Cldn16 +/-, renal tissue",pert
A375 melanoma cells treated with vehicle (0.1% DMSO),ctrl
HLA risk: Low;	Height: 147.2 cm;	Weight: 35.2 kg;	BMI: 16.2;	Age: 11.45 years;	Gender: Female;	Race: White;	Glucose: 247 mg/dl;	HbA1c: 6.7%,pert
race: caucasian;	age (years): 45;	stage: IA;	grade: 1;	histology: endometrioid,pert
"5-FU-primed bone marrow mononuclear cells, control transduction",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp1,pert
"ME180 cells, DMSO-treated",ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle, Galgt2 Transgenic",pert
liver-AHRWT-cornoil,ctrl
esr1 genotype: WT;	agent: saline control;	time point: 24h;	strain: C57bl6/Jx129;	age: adult (10+ weeks);	gender: ovariectomized female;	tissue: uterus,ctrl
"Wild type,pancreas",pert
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB with doxycycline for 3 days,pert
"Male, Wistar, 0 access to cocaine, nucleus accumbens",ctrl
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 67",pert
patient id: 209;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 13,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.4411,pert
cell line: MDA-LM2-shTARBP2;	transfection: shZNF395,pert
EA_SLE_CD8,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N2,pert
Rat left ventricle,pert
c-Kit + MA9 AML Zfx wt,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.44;	age of onset: 18 yr,pert
Human squamous cell lung cancer cells,pert
"fetal testis sample 21, 16 weeks gestation",pert
terminal end buds from mice,pert
tissue: skin;	individual: Patient N-4;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
5091212024_E,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
tissue: Pancreas;	strain: C57BL/6;	genotype: wildtype;	age: 8 weeks,ctrl
"frontal cortex, bipolar disorder",pert
control peptide-treated CEM 100mM 16h,ctrl
tissue: liver;	genotype: IR flox/flox albumin:CRE +,pert
cell line: U937;	shRNA construct: GSK3B Construct 1,pert
"twin pair: #6;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
patient E1535,ctrl
LSK cells SRF KO 3,pert
treatment: RISC-free control transfected;	cell type: Primary cell line,ctrl
"BOEC, not_at_risk 3",pert
FcgKO Non stim 2,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#3,pert
H157 siDJ-1 #2,pert
Normal cervix epithelium_03-4216,ctrl
"Liver, untreated, rep2, knockout mouse",pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu1,pert
EB_15_6_338_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.1;	transfection date: 2011-10-17,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 24 hours,ctrl
RNA from microdissected breast cancer cells from case 1363 labeled with Cy5,ctrl
"Patient  O, lesion, time: 0",ctrl
RNA from WT MEF (18h after serum shock),ctrl
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,pert
Normal cervix_05-4615,ctrl
left lung lobe,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Frozen sarcoidosis lung tissue,pert
microdissected epithelial cells from IPMC 2,pert
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: control,ctrl
Murine Hippocampus,ctrl
Cervical cancer_1721T,pert
"Huh7 cells, JFH-1 Infected, 18 hours.",pert
chip number: 5;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 1;	Exposures: 3,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
race: caucasian;	age (years): 64;	stage: IA;	grade: 2;	histology: endometrioid,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 95;	Sex: male;	region: LC;	age: 41;	genotype: Y/Mecp2-;TH/-,pert
"WT, PE treated whole heart",ctrl
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).;	,ctrl
mouse adipose tissue,pert
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: scrambled siRNA (control),ctrl
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
CON-3-COLLAGEN,ctrl
siOGT 24 hours_2,pert
"Lymphoblastoid cell lines derived from family 1757, member 1",pert
"Cnr1-/-/Cnr2-/- female number 1, 2 months old, whole ear tissue, untreated control ear",pert
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Age: 45;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
HeTH-4  stable cell lines,ctrl
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.163;	OD280: 0.612;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 60;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
condition: Psoriasis;	patient: 287;	tissue: LS skin biopsy;	kit: Ovation,pert
MCF 7 cell line drug resistant cell subline,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 112;	genotype/variation: WT;	age: 8 weeks,ctrl
gender: Female;	age: 68;	post-mortem delay: 6h;	ph: 6.4,ctrl
cell line: LNCaP-abl;	transfection: siControl,ctrl
Normal Pleura 1,ctrl
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
visceral_fat_Akt1+/-_female_8wk_rep1,pert
TRAF3 deleted,pert
Wild type pancreas,ctrl
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D pancreatic ductal epithelial cells, P7;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+",ctrl
"liver, Nrf2 knockout, Nrf2(-/-)",pert
Hematopoietic Stem Cells,pert
"RNA from HnRNP A1 IPs, HuR WT MEFs",ctrl
disease state: Diamond-Blackfan anaemia;	gender: Male,pert
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
rectal suction specimens,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-WT cells, expression not induced",ctrl
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Gata4loxP/+VillinCre adult male jejunum (6-8 wk). Control sample.,ctrl
OSE4 cells,pert
inguinal fat,ctrl
CD34+ cells from the patient (CML33),ctrl
patient: 21;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
genotype: EFLmDREAM;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P8;	clone: 0,ctrl
human ccRCC cell line,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 59 days;	subject: Mouse1;	genetic background: BALB/c,pert
PBMC SE T1,pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: untreated,ctrl
Strain: B6SJL-G93A-SOD1;	Age: 75 day,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 55 yr;	population: white,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 0,ctrl
PC-3 human prostate cancer cell line,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
cell type: Embryonic Stem Cell;	genotype: Mkl2-/-;	strain: C57BL/6,pert
alveolar epithelial cell line exposed to cyclic stretch 20% elongation for 4hr,pert
Normal heart,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 11,pert
"BALB/c, Male, CF",pert
cell line: E14;	treatment: Usp22 depletion,pert
Gallbladder - leptin treated,ctrl
human MBC_empty vector overexpression,ctrl
Cardiac biventricle of Tamoxifen injected PGC-1a-/-bf/f/MerCre mouse,pert
Strain: FVB/N;	Genotype: SP-C-hCFTR+|+/mCftr+|+,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,pert
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 27;	sex: F,ctrl
UC Inflamed ascending colon,pert
3 ERRg HET E18.5 male cadiac ventricles,pert
3 h-control (EtOH),ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 37;	gender: male;	tumor grade: AII,pert
patient: 30364;	sample: normal,ctrl
patient: 51572;	sample: normal,ctrl
Differentiation of hES cells line SA01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
patient: 32054;	disease state: LGSC;	component: Borderline,ctrl
cell line: IOSE80pc;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
cell type: granulocytes;	group: Patient;	patient treatment: Mtx,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 159;	colon ratio (mg/mm): 2.741;	myeloperoxidase activity (u/mg): 0.442;	tissue: colon;	treatment: 5% DSS,pert
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: TOX3 Vector,pert
"coronary smooth muscle cells (hcaSMC), treated with nebivolol for 72 hours",pert
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,ctrl
3T3 cells from cyclin D1KO mice infected with MSCV-GFP control.,pert
sex: Female;	Age: 6 months;	additional patient information found in Series supplementary file,ctrl
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
short term cultures of epidermal keratinocytes,ctrl
EE_IA_2_cauc_lcm,pert
"liver, STZ-treated fed 0.5% quercetin diet for 14 days",pert
RV83.09_CHF_day10,pert
(ca)Raf_3,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 64,pert
clone type: AtT20 clone types infected with empty vector rep1,ctrl
tissue: dental pulp cells;	genotype: control;	passages: 6,ctrl
airway epithelial brushing,pert
Dot1l flox/flox day 3 after transduction with control,ctrl
Fertility Status: Infertile,pert
M24met melanoma cell-line,pert
Differentiation of hES cells line VUB01 towards MPC-like cells;	Mesenchymal stem cells phenotype,ctrl
mononuclear cells after Ficoll purification,ctrl
treatment group: untreated in parallel to cadmium treated cells;	cell line: TK6 cells,ctrl
E with Cy5,ctrl
genotype: Nf1Prx1;	tissue: triceps muscle;	age: 3 months,pert
Tendon;Flexor-Pronator_Non-lesional,ctrl
Endometrium-Normal 7,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 72h,ctrl
"MaF pre-iPSC9P2, Vc untreated, lysed on D6",ctrl
Colon,ctrl
Cy3: Human Common Reference,ctrl
total RNA,pert
Cochleae from wild type mice at P7,ctrl
Cervical cancer_56-04T,pert
gender: male;	age (years): 53;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
RNA from whole tissue section of case 749 labeled with Cy5,ctrl
Mouse lungs infected with Mtb for 63 days,pert
Gender:female,pert
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
T143,pert
mRNA from Gastric tissue,pert
AIRE ko CD80lo mTEC sample2,pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
race: caucasian;	age (years): 49;	stage: IA;	grade: 1;	histology: endometrioid,pert
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump",pert
tissue: white blood cells;	age: 13.33;	Sex: male,pert
"Cultured ovarian cancer cell line HeyA8, Cisplatin treated",pert
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: A,pert
treatment: BirA control;	cell line: J1 ES cells,ctrl
gender: female;	age (years): 63;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
CHF NYHA III-IV pts,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,ctrl
db/db mice,pert
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
treatment: scrambled vector;	cell line: Esophagus cell line OE33;	array id: 5617835005,ctrl
cell line: KYSE30;	cell type: squamous cell carcinoma,pert
GFP-transfected JoMa1,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 168;	fata: 71;	eea: 1780;	wtkg: 89.3;	perfat: 27.6;	lbm: 62.9;	fat_mass: 2464.68,ctrl
cell line: KYSE50;	cell type: squamous cell carcinoma,pert
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: wild-type,ctrl
FIH null MEFs,pert
cell line: HCT116;	shRNA: CDK8;	treatment: low glucose,pert
MH1C1 cells exposed to 310 µM CoCl2 for 24 h,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,ctrl
Surgical sample,pert
MDA-231 cells,ctrl
Hdh knock-in mice striatal cells,pert
CEM-C1 cells treated with DMSO,ctrl
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
Common Myeloid Progenitors,pert
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: mir126 knockdown,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T84,pert
3T3-L1 Day 0 (passage 21) 48h after siLSD1 transfection,pert
Wild-type E11.5 129Sv,ctrl
3T3 cells,pert
gallbladder saline treated,ctrl
"skeletal muscle, normal control",ctrl
sex: Male;	family: 4;	age: 16;	disease status: Control;	tissue: Muscle: Biceps,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,pert
Total RNA from Monkey PBMC labeled with cyanine-5 (red),ctrl
Bone marrow,ctrl
cell line: SLM2;	mutation: WT;	treatment: Treated with Sorafenib,pert
"heart, Q10, 14 months",pert
MDA-MB-231_TR6196,pert
cell line: A375 melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 32;	tissue: Normal_Kidney_Biopsy,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.04;	OD280: 0.53;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 286;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
wild-type mES,ctrl
Intima media; type 2 diabetic patient,pert
E9.5 FVB/N erythroid cells-3,ctrl
231/ARF-2_3,pert
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,pert
"foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",ctrl
"E14 embryonic stem cells, VPA",pert
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,ctrl
Colon 17 days old,pert
Human LRRK2 (G2019S) heterozygous patient fibroblast,pert
purified Gfp+ photoreceptor cells,pert
"Lung, Normal Tissue",ctrl
tissue: hepatocellular carcinoma tumor;	treatment: vehicle;	strain: Wistar,ctrl
sex: Male;	Age: 50 months;	additional patient information found in Series supplementary file,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,ctrl
"Lymphoblastoid cell lines derived from family 1725, member 1",pert
striatum_21 month,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 18.18082,ctrl
Bone marrow derive macrophage,pert
treatment: DMSO;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
Tfam+/- MEF,pert
"12 weeks old normal mice, cerebellum",ctrl
human skeletal muscle,pert
U937 cell line infected with GSK3A Construct 6 shRNA,pert
"mouse embryonic fibroblasts derived from WT mice, E",ctrl
"Gender: Female, Age: 31, BMI: 21, Tissue: luteinized cumulus cells",ctrl
strain: HNF4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 58;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Anterior tibialis,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#102,pert
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 72h,pert
Normal breast stroma,ctrl
XBP1s_B_cells_spleen_20weeks,pert
tissue: muscle;	sample group: placebo;	treatment: before;	gender: Female,ctrl
"female,21,Caucasian",pert
condition: Discoid Lupus;	patient: L3;	tissue: LS skin biopsy;	kit: Ovation,pert
"Mouse liver, wild type, healthy, 3 months",ctrl
transplanted heart,ctrl
status: control,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Colon",pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 8/1/03,ctrl
kidney tissues from obese rats on control diet,ctrl
primary normal lung tissue 1103,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 209,pert
batch: A;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 59 yr;	population: white;	dsm-iv: 296.5;	age of onset: 48 yr,pert
"HeLa, epithelial cells, adenocarcinoma (CCL-2; American Tissue Culture Collection ATCC, Manassas, VA, USA)",pert
Human LRRK2 (G2019S) homozygous induced pluripotent stem cells,pert
Aquaporin-11+/+_mouse P7 kidney #2-1,ctrl
patient E1542,pert
SV589_NoKD_SerumStarved->1hr EGF,pert
mouse full-thickness skin,pert
Tissue: lung,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 131;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
HEK293 cells + control siRNA 72h,ctrl
Subtype: RAEB1;	Karyotype: normal,pert
lung_wt_mock_repC,ctrl
RWPE1 cells treated for 6 hours with vehicle (0.1% ethanol),ctrl
Sample ID: TP35;	Twin Pair ID: CCE3.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : Epilim,pert
"5 x 10^4 Zfx-flox LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-flox mice.",ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 2,pert
Primary hepatocytes isolated from Donor 3 treated with DMSO for 24h,ctrl
abl cells depleted of EZH2 under hormone depleted conditions,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 19 yr;	population: white;	dsm-iv: 296.73;	age of onset: 17 yr,ctrl
"glioblastoma stem cells, stem, 4 days",ctrl
liver_Wt_female_8wk_rep3,ctrl
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
cell type: HeLa;	genotype/variation: nucleofacted with HIRA siRNA,pert
tissue type: Primary lung tumor;	histology: LA,pert
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: scramble,ctrl
gastrointestinal stromal tumor,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: test compound CP-529414 (CETP+ /BP+ THQ+);	dose: 100 nM;	time: 3 hr,pert
3 day LAD ligated heart from C57BL/6 strain,pert
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
DP (CD4+/8+) cells from Normal Thymus,ctrl
mouse pituitary gland cells,ctrl
Lung of control animal,ctrl
Mus musculus tissue,ctrl
"Wild type, snap frozen, diaphragm muscle, 10 month age animal",ctrl
CD47 null lung Endothelial cells,pert
P3B Progranulin-cerebellum,pert
Normal skin from lmq_control mouse,ctrl
GC resistant clone C7H2-R3B5 treated for 6 hours with EtOH,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 48h",pert
"9B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 93min;	race: White;	sex: Female,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 27,ctrl
Strain:C57BL/6;	Gender:male;	Age:8 weeks,pert
Paclitaxel-resistant,pert
DBA mouse untreated control,ctrl
HL-60 cell line infected with GSK3A Construct 5 shRNA,pert
strain: C57Bl/6;	genotype: Myc(F/F);CreER;	cell type: CD8+ T cells,pert
"liver, control, 6 months",ctrl
"Cnr1-/-/Cnr2-/- female number 2, 2 months old, whole ear tissue, untreated control ear",pert
chip number: 11;	transfection plate: 3B;	target gene: EP300;	kd level: 0.62;	rin: 9.4;	transfection date: 2012-03-26,pert
tissue: bone marrow;	genotype: HEB-KO;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),pert
"twin pair: #6;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
INS-1 cell line #5a with non-induced HNF1b mutant P328L329del,ctrl
Brain from 60 days Npc1+/+ mouse2,ctrl
CD4+ T cells from B6.Sle1a.1 mice,pert
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 1",pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,ctrl
Sample ID: TP27;	Twin Pair ID: CCN5.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 34;	Current Age (2007): 37;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
"DHL6, R406, 2h",pert
individual: patient10;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Male Nrf2 Wild-type mice, liver sample",ctrl
Total RNA from bone marrow derived macrophage from BalbC mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 147;	genotype/variation: WT;	age: 8 weeks,ctrl
Age: 47;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
treatment: Non-specific shRNA (shNS);	cell line: MDA-MB-231,ctrl
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: normal, homogenized",ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
RNA from microdissected breast cancer cells from case 518 labeled with Cy5,ctrl
Human colon biopsies from UC patient with active disease (non-involved mucosa),pert
"male;	CABG patient, atrial tissue;	propofol anesthesia, after CABG surgery",pert
"Setd2 knockout mESCs, biological rep3",pert
Murine osteoclasts,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: hepatocellular carcinoma (HCC),pert
human thyroid,pert
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep2,ctrl
STING knock out BMDCs tumor-derived DNA stimulation,pert
"Well-differentiated human lung epithelial cells, infected with KY/180 (pdmH1N1) for 36h",pert
status: Control;	gender: Female;	age: 49;	tissue: Blood,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-14;	Primary Site:Floor of Mouth;	Age:60;	Sex:F;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
RNA from microdissected breast cancer cells from case 547 labeled with Cy5,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
PancreaticSample54-Normal,ctrl
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 15 pack-years",pert
28 Day Mouse leg muscle,pert
HOX424 Control Day14,ctrl
"Lymphoblastoid cell lines derived from family 1727, member 1",ctrl
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
R1 control ES cells,ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: E14,pert
olfactory epithelium,pert
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
Disease_status: Bipolar disorder;	Age (years): 64;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 45;	Brain pH: 6.10;	Post mortem interval (hours): 16;	Side of brain: Right;	Fluphenazine mg. Equivalents: 130000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
"Lymphoblastoid cell lines derived from family 1725, member 1",ctrl
striatum_21 month,ctrl
"Histopathological diagnostic: oligodendroglioma, grade 2",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 5,ctrl
Peripheral blood mononuclear cells;	TTF=137min;	Race=White;	Sex=Male,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",pert
A HID B_B082,pert
"strain background: C57BL/6;	genotype/variation: Cdh1 knock-out; Cdh1-, P53+;	age: 2 months;	gender: female;	tissue: uterus",pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.09mM, 72 h",pert
mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 28;	tissue: Normal_Kidney_Biopsy,ctrl
"NCI-H1650, Untreated",ctrl
F6.04,pert
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: NO,ctrl
Cdx2 overexpression,ctrl
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node",ctrl
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
tissue: white blood cells;	age: 13.75;	Sex: male,pert
A549 cells,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 2",pert
8 wk old male mdx5cv gastroc,pert
strain: C57/Bl6;	genotype: Akt1¬-/-;	gender: PND70 female,pert
"12 weeks old PS-NA mice, cerebrum",pert
tissue: white blood cells;	age: 8;	Sex: male,ctrl
gastric biopsies,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
Parkinson's Disease;	male,pert
Immature dendritic cells cultivated together with Aspergillus fumigatus germ tubes for 6h,pert
disease: cardiopathy;	gender: female;	age: 200 days;	tissue: thymus,ctrl
tissue: testis;	genotype: repro9/repro9;	age: 17dpp,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: shRNA against β-catenin;	time: 72hr,pert
"n12, surgically resected from patient of gastric cancer.",ctrl
EE_IB_1_cauc_lcm,pert
AL,pert
coc-57,pert
Mouse liver tissue,pert
M537_KO,pert
Aquaporin-11-/-_mouse P7 kidney #3-4,pert
P7B Progranulin-cerebellum,pert
"Strain: MRL/MpJ;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
A39 WT3	F7/3	A39	wild type	Mouse	4 months	Cerebellum	Male,ctrl
Retina moderate glaucoma,pert
Myd88 KO control tissue  5,pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 wildtype;	age: 42 days;	tissue: retina,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
"Cultured ovarian cancer cell line OVCAR-10, untreated",ctrl
P7A Progranulin-frontal,pert
Cervical Cancer_1981T,pert
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Normal cervix epithelium_03-5438,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 221,pert
Breast Cancer Cell Line,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 3),pert
"cell type: MYC negative B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",ctrl
strain: FVB;	transduction: none;	tissue: Primary prostate epithelial cell culture,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IA, HPV 45",pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: untreated,pert
THP-1 cell line infected with GSK3B Construct 1 shRNA,pert
"Gender: Female, Age: 31, BMI: 37, Tissue: luteinized cumulus cells",pert
HeLa cells were treated with the siRNAs for 72 hrs,ctrl
"LCL GM19238, Kd GTF2B, 72hrs",pert
"Cultured ovarian cancer cell line A2780, Cisplatin treated",pert
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 3",pert
Nanog overexpressing liver,pert
prefrontal cortex (BA46);	schizophrenia,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,pert
cell line: MCF-7;	agent: gamma tocotrienol,pert
PBMC;	Age: day 14,pert
"BOEC, at_risk 3",pert
Rat Dorsal Root Ganglia,pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
Sex: male;	Age at operation: 37 years;	Site: thigh;	Size in cm: 7x14x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: yes,ctrl
individual: patient13;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,pert
subject: 21U;	cohort: 21;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
CGR8 embryonic stem cells,ctrl
Bronchial epithelium,ctrl
A2058 Ctrl siRNA,ctrl
negatively selected CD4+ splenocytes from an individual mouse treated with sham laparotomy,ctrl
tMLL01,ctrl
"Ishikawa cell line, control, 24hr",ctrl
quadriceps_muscle_Wt_female_8wk_rep1,ctrl
mouse embryonic stem (ES) cells,pert
unstimulated confluent HUVECs,ctrl
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
"Lymphoblastoid cell lines derived from family 1727, member 2",pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 2,ctrl
Sample ID: TP18;	Twin Pair ID: CCN2.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 3,pert
disease state: endometrioma;	patient: 19,pert
HCC SNU-398_control,ctrl
genotype: SRC-2 null;	tissue: Liver;	genetic background: C57;	Sex: Female,pert
lung fibroblasts from patient with fibrosing alveolitis associated with systemic sclerosis,pert
"LIGHT Tg, HFD 2wks",pert
"mNB-A1, DMSO",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 170min;	race: White;	sex: Female,pert
HL-60 cell line infected with GSK3A Construct 5 shRNA,ctrl
SK-BR-3 breast cancer cells stably transfected with empty vector,ctrl
visceral_fat_Akt1+/-_female_8wk_rep3,pert
MCF7 cells treated with 2uM Sangivamycin,pert
"GV oocyte, Ring1 mutant",pert
"seminoma specimen, pT2, patient age: 30y",pert
HL-60 cells treated for 24h with 100 µM curcumin,pert
Patient liver biopsy,pert
patient: 30582;	sample: normal,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 73;	Usage number: 1;	Exposures: 4,pert
Liver from C57BL/6 mouse,ctrl
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 10 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,pert
strain: 129/Sv;	group: knock-out;	genotype (hdh cag repeat length): null;	differentiation status: undifferentiated,pert
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
MOLM-13 cells,pert
"Mouse, ATF6aKO, colon, UT, rep1",pert
Homogenized lung tissue,pert
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: CLDN18_KnockOut;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T2, N1, M0, G4",pert
F16.01,pert
Gastric biopsies,ctrl
Murine skeletal muscle,ctrl
wild type E12.5 fetal liver derived megakaryocyte progenitors,ctrl
DH 2,pert
HeLa cells transiently transfected with a control siRNA,ctrl
A39 WT7	F2/14	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
patient: 5;	disease state: hypertension;	tissue: Atheroma plaque,pert
PBMC from T cell Large granular lymphocyte leukemia patient#101,pert
"Mouse brain, Aged, 4hr post saline ip injection",ctrl
HLA risk: Low;	Height: 171.7 cm;	Weight: 66.4 kg;	BMI: 22.5;	Age: 13.4 years;	Gender: Female;	Race: White;	Glucose: 101 mg/dl;	HbA1c: NA,ctrl
BB Rat day 65 female diabetic resistant mast cells from pancreatic lymph node,ctrl
"genetic background: B6;	genotype/variation: Gata1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
Ada3FL/FL MEFs_Cre adenovirus,pert
Tsc1-deficient CD8 naïve cells,pert
subject id: 44;	infection: DENV;	status: DF;	tissue: whole blood,pert
treatment: ethanol,pert
SV589_8Day KD,ctrl
transgene: none;	treatment: siRNA trasfected - 48h of depletion from FTO,pert
Treated with 50uM Zinc for 4 hrs -- replicate #2,pert
EA_SLE_CD4,pert
Endometrium from tibolone-treated postmenopausal woman,pert
tissue: Frontal cortex;	age: 72;	Sex: F,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 24;	maternal age: 24,ctrl
T-ALL,pert
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,pert
"gastrocnemius, 30 months of age, resveratrol diet",pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,pert
LNCaP cells treated with R1881 and ELK1-shRNA,pert
primary normal lung tissue 1502,ctrl
gender: male;	disease state: healthy,pert
inguinal fat,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): EtOH vehicle,ctrl
PC-3 cell  pre mir-221,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.8,pert
cell line: HCT116;	shRNA: non-target;	treatment: untreated,ctrl
cell type: Primary hepatocytes;	donor: 6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 210min;	race: White;	sex: Female,pert
iFGFR1 mammary gland NT,ctrl
NSC_FOXO_WT-2,ctrl
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 6h,pert
PBMC sample from Chronic hepatitis B carriers,pert
HDC-expressing CD11b+Gr-1+ myeloid cells sorted from the bone marrow of HDC-EGFP/HDC-KO transgenic mice,pert
Igf1 +/+ mouse vestibular organs 15day old (P15),ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
Heart sample from 8-week-old C57BL/6 mice,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 27 (STAG2 wild-type),ctrl
P0 Whole Brain,pert
SV589_8DayKD_SerumStarved,pert
disease state: Control;	gender: Male,ctrl
cell line: SF539;	transfection: Scramble siRNA,ctrl
GM9016,pert
A61 NES 142Q TG3	F6/23	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
cell type: hepatoma cells;	cell line: Huh7,pert
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Differentiation medium for 3 days,pert
"BOEC, normal 27",ctrl
cultured LNCaP cells;	refer to ATTC,pert
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,pert
patient E1610,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
strain: C57BL6,ctrl
control endometrium,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: T,pert
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",ctrl
RV63.10_CHF_day19,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.69;	Ratio: 2.13,pert
IMR-32_pCMV-DPP3_48hr,pert
tissue: skin;	individual: Patient P10;	condition: AL;	eczema severity: SCORAD: 37,pert
HT144 melanoma cell line,ctrl
Post Transduction:12 hr; treatment:WT;,ctrl
patient: 51176;	sample: tumor,pert
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: control,ctrl
cell line: U2OS;	treatment: shBAP1 #1,pert
"MCF-7 cells, siCtrl treatment 60h, 0.1%EtOH for 24h",ctrl
"ADIPOSE TISSUE, RES, Before",ctrl
T146,pert
Murine lymph node,pert
renal vesicle from E12.5 Lim1 mutant kidney,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,pert
Control mice,ctrl
fresh tissue: splenocytes;	strain: DBA/2,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
rd1 mouse retina at age postnatal day 2,pert
cell type: embryonic stem cells;	genetic modification: Dicer knockout,pert
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i+);	er: 1;	pgr: 1;	dfs-month: 17;	dfs-event: 0;	distant metastasis: 0",pert
E14 +/+ wiltype ES cell line (control for Cdk4+/- ES cell line),ctrl
no_17,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 21;	gender: male,ctrl
Vehicle 24 hours_1,ctrl
Endometrium/Ovary-Disease 10,pert
Extensor carpi radialis brevis muscle from cerebral palsy patient,pert
A549 NSCLC cell line,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 1,pert
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: wild type,ctrl
Treated with 25uM Zinc for 4 hrs -- replicate #3,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Female. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal polyp from small intestine (jejunum/ileum region).",pert
strain: C57BL/6J;	genotype/variation: WT;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,ctrl
KO hippocampus Veh,pert
cell line: LKR13,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-17;	Primary Site:Tongue;	Age:47;	Sex:M;	TNM:T4N3M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
"Deltoid, FSHD, cohort 13, subject 13B",pert
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.318;	OD280: 1.187;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 66;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
strain: C57/Bl6;	genotype/variation: wild-type;	gender: male;	tissue: epididymal white adipose tissue,ctrl
Lung; wild type; VILI,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hr AP20187,pert
HCC_32N,ctrl
Tendon;EDC_Non-lesional,ctrl
B2_saline_overexpressor_422,pert
VCaP/NC siRNA,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, DMSO-treated",pert
genotype: Male;	age: 15 years adolescent male,pert
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: none,ctrl
"seminoma specimen, pT3, pN1, pM1, patient age: 23y",pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed Foxd3,pert
cell line: D3;	genotype/variation: scrambled sequence control (siSCR);	cell type: undifferentiated embryonic stem cells,ctrl
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",pert
construct: Luciferase Control shRNA;	cell type: Primary human erythroid progenitor cells,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP-,ctrl
8 wk old male mdx5cv TA,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 248;	age-at-biopsy-years: 49,pert
race: caucasian;	age (years): 57;	stage: IB;	grade: 1;	histology: endometrioid,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 55, stage IIIB, HPV 16",pert
INS-1 cell line #1a with induced HNF1b,pert
gastrocnemius muscle,pert
tissue: PBMCs;	treatment: after IFNb-1a in-vivo treatment,pert
"Patient SE, stable renal transplant recipients, male, 31 years old, T1 (3 months after the switching of the therapy)",pert
Mouse embryo fibroblast,pert
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",ctrl
HaCaT cells at day 12 of in-vitro calcium induced differentiation,ctrl
"reference, C2siRNA treated sample",ctrl
"sodium arsenite added to food: 10 ppb, 5wk;	diet: LRD-5001",pert
chip number: 22;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.77;	rin: 9.4;	transfection date: 2012-03-26,pert
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep2,pert
"Patient #7, Untreated",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: healthy control,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 16 weeks;	Tissue: testis;	;	,ctrl
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus;	organism class: Gram pos,pert
"FACS purified YFP+ muscle stem cells, harvest immediately after isolation",ctrl
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed vector control,ctrl
sample description: pool of total RNA from 10 human cell lines,ctrl
HEK293 cell line #1 with induced HNF1beta,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-SOX2,pert
Temporal cortex of AD brain,pert
murine Pten null prostate,pert
gender: Male;	age (y): 39;	tissue: prolactinoma,pert
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/-;K14-Cre;	strain: C57/BL6,pert
HeLa cells transiently transfected with a nonspecific control siRNA,ctrl
spinal cord,pert
tissue: lymph node;	genotype: Dicer WT;	cell type: CD4+CD62L- resting T cells,ctrl
strain: C57BL6/J;	Sex: female;	genotype: Pdpn-/-;	cell type: mouse embryonic fibroblasts,pert
"57B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: control,ctrl
"30B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"22B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,ctrl
Total RNA from Gsk-3b-/- ESCs,pert
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",ctrl
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 2",pert
Skeletal muscle tibialis anterior (TA) from mdx line,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 60,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.675;	OD280: 0.838;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 234;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
tMLL07,ctrl
BJ-iPSC_2,ctrl
RNA from microdissected breast cancer cells from case 356 labeled with Cy5,pert
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: PtenloxP/loxP,ctrl
Mouse hypothalamus,ctrl
"Gastrocnemius-soleus muscles, basal status, integrin alpha7 transgenic mouse",pert
Patient: A;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
ErbB3 DOX-KO,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.42192,pert
homozygot FH P269 (human CD3 positive T cells),pert
Aldosterone-producing adenoma,pert
"C2C12 myoblasts, untreated",ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 2,pert
amnion mesenchymal cells treated with interleukin-1-beta for 1h,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: KIT mutation detected,pert
"Lymphoblastoid cell lines derived from family 1744, member 1",pert
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep1,pert
Ebs at Day2.5 were treated with SB431542 for 2 h,ctrl
con-15,ctrl
"HCT116 cells, parental",ctrl
"PCOS, biological rep 2",pert
patient: 40645;	sample: tumor,pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Her2 and Myc over-expression,pert
Total skin,pert
EB_2_8d_220_HCHO_Nasal_Rat230_2_CIIT05024,pert
patient: 117;	current medication: Loperamide;	birth date: 3/31/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
patient id: 325;	tissue: Normal cortex;	gender: Female;	age: 80;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"brain, brainstem",pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3KO;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,pert
A375 melanoma cell-line,ctrl
Female - caucasian - N-04-M,pert
cell culture: grade VI GBM short term cultures,pert
"Patient #5, Untreated",pert
patient: 16;	disease state: hypertension;	tissue: Atheroma plaque,pert
surgically resected material,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 3,ctrl
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: curcumin,pert
siRNA treated MCF-7 breast carcinoma cell line,ctrl
"mouse back skin, K5-IKKbeta transgenic",pert
chip number: 19;	transfection plate: 3B;	target gene: YY1;	kd level: 0.63;	rin: 9.3;	transfection date: 2012-03-26,pert
Rybp#10 (OHT+)_12d,pert
bulk normal breast or normal bresat organoid,ctrl
"E14 molar teeth, DMSO control",ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,ctrl
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0;	agent: none,ctrl
"ALL, Non-Down syndrome",ctrl
Age (mean +- SE),pert
background strain: C57Bl/6;	developmental stage: E11.5;	tissue: fore-limb;	genotype/variation: Sost-/-; Sostdc1-/-,pert
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,pert
Retina of 2 month old RPE65 -/- mouse,pert
ref,pert
Heart RNA,ctrl
CON-1-COLLAGEN,pert
Tip60 KD mouse embryonic stem cells,pert
Head RNA of littermate wild@E13.5 No.4,ctrl
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 13;	gender: male;	tumor grade: IV,pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,pert
resected liver tumor,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 83,pert
siRNA-2-COLLAGEN,ctrl
Ramos Cells,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
Adipose tissue from male wild-type animal (C57/Bl6 background),ctrl
"NCI-H460, cisplatin, 2 hr",pert
liver_Akt1+/-_female_8wk_rep3,pert
"Gender: Female, Age: 25, BMI: 23, Tissue: luteinized cumulus cells",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
strain: CD1;	tissue type: back skin,ctrl
"Gender: female, Age: 35 years, Tissue: VIN 3",pert
Gender: male;	Age: 40;	Ethnicity: black,ctrl
"Entire small intestine, CF, lubiprostone treated",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 31.0;	age of psoriasis onset: 23,pert
gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2,pert
SKM-1 acute myeloid leukemia cells,ctrl
"HMEC-TR, SiRNA anti-TIF1γ",pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 50;	sex: F,ctrl
K562 cells,ctrl
Mock infected macrophages harvested at 6h post-treatment from donor 2,ctrl
"liver, wild type",pert
Patient: A;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Zfx-null TC1 ESC;	Cultured in 15% KO + LIF without feeders,pert
"gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: 3 days in N2B27,ctrl
embryonic stem cell,ctrl
LIN-CB,pert
Unpooled PBS-treated 4 hr spinal cord cultures,pert
treatment: siRNA against ETS2;	cell line: H441,pert
tissue: brain;	genotype: WT mix background B;	age: E14,ctrl
chip number: 23;	transfection plate: 4;	target gene: IRF7;	kd level: 0.76;	rin: 9.3;	transfection date: 2011-10-17,pert
MPM tumor specimen 15,pert
PDAC_T_91,pert
"SBC-5 cells, siEGR4 (target), 24 hr after siRNA, duplicate sample 2",pert
Peripheral Blood Mononuclear Cells;	Unknown Age and Gender,ctrl
tissue: lung;	strain: Balb/c;	genotype: wild-type;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,ctrl
Irradiated-ATM-KO Replicative3,pert
CD34+ cells from the patient (CML32),ctrl
MCF-7 cell line treated with control siRNA and vehicle (control),ctrl
CD11b+Gr1- cell sample_2 (derived from IL17RC Knock out mouse),pert
"Male, Wistar, 0 access to cocaine, amygdala",ctrl
Septic shock;	gender: Female;	Survivor;	organism: None,pert
"Ager/Rage null C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",pert
HLA risk: High;	Height: 125 cm;	Weight: 23.3 kg;	BMI: 14.7;	Age: 8.02 years;	Gender: Female;	Race: White;	Glucose: 328 mg/dl;	HbA1c: 6.5%,pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 24 hr,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P3,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 2h,pert
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD8+ T-cells",pert
Frontal cortex brain tissue from HIVE-control patient,ctrl
RNA from whole tissue section of case 878 labeled with Cy5,ctrl
MRF conditional knockout cultured oligodendrocytes,pert
Group5: 6 days differentiated Flk1+ Tal-1-/- ES cells,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 51 yr;	population: white,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 74;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
Primary hepatocytes isolated from FVB mouse strain treated with DMSO for 24h,ctrl
strain: C57BL/6;	diet: normal chow (normal);	tissue: liver,ctrl
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 52;	gender: m;	treatment: NSAIDs,ctrl
strain background: C57BL;	genotype/variation: wild-type;	tissue: liver,ctrl
GFP_Untreated_24hr,ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
agent: Cadmium 1.2 µM,pert
"Cell type: endothelial, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",pert
hippocampus,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
OV1002 Carbo Day4,pert
chip number: 11;	transfection plate: 6;	target gene: JUND;	kd level: 0.77;	rin: 9.1;	transfection date: 2012-03-26,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 3,pert
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 78;	time: 0;	batch: 3,ctrl
"mammary epithelial cells, p53-",pert
subject id: 47;	infection: DENV;	status: DF;	tissue: whole blood,pert
Normal - no fibrosis,ctrl
IM CD34+ progenitors cells,pert
Sprague-Dawley Rat retina (male); 3d post injury,pert
CD71+ bone marrow cells from CD70TG (clone F13) mouse 3,pert
tissue: Temporal cortex;	age: 88;	Sex: F,pert
Pooled PBMC sample from normal control subjects,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 4;	Exposures: 3,pert
siRNA-3-COLLAGEN,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 35;	gender: male,ctrl
cell line: Panc-1;	transfected with: pCIG (empty vector),ctrl
A HID B_B017,pert
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 22;	maternal age: 20,pert
"age at diagnosis: 64;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 26;	dfs-event: 0;	distant metastasis: 0",pert
A673 cell line that has been treated with Puromycin for 5 days with concentration of 0.09 uM (EC50).,pert
MDA-MB-231_TR6194,pert
Kin- S49 Cells 6h cAMP treatment,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
kidney tissues from lean rats on diet with rosiglitazone,pert
strain: C57BL/6;	tissue: Spleen;	genotype: Xbp1 KO,pert
condition: Discoid Lupus;	patient: L5;	tissue: LS skin biopsy;	kit: Ovation,pert
Healthy volunteer blood,ctrl
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: ZMPSTE24 silencing,pert
cell type: breast cancer cells;	agent: 200 uM Lacciac Acid A,pert
"mature (CD44+, NK1.1+) thymic natural killer T cells",pert
Epidermal keratinocytes treated with EphB2 for 4h,pert
T129,pert
CD8_T_cell_pool_melanoma_M05+M06,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.229;	OD280: 1.143;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 297;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
E12.5 Lim1 mutant embryo renal vesicles isolated by laser capture microdissection,pert
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,pert
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",ctrl
treatment: STAT3 siRNA;	cell line: Esophagus cell line OE33;	array id: 5617835005,pert
"Normal, biological rep 3",ctrl
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 6h;	gender: Female;	age: 5 months,ctrl
EB_0_24h_58_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
Female - caucasian - E-05-M,pert
tissue: skin;	individual: Patient P4;	condition: ANL;	eczema severity: SCORAD: 0,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 69,pert
Endometrium from estradiol-treated postmenopausal woman,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 340;	age-at-biopsy-years: 41,ctrl
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"human post-mortem brain tissue, bipolar disorder",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.40822,pert
H295R adrenocortical carcinoma cell line,pert
"Lymphoblastoid cell lines derived from family 1743, member 1",pert
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
NE,ctrl
cell line: SUM149,ctrl
cell line: MCF10A;	gender: female;	tissue: breast;	expression: HER2 over-expression,pert
WT hippocampus Veh,ctrl
OCI-Ly7 BCL6siRNA,pert
mortality: alive;	ethnicity: White;	gender: F;	age (yrs): 65;	tissue: Normal_Kidney_Biopsy,ctrl
cell type: preadipocytes;	tissue: white adipose tissue,ctrl
"Lymphoblastoid cell lines derived from family 1757, member 1",ctrl
Strain: (129S4/SvJae) (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
SK-BR-3 breast cancer cells stably overexpressing TFPIbeta,pert
subject: 33;	disease: TD;	muscle: ST;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.1,ctrl
"human post-mortem brain tissue, healthy control",ctrl
race: caucasian;	age (years): 56;	stage: IA;	grade: 2;	histology: endometrioid,pert
cell line: THP-1;	shRNA construct: GSK3B Construct 1,pert
Tumor,ctrl
Placental tissue from early onset Preeclampsia,pert
"t17, surgically resected from patient of gastric cancer.",pert
"AZ521 dnSox2 cells, induced, 12h",pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
GC resistant clone C7H2-R9C10 treated for 6 hours with GC,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 58.44932,ctrl
"male, healthy, no medicamentation",pert
PC-3M/NC siRNA,ctrl
cell line: U373;	cell type: glioma;	vector: Deltex1 (Myc-tagged),pert
S8A Sporadic-frontal,ctrl
Celecoxib_#4875,pert
Tissue: normal thyroid; Gender:female; Age:48,ctrl
Septic shock;	gender: Male;	Non survivor;	organism: Group B Strep;	organism class: Gram pos,pert
gender: mixed;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
Trizol extracted total RNA from myometrium tissue. Trizol extracted total RNA from myometrium tissue (HLRCC).,ctrl
Sex: male;	Age: 14;	SL: 3.57;	House: 0;	Severity: SS;	Ashworth: 3;	Zancolli: 3;	PEFF: 45;	PESF: 40;	AEFF:,pert
age	54;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.7;	leukocyte count (/nl)	52.2;	hemoglobin (g/dl)	9.3;	platelet count (/nl)	388,pert
genotype: Sox3 positive;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,ctrl
"ASC, obese patient (ASCmo)",pert
"Hippocampus, soman, 48h",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 14.0;	age of psoriasis onset: 11,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.1;	colon weight (mg): 170;	colon ratio (mg/mm): 2.62;	myeloperoxidase activity (u/mg): 0.463;	tissue: colon;	treatment: 5% DSS,pert
HepG2 cell line from ATCC at 8th generation after 30 minutes of PCB77 treatment.,pert
tissue: testis;	gestational age: 16 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: undifferentiated,pert
subject: 15V;	cohort: 15;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
HCC_15T,pert
"PCOS, biological rep 7",pert
postnatal 3 weeks pitx2 cko heart,pert
"liver, STZ-treated fed AIN93G diet for 14 days",pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"n24, surgically resected from patient of gastric cancer.",ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 41;	donor: 28;	disease state: Lesional,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 1,ctrl
tissue: Temporal cortex;	age: 65;	Sex: F,ctrl
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD4+ T-cells",pert
age: 31;	gender: male;	ejection fraction: 52;	left ventricular end diastolic diameter: 57;	inflammation/PVB19: positive,pert
non-infected MBT/Pas fibroblasts,ctrl
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
"TGCT cell line 2102Ep/clone 2A6, treated 7 days with retinoic acid",pert
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),ctrl
"hMSC-Tert, RNF40 siRNA, undifferentiated",pert
CD4+/CD25- T effector cells in resting phase,ctrl
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA scrambled,ctrl
murine whole heart tissue,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L015,ctrl
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 30.4, Strain:DBA/2J",pert
cerebellum,ctrl
157_SIO,pert
cell line: A549;	agent: decitabine;	dose: 1 uM,pert
KSR1-null MEFs with KSR1,ctrl
agent: pristane;	time: 18 days;	strain: DBA;	tissue: mesentery,pert
strain: C57BL/6J;	genotype: K14-Cre;Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 4 hour",ctrl
Kidney,pert
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: acute,pert
kidney,pert
Bone Marrow Mononuclear Cells;	27y Male,ctrl
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with 100 nM T3 for 6h,pert
"gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Time:0 day; condition:ctr;,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-3,pert
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E14.5;	tissue: kidney,ctrl
Carboplatin;	Carboplatin 24 hours set 2,pert
Human monocyte-derived macrophages,ctrl
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,pert
adult peripheral blood mononuclear cells without LPS-treatment,ctrl
tissue: brain;	genotype: WT mix background A;	age: P0,ctrl
Heart sample1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,pert
whole heart,ctrl
SK-BR-3 breast cancer cells stably overexpressing TFPIalpha,pert
Normal bladder,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),pert
genotype: Btk KO;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,pert
cell type: F442A cultured adipocyte;	cell line: 3T3L1;	back ground strain: Swiss,ctrl
Patient: H;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 3,pert
"brain, cerebellum, Purkinje cells, wild type",ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 8h,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: FRAG.cRNA-4A,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
whole lung,ctrl
"mental retardation or developmental delay, Male",pert
chip number: 20;	transfection plate: 4;	target gene: HCST;	kd level: 0.88;	rin: 9.7;	transfection date: 2011-10-17,pert
tissue: lung;	genotype: PPTA knockout;	treatment: cecal ligation and puncture surgery;	age: 8-10 weeks,pert
coc-51,pert
Postmenopausal female. Untreated control. nr 33.,ctrl
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: none,ctrl
Patient: D;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 6h;	gender: Male;	age: 6 months,pert
Postmenopausal female. Tibolone treated. Patient 26.,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.06301,pert
cell line: BL2;	transfection: scrb siRNA;	batch: 1,ctrl
N12A Normal-frontal,ctrl
"Oct4-Gip ES cells, Luc RNAi, 72h post transfection",ctrl
Igf1 -/- mouse vestibular organs 90 days old (P90),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.054;	OD280: 1.504;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 365;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
EB_0_6h_50_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
cell line: IOSE80pc;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
non-transgenic spleen B cells,ctrl
EB_2_19d_230_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu1,pert
colorectum,ctrl
RNA from whole tissue section of case 1260 labeled with Cy5,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 122;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
CD8 T cells isolated from tumor,pert
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
"Cultured ovarian cancer cell line DOV13, Cisplatin treated",pert
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 3",pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: B;	experimental sample name: PC12-R,pert
KM-H2 non-silencing,ctrl
tissue: Aorta;	genotype/variation: SRF-flex2neo -SM22CreERT2ki/+;	genotype/variation: smooth muscle specific SRF knockout;	age: 4 month-old,pert
"BT474-J4 breast cancer cell line, lapatinib",pert
cell line: non-clonal BMSC cultures,ctrl
Empty vector transduced CCE embryonic stem cells (empty vector CCE ES cells),ctrl
"cell type: Primary chondrocytes;	genotype: Wt;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",ctrl
"129/B6 background, 6-10 weeks",pert
patient E1521,ctrl
WT Liver - Pooled -Cy3,ctrl
pre-iPSC- siRNA to luciferase- biological replicate1,ctrl
Monocyte human control sample,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: untreated; biological replicate: 1,ctrl
treatment: DMSO (control);	cell line: K562,ctrl
EB_0_19d_73_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
tissue: Gastrocnemius muscle;	genotype: WT;	age: YOUNG,ctrl
cell type: tumor nodule cells;	ikk2 status: IKK2 -/-,pert
SV589_15Day KD,ctrl
cell line: MCF7;	treatment: none,ctrl
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:37h",pert
"Gracilis Mucle, Cerebral Palsy",pert
treatment: Sirt1 siRNA Knockdown Control;	cell line: Caco-2,ctrl
tissue: Spleen;	genotype: TRAF3flox/flox (littermate control),ctrl
RNA from whole tissue section of case 856 labeled with Cy5,ctrl
"CD3+ T cells, peripheral blood derived, healthy volunteers",ctrl
Lung of hemorrhaged animal 3h,pert
gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7,ctrl
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 26;	maternal age: 27,ctrl
primary normal lung tissue 1112,ctrl
"Peripheral blood mononuclear cells, RF- polyarthritis",pert
OV1002 Control Day14,ctrl
patient E1532,pert
8 Month Wild Type Ovary_03,ctrl
CD4_Tcells_healthy_donor,ctrl
"whole brain, nicotinic acetylcholine receptor subunit mutant mice and littermate controls",ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 45 yr;	population: white,ctrl
Cbx2_KO_XY gonads at E11.5,pert
tissue: brain;	genotype: WT inbred background;	age: P0,ctrl
hair follicles from anagen-deleted area (presence of functional Notch1),pert
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 1",pert
Strain : 100% C57BL/6;	Gender: Male;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
aortic valve cells treated with DMSO,ctrl
Cardiac muscle,ctrl
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 21;	gender: m;	treatment: -,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genotype: HDAC6 knock out,pert
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 16h,pert
Mouse female ES cells PGK12.1 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-4 in PGK12.1.,pert
"ADIPOSE TISSUE, PLC, Before",ctrl
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10.5,pert
cell type: ovarian cancer;	ets-1 expression status (western blot): High levels of Ets-1 protein expression,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 36,ctrl
"H1299 treated with Lipofection GAPDH siRNA, 12hr",pert
Gb5 KO,pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 32;	maternal age: 29,pert
"Human LIMA artery from patient 2, treatment: paclitaxel-eluting stent",pert
C3H10T1/2 cell line,pert
Age: 44;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 20;	Brain pH: 6.60;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,ctrl
"Control, Liver, 14M",ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 180;	colon ratio (mg/mm): 2.81;	myeloperoxidase activity (u/mg): 0.031;	tissue: colon;	treatment: 5% DSS,pert
"10 days normal mice, cerebrum",ctrl
umbilical cord tissue; high gestational age,ctrl
MPM tumor specimen 41,pert
colonoscopic biopsy from adult with unaffected colon with Crohn's disease,pert
"B6, HFD 2wks",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: E;	experimental sample name: PC3-R,ctrl
cell line: HUES6;	treatment: control,ctrl
chip number: 20;	transfection plate: 6;	target gene: RAD21;	kd level: 0.9;	rin: 9.7;	transfection date: 2012-03-26,pert
tissue type: normal thyroid;	matched/unmatched: matched to T16,ctrl
Panc-1_Gli3T,pert
treatment: control;	cell line: MCF7-FR,ctrl
"fetal testis sample 26, 20 weeks gestation",ctrl
Extract:LOX-1:213501;	Extract Description:LOX1_Untreated_24hr:213501;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.65;	Quality: Background Mean Dev.:0.43;	Quality: Absent (%):59.43;	Quality: Absent (%) Dev.:0.91;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.18;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295893,pert
HMEC,pert
Human polymorphonuclear (PMN) leukocytes,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp3,ctrl
"Frontal cerebrocortex, vehicle control (corn oil), 6 hours",ctrl
cell line: L-540;	cell type: Human Hodgkin Lymphoma,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
MPM tumor specimen 6,pert
WT CD80lo mTEC sample2,ctrl
"2B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 43;	gender: male;	tumor grade: AIII,pert
"gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
gender: female;	age (years): 45;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Mouse Sciatic Nerve, Diabetic Rosi",pert
genotype/variation: AhR knockout;	strain: AhRtm1Bra;	gender: female;	cell type: skin melanocytes,pert
Genotype: p38alpha wt;	Age: E13.5,ctrl
disease state: paediatric glioblastoma;	age: 2;	gender: F;	h3.3_status: wt,ctrl
"wild type Treg, replicate 3",ctrl
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
Control AGS cells (transduced with non targetting shRNA) treated with 10 microM LPA for 4 hr,pert
Diagnosis: AML M1;	Age: 68y;	Gender: Female;	Blast %: 81;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
Untreated HeLa cells,ctrl
Genotype: Homo sapiens,pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"villin-creERT2:beta-catenin-/lox, induced by tamoxifen for 2days",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu3,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",pert
"Amniocytes, euploid, 1563",ctrl
left hippocampus of 5HTT +/- control mice,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 77min;	race: White;	sex: Female,ctrl
5-KO_RD3a,pert
HLA risk: Low;	Height: 178 cm;	Weight: 81.7 kg;	BMI: 25.6;	Age: 32.78 years;	Gender: Male;	Race: White;	Glucose: 114 mg/dl;	HbA1c: NA,ctrl
agent: EphB2-Fc conjugate;	time: 24h,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-16;	Primary Site:Mandible;	Age:50;	Sex:F;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
HeLa cells nucleofacted with HIRA siRNA,pert
Beta4 nAChR subunit null mice without treatment,pert
MCF7 Control cells Array 1,ctrl
infection status: mock-transduced control;	cell type: human ccRCC cell line,ctrl
"twin pair: #9;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"Patient  I, lesion, 12 week",pert
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: 20μM celecoxib for 24hrs,pert
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1-/-Rnf2F/F (Ring1 mutant),pert
liver_wild-type,ctrl
treatment: no DOX,ctrl
"affected status (disease state): control;	gender: male;	age-at-examination: 66;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
A HID U_B081,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep1,pert
B cell lymphocytes from MCL patient,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: male;	tumor grade: IV,pert
wild-type littermate of B6.BKS Ighmbp2nmd-2J mice;	6 weeks of age;	male,ctrl
EB_2_19d_234_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"MCF-10A cells, shRNA targetting p63 TA",pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
Age: 45;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
Sample Group: HD patient; Gender: male; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/45,pert
"Patient #3, Untreated",pert
MDA cells resistant to paclitaxel,pert
Strain: J1 Cell type: mouse embryonic stem cell,ctrl
Tendon;ECRB_Lesional,pert
"paraventricular nucleus of the hypothalamus, LPS, 10 micrograms, 1 hours",pert
IMR-32_pCMV-SQSTM1_48hr,pert
"Cervical cancer cell line, SW756",pert
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",pert
Universal Human Reference RNA,ctrl
age	28;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	11.2;	leukocyte count (/nl)	164;	hemoglobin (g/dl)	9.5;	platelet count (/nl)	842,pert
Unaffected MZ twin pair 3 (Unaffected patient of MZ twin pair CCN3),ctrl
model: model: Fischer  344;	gender: Male;	age: 21 to 22 months old,pert
"Rat pups treated with acrylamide, spinal cord",pert
cell line: LNCap;	sirna transfection: siRNA COP1,pert
PC-3M/MYB siRNA,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,ctrl
genotype: wild type;	strain: CBA;	cell type: Splenic B-cells;	developmental stage: Transitional Type 1,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET3 transcript,pert
CD3+ cells,pert
gender: Female;	age: 52;	cell type: PBMC;	individual: Patient 13;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
"Retina, 42 days old homozygous Egr-1 knock-out mice",pert
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Human skeletal muscle biopsy sample;	Patient #186 with NORM,ctrl
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with seronegative arthritis",ctrl
"WT, untreated whole heart",ctrl
"medulloblastoma, M2, cMYC silenced",pert
tissue: large intestine;	genotype: HDAC3ΔIEC;	strain: C57BL/6,pert
tissue: skin;	individual: Patient N-3;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
WT leukemia stem cell,ctrl
cell type: IMR90 (Normal human diploid lung fibroblast);	gender: Female;	overexpression: H-RasV12;	treatment: Metformin,pert
tissue: Hippocampus;	age: 83;	Sex: M,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P60,pert
Time of Surgery:Post;,ctrl
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: Klf3 KO,pert
peripheral blood mononuclear cells,ctrl
Normal cervix_05-1981,ctrl
hippocampi pool from 3 SLA rats,pert
CD4_T_cell_pool_melanoma_M11+M12,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,ctrl
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
strain background: C57BL/6;	gender: female;	genotype/variation: MMA wild type;	tissue: kidney;	diet: high protein diet for 2 months,ctrl
"Control #8, Untreated",ctrl
Cardiac muscle,pert
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: wild type;	cell type: mouse embryonic fibroblasts (MEF cells),ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 361;	age-at-biopsy-years: 57,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 41;	gender: male,pert
"uterine sample from cKO female mouse, 24h vehicle treated",pert
breast cancer cell line transduced with eGFP,ctrl
Strain: C57BL/6;	Age: 2 months;	Tissue: retina,ctrl
gender: male;	agent: E2;	cell type: Hematopoietic stem cells,pert
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
Human skeletal muscle biopsy sample;	Patient #63 with NORM,ctrl
phenotype: preglaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 4.5 months,ctrl
mouse: 3;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 72;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
cell line: HT1080;	clone: 21;	genotype: Knockout,pert
primary mouse embryonic fibroblasts,ctrl
NTera-2 cells transfected with Ambion Silencer Select Negative Control #1,ctrl
Embryonic stem cell,pert
LNCaP/MYB siRNA,pert
HCC_41N,ctrl
MCF7 breast cancer cells,ctrl
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
"Liver, LmnaG609G/G609G",pert
cell type: Anaplastic thyroid carcinoma;	expression: TL3 LAMC2 shRNA;	cell line: TL3,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 140-day-old male;	40 mg liver used for RNA extraction,ctrl
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 7,pert
Tissue: Primary Human Hepatocyte;	Gender: female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.789;	OD280: 0.949;	Ratio: 1.83;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 132;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,pert
"Calu3 human non-small lung cancer cells, parental (ATCC)",ctrl
Monocyte human familial combined hyperlipidemia (FCH) sample,pert
hdh genotype: Q111/Q111;	tissue: striatum;	age: 3~10 weeks,pert
"MUSCLE, RES, Before",ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 2,pert
"ASC, non-obese individual (ASCn)",ctrl
rtTA-Dmrt5 day 7 -Dox,ctrl
"skeletal muscle, long duration",pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 48 hrs,ctrl
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_1,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: F;	experimental sample name: PC14-R,pert
HeLa cell line treated with esiRNA,pert
Endometrium-Normal 10,pert
PTC histology,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 Hmga2 KO;	age: Embryonic Day 18.5,pert
Rat heart ventricle,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,ctrl
age: 40;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 16.848;	Ratio: 2.11,pert
"Spleen, CD4+CD25hi Tregs, Gata1 knockout",pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA;	treated with: 100nM PD173074 for 48 hrs,pert
"10 week, control;	SOD1(G93A);	Male",ctrl
Wild-type postnatal day 10,ctrl
sample type: Primary culture of type II cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
HLA risk: High;	Height: 170 cm;	Weight: 59 kg;	BMI: 20.4;	Age: 40.56 years;	Gender: Female;	Race: White;	Glucose: 74 mg/dl;	HbA1c: NA,ctrl
"Wild type, pancreas",ctrl
wild type mouse stria vascularis postnatal 3~5 days,ctrl
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: fluoxetine,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 1,pert
age: 11;	sex: F;	disease status: control subject;	Filter number: 81;	Usage number: 1;	Exposures: 3,ctrl
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.92;	choa: 190;	fata: 15;	eea: 1160;	wtkg: 71.1;	perfat: 33.2;	lbm: 45.3;	fat_mass: 2360.52,ctrl
GC resistant clone C7H2-R19F2 treated for 6 hours with EtOH,ctrl
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
"Deltoid, control, cohort 22, subject 22U",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,pert
Human mammary epithelial MCF10A cells,pert
mononuclear cells isolated from peripheral blood or bone marrow,pert
HEK293 cells,ctrl
Brain of WT mice,ctrl
CONTROL;	Age = 18;	Sex = F,ctrl
cell line: Normal bone cell line 1705;	phenotype: Parental;	cell type: human osteoblast (hOB),pert
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KDM3A,pert
"age at diagnosis: 80;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): NX;	er: 1;	pgr: 1;	dfs-month: 45;	dfs-event: 0;	distant metastasis: 0",pert
MLL_PTD15,pert
aortic valve cells treated with DAPT,pert
age: 3 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
tissue: skeletal muscle;	disease status: healthy control,ctrl
HeLa cells transiently transfected with a Stau1 siRNA,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
"Normal cervix epiethelium, microdissected, Age 48",ctrl
"psoriatic epidermis, phototherapy, 1 month",pert
PBMC from T cell Large granular lymphocyte leukemia patient#111,pert
Rat skeletal muscle (gas),ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep1",pert
MDA-MB231 PIAS1 shRNA cells,ctrl
"Biceps, control, cohort 13, subject 13U",ctrl
2102Ep cells transfected with Ambion Silencer Select SOX2 siRNA,pert
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: Tet1;	overexpression: none,pert
Peripheral blood from individuals with systemic lupus erythematosus,pert
"BMMC, WT, activated",ctrl
cell line: Abelson B cell line,pert
P910,ctrl
disease state: ovarian adenocarcinoma;	specimen: ovarian cancer epithelia cells,pert
4T1.2 IRF7 expressing cell,pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
strain: FVB/N;	tissue: forebrain,pert
"Soleus muscle, basal state, WT",ctrl
"adult female mouse colon, wildtype",ctrl
lox95 control mouse,ctrl
"NeuroD1 cKO at ZT6, pineal gland",pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep2",pert
genotype: E-mu-BRD2;	cell-type: lymphoma_aggressive;	splenomegaly: severe;	Ig clonality: monoclonal,pert
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER; LSL-MIST1myc;	age: 8 weeks,pert
WIld-type control 3,ctrl
Patient: J;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,ctrl
mononuclear cells after Ficoll purification,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT6,pert
Pooled total RNAs from lymphoblastoid cells of 14 individuals,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 48h,ctrl
olfactory bulb,pert
"patient: 208;	current medication: Prednisolone 25mg/d, Pentaza 1g BD, Fosomax weekly;	birth date: 8/16/85;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/04;	diagnosis date: 6/25/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 17;	crp: 3;	hb: 121;	wcc: 8;	neutrophils: 5;	albumin: 39;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
tissue: Temporal cortex;	age: 83;	Sex: M,pert
MCF-10A_sh53BP1-2,pert
new onset sJIA,pert
OC1-WT embryonic retina at E14,ctrl
"HSCs from male mice treated with oil, replicate 3",ctrl
Septic shock;	gender: Female;	Survivor;	organism: Group A Strep,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Patient: L;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Vehicle 12 hours_1,ctrl
treatment: STI (Imatinib);	cell line: K562,pert
Septic shock;	gender: Female;	Survivor;	organism: Strep pneumo,pert
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker,ctrl
unstimulated CD4+ T-cells from Wt C57BL/6 mice,ctrl
LOX1_0hr,pert
"MHC class II high thymic medullary epithelial cells, NODaireKO",pert
tissue: Temporal cortex;	age: 77;	Sex: M,ctrl
phytohemagglutinin-activated PBMCs from normal control subject K,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 24.0;	age of psoriasis onset: 31,pert
whole blood,pert
PS_IA_2_cauc_lcm,pert
NB83,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 1;	choa: 379;	fata: ;	eea: 1510;	wtkg: 63.2;	perfat: 25.7;	lbm: 41.6;	fat_mass: 1624.24,ctrl
Wistar-derived-Liverpool John Moores University rats,ctrl
strain background: C57BL/6;	genotype/variation: control mice (Runx1floxed/floxedMxCre-/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,ctrl
The control subjects had normal glucose tolerance and no family history of diabetes.,ctrl
1833 cells,ctrl
diseasedl_IL-13,pert
"HEK293, Control RNA treatment",ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 12h,ctrl
sirna: control;	plate: plastic;	cell line: MCF10A,pert
Mixed_E18.5_Whole_Kidney,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 76,pert
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],ctrl
disease state: paediatric glioblastoma;	age: 7.3;	gender: M;	h3.3_status: wt,ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 0,pert
pancreatic beta-cells,ctrl
Gender: Male; Tissue: Prostate.,pert
EB_0_6_325_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,pert
"Male, 49 years old, HIV infection of ~3 months",pert
CD46+/STAT1-KO hippo - Untreated-E,pert
"Liposarcoma culture from tumor 391, doxorubicin treated",pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep4",pert
cell line HCT-116,ctrl
cell line: L428;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
MCF7 fulvestrant-resistant cell line transfected by antisense hsa-miR-221,pert
16 with Cy5,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 49;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
race: caucasian;	age (years): 61;	stage: IB;	grade: 1;	histology: endometrioid,pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
"LNCaP cells, treated with R1881, biological rep 2",ctrl
sex: Male;	Age: 60 months;	additional patient information found in Series supplementary file,ctrl
"n04, surgically resected from patient of gastric cancer.",ctrl
Control right atria,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 39;	Sex: male;	region: M1;	age: 44;	genotype: Y/Mecp2-;G42/-,pert
transfection: control siRNA (siCon);	cell: C2C12,ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P13,ctrl
cell line: Huh7.5.1;	tissue: liver;	agent: Ribavirin,pert
WILDTYPE cerebellum at 10 days,ctrl
Total RNA from Gsk-3a-/- ESCs,pert
"HCT116 shCDK8, normal growth",pert
Gender: male;	Source tissue: lymph node of the scalp/neck,pert
U2OS_siNS_2h,ctrl
Age: 58;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
IMR-32_pCMV_48hr,ctrl
Tissue:Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
tissue: Cop1 control embryos,ctrl
"'cervical cancer cell line C4-I' , 'squamous cell cancer'",pert
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 6h;	gender: Female;	age: 3 months,pert
prefrontal cortex (control),ctrl
S10A Sporadic-frontal,ctrl
murine Pb-Cre+;PtenL/W;K-rasG12D/W prostate,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 38;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Mouse Soleus 4 weeks post birth,ctrl
affected status (disease state): control;	gender: male;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
cell type: glioma stem cells;	treatment: SIO,pert
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep1,ctrl
Extract:LOX-1:213302;	Extract Description:LOX1_Untreated_6hr:213302;	Quality: Classification:Bad;	Quality: Gradient Severity:0.08;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.99;	Quality: Absent (%):60.73;	Quality: Absent (%) Dev.:1.92;	Quality: Scaling Factor:1.1;	Quality: Scaling Factor Dev.:4.2;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295663,pert
Pcgf6_2_shRNA1-dox,ctrl
H4-II-E-C3 cells untreated,ctrl
IL8 human transgenic mouse colon cancer tumor (control),pert
14-week-old WT liver_613WT,ctrl
S7C Sporadic-hippocampus,ctrl
Cell line established from CA1 HESC using pClip vector,pert
hTERT-immortalized human skin fibroblasts,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
gender: F;	age at blood draw: 62;	tissue: whole blood,pert
33A;pretreatment;female;breast tumor,ctrl
HUVEC treated with 1 nM for 24 h,pert
HCC_14N,ctrl
Age: 40;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
tissue: Terminal end bud (mammary gland);	gender: female;	age: 4.5 week old;	genotype: Ovol2flox/+;	strain: C57/BL6,ctrl
"TNFa siRNA-A, replicate 1",pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
treatment: TRPM2-AS siRNA;	cell line: PC3,pert
Gastrocnemius muscle mRNA from young (10 week old) wild-type mice,ctrl
Sprague-Dawley Rat retina (male); 7d post injury,pert
KO,pert
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 4,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: Wild type,ctrl
protocol: Transfection Reagent;	cell line: MCF7,ctrl
"brain, wild type",pert
"MOLM-14 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
pool,ctrl
tissue type: Normal lung;	histology: Normal lung,ctrl
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): iTreg,pert
monocytes,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-8;	Primary Site:Tongue;	Age:77;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
cell line: SLM2;	mutation: WT;	treatment: Control,ctrl
"LCL GM19238, Kd ESRRA, 72hrs",pert
phenotype: alcoholic;	gender: male;	case_id: 417;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 20;	brain ph at time of freezing: 6.64;	labeling_batch: 2,pert
cell line: BV2;	treatment: Curcimun,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 24;	maternal age: n/a,ctrl
HeLa treated with water (mock experiment),ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.23288,pert
tissue: microsatellite instability (MSI) colorectal tumor,pert
whole mouse lung homogenate,ctrl
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk+/+, Pdk1 wild-type;	tissue: tumor",ctrl
mouse embryo forelimbs,pert
siGFP-transfected sample 1,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.06301,pert
tissue: Temporal cortex;	age: 89;	Sex: M,pert
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 1;	distant metastasis: 0",pert
Male 6-8 week BALB/c trachea,ctrl
pool of thyroids from 6 months old wild type mice,ctrl
INS-1 cell line #2b with non-induced HNF1b,ctrl
10uM H2O2,pert
cell line: MLL-AF9 AML cell line 10986 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
HCC_16T,pert
PancreaticSample9-Normal,ctrl
gender: male;	individual: patient 5;	treatment: control,ctrl
Strain:  C57BL/6,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",pert
S6A Sporadic-frontal,ctrl
Bronchial biopsies from lung tissue,ctrl
tissue: heart;	genotype: Gata6_KO;	age: 8 week adult mice,pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #2,pert
protocol: NGN1 overexpression;	cells: Human Neural Stem Cell Line F3,pert
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
Cell line: human ES cell HES2,ctrl
"ERRa wt ventricle, baseline",pert
MCF-7cells treated with 500 nM 4-hydroxytamoxifen and scrambled siRNA,pert
cell line: D3;	treatment: siPRMT1,pert
A549 cell siRNA against STAT3,pert
negatively selected CD4+ splenocytes from an individual mouse treated with cecal ligation and puncture,pert
"65B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: testis;	genotype: repro9/repro9;	age: 14dpp,pert
"Liposarcoma culture from tumor 386, untreated",ctrl
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"jejunum, control, 1",ctrl
55A;pretreatment;female;breast tumor,ctrl
"Deltoid, FSHD, cohort 07, subject 07A",pert
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #2,ctrl
cell line: MCF-7;	agent: control,ctrl
"Gender: female, Age: 36 years, Tissue: VIN 3",pert
Immature dendritic cells cultivated in medium for 6h,ctrl
WT S49 Cells 6 h cAMP treatment,ctrl
"CA2, parental control SOX17 HESC- clone2",ctrl
Mouse embryonic fibroblasts,pert
"brain, hippocampus",pert
sample: #12;	subject: PD case #1;	brain: T-243;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
HeLa cell line,ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 2,pert
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),ctrl
muscle,ctrl
sex: Female;	Age: 8 months;	additional patient information found in Series supplementary file,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.8;	colon weight (mg): 174;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.238;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 2,pert
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",pert
gender: female;	age (years): 46;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
DBA mouse treated with pristane for 18 days,pert
sciatic nerve,pert
Gender: Male;	Age: 57;	Ethnicity: White,ctrl
strain: FVB/N;	genotype/variation: KLF1-/-;	age: embryonic day 9.5;	cell type: erythroid cells,pert
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 6h;	gender: Male;	age: 73 years old,pert
immortalized mouse brown preadipocyte,pert
E15.5 K14-Cre;Tgfbr2 fl/fl Conditional Knockout Mutant Mouse Model,pert
cell line: MDA-231;	transfection: pCMV-TARBP2,pert
medial gastrocnemius,ctrl
RNA from whole tissue section of case 295 labeled with Cy5,pert
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, recurrent;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
pancreas,ctrl
"TNFa-OMe-P siRNA-C, replicate 3",pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
PBMC from T cell Large granular lymphocyte leukemia patient#121,pert
subject: 15A;	cohort: 15;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
hepatocytes treated with 522 μM MeOPP,pert
Gender:F;	Age:48;	Tissue: Mucosa,ctrl
tissue: blood;	control: 5;	gender: male;	age: 41,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 72h,ctrl
39A;pretreatment;female;breast tumor,ctrl
MPM tumor specimen 25,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P9;	clone: 0,ctrl
ST045849 12 hours_2,pert
"Brain tissue from Fisher 344 male rat, Animal #243, control (0mg/kg) D-Serine",ctrl
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
cell: MCF-7;	treatment: control siRNA and vehicle (control),ctrl
CH 1,ctrl
age: 45;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 62;	inflammation/PVB19: positive,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 140min;	race: White;	sex: Female,pert
gender: Female;	age: 81;	post-mortem delay: 22h,pert
from Lim1 mutant mice E 12.5 renal vesicle,pert
IRAK2 KO macrophages stimulated with MALP-2 for 8 h,pert
EB_0_8d_68_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
sigmoid colon biopsy,ctrl
pool of thyroids from 2 months old RET-PTC transgenic mice,pert
Peripheral blood mononuclear cells;	TTF=150min;	Race=Black/African American;	Sex=Male,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
Patient: I;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Myeloid cell line, control siRNA",ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,pert
multiple sclerosis_7,pert
100uM H2O2 rep 3,pert
tissue: colon;	cell line: HT29,ctrl
tissue: Hippocampus;	age: 78;	Sex: F,ctrl
lesional skin bioposy obtained from patient after 14 days of treatment,pert
lateral hypothalamus,ctrl
Hippocampus of of AD brain,pert
"Human breast, post AF treatment",pert
agent: control;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,ctrl
agent: control (untreated);	time: 4h,ctrl
patient: 40730;	sample: normal,ctrl
mouse,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock).,ctrl
siRNA treated MCF-7 breast carcinoma cell line,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 19.67397,pert
age	24;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.2;	hemoglobin (g/dl)	12.5;	platelet count (/nl)	235,ctrl
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 112min;	race: White;	sex: Male,pert
chip number: 17;	transfection plate: 4;	target gene: IRF8;	kd level: 0.64;	rin: 9.7;	transfection date: 2011-10-17,pert
U2-OS-ERb,ctrl
"LCL GM19238, Kd NS, 72hrs",ctrl
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Skinbiopsy from healthy controls,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 38 yr;	population: Hispanic;	dsm-iv: 295.9;	age of onset: 17 yr,pert
Hypothalamus,ctrl
"BMDM, Nod2 KO, uninfected",pert
"male;	CABG patient, atrial tissue;	sevoflurane anesthesia, after CABG surgery",pert
patient id: 233;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
agent: control (untreated);	time: 24h,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 9.5;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 62;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
cell line: KYSE150;	cell type: squamous cell carcinoma,pert
"Contralateral knee articular cartilage, 4 weeks following OA surgery",ctrl
Bone Marrow Mononuclear Cells;	Unknown Age;	Unknown Gender,ctrl
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: p400,pert
Caco-2 Control siRNA 2,ctrl
"H1 hESCs, OE-NANOG",pert
chip number: 12;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.5;	transfection date: 2012-03-26,ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
day16 ES derived neuron,ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
subject id: 45;	infection: DENV;	status: DHF;	tissue: whole blood,pert
mouse embryonic stem cells,pert
A VIS _B033,pert
TTF=122min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_N,pert
"human ES cells line from Cellartis, Sweden; commercial line derived from normal embryos;	Karyotype: X,Y",ctrl
individual: patient17;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"ICL670 50uM 16hrs, K562 cells",pert
Human LRRK2 (G2019S) heterozygous induced pluripotent stem cells,pert
"human ES cells line from AZ-VUB laboratory, Belgium; derived from a blastocyst obtained after an in vitro fertilization carried out during a PGD procedure for DM1;	Karyotype: X,X",pert
Neocortex E14.5 mouse Eomes KO,pert
"Mouse, ATF6aKO, colon, DSS, rep2",pert
disease state: Healthy;	cell type: CD4+T;	twin: U,ctrl
N1A Normal-frontal,ctrl
2.5-4.5 month old ovarioectomized female mouse,ctrl
tissue: Lung Epithelium,ctrl
Gene expression profiling of normal cortex of patient T144,ctrl
"B cells, wild type, stimulated",ctrl
U2OS PRC shRNA1_pLenti_2007,pert
"T47D, sh3293",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q,pert
Human lung adenocarcinoma cell line,ctrl
agent: EphB2-Fc conjugate;	time: 48h,pert
subject: 2827 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
gender: F;	age at blood draw: 63;	tissue: whole blood,pert
"C57BL/6J female number 2, 2 months old, whole ear tissue, untreated control ear",ctrl
Human colon cancer cell line Caco-2,ctrl
Mouse embryonic fibroblasts,ctrl
Shn2_mutant,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female. Age:;	Eight and a half weeks (at tissue isolation). Tissue: small intestine (jejunum/ileum).",ctrl
phenotype: alcoholic;	gender: female;	case_id: 337;	age: 62;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 22;	brain ph at time of freezing: 6.74;	labeling_batch: 1,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp2,pert
patient: 51294;	sample: tumor,pert
whole brain,ctrl
Human colon biopsies from UC patient in remission (involved mucosa),pert
3T3-L1 Day 0 (passage 21) 48h after siLSD1 transfection,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 -/-,pert
"lung homogenates, WT, PBS control",ctrl
"Amniocytes, trisomy 21, 1549",pert
"CD3+ T cells, bone marrow derived, healthy volunteers",ctrl
M559_WT,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),ctrl
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: PBS;	tissue: liver,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 24;	maternal age: n/a,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 1,pert
GC resistant clone C7H2-R19E5 treated for 6 hours with EtOH,ctrl
"Strain: Wild-type Polg+/+;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 92;	Usage number: 4;	Exposures: 3,pert
EB_07_24h_134_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Freshly dissected rat spinal cord,ctrl
PS-/- cerebellum at 20 days,pert
RKO human colorectal carcinoma cells,ctrl
age_years: 42;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
"Patient  I, lesion, 2 week",pert
A HID B_B088,pert
strain:C57BL/6; VillinCRE-HNF4loxp; male; tissue colon; mutant,pert
tissue: liver;	treatment: CCl4 and erlotinib 2mg;	strain: A/J,pert
"Cultured ovarian cancer cell line C13, Cisplatin treated",pert
EA_Control_CD4,ctrl
R7_Pseudomonas_wildtype_422,ctrl
"Liposarcoma culture from tumor 387, untreated",ctrl
(ca)Raf_2,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,pert
Human peripheral blood mononuclear cells,ctrl
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 24h",pert
H4-II-E-C3 cells,pert
LNCaP prostate cancer epithelial cell line,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P30 postnatal stage,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 37.89315,pert
cell line: U937;	shRNA construct: GSK3B Construct 2,pert
"10 days old prosaposin knockout mice, cerebellum",pert
Kdm2b KD E14,pert
"Embryonic stem cells, control shRNA",ctrl
Skin biopsy from upper nates no nickel exposure,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 88;	Usage number: 4;	Exposures: 3,pert
L4/L5 dorsal root ganglia from adult rats (2 months old) 7 days after sham surgery,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day14,ctrl
RNA from whole tissue section of case 868 labeled with Cy5,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#5,ctrl
WILDTYPE cerebellum at 4 weeks,ctrl
Extract:LOX-1:213502;	Extract Description:LOX1_Untreated_24hr:213502;	Quality: Classification:Good;	Quality: Gradient Severity:0.07;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.06;	Quality: Absent (%):57.27;	Quality: Absent (%) Dev.:0.76;	Quality: Scaling Factor:0.47;	Quality: Scaling Factor Dev.:1.26;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295903,pert
RNA,ctrl
race: caucasian;	age (years): unknown;	stage: IC;	grade: 1;	histology: endometrioid,pert
con-13,ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,ctrl
cell type: tumor-derived cell line;	ikk2 status: WT,ctrl
Healthy-8 baseline,ctrl
hair bulbs only from 9-day-old mice,ctrl
"Gender: Female, Age: 35, BMI: 22, Tissue: luteinized cumulus cells",pert
cell type: DN4,pert
triplicate 2 of S. aureus infected HepG2 nt cells,ctrl
"UM-UC-3 bladder cancer cells, stably transfected with GFP (control), biological replicate B",ctrl
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: WT,ctrl
HCC_7N,ctrl
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,pert
maternal diet: Control;	genotype/variation: Wildtype;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),ctrl
WT AA 3,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 2",ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 3 months;	tissue: liver;	disease status: healthy,ctrl
"imr-32,",pert
T84,pert
Wild type  lung at birth (term),ctrl
cell type: ovarian cancer;	ets-1 expression status (western blot): No detectable Ets-1 protein expression,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339046,ctrl
Tendon;Patellar_Non-lesional,ctrl
Primary hepatocytes isolated from BL6 mouse strain treated with DMSO for 24h,ctrl
CD71+ bone marrow cells from CD70TG (clone F13) mouse 2,pert
IFNb treated,pert
(ca)erbB-2_2,pert
patient id: 233;	tissue: Normal cortex;	gender: Female;	age: 79;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
hypothalamus,ctrl
Patient: B;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
EB_0_5d_63_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to 30 min intravenous saline challenge""",ctrl
No_drug_#4865,ctrl
Uninfected NT mouse brain at 5 d.p.i.,ctrl
Unaffected MZ twin pair 2 (Unaffected patient of MZ twin pair CCN2),ctrl
"E17.5 preB cells, Smchd1 wildtype",ctrl
heterozygot FH P265 (human CD3 positive T cells),pert
At Risk: -;	Age: 8;	Sex: M,pert
Sample isolated from loxP flanked Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,pert
cell line: MCF7 breast cancer cells;	genotype/variation: control,ctrl
genotype: Wild type,ctrl
"ID:c 1-1, Genotype=(C57BL/6J), Treatment= none",pert
genotype/variation: control;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,ctrl
"Normal, biological rep 1",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.79726,pert
strain: C57BL/6;	genotype: wildtype,ctrl
Gender: male;	Age: 80;	Source: left arm,pert
human peripheral blood derived monocytes,ctrl
SFM,ctrl
subject: 28;	disease: TD;	muscle: ST;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Superior Frontal Gyrus from 5 year-old normal girl,ctrl
M AA T41A,pert
Aquaporin-11+/+_mouse P7 kidney #3-1,ctrl
"Skin biopsy, non-lesional",pert
E14 +/+ wildtype ES cell line (control for Cdk4 +/- ES cell line),ctrl
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),ctrl
lymphocytes (blood),ctrl
Cdx2 null ES cells expressing human Gata3 T2ER fusion,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
Placenta_PE(EO)1 with Cy5,pert
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,ctrl
CML cell line: KCL-22,pert
genotype/variation: C56B/6 and CD-1 mixed;	strain background: Shh mutant;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,pert
Aortas isolated from captopril-treated APOE-deficient mice,pert
SNB19 GBM cell line,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 30.888;	Ratio: 2.10,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 2,ctrl
UIP lung explant,pert
Mus musculus liver - txnrd1 null,ctrl
"H295R adrenocortical carcinoma cells, 2-OH-BDE85-treated",pert
disease state: endometrioma;	patient: M2,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.34 uM (2 x EC50).,pert
gender: Female;	age: 85;	post-mortem delay: 3.5h;	ph: 5.9,pert
"LNCaP cells, treated with R1881, biological rep 1",pert
MCF-10A_shCHK1-3,pert
Trizol extracted total RNA from myometrium tissue. Trizol extracted total RNA from myometrium tissue.,ctrl
146_SIO,pert
cell type: Embryonic stem cells;	genotype: wild type;	culture condition: ESC media,ctrl
CON - R19,ctrl
sample 1:;	age: 58;	gender: male;	sample 2;	age: 69;	gender: female,ctrl
"Cultured ovarian cancer cell line PA-1, Cisplatin treated",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.588;	OD280: 0.789;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 127;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T3;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 21;	dfs-event: 1;	distant metastasis: 1",pert
Knockout liver DEN-injected 12weeks repl3,pert
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",pert
"A5_tumor, lung tissue",pert
HCT116 cells,pert
R5_Pseudomonas_wildtype_48,ctrl
63A;pretreatment;female;breast tumor,ctrl
Whole testis RNA from WT mouse #146 at 0h,ctrl
cell type: Bladder cancer;	treatment: mock,ctrl
MPM tumor specimen 28,pert
Postmenopausal female. Untreated control. nr 21.,ctrl
primary normal lung tissue 2266,ctrl
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 36;	maternal age: n/a,ctrl
RNA from microdissected breast cancer cells from case 1218 labeled with Cy5,pert
Bone Marrow SMM patient,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 7,pert
lung_wt_mock_repA,ctrl
Liver_control mouse,ctrl
"Wild type, snap frozen, tibialis anterior muscle, 10 month age animal",ctrl
Melanoma,pert
231/NS (nonsilence)_3,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-1,pert
"Lymphoblastoid cell lines derived from family 1717, member 1",pert
A HID B_B012,pert
MCF7 cells treated with 2uM ARC for 24 hours Array 2,pert
"genotype: mutation in the NOTCH 1 gene (Weng et al., 2004, Science, 306, 269-271)",ctrl
tissue: white blood cells;	age: 15.72;	Sex: male,pert
92.1 cells,ctrl
tissue: resected liver tumor;	genotype: minor [rs8099917 TG/GG],pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Male,pert
"ID: MLL_00268;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: wild type;	cell subtype: 10 days old tumor spheroids,ctrl
liver_Akt1+/-_female_35wk_rep3,pert
Gene expression profiling of normal cortex of patient 1393,ctrl
Human monocyte-derived macrophages,pert
strain: FVB;	genotype: E2F1 null;	tissue: mammary gland tumor,ctrl
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE,CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
sciatic nerve of P4 Pmp22 knockout mice,pert
Notch2 f/f C57Bl/6,ctrl
Hdh mutant (111/111-polyQ) 1,pert
Lung,pert
"ID:9-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
tissue: heart;	gender: male;	genotype: WT;	age: 3 months;	strain: C57BL/6,ctrl
WT_lung_bleomycin,pert
Patient: J;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
"Total RNA, Tet2 KO GMP",pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days osteoblast differentiation,ctrl
"tissue: Cardiac, ventricular tissue;	genotype: caAkt;	age: 8 weeks-old",pert
developmental stage: E14.5;	genotype: Prmt5F/FNes;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: Prmt5 depletion,pert
NORMAL #99-0636,ctrl
"patient 7, baseline",ctrl
ex vivo cultivated melanocytes,pert
Genotype: Mdr2-KO homozygous mouse;	Age: 3 month,pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
Brain from 67 days Npc1+/+ mouse1,ctrl
Control F344 RAT penis,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 98min;	race: White;	sex: Male,ctrl
Morbidly obese control subject,ctrl
"hESC derived-NSCs passage 14, 24h",ctrl
2 with Cy5,pert
"PCOS, biological rep 3",pert
A YOKE_B025,pert
"SPC-c-raf transgenic mice, 14 month old, male, tumor",pert
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 3;	age: Post natal day 3-15,pert
"Liposarcoma culture from tumor 394, doxorubicin treated",pert
cell line: A549;	cell type: human lung cancer;	sirna: FAM60A targeting,pert
subject id: 55;	infection: DENV;	status: DF;	tissue: whole blood,pert
U-87MG,pert
tissue: sciatic nerve;	age: 2 months;	genotype: Bl6 wild type,ctrl
"strain background: C57BL/6;	genotype/variation: P53 knock-out; Cdh1+, P53-;	age: 2 months;	gender: female;	tissue: uterus",pert
treatment: siYAP RNA #1 transfected;	cell type: Primary cell line,pert
"Liver, untreated, rep1, knockout mouse",pert
bone marrow-derived macropahges,pert
cell line: rtTA-Dmrt5;	differentiation: 7 days;	treatment: -Dox,ctrl
cell line: KOPT-K;	cell type: human T-ALL cell line;	agent: control,ctrl
"Whole blood - Autism with regression, Female",pert
cell culture,ctrl
tissue: tumor tissue from cancer patients;	genotype: p53 mutant;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,pert
age: 60;	gender: male;	ejection fraction: 34;	left ventricular end diastolic diameter: 76;	inflammation/PVB19: positive,pert
mouse bladder,ctrl
"Cell type: endothelial, age:54, gender:male, diagnostic group: schizophrenia, PMI:38h",pert
Patient: M;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
genotype: wildtype;	cell-type: activated;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
Sample Group: HD patient; Gender: female; Age: 36; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/51,pert
treatment: si222;	cell line: MCF7-FR,pert
RWPE1 cells treated for 48 hours with vehicle (0.1% ethanol),ctrl
"DBA/2J Chronic morphine treated, biological replicate 3",pert
"BMDM, 1alpha,25(OH)2D3 and IFNgamma treated, KO Vdr -/-",pert
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.54;	age of onset: 22 yr,pert
sample: #8;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Inferior olivary nucleus,ctrl
disease state: healthy;	tissue: tibialis posterior;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
CML cell line: JURL-MK1,pert
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 33 yr;	population: white,ctrl
HCC_25T,pert
"WT uterus, saline control",ctrl
"glioblastoma stem cells, differentiation, 4 days",pert
"HSCs from male mice treated with E2, replicate 1",pert
treatment: control;	cell line: NTERA2/D1,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 6h,pert
"51B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
duration of untreated disease in month: 20.6;	age at onset: 6.0,pert
S6C Sporadic-hippocampus,ctrl
strain: 129;	cell type: EBs;	genotype/variation: WT,ctrl
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P7,pert
disease state: control;	patient: 3,ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,pert
Wild type MEFs from 13.5 day embryos,pert
Primary human erythroid progenitor cells expressing HDAC2 B10 shRNA,pert
lox62 control mouse,ctrl
wild type control tissue  5,ctrl
Mouse male kidney C57BL/6J,ctrl
ovaries dissected from 0-day old Sprague-Dawley rats and cleaned of ovarian bursa.,ctrl
cell line: KYSE140;	cell type: squamous cell carcinoma,pert
"Lesional skin biopsy from psoriasis patient, Week2_etanercept",pert
14-week-old WT liver_393WT,ctrl
"RNA was prepared from papilomas of 2-3 mice (2 for WT and 3 for Knockout) and this was pooled to perform the array. Each pooled sample was run in triplicates.   The mice were treated once with DMBA, followed by TPA application for 30 wks.",ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 6h;	gender: Male;	age: 44 years old,pert
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous saline challenge""",ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: kidney;	age: 12 weeks,ctrl
TTF=90min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
Atopic eczema,pert
Vector expression/TBK1 suppression,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 69;	age-at-onset: 65;	geographical origin: Mirandela;	clinical characteristics: Hypertension, diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"eye, cornea",pert
Cochleae from a9 null mice at P13,pert
cell line: Mc3T3-E1;	cell type: osteoblastic cells,ctrl
Disease_status: Bipolar disorder;	Age (years): 30;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 8;	Brain pH: 6.1;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
chip number: 13;	transfection plate: 5;	target gene: STAT2;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
age_years: 56;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
N10B Normal-cerebellum,ctrl
"Cultured ovarian cancer cell line OVCAR-10, Cisplatin treated",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 86min;	race: White;	sex: Female,pert
F9 embryonal Carcinoma cells,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,pert
PancreaticSample4-Normal,ctrl
"Setd2 knockout mESCs, biological rep2",pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 12.6235455167693;	age of psoriasis onset: 37,pert
CD34+/CD38-,ctrl
postmortem brain tissue,ctrl
WT_lung_bleomycin,ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: No,ctrl
Aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks.,ctrl
Resting CD4 T cells,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,ctrl
MPM tumor specimen 7,pert
"Gender: Female, Age: 32, BMI: 30, Tissue: luteinized cumulus cells",ctrl
cell line: MOLM-14;	shRNA construct: Scrambled Control,ctrl
U-87 cells transfected with sh-control RNA and treated with DMSO for 16 hours,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.381;	OD280: 0.716;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 222;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 14.5x7.5x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genotype/variation: Vax2-/-;	age: E12.5;	tissue: whole eye,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.843;	OD280: 0.95;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 52;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
astrocytes from second trimester human fetal brains,pert
pSuper vector control 3,ctrl
100uM H2O2,pert
"T47D, WT",ctrl
strain: C57BL/6;	tissue: visceral_fat;	gender: female;	age: 8week,pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/ HeOuJ,ctrl
Striatum of 6-10 week old C57BL/6J mice,ctrl
"Pancreatic islets, VhlhKO, 03",pert
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Female;	Age of onset (years): 21;	Duration of illness (years): 14;	Brain pH: 6.10;	Post mortem interval (hours): 17;	Side of brain: Right;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.43014,pert
Sample ID:DCBD2.1;	Twin Pair ID:TP8 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :none,ctrl
"Control, Liver, 11M",ctrl
chip number: 13;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 9.5;	transfection date: 2011-10-17,pert
gender: female;	age (years): 36;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
cell type: umbilical cord endothelial cells (HUVEC);	passage: 4,pert
"DP thymocytes, dicer KO",pert
wild-type macrophages unstimulated,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene;	molecule: total RNA,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/db;	phenotype: diabetic,pert
scan batch: Batch 1;	group: autism;	subject age: 2;	paternal age: n/a;	maternal age: n/a,pert
HEK293 cells unstimulated,ctrl
mRNA of substantia nigra from 10mg/kg methylphenidate-treated mouse,pert
patient E2644,ctrl
P7C Progranulin-hippocampus,pert
Soleus muscles from male BERKO ( estrogen receptor beta knockout).,pert
"Patient CCa, stable renal transplant recipients, female, 70 years old, T0 (time of enrollment)",ctrl
MLL_PTD10,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,ctrl
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: wild type;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,ctrl
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: 32;	maternal age: n/a,ctrl
"tissue: heart;	strain: mixed background of C57BL/6, 129/sv, and Balb/c",ctrl
HCC_29T,pert
amnion mesenchymal cells with no treatment,ctrl
"seminoma specimen, pT1, patient age: 36y",pert
race: caucasian;	age (years): 54;	stage: IB;	grade: 1;	histology: endometrioid,pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
"28B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Gene expression profiling of normal cortex of patient T164,ctrl
sampleID: SAM630144;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
strain: Myd88 KO;	gender: n/a;	weight: 25-30g;	age: 4 month;	tissue: whole trachea,pert
>95% CD3+ T cells negatively isolated with Dynal kit from SLE patient,pert
CD34+ hemopoietic progenitors purified from bone marrow of healthy controls,ctrl
cadmium_32hr,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 56;	gender: m;	treatment: -,ctrl
patient: 13;	disease state: hypertension;	tissue: Atheroma plaque,pert
"prostate cancer cell line, non-target control",ctrl
tissue: inner ear;	genotype/variation: Dlx5-null;	age: E10,pert
Colon 21 days old,pert
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"hMSC-Tert, RNF40 siRNA, 2 days osteoblast differentiation",pert
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: IRF8 KO;	genetic background: H-2b,pert
"WM 266.4 metastatic melanoma cell line, siPIR",pert
Sample Group: control; Gender: male; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
HCC_5N,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 32;	disease state: Lesional,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 27,ctrl
344SQ with control shRNA,ctrl
"coronary smooth muscle cells (hcaSMC), treated with control medium for 72 hours",ctrl
Sample: alpha-TM180;	Replicate: 4;	Pool: P,pert
Sarcoma cell line Null for Dicer,pert
tissue: brain;	genotype: WT;	genetic background: C57BL/6,ctrl
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
genotype: WT;	gender: Female;	cell type: MEF,ctrl
P16_WT_pancreas_rep1,ctrl
tissue: Frontal cortex;	age: 88;	Sex: M,pert
Placenta_PE(EO)2 with Cy5,pert
8 week old mouse extraocular muscle,pert
c48 is a clonal Nurr1 stably-expressing stem cell line,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/85;	differentiation status: undifferentiated;	cell line: Q91,pert
"Liposarcoma culture from tumor 400, untreated",ctrl
L-540_Perifosine 10µM_24hrs,pert
sirna: NR2F2 knockdown;	cell line: ES2;	cell type: Ovarian cancer cell line,pert
E13.5 Tgfbr2 Wildtype Mouse Model Primary Palate Mesenchyme collected after 2 passages in culture,ctrl
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",ctrl
DLBCL_FOXP1 overexpression,pert
SKM-KO,ctrl
cell line: SKBR3 resistant;	treatment: 0.1uM Lapatinib,pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 3,pert
RNA pool from untreated LCLs generated from unaffected controls,ctrl
Regulatory T-cells CD4+CD25+,ctrl
"metastasis: metastatic recurrence;	Stage: 2b;	tissue: cancer, homogenized",pert
RNA from whole tissue section of case 1405 labeled with Cy5,ctrl
Time:0 day; condition:Emerin ko;,pert
"whole ear tissue, untreated control ear",ctrl
"TNFa siRNA-A, replicate 6",pert
"Ishikawa cell line, control, 8hr",ctrl
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2,pert
"A549 cells (lung epithelial cells, a common cell line used in IFN assays)",pert
"Endothelial control cells, passage 11",ctrl
bone marrow-derived macrophages,ctrl
Bone marrow from naive C57BL/6 mice,ctrl
tissue: Gastrocnemius muscle;	genotype: KO;	age: YOUNG,pert
strain: C57BL6J;	genotype: H3f3b -/-;	age: E12.5;	tissue: 1 of 2 mouse testes,pert
"Control #3, Untreated",ctrl
Paclitaxel-resistant,ctrl
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N1,pert
age: 53;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
skNAC knockout heart,pert
strain: C57Bl/6;	genotype: Myc(F/F);	cell type: CD8+ T cells,ctrl
2824 TG,pert
"metastatic, pooled, prostate cancer",pert
wildtype luminal mammary epithelial cells,ctrl
Patient identifyier: R;	Sex: male;	Age of patient: 56 years;	Duration of psoriasis: 16 years;	Body surface area: 30 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep5",pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
cell line: L428-PAX5;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
"1104, control, skin fibroblasts",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.515;	OD280: 0.791;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 232;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
U937 cell line infected with GSK3A Construct 5 shRNA,pert
"cell line: 5850, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
Retina RNA,ctrl
Full-thickness epidermis,pert
temporal lobe,pert
cells: CD8+ cells;	tissue: spleen;	strain: Elf4-/- KO,pert
48A;pretreatment;female;breast tumor,ctrl
cell line: HepG2;	genotype/variation: HNF4a knockdown,ctrl
Subtype: RA;	Karyotype: del(5q),pert
strain: CD-1;	tissue: lung;	age: 20 week;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-alpha promoter,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 5",ctrl
HeLa Cells,pert
age: 61;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
postnatal 12 weeks control heart,ctrl
"C57BL/6J Acute morphine treated, biological replicate 1",pert
R1/E ESC,ctrl
Patient: A;	Time: 0;	Group: responder;	Condition: lesional,ctrl
Embryonic Cardiac Progenitors - mutant,pert
"heart, control, 6 months",ctrl
Pre-Frontal contex of naïve AChE-R mice,pert
"Normal cervix epithelium, Age 64",ctrl
tissue: brain;	genotype: mutant Ndel ko/+ mix background;	age: P14,pert
MPM tumor specimen 26,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 7 hours,ctrl
RAW 264.7 macrophage cell line,pert
strain background: C57Bl/6J;	gender: male;	strain background: Glo1 overexpression;	age: adult;	tissue: whole brain,pert
HUVEC transfected with a scramble-LNA,ctrl
strain: myd88 KO;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,pert
genotype/variation: WT;	strain: C57BL6/N,ctrl
Bone Marrow Mononuclear Cells;	44y Female,ctrl
S46 WT2	F5/8	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
"Liposarcoma culture from tumor 340, untreated",ctrl
cell type: peripheral blood mononuclear cell (PBMC);	disease status: pancreatic cancer,pert
CD34+ cells isolated from the bone marrow of an MDs patient,pert
Alb69 mutant mouse,pert
foxp3 expression: YES;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 wild type;	gender: female;	treatment: none,ctrl
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
breast adenocarcinoma from 69yr old female caucasian,ctrl
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 3hr,ctrl
race: caucasian;	age (years): 75-80;	stage: n/a;	grade: n/a;	histology: weakly proliferative w/cystic changes,ctrl
strain: C57BL/6J;	cell type: MEP;	genotype/varation: ∆Hmga2,pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,ctrl
6 with Cy5,pert
Notch3 knockout cerebral microvascular fragments,pert
"Liver, Nrf2 deficient",pert
"HEK293T human embryonic kidney cells, Wnt3A, si-TNIK",pert
Female - caucasian - N-04-M,ctrl
cell culture: grade VI GBM short term cultures,ctrl
primary CD4+ T cells from spleen and lymph nodes,ctrl
Embryonic fibroblast isolated from mouse,ctrl
Ovarian cancer cell line,pert
prefrontal cortex (BA10);	schizophrenia,pert
"Mouse, ATF6bKO, colon, UT, rep2",pert
"Gastrocnemius, 2 months old",ctrl
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 24hr,pert
Strain: 129SV/EV IFNAR1-/-;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
age	64;	gender	male;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	7.1;	leukocyte count (/nl)	38.3;	hemoglobin (g/dl)	14.1;	platelet count (/nl)	212,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 24h,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-3,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,ctrl
WT CD80lo mTEC sample1,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 359;	age-at-biopsy-years: 48,pert
"Liver, fasted, PBS",pert
"Cell type: neuronal, age:49, gender:female, diagnostic group: control, PMI:45h",ctrl
"liver, PPAR KO_ctr_117",pert
background strain: C57Bl6;	genotype/variation: WT;	age: 9 weeks old;	tissue: whole heart ventricle,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 218,pert
Mouse male ES cells WD44 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-2 in WD44.,pert
agent: ConA;	time point: 1 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
subject: 8;	disease: CP;	muscle: ST;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
"vehicle treatment, 72 hour time point, biological replicate 2",ctrl
E18.5 top2b-/- brain,pert
INS-1 cell line #2 with induced HNF4a2,pert
"Female (age range 33-49), skin biopsy upper nates. No nickel exposure",ctrl
gender: female;	batch: 1;	age (years): 25;	patient id: Control_2;	fev1 (% predicted): 103;	fvc (% predicted): 107;	medication: None;	cell type: CD4+ T-cells,ctrl
"Spleen homogenate, infected, 7 weeks",pert
treatment: baseline;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
human CF cell lines airway with 24 hours of DMNQ treatment,pert
Panc1005 cell line,pert
Spleen and lymph nodes,pert
Mouse: strain C57,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 2,ctrl
resected non-tumor liver tissue,pert
cell line: prostate cancer cell line PC-3;	telomere status: Short;	exogenous htert: absent,ctrl
56 Day MOuse extraocular muscle,ctrl
MCF-7cells treated with vehicle and scrambled siRNA,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.32603,pert
skin_tissue,pert
"Postnatal day 11 Cerebellum, knockout for L1CAM, replicate 3",pert
HCC_33N,ctrl
Human PBMC,ctrl
"MCF-7 breast cancer cell, transfected, pcDNA3.2-BP1",pert
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",pert
HeLa,ctrl
Huh7,pert
spleen,ctrl
IOSE80pc Cells,ctrl
gene-targeted derived R1 cell line,pert
tissue: blood;	patient: 5;	gender: male;	age: 38,pert
"metastasis: none;	Stage: 3c;	tissue: cancer, homogenized",pert
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1+/+;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: None,ctrl
"patient: 203;	current medication: Asacol 800mg BD, Simvastatin;	birth date: 1/10/35;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/92;	diagnosis date: 3/23/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/1/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 14;	crp: 0;	hb: 147;	wcc: 6;	neutrophils: 4;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: HISTOLOGICAL;	diagnosis recto sigmoid: HISTOLOGICAL;	diagnosis splen flex: HISTOLOGICAL;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/57;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 0,pert
"age at diagnosis: 53;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
patient: 3;	disease state: hypertension;	tissue: Atheroma plaque,pert
EB_07_24h_133_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
murine neural crest,ctrl
duration of untreated disease in month:6.5;	age at onset:7.7,pert
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 0;	pgr: NA;	dfs-month: 15;	dfs-event: 1;	distant metastasis: NA",pert
D with Cy5,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
HLA risk: Low;	Height: 181.1 cm;	Weight: 76 kg;	BMI: 23.2;	Age: 16.82 years;	Gender: Male;	Race: White;	Glucose: 75 mg/dl;	HbA1c: NA,ctrl
bone marrow-derived macrophages,pert
patient E1709,ctrl
"treatment: diclofenac;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
background mouse strain: C57B16;	genotype: WT;	treatment: Vehicle,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 3;	age: Post natal day 3-6,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.946;	OD280: 0.992;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 129;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
skeletal muscle myoblast_OE_day3,pert
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 +/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,ctrl
strain background: C57BL/6;	genotype/variation: Runx1-knockout mice (Runx1floxed/floxedMxCre+/-);	tissue: bone marrow;	cell type: sorted c-Kit+/Sca-1+/Lin-/IL7Ra- (KSL) cells;	experimental procedure: 3 months after poly IC treatment,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
"pooled adult mouse intestine, kidney, and liver plus fetus tissue",ctrl
"Autism no regression, Male",pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).,ctrl
ICR MEF infected  with pMX-jhdm1b retrovirus,pert
gender: Female;	age (y): N/A;	tissue: normal pituitary,ctrl
GC resistant clone C7H2-R9C10 treated for 6 hours with EtOH,ctrl
"primary cortical neurons, luciferase shRNA",ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: m;	treatment: -,ctrl
"Huh7 cells, Mock Infected, 24 hours",ctrl
tissue: Frontal cortex;	age: 88;	Sex: F,pert
"Adult mouse, C57black background, left ventricle of heart",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 185min;	race: Asian;	sex: Female,pert
SLE patient,pert
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
NBD inhibitory peptide-treated DND41 100mM 16h,pert
"mouse skin, Tcfap2c mutant",pert
clear cell sarcomas of the kidney and Wilms tumors,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.542;	OD280: 0.787;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 62;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Trained diabetic mice, time point 3 week",pert
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 28;	maternal age: 27,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.59178,pert
myoblasts transduced with lentivirus carrying DUX4-fl,pert
ARPE-19,pert
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,pert
U2OS PRC shRNA4_pLenti,pert
Karyotype: inv(14)(q11q32);	Age: 74 years;	Gender: female,pert
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,pert
Rat Heart,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, FLX treated",pert
Healthy controls; individual=JR; time=2; beverage=water,ctrl
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 2,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
B_cell_pool_melanoma_M03+M04,pert
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"psoriatic epidermis, phototherapy, 2 months",pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: E2;	time: 4h,pert
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: overexpression control,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.793;	OD280: 0.877;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 143;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CRG,pert
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: littermate control, Atoh1-Cre;Dicer1(flox/wt);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 3,pert
"RNA from HnRNP A1 IPs, HuR KO MEFs",pert
Proliferative Phase Endometriosis,pert
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 4",ctrl
Human Fresh Bronchial Epithelial cells,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 219,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 32, stage IIIB, HPV 16",pert
13 with Cy5,pert
Glioma cells not expressing Cyr61,ctrl
disease state: healthy control;	tissue: epidermis;	age: 40;	gender: male;	treatment: untreated;	time: control,ctrl
PBMC from Rhesus Macaque,pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,ctrl
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,ctrl
tissue: white blood cells;	age: 18.57;	Sex: female,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 7",pert
sparse HUVECs stimulated with Angiopoietin for 1 hour after overnight starvation,pert
"seminoma specimen, pT1, patient age: 39y",pert
treatment: shcontrol;	cell line: U138MG,ctrl
"Transgenic, snap frozen, diaphragm muscle, 7month age animal",pert
GM8922A,pert
"male;	CABG patient, atrial tissue;	baseline before CABG surgery",ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu2,pert
HCC_27N,ctrl
F1 ES Cells,ctrl
heart of 4 week control male mouse,ctrl
"HSCs from male mice treated with oil, replicate 1",ctrl
"genetic background: B6;	genotype/variation: Eos (Ikzf4) knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
chip number: 23;	transfection plate: 4;	target gene: RDBP;	kd level: 0.79;	rin: 9.5;	transfection date: 2011-10-17,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.167;	OD280: 1.069;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 134;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.77534,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 33 yr;	population: white;	dsm-iv: 296.53;	age of onset: 15 yr,pert
gender: male;	strain: BALB/c;	tissue: liver,pert
cell line: JCRB0033 [CEM];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
mutant Ndel ko/+,pert
A61 NES 142Q TG2	F6/22	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
injury stage: Spinal 60 days;	gender: male;	strain: Wistar,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 27.167;	Ratio: 2.13,pert
Cell line: human ES cell HES2,pert
patient id: 324;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 60;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"cell type: MYC positive B-cell;	transgene: MycEGFP (a Myc reporter allele, in which a MYC-EGFP fusion protein (MYCEGFP) is expressed from the endogenous Myc locus);	genetic background: C57/Bl6",pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 350;	age-at-biopsy-years: 47,ctrl
Squamous cell lung cancer patient 36,pert
"Genotype: c-Myc transgenic;	c-Myc transgenic female mice displayed morphological alterations with varying degree of nuclear atypia, such as bronchiolo-adenomas and bronchiolo-adenocarcinomas. Thus, different stages of malignant transformation of alveolar epithelium were observed.",pert
mouse embryonic fibroblasts,pert
MCF-10A_shATM-1,pert
individual: Control1;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
harmane 1uM batch 3,pert
Wild-type bone marrow-derived macrophage,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 minutes after intravenous saline challenge""",ctrl
patient: 40836;	sample: normal,ctrl
tissue: heart;	genotype: WT;	genetic background: C57BL/6,pert
"dy3K/dy3K, mouse model for congenital muscular dystrophy type 1 A",pert
Tendon;Brachialis_Non-lesional,ctrl
CD4_Tcells_severe_asthma,pert
KO fed  regular chow,pert
disease group: normal;	cell type: chondrocytes;	cell culture: monolayer,ctrl
gender: male;	age (years): 39;	evolution time (years): 3;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Wild type,ctrl
MCF7 fulvestrant-resistant cell line,ctrl
Hippocampus from mouse,ctrl
RV83.02_CONTROL_day10,ctrl
NCI-H716,ctrl
background strain: Derived from BL6 blastcysts.;	cell line: WD44;	cell type: ES cell;	passage: 14-18,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: pre-UV,pert
oocyte,ctrl
C57BL6_lung,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2, M0, G4",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.279;	Ratio: 2.12,pert
Striatum of 8-10 week old C57BL/6J mice,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 62.05479,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: F;	age: 50,ctrl
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: cardiac muscle,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: liver;	age: 12 weeks,pert
Bone Marrow MGUS patient,pert
HLA risk: High;	Height: 145.1 cm;	Weight: 32.1 kg;	BMI: 15.2;	Age: 10.16 years;	Gender: Female;	Race: White;	Glucose: 188 mg/dl;	HbA1c: 6.1%,pert
"Lymphoblastoid cell lines derived from family 1734, member 2",ctrl
tissue: testis;	gestational age: 22 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
Dot1l flox/flox day 7 after transduction with control,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 288;	age-at-biopsy-years: 52,ctrl
"WT cells, replicate 1",ctrl
gender: Female;	age: 87;	post-mortem delay: 14.5h;	ph: 6.5,ctrl
age: 7dpp;	genotype/variation: wild type;	tissue: testis,ctrl
Neuroblastoma cell line,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 46;	donor: 29;	disease state: Non-lesional,ctrl
mouse B6xCF-1  Non-transgenic (control-2),ctrl
"human embryonic stem (hES) cells line VUB01, biological replicate  1",ctrl
microdissected epithelial cells from normal main pancreatic duct 4,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 311,pert
Mouse cardiac left ventricle,pert
THP-1 cell line infected with scrambled control shRNA,ctrl
"BALB/c BMDM infected with WA(pTTS, pP60)",pert
uterine normal myometrium,ctrl
"Hereditary gingival fibromatosis (HGF) is a benign disorder manifested by a slowly progressive enlargement of the oral gingival tissues, which results in the teeth being partially or totally engulfed by keratinized gingiva.Affected gingiva tissues were removed from HGF volunteers during surgical procedure.",pert
RNA from whole tissue section of case 1037 labeled with Cy5,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 47;	gender: male;	tumor grade: AIII,pert
"HCT116 cells, XIAP shRNA, early passage",pert
clear cell sarcomas of the kidney and Wilms tumors,ctrl
0810A-01_scrambled control-2,ctrl
CD71+ bone marrow cells from Ifng-/- mouse 2,pert
8 wk old male C57BL10,ctrl
cell line: HL-60;	replicate: Replicate2;	treatment: shSYK_1,pert
genetic background: 129SV;	genotype: WFS1 WT;	tissue: hypothalamus,ctrl
"Microdissected normal cervical epithelium, Age 38",ctrl
8 Week cardiac muscle,ctrl
"Heart, mdx, 2 months old",ctrl
tissue: embryonic fibroblasts,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 40;	maternal age: 39,ctrl
hiPSC-derived 6-week-old neurons,ctrl
ET patient,pert
murine whole heart tissue,pert
CD8 KLF13 KO,pert
tissue type: Lesional skin;	time: Week2_etanercept,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 5,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 3,ctrl
immortalized cells derived from brown fat tissue of mouse of mixed background. passage number: 4.,ctrl
Ficoll/PBMC,ctrl
MCF10A-HER2-FKBP-HA cells,ctrl
"Cultured ovarian cancer cell line OVCAR-8, untreated",ctrl
ERα-positive breast tumors with PIK3CA mutation,pert
"liver, conditional Nrf1 knockout, Nrf1(dN/-)::Alb-Cre",pert
gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7,ctrl
"ID: MLL_00230;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
S5A Sporadic-frontal,ctrl
disease state: healthy control;	cell type: Peripheral blood mononuclear cells,ctrl
"skin fibroblasts, passage #1",ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: wild-type;	age: 32 weeks,ctrl
Mouse jejunum PND30,pert
chip number: 11;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.79;	rin: 9.6;	transfection date: 2012-03-26,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 147;	time: 0;	batch: 4,ctrl
Sarcoma cell line heterozygous for Dicer,ctrl
cell line: prostate cancer cell line DU145;	genotype/variation: negative control siRNA,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 4;	gender: male,ctrl
human liver; advanced HCC,pert
"RWPE1 cells treated for 6 hours with 100 nM 1,25(OH)2D",pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 1,ctrl
CD34+ cells from the patient (CML35),pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 1;	Exposures: 3,ctrl
HL60 AML cells,pert
clone type: AtT20 clone types overexpressing NSBP1WT protein rep3,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 20;	age of psoriasis onset: 33,pert
"NCI-H460, cisplatin, 24 hr",pert
astrocyte,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 6 months,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
subject: 38;	disease: CP;	muscle: GR;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
cell line: MCF7;	condition: siRNA Med12 + Estrogen,pert
batch: B;	knock-in: Twist-DQD;	cell line: MycCap prostate cancer cells,pert
"SRF silenced, treated with R1881, biological rep 3",pert
PKCZ -/- male mice angiotensin II treated,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: normal,pert
Heart tissues,pert
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
GFP_0hr,ctrl
"TNFa siRNA-A, replicate 2",pert
"fetal testis sample 21, 16 weeks gestation",ctrl
full thickness aortic wall biopsy,ctrl
sex: Male;	Age: 47 months;	additional patient information found in Series supplementary file,pert
"brain, Entorhinal Cortex",pert
"genotype Cldn16 -/-, renal tissue",pert
Brain (Inferior Olivary Nucleus)_control subject_#5,ctrl
"Patient  G, lesion, time: 0",ctrl
C8161 cell line,ctrl
RNA pool from MPH-treated LCLs generated from unaffected controls,pert
histology: chronic plaque;	disease state: multiple sclerosis after inflammation has subsided-late stage;	tissue: multiple sclerosis brain lesion,pert
homozygous_2,pert
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 1,pert
genotype/variation: PtenL/L (isogenic wildtype);	cell type: embryonic fibroblasts;	time: control;	genetic background: C57BL\6,ctrl
cell type: endometrial stromal cells;	growth phase: early passage,ctrl
7 Day Mouse Leg muscle,pert
mutant 14-3-3 ko/ko,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 25;	maternal age: 27,ctrl
Male Sprague-Dawley (Crl:CD(SD)IGS Br;	Age: between 5 and 6 weeks old,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 27;	maternal age: 24,pert
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: 3-D,pert
multiple sclerosis_5,pert
Old Control;	female,ctrl
MEF,ctrl
cerebellum_21 month,ctrl
"mouse, liver (CCl4), treated with erlotinib 5mg (week 18)",pert
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with non-targeting vector,ctrl
remitted schizophrenia patient,pert
"liver, STZ-treated mice",pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 31;	maternal age: 28,pert
"Total RNA, WT CMP",ctrl
gender: Female;	age: 82;	post-mortem delay: 8.5h;	ph: 5.9,pert
BaF3 cell line transduced MPLW515L3 mutant grown in 0.8 uM INCB18424 for 4 wks,pert
subject: 32;	disease: CP;	muscle: ST;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",ctrl
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
"HSCs from male mice treated with E2, replicate 3",pert
"gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
NK_cell_pool_melanoma_M09+M10,pert
Heart dissected from E12.5 fetus with a null mutation for the Sp3 transcription factor.,pert
"Undifferentiated C2C12 myoblasts, passage #11;	",pert
"Liposarcoma culture from tumor 379, untreated",ctrl
HaCat cells infected with a control lentiviral construct. Replicat 2,ctrl
B cells -  wildtype mice - influenza-infected,pert
explanted neonatal cardiomyocyte,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 72 years,pert
gallbladder-saline treated,pert
"whole brain, nicotinic acetylcholine receptor subunit mutant mice and littermate controls",pert
disease state: healthy control;	tissue: epidermis;	age: 47;	gender: female;	treatment: untreated;	time: control,ctrl
strain background: mixed (SV 129/C57BL/6);	genotype/variation: wild type (Rnh1 +/+);	age: embryonic day E9.5;	tissue: yolk sac,ctrl
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,ctrl
146_DMSO,ctrl
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 25y/female/caucasian. Cause of death: pneumonia.,ctrl
sampleID: SAM630143;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Male, 32 years old",ctrl
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 4051964034;	hybridization batch: II,ctrl
cell line: U87;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
GATA-1deltaNeodeltaHS mutant E12.5 fetal liver derived megakaryocytes,pert
Celecoxib_#4861,pert
S4_Sham_wildtype_8,ctrl
"100-200 motor neurons, sacral spinal cord, 21 days post injury",pert
Disease_status: Bipolar disorder;	Age (years): 58;	Gender: Female;	Age of onset (years): 27;	Duration of illness (years): 31;	Brain pH: 6.50;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
rectal suction specimens,ctrl
SK-MEL-2 Melanoma cell line,ctrl
MOLM-14 cell line infected with GSK3A Construct 5 shRNA,pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 WT;	tissue: liver,ctrl
Sample Group: HD patient; Gender: female; Age: 41; Tissue: lymphocytes (blood); IT15 CAG repeats: 24/49,pert
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14502;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Embryoid bodies, 12h,Min Dox",ctrl
"Pool of four samples (n=4);;	gender: three female/one male;;	age: 19/57/40/70 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
NK_cell_pool_healthy_H07+H08,ctrl
age: 21 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hr AP20187,pert
"tissue: Cardiac, ventricular tissue;	genotype: wild-type;	age: 8 weeks-old",ctrl
subject: 1;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
EmptyVector 1,ctrl
race: caucasian;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).;	,ctrl
Mutator,pert
"Gender: Female, Age: 358, BMI: 30, Tissue: luteinized cumulus cells",pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#2,pert
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-NME2-MYC,pert
"Male, 32 years old, HIV infection of ~4 months",pert
EB_0_8d_67_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
Undifferentiated mouse embryonic stem cells,ctrl
subject id: 32;	infection: DENV;	status: DHF;	tissue: whole blood,pert
"Nrl-ko, purified Gfp+ photoreceptor cell",ctrl
Female - caucasian - N-01-M,pert
"Female Nrf2 Knock-out mice, liver sample",pert
J1 ES Cells,pert
wild-type male mice non-treated,pert
Human umbilical vein endothelial cell,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 95;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
"Csbm/m mouse, cerebellum, standard diet ad lib",ctrl
cell line: LNCaP,ctrl
bone marrow,pert
strain/background: mixed B6/129/FVB;	genotype: MMTV-Cre;Runx1L/L;R26Y;	gender: female;	developmental stage: adult virgin;	cell type: mammary gland luminal epithelial cells,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 24h",pert
"15B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.881;	OD280: 0.457;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 310;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
Peripheral Blood Mononuclear Cell (PBMC),pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 37,pert
hematopoietic stem cells transduced with control,ctrl
"Wild type, 6 weeks old",ctrl
"age at diagnosis: 34;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 61;	dfs-event: 1;	distant metastasis: 0",pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N0,pert
cell line: SKMEL28;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 2hr,pert
strain background: C57BL/6;	genotype/variation: IL-22-/-;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,pert
"ID:3-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
Stratagene reference,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
cultured human melanoma cancer cell 224,ctrl
"skin fibroblasts, passage #4",pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 24,pert
BJ fibroblast replicate 2,ctrl
"Fmr1 knockout mouse, blood",pert
"ID:11-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
primary cell culture,ctrl
"Deltoid, FSHD, cohort 20, subject 20A",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 12h,pert
BB Rat day 65 female diabetic prone mast cells from pancreatic lymph node,pert
cerebellum_21 month,pert
chip number: 17;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.4;	transfection date: 2012-03-26,pert
HepG2 cell line from ATCC at 8th generation.,pert
"12-week-old 12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 3,ctrl
ID: MLL_00114;	cell type: PBMC;	disease state: control,ctrl
"FACS-sorted cones, P50 C-DGCR8 KO mice",pert
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"Frontal cerebrocortex, Permethrin (1 mg/kg), 6 hours",pert
HCC_6T,pert
tissue: white blood cells;	age: 11;	Sex: male,ctrl
"PCOS, biological rep 5",pert
cell type: Immortalized AR positive myofibroblast,ctrl
ST045849 24 hours_1,pert
lung tissue,ctrl
P19_exPKO_pancreas,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch2",ctrl
Treated with 5% mannitol for 4 hrs -- replicate #1,ctrl
HEK293 cell line #2 with induced HNF1beta,pert
27 weeks female,ctrl
patient: 251;	current medication: Bumetanide Asprin Lisinopril Colifoam;	birth date: 5/22/21;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/05;	diagnosis date: 6/6/05;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/6/05;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Vaginal Prolapse-Angina;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
sex: Female;	family: 3;	age: 32;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
Primary human monocytes,ctrl
"heart, atrial tissue, after CABG surgery",pert
tissue: Hippocampus;	age: 84;	Sex: F,ctrl
subject: 15V;	cohort: 15;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 107kb;	age (y): 60;	Sex: F;	batch: Batch_5,ctrl
bladder epithelial cells,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 3,ctrl
"affected status (disease state): control;	gender: male;	age-at-examination: 50;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.33973,ctrl
"mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 61;	ld: HCV;	creatnine: 1.7;	mdrd: 47;	gfr: UN;	protein: 3;	hematuria: 1;	c3: 1;	c4: 1;	rf: 1420;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.7;	meld: 14;	ana: POS;	gp: Mild mesangial immune complex glomerulonephritis, Severe tubular atrophy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 0;	igg: 1;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 0;	bmd: 0;	edd: 1;	no of glomeruli: 9;	glomerulosclerosis: 0.11;	intact t: 0.3;	arteries: intimal duplication;	if: IGM+IGG+C3+C1Q++mesangial;	mesangium ig: MGC;	tissue: Kidney_Biopsy_Liver_disease",pert
Postmenopausal female. Untreated control. nr 17.,ctrl
RV16;	Age = 22;	Sex = M,pert
"Deltoid, FSHD, cohort 21, subject 21A",pert
"MCF-7 cells, siERK2 treatment 60h, 10 nM E2 for 4h",pert
subject id: c5;	infection: control;	status: control;	tissue: whole blood,ctrl
male,pert
Human glioblastoma cell line U87MG treated with a control siRNA,ctrl
P19_WT_pancreas,ctrl
Retina no glaucoma,ctrl
GFP+ one marrow cells transduced with pSF91-MN1-IRES-GFP 4  weeks after Tx,ctrl
thymic tumor IkL/L mouse,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 37;	gender: f;	treatment: NSAIDs,ctrl
sex: Female;	family: 2;	age: 38;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
strain: C57BL/6;	diet: MCD + HF diet mixed with 0.1% metformin (nash metformin);	tissue: liver,pert
"Lymphoblastoid cell lines derived from family 1736, member 1",pert
mouse strain: C57BL/6J;	genotype/variation: AhR null,pert
chip number: 11;	transfection plate: 4;	target gene: IRF9;	kd level: 0.77;	rin: 9.1;	transfection date: 2011-10-17,pert
wild type embryo MEF cells,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 49;	gender: male,pert
Patient: L;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
18h fasted hearts,ctrl
human preadipocytes+oligo2_day0_rep2,pert
RV64.03_CONTROL_day25,ctrl
gender: male;	disease state: healthy,ctrl
Human melanoma cell lines,ctrl
age: 7dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
"C57BL6J-backcrossed, male",pert
B_cell_pool_healthy_H01+H02,ctrl
human breast cancer cell line,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep3",pert
WA09 human embryonic stem cells,ctrl
Gender:F;	Age:45;	Tissue:Mucosa,pert
"lung homogenates, AhR KO, PBS control",pert
NSCLC cell line H157. Transfected with siRNA oligomers targeting DJ-1 - #1,pert
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3 and stem cell factor,pert
E14.5 WT 2,ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
"BN strain, male, age 21 weeks",ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 65;	donor: 21;	disease state: Lesional,pert
siOGT 12 hours_3,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#4,pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
"GI, P.Col",ctrl
PancreaticSample27-Tumor,pert
Time:3 day; condition:ctr;,ctrl
Mouse liver (8 weeks),ctrl
1uM H2O2 rep 4,pert
strain/background: C57BL/6N;	genotype: wild-type;	tissue: liver,ctrl
tissue: skin;	individual: Patient P1;	condition: ANL;	eczema severity: SCORAD: 0,pert
8 wk old male mdx soleus,pert
"Liposarcoma culture from tumor 337, untreated",ctrl
mouse: 5;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
Healthy-5 baseline,ctrl
"21B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: male,pert
WILDTYPE cerebellum at 20 days,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,pert
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 32;	Usage number: 4;	Exposures: 3,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: a9 knockout;	age: P13,pert
Mock infected macrophages harvested at 6h post-treatment from donor 1,ctrl
R,pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
PIK3CA.DMSO.3,pert
Mouse spleen at 4 month,ctrl
cell type: Embrionic stem cell line;	genotype: wild-type,ctrl
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IV;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 1;	dfs-month: 16;	dfs-event: 1;	distant metastasis: 1",pert
Diagnosis: AML M5;	Age: 38y;	Gender: Female;	Blast %: 97;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 1,pert
Mouse striatum,pert
NORMAL LIVER TISSUE,pert
striatum_6 month,ctrl
"Normal cervix, microdissected, Age 42",ctrl
tissue type: Primary lung tumor;	histology: AS,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 176,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 31;	gender: male,pert
chip number: 21;	transfection plate: 6;	target gene: JUND;	kd level: 0.79;	rin: 9.3;	transfection date: 2012-03-26,pert
"LCL GM19238, Kd IRF3, 72hrs",pert
cell type: MEF derived stable cell line;	genotype/variation: Tet-off control cells,ctrl
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with DMSO,ctrl
tissue: Temporal cortex;	age: 86;	Sex: F,ctrl
ICL670 10uM for 16hrs,pert
cell line: HL-60 promyelocytic leukemia cell line;	leukemia type by fab: M2;	agent: TCDD,pert
PS_IA_3_aa_lcm,pert
"12 weeks normal mice, cerebrum",ctrl
patient: 8;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
S25 WT2	F41/390	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
Gender: male;	Age: 34;	Ethnicity: white,ctrl
Carboplatin;	Carboplatin 30 hours set 2,pert
A YOKE_B095,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.4;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IV, HPV 16",pert
25 uM chlorpyrifos batch 2,pert
"- Rosiglitazone, - PPARg, 24 hrs",ctrl
PancreaticSample14-Normal,ctrl
Gastrocnemius muscle wild-type mouse,ctrl
B6 wild type;	Age: 4-8 wks,ctrl
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,pert
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 4,ctrl
"Mouse Sciatic Nerve, Diabetic Vehicle",ctrl
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 48 hours",pert
"white adipose tissue, wild type",ctrl
Lineagelow Sca1+cKit high Cells,ctrl
"Brain tissue from Fisher 344 male rat, Animal #247, 500mg/kg D-Serine",pert
P1 eyeball,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 42 yr;	population: white;	dsm-iv: 296.64;	age of onset: 20 yr,pert
PBMC from T cell Large granular lymphocyte leukemia patient#128,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 24h",pert
"cell line: HeTH-4;	genotype/variation: control;	comments: HeLa cell line with inducible THOC1-depletion, non induced",ctrl
patient: 40645;	sample: normal,ctrl
cell line: RT112;	transduced: EGFP shRNA;	doxycycline treatment: no,ctrl
"Deltoid, FSHD, cohort 09, subject 09A",pert
Parental JoMa1,ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 116;	genotype/variation: WT;	age: 8 weeks,ctrl
Age: 50;	Cycle: NA;	BRCA1/2 mutation: BRCA1 917delTT;	Family History: Yes,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus trisomy8 plus other,pert
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: negative,pert
CD4_T_cell_pool_melanoma_M07+M08,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day7,ctrl
Patient: H;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
HCC_13T,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
mouse liver,pert
tissue: Temporal cortex;	age: 80;	Sex: F,ctrl
cell type: brown preadipocyte;	genotype: Ezh2 +/+,ctrl
cell type: Endothelial cells,pert
Sex: male;	Age at operation: 60 years;	Site: thigh;	Size in cm: 7.5x6x5.5;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
gender: Female;	age: 88;	post-mortem delay: 5h;	ph: 6.8,ctrl
tissue: skin;	individual: Patient P2;	condition: AL;	eczema severity: SCORAD: 28,pert
"soleus muscle, young female pathogen-free Wistar rats",ctrl
no_02+05+08,ctrl
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIb;	Sex: F;	age: 52,pert
race: african american;	age (years): 37;	stage: IA;	grade: 2;	histology: endometrioid,pert
Strain C57BL/6;	Tissue: Backskin;	Age: e18,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,ctrl
MCF7 - Control,ctrl
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: mammary gland",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Female,pert
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 33;	maternal age: 29,pert
Cell line,pert
(ca)Raf_1,pert
cell line: MCF7;	condition: control,ctrl
Extract:LOX-1:213503;	Extract Description:LOX1_Untreated_24hr:213503;	Quality: Classification:Bad;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.03;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.74;	Quality: Background Mean Dev.:2.24;	Quality: Absent (%):61.27;	Quality: Absent (%) Dev.:2.34;	Quality: Scaling Factor:1.66;	Quality: Scaling Factor Dev.:9.07;	Pretreatment [C]:LOX1;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_24hr;	RNA extraction source key [A]:282295913,pert
normal;	Adjacent pair of T18,ctrl
ApoE-/- mouse infected wtih a control adenovirus expressing GFP,ctrl
Mannitol control treated A549 human lung cancer cell cultures replicate A,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
disease: cardiopathy;	gender: male;	age: 9 years and 10 months;	tissue: thymus,ctrl
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: Cre knockout of Dicer;	tissue: uterine;	age: 15 days,pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Female,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
YFP-pos GMPs,pert
F9 embryonal Carcinoma cells,pert
tissue: Temporal cortex;	age: 88;	Sex: M,pert
human breast cancer cell line,ctrl
Lung Cancer,pert
"Benign, Prostate tissue",ctrl
tissue: colon biopsie,ctrl
cell line: FOXO null,pert
"Transgenic, brain hemisphere",pert
Rybp#15 (OHT-)_4d,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.814;	OD280: 0.932;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 137;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep1",ctrl
"BOEC, normal 14",ctrl
Tissue:tumor; Gender:female; Age:43; Tumor stage:T1N1aMx,pert
EB_15_6_342_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
Aquaporin-11+/+_mouse P7 kidney #4-2,ctrl
HGPS-fib_1,pert
EB_2_19d_233_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
HT29 cell line,pert
DBA mouse treated with pristane for 3 days,pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB with doxycycline,pert
"Patient  J, lesion, time: 0",ctrl
CD71+ bone marrow cells from WT mouse 1,ctrl
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
patient: 231;	current medication: prednisolone 40mg heparin clarithromycin;	birth date: 10/29/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/00;	diagnosis date: 11/19/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/28/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"BMDM, WT, uninfected",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 50;	gender: male,pert
tissue: Biceps muscle;	patient: P.b.5;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
482 cells Sox2shRNA-rep3,pert
disease state: control;	patient: 18,ctrl
strain: GNMT KO;	developmental stage: Post natal day 90,ctrl
strain: F1 (C57BL6 X 129/SvEv);	genotype: wild type mice;	tissue: kidney;	gender: male;	treatment: NS diet,ctrl
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: Ogt silencing,pert
"Wt mouse, cerebellum, young, saline treatment",ctrl
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",pert
CD4+T cells,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: moderate;	Ig clonality: oligoclonal,pert
anti-FGFR1,pert
Modified MCF10A Cells,ctrl
"Transgenic, snap frozen, gastrocnemus muscle, 10 month age animal",pert
KO_d00_e0,pert
CD3-stimulated CD4+ T-cells from Itk knockout C57BL/6 mice,pert
Treated with 5% mannitol for 4 hrs -- replicate #2,ctrl
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
MPM tumor specimen 3,pert
cell line: BL2;	transfection: scrb siRNA;	batch: 2,ctrl
rd1 mouse retina at age postnatal day 8,pert
MCF-10A_shCHK2-2,pert
subject: 12U;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 2,ctrl
"strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: TCPOBOP; 1,4-bis[2-(3, 5-dichloropyridyloxy)]benzene",pert
PBS Treated Cells 1,ctrl
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 48 hr,ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C11,pert
strain: C57BL/6;	diet: methionine- and choline-deficient diet+ high fat diet (NASH);	tissue: liver,ctrl
normal;	Adjacent pair of T10,ctrl
patient id: T165;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 40;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
tissue: Brain;	genotype: Npc1+/-;	age: 81 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
F6.04,ctrl
tetracycline inducible Ngn3 ESC differentiated for 10 days as EB without doxycycline,pert
"ID:c 4-2, Genotype=(C57BL/6J), Treatment= none",pert
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal, mucinous;	tumor grade: G1;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
Postmenopausal female. Estradiol treated. Patient 36.,pert
cell line: DBTRG;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 23;	gender: male,ctrl
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: untreated;	treatment time: 16 hours,ctrl
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: TCF-1-deficient;	age: over 80 days after infection,pert
primary normal lung tissue 1455,ctrl
WT S49 2 h cAMP treatment,ctrl
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,pert
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,pert
HeLa treated with siRNA specific for optineurin mRNA,pert
"Heart, Cmah KO, mdx, 2 months old",pert
RNA from microdissected breast cancer cells from case 772 labeled with Cy5,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day4,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: post-UV,pert
disease state: healthy control;	tissue: epidermis;	age: 17;	gender: male;	treatment: untreated;	time: control,ctrl
2825 WT,ctrl
B-CLL PB P136,pert
Strain: C57BL/6;	Gender:male;	Tissue:liver,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T2, N3, M0, G4",pert
resected liver tumor,pert
condition: Non-syndromic cleft lip/palate (NSCL/P);	tissue: decidous teeth dental pulp;	gender: female,pert
transfection: CDK8-2;	cell line: HeLa S3,pert
BV2_Curcumin_rep1,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
patient: 32;	disease state: hypertension;	tissue: Atheroma plaque,pert
C2_CLP_overexpressor_12,pert
B1_saline_overexpressor_422,pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
Strain:  C57BL/6,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 49 yr;	population: white,ctrl
subject id: 80;	infection: DENV;	status: DF;	tissue: whole blood,pert
kidney biopsy from patient after Tumor Nephrectomy,ctrl
genotype: MLL translocation,ctrl
"LY2 cell line, SRC-1 siRNA untreated, biological rep1",ctrl
Strain C57BL/6;	Tissue: Backskin;	Age: e18,pert
Synovium_Synov,ctrl
WT Mouse spleen Ter19+CD71high sorted cells,ctrl
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
28 Day Mouse Diaphragm muscle,ctrl
myocardium sold commercially,ctrl
WT Thymus,ctrl
strain: Gata4tm1.1Sad/J;	infection: Mouse GATA4;	culture: Growth medium,pert
Rnh1 Knock out  embryo yolk sac,pert
Labeled microRNA,ctrl
cell line: SKMEL28;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
age: 15;	sex: F;	disease status: control subject;	Filter number: 95;	Usage number: 1;	Exposures: 3,ctrl
B_cell_pool_healthy_H11+H12,ctrl
TL3 cell lines,pert
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
HOX424 Carbo Day2,pert
Wildtype pancreatic RNA 36 hours post-tamoxifen,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 24 hour",pert
chip number: 13;	transfection plate: 4;	target gene: IRF5;	kd level: 0.79;	rin: 9.3;	transfection date: 2011-10-17,pert
cell line: CAL27;	treatment: PBS,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: F;	experimental sample name: PC11-R,pert
disease state: paediatric glioblastoma;	age: 9;	gender: M;	h3.3_status: wt,ctrl
29 with Cy5,pert
Sh2b-/-  NOTCH1 induced tumors,pert
"Patient  H, lesion, time: 0",ctrl
triplicate 2 of uninfected HepG2 nt cells,ctrl
chip number: 22;	transfection plate: 4;	target gene: IRF5;	kd level: 0.65;	rin: 9.1;	transfection date: 2011-10-17,pert
patient: 51783;	sample: normal,ctrl
"Cell line:  Fibroblast TTP WT cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
REH E/R positive leukemia cell line,ctrl
KSL cells from control mice (Runx1floxed/floxedMxCre-/-),ctrl
"Sample Type: tissue, Tissue: testis",pert
Nontransgenic littermate mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	Treatment: tamoxifen,ctrl
quadriceps femoris,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 -/-,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.54521,pert
Disease_status: Bipolar disorder;	Age (years): 33;	Gender: Female;	Age of onset (years): 15;	Duration of illness (years): 18;	Brain pH: 6.51;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
age_years: 67;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: Control",ctrl
"WT mouse bone marrow macrophages, unstimulated, 4 hours",ctrl
Sex: male;	Age at operation: 53 years;	Site: thigh;	Size in cm: 10x3x5;	Histological Subtype: atypical liposarcoma;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: LSD1;	transfection time: 48h,pert
"embryonic stem cells, KD replicate A",pert
cell type: peripheral blood mononuclear;	disease state: healthy,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks,ctrl
Brain from 54 days Npc1-/- mouse1,pert
A HID B_B013,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 13.666;	Ratio: 2.07,ctrl
disease unaffected colon of a adult with Crohn's disease (CD),pert
"disease state: Nasopharyngeal carcinoma;	stage: IVC, T4, N3, M1, G4",pert
Diagnosis: AML M5;	Age: 60y ;	Gender: Male;	Blast %: 71;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
WT S49  2h cAMP treatment,ctrl
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: KSR2-/-,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: media-only control,ctrl
HCC_35N,ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
U937 cell line infected with GSK3B Construct 1 shRNA,pert
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
HNF4loxp/-villin cre,pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
Tumor_Pdk1 WT,ctrl
"Huh7 cells, Mock Infected, 6 hours.",ctrl
C5star_CLP_wildtype_8,ctrl
cell type: neuron progenitor cells (NPC);	disease group: schizophrenia,pert
Cultured cell line,ctrl
sample: #23;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1 knockout (SKO);	tissue: Dorsal skin;	age: 8-9 wks old,pert
CML cell line: KU-812,pert
disease state: paediatric glioblastoma;	age: 16;	gender: F;	h3.3_status: wt,ctrl
strain: C57/Bl6;	age: 4 month;	gender: n/a;	weight: 25-30g;	tissue: whole trachea,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
microdissected epithelial cells from IPMA 4,pert
age: 12 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
"CD14+ monocytes, by positive selection",ctrl
cell type: iPSC;	genotype: healthy control,ctrl
mixed background e18.5 male cardiac ventricle,ctrl
Backskin_Get1_e18,pert
strain: GNMT WT;	developmental stage: Post natal day 90,pert
"Uninfected treated with 1,25D, replicate 3",pert
23 Day Mouse leg muscle,ctrl
"MEFs carrying a tet-inducible Pten transgene, 24 hrs after inducing PTEN",pert
Concordant for Epilepsy twin pair 4 (Affected patient of MZ twin pair CCE4),pert
cells: CD8+ cells;	tissue: spleen;	strain: C57BL/6,ctrl
Gender:M;	Age:44;	Tissue: Mucosa;	,pert
Human umbilical vein endothelial cell,pert
"Epithelial prostate primary cells from fresh explant from normal tissue, obtained from a cystoprostatectomy of a patient with a bladder carcinoma with no lesions in the prostate",ctrl
biopsy of normal esophagus from the same patient as a matched Barrett's esophagus biposy,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 53 years,ctrl
CD11b+Gr1- cell sample_3 (derived from wild type mouse),ctrl
cell line: U937;	shRNA construct: GSK3A Construct 6,pert
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting KLF2,pert
Patient: F;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
"Mmp7-/- epithelium, uninfected, 0h",pert
"hippocampus, SSM",pert
Strain: C57BL/6JNIA;	Age: 2 months;	Gender: Male;	Tissue: Whole hippocampus,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 3,ctrl
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
age_years: 58;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
Laser-capture microdissected high grade serous carcinoma,pert
strain: B6/C3H hybrid;	gender: male;	age: 30-month-old,ctrl
gastrointestinal stromal tumor,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Post mortem interval (hours): 22;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
cell culture,pert
disease state: tibial muscular dystrophy (TMD);	tissue: extensor digitorum longus;	age at biopsy: 65;	Sex: male,pert
"t15, surgically resected from patient of gastric cancer.",pert
N2A cells_Pou3f3 knockdown construct,pert
whole right lung,pert
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: vehicle only (5% DMSO in corn oil),ctrl
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
tissue: resected non-tumor liver tissue;	genotype: minor [rs8099917 TG/GG],pert
age: 34;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 5;	Exposures: 3,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 309;	age-at-biopsy-years: 49,ctrl
S25 NLS 142Q TG2	F4/26	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
cell line: H1;	cell type: embryonic stem cells;	shRNA: control,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 51;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
TTF=127min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
"HL-60 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
Mouse inner ear,ctrl
1000uM H2O2 rep 2,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 30,pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",ctrl
TR71 KD mES,pert
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: Nfix depleted,pert
HCC_23T,pert
breast cancer cell line transduced with GATA3,pert
Gene expression profiling of normal cortex of patient T79,ctrl
gastric bipsies,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 43.0;	age of psoriasis onset: 15,pert
"Liver, fasted, phenobarbital",pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
disease state: endometrioma;	patient: 9,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep4",pert
HepG2 cell line from ATCC at 8th generation.,ctrl
ID: MLL_00111;	cell type: PBMC;	disease state: control,ctrl
"twin pair: #10;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,pert
patient: 40656;	sample: normal,ctrl
0810A-01_clone 2-2,pert
coc-42,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic,ctrl
REH E/R positive leukemia cell line,pert
disease state: skin squamous cell carcinoma,pert
hdh genotype: Q7/Q7;	tissue: cerebellum;	age: 3~10 weeks,ctrl
"gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"SKO-transduced MEFs, Vc treated, lysed on D8",pert
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh+/+,ctrl
genotype:Rb null;	Age: e12.5,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shControl.2,ctrl
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 3,pert
"Gender: Female, Age: 25, BMI: 16, Tissue: luteinized cumulus cells",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Male,ctrl
NOMO-1 cells infected with scrambled shRNA control,ctrl
genotype/variation: Cavin-1 deficiency;	age: newborn 0-6 h;	tissue: Lung,pert
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 31;	maternal age: 31,pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"Setd2 wild type mESCs, biological rep1",ctrl
NZM12 metastatic melanoma cells treated with PAX3 siRNA,pert
"LCL GM19238, Kd NR3C1, 72hrs",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",pert
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; mutant,pert
"Liposarcoma culture from tumor 386, doxorubicin treated",pert
HUVEC monolayer,pert
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: empty vector control,ctrl
"Tibialis posterior, healthy control",ctrl
A375P cells expressing Control shGFP,pert
10.5 months cardiac muscle,pert
HCC_26T,pert
lesional skin bioposy obtained from patient at baseline,ctrl
cell line: Hep G2;	genotype: wild-type THRB and;	treatment: with 100 nM T3 for 6h,pert
MycCap prostate cancer cells,ctrl
hippocampal CA1 tissue,ctrl
CD8_T_cell_pool_melanoma_M03+M04,pert
tissue type: normal esophageal tissue of surgically resected human esophagus;	cell type: fibroblast,ctrl
"BioBreeding  DRlyp/lyp rat, day 65, mast cells derived from pancreatic lymph node",pert
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
6 h-apra-2 nM,pert
T74,pert
"urogenital ridge epithelium, E10.5, +/+",ctrl
tissue: Temporal cortex;	age: 55;	Sex: M,ctrl
PS-NA cerebrum at new born,pert
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: WT,ctrl
treatment: control;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 38;	Sex: male;	region: M1;	age: 38;	genotype: Y/Mecp2-;YFPH/-,pert
microdissected epithelial cells from invasive cancer originating in IPMN 1,pert
Strain: C57BL/6J;	Gender: Male;	Age: 2-3 months;	Tissue: heart,ctrl
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: negative,ctrl
Human Leukemia cell line RS4.11,pert
cell line: prostate cancer cell line PC-3M;	genotype/variation: MYB siRNA,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 38,pert
Shn2_wild type,ctrl
male_control,ctrl
malignant tissue_TMPRSS2:ERG fusion positive,pert
"Age: 48;	Sex: M;	Ancestry: European;	Smoking status: smoker, 20 pack-years",pert
Whole blood,ctrl
cell line: Panc-1;	transfected with: pCIG-Gli3T (expressing Gli3T),pert
Human skeletal muscle biopsy sample;	Patient #50 with NORM,ctrl
Patient: O;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
FCHL patient #99-0562,pert
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 5,pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
MDA-MB-231_TR20003,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),ctrl
Gastric tissue normal region,ctrl
T4.02,pert
"Gata4-KO heart, CRE, biological rep1",pert
Isolated PBMCs from diabetic male patient_RES-enriched Grape extract_12 months,pert
tissue source: patients with a mutation (Arg1174Gln) in the tyrosine kinase domain of the insulin receptor gene (INSR);	tissue: Vastus lateralis muscle;	tissue state: basal state,pert
CD11b+Gr1+ cell sample_3 (derived from wild type mouse),ctrl
myotubes from type 2 diabetes subject,pert
CD71+ bone marrow cells from WT mouse 2,ctrl
"Fibroblasts from UIP histology lung tissue, IPF-21",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.459;	Ratio: 2.10,pert
Bronchial epithelium,pert
"patient: 254;	current medication: Asacol 800mg TDS, Predfoam;	birth date: 7/25/59;	gender: F;	ethnicity: ASIAN;	symptoms onset date: 1/1/00;	diagnosis date: 11/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
subject id: 48;	infection: DENV;	status: DHF;	tissue: whole blood,pert
Post Transduction:24 hr; treatment:WT;,ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 0 hrs,ctrl
diagnosis: healthy;	tissue: blood,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.53;	age of onset: 33 yr,pert
subject: 39;	disease: CP;	muscle: ST;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
Mature mice skeletal intercostal muscle sample,ctrl
Control rep 2,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 7",ctrl
"paraventricular nucleus of the hypothalamus, LPS, 1 hour",pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 10",pert
Sample Group: HD patient; Gender: female; Age: 56; Tissue: lymphocytes (blood); IT15 CAG repeats: 18/43,pert
8 week old H3ff3b WT,ctrl
"Brain tissue from Fisher 344 male rat, Animal #256, 200mg/kg D-Serine",pert
"Wild type, snap frozen, tibialis anterior muscle, 7month age animal",ctrl
tissue: brain;	genotype: WT mix background A;	age: P14,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: VhlhKO",pert
Brain from 40 days Npc1+/- mouse1,ctrl
skeletal muscle myoblast_KO_day3,pert
8wk old male mdx diaphragm,pert
patient: 40726;	sample: tumor,pert
Mouse_Klf5 KO_ES_clone 2,pert
"metastasis: none;	Stage: 2b;	tissue: cancer, homogenized",pert
Ramos Cells,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.09041,pert
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
25 uM chlorpyrifos batch 3,pert
WT 1 Quadriceps,ctrl
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutJ",pert
ethnicity: Hispanic;	Gender: Male;	Age: 31;	Tissue: primary human bronchial smooth muscle cells,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp2,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 74;	age-at-onset: 73;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
M535_WT,ctrl
patient: 245;	current medication: Pentaza 1g BD;	birth date: 11/4/67;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/4/04;	diagnosis date: 3/16/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/16/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/16/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 6/3/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
WM164 Melanoma cell Line,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
HCC_35T,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
Mesangial Cells,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 351;	age-at-biopsy-years: 35,pert
C57BL/6 BMDM naive,ctrl
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: n/a,pert
Head RNA of littermate wild@E13.5 No.2,ctrl
A375 melanoma cells treated with vehicle (0.1% DMSO) batch A,ctrl
DLBCL_empty vector overexpression,ctrl
transfection: scrambled transfected,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 128;	fata: 117;	eea: 1790;	wtkg: 78.3;	perfat: 20;	lbm: 60.4;	fat_mass: 1566,ctrl
Cal51 cells,pert
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
platelet from control,ctrl
glioma cell line,pert
"adult mouse jejunum, hnf1alpha mutant",pert
tissue: Brain;	genotype: Npc1+/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
age_years: 60;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.509;	OD280: 0.793;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 58;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
age: 21dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
P16_exPKO_pancreas_rep1,pert
Liver endothelial cells,pert
tissue: skin;	cell line: NZM12;	tumour stage: metastatic melanoma;	tumour site: small intestine;	treatment: PAX3 siRNA,pert
"hippocampus, MSS",pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-C104A/C131A cells, expression not induced",ctrl
NB42,ctrl
65A;pretreatment;female;breast tumor,ctrl
CD11b+Gr1- cell sample_3 (derived from IL17RC Knock out mouse),pert
RNA from RAW 264.7,pert
human_hepatocyte_levofloxacin_24hr,pert
Murine cell culture,pert
uninvolved skin from cases,pert
"disease group: Atopic Dermatitis;	Sex: m;	age: 50s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 34.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 510;	ige (kiu/l): normal (0-48.5 kIU/L): 710;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
GFP+ one marrow cells transduced with pSF91-MN1VP16-IRES-GFP 4  weeks after Tx,pert
Heart sample7,pert
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: C,ctrl
microdissected epithelial cells from IPMA 6,pert
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: eX,ctrl
"Liposarcoma culture from tumor 388, untreated",ctrl
"TNFa-OMe siRNA-B, replicate 6",pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 66;	donor: 31;	disease state: Non-lesional,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 42;	tissue: Normal_Kidney_Biopsy,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 1;	gender: male,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.539;	OD280: 1.303;	Ratio: 1.91;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 221;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Vehicle-Control;	Vehicle-Control 36 hours set 1,ctrl
Control 26 appendix,ctrl
SPC KO lung adult,pert
tissue: cerebellum;	strain: tia1 knock out;	age: 3 months;	genetic background: C57Bl/6,pert
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with control empty vector,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 6",ctrl
SBVGA1,pert
DA rat colon treated 1 h,pert
colon biopsy,pert
CD3-stimulated CD8+ T-cells from Itk knockout C57BL/6 mice,pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Wild type,ctrl
Embryonic day 14.5 and 16.5 pancreas,ctrl
Disease_status: Down syndrome;	Age (years): 76;	Gender: Female;	Post mortem interval (hours): 18;	Braak stage: VI;	Cause of death: Unknown,pert
"SRF silenced, treated with EtOH, biological rep 3",ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 4",pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 12-14 mo;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,pert
14 Day Mouse extraocular muscle,pert
cell type: PBMCs;	disease state: remitted schizophrenia patient;	gender: male,pert
non-targeting siRNA treated for 10 days,ctrl
HGPS-iPSC_1,pert
KO_24A_4,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
treatment: PLX4720;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
Gender:M;	Age:27;	Tissue: Mucosa,ctrl
RPMI8226_shLuc,ctrl
S46 WT4	F5/13	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
condition: control;	tissue: decidous teeth dental pulp;	gender: male,ctrl
"Biceps, FSHD, cohort 20, subject 20A",pert
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 103;	Usage number: 5;	Exposures: 3,pert
Genotype: HtrA2 knockout,pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: mock control;	transfectant: ONS76_si_mock,ctrl
treatment: no DOX,pert
"cell line: 10590, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L016,ctrl
genotype/variation: Wildtype_XX;	tissue: gonads;	age: E11.5,ctrl
tissue: liver;	treatment: CCl4 and erlotinib 5 mg;	strain: A/J,pert
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,pert
"Fetal liver, CD-1 background",ctrl
ICR MEF infected  with pMX-GFP retrovirus,ctrl
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
"Ad(moi10)-infected, vehicle-treated for 24hr",ctrl
Rap1 knockout liver,pert
Sprague-Dawley Rat retina (male); 1d post injury,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.088;	OD280: 0.579;	Ratio: 1.8;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 289;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
CON - R17,ctrl
prostate from wild-type model,ctrl
"patient 11, left arm treated with pimecrolimus until day 22",pert
T140,pert
"129P3/J Saline treated, biological replicate 1",ctrl
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: WT,ctrl
murine ES cells,ctrl
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed",pert
disease state: endometrioma;	patient: M3,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.3;	age of onset: 9 yr,pert
race: african american;	age (years): 59;	stage: IC;	grade: 2;	histology: endometrioid,pert
"Biceps, control, cohort 15, subject 15V",ctrl
cell line: HCT116;	clone: 21;	genotype: Knockout,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P7,ctrl
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/FZp3-cre (Rnf2 mutant),pert
EB_6_8d_301_HCHO_Nasal_Rat230_2_CIIT05024,pert
subject: 34;	disease: CP;	muscle: ST;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
tissue type: Primary lung tumor;	histology: LCNEC,pert
"wild type; BMDM; 1alpha,25(OH)2D3 treated",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.221;	OD280: 0.621;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 152;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: lung;	age: 12 weeks,pert
human preadipocytes+siCtrl_day0_rep2,ctrl
"Heart, wild type1",ctrl
tissue: left lung;	genotype: Wild Type;	age: 8-week-old,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: PBS;	gender: Female;	time: 10 dpi;	tissue: heart,ctrl
Array Type: HG-U133A_2;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Gene expression data spleen follicular B in WT,ctrl
HCC_3T,pert
systolic heart failure due to idiopathic dilated cardiomyopathy,pert
NK_cell_pool_healthy_H05+H06,ctrl
knockdown: shLOXL2;	cell line: MDA-MB-231,pert
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells,ctrl
Primary combined SCLC-AD 1870,pert
"fatty (fa/fa), liver, Troglitazone",pert
+/+ mouse liver,ctrl
"Spleen, CD4+CD25hi Tregs, Eos (Ikzf4) knockout",pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 42;	gender: m;	treatment: colchicine,ctrl
treatment: control scrambled siRNA;	cell line: H441,pert
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: WT;	genetic background: C57BL/6,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 48.72877,ctrl
"Trim28 conditional KO mice Treg cell, replicate 3",pert
Age: 61;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
hepatocytes,pert
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Right",pert
A549 non-small cell lung cancer (NSCLC) cell line,pert
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
INS-1 cell line #1 with non-induced HNF6,ctrl
"Lymphoblastoid cell lines derived from family 1725, member 2",pert
cell line: MCF10A;	gender: female;	tissue: breast;	expression: Myc over-expression,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 48 hours,pert
Primary hepatocytes isolated from Donor 4 treated with Wy14643 for 6h,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 6,ctrl
RIP-Aire transgenic,pert
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: +Dox,pert
braf status: not determined;	tissue: normal thyroid tissue,ctrl
Age: 41;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",ctrl
individual: patient7;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"twin pair: #2;	individual: healthy individual, non-inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",ctrl
"strain background: mixed 129S6/SvEvTac, C57BL/6J, Balb/c;	genotype/variation: WildType;	age: 3-4 months;	gender: Male;	tissue: whole lung tissue",ctrl
Mouse Reference,ctrl
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.222;	OD280: 1.139;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 64;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 28;	maternal age: 28,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 36 yr;	population: white;	dsm-iv: 295.9;	age of onset: 33 yr,pert
patient: 125;	current medication: OCP;	birth date: 3/17/78;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: Diarrhoea predominant IBS;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"GI, D.Col",ctrl
mucosa collected and archived within 30 mins after sugery,pert
Wild type mouse pDCs,ctrl
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;Mef2cAHF::Cre;	tissue: heart;	developmental stage: adult,pert
Trizol extracted total RNA from myometrium tissue.,ctrl
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 3",pert
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
Mock-treated SCC-2,ctrl
liver_Wt_female_8wk_rep1,ctrl
patient id: T84;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T4N1M1;	Stage: IV;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"T47D, shEGFP",ctrl
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
triplicate 3 of S. aureus infected HepG2 HIF-1-/- cells,pert
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"Mouse brain, Adult, 4hr post LPS ip injection",pert
total RNA from testis,pert
"cultured PBMC, treated with Bt5",pert
individual: Control5;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
treatment group: cadmium chloride 0.1 uM;	cell line: TK6 cells,pert
J1 ES Cells,ctrl
EB_6_24h_290_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell line: C13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"heart tissue, untreated controls",pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
"Liver, fasted",ctrl
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,pert
cell line: PC3;	treatment: Wee1 inhibitor II,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,ctrl
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: none,ctrl
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 35;	dfs-event: 0;	distant metastasis: 0",pert
cell line: MCF7-ADR;	treatment: Multi-step doxorubicin-selected subline,pert
astrocytes from second trimester human fetal brains,ctrl
MLL_PTD04,pert
T21,pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
Normal cervix epithelium_03-5419,ctrl
murine ES cells overexpressing Satb1,pert
Embryonic day 14.5 pancreas,ctrl
gender: female;	genotype: Homozygous for the Q65X mutation in the TWIST2 gene,pert
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
ERRa KO kidneys,pert
Insm1 mutant #2_pituitary gland,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-OCT4,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 0.1% quercetin diet for 14 days,pert
tissue: white blood cells;	age: 12.35;	Sex: female,pert
TRPM7-/- mESC,pert
"fetal testis sample 23, 20 weeks gestation",pert
"seminoma specimen, pT2, patient age: 27y",pert
Extract:LOX-1:113203;	Extract Description:GFP_Untreated_2hr:113203;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:2.09;	Quality: Background Mean Dev.:0.23;	Quality: Absent (%):59.1;	Quality: Absent (%) Dev.:0.66;	Quality: Scaling Factor:0.68;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295493,ctrl
"MOLM-14 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
"BOEC, normal 26",ctrl
Paraquat wild-type,ctrl
age: 46;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 74,ctrl
Macrophages derived from pheripheral blood,ctrl
"Cultured ovarian cancer cell line OVCA433, untreated",ctrl
Raji cells transfected with control mimic at 24 hours,ctrl
genotype: Fog2flox/delta;	treatment: alpha MHC Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 209,ctrl
"cultured human airway smooth muscle, no treatment, replicate 1",ctrl
cell line: MCF10A;	transduction: Empty vector,ctrl
in vitro differentiated DCs,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: untreated,pert
"Lymphoblastoid cell lines derived from family 1712, member 2",ctrl
"Peripheral blood, normal control",ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: control; biological replicate: 1,ctrl
"whole right lung, 3 weeks after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
chip number: 21;	transfection plate: 5;	target gene: RXRA;	kd level: 0.86;	rin: 9.1;	transfection date: 2011-10-17,pert
Rb null MEFs without cisplatin treatment,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6.4;	colon weight (mg): 162;	colon ratio (mg/mm): 2.53;	myeloperoxidase activity (u/mg): 0.815;	tissue: colon;	treatment: 5% DSS,pert
none provided,ctrl
tissue: retina;	age: postnatal day 4;	genotype: wild type,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: I, T1, N0, M0, G4",pert
WM1205 cell line,ctrl
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
HCT116,ctrl
FCHL patient #98-1405,pert
17beta estradiol: 0 pM,ctrl
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",ctrl
tissue: Frontal cortex;	age: 101;	Sex: F,pert
strain: F1 (C57BL6 X 129/SvEv);	genotype: AGTR1A-KO mice;	tissue: kidney;	gender: male;	treatment: NS diet,pert
gender: male;	agent: control;	cell type: Hematopoietic stem cells,ctrl
human endothelial cells isolated from postmortem dorsolateral prefrontal cortex,ctrl
Kin- S49 Cells,pert
Gfp+ photoreceptor cells,pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
Extract:LOX-1:113301;	Extract Description:GFP_Untreated_6hr:113301;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.52;	Quality: Background Mean Dev.:1.13;	Quality: Absent (%):61.55;	Quality: Absent (%) Dev.:2.56;	Quality: Scaling Factor:0.77;	Quality: Scaling Factor Dev.:1.36;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295593,ctrl
Disease_status: Bipolar disorder;	Age (years): 37;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 23;	Brain pH: 6.5;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: 1200;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 4;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
PC-3 cells,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 0,pert
adjacent non-tumorous liver,ctrl
cell line: DBTRG;	treatment: 10 uM Y15;	cell type: glioblastoma cancer cell line,pert
cell line: HCT 116;	treatment: siChe-1,pert
cell line: MCF-7;	cell type: Breast Cancer Cells,pert
hippocampal tissue from cbp+/- mice (standard cage),pert
T1alpha (-/-) fetal lung dpc 18.5,pert
"NALT infected with wild type 90-226, biological rep2",pert
TIG3 diploid lung embryonic fibroblasts,pert
strain: C57BL/6;	tissue: heart;	genotype/variation: WT;	age: 6-weeks old,ctrl
liver control mouse,ctrl
EE_IA_1_cauc_lcm,pert
"seminoma specimen, pT1, patient age: 43y",pert
44A;pretreatment;female;breast tumor,ctrl
condition: Normal;	patient: N_LJ_10;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 48 hr,pert
MLL_PTD02,pert
Gastrocnemius muscle from integrin alpha7 transgenic mouse;	Strain: SJ6/C57BL6 background;	Genotype: integrin alpha7 transgenic;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,pert
strain: 129/Sv,pert
duration of untreated disease in month:0.6;	age at onset:5.5,pert
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",pert
Six week old male C57BL/6 mouse.,ctrl
Gender:F;	Age:44;	Tissue: Mucosa,ctrl
iFGFR1 mammary gland not treated,ctrl
human epithelial colorectal adenocarcinoma cells (Caco-2),pert
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
Calu-3_Scr_control,ctrl
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Untreated,ctrl
LNCaP/NC siRNA,ctrl
Gender: Male;	Age: 37;	Ethnicity: White,pert
Renal vesicles from Lim1 mutant E12.5 embryos isolated by laser capture microdissection.,pert
RBP2-/- MEF,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 8 hrs AP20187,pert
"Uninfected treated with 1,25D, replicate 2",pert
cell line: mda-mb-231;	transfectant: siRNA for p53,pert
mouse embryonic stem (ES) cells,ctrl
S9C Sporadic-hippocampus,ctrl
chip number: 16;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.55;	rin: 7.8;	transfection date: 2011-10-17,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119+;	genotype/variation: wildtype,ctrl
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: wild type;	age: adult;	gender: male;	tissue: hippocampus,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: post-UV,pert
normal control,pert
Rat Adipose Tissue,ctrl
Intima media,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: unstimulated;	genotype: Trim28CKO,pert
"PC from MM patient,isolated using CD38-APC.",pert
T92,pert
cell line: NOMO-1;	genotype: ZFX knock-down,pert
PolyRF+,pert
chip number: 13;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.61;	rin: 9.6;	transfection date: 2012-03-26,pert
"Mdr2-KO heterozygous mouse, 12 month old mouse, liver sample",ctrl
"pancreas, control diet, STZ injected",pert
RNA from microdissected breast cancer cells from case 823 labeled with Cy5,pert
aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks.,ctrl
schizophrenia,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,ctrl
RV82.01_CONTROL_day10,ctrl
"BOEC, normal 12",ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 7,ctrl
Strain: C57BL/6;	Age: 4 months;	Tissue: retina,ctrl
Gender: Male;	AJCC Stage: II;	Pathological T: 4;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Hepatic Flexure;	Drug Treatment: NO,ctrl
gender: male;	strain: C57/BL6;	tissue: heart;	genotype/variation: KLF15-null,pert
sample: #18;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Inferior olivary nucleus,pert
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: none,ctrl
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,pert
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
cell line: NCI-H716;	treatment: none,ctrl
patient id: T26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 73;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
Tissue:tumor; Gender:female; Age:31; Tumor stage:T4aN1bMx,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: EF1a-control,ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, U0126-treated",pert
Cervical cancer_1875T,pert
MPM tumor specimen 39,pert
Cervical cancer_1907T,pert
gender: female;	age (years): 55;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
CUTLL1 MigR1 GSIwash2h,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 6",ctrl
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
"gender: Female;	age: 97;	post-mortem delay: 3.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Genotype: Taf7l knockout;	Strain: C57BL/6J;	Age: 8-weeks,pert
"Whole blood - mental retardation or developmental delay, Male",pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 6;	gender: male,pert
gender: male;	strain: CBA/C57BL/6;	genotype/variation: wild type;	tissue: colon cancer tumor,ctrl
cell line: MCF7;	condition: siRNA Med12,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 2,ctrl
TET-on Human lung carcinoma H1299,pert
"CD3+ T cells, bone marrow, SAA patients post therapy / in hematological remission",pert
strain: CB6F1;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Control,ctrl
8 wk old male C57BL10 gastroc,ctrl
"gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
strain background: C57Bl/6;	genotype/variation: Lrp5-/-;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,pert
MCF10A-HER2-FKBP-HA cells,pert
tissue: temporal lobe;	strain: 129SV;	genotype: WT,ctrl
M539_KO,pert
Cdh1 knock-out,pert
strain: C57BL/6;	genotype/variation: Wildtype;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),ctrl
tissue: Mouse heart;	genotype: akt2-/-;	strain: C57BL/6,pert
RNA from whole tissue section of case 547 labeled with Cy5,pert
genotype/variation: K14CREER:SOX2fl/fl mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,pert
human skeletal muscle from insulin sensitive individuals before insulin therapy,ctrl
Cervical cancer_CC140,pert
"brain, wild type",ctrl
"Spleen, CD4+CD25hi Tregs, Xbp1 knockout",pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
NK_cell_pool_melanoma_M03+M04,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.408;	OD280: 1.228;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 342;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
FCHL patient #99-1225,pert
RV16;	Age = 21;	Sex = F,pert
Proliferative Stage Endometrial Biopsy,ctrl
airway epithelial brushing,ctrl
"human post-mortem brain tissue, Down syndrome",pert
CD4_T_cell_pool_healthy_H11+H12,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with DMSO for 24h,ctrl
disease state: paediatric glioblastoma;	age: 7;	gender: M;	h3.3_status: wt,ctrl
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 546,ctrl
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
strain: C57BL/6J;	genotype/variation: CD70TG;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with rheumatoid arthritis",ctrl
Un-stimulated CD4+CD25+high regulatory T cells from PBMCs,pert
"testis, wild type",pert
"HEK293T human embryonic kidney cells, Wnt3A, si-control",pert
OV1002 Carbo Day1,pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 11 Month;	tissue type: Tumor,pert
Sorted Zfx wt myeloid progenitors overexpressing only GFP selectable marker,ctrl
"cervical cancer cell line, MS751",pert
strain: Ola129;	cell type: Embryonic Stem Cells;	genotype/variation: control,ctrl
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: mock retroviral transduction,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day2,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/- (CD1) mice;	genotype/variation: ID4+/-TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,pert
"gender: male;	batch: 2;	age (years): 35;	patient id: Non_severe_3;	fev1 (% predicted): 77;	fvc (% predicted): 89;	medication: Becotide, Ventolin;	cell type: CD8+ T-cells",pert
"cell line: hgps-ipsc_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below.",pert
lung from control mouse,ctrl
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
mRNA from Gastric tissue,ctrl
PIK3CA.DMSO.1,pert
cell line: CL-0;	transfection: YWHAZ vector,pert
Germinal center B-cells,pert
age: 28dpp;	genotype/variation: wild type;	tissue: testis,ctrl
"brain, motor cortex, layer 5 thick tufted pyramidal neurons, wild type",ctrl
"Gender: Female, Age: 25, BMI: 31, Tissue: luteinized cumulus cells",pert
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,pert
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: DMSO,ctrl
U937 cell line infected with scrambled control shRNA,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 65,pert
Gastric tissue tumor region,pert
patient: 40875;	sample: normal,ctrl
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,pert
patient: 40730;	sample: tumor,pert
Genotype: Rb null MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,pert
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.3,pert
heart of male mouse subjected 1 week to chronic constant hypoxia,pert
U2OS_siHic5_2_4h,pert
A549 cells EGF stimulated,ctrl
Hodgkin lymphoma cell line,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 46 years,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N0, M0, G4",pert
"55B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EB_07_5d_139_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
tissue: white blood cells;	age: 16.57;	Sex: female,pert
OTT1 knockout mouse;	sacrificed at gestational age,pert
Chemically-induced skin papillomas in control mice treated with tamoxifen for 1 week,ctrl
SPC WT lung adult,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 9.883;	Ratio: 2.1,pert
liver_Akt1+/-_female_8wk_rep1,pert
Diagnosis: AML M4;	Age: 53y ;	Gender: Male;	Blast %: 65;	Source: BM;	Cyto: No Data;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
Liver wildtype ND,ctrl
subject: 35;	disease: CP;	muscle: ST;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 73 years,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 99;	Sex: male;	region: M1;	age: 39;	genotype: Y/X;YFPH/-,ctrl
"Tumor sample from patient with p53 mutant, replicate 3",pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 100,pert
peripheral blood CD4 T cells,pert
cell type: ESC;	genotype/variation: control,ctrl
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 100;	Usage number: 4;	Exposures: 3,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 +/+,ctrl
"wild type Treg, replicate 4",ctrl
human bronchial smooth muscle cell_VitD_100nM_24h,pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: sensitive,ctrl
health control_2,ctrl
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet containing 0.05% quercetin for 20 weeks,pert
"human whole blood, PAXgene",ctrl
"Control, replicate 3",ctrl
uterus - Mid secretory endometrium from patient with  endometriosis,pert
A with Cy5,ctrl
"INS-1 cell line, clone #1-1.16",ctrl
Modified MCF10A Cells,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.27123,pert
Sex: female;	Age: 14;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
"LCL GM19238, Kd SREBF2, 72hrs",pert
CD8_T_cell_pool_melanoma_M01+M02,pert
"heart, 30 months of age, control diet",ctrl
MCF10A 7days,ctrl
"kidney, QH2, 6 months",pert
"endometrial stromal cell - control/vector1, 3 days post infection",ctrl
HCC_5T,pert
RNA from whole tissue section of case 648 labeled with Cy5,ctrl
gender: Male;	strain: C57BL/10ScNJ;	genotype: TLR4-/-;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,pert
age_years: 31;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1+dox,pert
"MCF7 cells, non specific control",ctrl
TRPM2-AS siRNA,pert
"Gender: Female, Age: 28, BMI: 30, Tissue: luteinized cumulus cells",ctrl
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: yes,pert
>95% CD3+ T cells negatively isolated with Dynal kit,ctrl
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cardiac allograft,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 67 years,pert
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
genotype/variation: Cyp27b1 flox/flox;Cre+;	tissue: breast tumor;	genetic background: FVB,pert
"Lens epithelium, wild-type mouse",ctrl
Primary hepatocytes isolated from Donor 2 treated with Wy14643 for 24h,pert
cell line: prostate cancer cell line LNCaP;	genotype/variation: MYB siRNA,pert
strain: C57BL/6J;	genotype/variation: wild type,ctrl
health control_3,ctrl
cell line: HL-60;	shRNA construct: GSK3B Construct 2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 62;	gender: male,ctrl
"patient 14, baseline",ctrl
sample type: Primary culture of typeII cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 2,pert
"macrophages, 4 days post UV-SeV inoculation",ctrl
murine total uterus,ctrl
Brain from Meg3 knock-out E18.5 mouse embryo,pert
FCHL patient #99-1191,pert
Normal tail skin from control mouse,ctrl
HCC_14T,pert
patient: 51091;	sample: tumor,pert
CONTROL;	Age = 22;	Sex = M,ctrl
"Human breast, post AFI treatment",pert
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: MED1 expression vector,pert
PBMC from HC,ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 35 yr;	population: white,ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep5",ctrl
"MCF-10A cells, overexpression TAp63γ",pert
Human mammary epithelial MCF10A cells,ctrl
Total RNA from MDA-MB-231 cells infected with a lentivirus shLOXL2,pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: U2OS;	cell type: human osteosarcoma cells;	transfected with: shControl,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: mid-UV,pert
PBMC from T cell Large granular lymphocyte leukemia patient#113,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siSox2,pert
"skin fibroblasts, passage #3",ctrl
Strain: C57BL/6; PGC1beta mutant mouse; Tissue: quadriceps muscle,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto,pert
Human heart,pert
"Mouse brain, Adult, 4hr post saline ip injection",ctrl
tissue: white blood cells;	age: 17.74;	Sex: female,pert
HCC_34N,ctrl
EB_15_6_337_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
gender: Male;	age: 61;	post-mortem delay: 16.5h;	ph: 6.2,ctrl
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
TTF=103min;	Race=Caucasian/White;	Sex=Female;	Group=A;	Prototype_N,pert
cell type: Human melanoma cell line;	cell line: M229_R5;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
patient: 51084;	sample: normal,ctrl
patient: 10;	disease state: hypertension;	tissue: Atheroma plaque,pert
PS-/- cerebellum at 10 days,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 3,pert
treatment protocol: control,ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 82;	Usage number: 4;	Exposures: 3,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days",ctrl
unaffected brother,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
"left ventricle,Hsp22 WT,basal condition",ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 2,ctrl
background strain: C57Bl6;	genotype: Polgtm1Lrsn+/+;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,ctrl
SHEP-SF neuroblastoma,ctrl
"Quadricpes muscle, control mouse",ctrl
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 1,pert
"airway epithelium, smal airways, obtained by bronchoscopy and brushing",ctrl
Head RNA of littermate wild@E13.5 No.3,ctrl
Soleus muscle,ctrl
"Gender: female, Age: 39 years, Tissue: VIN 3",pert
Cochleae from wild type mice at P13,ctrl
Healthy-3 baseline,ctrl
CH 3,ctrl
oocyte,pert
genotype: Kdm2b knockdown;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,pert
"129P3/J Saline treated, biological replicate 2",ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 206,ctrl
chip number: 21;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9;	transfection date: 2011-10-17,pert
IGF,pert
subject id: 35;	infection: DENV;	status: DF;	tissue: whole blood,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 184;	fata: 14;	eea: 1070;	wtkg: 62.6;	perfat: 33.6;	lbm: 38.9;	fat_mass: 2103.36,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
genotype: wild type;	tissue: triceps muscle;	age: 3 months,ctrl
Postmenopausal female. Tibolone treated. Patient 32.,pert
Heart sample 10,ctrl
MDA-MB-231 cells_siRhoGDIbeta transfected_3 days post-tranfection,pert
CON-1-COLLAGEN,ctrl
cell type: CD4+CD25+;	strain: C57BL6;	genotype/variation: fl-DNMT1/Foxp3cre,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Wild type,ctrl
Heart sample 12,pert
chip number: 14;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
patient: 428;	disease state: LGSC;	component: Invasive,pert
iFGFR1 mammary gland 16 hr AP20187,pert
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: WT,ctrl
gender: female;	age (years): 54;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,ctrl
gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6,ctrl
Patient: K;	Time: 1 week;	Group: responder;	Condition: lesional,pert
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET1 transcript,pert
tissue type: Malignant prostate tissue;	tmprss2: ERG fusion status: positive,pert
patient: 270;	current medication: Becotide inhaler;	birth date: 4/30/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/99;	diagnosis date: 8/24/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/24/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 8/24/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Asthma;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
B-lymphoid,pert
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system the base vector (BV);	expressing: base vector (BV);	tissue: Mammary Tumour,ctrl
blood-derived macrophages,ctrl
ESCs_control siRNA,ctrl
cell type: bone marrow cells;	strain: DBA/2,ctrl
age: 49;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"BL from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
tissue: arterial;	status: unruptured aneurysm,pert
Nasal Epithelium,pert
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
patient: 20;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"T3 fetal heart (treated on gd14.5 via oral gavage, collected on gd 17.5)",pert
"liver, ctrl mice",ctrl
cell type: AML blasts;	fab classification: M4,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 48h",pert
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 4 hours,pert
Bone marrow CD34+ cells,pert
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: +OHT;	genotype/variation: wt,pert
Cell line established from CA2 HESC using pClip vector,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.701;	OD280: 1.82;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 354;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 49;	maternal age: 36,pert
tMLL09,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 72h,pert
MPM tumor specimen 23,pert
chip number: 18;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.83;	rin: 9.3;	transfection date: 2012-03-26,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",pert
Sex: female;	Age at operation: 85 years;	Site: lower arm;	Size in cm: 11x8x4;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Lesional,pert
Insm1 control #4_pituitary gland,ctrl
liver_Akt1+/-_female_35wk_rep4,pert
"Primary, localized, pooled tissue, prostate cancer",pert
patient: 51677;	sample: tumor,pert
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
control appendix,ctrl
3T3-L1 0.1% DMSO,ctrl
"treatment: diclofenac;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
C57BL,ctrl
231/ARF-4,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days osteoblast differentiation,ctrl
diagnosis: NSIP;	fvc-group: FVC3;	tissue: lung,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 2,pert
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: induced,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 18.2, Strain:DBA/2J",ctrl
strain: 129/Sv;	group: control;	genotype (hdh cag repeat length): 7/7;	differentiation status: undifferentiated,ctrl
"Cultured ovarian cancer cell line OVCA429, untreated",ctrl
mouse B6xCF-1  RNAi transgenic,ctrl
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 23;	maternal age: 22,pert
tissue: prostate tumor;	genotype: Pten null;	age: older than 20 weeks,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 48 hours,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 44;	donor: 33;	disease state: Non-lesional,ctrl
"Deltoid, control, cohort 09, subject 09U",ctrl
"mNSC nucleofected with miR-Control, replicate",ctrl
cell type: embryonic stem cells;	genotype/variation: control,ctrl
agent: Chromium 1 µM,pert
ICL670 50uM 16hrs,pert
patient: 22;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
tissue: aorta;	genetic background: C57BL/6J;	genotype: APOE-deficient;	treatment: vitamin E;	sample type: aortas from vitamin E-treated APOE-deficient mice,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L027,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 32;	maternal age: n/a,pert
rat heart,pert
"HEK293 cell, MIF Knockdown",pert
tissue: liver;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
chip number: 18;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
Wildtype liver DEN-injected 12weeks repl1,ctrl
"Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
8 week old H3f3b WT,ctrl
Brain from 54 days Npc1+/- mouse1,ctrl
Trib1 #1 KO macrophages were treated with LPS,pert
HGPS-fib_2,pert
Infergen_6hr,pert
strain/background: C57BL/6N;	genotype: Ctnnb1 flox(ex3)/+;	tissue: tumor,pert
WT_24A_2,ctrl
"8 weeks old sex age matched littermates, lung typeII cells",pert
phenotype: control;	gender: female;	case_id: 477;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.21;	labeling_batch: 1,ctrl
tissue: white blood cells;	age: 11.58;	Sex: female,pert
"subjects: heart-beating, brain-dead donor;	tissue type: normal aortic tissue",ctrl
Genotype: MMTV-c-myc/Hunk KO; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,pert
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 200 mg/kg,pert
tissue: Temporal cortex;	age: 90;	Sex: M,pert
"primary cortical neurons, FMR1 shRNA",pert
14-week-old Trim24-/- liver_395M,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L017,ctrl
"Gastrocnemius, WT, 2 months old",ctrl
WT mice fed with a HFD for 6 weeks,ctrl
"20 days old prosaposin knockout mice, cerebrum",pert
"Deltoid, control, cohort 20, subject 20U",ctrl
WT J1 ESCs on day 0,ctrl
RNA from microdissected breast cancer cells from case 295 labeled with Cy5,pert
Retina of 2 month old RPE65-/- mouse,pert
normal thyroid,ctrl
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
laser-captured pancreatic islets,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 24hr,pert
Mouse testis,ctrl
wildtype MEFs without cisplatin treatment,ctrl
RNA from whole tissue section of case 651 labeled with Cy5,pert
tissue: pancreas;	genotype: Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 9 weeks-old,ctrl
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
LNCaP cells treated with vehicle and control shRNA,ctrl
Normal cervix epithelium_03-3505,ctrl
"A2 corrected_C2_transgenic but unaltered, lung tissue",pert
"Sodium arsenite added to food: 10 ppb, 5wk; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: None",pert
MCF10A cells in 3-D culture,ctrl
kidney tissues from lean rats on control diet,ctrl
Frontal cortex brain tissue from HIVE patient,pert
siZMPSTE24-treated SCC-40,pert
VHL null MEFs,pert
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD8+ T-cells,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
"Human lung carcinoma H1299 cells (p53 null, no p63 expression) Tet-on",pert
Rb heterozygous 129sv matings,ctrl
CCE embryonic stem cells (CCE ES cells).,ctrl
tissue: retina;	age: postnatal day 6;	genotype: wild type,ctrl
patient id: 209;	tissue: Normal cortex;	gender: Male;	age: 63;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
normal liver tissue,ctrl
Disease_status: Bipolar disorder;	Age (years): 19;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 2;	Brain pH: 5.97;	Post mortem interval (hours): 12;	Side of brain: Right;	Fluphenazine mg. Equivalents: 2000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: untreated; biological replicate: 2,ctrl
"Hippocampus, soman, 6h",pert
tissue: non-neoplastic salivary gland;	organ site at which tumor arose: submandibular salivary gland;	donor sex: unknown,ctrl
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
lesional skin bioposy obtained from patient after 1 day of treatment,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 24hr,ctrl
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: mock,ctrl
"MCF-7 cells, siCtrl treatment 60h, 10 nM E2 for 4h",pert
strain: C57BL6J;	genotype: H3f3b WT/WT;	age: E12.5;	tissue: 1 of 2 mouse testes,ctrl
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 1, clone 1",pert
tissue: white blood cells;	age: 15.23;	Sex: male,pert
Prdm14(+/+) ESCs,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs AP20187,pert
cell line: OVCA433;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes KO;	genetic background: C57BL\6,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,ctrl
HepG2,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: none,ctrl
24A;pretreatment;female;breast tumor,ctrl
Brain,pert
control peptide-treated HPB-ALL 100mM 16h,ctrl
"seminoma specimen, pT2, patient age: 45y",pert
strain/background: C57BL/6;	genotype: wild-type;	tissue: anterior prostate;	age: 12 weeks,ctrl
"Cell type: neuronal, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8,ctrl
KGN,ctrl
condition: Psoriasis;	patient: PS-M;	tissue: LS skin biopsy;	kit: Affy,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.70685,pert
TAMs sorted from imatinib treated tumors,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: E;	experimental sample name: PC7-R,ctrl
strain: C57BL/6;	genotype: Nrf2 KO;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),pert
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 1,pert
CD11b+Gr1- cell sample_5 (derived from wild type mouse),ctrl
EB_0_24h_54_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
Trnp1 knockdown tissue,pert
gender: male;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: non-infected,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",ctrl
Bronchoalveolar lavage cells,pert
"Cultured ovarian cancer cell line DOV13, untreated",ctrl
25 uM cyfluthrin batch 2,pert
strain: 129SV;	gender: male;	genotype/variation: SIRT4 KO;	tissue: liver,pert
Nonirradiated-ATM-WT Replicative1,ctrl
sample 1:;	age: 45;	gender: female;	sample 2;	age: 81;	gender: female,pert
scram_lo_1,ctrl
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 72 hours;	agent: ozone;	exposure dose: 0.3 ppm O3;	test article cas no: 10028-15-6",pert
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 6h;	gender: Male;	age: 73 years old,ctrl
Liver from a 24 month old Myc heterozygous mouse,pert
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against TAK1,pert
"age at diagnosis: 39;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: 0;	dfs-month: 15;	dfs-event: 1;	distant metastasis: 0",pert
PBMC from T cell Large granular lymphocyte leukemia patient#131,pert
OV1002 Control Day0,ctrl
patient: 40977;	sample: normal,ctrl
Primary human erythroid progenitor cells expressing HDAC1 G10 shRNA,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.8274,pert
subject: 12;	disease: TD;	muscle: GR;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"seminoma specimen, pT1, patient age: 51y",pert
62 y/o male,ctrl
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
phenotype: alcoholic;	gender: female;	case_id: 327;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19.5;	brain ph at time of freezing: 6.63;	labeling_batch: 1,pert
CD34+ cells from the patient (CML34),pert
Normal heart from C57BL/6 strain,ctrl
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,pert
HUVEC cell culture,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.767;	OD280: 1.439;	Ratio: 1.87;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 133;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Livers of TAK1 ko mice  sacrificed at 4 weeks,pert
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  1",pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 3",ctrl
2826 TG,pert
HCC_9T,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 5;	Exposures: 3,ctrl
CHF - LV09,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.;	Mouse supplier: Charles River.  Cultures were completed in Frank Beiers laborartory by Veronica Ulici and Claudine James",ctrl
"from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
WT mouse liver after 16 hrs fast,ctrl
"49B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Irradiated-ATM-KO Replicative1,pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: uninduced;	time point: 18h,ctrl
rat liver,ctrl
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 24h;	gender: Male;	age: 4 months,pert
tissue: colon;	cell line: HT29,pert
EB_2_24h_212_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
pooled 4 -1.0 square centimeter rat skin excisions,ctrl
"ADIPOSE TISSUE, RES, After",pert
"Whole embryo, E9.5",pert
A SIT_B035,pert
mouse intestine pLagl2 knockout 3,pert
tissue: brain;	genotype: mutant Ndel ko/+ inbred;	age: P0,pert
R4_saline_wildtype_422,ctrl
"female,21,Caucasian",ctrl
Old heart,pert
Normal cervix epithelium_CaCx5,ctrl
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
condition: Psoriasis;	patient: PS-E;	tissue: LS skin biopsy;	kit: Affy,pert
Muscle from a 5 month old Myc heterozygous mouse,pert
Panc0504 cell line,pert
control retinal progenitors,ctrl
G93A mouse 1262,pert
"patient: 209;	current medication: AZA 150mg/d, Mesalazine 800mg TDS;	birth date: 3/27/80;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 10/15/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/15/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
CONTROL;	Age = 24;	Sex = F,ctrl
"Brain tissue from Fisher 344 male rat, Animal #263, 20mg/kg D-Serine",pert
CON-2-PLASTIC,ctrl
MPM tumor specimen 9,pert
strain: C57 BL6NCr;	tissue: Distal colon;	genotype: Myd88-/-,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"t21, surgically resected from patient of gastric cancer.",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: A,ctrl
pool of thyroids from 10 months old RET-PTC transgenic mice,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,pert
race: caucasian;	age (years): 75;	stage: IB;	grade: 2;	histology: endometrioid,pert
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
25 weeks male,pert
parental Ainv15 ESC differentiated as EB for 10 days,ctrl
Cre-negative (control),ctrl
"lymphoblastoid cell line from T9.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: DMSO for 48h,ctrl
source: Breast adenocarcinoma;	cell line: MCF-7;	treatment: ethanol;	knockdown: FOXM siRNA,pert
Sample ID: TP23;	Twin Pair ID: CCN3.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
pre-iPSC- siRNA to luciferase- biological replicate3,ctrl
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
cell type: CFBE41o-  wt-CFTR,ctrl
Neurons overexpressing Hes1 and GFP,pert
cell type: CD43+/41+/235+ progenitors generated from euploid iPSCs,ctrl
chip number: 13;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.64;	rin: 9.4;	transfection date: 2012-03-26,pert
"Hematopoietic stem and progenitor cells (LineageLow, Sca1+, Kit+; LSK)",pert
human embryonic stem cells cultured with mouse embryonic fibroblasts,ctrl
cell line: THP-1;	disease state: monocytic leukemia,pert
sample: #10;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Inferior Olivary Nucleus,ctrl
thyroid sample containing tumor cells,pert
tissue: skin;	individual: Patient P6;	condition: ANL;	eczema severity: SCORAD: 0,pert
"Cell type: endothelial, age:55, gender:male, diagnostic group: control, PMI:31h",ctrl
Gene expression profiling of normal cortex of patient 324,ctrl
Mid Secretory Phase Normal,ctrl
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: control,ctrl
HCC_4T,pert
"seminoma specimen, pT1, pN1, patient age: 42y",pert
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shScr,ctrl
Lesional skin from imiquimod-treated mouse,pert
Mouse WT mandibular molar,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 4,ctrl
HEK293 cells transfected with SIRT6 construct  and unstimulated,pert
patient: 23;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"Strain: Wild-type, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",pert
R2_saline_wildtype_48,ctrl
6-month mouse dorsal prostate,pert
CD3-stimulated CD8+ T-cells from Wt C57BL/6 mice,ctrl
Primary human erythroid progenitor cells expressing a luciferase control shRNA,ctrl
Control liver sample 3,ctrl
tissue: Aorta;	genotype/variation: SRF-flex2neo;	genotype/variation: SRF-flex2neo littermates (control);	age: 4 month-old,ctrl
"Patient  G, lesion, 4 week",pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 1;	age: Post natal day 3-4,ctrl
C57BL6,ctrl
tissue: Biceps muscle;	patient: P.b.2;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 1",pert
EE_IB_2_cauc_lcm,pert
Gene expression profiling of normal cortex of patient 26,ctrl
32 with Cy5,pert
tissue: skin;	individual: Patient N-8;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
wild-type E18.5 mouse,ctrl
"primary cortical neurons, SHANK3 shRNA",pert
60 day LAD ligated heart from C57BL/6 strain,pert
Mammary Gland,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 72h",pert
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",pert
Tissue: brain (frontal cortex);	Disease state: HIVE,pert
No_drug_#4862,ctrl
"fetal testis sample 17/18, 22 weeks gestation",pert
Genotype: p38alpha KO;	Age: E13.5,pert
A HID U_B016,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
"Amniocytes, euploid, 1561",ctrl
Rybp#10 (OHT-)_4d,ctrl
S25 NLS 142Q TG1	F4/23	S25	NLS Htt exon 1 142Q	Mouse	3 months	Cerebellum	Male,pert
heart of 2 week control male mouse,ctrl
RF- polyarthritis,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 12,ctrl
IkL/L thymocytes,pert
agent: Nickel 40 µM,pert
"liver, SCD-/-",pert
"TNFa-OMe siRNA-B, replicate 3",pert
"Wild type, 2 month old male mice parietal cell",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 334;	age-at-biopsy-years: 42,ctrl
"Frontal Cerebrocortex, permethrin (100 mg/kg), 6 hours",pert
PBMCs enriched for CD8+ cells from normal control subject J,ctrl
"Normal cervix epithelium, microdissected, Age 42",ctrl
NCI-H69 human small cell lung cancer,pert
"Deltoid, control, cohort 15, subject 15V",ctrl
MDA-MB-231 breast cancer cells,pert
murine lymph node,pert
"Female Nrf2 wild-type mice, liver sample",ctrl
"human embryonic stem (hES) cells line SA01, biological replicate  3",ctrl
"Patient CCo, stable renal transplant recipients, male, 38 years old, T1 (3 months after the switching of the therapy)",pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 46;	maternal age: 42,pert
tissue: brain;	genotype: mutant Ndel ko/cko;	age: E14,pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Myc heterozygous,pert
RNA,pert
"endometrial stromal cell - control/vector2, 3 days post infection",ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 29;	maternal age: 32,pert
"CA1, parental control SOX7 HESC- clone1",ctrl
G93A mouse 1266,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
E2A-deficient double positive cells sorted from thymus of 8 week old mouse,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 201,ctrl
Human Neural Stem cell line with Nurr1 overexpression,pert
condition: Psoriasis;	patient: PS-B;	tissue: LS skin biopsy;	kit: Affy,pert
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: e0,pert
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF KO,pert
patient: 17;	disease state: hypertension;	tissue: Atheroma plaque,pert
"DP thymocytes, control",ctrl
6 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24719,ctrl
cell line: A549;	agent: azacitidine;	dose: 0.3uM,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: severe;	Ig clonality: oligoclonal,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 4;	gender: male,pert
Soleus muscles from male wildtype C57BL/6,ctrl
CD34+ cells isolated from the bone marrow of a normal control,ctrl
aggressive E-mu-BRD2 mediated lymphoma,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: control",ctrl
fully differentiated (day 6) myotubes,ctrl
RNA from NCCIT human cells treated with a control non-targeting siRNA,ctrl
Endometrium/Ovary-Disease 7,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 72,pert
male;	48 yr old;	White,pert
"AZ521 dnSox2 cells, induced, 8h",pert
Peripheral blood from healthy individuals,ctrl
control rep 4,ctrl
patient: 40899;	sample: tumor,pert
"12 weeks old PS-NA mice, cerebellum",pert
sample: #19;	subject: PD case #4;	brain: T-9;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
KO LSK,pert
uninfected hRPE cells,ctrl
"DHL4, R406, 24h",pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 4",ctrl
TG mouse left ventricle treated with tamoxifen,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 5;	gender: male,ctrl
chip number: 19;	transfection plate: 5;	target gene: RELA;	kd level: 0.68;	rin: 8.9;	transfection date: 2011-10-17,pert
chip number: 16;	transfection plate: 4;	target gene: HCST;	kd level: 0.86;	rin: 9.2;	transfection date: 2011-10-17,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep2",ctrl
transfected with YAP-specific siRNA,pert
mouse liver,ctrl
H441 lung cancer cells,ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 8 months;	tissue: liver;	disease status: healthy,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 202,ctrl
Postmenopausal female. Tibolone treated. Patient 16.,pert
"LCL GM19238, Kd CEBPG, 72hrs",pert
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: TGF-alpha,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 46;	gender: male;	tumor grade: IV,pert
genotype/variation: MBD1 KO;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),pert
8 wk old male mdx diaphragm,pert
Psoriasis-5 baseline,pert
Peripheral Blood,ctrl
TG mouse left ventricle,pert
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 7,pert
"CD11b, WT",ctrl
individual: patient16;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
disease state: Control;	tissue: peripheral blood,ctrl
breast epithelium adjacent to tumor,pert
"Hippocampus, soman, 24h",pert
human peripheral blood derived monocytes,pert
age: 35;	sex: M;	disease status: control subject;	Filter number: 92;	Usage number: 1;	Exposures: 3,ctrl
OTT1 null/wt mouse;	sacrificed at gestational age,ctrl
minor salivary gland,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.02;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 31;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siNonTarget,ctrl
"Lymphoblastoid cell lines derived from family 1727, member 2",ctrl
scram_lo_3,ctrl
"Peripheral blood mononuclear cells, RF+ polyarthritis",pert
"Lymphoblastoid cell lines derived from family 1734, member 1",pert
subjectid: 5258;	imatinib: NoIM;	lbh589: NoLBH,ctrl
E9.5 FVB/N erythroid cells-2,ctrl
patient id: 265;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
"medulloblastoma, M2, scrambled",ctrl
Dermal fibroblasts from DBA patient,pert
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 59.88 nM (EC50).,pert
"Liposarcoma culture from tumor 388, doxorubicin treated",pert
HEK293 cell line #5 with induced HNF1beta mutant A263insGG,pert
genotype: wild type;	cell type: FoxP3+ Treg,ctrl
HCC_39T,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: trisomy8,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
maternal diet: Control;	genotype/variation: Cited2 -/-;	strain: C57BL6/J;	developmental stage: Embryonic (8.5 days post coitum),pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 49;	age-at-onset: 48;	geographical origin: Porto;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC,ctrl
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate B,pert
strain background: C57BL/6N;	genotype/variation: Sta1 Wildtype (wt);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),ctrl
disease state: healthy control;	tissue: epidermis;	age: 67;	gender: male;	treatment: untreated;	time: control,ctrl
MLL_PTD03,pert
LT-HSCs of LRF knockout mouse,pert
chip number: 12;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.82;	rin: 9.2;	transfection date: 2012-03-26,pert
gender: female;	age (years): 43;	evolution time (years): 7;	disease extension: Pancolitis;	treatment: Azathioprine,pert
Common Reference 2 round amplification 2 ug,ctrl
MPM tumor specimen 27,pert
left hippocampus,pert
chip number: 19;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
cell line: MCF7 breast cancer;	treatment: RL silenced,ctrl
S3C Sporadic-hippocampus,ctrl
Mouse female ES cells PGK12.1 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-4 in PGK12.1.,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: WT,pert
CD8_T_cell_pool_healthy_H09+H10,ctrl
"ME180 cells, 10μM ATRA, 3 hours",pert
control participant P310 (human CD3 positive T cells),ctrl
Patient 9 appendix,pert
"Sv129/C57B6 hybrid strain, 12 week old male",pert
Nanog overexpressing esophagus,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 28;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
B-lymphoid,ctrl
diagnosis: systemic lupus erythematosus (SLE);	tissue: blood,pert
strain/background: C57BL/6;	genotype: Pb-Cre4;PtenLoxP/LoxP;	tissue: anterior prostate;	age: 12 weeks,pert
Aortas isolated from non-transgenic C57BL/6J control mice,ctrl
cell line: lymphoblastoid cell line;	family id: 1733;	coriell cell line repository identifier: GM14501;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",pert
WT kidneys,ctrl
gender: male;	disease state: healthy;	tissue: peripheral blood;	cell type: white blood cells;	sample type: matched control,ctrl
Patient: D;	Time: 0;	Group: responder;	Condition: lesional,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 3,pert
cell line: Hep3B;	treatment: transfected with YAP-specific siRNA,pert
cell line: HepG2;	genotype/variation: control,pert
Oral Squamous Cell Epithelium Tissue,pert
PBMC,pert
"Csbm/m mouse, cerebellum, young, saline treatment",ctrl
MV4-11 cells,ctrl
strain: FVB/N;	tissue: Skin;	gender: female;	age: E17.5;	genotype/variation: Ovol2 overexpression (Ovol2 BT),pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 61;	donor: 16;	disease state: Non-lesional,ctrl
Tissue: Lung,ctrl
"Lymphoblastoid cell lines derived from family 1712, member 2",pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation. At the end of the treatment, drug level in the plasma was assessed by Tandem mass Spectrometry LC- MS/MS.",pert
"gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
CLL cells,ctrl
"Undifferentiated C2C12 myoblasts, passage #11",ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 8 hours,pert
clone type: AtT20 clone types infected with empty vector rep3,ctrl
strain: C57BL/6;	genotype/variation: Wild type;	cell type: Regulatory T cells,ctrl
subject: 18;	disease: TD;	muscle: ST;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Psoriasis-8 baseline,pert
VCaP/MYB siRNA,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 27,ctrl
sample 1:;	age: 51;	gender: male;	sample 2;	age: 84;	gender: female;	sample 3:;	age: 74;	gender: female,pert
"5 x 10^4 Zfx-cko LSK (Lin-, Sca1+, c-Kit+) cells were sorted directly into Trizol Reagent (Invitrogen) form pooled bone marrow cells from Zfx-cko mice.",pert
cell line: HCT116;	clone: 15;	genotype: Wild type,ctrl
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
age_years: 34;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 47;	gender: male;	tumor grade: IV,pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G diet for 14 days,ctrl
microdissected epithelial cells from IPMC 3,pert
scan batch: Batch 1;	group: autism;	subject age: 8;	paternal age: 33;	maternal age: 29,pert
"CA2, SOX17 expressing HESC - clone2",pert
non-transgenic spleen B cells_20 weeks,ctrl
sex: Male;	Age: 15 months;	additional patient information found in Series supplementary file,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 99min;	race: White;	sex: Female,pert
patient id: 42;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 45;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Rat left ventricle,ctrl
c-Kit + MA9 AML Zfx wt,ctrl
Isolated PBMCs from diabetic male patient_Grape extract group_12 months,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 2",pert
HCC_15N,ctrl
"ACI strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
MPA-treatment for 48hrs,pert
"Mouse liver, GNMT knockout, non-alcoholic steatohepatitis, 3 months",pert
MCF-10A_shCHK1-4,pert
affected status (disease state): control;	gender: male;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Vila-Real,ctrl
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
strain: C57BL/6J;	cell type: bone marrow derived macrophage,pert
Severe asthma,pert
18.5 dpc mouse small intestine wild type,ctrl
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: control,ctrl
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Mirandela;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
Nonspecific siRNA,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Ctr MCF10A.B2,ctrl
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 1",pert
"ALL, Down syndrome",pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with Phosphate-Buffered Saline, Deficient in Dystrophin",ctrl
patient id: 26;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
strain: C57BL/6N;	genotype: wildtype;	tissue: liver;	age: 5-6 months;	gender: male;	treatment: streptozotocin,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 18;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
cell type: myeloid monocytic cells;	protocol: 28h medium,ctrl
Disease_status: Healthy control;	Age (years): 68;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.3;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Sex: female;	Age at operation: 69 years;	Site: lower arm;	Size in cm: 4.5x3.5x2.2;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: low;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
Septic shock;	gender: Female;	Non survivor;	organism: Strep pneumo,pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu3,pert
"Cultured ovarian cancer cell line CH1, Cisplatin treated",pert
genotype/variation: Pou4f1+/+;	agent: control virus;	tissue type: fetal liver,ctrl
A HID I_B056,pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",ctrl
Left ventricle,pert
adult male,ctrl
Myeloid cells pooled from 2-3 7 week old wild type mice,ctrl
Postmenopausal female. Tibolone treated. Patient 30.,pert
Klf9 wild type (Klf9WT) and mutant (Klf9KO) mice jejunum; Age: PND 30,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: normal,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 3;	gender: male,ctrl
Patient: O;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
Whole testis RNA from WT mouse #147 at 0h,ctrl
"DHL4, DMSO",ctrl
cell line: SC263;	treatment: PBS,ctrl
sirna: NT control;	cell line: TOV112D;	cell type: Ovarian cancer cell line,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 1,ctrl
Aortas isolated from vitamin E-treated APOE-deficient mice,pert
CD4_T_cell_pool_melanoma_M03+M04,pert
"Sample Type: tissue, Tissue: testis",ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
Differentiation of hES cells line VUB03_DM1 towards MPC-like cells;	Mesenchymal stem cells phenotype,pert
Strain: NMRI mouse;	Age: 14 d embryo;	Tissue: molar tooth germs,ctrl
BATF_KO_P14_Naive,pert
HL60 cell line,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 37;	maternal age: 32,pert
Insm1 mutant #1_pituitary gland,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 75;	Usage number: 1;	Exposures: 4,pert
Trabecular meshwork tissue,pert
"Heart, KO2",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 2,pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 2",pert
"jejunum, GATA4 mutant, 2",pert
Pfeiffer NTshRNA,ctrl
"liver, PPAR WT_ctr_54",ctrl
Patient: I;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Splenic CD11b+Gr-1 high cell populations,ctrl
Hematopoietic Stem Cells,ctrl
Braf 3,pert
treatment: siThoc5;	cell line: HeLa,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 10",ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 72 hr,ctrl
2B1 Otic vesicle cell line over-expressing GFP only,ctrl
plantaris muscle,ctrl
Female - caucasian - N-05-M,ctrl
"Biceps, FSHD, cohort 18, subject 18A",pert
patient id: T79;	tissue: Normal cortex;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
BALB/c BMDM infected with WA(pYV),pert
BTBR-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,pert
patient: 4;	disease state: hypertension;	tissue: Atheroma plaque,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.89;	choa: 197;	fata: 43;	eea: 1380;	wtkg: 61.8;	perfat: 26.9;	lbm: 43;	fat_mass: 1662.42,ctrl
Liver endothelial cells,ctrl
Primary epithelial cell culture from esophageal biopsies,pert
tissue: white blood cells;	age: 13.87;	Sex: female,pert
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
UV-inactivated Sendai virus infected mouse tracheal epithelial cells.,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 318;	age-at-biopsy-years: 38,pert
tissue: minor salivary gland;	disease status: moderate SS,pert
5091212024_C,ctrl
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 69, stage IIB, HPV 16",pert
hair bulbs only from 9-day-old mice,pert
Whole Brain,ctrl
mouse NB N1-115 cell line,ctrl
Male wild-type BALB/c,pert
"Liver, fasting",pert
Fetal lung CD-1 background,pert
cell line: HEK293E,pert
PBMC from T cell Large granular lymphocyte leukemia patient#120,pert
male;	36 yr old;	Hispanic,pert
Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 6h,pert
Calu-3 human lung epithelial cells,pert
Gender: female;	Age: 10 weeks,pert
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
cell line: HCT116;	shRNA: CDK19;	treatment: low glucose,pert
original diagnosis: PolyRF+;	cell type: Peripheral blood mononuclear cells,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, mock (24h post-infection)",ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 2,ctrl
PC12 line PFR3,ctrl
"NALT infected with wild type 90-226, biological rep3",pert
disease state: endometrioma;	patient: 14,pert
obtained from RIKEN CELL BANK,pert
Mouse Soleus 4 weeks post birth,pert
disease affected colon of an adult with bacterial infectious colitis (INF).,pert
untrained wt,ctrl
race: caucasian;	age (years): 60;	stage: IB;	grade: 3;	histology: endometrioid,pert
N5A Normal-frontal,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
SUM149 cells transfected with siGENOME Non-Targeting siRNA Pool (control siRNA),ctrl
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
"Deltoid, FSHD, cohort 12, subject 12B",pert
MDA-MB231 control shRNA cells,ctrl
"YAP-overexpressing cells, biological rep2",pert
Primary hepatocytes isolated from Donor 2 treated with DMSO for 24h,ctrl
duration of untreated disease in month:6.1;	age at onset:1.8,pert
"brain, knock out",ctrl
PS_IB_3_asian_lcm,pert
GFP (control) shRNA-transfected ES cells in ES cell culture,ctrl
age: 12 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.15;	OD280: 0.539;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 217;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: monosomy7/del(7q),pert
Hodgkin lymphoma cell line,pert
Bone Marrow MM patient,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 13,ctrl
"LCL GM19238, Kd NFE2L1, 72hrs",pert
cell line: OVCA420;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
"patient 7, right arm treated with pimecrolimus until day 22",pert
"NeuroD1 cKO at ZT6, retina",pert
cell line: MCF7 breast cancer;	treatment: SIN3A silenced,pert
gonadal WAT of five wild-type mice,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: WT,ctrl
Patient: O;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
human normal cell lines airway,ctrl
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: rosiglitazone at 1uM,pert
HNF4loxp/-,ctrl
"twin pair: #12;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: DOX,pert
Normal myocardium sold commercially,ctrl
"Biceps, control, cohort 22, subject 22U",ctrl
"strain background: mixed C57BL/6, FVB, 129 background;	genotype/variation: BrafV600E::Pten-/-::Pdk1-/-, Pdk1 knock out;	tissue: tumor",pert
mouse embryo forelimbs,ctrl
Large PreB,pert
RNA from microdissected breast cancer cells from case 25 labeled with Cy5,pert
WI-38 cells exposed to 0.1 uM BPDE for 24 h,pert
Colo-205 cell line,pert
Flp-In™ 293 T-Rex,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-5;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T1N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
tissue: retina;	age: postnatal day 2;	genotype: wild type,ctrl
Disease_status: Bipolar disorder;	Age (years): 49;	Gender: Female;	Age of onset (years): 20;	Duration of illness (years): 29;	Brain pH: 6.39;	Post mortem interval (hours): 38;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
BALB/DBA F1 mouse untreated control,ctrl
HEK293 cell line #2 with uninduced HNF1beta,ctrl
SKM-Tg,pert
"Transgenic, snap frozen, tibialis anterior muscle, 7month age animal",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.98904,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 1",ctrl
Alveolar type 2 cells_control,ctrl
"liver, wild type",ctrl
ES cells,ctrl
"Cervical cancer cell line, ME-180, Human, squamous cell cancer",pert
Group3: 6 days differentiated Flk1+ WT ES cells,ctrl
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: lung",pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Good-responder).,ctrl
disease state: endometrioma;	patient: 6,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.7;	age of onset: 33 yr,pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #3,pert
sex: Male;	family: 5;	age: 38;	disease status: Affected;	tissue: Muscle: Biceps,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,ctrl
Diagnosis: Secondary AML;	Age: 36y ;	Gender: Female;	Blast %: 67;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
Sprague-Dawley Rat retina (male); 30d post injury,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 2, Units of Harvest Time Point: hr",pert
"twin pair: #1;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
cell line: KYSE180;	cell type: squamous cell carcinoma,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 8,ctrl
36M2 cell line from ovarian serous carcinoma cells,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
"LNCaP cells, treated with EtOH, biological rep 3",ctrl
10.5 months cardiac muscle,ctrl
F9 RARaKO treated 8hr with atRA,pert
treatment: Sirt1 Overexpression;	cell line: Caco-2,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 47;	age-at-onset: 43;	geographical origin: Vila-Real;	clinical characteristics: Hypercholesterolemia,pert
Brain (Inferior Olivary Nucleus)_control subject_#2,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 70 years,pert
Human polymorphonuclear (PMN) leukocytes,ctrl
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 25+29=54;	Sex: male;	region: M1;	age: 38,41;	genotype: Y/X;G42/-",ctrl
RNA from microdissected breast cancer cells from case 607 labeled with Cy5,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.08;	RNA Integrity Number: 9.1;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"treatment: control;	batch: 4;	donor: 30;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
tissue type: adjacent non-tumorous liver,ctrl
A39 WT6	F2/11	A39	wild type	Mouse	10 months	Cerebellum	Male,ctrl
C57/BL,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 40 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
bronchoalveolar stem cells,ctrl
strain background: mixed (SV 129/C57BL/6);	genotype/variation: Rnh1 Knock out (Rnh1-/-);	age: embryonic day E9.5;	tissue: yolk sac,pert
"Gender: Female, Age: 27, BMI: 19, Tissue: luteinized cumulus cells",pert
"Brain tissue from Fisher 344 male rat, Animal #255, 200mg/kg D-Serine",pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 8 hours,ctrl
CIS,pert
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 85;	Usage number: 4;	Exposures: 3,pert
age_years: 73;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
C57Bl6N Mouse;	gd17.5 fetal heart,pert
fluorescent activated cell sorter (FACS)-selected cells,pert
SK-MEL-2 cells,ctrl
Gene expression data spleen marginal zone B in IRF8 conditional KO,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 8",pert
"amniocytes, euploid, 1569",ctrl
"SRF silenced, treated with EtOH, biological rep 2",ctrl
BT-20 cells,ctrl
BA osteoblastic lineage cells 5-6 weeks post doxycylin withdrawal,pert
Heart sample2,pert
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,pert
Untreated WT,ctrl
"FACS-sorted cones, P40 C-DGCR8 KO mice",pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",ctrl
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
"Male, 27 years old, HIV infection of ~1 months",pert
NPC 5-8F cells with NESG1 overexpression,pert
A HID B_B091,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
"B cells, transgenic, stimulated",pert
"BOEC, not_at_risk 8",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: internal tandem duplication (ITD),ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 2,pert
"Ishikawa cell line, BPA, 1pM, 24hr",pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 2;	age: Post natal day 3-8,pert
GFP_Untreated_6hr,ctrl
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.3,pert
112 Day Mouse extraocular muscle,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
race: african american;	age (years): 91;	stage: IB;	grade: 3;	histology: papillary serous,pert
scram_hi_9,ctrl
"5-FU-primed bone marrow mononuclear cells, Evi1-transduction",pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 21.1863,ctrl
"GI_canc, Duo1",pert
129 mouse pineal gland tissues taken at postnatal day zero.,ctrl
tissue: heart;	genotype: CRE;	age: 8 week adult mice,ctrl
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 25;	gender: male,pert
sampleID: SAM630131;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Cell type: endothelial, age:44, gender:male, diagnostic group: schizophrenia, PMI:9h",pert
Soleus muscle,pert
strain: C57BL/6;	genotype/variation: Fcg-chain KO;	cell type: Peritoneal MF,pert
cell line: Hep G2;	genotype: HCC-THRA mutant al;	treatment: with vehicle for 6h,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 LAMC2 shRNA;	cell line: HTH83,pert
platelet from sickle cell patient,pert
"H1299 treated with PTD-DRBD GAPDH siRNA, 24hr",pert
Strain: J1 Cell type: mouse embryonic stem cell,pert
"LCL GM19238, Kd CLOCK, 72hrs",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day7,ctrl
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
2-WT_RD1b,ctrl
Trib1 #2 Wild-type macrophages were treated with LPS,ctrl
patient: 40977;	sample: tumor,pert
Wild type fetal lung dpc 18.5,ctrl
control MCF-7 cells,ctrl
CD4_Tcells_non_severe_asthma,pert
"seminoma specimen, pT3, patient age: 42y",pert
"NALT infected with 90-226att, 24h, biological rep3",pert
A YOKE_B093,pert
PBMC from T cell Large granular lymphocyte leukemia patient#100,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 24 hr AP20187,pert
heart tissue,ctrl
wild type mouse retina at age postnatal day 2,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: soleus;	age at biopsy: 52;	Sex: male,pert
8 Month FORKO Ovary_01,pert
cell type: Immortalized lung epithelial cells,pert
strain: C57BL/6;	tissue type: back skin,pert
"Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow, non-fasted; Genetic modification: Scd1 -/-.",pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 68;	age-at-onset: 66;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,pert
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,pert
chip number: 17;	transfection plate: 3A;	target gene: NFYC;	kd level: 0.54;	rin: 9.6;	transfection date: 2012-03-26,pert
Strain: C57BL/6J;	Gender: F;	Age: 6 weeks;	Treatment: untreated,ctrl
Diagnosis: AML M5;	Age: 58y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: No Data,pert
disease state: paediatric glioblastoma;	age: 6;	gender: M;	h3.3_status: wt,ctrl
"Ishikawa cell line, BPA, 1uM, 48hr",pert
embryons of mice at 14.5 days.,ctrl
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: siRNA against TET2 transcript,pert
lesional skin bioposy obtained from patient after 7 days of treatment,pert
E18.5 Embryonic Liver,ctrl
tissue: Embrionic stem cell line;	genotype/variation: Δexon2/+,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  2",pert
KrasG12D Pten L/+ PDEC,pert
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep1,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: DMSO,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 54, stage IIIB, HPV 16",pert
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: none,ctrl
SP-C-rtTA/(tetO)7CMV-Cre/Stat3flx/flx triple-transgenic mice,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",pert
Cell culture of Melanoma Cell Line - A375,ctrl
cell type: B-cell;	cell line: Pfeiffer DLBCL,pert
8 wk old male mdx5cv diaphragm,pert
Peripheral blood mononuclear cells;	TTF=101min;	Race=White;	Sex=Male,pert
No_drug_#4864,ctrl
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + morphine,pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: mammary gland",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 52 years,ctrl
Subtype: RA;	Karyotype: other,pert
"Postnatal day 11 Cerebellum, knockout for L1CAM",pert
"Male, 29 years old, HIV infection of 3.5 years",pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
cell line: HEK-293;	genotype: NOD2 L1007fsinsC;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,pert
CD8+CD28low regulatory T cells,ctrl
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
OVSAYO ovarian cancer cell line,ctrl
"liver sample of Wistar rat fed for 12 weeks with lard diet, after overnight fast",pert
Human hepatoma cell line (HepG2),ctrl
parental cell line: WC;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
A VIS _B032,pert
Sample ID: TP22;	Twin Pair ID: CCE1.2;	Clinical Status:  Childhood Absence Epilepsy + Febrile Seizures;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : None,pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 49;	donor: 35;	disease state: Non-lesional,ctrl
tissue: skeletal muscle;	disease status: dermatomyositis,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
gender: F;	age at blood draw: 58;	tissue: whole blood,pert
HepG2 cell line from ATCC at 8th generation before PCB77 treatment.,ctrl
"MOLT4 cell line, untreated",ctrl
"BOEC, at_risk 6",pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,ctrl
41A;pretreatment;female;breast tumor,ctrl
HLA risk: Medium;	Height: 151.2 cm;	Weight: 42.9 kg;	BMI: 18.4;	Age: 11.22 years;	Gender: Female;	Race: White;	Glucose: 230 mg/dl;	HbA1c: 6.8%,pert
SV589 8 Day KD Serum Starved-> 1hr EGF,pert
human glioblastoma cell line,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: White;	sex: Female,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
human CF cell lines airway,ctrl
S46 WT3	F5/11	S46	wild type	Mouse	3.5 months	Cerebellum	Female,ctrl
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,ctrl
Extract:LOX-1:113201;	Extract Description:GFP_Untreated_2hr:113201;	Quality: Classification:Medium;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:1.93;	Quality: Absent (%):59.17;	Quality: Absent (%) Dev.:0.71;	Quality: Scaling Factor:0.64;	Quality: Scaling Factor Dev.:0.22;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295473,ctrl
cell line: HUVEC,ctrl
"MCF-7 human cell line, siLRH-1_#3",pert
"age at diagnosis: 33;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1mi;	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
primary normal lung tissue 1319,ctrl
F6.06,ctrl
GATA6 KO lung E18.5 mixed strain,pert
subject: 2830 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
N-BMSCs were transfected with negative control (siNC) construct,ctrl
"Zen-Bio, Inc. (Research Triangle Park, NC) - SL0044",ctrl
Bone marrow HSC,pert
normal gingiva tissue from volunteers,ctrl
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
colon biopsy,ctrl
Embryonic day 14.5 and 16.5 pancreas,pert
"Infected with H37Rv, replicate 2",ctrl
strain: FVB;	genotype: E2F3 heterozygous;	tissue: mammary gland tumor,pert
subject: 8;	disease: CP;	muscle: GR;	gender: M;	age: 16.7;	gmfcs: 5;	popliteal angle: 90,pert
A YOKE_B094,pert
cell line: KYSE170;	cell type: squamous cell carcinoma,pert
ventral prostate,ctrl
Normal heart from MRL/MpJ strain,ctrl
"Ulcerative colitis patient, biopsy taken from the colon, no macroscopic signs of inflammation.",pert
"Patient  H, lesion, 2 week",pert
biopsy of non-malignant nasopharyngeal control,ctrl
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
RNA from microdissected breast cancer cells from case 849 labeled with Cy5,pert
A2CNT2,ctrl
Wildtype H9 hESC derived NSC 3,ctrl
Female - caucasian - E-06-G,pert
Array Type: HG-U133A_2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
CD3-purified cells from normal peripheral blood sample. >95% purity,ctrl
cell line: HEK293;	genotype/variation: tranfected with SNRK-pEGFPN3,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 132min;	race: White;	sex: Female,pert
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: control,ctrl
age	24;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	4.7;	hemoglobin (g/dl)	14.2;	platelet count (/nl)	192,ctrl
chip number: 12;	transfection plate: 3A;	target gene: BATF;	kd level: 0.52;	rin: 9.9;	transfection date: 2012-03-26,pert
"Normal cervix, microdissected epithelium, Age 45",ctrl
control siRNA,ctrl
patient: 256;	current medication: None;	birth date: 10/16/44;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 4/1/05;	diagnosis date: 6/2/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 10;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
patient: 32023;	disease state: LGSC;	component: Borderline,ctrl
gallbladder -saline treated,pert
inflammatory cardiomyopathy,pert
"ID:11-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
sample: #7;	subject: Control case #3;	brain: T-638;	age: 78;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
"ID:14-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
Neonatal mouse ovaries cultured in4-Vinylcyclohexene Diepoxide (50uM),pert
cell type: CD47 null Endothelial cells;	strain: C57Bl/6;	genotype/variation: CD47 null,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: B,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,ctrl
"Cell type: neuronal, age:44, gender:female, diagnostic group: schizophrenia, PMI:26h",pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
cell type: bone marrow derived mast cells;	genotype: NTAL knock out;	genetic background: C57BL/6;	treatment: none;	vector: none;	activation: 2 h 100 ng/ml TNP-BSA,pert
"Untreated LNCaP cells not stimulated with DHT, biological replicate 2",ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
cell line: A549;	cell type: human lung cancer;	sirna: non-targeting,ctrl
MPM tumor specimen 5,pert
"BOEC, normal 17",ctrl
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
plasma;	patient with sepsis only,ctrl
Primary hepatocytes isolated from DBA mouse strain treated with Wy14643 for 24h,pert
Mid Secretory Phase Endometriosis,pert
cell type: R1 mouse embryonic stem cells stably transfected with shRNA mismatch control sequence,ctrl
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: Sham (intact) control,ctrl
Sample Group: HD patient; Gender: female; Age: 43; Tissue: lymphocytes (blood); IT15 CAG repeats: 15/50,pert
HepG2 human hepatocellular carcinoma cell line,ctrl
"46, XX",ctrl
INS-1 cell line #5a with induced HNF1b mutant P328L329del,pert
treatment: baseline;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant",pert
PS_IA_3_cauc_lcm,pert
liver biopsy sample,ctrl
diet: LRD-5001,ctrl
HeLa cells were treated with the siRNAs for 72 hrs,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
cell line: MCF-7 breast cancer cell line;	agent: estradiol (E2);	time: 3hr,pert
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: NSC319726 (1 µM) for 24 hrs,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
"Mouse liver tumoral tissue, MAT1A knockout, hepatocellular carcinoma, 15 months",pert
NK_cell_pool_melanoma_M11+M12,pert
CD11b+Gr-1+ myeloid cells sorted from the colon tumors of HDC-EGFP transgenic mice induced with AOM/DSS,ctrl
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD4+ T-cells",pert
Genotype: Wild type,ctrl
tissue: skin;	individual: Patient P11;	condition: AL;	eczema severity: SCORAD: 64,pert
whole skin,ctrl
Percutaneous biopsies of vastus lateralis,ctrl
NPC 5-8F cells with NESG1-negative expression,ctrl
control;	control,ctrl
"Male, 26 years old, HIV infection of ~5 months",pert
cell line: MDA-MB-231 breast cancer cell line;	genotype/variation: ARF1 siRNA,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 23;	maternal age: 19,pert
"WT epithelium, uninfected, 0h",ctrl
cell type: Oct4-Gip ES;	RNAi: Luciferase;	treatment time: 72h,ctrl
gender: male;	genotype: TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,ctrl
Jurkat T-cells transfected with siRNA #6 for Sp3 for 48 hours,pert
Aquaporin-11-/-_mouse P7 kidney #3-3,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: monosomy7/del(7q),pert
Bladder urothelium,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 51 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
P16_exPKO_pancreas_rep2,pert
NOMO-1 cells infected with GFP lentivirus,ctrl
strain: C57BL/6;	genotype/variation: Ret Deficient;	tissue: whole embryonic kidney;	age: gestational day 12.5 (E12.5),pert
"Patient  B, lesion, 12 week",pert
genotype: Wildtype;	Sex: Male;	tissue: Liver;	compound: vehicle;	route: IP;	dose: 0 mg/kg,ctrl
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-,ctrl
chip number: 18;	transfection plate: 4;	target gene: IRF7;	kd level: 0.71;	rin: 9;	transfection date: 2011-10-17,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.20;	Post mortem interval (hours): 10;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",ctrl
WM35 cell line,ctrl
tMLL03,ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
gender: male;	individual: patient 1;	treatment: control,ctrl
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14583;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"RET-PTC, 10 months",pert
strain: C57BL/6;	genotype: PTEN+/- IKK2ca/ca (epithelium);	age: 12 months;	tissue: lateral prostate,pert
PBMCs from normal control subject K,ctrl
NORMAL LUNG TISSUE,pert
SARS patient blood sample,pert
INS-1 cell line #2b with induced HNF1b,pert
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 132min;	race: White;	sex: Female,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 50;	gender: male;	tumor grade: IV,pert
thorax from embryo of OTT1 null/wt E18.5 mouse,ctrl
HSC-3 cell line with control vector,ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: H;	transfectant type: stably transfected with scramble control,ctrl
patient: 51721;	sample: normal,ctrl
cell line: A549;	agent: DMSO;	dose: control,ctrl
Strain: FVB/N;	Genotype: mCftr+|+,ctrl
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 24h;	gender: Female;	age: 70 years old,ctrl
HCT116 cells,ctrl
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: KM-H2;	treatment: Non-silencing control,ctrl
"NB4 cell line, wild-type, ATRA, 72hr",ctrl
Whole adrenal RNA from Crem-/- mouse #2 at 0h,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 82min;	race: White;	sex: Male,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep7",pert
E12.5 Whisker pad wild-type,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L010,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
human normal pituitary,ctrl
"Patient  F, lesion, 1 week",pert
knockdown: BAP1;	cell line: 92.1,pert
"MUSCLE, CR, Before",ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
subject: 20A;	cohort: 20;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,ctrl
normal rat testis,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: Black/African American;	sex: Male,pert
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre-;	phenotype: wild-type;	treatment: dextran sodium sulfate (DSS),ctrl
U2OS_shCHK1-3,pert
HPRT KO ES cells,pert
Tissue: endothelial cells,ctrl
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10+,ctrl
cell line: MCF-7 breast cancer cell line;	sirna: ER siRNA;	agent: control (vehicle);	dose: n/a,pert
Supraoptic nucleus_control,ctrl
ONH preglaucoma,ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14480;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 50 mg/kg,pert
Asthmatic after Placebo,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: ZXDC1 knockdown;	agent: PMA,ctrl
"C2C12 myoblasts, treated with 50 mM sodium pyruvate for 72 hr",pert
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",ctrl
"triceps, mutant mouse",pert
"Patient  D, lesion, 4 week",pert
tissue: white blood cells;	age: 11.16;	Sex: female,pert
RNA from whole tissue section of case 1370 labeled with Cy5,ctrl
MycCap prostate cancer cells,pert
"TNFa siRNA-A, replicate 5",pert
Stroma associated to breast invasive tumor,pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, Harlan Teklad TD03045 diet, liver",ctrl
cell line: MCF7;	condition: siRNA Smc3 + Estrogen,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 44 yr;	population: white,ctrl
gender: Female;	tissue: Tendon;Biceps;	age: 65;	donor: 21;	disease state: Non-lesional,ctrl
Whole lung tissue_early IPF_biopsy,pert
rheumatoid arthritis,pert
Calu-3 human lung epithelial cells,ctrl
chip number: 20;	transfection plate: 4;	target gene: IRF9;	kd level: 0.75;	rin: 9.2;	transfection date: 2011-10-17,pert
RV83.10_CHF_day10,pert
"jejunum, GATA4 mutant, 3",pert
Heart tissues,ctrl
MCF7 Argyrin A treated 24h,pert
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: Foxa2-/-",pert
"SBC-5 cells, siEGR4 (target), 48 hr after siRNA, duplicate sample 2",pert
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: OC1-KO,pert
carcinoma,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 7,ctrl
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch3",ctrl
WT_embryonic brain_rostral,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,ctrl
"100-200 motor neurons, sacral spinal cord, 21days post sham opration",ctrl
Uninfected TG mouse brain at 5 d.p.i.,pert
12h control (1);HT-29;colon:carcinoma;NONE;42994,ctrl
quadriceps muscle tissue of presymptomatic DMD children,pert
HUVECs transfected with FoxP1 siRNA,pert
Celecoxib_#4858,pert
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, lobular;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 1;	pgr: NA;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 72;	tissue: Blood,pert
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 95;	Usage number: 5;	Exposures: 3,pert
Placenta_nl2 with Cy5,ctrl
strain: mixed background of 129/SV and C57BL/6;	cell type: macrophage;	genotype/variation: PPARg WT,ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 0h,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
"rat, hepatocellular carcinoma (DEN 50mg), treated with vehicle (week 18)",ctrl
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",pert
EB_0_6_355_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
14-week-old WT liver_611WT,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 4,pert
cell line: LNCaP;	overexpression vector: GFP,ctrl
"Brain tissue from Fisher 344 male rat, Animal #246, control (0mg/kg) D-Serine",ctrl
S9A Sporadic-frontal,ctrl
WT Primary Hepatocytes - Pooled -Cy3,ctrl
control participant P332wh (human CD3 positive T cells),ctrl
control tissue,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 4",pert
MCF-7 Pit-1 overexpression,pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHC chimera,ctrl
amygdala,ctrl
Rat liver,ctrl
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: 5HTT +/-;	treatment: control,pert
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
RNA from microdissected breast cancer cells from case 420 labeled with Cy5,pert
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,pert
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
duration of untreated disease in month:3.2;	age at onset:8.4,pert
"cell line: SW480-Vector, vector control treated stable line",ctrl
heart tissue from WT mouse,ctrl
"Patient  N, lesion, 1 week",pert
3 ERRg KO E18.5 male cadiac ventricles,pert
cell line: HT1080;	clone: 2;	genotype: Wild type,ctrl
Adult Tg mouse whole brain,pert
"Cell type: endothelial, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
tissue: bone marrow;	genotype: Wild type;	strain: C57bl/6;	age: 10-13 weeks old;	cell type: FACS sorted LY6D- CLP cells (LIN-FLT3+CD127+),ctrl
agent: control;	strain: BALB/c;	tissue: mesentery,ctrl
"seminoma specimen, pT2, patient age: 46y",pert
35/1-22 - Dox +48h E2_1,pert
MLL_PTD08,pert
agent: EFNA4-Fc conjugate;	time: 4h,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.15616,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: wild-type control,ctrl
EB_0_6_354_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",ctrl
"heart, wild type",pert
tissue: blood;	patient: 1;	gender: male;	age: 54,pert
tibialis anterior Muscle homo,pert
tissue: Hippocampus;	age: 83;	Sex: M,ctrl
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: Akt inhibitor AktI-1/2,pert
WI-38 cells exposed to DMSO vehicle control for 24 h,ctrl
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Tongue,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate B,pert
epithelium from colon of control mouse no.2,ctrl
"Hippocampus, soman, 3h",pert
Hippocampus,ctrl
"gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"Mouse liver, wild type, healthy, 15 months",ctrl
genotype/variation: Tpl2 wild type;	treatment: unstimulated,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 428,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 8 hours,pert
"SW480, stable line of treatment of luciferase RNAi. Incubate in L15 medium, 37.0°C, air 100%",ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2A shRNA,pert
"General population, Female",ctrl
liver_Wt_female_35wk_rep2,ctrl
"Female (age range 33-49), skin biopsy taken from upper nates 48 hours after nickel exposure",ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day1,ctrl
cell line: HCT116;	clone: 23;	genotype: Wild type,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 5",pert
triplicate 1 of S. aureus infected HepG2 nt cells,ctrl
MPM tumor specimen 22,pert
Lung Epithelial Cell Line,pert
female;	37 yr old;	Black,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 ko;	tissue: mouse liver, 10 weeks",pert
genotype/variation: Tsc2 wildtype;	tissue: cerebellum;	gender: Female,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 28;	maternal age: 27,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
Cell line: TOM-1,ctrl
tissue: skin;	individual: Patient N-7;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
tissue: skin;	individual: Patient P6;	condition: AL;	eczema severity: SCORAD: 70,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 5,pert
WILDTYPE cerebellum at 18 weeks,ctrl
Skeletal muscle biopsy,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Brd4 shRNA,pert
"Female (age range 33-49), skin biopsy from upper nates taken 48 hours after nickel exposure",ctrl
Strain: C57BL/6;	Gender: male;	Age: 9 - 12 weeks;	Tissue: liver;	Treatment: 50 mg/kg of phenobarbital,pert
MDS BM CD34 CELLS,pert
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: Dicer lox/lox control,ctrl
untreated control,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,pert
GC resistant clone C7H2-R3B5 treated for 6 hours with GC,pert
"Cell type: neuronal, age:51, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 125min;	race: White;	Sex: Female;	fstl-1 (ng/ml): 94,pert
Hypothalamus,pert
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR+/+;	treatment group: vehicle 0 mg/kg,ctrl
Asthmatic at baseline,pert
agent: ConA;	time point: 1 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
protocol: hsa-mir-30a/30d depletion,pert
PancreaticSample9-Tumor,pert
BT-20 cells,pert
"SRF silenced, treated with EtOH, biological rep 2",pert
Abca1 +/- ES cell line,pert
strain: C57/BL6;129Ola mixed;	genotype/variation: Insm1 -/-;	developmental stage: embryo;	age: E17.5;	tissue: pituitary gland,pert
carcinoma,ctrl
S46 NLS 142Q TG1	F5/2	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Male,pert
Retina of 4 month old C57BL/6 mouse,ctrl
lymphocytes,pert
B-CLL PB P33,pert
ApoD knock-out,pert
"NRK-52E cells (DeLarco and Todaro, 1978) (ATCC, CRL-1571)",pert
HSF1-/- T cells activated at 37oC,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 41.5589,pert
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): nTreg,ctrl
"BALB/c, Female, CF",pert
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Cell line: MDA-MB-231,ctrl
"twin pair: #7;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
patient id: 260;	tissue: Normal cortex;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
subject: 22U;	cohort: 22;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
Myd88 KO control tissue  1,pert
treatment: treated with R1881 and control shRNA;	cell line: LNCaP,ctrl
metoprolol treated muscle cells,pert
tissue: whole whisker pad;	genotype: homozygous Trps1 mutant;	age: E12.5,pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,pert
"Postnatal day 11 Cerebellum, knockout for L1CAM, replicate 2",pert
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: mammary gland",pert
"TGCT cell line 2102Ep/clone 2A6, untreated, undifferentiated",pert
cell line: bj-ipsc_2: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
cell type: CFBE41o-  ∆F508-CFTR,pert
Aquaporin-11-/-_mouse P7 kidney #2-4,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: wild type,ctrl
Cervical cancer_CC218,pert
"H295R adrenocortical carcinoma cells, control",ctrl
27 weeks male,pert
"Peripheral blood, patient with recurrent events",pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Myc heterozygous,pert
HT29 methotrexate-resistant cells,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,ctrl
E9.5 KLF1-/- erythroid-8,pert
cell type: Embrionic stem cell line;	genotype: HPRT -/-,pert
cell line: U20S;	tissue type: osteosarcoma,ctrl
tMLL08,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 6h;	gender: Male;	age: 44 years old,ctrl
"mouse, liver (CCl4), treated with erlotinib 2mg (week 18)",pert
"HCT116 cells, XIAP shRNA, late passage",pert
genotype: WT;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,ctrl
Sample: alpha-TM180;	Replicate: 3;	Pool: NP,pert
human adenoid cystic carcinoma grown as xenograft in mouse host,pert
Neuroblastoma cell line,pert
S1_sham_overexpressor_12,pert
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: wild type;	age: 6 months,ctrl
"fetal testis sample 18L, 22 weeks gestation",ctrl
sirna: Syk siRNA knockdown;	plate: collagen coated;	cell line: MCF10A,ctrl
NB58,ctrl
HCC_17N,ctrl
Primary hepatocytes isolated from SV129 mouse strain treated with DMSO for 24h,ctrl
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 3",pert
"64B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
(ca)erbB-2_3,pert
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,ctrl
sample type: Primary culture of typeII cells collected from SPC WT lung (adult);	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C WT;	genetic background: 129S6/SvEvTac,ctrl
cell type: Primary hepatocytes;	donor: 5;	agent: Wy14643;	time: 24h;	gender: Male;	age: 73 years old,pert
"age at diagnosis: 51;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
"NCI-H460, control, 24 hr",ctrl
Gender:M;	Age:44;	Tissue: Mucosa,ctrl
"Cultured ovarian cancer cell line OVCA429, Cisplatin treated",pert
tissue: lesional skin;	urticaria status: affected;	patient: 4,pert
Ring1b_KD,pert
Diagnosis: MDS/AML;	Age: 53y ;	Gender: Male;	Blast %: 77;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
NeuoD1 transgenic animals die very shortly after birth.,pert
cell line: HL-60;	shRNA construct: Scrambled Control,pert
CON - LV21,ctrl
cell line: HepG2;	genotype/variation: control,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 35;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
cell type: pre-iPSCs;	sirna mediated knockdown: control,ctrl
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Male;	Age of onset (years): 28;	Duration of illness (years): 28;	Brain pH: 6.07;	Post mortem interval (hours): 23;	Side of brain: Right;	Fluphenazine mg. Equivalents: Unknown;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: Yes (60 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Treg cell,pert
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 80;	tissue: Blood,pert
trained plakoglobin (+/-),pert
"left ventricle,Hsp22 KO,basal condition",pert
Skin from Irf6 null,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,ctrl
Esophagus cell line OE33 Control,ctrl
"BOEC, at_risk 1",pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
Lin- Rosa26rtTA cells untransduced,ctrl
liver_Wt_female_8wk_rep2,ctrl
umbilical cord tissue; high gestational age,pert
EB_0_19d_77_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
genotype/variation: Gfi1b wt,ctrl
"HepG2 cells; (HB-8065; ATCC, Manassas, VA)",pert
F9 RARaKO treated 8hr with EtOH,pert
diagnosis: NSIP;	fvc-group: FVC2;	tissue: lung,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P90;	genotype: Igf1 +/+,ctrl
Y VIS _B029,ctrl
transfection: H19 siRNA (simH19);	cell: C2C12,pert
Peripheral Blood Mononuclear Cells;	unknown age and gender,ctrl
S2_sham_overexpressor_12,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: other,pert
Skeletal muscle biopsy,pert
Healthy-6 baseline,ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 69;	Usage number: 1;	Exposures: 4,pert
Healthy donors,ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 2,pert
5091212024_B,pert
tissue biopsy of urticaria lesion from CIU patient,pert
"CD8 DC, KO",pert
MCF7 DMSO+E2,pert
cell type: primary p53-null neural stem cells;	retroviral expression: vector,ctrl
T137,pert
"Gastrocnemius-soleus muscles, basal status, integrin alpha7 transgenic  mouse",pert
Myd88 KO control tissue  3,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T1N1,pert
Primary hepatocytes isolated from SV129 mouse strain treated with Wy14643 for 6h,pert
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
patient id: T158;	tissue: Normal cortex;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
EE_IC_2_aa_lcm,pert
"RNA from Cell line SLM2, mutant status WT, condition Control",ctrl
mouse strain: C57BL/6J;	genotype/variation: AhR-d,pert
Bone marrow HSC,ctrl
PancreaticSample34-Tumor,pert
"Zen-Bio, Inc. (Research Triangle Park, NC) - SL0044",pert
strain: 170;	Disorder: normal scar;	Condition: +hydrocortisone,pert
"spc-c-raf transgenic mice, age: 7 month old, Gender: male, Tissue: unaltered",pert
cell type: Primary neonatal keratinocytes;	genotype/variation: control,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L016,pert
HEL cell line_Control shRNA (GFP),ctrl
"WT C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",ctrl
293T cells stably transfected with 2 shRNA constructs (si1340/si1428) against LEDGF transcript (PSIP1 gene).,pert
patient: 109;	current medication: None;	birth date: 10/10/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: FH of Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
"brain, Entorhinal Cortex",ctrl
UC Uninflamed ascending colon,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 1,pert
tissue: Temporal cortex;	age: 78;	Sex: F,ctrl
7 Day Mouse leg muscle,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 173;	Sex: male;	region: LC;	age: 38;	genotype: Y/X;TH/-,ctrl
"MaF pre-iPSC9P2, Vc untreated, lysed on D3",ctrl
tissue: Breast adenocarcinoma,pert
cell line: U373;	cell type: glioma;	vector: EGFP,ctrl
affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
colonoscopic biopsy from adult with affected colon from adult with INF,pert
"LCL GM19238, Kd YY1, 72hrs",pert
P32_WT_pancreas,ctrl
Gene expression data spleen marginal zone B in WT,ctrl
"ID:10-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: fl-p300/Foxp3cre,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
genotype/variation: wt;	age: P60;	tissue: Whole eye,ctrl
tissue type: Benign prostate tissue,ctrl
Lung of hemorrhaged animal 48h,pert
"Total RNA, Tet2 KO LSK 5th plating",pert
"Male, 40 years old, HIV infection of 7 years",pert
"vehicle treatment, 72 hour time point, biological replicate 1",ctrl
cell line: HepG2,pert
CD4_T_cell_pool_healthy_H07+H08,ctrl
B with Cy5,ctrl
HCC_10N,ctrl
"A pool of two pure subsets of peripheral blood CD56dim natural killer cells (CD19- CD3- CD56dim Cd16+), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: untreated,pert
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	cell type: embryonic stem cell,ctrl
genotype/variation: Pou4f1+/+;	agent: MSCV-Pou4f1 virus;	tissue type: fetal liver,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu1,pert
hippocampal tissue from wild-type mice,ctrl
CD3+ cells,ctrl
Extract:LOX-1:213402;	Extract Description:LOX1_Untreated_12hr:213402;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.55;	Quality: Background Mean Dev.:0.39;	Quality: Absent (%):57.62;	Quality: Absent (%) Dev.:0.49;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.52;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295783,pert
PBMC from Rhesus Macaques,pert
embryonic fibroblasts from male IRAK4 kinase dead Balb/c mice,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 58;	gender: male,pert
FACS sorted IgM+IgD+ cells,ctrl
HEK293 cell line #1 with induced HNF1alpha,pert
"human embryonic stem (hES) cells line SA01, biological replicate  1",ctrl
"Brain tissue from Fisher 344 male rat, Animal #269, 5mg/kg D-Serine",pert
Kidney tissue from obese rats on control diet,ctrl
"cell type: Human mammary epithelial cells infected with retrovirus carrying hTERT and the oncogenic allele of H-Ras, H-RasV12 described in (Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC, and Weinberg RA (2001) Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev 15: 50-65)",pert
T3.02,ctrl
"C1_transgenic but unaltered, lung tissue",pert
cell type: embryonic fibroblasts (MEFs);	genotype: wild type,ctrl
hNHEPS human hepatocytes exposed to 10 μM VX 6 h after exposure,pert
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 1,pert
"Age: 50;	Sex: M;	Ancestry: European;	Smoking status: smoker, 38 pack-years",pert
Control mouse embryonic stem cells,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Endothelial Cell,ctrl
cell line: AST18;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 94;	Usage number: 5;	Exposures: 3,pert
EB_07_24h_136_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep4",ctrl
Normal donor Lung,ctrl
GM9018,ctrl
treatment: progesterone;	genotype: wild type;	treatement time: 40 hours,ctrl
genotype: WT;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,ctrl
NK_cell_pool_healthy_H09+H10,ctrl
"100-200 motor neurons, sacral spinal cord, 60 days post sham opration",ctrl
2A;pretreatment;female;breast tumor,ctrl
H295R adrenocortical carcinoma cells,pert
Disease_status: Healthy control;	Age (years): 35;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 52;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
cell line: HUES6;	treatment: VGLL4 overexpression,pert
cell line: SUP-B15;	tissue: Human B cell precursor leukemia,pert
HEK293 F18 WTX inducible,pert
affected status (disease state): control;	gender: male;	age-at-examination: 53;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever smoker,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 72h",pert
CD11b+Gr1+ cell sample_3 (derived from IL17RC Kock out mouse),pert
subject: 03U;	cohort: 3;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
HUVECs transfected with control siRNA,ctrl
tissue source: matched healthy control;	tissue: Vastus lateralis muscle;	tissue state: basal state,ctrl
genotype/variation: wildtype ThPOK (control),ctrl
MCF-7_ethanol_ethanol,ctrl
MDA-MB-231 breast cancer cell line,pert
Primary CLL cells (untreated),ctrl
CD4+CD8+ double positive (DP) thymocytes 3h medium treated,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 30;	maternal age: 27,pert
"Spinal Cord, Epicenter (~T8)",ctrl
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 9.8;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Age: 42;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
gender: F;	age at blood draw: 41;	tissue: whole blood,ctrl
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
"genotype/variation: Pten-null (Ptenloxp/loxp), with doxycycline-inducible PTEN transgene;	cell type: embryonic fibroblasts;	transgene: tet-inducible Pten transgene;	time: 24 h;	genetic background: C57BL\6",pert
H6PDH knockout,pert
cell line: MCF-7;	sirna knockdown: siLRH-1_#2,pert
cell line: SV589;	knockdown (days): 3;	treatment: no treatment,ctrl
"ID:c 4-1, Genotype=(C57BL/6J), Treatment= none",pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 2,pert
age: 50;	sex: M;	disease status: control subject;	Filter number: 101;	Usage number: 1;	Exposures: 3,ctrl
cell line,ctrl
UACC903 cell line,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,pert
strain: C57BL6,pert
THP-1 AML cells,pert
chip number: 19;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.4;	transfection date: 2011-10-17,ctrl
MGHU3 Cells_Control siRNA + PD173074,pert
cell line: SNB19;	transfection: PARK2 siRNA#1,pert
patient: 243;	current medication: Atenolol Pravastatin Asprin Adalat BFZ Balsalizide;	birth date: 2/17/25;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/04;	diagnosis date: 3/29/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: NEW;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Deaf;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Type II cells from Nrf2-/- mouse.,pert
157_DMSO,ctrl
hepatoma cells,pert
cell line: ARPE-19;	clone: parental;	genotype: Wild type,ctrl
Sample Group: control; Gender: male; Age: 42; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
"BioBreeding DRlyp/lyp rat, day65, mast cells derived form pancreatic lymph node",pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
cell line: HEK293 human embryonic kidney cell line;	protocol: control (control RNA),ctrl
cell line: H1299;	agent: decitabine;	dose: 0.3 uM,pert
tissue: Brain;	genotype: Npc1-/-;	age: 84 days;	subject: Mouse1;	genetic background: BALB/c,pert
"transfected with pSuper-shMTDH, cultured with HMVEC-L and then purified by FACS",pert
patient id: 75;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 48;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N0M0;	Stage: II;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"16B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 34,pert
"Well-differentiated human lung epithelial cells, un-infected for 36h",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 37;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
treatment: Overexpression Control;	cell line: Caco-2,ctrl
"Quadriceps muscle, PGC1beta mutant mouse",pert
Colo205RC PLX4720 resistant cell line,pert
"kidney, Q10, 6 months",pert
patient: 239;	current medication: Asacol Fybogel Amitriptiline;	birth date: 4/10/41;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/1/63;	diagnosis date: 12/12/64;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug Control siRNA;	treated with: 100nM PD173074 for 48 hrs,ctrl
Patient identifyier: E;	Sex: male;	Age of patient: 51 years;	Duration of psoriasis: 24 years;	Body surface area: 8 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
cell line: PC-3;	treatment: gefitinib;	treatment duration: 24h,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 3h EGF,pert
tissue: lesional skin;	urticaria status: affected;	patient: 6,pert
treatment: naïve;	transgenic variant: FVB/N;	tissue: Caudate-Putamen;	genetic background: FVB/N,ctrl
C1_CLP_overexpressor_12,pert
chip number: 18;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.67;	rin: 9.5;	transfection date: 2012-03-26,pert
"Xenograft of Panc-1 (Human pancreatic carcinoma) cell line, in mouse",pert
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): pituitary,ctrl
Patient: B;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,pert
"HEK293T human embryonic kidney cells, Wnt3A, si-control",ctrl
Sample ID:TP6;	Twin Pair ID:DCBD1.2;	Clinical Status:Control ;	Age of Onset:-;	Age at interview & blood sampling:55 ;	Current Age (2007):58 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
"KO, Tumor, 14M",pert
"48B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Ebs at Day2.5 were treated with Activin for 2 h,ctrl
RNA from microdissected breast cancer cells from case 1045 labeled with Cy5,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 4,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 55 years,ctrl
"Cell type: neuronal, age:42, gender:male, diagnostic group: bipolar disorder, PMI:32h",pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 6 hr,ctrl
tissue: skin;	individual: Patient P14;	condition: ANL;	eczema severity: SCORAD: 0,pert
gender: male;	strain: BALB/c;	tissue: liver,ctrl
tissue: brain;	strain: C57/BL6 Vert-X;	genotype: IL-10eGFP;	age: 6-8 weeks;	cell type: CD8 T cells that are IL-10-,pert
Postmenopausal female. Tibolone treated. Patient 6.,pert
MCF7 CHX+EtOH,pert
"Gracilis Mucle, Control",ctrl
cell line: DOV13;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
Mouse whole brain,pert
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: empty vector,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 237;	age-at-biopsy-years: 55,pert
cell line: 344SQ lung cancer cell line;	genotype.variation: control,ctrl
cell line: HEK293 cells WTX inducible clone F5;	agent: doxycycline,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
"patient 6, baseline",ctrl
"ID:7-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
cell line: PC-3;	treatment: none;	treatment duration: 0h,ctrl
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
treatment: Cyclin D1 siRNA Vehicle;	cell line: MCF7,pert
monocyte derived DCs,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 42;	maternal age: 32,pert
cell line: LNCaP-abl;	transfection: siMED19,pert
"ID:c 4-4, Genotype=(C57BL/6J), Treatment= none",pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous endotoxin challenge""",pert
genotype/variation: Fmr1 wildtype;	tissue: cerebellum;	gender: Female,ctrl
"Neural precursor cells derived from hES cells line SA01, biological replicate  2",ctrl
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 7d,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 5.5;	colon weight (mg): 164;	colon ratio (mg/mm): 2.982;	myeloperoxidase activity (u/mg): 0.301;	tissue: colon;	treatment: 5% DSS,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.894;	OD280: 0.979;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 61;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
HCC_9N,ctrl
phenotype: control;	gender: male;	case_id: 335;	age: 44;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 50;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: arteriosclerotic cardiovascular disease,ctrl
age_years: 61;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
"COP strain, male, age 21 weeks",ctrl
HCC_13N,ctrl
bone-marrow mesenchymal stromal cells extracted from healthy donor,ctrl
Mixed_E14.5_Whole_Kidney,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 110min;	race: White;	sex: Female,pert
"Pancreatic islets, control, 01",ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:56;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 1),ctrl
Eed KO J1 ESCs on day 7,pert
HOX424 Carbo Day4,pert
cell line: MDA-MB-231,ctrl
individual: Control8;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"Epididymal fat, control",ctrl
cerebellar total RNA,ctrl
"Cultured HepG2 cells,  ATCC# HB-8065",ctrl
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 86;	Usage number: 5;	Exposures: 3,pert
patient skin sample-Acne Lesion,pert
mixed reference (MR = CRG + FR),pert
strain/background: A/J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
GM8839,pert
treatment: DMSO;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 1h EGF,pert
age: 54;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
gender: male;	strain: BL6/C57;	genotype/variation: wildtype;	age: 12 weeks,ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: LSD1;	transfection time: 24h,pert
cell type: hepatoma cells;	cell line: Huh-7;	transfection: luciferase,ctrl
BTBR-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 27;	maternal age: 39,pert
"C57BL/6 mice, thymus and spleen pooled",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 55;	gender: m;	treatment: -,ctrl
THP-1 AML cells,ctrl
"AML blasts from bone marrow (at diagnosis), wild-type NPM",ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
tissue: liver;	genotype: IR flox/flox albumin:CRE -,ctrl
DH 1,pert
tissue: Lung;	strain: Lewis;	treatment: control,ctrl
"patient: 227;	current medication: Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD;	birth date: 4/17/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/90;	diagnosis date: 1/1/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/72;	smoking amount: 5-14;	other illnesses: Prostate cancer 1985, Previous DVT's on warfarin;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
disease state: control;	patient: 24,ctrl
"age at diagnosis: 54;	diagnosis: Adenocarcinoma of breast, ductal, lobular features;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 15;	dfs-event: 0;	distant metastasis: 0",pert
strain: HNF4 null;	age: 1 month;	tissue: small intestine;	sex: female,pert
microdissected epithelial cells from invasive cancer originating in IPMN 3,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: mid-UV,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 1,pert
PBMC from T cell Large granular lymphocyte leukemia patient#130,pert
"CD3+ T cells, bone marrow derived, SAA patients",pert
Placental tissue from normal pregnancy,ctrl
SKI-DLCL cells were treated with AraC alone at concentration 20nM for 24h. Total RNA was isolated.,pert
A375 melanoma cell-line,pert
Whole brain hemispheres,pert
gender: female;	batch: 1;	age (years): 26;	patient id: Control_3;	fev1 (% predicted): 105;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
M548_WT,ctrl
"Embryoid bodies, 48h,Min Dox",ctrl
treatment: Mepenzolate;	time: 25,pert
patient: 16;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 49days;	genotype/variation: NSun2 KO,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T183,pert
strain: C57/Bl6;	genotype/variation: Caspase 1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 42;	Usage number: 1;	Exposures: 3,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 119.76 nM (2 x EC50).,pert
"Total colon, pooled sample",ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 3,pert
treatment: after Rituximab,pert
Vehicle 24 hours_2,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 1,pert
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: untreated,pert
P1 eyeball,ctrl
"maternal exposure to vehicle, HypM",ctrl
pcdh12-deficient placenta embryonic day 12.5,ctrl
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin treated with FTI;	cell line: GM00038,pert
full differentiated 3T3F422A adipocyte,pert
Human skeletal muscle biopsy sample;	Patient #16 with PM,pert
strain: C57BL/6;	genotype: Wild Type;	replicate: 1,ctrl
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: lung",pert
Ileum epithelials cells,pert
race: african american;	age (years): 69;	stage: IB;	grade: 2;	histology: endometrioid,pert
"Distal and Proximal Large Intestine, 8week old mouse",ctrl
HeLa cells treat with luciferase siRNA,ctrl
MCF7 cells from controls,ctrl
phenotype: alcoholic;	gender: male;	case_id: 303;	age: 67;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 48;	brain ph at time of freezing: 6.4;	labeling_batch: 2,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P1,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 49;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: MCF-7;	sirna knockdown: siControl,ctrl
tissue: glioblastoma xenografts,pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 2,pert
control participant P336 (human CD3 positive T cells),ctrl
Mouse lungs infected with Mtb for 63 days,ctrl
E14.5 cKO 1,pert
CD8_T_cell_pool_healthy_H03+H04,ctrl
Against CDK19-1 transfected HeLa S3 cell,pert
CD8_Tcells_severe_asthma,pert
status: Slow;	age: 68;	gender: female;	tissue: cultured human fibroblasts,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 130min;	race: White;	sex: Female,pert
A HID I_B087,pert
Genotype: KO,pert
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,ctrl
A673 cell line that has been treated with cytarabine (ARA-C) for 5 days with concentration of 0.17 uM (EC50).,pert
Strain: (129S1/SvImJ) (wildtype);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
EB_0_19d_76_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
human umbilical vein endothelial cells,pert
male;	41 yr old;	White,ctrl
subject id: 39;	infection: DENV;	status: DHF;	tissue: whole blood,pert
No_drug_#4879,ctrl
subject: 18A;	cohort: 18;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
strain: C57BL/6;	genotype/variation: Foxo1KO;	cell type: Regulatory T cells,pert
cell type: Primary hepatocytes;	strain: SV129;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
GIST Tumor,pert
Mouse lungs-uninfected,ctrl
Psoriasis-3 baseline,pert
"psoriatic epidermis, before phototherapy",pert
strain: C57BL/6;	genotype: RORalpha1delDE;	replicate: 3,pert
Wistar rat liver tissue (control),ctrl
E14.5 cKO 3,pert
chip number: 3;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-03-29,ctrl
N with Cy5,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 5 days osteoblast differentiation,pert
skin from mice,ctrl
S46 NLS 142Q TG5	F4/1	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
IFN_Gamma_6hr,pert
sex: male;	tissue: liver,pert
Strain: C57BL/6J;	Gender: Male;	Tissue: primary culture tracheal epithelial cells,pert
N7A Normal-frontal,ctrl
"lateral prostate, PTEN+/- IKK2ca/ca epithelium, 12 months",pert
4_2,ctrl
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,ctrl
"Pancreatic tumor cells, replicate 6",pert
scan batch: Batch 1;	group: autism;	subject age: 11;	paternal age: 24;	maternal age: 24,ctrl
"Ad(moi10)-infected, TOT-treated for 24hr",pert
agent: control (untreated);	time: 1h,ctrl
A HID I_B052,pert
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_4;	fev1 (% predicted): 65;	fvc (% predicted): 81;	medication: Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn;	cell type: CD4+ T-cells",pert
HCC_24T,pert
"Female Nrf2 Wild-type mice, spleen sample",ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,pert
construct: HDAC2 B10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
INS-1 cell line #1 with induced HNF4a2,pert
The placenta (E 10.5) of a congenic adra2B+/+ mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,ctrl
PyV-mT St6gal1-/- tumor,pert
cell line: H4-II-E-C3,pert
tissue: skeletal muscle;	status: diabetic;	agent: untreated,ctrl
MDA-MB-231 breast cancer cells,ctrl
subject: 30;	disease: CP;	muscle: GR;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
B-CLL PB P249,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T142,pert
braf status: BRAF wild type;	tissue: PTC without a BRAF mutation,pert
status: Control;	gender: Female;	age: 61;	tissue: Blood,ctrl
293T cells with LEDGF transcript knockdown (PSIP1 gene).,pert
disease state: control;	patient: 4,ctrl
3T3-L1 Day 0 (passage 19) 24h after siLSD1 transfection,ctrl
white blood cells,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M4e;	flt3 status: WT,ctrl
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,pert
mouse TMJ-cartilage from wild type mouse WT_Tal6,ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep4",ctrl
heart from beta1-Gly389 transgenic mice,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: 0.3% Tween-20 vehicle,pert
"Cultured ovarian cancer cell line PA-1, untreated",ctrl
Heart sample 11,ctrl
primary human monocyte-derived macrophages,pert
"liver, fed control AIN93G diet for 14 days",ctrl
F9 RARaKO treated 8hr with EtOH,ctrl
race: caucasian;	age (years): 66;	stage: IB;	grade: 2;	histology: endometrioid,pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 0;	dose: 0;	agent: none,ctrl
genotype/variation: Zfx fl/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,pert
"Total colon, pooled sample",pert
HCC_41T,pert
"strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: cbp+/-  (CBP deficient, heterozygous);	age: 3 months;	tissue: hippocampus",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 69 years,ctrl
subject id: 66;	infection: DENV;	status: DF;	tissue: whole blood,pert
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",pert
Six week old male C57BL/6 mouse with conditional liver p14 knock out.,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
Strain: B6SJL-G93A-SOD1H;	Age: 110 days,pert
GFAP-negative lamina cribrosa cells,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 357;	age-at-biopsy-years: 49,ctrl
"hESC derived-NSCs passage 14, 24h",pert
Biopsy 7 from cystectomy 5,pert
KO fed  High Fat Diet,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 39;	maternal age: 36,pert
RNA from RAW Cells,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
human promyelocytic leukemia cells,pert
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
"fatty (fa/fa), skeletal muscle (gastrocnemius)",ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.04;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 36;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
7A;pretreatment;female;breast tumor,ctrl
"MCF-7 cells, siCtrl treatment 60h, 0.1%EtOH for 4h",ctrl
A SIT_B100,pert
"47B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
T115,pert
MCF7 cells treated with 2uM ARC,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 24h",pert
ID: MLL_00106;	cell type: PBMC;	disease state: control,ctrl
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 45y/female/caucasian. Cause of death: multi-system organ failure,ctrl
chip number: 13;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
patient: 51722;	sample: normal,ctrl
"-Rosi, +PPAR, 72hrs",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.975;	OD280: 1.082;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 338;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
The RNA samples from DHT 16hr treated LNCaP cells,pert
Weight:High;	CFstatus:control;	Sex:Female,ctrl
Sample ID:TP10;	Twin Pair ID:DCBD3.2 ;	Clinical Status:Control;	Age of Onset:-;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :None,ctrl
bone marrow cells,pert
"patient: 207;	current medication: Asacol 800mg BD, Colifoam Enemas Daily;	birth date: 4/29/47;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/88;	diagnosis date: 8/18/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/14/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 10/14/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/10/62;	smoking stop date: 3/15/75;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
BL2,ctrl
C4,ctrl
Myeloid cells pooled from 2-3 7 week old knockout mice,pert
wild type 2 cell embryo rep2,ctrl
IOSE80pc Cells,pert
spleen,pert
HT1080,pert
cell line: OSE4;	knockdown: control;	cell type: ovarian surface epithelial cells,ctrl
"FACS-sorted cones, P30 C-DGCR8 KO mice",pert
Mus musculus tissue,pert
"Frontal Cerebrocortex, permethrin (10 mg/kg), 6 hours",pert
Endometrium/Ovary-Disease 4,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,ctrl
Mouse lungs infected with Mtb for 42 days,ctrl
"whole liver, treated with IL-6",pert
disease state: sarcoidosis;	biopsy type: surgical;	tissue: lung,pert
HSC,ctrl
PBMCs from Crohn's Disease subject,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.8;	choa: 88;	fata: 71;	eea: 1480;	wtkg: 67.1;	perfat: 21.8;	lbm: 50.8;	fat_mass: 1462.78,ctrl
Buffy Coat blood of healthy donors,ctrl
tissue: Gastrocnemius muscle;	genotype: KO;	age: OLD,pert
HCC non-tumor,ctrl
14-week-old WT liver_616WT,ctrl
"Pool of three samples (n=3);;	cells: CD3+ T cells, peripheral blood;;	healthy volunteers; gender: two females, one male; age: 25 and 37 years old ",ctrl
"wild type naïve CD4 positive cell, unstimulated, replicate 1",ctrl
25 uM cyfluthrin batch 1,pert
wild type 2 cell embryo rep3,ctrl
"Patient  N, lesion, time: 0",ctrl
strain/background: C57BL/6;	genotype/variation: non-transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,ctrl
hepatocytes treated with 35 μM TFMPP,pert
C,pert
siPsmd14,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Mbd3,pert
SP-C-rtTA/(tetO)7CMV-Cre double transgenic mice,ctrl
"disease status: non allergic non asthmatic subject, without any stimulation;	tissue: bronchial biopsies",ctrl
CD8_T_cell_pool_melanoma_M07+M08,pert
HCC_1T,pert
skin from mice,pert
SBVGA3,ctrl
EE_IB_2_aa_lcm,pert
"ID:11-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"mouse embryonic fibroblasts derived from WT mice, F",ctrl
RNA from microdissected breast cancer cells from case 1206 labeled with Cy5,pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",ctrl
CP Pool,pert
Zucker rats,ctrl
DCIS,pert
"t05, surgically resected from patient of gastric cancer.",pert
Liver GPR120KO HFD,pert
FACS sorted IgM+IgD+ cells,pert
7dpp Ubb knockout testis,pert
Endometrium-Normal 6,ctrl
patient E1546,pert
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 137min;	race: White;	sex: Female,pert
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Tongue;	age: E14.5;	gender: Not determined,pert
"Tibialis Anterior Muscle, Desmin Knockout, Aged",pert
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 2",ctrl
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA2-dox,ctrl
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
subject: 21B;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
PBMC from T cell Large granular lymphocyte leukemia patient#104,pert
dermal fibroblast from CCALD patient,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 11;	tissue: GIST Tumor,ctrl
"Lesional skin biopsy from psoriasis patient, Pre-dose",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.469;	OD280: 1.802;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 355;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
S49 WT Cells 6 h cAMP treatment,ctrl
CSTB KO_cerebellum at P7,pert
ST045849 24 hours_2,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 215,pert
"Lymphoblastoid cell lines derived from family 1736, member 2",ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P12;	clone: C11,pert
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: SDC1-silenced group,pert
Squamous cell lung cancer patient 33,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 24;	gender: male,pert
sampleID: SAM630136;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
At Risk: +;	Age: 13;	Sex: M,pert
"gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: liver;	age: 12 weeks,ctrl
31A;pretreatment;female;breast tumor,ctrl
Jurkat T-cells transfected with siRNA for GAPDH,ctrl
PDAC_P_117,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 28;	maternal age: 28,pert
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 3,pert
treatment: treated with vehicle and control shRNA;	cell line: LNCaP,ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T3N2,pert
"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 4h",pert
"brain, control (water-treated), P70 male",ctrl
p300_Regulatory T-cells CD4+CD25+,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 97min;	race: White;	sex: Female,ctrl
cell: ES cells;	genotype/variation: UTX knockout,pert
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 18 months;	treatment: daily injections of saline for one week,ctrl
status: Rapid;	age: 49;	gender: male;	tissue: cultured human fibroblasts,pert
strain: CD-1;	genotype/variation: Pkd1null/null mutant;	developmental stage: embryo;	age: E17.5;	tissue: kidney,pert
TTF=180min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,ctrl
"Line A39 control cerebellum, mouse, male, 10 months",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
At Risk: -;	Age: 14;	Sex: F,pert
PC3 cells Untreated,ctrl
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 40;	gender: male,pert
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 0;	dfs-event: 1;	distant metastasis: 1",pert
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,pert
"t14, surgically resected from patient of gastric cancer.",pert
0810A-01_scrambled control-1,ctrl
RNA from microdissected breast cancer cells from case 1368 labeled with Cy5,ctrl
20 hour after cadmium treatment,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,pert
genotype: C57BL/6;	gender: male;	age: 10 weeks;	tissue: Liver;	diet: chow diet,ctrl
status: Slow;	age: 71;	gender: male;	tissue: cultured human fibroblasts,pert
cell type: primary human monocyte-derived macrophages;	differentiation factor: CXCL4,pert
genotype: Wild Type;	treatment: Low fat diet;	gender: male;	tissue: liver,ctrl
breast tumor,pert
chip number: 14;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2011-10-17,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 7 days;	Tissue: kidney,pert
CHF - R09,pert
"kidney, QH2, 14 months",pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 79;	Usage number: 5;	Exposures: 3,pert
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 5,ctrl
"SKO-transduced MEFs, Vc untreated, lysed on D3",ctrl
"murine kidney, wild-type littermate controls",ctrl
"age at diagnosis: 66;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 30;	dfs-event: 0;	distant metastasis: 0",pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,pert
genotype/variation: Cyp27b1 flox/flox;Cre-;	tissue: breast tumor;	genetic background: FVB,ctrl
strain background: C57BL/6;	genotype/variation: WT;	infected with: ME49 strain of T. gondii;	time point: at day 5 post-infection;	tissue: ileum,ctrl
age_years: 39;	sex: F;	ethnicity: Latino;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 56 yr;	population: white;	dsm-iv: 296.54;	age of onset: 28 yr,pert
BJ-iPSC_1,ctrl
ancestral background: African-American (AA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
genotype/variation: Gfi1b KO,pert
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,pert
NORMAL #99-0693,ctrl
"hippocampus, CC",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: tumor;	sample name: 5-tu3,pert
treatment: SCY1-like 1 esiRNA;	cell line: HeLa,pert
"129P3/J Chronic morphine treated, biological replicate 3",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.0;	age of psoriasis onset: 25,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with 100 nM T3 for 6h,pert
cell line: Mkn28;	cell type: human gastric tubular adenocarcinoma;	tissue origin: stomach (70 year-old female),pert
cell type: embryonic fibroblasts (MEFs);	genotype: VHL null,pert
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
"Strain: C57BL/6, Gender: female, Age: 6-10 weeks;	Tissue: nasal-associated lymphoid tissue (NALT)",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: C;	experimental sample name: PC2-R,ctrl
tissue: Hippocampus;	age: 87;	Sex: F,ctrl
original diagnosis: ExtendedOligo;	cell type: Peripheral blood mononuclear cells,pert
MLL_00261,pert
"Human LIMA artery from patient 5, control (unstented)",ctrl
Pool stratagene human,ctrl
"HEK001, siLuciferase",ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-6A,pert
vulva biopsy of vulvar intraepithelial neoplasia (VIN),pert
dental pulp stem cells extracted from deciduos tooth,pert
affected status (disease state): control;	gender: male;	age-at-examination: 69;	age-at-onset: n/a;	geographical origin: Lisboa,ctrl
epithelium from colon of HDAC2 KO mouse no.1,pert
R2_saline_wildtype_422,ctrl
developmental stage: E14.5;	genotype: Prmt5F/F;	genetic background: mixed C57BL/6 X 129S1/SvlmJ;	cell type: NPC;	treatment: control,ctrl
Pool Eu_P15,ctrl
sample: #20;	subject: PD case #1;	brain: T-9;	age: 74;	sex: Male;	region: Inferior olivary nucleus,pert
Endometrium-Normal 7,ctrl
race: caucasian;	age (years): 70-75;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
mature Ly-6G+ thioglycollate-elicited peritoneal neutrophils,pert
Murine Heart Apex,pert
S4_sham_overexpressor_12,pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P15 postnatal stage,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 60;	sex: M,ctrl
chip number: 7;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
Cervical cancer_103-04T,pert
WT AA 2,ctrl
"gender: Female;	age: 67;	post-mortem delay: 6h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
age: 12 wk;	tissue: whole heart;	genotype: MCKcre Pitx2 Flox/Flox,pert
CLL,pert
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: U,pert
EE_IA_2_aa_lcm,pert
Patient: C;	Time: 0;	Group: responder;	Condition: lesional,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 31;	age of psoriasis onset: 25,pert
cell type: Heptaocellular carcinoma cell line (non-target control cells),ctrl
clone type: AtT20 clone types treated with NSBP1 siRNA rep 1,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep2",pert
"Biceps, FSHD, cohort 03, subject 03A",pert
patient: 30162;	sample: tumor,pert
Extract:LOX-1:113103;	Extract Description:GFP_0hr:113103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.49;	Quality: Absent (%):58.03;	Quality: Absent (%) Dev.:0.17;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295433,ctrl
Sex: male;	Age at operation: 74 years;	Site: thigh;	Size in cm: 16.5x9x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-C104A/C131A;	overexpression induced with doxycline: Yes,pert
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
patient: 15;	disease state: hypertension;	tissue: Atheroma plaque,pert
cell type: Primary hepatocytes;	strain: SV129;	agent: Wy14643;	time: 6h;	gender: Male;	age: 4 months,pert
"chimeric kidneys from mouse E15.5 embryos derived from blastocysts that were injected with GFP-positive, transferrin receptor (Tfrc)-deleted embryonic stem cells",pert
RKO cells transfected with NEG Stealth siRNA treated 6 h with vehicle DMSO 0.5%,ctrl
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 12h",pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 38;	Usage number: 4;	Exposures: 2,pert
control untransduced myoblasts,ctrl
ESC Cultured in 15% KO + LIF without feeders,pert
"treatment: diclofenac;	batch: 7;	donor: 53;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p28;	strain: E14,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-15;	Primary Site:Floor of Mouth;	Age:51;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
"Toral RNA, commercial",ctrl
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
tissue: blood;	patient: 2;	gender: male;	age: 38,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,pert
Caudate-Putamen of naive FVB/N mice,ctrl
NSC_FOXO_WT-1,ctrl
Ebola-infected macrophages harvested at 6h post-treatment from donor 1,pert
"ID:12-2 Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
age: 38;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 5;	Exposures: 3,ctrl
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: YES,pert
"HCT116 shCDK19, low glucose",pert
"Ishikawa cell line, BPA, 1pM, 8hr",pert
cell line: MDA-MB-231,pert
"Please refer to Lilly et al., Am J Respir Crit Care Med. 2005 Mar 15;171(6):579-86",pert
OV1002 Carbo Day14,pert
Hep G2 treated with Mercury (II) chloride,pert
HCT116 human colon cancer cells with PTEN -/-,pert
age: 21dpp;	genotype/variation: wild type;	tissue: testis,ctrl
EB_0_6h_53_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
"primary cortical neurons, naïve",ctrl
murine adult bone marrow,ctrl
"Cell type: neuronal, age:35, gender:male, diagnostic group: bipolar disorder, PMI:35h",pert
"seminoma specimen, pT2, patient age: 35y",pert
Disease_status: Bipolar disorder;	Age (years): 42;	Gender: Male;	Age of onset (years): 18;	Duration of illness (years): 24;	Brain pH: 6.65;	Post mortem interval (hours): 32;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 20s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 15.2;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 290;	ige (kiu/l): normal (0-48.5 kIU/L): 2578;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
race: caucasian;	age (years): 67;	stage: IB;	grade: 1;	histology: endometrioid,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 40 yr;	population: white;	dsm-iv: 295.9;	age of onset: 21 yr,pert
S46 WT5	F5/53	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
E14 cell cultured 3 days in N2B27,ctrl
hOB695_shEV_24hr_IR,ctrl
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: foretinib,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: yes,pert
cell line: U937;	shRNA construct: Scrambled Control,ctrl
cell line: MOLM-14;	replicate: Replicate3;	treatment: shLuciferase,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous saline challenge""",ctrl
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 1),pert
Epithelial prostate primary cells from fresh tumor explant,pert
cell line: A375 melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
Heart sample from 8-week-old Ppif-/- mice,pert
WT_R6,ctrl
patient id: 1393;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 83;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 1;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
Kin- S49 Cells 0h,pert
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: untreated,pert
heart fasted,ctrl
cell line: A2008;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
tissue: retina;	age: postnatal day 4;	genotype: rd1,pert
status: Slow;	age: 72;	gender: female;	tissue: cultured human fibroblasts,pert
patient: 31;	disease state: hypertension;	tissue: Atheroma plaque,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 37;	gender: male,ctrl
1-WT_RD1a,ctrl
SCLC cell line DMS53,pert
postnatal 12 weeks pitx2 cko heart,pert
C6,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 48 hours,pert
subject: 18U;	cohort: 18;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
CEM-C1 cells treated with rapamycin for 3 hours,pert
control esophagus,ctrl
Stable lentiviral shRNA;	,pert
PBMC from TB,pert
RNA from microdissected breast cancer cells from case 856 labeled with Cy5,ctrl
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: vehicle control,ctrl
tissue: murine embryonic stem cells;	genotype: Wild type;	strain: 129SV/C57BL/6,ctrl
"Heart, MAT1 CKO, 2 wk, sample 4",pert
"K562, 250nM1R-Chl, 24hrs, rep2",pert
RNA from microdissected breast cancer cells from case 662 labeled with Cy5,pert
A VIS _B097,pert
disease state: endometrioma;	patient: 7,pert
condition: Psoriasis;	patient: PS-F;	tissue: LS skin biopsy;	kit: Affy,pert
Trizol extracted total RNA from myometrium tissue (HLRCC).,ctrl
CHF - R15,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 57;	sex: F,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
tissue: muscle;	genotype: ClpP KO;	genetic background: C57BL/6,pert
chip number: 22;	transfection plate: 3B;	target gene: YY1;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
tissue: Brain;	genotype: Npc1+/-;	age: 54 days;	subject: Mouse3;	genetic background: BALB/c,ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P9;	clone: 0,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 54;	tissue: Blood,pert
RNA from microdissected breast cancer cells from case 1047 labeled with Cy5,ctrl
Sample ID: TP39;	Twin Pair ID: CCE4.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-11.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim & Lamictal,pert
"Otx2 deficient mouse strain (Puelles et al., 2003, Nature Neuroscience Vol 6(5))",pert
Wildtype liver DEN-injected 12weeks repl2,ctrl
"Animal id 544, right retina, 8 months, female, DBA/2J",pert
RNA from microdissected breast cancer cells from case 469 labeled with Cy5,ctrl
"vehicle treatment, 24 hour time point, biological replicate 2",ctrl
subject: 1;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 2;	age: Post natal day 3-14,pert
strain: FVB/N;	genotype/variation: Bmpr2-R899X mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
"ID:1-2, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
"Heart, MAT1 CKO, 2 wk, sample 3",pert
subject: 22U;	cohort: 22;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 60kb;	age (y): 43;	Sex: F;	batch: Batch_5,ctrl
strain: 129/Sv;	genotype/variation: wild type;	tissue: madibular condyle cartilage,ctrl
tissue: glioblastoma xenografts,ctrl
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 38;	Usage number: 1;	Exposures: 4,pert
Normal cervix epithelium_03-4508,ctrl
deletion in 337TR,pert
"5850, control, skin fibroblasts",ctrl
strain: C57BL/6J;	genotype: Tmod3+/+;	phenotype: normal,ctrl
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,ctrl
strain: C57BL/6J;	cell type: LSK cells;	genotype/variation: wt,ctrl
Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,pert
Peripheral Blood,pert
CFU-PreB colonies Wildtype littermate,ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.435;	OD280: 0.745;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 287;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"4 weeks old normal mice, cerebellum",ctrl
Time:3 day; condition:Emerin ko;,pert
control_08hr,ctrl
"FACS-sorted cones, P30 wild type mice",ctrl
DA rat jejunum control,ctrl
"Deltoid, control, cohort 19, subject 19U",ctrl
"eye, cornea",ctrl
60 day LAD ligated heart from MRL/MpJ strain,pert
tissue: Embryonic lung E18.5;	genotype: C57BL/6 WT;	age: Embryonic Day 18.5,ctrl
0810A-01_clone 3-2,pert
mouse bone marrow-derived mast cells treated with IL3+SCF,pert
cell line: sh2608 T47D;	sherbb3: +,pert
diagnosis: Normal;	fvc-group: Normal;	tissue: lung,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 8 hrs AP20187,pert
disease: cardiopathy;	gender: male;	age: 30 days;	tissue: thymus,ctrl
strain background: Mixed;	genotype/variation: VMH-specific FoxO1 Knockout;	tissue: ventromedial hypothalamus (VMH),pert
hdh genotype: Q7/Q7;	tissue: striatum;	age: 3~10 weeks,ctrl
granulocyte RNA from patient achieved remission on MTX,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 87min;	race: White;	sex: Male,ctrl
"12-week-old Wistar Kyoto (WKY), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",ctrl
Eed KO J1 ESCs on day 3,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.758;	Ratio: 2.11,pert
Runx1  knockout,pert
Skin from Irf6 wt,ctrl
cell line: U2OS;	treatment: shControl,ctrl
26 weeks male,pert
RNA from whole tissue section of case 1279 labeled with Cy5,ctrl
Patient: J;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
Sorted DN2 cells from fetal thymus,pert
genotype/variation: C56B/6 and CD-1 mixed;	strain background: wild type;	age: E9.5;	tissue: E9.5 embryos;	microdissection: posterior second heart field,ctrl
status: Control;	gender: Female;	age: 63;	tissue: Blood,ctrl
sample: #2;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Inferior olivary nucleus,ctrl
"strain background: C57BL/6J;	genotype/variation: IRF4 -/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",pert
erythroblast transduced with shZBP-89,pert
cell type: R1/E ESC;	RNAi: Luciferase,ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,ctrl
dorsal mouse skin,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
rat heart,ctrl
sample type: HeLa-Ctrl-siRNA-4d;	cell line: HeLa;	knockdown: Ctrl-siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,ctrl
age: 12 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
quadriceps_muscle_Akt1+/-_female_8wk_rep2,pert
"brain, QH2, 6 months",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day14,pert
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer heterozygous deletion;	cell type: YFP-positive  granulocyte-macrophage progenitor",pert
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: n/a;	maternal age: n/a,ctrl
nucleus accumbens,pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
phenotype: control;	gender: male;	case_id: 339;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 37;	brain ph at time of freezing: 6.76;	labeling_batch: 1,ctrl
phenotype: control;	gender: female;	case_id: 299;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 23;	brain ph at time of freezing: 6.65;	labeling_batch: 2,ctrl
duration of untreated disease in month:16.1;	age at onset:3.9,pert
"disease group: Atopic Dermatitis;	Sex: m;	age: 20s;	race: Native American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 990;	ige (kiu/l): normal (0-48.5 kIU/L): 4136;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 43;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
genotype/variation: Snf2h lens-conditional knockout;	strain: C57BL/6;	age: newborn,pert
"WT cells, replicate 2",ctrl
tissue: adipose tissue (epididymal);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
age in weeks: 8-10wk;	gender: Male;	strain: C57BL/6,ctrl
cell line: Abelson B cell line,ctrl
heart of male mouse subjected 2 week to chronic intermittent hypoxia,pert
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 4 hours,pert
"Amniocytes, euploid, 1559",ctrl
MV4-11 cells,pert
PMBCs,ctrl
Colo 668 SCLC cell line,pert
Trib1 #2 KO macrophages were treated with LPS,pert
MLL_PTD06,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,ctrl
Lung tissue,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 1h EGF,pert
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
SHEP-SF neuroblastom,pert
wild type Jurkat cells,ctrl
B6_pseudomonas_overexpressor_422,pert
"Embryonic stem cells, untreated",ctrl
Adipose from a 24 month old wild type mouse,ctrl
HCT116 human colon cancer cells with PTEn -/-,pert
Omental adipose tissue,ctrl
brown fat cells differentiated for seven days,ctrl
Whole adrenal RNA from WT mouse #78 at 0h,ctrl
BMMs_untreated control_wt,ctrl
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
"Trabecular meshwork tissue from POAG donor B. 77y/female/africanamerican. Cause of death: renal failure. Other ocular diseases: cataracts. IOP: 15-25. Drug therapy: Xalatan, cosopt.",pert
Peripheral Mononuclear Blood Cells,pert
CD34+ cells from normal donor after in vitro TCDD exposure,pert
individual: patient12;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 18;	Brain pH: 6.74;	Post mortem interval (hours): 39;	Side of brain: Left;	Fluphenazine mg. Equivalents: 4500;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
Normal BM CD34 cells,ctrl
disease state: healthy;	tissue: extensor digitorum longus;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 105;	Usage number: 4;	Exposures: 2,pert
"Trained diabetic mice, time point 1 week",pert
Control PB C104,ctrl
"MCF-7 cells, siERK1 treatment 60h, 10 nM E2 for 4h",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 6,ctrl
Gastrocnemius muscle wild-type mouse: control mouse for integrin alpha7 overexpressing;	Strain: SJ6/C57BL6 background;	Genotype: wild type;	Gender: Female;	Age: 5 week;	Tissue: gastrocnemius and soleus muscle;	Feeding condition: non-fasted,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 71,pert
Strain: CBA/N (mutation R28C),pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 63;	tissue: Blood,pert
"xenograft: Panc-1 human pancreatic carcinoma cell line, grown in mice;	treatment: GSK3B shRNA",pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 106;	Sex: male;	region: LC (locus coeruleus);	age: P23;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
normal;	Adjacent pair of T20,ctrl
patient: 214;	current medication: NONE;	birth date: 1/10/37;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/59;	diagnosis date: 1/10/61;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 1;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 11/12/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 12/9/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: CENTRAL RETINAL VEIN OCCLUSION 01/04;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
RNA from microdissected breast cancer cells from case 59 labeled with Cy5,pert
14-week-old Trim24-/- liver_466M,pert
disease state: B-CLL;	tissue: peripheral blood,pert
chip number: 2;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.79;	rin: 9.7;	transfection date: 2011-03-29,pert
cell type: Bladder cancer;	treatment: VprBP-depleted,pert
NCI-H716,pert
Cy5 labeled Liver RNA,ctrl
CD8_T_cell_pool_healthy_H05+H06,ctrl
subject: 20U;	cohort: 20;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
endometrioma,pert
C2C12 MYTOUBES,ctrl
Frontal cortex of non-AD brain,ctrl
F6.01,pert
"Right brain hemisphere ,C57BL male mouse,Haloperidol treated,Orally,4 weeks",pert
Weight:High;	CFstatus:knockout;	Sex:Female,pert
cell line: mOS482;	cell type: osteosarcoma,ctrl
HCC_16N,ctrl
Sorted DN2 cells from fetal thymus,ctrl
PDAC_P_104,ctrl
"12B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",ctrl
No_drug_#4872,ctrl
MCF10A-HER2(+) 7days,pert
MCF-7 cells from ATCC,ctrl
treatment: Control siRNA Estradiol;	cell line: MCF7,ctrl
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 560,ctrl
microdissected epithelial cells from IPMA 1,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 209-day-old male (concurrent control to Alb73);	90 mg liver used for RNA extraction,ctrl
HCC_39N,ctrl
SNCA triplication iPSCs,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day14,pert
Caco-2 Control siRNA 1,ctrl
Wild-type control 1,ctrl
breast precancerous tissue,ctrl
Mus musculus brain hemisphere,pert
MPM tumor specimen 40,pert
Z138-shSOX11,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 40;	gender: male;	tumor grade: AII,pert
"Fmr1 wildtype mouse, blood",ctrl
Aorta from ApoE-/-  RAGE-/- mouse without diabetes sacrificed at 9 weeks.,pert
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),pert
"patient: 233;	current medication: Asacol 1.2g Asprin 75mg Amilodipine 10mg;	birth date: 2/2/29;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/92;	diagnosis date: 1/1/92;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/1/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/86;	smoking amount: 15-24;	other illnesses: MI 1986, Prostate cancer 1994;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
Pooled PBMC sample enriched for CD8+ cells from normal control subjects,ctrl
"Lesional skin biopsy from psoriasis patient, Week1_etanercept",pert
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Patient: E;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 5,pert
"Cultured ovarian cancer cell line OV90, untreated",ctrl
49A;pretreatment;female;breast tumor,ctrl
Superior Frontal Gyrus from a 2 and 4 year-old RTT girl,pert
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: NA;	dfs-month: 9;	dfs-event: 0;	distant metastasis: 0",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.853;	OD280: 0.955;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 290;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
WILDTYPE cerebrum at 12 weeks,ctrl
C3_CLP_wildtype_8,ctrl
Human CD34+ cord blood cells expressing BCR/ABL1,pert
human skin biopsy,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 6,ctrl
human_hepatocyte_grepafloxacin_24hr,pert
"LCL GM19238, Kd EP300, 72hrs",pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 3,pert
Primary hepatocytes isolated from DBA mouse strain treated with DMSO for 6h,ctrl
normal mammary gland,pert
"Liposarcoma culture from tumor 314, doxorubicin treated",pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,ctrl
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 328;	age-at-biopsy-years: 39,ctrl
cell line expressing inducible wt-GFP-lamin A. Induction: Day 0. Replicate A,ctrl
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 0;	Pathological M: 1;	Grade: well;	Tumor Site: Hepatic Flexure;	Drug Treatment: YES,pert
whole splenic B-cells from adult Btk KO mice,pert
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl; Wnt1-Cre;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,pert
"fetal testis sample 26, 20 weeks gestation",pert
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"DSS colon tissue, biological rep2",pert
"18B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 320;	age-at-biopsy-years: 34,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 26,ctrl
Normal cervix_05-31,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 2",pert
cell line: NOMO-1,ctrl
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 1,pert
Pancreatic islets,ctrl
condition: Discoid Lupus;	patient: L2;	tissue: LS skin biopsy;	kit: Ovation,pert
"gender: Female;	age: 53;	post-mortem delay: 11h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Patient: B;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: Ing2 KO,pert
2B1 Otic vesicle cell line over-expressing Dlx5 and GFP,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: parotid salivary gland;	donor sex: female,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid cell;	matched/unmatched: unmatched,pert
Genotype: Homo sapiens,ctrl
genotype/variation: K5-IKKbeta transgenic;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 29,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 77;	time: 0;	batch: 2,pert
"skin fibroblasts, passage #3",pert
strain: C57BL/6;	genotype: WT;	gender: Male;	age: 9 weeks;	tissue: kidney;	treatment: intraperitoneally injected with a single dose of vehicle (saline),ctrl
A HID U_B045,pert
CONTROL;	Age = 19;	Sex = F,ctrl
human embryonic stem cells cultured with mouse embryonic fibroblasts,pert
Postmenopausal female. Untreated control. nr 2.,ctrl
Sendai virus infected mouse tracheal epithelial cells.,pert
liver biopsy sample,pert
braak stage: BR12;	rin: 72;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,ctrl
genotype/variation: Fmr1 knockout;	tissue: blood;	gender: Female,pert
db/db mice,ctrl
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox (Ctrl);	litter: brother of the same litter,ctrl
B6.BKS Ighmbp2nmd-2J mouse;	6 weeks of age;	male,pert
Genotype: E2F4 Null,pert
human lung,pert
"seminoma specimen, pT3, patient age: 48y",pert
CD11b+Gr1+ cell sample_2 (derived from wild type mouse),ctrl
DS fibroblast-derived iPSC,pert
strain: B6129SF2/J;	tissue: lung;	genotype: wild-type,ctrl
"Lymphoblastoid cell lines derived from family 1720, member 2",ctrl
braak stage: CTRL;	rin: 70;	tissue: substantia nigra;	disease state: control,ctrl
Treg cells from WT mouse,ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 14.5, Tissue: Palatal Shelves",ctrl
patient: 27;	disease state: hypertension;	tissue: Atheroma plaque,pert
"brain, hippocampus",ctrl
Subtype: normal;	Karyotype: normal,ctrl
chip number: 19;	transfection plate: 3B;	target gene: ESRRA;	kd level: 0.84;	rin: 9.4;	transfection date: 2012-03-26,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 1393,ctrl
MCF-10A_shATM-3,pert
cell type: myoblast;	transduction: untransduced,ctrl
TIG3  diploid lung embryonic fibroblasts,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 130min;	race: White;	sex: Male,ctrl
Huntington's disease,pert
HCC_29N,ctrl
patient: 11;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
after 30 days intervention with placebo,ctrl
strain: 4th Gen. FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/+,ctrl
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 28;	age of psoriasis onset: 16,pert
BJ fibroblasts,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 24.116;	Ratio: 2.13,pert
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 63,ctrl
Aquaporin-11-/-_mouse P7 kidney #4-4,pert
human head and neck normal mucosa,ctrl
treatment: treated with vehicle and ELK1-shRNA;	cell line: LNCaP,pert
pancreatic cancer cell line FA6 transiently transfected with non-targeting siRNA,ctrl
patient: 51104;	disease state: LGSC;	component: Borderline,ctrl
tissue type: Bone Marrow;	cell type: Multiple Myeloma (MM) plasma cells,pert
PGC-1a KO mouse striatum,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"ID: MLL_00261;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"Diabetic mice, time point 1 week",pert
PIK3CA.DMSO.2,pert
WM164 Melanoma cell Line,pert
At Risk: +;	Age: 16;	Sex: F,pert
Gene expression profiling of normal cortex of patient T142,ctrl
5091212024_F,ctrl
Postmenopausal female. Estradiol treated. Patient 24.,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N1,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 2,ctrl
gender: female;	genotype: Homozygous for the Q119X mutation in the TWIST2 gene;	ethnicity: Puerto Rican,pert
Array Type: HG-U133A_2;	Ratio: 2.04;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
482 cells scrambledshRNA rep1,ctrl
EB_6_6h_286_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
cell line: MDA-MB231;	treatment: control shRNA;	media: SCM,ctrl
cell line: TOM-1;	tissue: Human B cell precursor leukemia,ctrl
sigmoid colon biopsy,pert
LOX1_Untreated_24hr,pert
Whole testis,pert
primary osteoblasts untreated,ctrl
pancreatic islets,ctrl
disease state: paediatric glioblastoma;	age: 5.4;	gender: M;	h3.3_status: wt,ctrl
Alb67 mutant mouse,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.169;	Ratio: 2.11,pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 5,pert
estrogen treated ipsilateral to stroke replicate,pert
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep3",ctrl
sirna: Claudin 1;	treated with tnfα: NO,pert
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P0,pert
cell type: peripheral blood mononuclear cell (PBMC);	disease status: gastric cancer,pert
"ICR10 mouse strain (WT,)  gender- female, age- 2 months, n = 1, # of tissue = 1, tissue: Lung, Cell:Type II.",ctrl
"brain, frontal cortex",pert
"Setd2 wild type mESCs, biological rep2",ctrl
MCF-7 breast cancer cells,pert
"Gender: Female, Age: 28, BMI: 17.1, Tissue: luteinized cumulus cells",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q,pert
patient: 30308;	sample: normal,ctrl
"Biceps, FSHD, cohort 22, subject 22A",pert
Prmt6 overexpressed embryonic stem cells,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, non-treated",ctrl
Hep G2 treated with Bis [(+)-tartrato] diantimonate (III) dipotassium trihydrate,pert
tissue: Liver;	strain: C57BL/6;	genotype/variation: PXR-/-;	treatment group: vehicle 0 mg/kg,pert
Sex: female;	Age: 15;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 65;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",pert
L-540_CTRL_24hrs,ctrl
"Amniocytes, euploid, 1567",ctrl
patient: 27;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: female,pert
U2OS_siNS_24h,ctrl
coc-16,pert
C57Bl6N Mouse;	gd17.5 fetal heart,ctrl
basolateral amygdala,ctrl
control peptide-treated DND41 100mM 16h,ctrl
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 2;	time: Baseline,ctrl
Tissue: normal thyroid; Gender:male; Age:43,ctrl
tissue: Lung;	strain: Lewis;	treatment: exposed to silica,pert
BMMs_untreated control_db,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 3,ctrl
kidney biopsy from patient after Tumor Nephrectomy,pert
"Liposarcoma culture from tumor 338, doxorubicin treated",pert
normal colonic mucosa,ctrl
"ACC3 cell line, Sox4 RNAi knockdown with lacZ as control",ctrl
K562 Cell line,pert
Patient: H;	Time: 1 week;	Group: responder;	Condition: lesional,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.34 uM (2 x EC50).,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 3x1h exposure per day",ctrl
"C57BL/6J Saline treated, biological replicate 2",ctrl
isolated keratinocytes from mouse skin,pert
Gene expression profiling of normal cortex of patient 42,ctrl
MCF-7,ctrl
sample: #22;	subject: PD case #5;	brain: T-72;	age: 81;	sex: Male;	region: Inferior olivary nucleus,pert
peripheral blood CD8 T cells,pert
tissue: Hippocampus;	age: 74;	Sex: M,ctrl
genotype/variation: Fmr1 knockout;	tissue: cerebellum;	gender: Female,pert
condition: Normal;	patient: N_LJ_5;	tissue: Normal skin biopsy;	kit: Affy,ctrl
subjectid: 5269;	imatinib: NoIM;	lbh589: NoLBH,ctrl
"Patient  K, lesion, time: 0",ctrl
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 35;	Usage number: 4;	Exposures: 2,pert
Gata4Loxp/-VillinCre adult male jejunum (6-8wk). GATA4 conditional knockout (mutant) sample.,pert
SCLC cell line SBC-2,pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",ctrl
control participant P338 (human CD3 positive T cells),ctrl
14dpp wild type testis,ctrl
tissue: tumor;	disease state: IDC,pert
heterozygot FH P387 (human CD3 positive T cells),pert
Mouse testis,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 368;	age-at-biopsy-years: 49,ctrl
wild-type naïve CD4 T cells,ctrl
gender: Male;	tissue: Tendon;EDC;	age: 48;	donor: 9;	disease state: Non-lesional,ctrl
human pancreatic cancer cell line BxPC3 transfected with control vector,ctrl
"midbrain,12weeks,WT",ctrl
U-87 cells transfected with sh-p105 RNA and treated with DMSO for 16 hours,pert
"CD3+ T cells, peripheral blood, SAA patients post therapy / in hematological remission",pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 76;	Usage number: 1;	Exposures: 4,pert
MLL_00259,pert
AIRE ko CD80lo mTEC sample1,pert
"liver,24weeks,WT",ctrl
"Normal cervix epithelium, Age 53",ctrl
tissue: Mouse heart;	genotype: wild type;	strain: C57BL/6,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 43.41918,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.2;	colon weight (mg): 156;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.057;	tissue: colon;	treatment: 5% DSS,pert
uterus,ctrl
Strain: mixed;	Tissue: liver;	Age: 28 days,pert
Rb heterozygous 129sv matings,pert
H with Cy5,ctrl
Histopathological diagnostic: non-tumor,ctrl
agent: Control;	selection protocol: negatively selected cells,ctrl
uterus - Early secretory endometrium from normal patient,ctrl
Wistar-derived-Liverpool John Moores University rats,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT6,pert
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 null;	Age: Embryonic day 17.5,pert
tissue: peripheral blood;	subject: Control;	rna prep: PBMC;	molecule: RNA extracted from PBMC,ctrl
"Biceps, control, cohort 12, subject 12V",ctrl
Gastrocnemius muscle mRNA from old (24 month old) knock-out mice,pert
Treated with 50uM Zinc for 4 hrs -- replicate #3,pert
WT thymocyte,ctrl
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep4",pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp2,ctrl
sampleID: SAM630146;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
cell line: SKBR3 parental;	treatment: 1uM Lapatinib,pert
17beta estradiol: 10 pM,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep3",ctrl
cell type: AML blasts;	fab classification: M2,pert
"cell type: Primary chondrocytes;	genotype: Mir140 KO;	antibody: Ago2 antibody;	genetic background: 129sv/C57 mixed background, backcrossed to C57B6 twice, C57B6 dominant;	antibody manufacturer: Wako biochemicals;	antibody catalog #: 292-67301;	antibody lot #: PEK486",pert
fibroblast-derived iPSC,ctrl
strain: C57BL/6J;	genotype/variation: Transgenic;	gender: Male;	age: embryonic day 15;	tissue: frontal cortex,pert
tissue: heart;	developmental stage: E10.5;	genotype/variation: Dbh-/-,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: nasal cavity;	donor sex: male,pert
Intestinal Epithelial Cells (IECs),ctrl
"non-transgenic mice, 7 month old, female",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,ctrl
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",ctrl
Vehicle-Control;	Vehicle-Control 30 hours set 2,ctrl
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 90;	Usage number: 4;	Exposures: 3,pert
Fertility Status: Fertile,ctrl
strain: Wistar;	agent (mother exposed to): TCDD;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,pert
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 3,ctrl
RNA from microdissected breast cancer cells from case 374 labeled with Cy5,pert
Kidney from mice treated with 7 daily ip injections of vancomycin at 200 mg/kg,pert
Patient: F;	Time: 12 weeks;	Group: non-responder;	Condition: lesional,pert
"47, XX, +21",pert
Braf 1,pert
chip number: 12;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.5;	transfection date: 2012-03-26,pert
Neo6 cell line,ctrl
"TNFa-OMe-P siRNA-C, replicate 2",pert
sirna: control (siSTABLE V2 non-targeting siRNA#1);	treated with tnfα: YES,ctrl
"IRAK4 kinase dead mouse bone marrow macrophages, unstimulated, 4 hours",pert
Human hepatocellular carcinoma cell line,ctrl
CD19 selected B-cells,pert
DBA/2J hippocampus-Fluoxetine,pert
patient: 51084;	sample: tumor,pert
cerebellum_6 month,ctrl
age: 38;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 5;	Exposures: 3,ctrl
3_1_MOE_430A_HE,pert
A VIS _B096,pert
Gata3 overexpression in Cdx2 null cells,pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
fibroblast,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.254;	OD280: 0.641;	Ratio: 1.98;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 296;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
age: 18 month postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,pert
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: wt,ctrl
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Inferior olivary nucleus,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.920;	Ratio: 2.12,pert
mutant Ndel ko/+ inbred,pert
rat hippocampus (CA1 region)_sham,ctrl
cell type: Primary hepatocytes;	donor: 1;	agent: control;	time: 24h;	gender: Male;	age: 63 years old,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK2-2,pert
strain background: Mixed background;	genotype/variation: Wildtype;	developmental stage: E13;	gender: not determined,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: lung bronchus;	donor sex: female,pert
disease state: paediatric glioblastoma;	age: 6;	gender: F;	h3.3_status: K27M,pert
"Trained mice, time point 3 week",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 19.96712,pert
"Lymphoblastoid cell lines derived from family 1712, member 1",pert
Klf9 mutant (Klf9KO) mouse jejunum; Age: PND 30,pert
"seminoma specimen, pT2, patient age: 34y",pert
Embryonic Stem Cells,pert
heterozygot FH P273 (human CD3 positive T cells),pert
Cav3KO 1505,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp3,pert
Tissue: Spleen;	Type: CLP;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
"age at diagnosis: 70;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: NA;	pgr: NA;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
E9.0 embryo yolk sacs,pert
KO_lung_bleomycin,pert
MDA-MB-231 cells_siLuc transfected_3 days post-tranfection,ctrl
agent: Nickel 400 µM,pert
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #2.",ctrl
GFP_Untreated_12hr,ctrl
source tissue: lymphoid;	cell type: Splenic CD11b+Gr-1 cells;	disease state: no tumor;	genotype: wild type;	genetic background: H-2b,ctrl
"Patient  F, lesion, 12 week",pert
tissue: brain;	genotype: mutant Lis1 ko/+;	age: E14,pert
optic nerve head astrocyte,pert
Cav1KO 1758,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu3,ctrl
Control 2 appendix,ctrl
Wildtype liver_saline-injected 12weeks repl1,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#136,pert
pooled reference mRNA from 4 harvests of HME-CC cells,ctrl
Bone Marrow Mononuclear Cells;	Unknown Age/Unknown Gender,ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: NSun2 KO,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Myc heterozygous,pert
56 Day Mouse Diaphragm muscle,ctrl
"DHL4, R406, 6h",pert
Staggererer mice fed with a HFD for 6 weeks,pert
Carboplatin;	Carboplatin 36 hours set 1,pert
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic without knockout (Rsk2+/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,ctrl
"Liposarcoma culture from tumor 338, untreated",ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 324,ctrl
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep1",pert
mutant Lis1 ko/cko,pert
siDdb1,pert
gender: F;	age at blood draw: 59;	tissue: whole blood,pert
gender: Female;	tissue: Tendon;Biceps;	age: 59;	donor: 34;	disease state: Non-lesional,ctrl
CON-1-PLASTIC,ctrl
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1-/-;	strain: C57BL/6,pert
cell type: primary mouse microglia;	genotype: TLR4 knockout,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 25;	maternal age: 27,ctrl
Y YOKE_B022,ctrl
RNA from RAW 264.7 Cells,ctrl
"Liver, wt control",pert
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: yes,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 42,pert
WT Primary Hepatocytes - Pooled -Cy5,ctrl
tissue: white blood cells;	age: 8.31;	Sex: male,pert
race: caucasian;	age (years): 58;	stage: IA;	grade: 1;	histology: endometrioid,pert
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate A,pert
condition: Normal;	patient: N_LJ_8;	tissue: Normal skin biopsy;	kit: Affy,ctrl
murine lungs,pert
gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.2,pert
HMEC control,ctrl
RUES2_shRNA control,ctrl
HEK293_SNRK,pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IB;	age:66;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=advanced gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=not determined",pert
wild-type male mice angiotensin II treated,ctrl
Mouse lung Gata5 knockout,pert
"Human cutaneous T cell lymphoma HuT-102 cells, shRNA-TAK1",pert
human late-stage OA repair tissue,pert
"Normal cervix, Age 50",ctrl
HL-60 cells treated for 24h with 0.5 % DMSO as control,ctrl
Human skin biopsy from psoriatic patient (lesional skin),pert
cell line: MDA-231;	transfection: pCMV-GFP,ctrl
"cell line: D890, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
"This allele contains a deletion of the second coding exon of Gata4, including the start codon and the Nterminal 46% of the coding region. The mice used in this study were all male and on a uniform F1 genetic background resulting from the cross of Gata4WT/Δex2 (abbreviated;	G4D) mice, backcrossed for greater than 8 generations into C57BL6/J, to wild-type FVB/N mice. G4D progeny from this cross were present at weaning at the expected Mendelian ratio (104/218, 48%), survived normally to 18 months of age, and had no evidence of structural heart disease (0 out of 15 embryos examined histologically at E15.5-E18.5). Gata4WT/WT littermates (WT) from these crosses were used as controls.",pert
affected status (disease state): IS patient;	gender: male;	age-at-examination: 46;	age-at-onset: 45;	geographical origin: Vila-Real;	clinical characteristics: Hypertension;	lifestyle characteristics: ever drinker,pert
strain: FVB/N;	genotype/variation: Wild-type;	cell type: pulmonary vascular microendothelial cells (PMVEC),ctrl
HeLa cells with the decreased expression of Sp1,pert
gender: male;	age: adult;	tissue: liver;	genotype: wild type;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,ctrl
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
hepatocytes treated with 467 μM MDBP,pert
Gender:F;	Age:48;	Tissue: Mucosa,pert
Sample Group: HD patient; Gender: female; Age: 44; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/48,pert
tissue: brain;	genotype: mutant Lis1 ko/+;	age: P14,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 30.2026009582478;	age of psoriasis onset: 30,pert
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: control vector (no trypsin-2 expression),ctrl
hepatocellular carcinoma,pert
3_2_MOE_430A_HO,pert
subject: 03U;	cohort: 3;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >40kb;	age (y): 42;	Sex: F;	batch: Batch_1,ctrl
Patient: J;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
36A;pretreatment;female;breast tumor,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: SHANK3 shRNA,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.371;	OD280: 0.727;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 283;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Nuclear RNA, HuR KO MEFs",pert
Patient identifyier: W;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 27 years;	Body surface area: 6 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
condition: Normal;	patient: N_AJ2;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
3T3 cells from cyclin D1KO mice infected with MSCV-D1a.,ctrl
cell line: U937;	shRNA construct: GSK3A Construct 5,pert
Strain: FVB/N;	Genotype: SP-C-hCFTR+|-/mCftr+|+,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
cell line: HCT116 Human colon cancer;	shRNA expressing: B-Galactosidase,ctrl
patient E1614,pert
siRNA-1-COLLAGEN,ctrl
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Gene expression profiling of normal cortex of patient 14,ctrl
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: moderately severe;	Ig clonality: oligoclonal,pert
SV589_NoKD_Serum Starved -> 3hr EGF,pert
siNonTarget,ctrl
IRF4-control_Th17_cells_42hr,ctrl
"Sorted erythroblasts, Sod2-/-",pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: endometrioid,pert
Subtype: RAEB2;	Karyotype: other,pert
Gene expression profiling of normal cortex of patient 325,ctrl
wild type mouse retina at age postnatal day 4,ctrl
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: wild type;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",ctrl
25 uM cyfluthrin batch 3,pert
gender: F;	age at blood draw: 50;	tissue: whole blood,pert
Human Umbilical Vein Endothelial Cells (HUVEC),pert
tissue: hepatocellular carcinoma tumor;	treatment: erlotinib 2mg;	strain: Wistar,pert
patient: 5;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 4h,pert
Transgenic ATF6-MER mouse;	Strain: C57BL6;	Gender: male;	Age: ~30 weeks;	Tissue: heart LV;	Treatment: tamoxifen,pert
SF539 GBM cell line,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 1,ctrl
"Normal testis, adjacent to germ cell tumor",ctrl
tissue: Barrett's,pert
"41B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: C;	tissue: Skeletal muscle (quadriceps),ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L015,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	2nd technical replicate,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Male,pert
"liver, PPAR WT_ctr_52",ctrl
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-IRES-YFP;	genotype/variation: negative control,ctrl
patient: 51294;	sample: normal,ctrl
treatment: naïve;	transgenic variant: AChE-R;	tissue: Pre-Frontal Cortex;	genetic background: FVB/N,pert
A2CNT3,ctrl
transgene: FTO;	treatment: 24h after induced espression of integrated copy of the FTO gene,pert
murine Satb1-/- ES cells,pert
treatment: baseline;	gender: F;	age (y): 47;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
strain background: C57BL/6;	genotype/variation: Parp-2-/-;	cell type: sorted Ter119+CD71+ bone marrow cells,pert
histology: control;	disease state: healthy control;	tissue: brain white matter,ctrl
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Differentiation medium for 3 days,ctrl
cell line: SKM-1,pert
PBMC from T cell Large granular lymphocyte leukemia patient#1233,pert
gender: Male;	age: 91;	post-mortem delay: 13h;	ph: 6.3,ctrl
"Huh7 cells, JFH-1 Infected, 48 hours",pert
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 24h;	gender: Female;	age: 70 years old,pert
passage: 10;	cell type: fibroblast;	treatment: overexpressing progerin;	cell line: GM00038,pert
race: african american;	age (years): 65;	stage: IA;	grade: 2;	histology: endometrioid,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 40;	gender: f;	treatment: NSAIDs,pert
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
"Female Nrf2 Knock-out mice, spleen sample",pert
"ONS76, KDM5A siRNA",pert
EB_6_5d_294_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-6;	Primary Site:Vestibule;	Age:72;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
Sprague-Dawley rat diaphyseal femur,ctrl
P53 knock-out,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,pert
Primary hepatocytes isolated from Donor 2 treated with DMSO for 6h,ctrl
"TNFa siRNA-A, replicate 3",pert
Primary hepatocytes isolated from Donor 4 treated with DMSO for 24h,ctrl
Strain: RPE65-/-;	Age: 6 months;	Tissue: retina,pert
Aortas isolated from atherosclerotic APOE-deficient mice,pert
control participant P312 (human CD3 positive T cells),ctrl
affected status (disease state): IS patient;	gender: female;	age-at-examination: 73;	age-at-onset: 70;	geographical origin: Vila-Real,pert
normal,ctrl
cell line: Normal bone cell line 695;	phenotype: Parental;	cell type: human osteoblast (hOB),ctrl
untreated or induced,ctrl
strain background: ICR;	genotype/variation: alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,ctrl
B cells - IFNAR1-/-mice - influenza-infected,pert
Primary hepatocytes isolated from Donor 5 treated with DMSO for 24h,ctrl
individual: Control6;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 34;	Usage number: 1;	Exposures: 4,pert
status: Slow;	age: 64;	gender: female;	tissue: cultured human fibroblasts,pert
genotype: STAT1-KO;	time (h): 0;	cell type: primary hippocampal neuron;	treatment: untreated;	genetic background: C57BL/6,pert
primary normal lung tissue 2911,ctrl
Cervical cancer_1898T,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 1,pert
"20 days old prosaposin knockout mice, cerebellum",pert
patient E1584,ctrl
"LNCaP cells, treated with R1881, biological rep 2",pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: DMSO,ctrl
genotype/variation: bitransgenic Pdx1-cre/Kras*A;	cell type: pancreatic tumor,pert
wt_TGFb_4hr_2,ctrl
human fibroblasts overexpressing prelamin A and ZMPSTE24,pert
Control PB C107,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: monosomy7/del(7q),pert
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 58y",ctrl
"liver, phenobarbital treated",pert
Extract:LOX-1:213303;	Extract Description:LOX1_Untreated_6hr:213303;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.1;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.96;	Quality: Background Mean Dev.:0.14;	Quality: Absent (%):57.57;	Quality: Absent (%) Dev.:0.53;	Quality: Scaling Factor:0.44;	Quality: Scaling Factor Dev.:1.44;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295673,pert
Extract:LOX-1:213301;	Extract Description:LOX1_Untreated_6hr:213301;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.02;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):57.11;	Quality: Absent (%) Dev.:0.88;	Quality: Scaling Factor:0.53;	Quality: Scaling Factor Dev.:0.69;	Pretreatment [C]:LOX1;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213301;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_6hr;	RNA extraction source key [A]:282295653,pert
BL Ramos cell line,ctrl
strain/background: C57BL/6;	genotype/variation: hsp70 transgenic;	tissue: brain (right cerebral hemisphere);	age: 7 days;	treatment: PBS control;	time post-infection: 5,pert
T183,pert
Airway epithelial cells,pert
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 1293del40;	Family History: Yes,ctrl
RNA from whole tissue section of case 605 labeled with Cy5,ctrl
testis,ctrl
subjectid: 5278;	imatinib: IM;	lbh589: NoLBH,pert
"Primary lymphoma cells, isolated from lymph nodes of Emu-myc,Suv39h1-/- mice and retrovirally transduced by Bcl2, ADR treated",pert
U2OS_siHic5_2_24h,pert
braak stage: BR34;	rin: 63;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
RNA from microdissected breast cancer cells from case 1205 labeled with Cy5,ctrl
Primary hepatocytes isolated from SV129 mouse strain treated with DMSO for 6h,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 5,pert
human frontal cortex,ctrl
"Retina, 30 days old wildtype mice",ctrl
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",ctrl
strain/background: mixed B6/129;	tissue: thymus;	cell type: CD4+CD8+ thymocytes;	genotype/variation: LckCre Dicer lox/lox knockout,pert
nTreg cells WT,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 40;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
cell type: HeLa cells,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
protocol: AP-2 gamma targetting siRNA 1;	cell line: MCF7,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
HMEC culture,pert
PBMC CCa T0,ctrl
age_years: 66;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 2,pert
"mouse, liver (control) (week 18)",ctrl
"Gender: female, Age: 33 years, Tissue: VIN 3",pert
"ID:14-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
age: 51;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
NORMAL #00-0074,ctrl
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 24 hr,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
gender: female;	age (years): 47;	evolution time (years): 1;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
human preadipocytes+siCtrl_day6_rep2,ctrl
Five-week-old C3H/HeN female mice liver,pert
"Well-differentiated human lung epithelial cells, infected with KY/136 (pdmH1N1) for 36h",pert
disease state: Diamond-Blackfan anaemia;	gender: Female,pert
Muscle from a 24 month old Myc heterozygous mouse,pert
"male,15,Caucasian",pert
"Brain tissue from Fisher 344 male rat, Animal #271, 5mg/kg D-Serine",pert
Healthy controls; individual=CM; time=2; beverage=water,ctrl
"Male, 33 years old, HIV infection of >3 years",pert
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: acrylamide,pert
disease state: tuberculosis;	tissue: PBMC,pert
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 24h;	gender: Female;	age: 54 years old,ctrl
gender: Male;	age: 90;	post-mortem delay: 6.75h;	ph: 6.2,ctrl
mutant Lis1 ko/+,pert
sampleID: SAM630139;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
wild type BxPC3 cells,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 159,pert
hur status: KO;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,pert
condition: Psoriasis;	patient: 252;	tissue: LS skin biopsy;	kit: Ovation,pert
age: 49;	sex: F;	disease status: control subject;	Filter number: 88;	Usage number: 1;	Exposures: 3,ctrl
cell type: primary mouse microglia;	genotype: wild-type,ctrl
cell line: HeLa,pert
status: Slow;	age: 73;	gender: male;	tissue: cultured human fibroblasts,pert
tissue: skin;	individual: Patient N-5;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: KSR1 and GFP;	background strain: DBA,ctrl
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 9 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 16 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
"mammary epithelial cells, WT",ctrl
56 Day Mouse extraocular muscle,ctrl
"Gender: Female, Age: 37, BMI: 31, Tissue: luteinized cumulus cells",pert
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: 7 day post sciatic nerve SNI injury,pert
"strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: CITCO; 6-(4-chlorophenyl)imidazo[2-1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime",ctrl
R5_Pseudomonas_wildtype_422,ctrl
"Biceps, FSHD, cohort 13, subject 13B",pert
Bmi1 transduced embryonic stem cells (Bmi1 ES cells).,pert
Granulocyte-Macrophage Progenitors,ctrl
EBS,pert
"t18, surgically resected from patient of gastric cancer.",pert
Subtype: RAEB2;	Karyotype: normal,pert
agent: pristane;	time: 3 days;	strain: DBA;	tissue: mesentery,pert
gender: male;	dietary group: grape extract (B);	time point: 12 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
"LCL GM19238, Kd USF1, 72hrs",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	RNA Integrity Number: 9.6;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 41;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
tissue: brain;	genotype: WT;	genetic background: C57BL/6,pert
"Total RNA, Tet2 KO LSK",pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: MEF2D shRNA,pert
strain: C57BL/6;	genotype: Captain Morgan (DOCK8 deficient animal strain),pert
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 3;	age: Post natal day 3-12,pert
WT sham kidney,ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 8h,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 200min;	race: White;	sex: Female,pert
transfection: CDK8-1;	cell line: HeLa S3,pert
age: 12 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 wild type,ctrl
Wild-type mice without treatment,ctrl
3 h-apra-2 nM,pert
HepG2 cell line from ATCC at 8th generation after 6 hours of PCB77 treatment.,pert
Paraventricular nucleus_control,ctrl
A549 lung cancer cells,pert
"twin pair: #4;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"COP strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.41096,ctrl
"Hippocampus, soman, 168h",pert
Regulatory T-cells CD4+CD25+ from wild type mice,pert
normal;	Biopsy Negative Control,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: TL3 SCR shRNA;	cell line: TL3,ctrl
strain: FVB/NCrIBR;	tissue type: tail skin,pert
ICL670-treated K562 cells,pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,pert
Neuroretina 8-week old db/+ mouse: BKS.Cg- (lean)/OlaHsd,ctrl
"gastrocnemius, 30 months of age, control diet",ctrl
human subcultured chondrocytes (passage 2) from normal donors,ctrl
duration of untreated disease in month:2.1;	age at onset:8.3,pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 99;	Usage number: 1;	Exposures: 2,ctrl
GFP- cells from Sox9-EGFP Mus Musculus pancreas at p23,ctrl
"Patient  A, lesion, 4 week",pert
race: caucasian;	age (years): 52;	stage: IB;	grade: 1;	histology: endometrioid,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 16 yr,pert
strain: c57/bl6;	weight: 25-30g;	age: 4 month;	gender: n/a;	tissue: whole trachea,ctrl
cell line: prostate cancer cell line LNCaP;	genotype/variation: negative control siRNA,ctrl
tissue: Lung;	strain: B6D2F1;	infection: uninfected;	time: control,ctrl
Sample isolated from wild type Foxp3 CD4+YFP+Ly5.2+ T cells following treatment with HR-MMPCreGFP and six week adoptive transfer.,ctrl
RNA from whole tissue section of case 607 labeled with Cy5,ctrl
PancreaticSample31-Normal,ctrl
Patient 10 appendix,pert
MDA cells resistant to paclitaxel,ctrl
MCF-7_vector control,ctrl
"SiRNA-scrambled, replicate 6",ctrl
cell line: LN229;	expression: control,ctrl
age_years: 35;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 6,pert
E16.5 Top2b+/+ brain,ctrl
MLL_PTD09,pert
cell line: MCF10A;	treatment protocol: SFN,pert
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject C,ctrl
"Patient CCa, stable renal transplant recipients, female, 70 years old, T1 (3 months after the switching of the therapy)",pert
CD8-IGF1R Transfected 3T3 cells treated with DMSO for 24 h,ctrl
Full-thickness epidermis,ctrl
Murine skeletal muscle,pert
Gastric biopsies,pert
"ID: MLL_00235;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
Control Treg,ctrl
EB_0_6h_49_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
subject: 31;	disease: TD;	muscle: ST;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"lymphoblastoid cell line from T5.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
strain: backcrossed 3-5 generations on C57BL/6 from FVB;	rna: TRAP;	driver: S100a10;	line: ES691/p11 KO;	tissue: cortex;	treatment: vehicle,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 4;	psoriasis duration: 19.0;	age of psoriasis onset: 17,pert
genotype:Rb null;	Age: e12.5,pert
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 47 yr;	population: white;	dsm-iv: 295.3;	age of onset: 20 yr,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 3 days with concentration of 0.17 uM (EC50).,pert
"Liposarcoma culture from tumor 393, doxorubicin treated",pert
"33B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
EB_0_24h_57_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
"Huh7 cells, JFH-1 Infected, 12 hours",pert
strain: BALB/c;	cell type: CD8 T;	genotype/variation: wild type,ctrl
"10 week, mutant;	SOD1(G93A);	Male",pert
SV cells isolated from inguinal White adipose tissue,ctrl
Strain: C57BL/6J;	Gender: male;	Age: 6 weeks;	Tissue: whole brain,ctrl
tissue: Hippocampus;	age: 90;	Sex: M,pert
disease state: control;	patient: 20,ctrl
482 cells Sox2shRNA-rep1,pert
"MCF7 cells, RL silenced, LIF 1h",pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 24 hours,ctrl
"2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",ctrl
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 2 hours,pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
"MCF7 cells stably transfected with pCDNA3.1, passage 6",ctrl
Brg1 mutant 2 cell embryo rep2,pert
WT,ctrl
condition: Normal;	patient: N_AJ3;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
No_drug_#4881,ctrl
human fibroblasts,ctrl
"MOLT4 cell line, treated with GSI",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 1 day;	treatment: 2R4F whole mainstream smoke 125 µg/ml, treatment over 1 day, 3x1h exposure per day",pert
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 158;	colon ratio (mg/mm): 2.03;	myeloperoxidase activity (u/mg): 0.043;	tissue: colon;	treatment: 5% DSS,ctrl
CD11b+Gr1- cell sample_4 (derived from IL17RC Knock out mouse),pert
ID: MLL_00109;	cell type: PBMC;	disease state: control,ctrl
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr.;	Timed-pregnant CD1 mice were purchased from Charles River Laboratories at embryonic day E15.5 mice (E15.5). Dexamethasone was obtained from Calbiochem and reconstituted in Dimethyl sulfoxide (DMSO, vehicle).",pert
Lung tissue,ctrl
HT29 methotrexate-sensitive cells,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus other,pert
Thoracic mammary glands were collected from three virgin wild type F1 CF-1/FVB mice at 16 weeks of age; RNA was pooled before synthesis of cDNA.,ctrl
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
MCF7 cells treated with 2uM Doxorubicin,pert
Human wildtype induced pluripotent stem cells,ctrl
KSR1-null MEFs with GFP,pert
tissue: peripheral blood from 8-10 E12.5 embryos;	genotype: Cbfb-/-;	progeny from cross: Cbfb+/- x Cbfb+/-,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: cisplatin;	timepoint: 24 hours,pert
EB_07_6h_130_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Mouse female ES cells PGK12.1 after double RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-1 in PGK12.1.,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
liver from Cmah KO mouse,pert
timepoint: Pre-Cediranib treatment,ctrl
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24717,pert
developmental stage: E14.5;	genotype: PtenloxP/+ and PtenloxP/loxP,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-18;	Primary Site:Floor of Mouth;	Age:52;	Sex:M;	TNM:T4N2M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
TTF=70min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
cell line: H1299;	agent: DMSO;	dose: control,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 27.08767,pert
Lung of hemorrhaged animal 24h,pert
Aquaporin-11+/+_mouse P7 kidney #2-2,ctrl
agent: control;	strain: DBA;	tissue: mesentery,ctrl
mixed reference (CRG + FR),ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 118,pert
HEK-293,pert
Disease_status: Down syndrome;	Age (years): 47;	Gender: Female;	Post mortem interval (hours): 8;	Braak stage: II;	Cause of death: Unknown,pert
NBD inhibitory peptide-treated HPB-ALL 100mM 16h,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: control (unimplanted samples were snap-frozen immediately);	host treatment: N/A,ctrl
EmptyVector 3,ctrl
chip number: 1;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
SV589_8Day KD_Serum Starved,pert
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,pert
Cervical cacner_654T,pert
Scrapings of the distal colon mucosa,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: non-treated;	tissue: liver,ctrl
n3_lo_5,pert
RNA from microdissected breast cancer cells from case 1370 labeled with Cy5,ctrl
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,pert
normally functioning myocardium from unused donor heart,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 82, HPV 16",pert
non-infected BALB/cByJ fibroblasts,ctrl
Gastrin Knockout fundus,pert
CON-2-COLLAGEN,ctrl
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep3,pert
Bladder urothelium,ctrl
DN4 cells sorted from mouse n°135 (Cre+),pert
Strain:B6.V-Lepob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
Wild Type Control for Pit-1 mutant (Snell) resulting in long lived dwarf pheontype,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN3 shRNA,pert
bone marrow macrophages from 1 female and 1 male IRAK4 kinase dead Balb/c mouse,pert
injection: IP 8hr 1 mg/kg sodium arsenite in saline;	diet: AIN-76A,pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.87;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 316;	age-at-biopsy-years: 39,pert
"MCF7 cells stably transfected with pCDNA3.1, passage 1",ctrl
subject: 19A;	cohort: 19;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
cell type: PBMC;	group: Healthy control;	patient treatment: not applicable,ctrl
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp+/+,ctrl
MLL_00235,pert
patient: 51308;	sample: tumor,pert
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene;	molecule: total RNA,ctrl
uterine leiomyoma,pert
X50 WT1	F2/8	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 6 hours",pert
E-mu-BRD2 resting B-Cells,pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",ctrl
HCC_40N,ctrl
293T cells stably transfected with 1 scramble shRNA construct. Control cell line for 293TsiLL cell line (LEDGF transcript knockdown - PSIP1 gene).,ctrl
chip number: 14;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.64;	rin: 9.5;	transfection date: 2012-03-26,pert
male_alcoholic,pert
Sample ID: TP15;	Twin Pair ID: CCN1.1R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1**,ctrl
RV63.01_CONTROL_day19,ctrl
"Neuroblastoma SH-SY5Y cells, transfected with scramble control",pert
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,ctrl
cell line: BxPC3;	genotype: CTNNB1 KO;	beta-catenin gene (ctnnb1): gene disrupted,pert
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24723,pert
CHF - R11,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
SV589 3 Day KD Serum Starved-> 1hr EGF,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#1,pert
WILDTYPE cerebellum at 12 weeks,ctrl
"BMMC, NTAL KO, activated",pert
"twin pair: #8;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
"neocortex, 30 months of age, control diet",ctrl
cell line: Breast carcinoma cell line Cal51;	genotype/variation: control;	agent: MMC,ctrl
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT30,ctrl
HEK293 cell line #1 with uninduced HNF1alpha,ctrl
H4-II-E-C3 cells,ctrl
SV589_8DKD,ctrl
"Gata6-KO heart, CRE, biological rep2",pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
"hippocampus, SSS",pert
Patient: J;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
"Lymphoblastoid cell lines derived from family 1724, member 2",ctrl
GATA6 KO lung E18.5 mouse,pert
"MCF7 cells, RL silenced, LIF 1h",ctrl
race: african american;	age (years): 74;	stage: IA;	grade: 2;	histology: endometrioid,pert
E1 clone infected with Deaf-1-expressing retrovirus.,pert
Gene expression profiling of normal cortex of patient 1524,ctrl
Patient: C;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"affected sister,",pert
"LCL GM19238, Kd POU2F1, 72hrs",pert
WT_d00_e0,ctrl
organ: Liver;	age: 14-week-old;	genotype: Trim24-/-,pert
strain: FVB;	developmental stage: newborn (4-day-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
Sodium arsenite added to food: None; Injection: IP 8hr 1 mg/kg Dexamethasone in saline; Diet: AIN-76A; Sodium arsenite added to drinking water: None,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",pert
G93A non transgenic littermate 805,ctrl
tissue: breast;	disease state: healthy,ctrl
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; no EGF,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.5;	Post mortem interval (hours): 8;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,pert
Tissue: tumor; Gender:male; Age:33  Tumor stage:T1N0MX,pert
bronchoalveolar stem cells,pert
"midbrain,6weeks,KO",pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
hOB1705_shRB1383_24hr_IR,pert
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L112,pert
cell type: myoblast;	transduction: lentiDUX4fl,pert
"wt, 2 ug/ml doxycycline",ctrl
"Male, 27 years old",ctrl
LSK cells SRF KO 1,pert
PancreaticSample26-Tumor,pert
patient: 4;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
RV63.03_CONTROL_day19,ctrl
Gender:F;	Age:49;	Tissue:Mucosa,pert
brown fat cells differentiated for 7 days,ctrl
siRNA-1-PLASTIC,ctrl
Primary combined SCLC-AD 4544,pert
Leukemia,pert
S49 Murine T-Lymphoma Cells,ctrl
NSCLC adenocarcinoma cell line,pert
NORMAL MAMMARY GLAND,ctrl
genotype: Sgk1-/-;	cell type: Th17,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.74;	age of onset: 14 yr,pert
Ischemic cardiomyopathy,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 40;	sex: F,ctrl
tissue: Frontal cortex;	age: 82;	Sex: M,ctrl
"genotype/variation: ApoE-/- RAGE-/-;	strain: C57BL/6;	mouse provider: Ann Marie Schmidt laboratory, Columbia University;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: non-diabetic",pert
HeLa cells nucleofacted with CABIN1 siRNA,pert
"Liver RNA, WT mice",ctrl
The nucleus accumbens from a neurologically normal Jpanese male (aged 60 yr).,ctrl
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 28.88767,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",pert
NFIA P16KO3,pert
"CBP, p300, CH1, TAZ1, hypoxia, MEF",pert
D425,pert
HT1080,ctrl
"Liposarcoma culture from tumor 385, doxorubicin treated",pert
"Cultured ovarian cancer cell line A2008, Cisplatin treated",pert
sampleID: SAM630129;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
tissue: Temporal cortex;	age: 84;	Sex: M,pert
subject: 19U;	cohort: 19;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.60;	Post mortem interval (hours): 11;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Mouse heart,ctrl
Peripheral blood mononuclear cells;	TTF=70min;	Race=White;	Sex=Female,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.413;	OD280: 1.719;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 323;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
adrenal gland,pert
Neonatal mouse ovaries cultured in Menadione (5uM),pert
"SBC-5 cells, siEGR4 (target), 48 hr after siRNA, duplicate sample 1",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 62;	gender: m;	treatment: NSAIDs,ctrl
EB_07_5d_137_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
clone type: AtT20 clone types infected with empty vector rep2,ctrl
"striatum,24weeks,KO",pert
cell line: COV434;	transfection: pFOXL2wt,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 70min;	race: White;	sex: Female,pert
"Deltoid, control, cohort 12, subject 12V",ctrl
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 8.1;	colon weight (mg): 200;	colon ratio (mg/mm): 2.47;	myeloperoxidase activity (u/mg): 0.016;	tissue: colon;	treatment: 5% DSS,ctrl
"Liposarcoma culture from tumor 392, doxorubicin treated",pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 24hr,ctrl
CD11b+Gr1- cell sample_1 (derived from IL17RC Knock out mouse),pert
liver_Akt1+/-_female_35wk_rep2,pert
Heart RNA,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 40, stage IIIB, HPV 16",pert
H1299_shPTK7,pert
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 1,pert
microdissected epithelial cells from normal main pancreatic duct 5,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,pert
patient id: 260;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: n/a;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0Mx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
Gender:M;	Age:36;	Tissue: Mucosa,pert
genotype/variation: ApoE-/-;	strain: C57BL/6;	mouse provider: Jackson labs (backcrossed >10 generations against C57BL/6 background).;	gender: Male;	age: 9 weeks;	tissue: Total aorta from root to bifurcation.;	disease state: diabetic,ctrl
Gender: Male; Tissue: prostate.,pert
strain: ICR;	cell type: bronchoalveolar stem cells (BASC);	genotype/variation: control,ctrl
"age at diagnosis: 44;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 16;	dfs-event: 0;	distant metastasis: 0",pert
"wild type naïve CD4 positive cell, unstimulated, replicate 4",ctrl
Strain:  B6.V-Lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
"patient 15, right arm treated with pimecrolimus until day 22",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: normal,pert
S2_Sham_wildtype_8,ctrl
"Cultured ovarian cancer cell line HeyC2, Cisplatin treated",pert
"LCL GM19238, Kd RDBP, 72hrs",pert
age_years: 48;	sex: M;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Primary hepatocytes isolated from BalbC mouse strain treated with Wy14643 for 24h,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 201,ctrl
PancreaticSample16-Normal,ctrl
"hippocampus, MSM",pert
cell type: Primary hepatocytes;	strain: DBA;	agent: Wy14643;	time: 24h;	gender: Female;	age: 3 months,pert
"Heart, MAT1 CKO, 2 wk, sample 2",pert
subject id: 40;	infection: DENV;	status: DHF;	tissue: whole blood,pert
phenotype: alcoholic;	gender: female;	case_id: 402;	age: 75;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 9;	brain ph at time of freezing: 6;	labeling_batch: 1,pert
"Normal cervix epithelium, Age 49",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,ctrl
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutE",pert
LIN-CB,ctrl
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",ctrl
"DBA/2J Saline treated, biological replicate 1",ctrl
cardiac allograft,pert
Total RNA from Ph+ ALL (C57Bl6),pert
"heart, non-transgenic mice at 90 days of age",ctrl
N10A Normal-frontal,ctrl
BALB/c mouse treated with pristane for 18 days,pert
Patient: E;	Time: 1 week;	Group: responder;	Condition: lesional,pert
Strain: 129S2/SvPasCrlf;	Sex: male;	Genotype: L1CAM knockout (-/Y),pert
"paraventricular nucleus of the hypothalamus, LPS, 10 micrograms, 3 hours",pert
Control knock out ESCs,ctrl
tissue: left lung;	genotype: Gata5 KO;	age: 8-week-old,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 6h;	gender: Male;	age: 2 months,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/43;	differentiation status: undifferentiated;	cell line: Q50,pert
"heart, knock out",ctrl
gender: Male;	tissue: liver;	genotype: FGF21-/-;	treatment: DMSO 3-day;	genetic background: C57BL/6,pert
Whole adrenal RNA from Crem-/- mouse #143 at 0h,pert
tissue type: Lesional skin;	time: Week1_etanercept,pert
lung fibroblasts from a patient (FASSc3) with fibrosing alveolitis associated with systemic sclerosis,pert
"wild type; BMDM; IFNgamma and  1alpha,25(OH)2D3 treated",ctrl
genotype: MLL partial tandem duplication,pert
Genotype: p38alpha wt;	Age: E15.5,ctrl
treatment: Cyclin D1 siRNA Estradiol;	cell line: MCF7,pert
Mixed_E14.5_Whole_Kidney,pert
Morbidly obese PCOS patient,pert
Septic shock;	gender: Male;	Survivor;	organism: None,pert
"Brain tissue from Fisher 344 male rat, Animal #266, 20mg/kg D-Serine",pert
WT inbred background,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: pre-UV,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L221,pert
Gene expression data spleen follicular B in IRF8 conditional KO,pert
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
CUTLL1 GSI,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 49;	donor: 35;	disease state: Lesional,pert
gender: male;	dietary group: resveratrol-enriched grape extract (C);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),pert
phenotype: alcoholic;	gender: male;	case_id: 326;	age: 61;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.93;	labeling_batch: 2,pert
pLenti transduced cell lines overexpressing CDH1a,pert
ID: MLL_00116;	cell type: PBMC;	disease state: control,ctrl
genotype: WT;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Male,ctrl
braak stage: BR34;	rin: 65;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
Genotype: Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
Normal Inflamed sigmoid colon,ctrl
LRRK2 mutant knockin H9 hESC derived NSC 3,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: DSS for 3 days,ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep1,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 46 yr;	population: white,ctrl
MCF-7,pert
"BMDM, 1alpha,25(OH)2D3 treated, KO Vdr -/-",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: ;	choa: 56;	fata: 125;	eea: 1860;	wtkg: 74;	perfat: 26;	lbm: 52;	fat_mass: 1924,ctrl
"brain, cerebellum",ctrl
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 8.5 weeks-old,pert
"Entire small intestine, CF, control",ctrl
age: 6 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
Tissue: HepG2 cells;	Gender: Male;	Source: ATCC;	1st technical replicate,pert
cells: spleen marginal zone B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
"ID: MLL_00255;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
RV82.09_CHF_day10,pert
"genetic background/strain: C57BL/6;	genotype: Alkbh1-/-;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",pert
tissue: Temporal cortex;	age: 74;	Sex: M,ctrl
strain: 129;	cell type: EBs;	genotype/variation: Trim33-KD,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.377;	OD280: 0.716;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 211;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
phenotype: control;	gender: male;	case_id: 367;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 18;	brain ph at time of freezing: 6.6;	labeling_batch: 1,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
genotype: EFLmDREAM;	stimulation: non stimulated;	cell type: B cells,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post Saline ip.,ctrl
PMBCs,pert
Epidermal keratinocytes treated with EFNA4 for 24h,pert
A2CKO3,pert
Patient: G;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
patient: 258;	current medication: Azathioprine 200mg Pentaza 1g TDS;	birth date: 10/26/64;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/1/87;	diagnosis date: 6/1/88;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 18 weeks;	genotype/variation: VhlhKO",pert
"Healthy control mice, time point 3 week",ctrl
dorsal skin from GR-/- E18.5 embryo,pert
tissue: small intestine;	genotype/variation: E-cadherin cKO,pert
tissue: lung;	genotype/variation: Tmem1002loxP/2loxP;ROSA26+/CreER,pert
"Normal cervix epithelium, Age 52",ctrl
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.94;	Post mortem interval (hours): 29;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: A;	experimental sample name: PC4-R,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 24h,ctrl
genotype/variation: Wild-type (E14K);	cell type: embryonic stem cells,ctrl
strain: C57BL/6J;	tissue: skin;	cell type: melanocyte;	genotype/variation: Ink4a-ARF1 null,ctrl
C57Bl/6 peritonial macrophages,ctrl
Vastus lateralis muscle,ctrl
E12 embryo proper,pert
Lung Tissue of Non-Transgenic Female Mice,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.692;	OD280: 1.387;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 49;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Female;	age: 88;	post-mortem delay: 7h;	ph: 5.7,pert
Bmpr1a-/- in ESC media,pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 2;	time: 6h,pert
"PCOS, biological rep 6",pert
"Control pancreas, sample 2",ctrl
Hippocampus of 2 months old Rsk2-KO males,pert
Vehicle 12 hours_3,ctrl
R1_saline_wildtype_422,ctrl
cell line: HL-60;	replicate: Replicate1;	treatment: shLuciferase,ctrl
subject id: 7;	infection: DENV;	status: DF;	tissue: whole blood,pert
CEM-C1 T-ALL cell line treated with DMSO,ctrl
cell type: B-cell;	cell line: OCI-Ly7 DLBCL,ctrl
cell type: bone marrow cells;	strain: DBA/2,pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT18,pert
"spinal cord, ventral spinal cord",ctrl
PyV-mT wild-type tumor,ctrl
PancreaticSample5-Tumor,pert
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 32;	maternal age: 29,ctrl
A549 lung cancer cells,ctrl
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: control,ctrl
age: 58;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P3,ctrl
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Mouse female ES cells PGK12.1 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-3 in PGK12.1.,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.5;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
cell type: Neuronal Stem Cells;	developmental stage: E14.5;	strain: CD-1 albino,pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 19;	gender: f;	treatment: NSAIDs,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 48h,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 57, stage IIB, HPV 18",pert
"whole-blood leukocytes, placebo, 0hr",ctrl
transfection with nonsense siRNA,ctrl
peripheral blood,pert
"age at diagnosis: 50;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T3;	n (lymph node metastasis): N3a;	er: NA;	pgr: NA;	dfs-month: 17;	dfs-event: 1;	distant metastasis: 1",pert
"Liposarcoma culture from tumor 391, untreated",ctrl
Sample ID: TP24;	Twin Pair ID: CCN3.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 25;	Current Age (2007): 28;	Sex: MALE;	Medication at blood sampling : None,ctrl
Brain from 37 days Npc1+/- mouse1,ctrl
"Deltoid, FSHD, cohort 18, subject 18A",pert
"PC from healthy donors, isolated using CD38-APC.",ctrl
Tissue: normal thyroid; Gender: male; Age:42,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 154;	fata: 54;	eea: 1420;	wtkg: 81.5;	perfat: 41.9;	lbm: 44.1;	fat_mass: 3414.85,ctrl
Epidermal keratinocytes treated with EFNA4 for 1h,pert
"MCF-7 cells, siERK1 treatment 60h, 0.1%EtOH for 4h",ctrl
"LCL GM19238, Kd SP3, 72hrs",pert
RNA from whole tissue section of case 1437 labeled with Cy5,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate B,pert
scc_07,pert
tissue: primary brain tumor;	cell type: astrocytoma;	age: 41;	gender: male;	tumor grade: AII,pert
Strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue:  gallbladder,ctrl
"MCF-7 cells, siGL3 treatment 72h, 0.1%EtOH for 24h",ctrl
Human_Hepatocyte_trovafloxacin,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 47;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
Endometrium/Ovary-Disease 3,pert
"Knee articular cartilage, 4 weeks following sham surgery",ctrl
age: 38;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 4h,ctrl
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
"LCL GM19238, Kd PAX5, 72hrs",pert
quadriceps femoris,ctrl
chip number: 15;	transfection plate: 3B;	target gene: STAT6;	kd level: 0.74;	rin: 9.5;	transfection date: 2012-03-26,pert
"NALT infected with 90-226 deltaM, 24h, biological rep3",pert
A HID U_B020,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS containing bleomycin (0.075U/mouse) for 5 days;	tissue: lung,ctrl
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 24h;	gender: Male;	age: 63 years old,pert
human CD14 positive monopcytes,pert
Patient 13 appendix,pert
adipocytes expressing GFP,ctrl
bleomycin injected mouse lung,pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F7;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
kidney from Cmah KO mouse,pert
Y VIS _B028,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 69;	tissue: Blood,pert
genotype/variation: MBD1 WT;	tissue type: thymus;	cell type: medullary thymic epithelial cell (mTECs),ctrl
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 11,pert
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Igf1 +/+ mouse vestibular organs 90 days old (P90),ctrl
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,ctrl
Cell line: SUP-B15,ctrl
F3-NGN1-1st,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 347;	age-at-biopsy-years: 43,ctrl
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.18 uM (2 x EC50).,pert
Embryonic Stem Cells,ctrl
"Patient  M, lesion, 1 week",pert
cell type: embryonic stem cells [E14];	transfected with: pooled non-specific siRNAs (control),ctrl
"Transgenic, snap frozen, tibialis anterior muscle, 10 month age animal",pert
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min,ctrl
WT 3 1782,ctrl
status: Normal;	age: 59;	gender: female;	tissue: cultured human fibroblasts,ctrl
primary normal lung tissue 1345,ctrl
CD8_Tcells_healthy_donor,ctrl
A549 cells,pert
Mouse lung wild type,ctrl
genotype: Wild-type;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
T119,pert
"ID:13-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Tendon;Suspraspinatus_Lesional,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 1",pert
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 26;	maternal age: 23,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 4",pert
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.09mM, 72 h",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 6h",pert
"129P3/J Acute morphine treated, biological replicate 2",pert
Glioma cells expressing Cyr61,pert
"Deltoid, control, cohort 07, subject 07U",ctrl
KM-H2 with PTPN1 siRNA knockdown,pert
cell type: NPC 5-8F cells;	genotype/variation: control,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 87;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
Postmortem human substantia nigra,pert
Subtype: RAEB2;	Karyotype: del(5q),pert
WT_24A_1,ctrl
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_2,pert
cell line: SV589;	knockdown (days): 0;	treatment: Serum Starved; 3h EGF,pert
primary MEFs,ctrl
"MCF7 cells, RL silenced, NS",ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 2",pert
sampleID: SAM630133;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
tissue: white blood cells;	age: 16.94;	Sex: female,pert
MOLM-14 cell line infected with GSK3B Construct 1 shRNA,pert
HCC_11N,ctrl
strain: Swiss;	tissue: Ovary;	agent: Menadione (5uM);	replicate: 1;	age: Post natal day 3-13,pert
Tissue: whole retina,pert
NORMAL #99-0160,ctrl
"lung, chronically exposed to silica",pert
"Patient  C, lesion, time: 0",ctrl
0810A-01_clone 3-1,pert
Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P;	Sample: nontransgenic control (NTG);	Replicate: 3;	Pool: P,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 1,pert
"Benign, pooled tissue, prostate",ctrl
gender: female;	batch: 2;	age (years): 44;	patient id: Non_severe_2;	fev1 (% predicted): 87;	fvc (% predicted): 92;	medication: flixotide;	cell type: CD4+ T-cells,pert
treatment: control scrambled siRNA;	cell line: H441,ctrl
saline injected mouse lung,ctrl
Spleen,ctrl
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed ,pert
"4B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Strain: C57BL/6J;	Gender: male;	Age: 8 weeks;	Tissue: whole brain,ctrl
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 7-9 wk,ctrl
MCF7 cells that were transfected by control siRNA.,ctrl
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
cell type: dental pulp cells,pert
Nonirradiated-ATM-WT Replicative2,ctrl
Rat Dorsal Root Ganglia,ctrl
"Ishikawa cell line, BPA, 100pM, 24hr",pert
Dysf -/- QF muscle,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 1,pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep1",pert
phenotype: alcoholic;	gender: male;	case_id: 274;	age: 81;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Ex;	post-mortem-interval (hrs): 36;	brain ph at time of freezing: 6.44;	labeling_batch: 1,pert
Mouse inner ear,pert
"Ls174T, dominant-negative Tcf4, induced",pert
tissue: Spleen;	genotype: TRAF3flox/flox-CD19+/cre (B-TRAF3-/-),pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
genotype/variation: c-Myb sufficient;	age: 4-5weeks,ctrl
cervical spinal cord,ctrl
nasopharynx,pert
"DBA/2J Chronic morphine treated, biological replicate 1",pert
"p53-null NSC, PlagL2",pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
"Patient  E, lesion, 12 week",pert
Lung Tissue,ctrl
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His-ZNF217 plasmid,pert
tissue: Frontal cortex;	age: 105;	Sex: F,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 24 hrs,ctrl
hOB1705_shRB1383_16hr_IR,pert
subject id: c2;	infection: control;	status: control;	tissue: whole blood,ctrl
Brain (Inferior Olivary Nucleus)_control subject_#4,ctrl
Total RNA,ctrl
"midbrain,12weeks,KO",pert
231/ARF-1,pert
MOLM-14 cell line infected with scrambled control shRNA,ctrl
mouse CD4+ T cells,pert
cell type: HeLa;	genotype/variation: Transfected with G392E Neuroserpin,pert
"lung, from control",ctrl
11A;pretreatment;female;breast tumor,ctrl
harmane 1uM batch 1,pert
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,ctrl
"heart, wild type",ctrl
unstimulated CD4+ T-cells from Itk knockout C57BL/6 mice,pert
"Transgenic, snap frozen, gastrocnemus muscle, 7month age animal",pert
"gender: Female;	age: 89;	post-mortem delay: 8h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
8 Month FORKO Ovary_03,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.621;	OD280: 0.822;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 130;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Human lung adenocarcinoma cells_Nrf2 siRNA transfected,pert
Sex: female;	Age at operation: 70 years;	Site: upper arm;	Size in cm: 3x5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu3,pert
Age: 59;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
"peripheral blood leukocytes, Cyclophosphamide-treated 1 day",pert
genotype: Wild Type;	stimulation: non stimulated;	cell type: B cells,ctrl
Genotype: Wild Type,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 99;	Usage number: 4;	Exposures: 3,pert
cell line: Du145-PCAT1 (HTB-81);	age: < 20 cell passages from derivation,ctrl
"LCL GM19238, Kd RELA, 72hrs",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",pert
Patient: K;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
heart from Cmah KO mouse,pert
Peripheral blood mononuclear cells;	TTF=140min;	Race=White;	Sex=Male,pert
A HID U_B007,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.7726,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
HT29 derived clone with vector expressing CD24 directed shRNA,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 209,ctrl
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,ctrl
agent: LMP-420;	selection protocol: negatively selected cells,pert
placenta (E 10.5),ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 690,ctrl
human MBC_FOXP1 overexpression,pert
subcuteneous fat,ctrl
Ebola-infected macrophages harvested at 6h post-treatment from donor 2,pert
E14.5 fetal liver TER119- wildtype,ctrl
"Cervical cancer cell line, HT-3",pert
race: african american;	age (years): 51;	stage: IB;	grade: 3;	histology: papillary serous,pert
cell line: HeLa cervical carcinoma,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 24 hr,pert
EE_IC_1_cauc_lcm,pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 1",ctrl
Panc-1 Pancreatic Cancer Cells,pert
Extract:LOX-1:213202;	Extract Description:LOX1_Untreated_2hr:213202;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.8;	Quality: Background Mean Dev.:0.27;	Quality: Absent (%):57.58;	Quality: Absent (%) Dev.:0.52;	Quality: Scaling Factor:0.62;	Quality: Scaling Factor Dev.:0.05;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295543,pert
N13B Normal-cerebellum,ctrl
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
SF539 GBM cell line,pert
RNA from microdissected breast cancer cells from case 1279 labeled with Cy5,ctrl
Heterozygous mouse pDCs,pert
25 uM chlorpyrifos batch 1,pert
"Biceps, FSHD, cohort 19, subject 19A",pert
chip number: 14;	transfection plate: 5;	target gene: RXRA;	kd level: 0.88;	rin: 8.9;	transfection date: 2011-10-17,pert
patient: 51783;	sample: tumor,pert
strain: C57BL6 mixed FVB;	genotype/variation: cMetflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: BaCl2 muscle injury;	tissue: hindlimb muscle contralateral to BaCl2 muscle injury;	cell type: CSC;	time: 2.5 days post injury,pert
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression",pert
"Mouse, WT, colon, DSS, rep2",ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 85;	Usage number: 1;	Exposures: 3,ctrl
age: 35;	sex: F;	disease status: control subject;	Filter number: 87;	Usage number: 4;	Exposures: 3,ctrl
female_control,ctrl
At Risk: +;	Age: 13;	Sex: F,pert
mouse whole lung,ctrl
patient code: 123;	gender: Male;	age: 74;	tumor grade: 3;	t-stage: 1;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
basolateral amygdala,pert
Y YOKE_B060,ctrl
"Sham NALT (PBS), biological replicate 1",ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 23;	sex: F,ctrl
cell type: fibroblast;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: 0;	clone: 0,ctrl
patient id: 14;	tissue: Normal cortex;	gender: Female;	age: 64;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
cell type: preadipocytes;	tissue: white adipose tissue,pert
HeLa cells treated with luciferase siRNA,ctrl
MLL_00112,ctrl
"LCL GM19238, Kd IRF7, 72hrs",pert
"BL from CLL patient, isolated using CD19-PE and CD5-APC.",pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: WT;	age: 3-month,ctrl
Mouse whole brain,ctrl
Aorta from ApoE-/- mouse without diabetes sacrificed at 9 weeks.,ctrl
Wild type C2C12 cells,pert
"SKO-transduced MEFs, Vc untreated, lysed on D4",ctrl
Mtb infected mouse lungs treated with PZA-63 days post infection,pert
"CD11b, KO",pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 80;	Sex: male;	region: LC (locus coeruleus);	age: P24;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
bone-marrow mesenchymal stromal cells extracted from myeloma patient,pert
Time:4 day; condition:Emerin ko;,pert
DLBCL cell line KARPAS-231 transfected with a non-targeting siRNA,ctrl
cell line: HM1 embryonic stem cell line;	genotype/variation: control,ctrl
cell line: M12;	treatment: EGR3 knockdown,pert
"Bone marrow-derived macrophages, MyD88 -/-, unstimulated, 0 minutes",ctrl
Trip12 mut/mut mouse embryonic stem cell,pert
untreated 24 hr,ctrl
cell type: PGC;	genotype/variation: Tcfap2c KO,pert
PancreaticSample1-Tumor,pert
"Patient  E, lesion, 1 week",pert
patient: 30;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p31;	strain: E14,ctrl
"NALT infected with 90-226 deltaM, 24h, biological rep1",pert
Brain BA22 post-mortem schizophrenic,pert
Whole testis from Ing2 WT littermate,ctrl
aorta from ApoE-/- mouse with diabetes sacrificed at 9 weeks,ctrl
tissue: colon biopsie,pert
Human medulloblastoma DAOY cell line,pert
HT29 methotrexate-resistant cells,ctrl
gastrocnemus muscle,pert
"liver RNA, WT  mouse",ctrl
"129P3/J Acute morphine treated, biological replicate 3",pert
Disease_status: Healthy control;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): 30;	Braak stage: 0;	Cause of death: Lung cancer,ctrl
mouse bone marrow-derived mast cells treated with IL3,ctrl
triplicate 3 of uninfected HepG2 nt cells,ctrl
imr-32,ctrl
F6.01,ctrl
"B cells, transgenic, unstimulated",pert
Celecoxib_#4871,pert
"TNFa-OMe-P siRNA-C, replicate 5",pert
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD20-APC;	cell type: CD20 positive B cells,pert
tissue: skin;	individual: Patient P4;	condition: AL;	eczema severity: SCORAD: 97.5,pert
tissue: adipose tissue;	sample group: resveratrol;	treatment: after;	gender: Female,pert
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,pert
"patient: 204;	current medication: AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin;	birth date: 8/15/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 7/1/02;	diagnosis date: 8/1/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/1/04;	indictation for procedure: ;	ucss: 5;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 0;	nod 702: 0;	nod 908: 0;	dlg5 133a: 0;	nod 1007 fs: 0;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/1/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/58;	smoking stop date: 1/1/01;	smoking amount: 25+;	other illnesses: Type 2 DM 02/2004.-Gout.;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed",pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 48h,ctrl
HL-60 cell line infected with scrambled control shRNA,ctrl
"Strain: C57BL/6, Tissue: Airway Epithlium, Culture: Organotypic Air Liquid Interface",ctrl
"hMSC-Tert, control siRNA, 2 days adipocyte differentiation",ctrl
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ shNotch3;	treatment: Ca 0.6mM, 72 h",pert
HUVEC culture,pert
thyroid cancer cell line,ctrl
gender: male;	strain: BALB/c;	tissue: liver;	diet: Western diet for 20 weeks,ctrl
chip number: 15;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.6;	transfection date: 2012-03-26,ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 4 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
"seminoma specimen, pT1, patient age: 37y",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 29;	maternal age: 26,pert
chip number: 13;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.62;	rin: 9.7;	transfection date: 2012-03-26,pert
10 weeks old,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,ctrl
tissue: cervical cancer cell line HeLa,ctrl
Male 6-8 week BALB/c grafts in Male 6-8 week C57Bl/6 host,pert
strain/background: C57BL/6;	genotype/variation: AhR-deficient knockout (AhR-/-);	tissue: lung;	treatment: PBS control,pert
pooled skins,pert
condition: Normal;	patient: N_LJ_1;	tissue: Normal skin biopsy;	kit: Affy,ctrl
"TNFa-OMe-P siRNA-C, replicate 8",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 160min;	race: White;	sex: Female,pert
"p53-null NSC, vector",ctrl
mouse heart,ctrl
"cell line: 9837, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
tissue: liver;	treatment: vehicle;	strain: A/J,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",pert
Mc3T3_untreated_5 days,ctrl
RNA from whole tissue section of case 59 labeled with Cy5,pert
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,ctrl
"Lymphoblastoid cell lines derived from family 1757, member 2",ctrl
gastrocnemius muscle,ctrl
MOLM-14 cell line infected with GSK3A Construct 6 shRNA,pert
HeLa cell,ctrl
LSK cell from Gfi1 wildtype mice,ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 6 hours",pert
"DSS + L-Arg colon tissue, biological rep2",pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 4x1h exposure per day",pert
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 24h;	gender: Female;	age: 54 years old,pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus other,pert
treatment: Arid3a overexpression high;	cell line: J1 ES cells;	sample type: single colony,pert
skeletal muscle (quadriceps); fasted 18h,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: WT,pert
cells origin: subcutaneous white adipose tissue;	individual characteristics: Morbidly obese patient,pert
"DHL6, R406, 6h",pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 4h,ctrl
"heart, knock out",pert
cell line: HT1080;	clone: 9;	genotype: Wild type,ctrl
"fetal testis sample 25, 20 weeks gestation",pert
genetic background: C57BL/6;	tissue: liver;	genotype: LmnaG609G/G609G knock-in;	gender: female;	age: 3 mo,pert
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 7 weeks-old,pert
cell line: HeLa,ctrl
At Risk: +;	Age: 12;	Sex: M,pert
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,pert
MCF7 DMSO+EtOH,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,pert
Trizol extracted total RNA from uterine fibroid tissue.,ctrl
"ID:c 4-3, Genotype=(C57BL/6J), Treatment= none",pert
Undifferentiated mouse embryonic stem cells,pert
sample: #4;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Inferior olivary nucleus,ctrl
"Fmr1 wildtype mouse, cerebellum",ctrl
scan batch: Batch 2;	group: autism;	subject age: 9;	paternal age: 37;	maternal age: 30,pert
RNA from microdissected breast cancer cells from case 1389 labeled with Cy5,ctrl
CD4+ T cells from B6 mice,ctrl
PancreaticSample28-Tumor,pert
spinal cord,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A and ZMPSTE24;	cell line: GM00038,pert
"cell line: Hec50co endometrial cancer cell line;	cell line traits: Loss of p53, loss of hormone receptors ER and PR;	disease state: Grade 3 endometrioid adenocarcinoma;	genotype/variation: control",ctrl
tissue: Hodgkin lymphoma;	cell line: KM-H2,ctrl
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 3",ctrl
"gender: Female;	age: 70;	post-mortem delay: 4.5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
wild-type heart,ctrl
patient: 51308;	sample: normal,ctrl
"control + L-Arg colon tissue, biological rep3",ctrl
PancreaticSample11-Tumor,pert
Disease_status: Bipolar disorder;	Age (years): 63;	Gender: Female;	Age of onset (years): 43;	Duration of illness (years): 20;	Brain pH: 6.97;	Post mortem interval (hours): 32;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
HeLa cells;	(cervical cancer cells),ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: PBS;	tissue: liver,ctrl
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 08/23/05;	# cells: 48;	Sex: male;	region: M1;	age: 48;	genotype: Y/Mecp2-;G42/-,pert
Healthy controls; individual=CJ; time=2; beverage=water,ctrl
cell line: mOS482;	cell type: osteosarcoma,pert
cell line: U251;	transduction: stably expressing non-target control shRNA,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 102;	Usage number: 5;	Exposures: 3,ctrl
"Liver, wild-type",ctrl
RNA from whole tissue section of case 1389 labeled with Cy5,ctrl
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
C57BL/6J Mouse Female Kidney,ctrl
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
strain: 129/Ola;	cell type: embryonic stem cells,ctrl
"Ishikawa cell line, control, 48hr",ctrl
heart of male mouse subjected 4 week to chronic constant hypoxia.,pert
"LY2 cell line, SRC-1 siRNA treated 120min, biological rep3",pert
Peripheral blood mononuclear cells;	TTF=75min;	Race=White;	Sex=Male,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p28;	strain: E14,pert
rat hippocampus (CA1 region)_IntermediateCort,pert
HOX424 Carbo Day7,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
Psoriasis-7 baseline,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
tissue: retina;	age: postnatal day 2;	genotype: rd1,pert
"tissue: bone marrow;	disease status: B-precursor acute lymphoblastic leukemia, Down syndrome",pert
Small intestine,pert
Alpha7 nAChR subunit L250T heterozygous mice without treatment,pert
A39 NES 142Q TG2	F5/52	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
Y SIT_B076,ctrl
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 36;	maternal age: 34,ctrl
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,ctrl
"Wild type, snap frozen, diaphragm muscle,10 month age animal",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 195min;	race: White;	sex: Female,pert
"P10 mouse back skin, control",ctrl
HCC_28N,ctrl
WT S49 cells 2 h cAMP treatment,ctrl
"Embryoid bodies, 48h,Plus Dox",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 42 yr;	population: white,ctrl
peripheral blood cell,ctrl
Bone marrow-derived macrophages from mice deficient in signaling adaptor molecule MyD88,ctrl
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"D5_non-transgenic mice, lung tissue",ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 8 hours,pert
disease: type 1 diabetes;	gender: female;	cell type: endothelial progenitor cell,pert
52A;pretreatment;female;breast tumor,ctrl
sample 1;	age: 68;	gender: male;	sample 2;	age: 77;	gender: female;	sample 3;	age: 72;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
Tissue: normal thyroid; Gender:male; Age:33,ctrl
Diagnosis: MDS/AML;	Age: 51y;	Gender: Female;	Blast %: 71;	Source: PB;	Cyto: t(15:17);	FLT3 ITD: 1;	FLT3 TKD: No Data,pert
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Mirandela;	lifestyle characteristics: ever drinker,ctrl
Brain BA22 post-mortem control,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 5",pert
genetic background: c57/bl;	gender: male;	tissue: heart;	genotype: MHC-Plin5,pert
Whole adrenal RNA from Crem-/- mouse #1 at 0h,pert
Karyotype: inv(14)(q11q32);	Age: 54 years;	Gender: female,pert
Aorta mutant,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P8;	clone: 0,pert
tissue: Liver;	genotype: wild-type;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 547,ctrl
"Cultured ovarian cancer cell line OVCA420, untreated",ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P0 postnatal stage,pert
genotype/variation: Rpt3 null;	strain: mlc1f-Cre/ Rpt3-floxed;	gender: female;	age: 6weeks;	tissue: tibialis anterior,pert
B_cell_pool_healthy_H07+H08,ctrl
embryonic stem cells,pert
tissue: xenograft tumor,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 58;	tissue: Blood,pert
chip number: 23;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.86;	rin: 9.6;	transfection date: 2012-03-26,pert
"Epidermal keratinocytes untreated control, 4h",ctrl
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,pert
"PTEN mutant 2 intestinal polyp, polyI:C, 30 days",pert
28 Day Mouse leg muscle,ctrl
patient: 230;	current medication: Asacol 1.6g/ day;	birth date: 12/27/57;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/12/02;	diagnosis date: 12/3/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/25/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/25/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: ? MS never proven;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
3 h-control (EtOH);HT-29;colorectal adenocarcinoma;Etha;24713,ctrl
H2009_shGFP,ctrl
Cardiac biventricle of vehicle injected PGC-1a-/-bf/f/MerCre mouse (control),ctrl
BALB/c BMDM naive,ctrl
"Heart, mdx, 2 months old",pert
3 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24716,pert
Patient: O;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
Normal HEK293 cell,ctrl
postmortem brain,pert
c42 is aclonal Nurr1 stably-expressing stem cell line,pert
untreated Murine 3T3-L1 cells,ctrl
SKM-KO,pert
Primary hepatocytes isolated from Donor 1 treated with DMSO for 24h,ctrl
tissue: minor salivary gland;	disease status: non-SS control,ctrl
cell line: RPMI8226;	cell type: Myeloma cells;	transduced with: shRNAs targeting luciferase (control),ctrl
sex: Male;	family: 2;	age: 30;	disease status: Affected;	tissue: Muscle: Deltoid,pert
Genotype: p38alpha KO;	Age: E15.5,pert
inflammatory Cardiomyopathy,pert
tissue: Biceps muscle;	patient: P.b.7;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
8 week old dy/dy dystrophic mouse diaphragm,pert
strain: C57BL/6;	tissue: liver;	genotype/variation: wild type;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,ctrl
n3_lo_4,pert
Tendon;Flexor-Pronator_Lesional,pert
Psoriasis-2 baseline,pert
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,ctrl
strain: C57BL/6J;	day: 15;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
tissue: Frontal cortex;	age: 95;	Sex: F,pert
XBP1s_B_cells_spleen_20 weeks,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
gender: female;	age (years): 36;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: control;	cell type: pancreatic beta-cell,ctrl
CD46+ hippo - Untreated-A,ctrl
tissue: whole whisker pad;	genotype: wild-type;	age: E12.5,ctrl
array type: Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
Disease_status: Down syndrome;	Age (years): 55;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
Murine liver,ctrl
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Female;	Age of onset (years): 33;	Duration of illness (years): 15;	Brain pH: 6.50;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
granulocyte RNA from healthy control,ctrl
genetic background: B6/129;	genotype: Tet2 KO;	cell type: Tet2 deficient CD150+ sorted LSKs,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 67,pert
gender: male;	age (years): 30;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
disease state: healthy control;	tissue: epidermis;	age: 43;	gender: male;	treatment: untreated;	time: control,ctrl
condition: Discoid Lupus;	patient: L8;	tissue: LS skin biopsy;	kit: Ovation,pert
MCF10A-HER2(+) 5days,pert
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T1N0,pert
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,pert
Age: 32;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: pre-UV,pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
"Patient  L, lesion, 4 week",pert
Mouse embryonic kidney,ctrl
"Patient  N, lesion, 12 week",pert
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 2,ctrl
"ACC3 cell line, Sox4 RNAi knockdown with lacZ as control",pert
"skin fibroblasts, passages #2 and 4",ctrl
strain: Swiss Webster;	treatment: Saline;	tissue: substantia nigra,ctrl
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
triplicate 3 of uninfected HepG2 HIF-1-/-  cells,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs cultured for another 12h,ctrl
gender: male;	individual: patient 1;	treatment: paclitaxel-eluting stent,pert
"Proximal, Small Intestine 21 days old",ctrl
Normal bladder biopsy,ctrl
"Cell type: neuronal, age:41, gender:female, diagnostic group: bipolar disorder, PMI:28h",pert
"SKO-transduced MEFs, Vc untreated, lysed on D8",ctrl
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 7;	Brain pH: 6.39;	Post mortem interval (hours): 48;	Side of brain: Left;	Fluphenazine mg. Equivalents: 9000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
duration of untreated disease in month:105.6;	age at onset:2.6,pert
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:35h",pert
patient E1796,pert
cell line: SW1736;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
"Mouse Sciatic Nerve, Diabetic Vehicle",pert
cell type: MEF derived stable cell line;	genotype/variation: Tet-off HA-Fbxl10,pert
"Hippocampus, naïve control",ctrl
cell line: T47D;	treatment: contol,ctrl
genotype/variation: wt;	age: E10.5;	tissue: whole eye,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep3",pert
Mouse female ES cells PGK12.1 after double RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-1 in PGK12.1.,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 84;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous adenoma (IPMA),pert
sex: Male;	Age: 1.5 months;	additional patient information found in Series supplementary file,pert
"Xenograft of Panc-1 (Human pancreatic carcinoma) cell line, in mouse",ctrl
pool of thyroids from 10 months old wild type mice,ctrl
Bone Marrow Healthy Donor,ctrl
age: 31;	sex: F;	disease status: Marfan subject;	Filter number: 36;	Usage number: 1;	Exposures: 4,pert
knockdown: siRNA-scrambled;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 151;	colon ratio (mg/mm): 2.52;	myeloperoxidase activity (u/mg): 1.06;	tissue: colon;	treatment: 5% DSS,ctrl
"K562, NoTreatmentControl, 24hrs, rep1",ctrl
KO mouse heart under basal conditions,pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 1 hour",ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, apical half;	age: postnatal day 16",pert
"Mouse, WT, colon, UT, rep1",ctrl
"ventricular myocardium, wild-type, saline, 24h",ctrl
14 with Cy5,pert
gallbladder-saline treated,ctrl
MPM tumor specimen 8,pert
Human sorted B cells,pert
unstimulated CD8+ T-cells from Wt C57BL/6 mice,ctrl
Rat Hippocampus,pert
cRNA;	embryonic day 18;	NFIA deficient,pert
"disease group: Atopic Dermatitis;	Sex: f;	age: 40s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 11.3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 430;	ige (kiu/l): normal (0-48.5 kIU/L): 319;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: pos",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.172;	OD280: 1.137;	Ratio: 1.87;	Dilution: 1:5;	RNA Integrity Number: 8.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 214;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: del5q plus other,pert
WT J1 ESCs on day 7,ctrl
treatment: DMSO;	time: Day1;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
"Male F344 rats, sacrificed at the age 18 weeks",ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 1,ctrl
Cell line,ctrl
genotype: T-ALL;	sample type: DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma);	genetic background: WT C57/BLACK6;	cell type: DP (CD4+/8+) cells,pert
U87 20 uM Temozolomide,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 38;	gender: male,pert
"+Rosi, -PPAR, 2hrs",pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: M,ctrl
tissue: non-lesional skin;	urticaria status: affected;	patient: 6,ctrl
postmortem brain,ctrl
"BOEC, not_at_risk 2",pert
9_1_MOE_430A_WT,ctrl
Pooled carious pulpal tissue,pert
"patient: 102;	current medication: Movicol 1 sachet daily;	birth date: 9/5/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: RIF pain, persistent anaemia.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: Yes,pert
H1299,pert
phenotype: control;	gender: male;	case_id: 507;	age: 52;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 32;	brain ph at time of freezing: 6.76;	labeling_batch: 2,ctrl
"Tibialis posterior, TMD",pert
"cardiac muscle, left ventricle",pert
normal sigmoid colon of adult,ctrl
"GI_canc, Col2",pert
Normal cervix_05-4959,ctrl
Human colon biopsies from UC patient with active disease (involved mucosa),pert
treatment group: untreated in parallel to arsenic treated cells;	cell line: TK6 cells,ctrl
sidroshaC-transfected sample,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 23 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
HeTH-4  THOC1-depleted,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 25;	maternal age: 24,pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
PS_IB_3_aa_lcm,pert
Nonirradiated-ATM-Ko Replicative3,pert
disease affected colon of an adult with ulcerative colitis (UC).,pert
"LCL GM19238, Kd IRF8, 72hrs",pert
cell line: ONS76;	cell type: medulloblastoma;	treatment: KDM5A siRNA;	transfectant: ONS76_si_KDM5A,pert
NORMAL #99-0694,ctrl
"Patient  C, lesion, 1 week",pert
8 wk old male mdx EDL,pert
strain: C57BL6/J;	genotype/variation: wild type;	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),ctrl
"Patient  J, lesion, 4 week",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
PancreaticSample19-Tumor,pert
"new born normal mice, cerebrum",ctrl
CONTROL;	Age = 22;	Sex = F,ctrl
"heart, control, 14 months",ctrl
epithelium from colon of HDAC2 KO mouse no.3,pert
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: tumor;	sample name: 2-tu1,pert
A SIT_B036,pert
race: caucasian;	age (years): 68;	stage: IA;	grade: 3;	histology: endometrioid,pert
Rapid progressing fibrosis,pert
affected status (disease state): IS patient;	gender: female;	age-at-examination: 54;	age-at-onset: 50;	geographical origin: Vila-Real;	clinical characteristics: Hypertension,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 37;	maternal age: 35,ctrl
cell type: embryonic stem cells;	genotype/variation: Satb1 knockout,pert
status: Rapid;	age: 48;	gender: male;	tissue: cultured human fibroblasts,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 41;	maternal age: n/a,ctrl
"Human LIMA artery from patient 5, treatment: paclitaxel-eluting stent",pert
pD  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
"Pancreatic tumor cells, replicate 1",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.37808,pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
Human cell line,ctrl
tissue: liver;	gender: female;	disease status: type 2 diabetes,pert
"famale Sprague-Dawley rat, 4-hydroxyphenylretinamide, 782 mg/kg diet for seven days, tissue: liver",pert
T4.02,ctrl
tissue: Biceps muscle;	patient: P.b.1;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
Brain from 59 days Npc1+/- mouse1,ctrl
Breast_cancer_cell_line,ctrl
liver tissue from 21 days old mice,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,ctrl
cell type: Anaplastic thyroid carcinoma;	expression: HTH83 SCR shRNA;	cell line: HTH83,ctrl
7 Day Mouse leg muscle,ctrl
mouse bladder,pert
"12 weeks anterior prostates, Pten deletion",pert
melanoma cell line,pert
KO striatum Veh,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr.",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: UK;	sex: Male,ctrl
disease state: normal (control);	tissue: liver,ctrl
race: caucasian;	age (years): 80;	stage: IC;	grade: 2;	histology: endometrioid,pert
Tissue: endothelial cells,pert
brain tumor tissue,pert
tissue: Brain;	genotype: Npc1-/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,pert
Capan2 cells transduced with control lentivirus,ctrl
B_cell_pool_melanoma_M11+M12,pert
patient: 29;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
Placental tissue from late onset Preeclampsia,pert
strain background: C57BL/6N;	genotype/variation: Stat1 KO (ko);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
homozygot FH P261 (human CD3 positive T cells),pert
age: 5;	sex: F;	disease status: control subject;	Filter number: 80;	Usage number: 1;	Exposures: 2,ctrl
dermal fibroblast from healthy control,ctrl
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,ctrl
wild type mouse,ctrl
alveolar macrophages obtained from bronchoalveolar lavage,pert
tMLL04,ctrl
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 151;	time: 0;	batch: 1,pert
EB_0_8d_66_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
B_cell_pool_healthy_H03+H04,ctrl
"male sprague-dawley rat, 21 days saline",ctrl
LNCaP-LM xenograft control,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.124;	OD280: 0.574;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 212;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-7;	Primary Site:Floor of mouth;	Age:48;	Sex:M;	TNM:;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
Sample: alpha-TM180;	Replicate: 2;	Pool: NP,pert
"27B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,ctrl
Array Type: HG-U133A_2;	Ratio: 2.04;	RNA Integrity Number: 9.6;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Age: 55;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: Yes,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
"63B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Control,ctrl
Patient 6 appendix,pert
disease: AML;	bcor mutation: BCOR mutation;	karyotype: normal karyotype,pert
race: caucasian;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
"skeletal muscle, quadriceps",pert
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: control,ctrl
CA1 hippocampus,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
"Frontal Cerebrocortex, deltamethrin (1 mg/kg), 6 hours",pert
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 1,pert
Whole skin tissue,pert
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,pert
chip number: 15;	transfection plate: 3B;	target gene: ZBTB38;	kd level: 0.65;	rin: 9.6;	transfection date: 2012-03-26,pert
CD11b+Gr1+ cell sample_5 (derived from wild type mouse),ctrl
strain: B6; gender: mix; age: 0-2d; tissue: calvariae; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
A HID U_B053,pert
Adipose tissue,pert
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 25;	maternal age: n/a,pert
"TIG3 diploid lung embryonic fibroblasts, background.",ctrl
ES cells,pert
cell line: MCF-7 breast cancer cell line;	agent: SFM (control);	time: 24hr,ctrl
disease state: homozygous Nxnl1 null;	strain: BALB/c AJ,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,pert
subject id: 36;	infection: DENV;	status: DF;	tissue: whole blood,pert
Germinal center B-cells,ctrl
Peripheral blood mononuclear cells;	TTF=119min;	Race=White;	Sex=Male,pert
P16_WT_pancreas_rep2,ctrl
glioma cell line,ctrl
HEK293T cell line,ctrl
peripheral blood from E12.5 Cbfb+/+  embryos,ctrl
HaCat cells infected with a control lentiviral construct. Replicat 3,ctrl
depression,pert
"10 days old normal mice, cerebellum",ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, mock (24h post-infection)",ctrl
"seminoma specimen, pT2, patient age: 40y",pert
treatment: 1 ug/ml doxycyline;	time: 96 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
sex: Male;	Age: 3 months;	additional patient information found in Series supplementary file,pert
Parkinson's Disease;	female,pert
Y HID_B037,ctrl
"differentiated U937 cells, 1uM curcumin treated, 4h",pert
gentrap derived AB2.2 ES cell,pert
"DMSO-treated, sham UV exposed",ctrl
tissue biopsy of normal skin from healthy control,ctrl
"Benign, prostate tissue",ctrl
chip number: 16;	transfection plate: 4;	target gene: IRF5;	kd level: 0.63;	rin: 9.3;	transfection date: 2011-10-17,pert
Insm1 control #9_pituitary gland,ctrl
tissue: lymph node;	genotype: Dicer KO;	cell type: CD4+CD62L- resting T cells,pert
CD34+/CD38-,pert
duration of untreated disease in month:1.1;	age at onset:4.7,pert
WT Non stim 1,ctrl
triplicate 2 of uninfected HepG2 HIF-1-/- cells,pert
Patient: B;	Time: 1 week;	Group: non-responder;	Condition: lesional,pert
subject: 2828 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
"SBC-5 cells, siEGFP (control), 72 hr after siRNA, duplicate sample 1",ctrl
DLBCL_FOXP1 siRNA,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.301;	OD280: 0.666;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 136;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"BT474 breast cancer cell line, lapatinib",pert
age: 45;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
ST045849 12 hours_1,pert
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
"primary cortical neurons, MEF2D shRNA",pert
tissue: oropharyngeal carcinoma KB,ctrl
Tendon;ECRL_Non-lesional,ctrl
Atxn1L null murine HSCs,pert
"female,20,Caucasian",pert
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 24;	maternal age: n/a,ctrl
sampleID: SAM630141;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
Gastrocnemius muscle mRNA from young (10 week old) knock-out mice,pert
"H1 hESCs, OE-OCT4",pert
EA_SLE_CD20,pert
"Frontal cerebrocortex, permethrin (100 mg/kg), 6 hours",pert
UACC903 cell line,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 6 months,ctrl
"embryonic stem cells, KD replicate A",ctrl
Mouse striatum,ctrl
"KPL4, Untreated",ctrl
G93A mouse 802,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: RNAi-1B,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 73;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
strain/background: C57BL/6;	genotype/variation: Wnt7aCre+;Esr1f/f (uterine epithelial ERα conditional knockout);	age: 8-10 weeks;	gender: female;	tissue: uterus;	treatment: saline;	time point: 24h,pert
Breast_cancer_cell_line,pert
AT2 E/R positive leukemia cell line,ctrl
FcgKO Non stim 1,pert
cell type: Human melanoma cell line;	cell line: M249_R4;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
liver sample group: : Alcoholic hepatitis,pert
patient: 28;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
subject: 12V;	cohort: 12;	tissue: Biceps;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
0-day rat ovary cultured 2 days,ctrl
pancreatic cancer cell line MiaPaCa2 containing empty vector pCEP4,ctrl
"Wt mouse, cerebellum, standard diet supplemented with resveratrol ad lib",pert
Gender: F;	Age: 49;	Tissue: Mucosa,pert
gender: F;	age at blood draw: 49;	tissue: whole blood,ctrl
"Granulosa Cell, 44-46hr PMSG",ctrl
Dot1l -/- day 3 after transduction with cre,pert
"H1 hESCs, SOX2 shRNA",pert
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Wild type,ctrl
tissue: brain;	genotype: mutant 14-3-3 ko/ko inbred;	age: P0,pert
NK_cell_pool_healthy_H11+H12,ctrl
S6B Sporadic-cerebellum,ctrl
"Human male subjects with familial combined hyperlipidemia  after treatment with atorvastatin (ATV), peripheral blood monocytes",pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 27;	gender: male,ctrl
train: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: control shRNA,ctrl
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,pert
"ERRA WT ventricle, baseline",pert
tissue: Primary human lung fibroblasts;	treatment: Formoterol;	patient: 1;	time: 3h,pert
"CD14+ monocytes, by positive selection",pert
B-CLL PB P271,pert
PS_IB_3_cauc_lcm,pert
"diet: AIN-76A;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"68B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"PCOS, biological rep 1",pert
"Heart, MAT1 CKO, 4 wk, sample 5",pert
"Gender: Female, Age: 25, BMI: 32, Tissue: luteinized cumulus cells",pert
"gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"Heart, MAT1 CKO, 4 wk, sample 4",pert
"strain background: C57BL/6J;	genotype/variation: IRF4 +/-;	tissue: spleen;	cell type: Naïve CD4+, CD62L hi, CD25 - T cells;	differentiation condition: Th17;	timepoint: 42 hrs",ctrl
"Epidermal keratinocytes untreated control, 1h",ctrl
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: +Dox,pert
MelJuSo cell line,ctrl
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  2",pert
HEK293 cell line #6 with uninduced HNF1beta mutant A263insGG,ctrl
CD8_T_cell_pool_healthy_H01+H02,ctrl
"lymphoblastoid cell line from T21.01, one out of seven of insensitive group, 50*10e6 cells",pert
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: WT;	Tissue: brown fat ,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 19.666;	Ratio: 2.14,pert
hepatocellular carcinoma cell line,ctrl
PancreaticSample23-Tumor,pert
wt_TGFb_24hr_2,ctrl
"34B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
CON - R21,ctrl
tissue: white blood cells;	age: 13;	Sex: male,ctrl
Mouse_E14 ES cell_Undifferentialted,ctrl
patient: 228;	current medication: None;	birth date: 11/22/48;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/80;	diagnosis date: 1/1/82;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 1/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Migraines;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
PDAC_P_105,ctrl
gender: male;	strain: C57BL/6J;	genotype/variation: Scd1flox/flox (Lox) control;	tissue: Dorsal skin;	age: 8-9 wks old,ctrl
"age at diagnosis: 68;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3;	er: 0;	pgr: NA;	dfs-month: 5;	dfs-event: 1;	distant metastasis: 1",pert
sample 1:;	age: 41;	gender: male;	sample 2;	age: 66;	gender: female,pert
TOV112D cells_treated with NSC319726,pert
TLR4 null sham kidney,pert
Sample ID: TP21;	Twin Pair ID: CCE1.1;	Clinical Status:  Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 22;	Current Age (2007):25;	Sex: FEMALE;	Medication at blood sampling : Epilim,pert
HCC_28T,pert
"LCL GM19238, Kd BATF, 72hrs",pert
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 48 hours,ctrl
"Undifferentiated Dicer +/- ES cell line, passage 20",ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
"Sv129/C57B6 intercrossed hybrid line, 12 week old male",ctrl
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Lesional,pert
"Normal cervix, commercial_Ambion",ctrl
MEFs were treated with an nonspecific adenoGFP virus.,ctrl
Mouse heart with no DOX treatmeant,ctrl
mouse TMJ-cartilage from wild type mouse WT_Tal3,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 63;	donor: 20;	disease state: Lesional,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.02;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: non-treated;	tissue: liver,pert
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Tongue;	age: E14.5;	gender: Not determined,ctrl
malignant tissue_TMPRSS2:ERG fusion negative,pert
coc-14,pert
"LCL GM19238, Kd NFYC, 72hrs",pert
"Cell type: neuronal, age:34, gender:male, diagnostic group: control, PMI:22h",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT20,ctrl
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
patient: 30068;	sample: normal,ctrl
normal lung,ctrl
cell line: NB4;	genotype: TG2 knockout;	treatment: untreated;	biological replicate: 2,ctrl
ONH moderate glaucoma,pert
C57BL6,pert
MCF7,pert
tissue: liver;	gender: male;	disease status: normal glucose tolerance,ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 8hr,ctrl
Male wild-type (C57BL/10SnJ) mice were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,ctrl
age: 50;	sex: M;	disease status: control subject;	Filter number: 89;	Usage number: 1;	Exposures: 3,ctrl
F1.02,ctrl
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,pert
age_years: 47;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
Time:3 day; condition:LaminA ko;,pert
cell type: Melanoma cell line;	cell line: A375,ctrl
cell type: Primary hepatocytes;	donor: 1;	agent: Wy14643;	time: 6h;	gender: Male;	age: 63 years old,pert
"fetal testis sample 19, 20 weeks gestation",pert
hippocampus,ctrl
CTCF-depleted oocyte,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,ctrl
Sample ID: TP17;	Twin Pair ID: CCN2.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 27;	Current Age (2007): 30;	Sex: MALE;	Medication at blood sampling : None,ctrl
"4 weeks normal mice, cerebrum",ctrl
genotype/variation: Vax2-/-;	age: P8;	tissue: Whole eye,pert
"24hr non-specific siRNA, 16hr vehicle treatment replicate 2",ctrl
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),ctrl
tissue: heart;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
SKI-DLCL cells untreated,ctrl
Mouse Bone Marrow,ctrl
cell line: HEK-293;	genotype: NOD2 wt;	stimulation: Muramyl-dipeptide (MDP) 10 µg/ml;	time point: 0 h,ctrl
cell line: HEK293;	genotype/variation: tranfected with pEGFPN3,ctrl
Psoriasis-10 baseline,pert
siOGT 24 hours_1,pert
Wildtype mice,ctrl
Disease_status: Down syndrome;	Age (years): 56;	Gender: Female;	Post mortem interval (hours): 6;	Braak stage: VI;	Cause of death: Unknown,pert
"Neural precursor cells derived from hES cells line SA01, biological replicate  1",ctrl
Thymus,pert
HT29 derived clone with 2 vectorS expressing CD24 directed shRNA,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: WT,pert
Primary chondroyctes; Wt; Ago2-IP,ctrl
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 2,ctrl
"patient: 103;	current medication: None;	birth date: 6/30/65;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/9/04;	indictation for procedure: Diarrhoea, now settled, Mum has UC;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
c-Kit + MA9 AML Zfx KO,pert
disease: Down syndrome;	gender: female;	age: 1 year and 6 months;	tissue: thymus,pert
Rat spinal dorsal horn,ctrl
unstimulated CD3+ T-cells from Wt C57BL/6 mice,ctrl
tissue: blood;	control: 4;	gender: male;	age: 26,ctrl
Pooled normal myocardium sold commercially,ctrl
Melanoma cells,ctrl
At Risk: +;	Age: 4;	Sex: F,pert
Female - caucasian - N-08-G,pert
status: Normal;	age: 58;	gender: female;	tissue: cultured human fibroblasts,ctrl
"midbrain,18month,WT",ctrl
early to medium response after cadmium treatment,pert
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 months old;	Tissue: cochlea;	For additional details about the strain used please refer to the following r;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
Human skeletal muscle biopsy sample;	Patient #80 with PM,pert
rd1 mouse retina at age postnatal day 4,pert
Mouse male ES cells WD44 after single RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-1 in WD44.,pert
lrrk2 genotype: GS / GS,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 24;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: DMSO for 48h,ctrl
cell line: MDA-MB231;	treatment: control shRNA;	media: DMEM,ctrl
"AZ521 dnSox2 cells, uninduced, 8h",ctrl
human endothelial cells isolated from postmortem dorsolateral prefrontal cortex,pert
"Heart, MAT1 CKO, 2 wk, sample 1",pert
lrrk2 genotype: GS / WT,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: lentivirus carrying shRNAs targeting LLGL1 transcript,pert
HUVEC control,ctrl
wild type; 10 months,ctrl
6 h-apra-10 nM,pert
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
Extract:LOX-1:213401;	Extract Description:LOX1_Untreated_12hr:213401;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.05;	Quality: Defective Area (%):0.27;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.51;	Quality: Background Mean Dev.:0.52;	Quality: Absent (%):56.98;	Quality: Absent (%) Dev.:0.98;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.12;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295773,pert
iTreg,pert
"NB4 cell line, wild-type, ATRA, 48hr",ctrl
strain: Myd88 KO;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 215,pert
patient: 51721;	sample: tumor,pert
CD71+ bone marrow cells from Ifng-/- mouse 1,pert
tissue: Frontal cortex;	age: 81;	Sex: F,ctrl
cell line: Normal bone cell line 695;	phenotype: RB1 knockdown;	cell type: human osteoblast (hOB),ctrl
"ID: MLL_00252;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 1h EGF,pert
The caudate nucleus from an XDP Filipino (aged 52 yr) .,pert
HEK293 cells,pert
saline injected mouse lung,pert
genotype: Sox3 null;	cell line: R1;	cell type: Embryonic stem cells differentiated into neural progenitor cells,pert
"mouse back skin, wild type",ctrl
MCF-7_DMSO,ctrl
NBD inhibitory peptide-treated CEM 100mM 16h,pert
age: 49;	sex: F;	disease status: control subject;	Filter number: 96;	Usage number: 1;	Exposures: 3,ctrl
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: 500nM PLX4032 for 16 days,pert
"Tissue: peripheral blood, Subject:Healthy Control",ctrl
chip number: 9;	transfection plate: 1;	target gene: E2F1;	kd level: 0.78;	rin: 9.9;	transfection date: 2011-03-29,pert
"liver, PPAR KO_ctr_116",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep2",ctrl
patient: 51315;	sample: tumor,pert
"Fetal lung, CD-1 background",ctrl
"brain, knock out",pert
A39 NES 142Q TG1	F5/51	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Female,pert
Brain BA10 post-mortem schizophrenic,pert
Mouse heart,pert
"BOEC, normal 6",ctrl
IRAK2 KO macrophages stimulated with MALP-2 for 2 h,pert
triplicate 1 of uninfected HepG2 HIF-1-/- cells,pert
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 1;	age: Post natal day 3-7,pert
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: Map3k7CreER;	treatment: tamoxifen,pert
Diagnosis: AML M2;	Age: 44y ;	Gender: Female;	Blast %: 75;	Source: BM;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
RV63.12_CHF_day19,pert
Total RNA from cervix,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 55 days;	subject: Mouse1;	genetic background: BALB/c,pert
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: DMSO (Vehicle);	treatment time: NA",ctrl
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep2",ctrl
RNA from whole tissue section of case 871 labeled with Cy5,pert
infected MBT/Pas fibroblasts (9 h post inf),pert
involved skin from cases,pert
cell type: Mouse embryonic fibroblasts (MEFs);	genome/variation: Wt1-null,pert
Sprague-Dawley Rat (male),ctrl
"SBC-5 cells, siEGFP (control), 24 hr after siRNA, duplicate sample 2",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.50137,pert
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
treatment: TRAF6 knockdown,pert
Tissue: tumor; Gender: male; Age:42  Tumor stage: T3NxMx,pert
RNA from microdissected breast cancer cells from case 829 labeled with Cy5,ctrl
RNA from whole tissue section of case 374 labeled with Cy5,pert
"LNCaP cells, treated with R1881, biological rep 3",pert
cell line: Y79;	passage: 25;	cell type: Retinoblastoma,pert
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 35;	maternal age: 24,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 6h",pert
status: Control;	gender: Female;	age: 53;	tissue: Blood,ctrl
"differentiated U937 cells, ROS exposed, 4h",ctrl
"Polyamide 1 treated LNCaP cells not stimulated with DHT, biological replicate 2",ctrl
"ID:c 1-2, Genotype=(C57BL/6J), Treatment= none",pert
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 6s,pert
T151,pert
status: Rapid;	age: 66;	gender: male;	tissue: cultured human fibroblasts,pert
cell type: Transcriptional 2 Follicular Progenitor (T2-FP) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
"Patient  K, lesion, 12 week",pert
control rep 3,ctrl
"129P3/J Chronic morphine treated, biological replicate 1",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 28, stage IIIB, HPV 45",pert
Septic shock;	gender: Female;	Survivor;	organism: Neisseria,pert
Brain from 25 days Npc1-/- mouse1,pert
SV cells isolated from inguinal White adipose tissue,pert
cell line: U937;	replicate: Replicate2;	treatment: shSYK_1,pert
disease state: normal;	age: 20 weeks;	tissue: ventral prostate;	strain: FVB,ctrl
"Ls174T, β-catenin siRNA, uninduced",pert
mouse: 2;	strain: C57Bl/6;	genotype/variation: Wild-type;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,ctrl
left hippocampus of control mice,ctrl
tissue: amnion;	cell type: mesenchymal;	agent: vehicle;	time: control,ctrl
E18.5 E-cadherin cKO,pert
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, mannitol (5% final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.226;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 223;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of saline for one week,ctrl
RKO cells transfected with HSF1 Stealth siRNA treated 6 h with DMSO 0.5%,pert
heart of male mouse subjected 2 week to chronic intermittent hypoxia.,pert
RPMI8226_shKLF2A#2,pert
Cervical cancer_CC126,pert
agent: 0.03% ethanol (control);	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,ctrl
NORMAL #99-0739,ctrl
chip number: 17;	transfection plate: 6;	target gene: NS;	kd level: NA;	rin: 9.1;	transfection date: 2012-03-26,ctrl
female heart 10 days post pbs injection,ctrl
human ccRCC cell line,pert
tissue: blood;	patient: 7;	gender: male;	age: 25,pert
cell line: HSC-3;	cell type: human tongue squamous cell carcinoma;	genotype/variation: overexpressing trypin-2,pert
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Caucasian,ctrl
"age at diagnosis: 40;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 47;	dfs-event: 0;	distant metastasis: 0",pert
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 2;	age: Post natal day 3-11,pert
genotype/variation: c-Myb deficient;	age: 4-5weeks,pert
MCF-10A_shATR-3,pert
40A;pretreatment;female;breast tumor,ctrl
cell line: A549;	cell type: Lung adenocarcinoma,pert
KRAS expression uninfected,pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
disease affected colon of an adult with Crohn's disease (CD). Replicate-2,pert
"thymus, DS",pert
"age at diagnosis: 62;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 1;	dfs-month: 37;	dfs-event: 0;	distant metastasis: 0",pert
HCC_21N,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.9;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
MPM tumor specimen 30,pert
2102Ep cells transfected with Ambion Silencer Select Negative Control #1,ctrl
"Spinal Cord, Epicenter (~T8)",pert
whole lung,pert
cell line: D3;	treatment: scrambled,ctrl
cell line: SNB19;	transfection: PARK2 siRNA#2,pert
Human skeletal muscle biopsy sample;	Patient #133 with NORM,ctrl
Mouse palatal shelf tissue at E14.5,pert
total cellular RNA from Jurkat T cells,ctrl
dy/dy mouse,pert
"Mouse liver, GNMT knockout, hepatocellular carcinoma, 8 months",pert
subject: 18;	disease: TD;	muscle: GR;	gender: F;	age: 17.4;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"Pancreatic islets, VhlhKO, 02",pert
"Pancreatic islets, VhlhKO, 01",pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: trachea;	donor sex: female,pert
cell type: late passage (LP50) LNCaP,pert
age: 63;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Striatum of 6-10 week old C57BL/6J mice,pert
Normal Pleura 3,ctrl
chip number: 22;	transfection plate: 5;	target gene: STAT2;	kd level: 0.64;	rin: 9.2;	transfection date: 2011-10-17,pert
MCF-10A_shATR-4,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 60 yr;	population: white,ctrl
"acutely admitted, severely psychotic schizophrenia patient",pert
Strain: C57BL/6;	Genotype: AMPK gamma3 mutant (R225Q) transgenic;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,pert
source tissue: lung;	strain: Insig1 ∆/∆ /Insig2 -/- (AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,pert
Normal cervix_05-1308,ctrl
Human cell line,pert
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
"FACS-sorted cones, P50 wild type mice",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#122,pert
strain background: B6/C3H;	genotype/variation: wildtype;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),ctrl
47A;pretreatment;female;breast tumor,ctrl
bone marrow cells,ctrl
"Mouse embryonic stem cells, day 0, wild type",ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 4",pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 6 weeks post infection 20 cercariae,pert
sirt7 allele: knock-out,pert
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: Brg1,pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 64;	gender: female;	tumor grade: IV,pert
EGFR+EGF_2,pert
whole kidney from KO mice,pert
GNMT-KO mouse hepatocytes,pert
"Whole embryo, E9.5",ctrl
genotype/variation: control;	tissue: skin;	age: 32 days;	sex: male;	strain: C57BL6 X DBA2,ctrl
wild type mouse retina at age postnatal day 8,ctrl
HCC_2T,pert
disease state: hepatocellular carcinoma;	cell type: Peripheral blood mononuclear cells,pert
Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours;	Treatment: D-penicillamine 150 mg/kg by oral gavage,pert
strain: C57BL6;	genotype: PDE10A KO;	tissue: striatum;	treatment: vehicle control,pert
Diabetic F344 RAT penis,pert
cell line: L428;	treatment: Mifepristone + 5-aza-2′-deoxycytidine + Trichostatin A (MAT);	duration of treatment: 5 days,pert
normal skin sample,ctrl
"Neural precursor cells derived from hES cells line VUB01, biological replicate  2",ctrl
alveolar macrophages obtained from bronchoalveolar lavage,ctrl
Cervical cancer_1900T,pert
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 19.1, Strain:DBA/2J",ctrl
background strain: C57Bl/6;	genotype/variation: Notch1 knockout,pert
intestinal crypt cells isolated by laser capture microdissection,pert
"LNCaP cells, treated with R1881, biological rep 1",ctrl
strain: C57Bl/6;	genotype/variation: : control ROSA(N1IC) mice (NICD wild-type),ctrl
sex: Male;	family: 5;	age: 39;	disease status: Control;	tissue: Muscle: Biceps,ctrl
Squamous cell lung cancer patient 35,ctrl
HLA risk: Medium;	Height: 124.8 cm;	Weight: 26 kg;	BMI: 16.9;	Age: 7.21 years;	Gender: Female;	Race: White;	Glucose: 180 mg/dl;	HbA1c: 7.5%,pert
MCF7 cells,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).,pert
"Trained mice, time point 1 week",ctrl
T44,pert
Supraoptic nucleus_1d dehydrated,pert
Whole testis RNA from WT mouse #80 at 0h,ctrl
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 3,pert
"Patient  I, lesion, 4 week",pert
U937-derived cell line harboring TRIPZ-shRNAmir TetOn cassette (clone ID: V3THS-381738),ctrl
oligoarthritis,pert
"gender: Female;	age: 87;	post-mortem delay: 5.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Gastrocnemius muscle for transgenic mouse overexpressing PPARalpha in a skeletal muscle-specific manner,pert
appendix sample removed from patient who went to the operating room with the diagnosis of acute appendicitis,pert
genotype: HDAC6 knock out,ctrl
Sex: female;	Age at operation: 70 years;	Site: thorax;	Size in cm: 1.9x1.3x1;	Histological Subtype: pleomorphic liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: residual tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
"10 week, mutant;	SOD1(G93A)",pert
patient E1546,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 42.82192,pert
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
R6_Pseudomonas_wildtype_48,ctrl
Sprague Dawley rats;	Gender: male;	Weight: 250-350 g,ctrl
"cervical cancer, SiHa, squamous cell cancer",pert
Patient  22 appendix,pert
"Hematopoietic stem and progenitor cells (LineageLow, Sca1+, Kit+; LSK)",ctrl
MPM tumor specimen 12,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: wild type;	agent: control,ctrl
cell line: THP-1;	disease state: monocytic leukemia,ctrl
A HID B_B010,pert
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 30 days;	tissue: retina,pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.9;	colon weight (mg): 167;	colon ratio (mg/mm): 2.11;	myeloperoxidase activity (u/mg): 0.088;	tissue: colon;	treatment: 5% DSS,ctrl
Brain from 62 days Npc1+/- mouse1,ctrl
T30,pert
tissue: prefrontal cortex from adult APPsa knock-in mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,ctrl
TG mouse lung,pert
"Liposarcoma culture from tumor 399, doxorubicin treated",pert
IL22KO_T. gondii-infected_5dpi_ileum,pert
"F348, WBS, skin fibroblasts",pert
"disease group: Psoriasis;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 3;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 110;	ige (kiu/l): normal (0-48.5 kIU/L): 31.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg / positive to Strep. Viridans",pert
strain: Sprague-Dawley;	cell type: aortic valve interstitial cells,ctrl
Igf1 -/- mouse vestibular organs at embrionic stage E18.5,pert
cell type: B220+ cells from preB colonies;	genotype/variation: Hspa9+/-,pert
Clcn5 knockout in proximal tubules of mouse kidney,pert
"4 weeks old PS-NA mice, cerebrum",pert
"brain, frontal cortex",ctrl
MCF-7 breast cancer cells,ctrl
Pax6 negative retinal progenitors,pert
RV64.04_CONTROL_day25,ctrl
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 59.88 nM (EC50).,pert
CD11b+Gr1+ cell sample_1 (derived from IL17RC Knock out mouse),pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 1",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 75min;	race: White;	sex: Male,ctrl
strain: 129SV;	gender: female;	age: 10 months;	tissue: right ventricle;	genotype: wt,ctrl
cell type: WAO9 human embryonic stem cells;	growth protocol: subjected to a hepatic differentiation protocol;	time: d15,ctrl
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Ileum",pert
26 weeks male,ctrl
Eed KO BM LT-HSC,pert
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 718,pert
"liver, fed Western diet for 20 weeks",ctrl
MHC-I-positive microdissected myofibers,pert
Colorectal cancer cell line HT29,ctrl
3T3 cells,ctrl
Wild type embryo yolk sac,ctrl
"Patient  O, lesion, 2 week",pert
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: BRAF inhibitor PLX4032 (Vemurafenib),pert
"TNFa-OMe-P siRNA-C, replicate 6",pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 3,ctrl
"BioBreeding DR+/+ rat, day 65, mast cells derived from pancreatic lymph node.",ctrl
cell line: HUVEC,pert
tissue: lung;	lung source: routine lung volume reduction;	phenotype: healthy;	gender: unknown;	age: unknown,ctrl
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: monuron 72 hr,pert
"Patient CCo, stable renal transplant recipients, male, 38 years old, T0 (time of enrollment)",ctrl
"Lymphoblastoid cell lines derived from family 1733, member 2",ctrl
lungs were over expressing nmyc-gfp fusion protein using the lung surfactant  c promoter.,pert
sample: #15;	subject: Control case #5;	brain: T-2017;	age: 74;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
wild type control tissue  2,ctrl
R1 ES cells expressing mouse Cdx2 T2ER fusion,ctrl
28 Day Mouse extraocular muscle,pert
12 h-apra-10 nM,pert
heart from non-transgenic mice,ctrl
Ribavirin Treated Cells 3,pert
agent: untreated;	time point: 0 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.236;	OD280: 1.154;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 374;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
strain: C57Bl/6;	genotype/variation: WT;	cell type: cDC;	cell type subset: CD11b+,ctrl
"tissue: whole brain;	strain: C57BL/6J;	genotype/variation: Sarm1-/-;	age: 8 weeks, 5 days;	infection: 107 pfu of VSV-Indiana strain",pert
hippocampi pool from 3 SHA rats,ctrl
"control + L-Arg colon tissue, biological rep1",ctrl
patient id: 1524;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
cell type: Primary hepatocytes;	donor: 3;	agent: control;	time: 6h;	gender: Female;	age: 70 years old,ctrl
"treatment: diclofenac;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
"Right brain hemisphere ,C57BL male mouse,Clozapine treated,Orally,12 weeks",pert
age: 48;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
spleens from mice on C57/Bl6 x 129 Sv background,pert
individual: Control9;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.732;	OD280: 0.907;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 138;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"ES cells: E14 (129P2/OlaHsd background), Genotype: Knockout (Phgdh-/-), C57BL/6J background, Gestation: 13.5 days, Tissue: head",pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 4,pert
R6_Pseudomonas_wildtype_422,ctrl
"LY2 cell line, SRC-1 scrambled untreated, biological rep4",ctrl
T81,pert
HCC_18T,pert
SV589_3DayKD_SerumStarved,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 40,pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,ctrl
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,ctrl
normal lung tissue,pert
"lung adenocarcinoma, cell line",pert
"Gender: female, Age: 48 years, Tissue: VIN 3",pert
PancreaticSample35-Normal,ctrl
Normal cervix epithelium_CaCX3,ctrl
"Spleen homogenate, infected, 6 weeks",pert
"maternal exposure to dioxin, pitM",pert
Celecoxib_#4874,pert
chip number: 15;	transfection plate: 3A;	target gene: SP3;	kd level: 0.62;	rin: 9.6;	transfection date: 2012-03-26,pert
tissue: Hippocampus;	age: 88;	Sex: F,pert
Embryonic fibroblast isolated from mouse,pert
sMPNST cells treated with vehicle (DMSO),ctrl
MCF10A 1.5days,ctrl
tissue: spleen Ter19+CD71high sorted cells;	genotype: Rb KO;	age: 3-month,pert
agent: Chromium 10 µM,pert
RNA from microdissected breast cancer cells from case 843 labeled with Cy5,pert
MLL_00248,pert
LNCaP cells treated with R1881 and control shRNA,ctrl
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Female;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
age: 40;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: siDsRed;	cell line: HeLa,ctrl
age: 14;	sex: M;	disease status: control subject;	Filter number: 97;	Usage number: 1;	Exposures: 3,ctrl
patient id: 83;	tissue: Normal cortex;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
"sebocyte cell line, SV-40 immortalized, ethanol treated",ctrl
"lymphoblastoid cell line from F1.02, one out of seven of sensitive group, 50*10e6 cells",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: other,pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	2nd technical replicate,pert
cell line: LKR13,pert
wild type primary mef,ctrl
STAT6 KO bone marrow-derived macrophage,pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 4 hours,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 62;	donor: 12;	disease state: Non-lesional,ctrl
Female - caucasian - E-04-M,pert
"BOEC, normal 1",ctrl
"Age: 3 months, Sex: Female, Retina: left, Final IOP (mm Hg): 15.3, Strain:DBA/2J",ctrl
tracheal tissue,ctrl
"TGCT cell line 2102Ep/clone 2A6, treated 3 days with retinoic acid, undifferentiated",pert
Age: 42;	Cycle: NA;	BRCA1/2 mutation: BRCA1 3875delGTCT;	Family History: No,pert
21dpp Ubb knockout testis,pert
NPCs derived from patient with schizophrenia,pert
race: african american;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
(ca)MEK_1,pert
cells: spleen marginal zone B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.905;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 53;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
genotype: MBD2–/–;	genetic background: Balb/c;	cell type: Regulatory T-cells CD4+CD25+,pert
siRNA-3-PLASTIC,ctrl
quiescent ulcerative colitis,ctrl
C2C12 myotubes,ctrl
Mouse: strain C57,pert
cell line: MCF7;	condition: Estrogen,ctrl
strain: FVB/N;	genotype/variation: Bmpr2-delx4+ mutation;	cell type: pulmonary vascular microendothelial cells (PMVEC),pert
cadmium_08hr,pert
"heart, middle septum",ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 1,ctrl
treatment: Sirt1 siRNA Knockdown 2;	cell line: Caco-2,pert
wild type; 2 months,ctrl
RNA from whole tissue section of case 772 labeled with Cy5,pert
injury stage: Sham 60 days;	gender: male;	strain: Wistar,ctrl
Strain: C57BL/6;	Gender: mixed;	Age:E9;	Tissue: whole embryonic body  ,ctrl
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Good-responder).,pert
Embryonic stem cell,ctrl
primary mouse embryonic fibroblasts,pert
HVS-CD4-control_unstim,ctrl
cell line: OSE4;	knockdown: ARID1A;	cell type: ovarian surface epithelial cells,pert
"BOEC, not_at_risk 9",pert
Patient identifyier: B;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 15 years;	Body surface area: 6 percent;	Overall erythema: severe;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
C4_CLP_wildtype_8,ctrl
"P10 mouse back skin, ADAM17 cKO",pert
human pluripotent cells,pert
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 16 hrs,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:58;	Sex: female, male:female;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
Total RNA from Ph+ ALL (C57Bl6),ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 72h,ctrl
Postmenopausal female. Estradiol treated. Patient 28.,pert
B_cell_pool_healthy_H05+H06,ctrl
transduced NIH-3T3 cellline,pert
cell type: Primary hepatocytes;	donor: 6;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
strain: 58;	Disorder: normal;	Condition: no hydrocortisone,ctrl
gender: Male;	tissue: Tendon;ECRB;	age: 55;	donor: 26;	disease state: Lesional,pert
strain: 129SV;	gender: female;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
strain: C57BL/6;	Gender: male;	Age: 8-12 week;	nmMLCK-/-,pert
AJSHAM,ctrl
Lung of hemorrhaged animal 16h,pert
"genotype: Gata6-WT;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",ctrl
GC resistant clone C7H2-R19F2 treated for 6 hours with GC,pert
RNA from whole tissue section of case 317 labeled with Cy5,pert
"NALT infected with 90-226att, 24h, biological rep4",pert
HeLa cells with depleted BRCA1,pert
Irradiated-ATM-KO Replicative2,pert
chip number: 11;	transfection plate: 4;	target gene: RDBP;	kd level: 0.78;	rin: 8.9;	transfection date: 2011-10-17,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 14 months,ctrl
"postnatal 3~5 days, mixed gender, C57BL6/129 mixed background",ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: unknown;	tissue: GIST Tumor,pert
Subconfluent wild type primary mouse embryonic fibroblasts at passage 3.,ctrl
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 5;	Exposures: 3,pert
HCC_20T,pert
SD rat femur,pert
Skinbiopsy from patient with atopic eczema,pert
"hMSC-Tert, control siRNA, 2 days osteoblast differentiation",ctrl
Dilated cardiomyopathy,pert
"testis, knock out",ctrl
Hippocampus from mouse Rasgrf1 knockout,pert
"epidermoid carcinoma, cell line",pert
Vehicle 12 hours_2,ctrl
"ID:1-1, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
"Primary lymphoma cells, isolated from lymph nodes of Emu-myc,Suv39h1-/- mice and retrovirally transduced by Bcl2, untreated",ctrl
"Wt Gata4, Wt Gata6, heart, CRE transgenic, biological rep2",ctrl
WT CD80hi mTEC sample2,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 36;	maternal age: 36,pert
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
"cirrhotic liver, vehicle treatment",ctrl
"Endothelial control cells, passage 7",ctrl
Brg1 mutant 2 cell embryo rep1,pert
strain/background: C57/B6x129 mixed background;	genotype/variation: control;	age: 12.5 dpc;	cell type: mouse embryonic fibroblasts,ctrl
cell type: Primary neonatal keratinocytes,pert
"PMVEC isolated from mice carrying TetO7-Bmpr2-delx4, immortomouse and Rosa26-rtTA transgenes",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.007;	OD280: 0.497;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 67;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Male;	age: 82;	post-mortem delay: 19.5h;	ph: 5.8,pert
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"Normal cervix epithelium, Age 50",ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 39.807665982204;	age of psoriasis onset: 25,pert
"LY2 cell line, SRC-1 scrambled untreated, biological rep1",ctrl
Cultured human trabecular meshwork cells (passage 3) obtained from a donor with no known history of glaucoma. 58y/male/caucasian. Cause of death: cancer,ctrl
MLL_PTD07,pert
genetic background strain: C57BLKS/J;	tissue: Neuroretina;	age: 8-week old;	genotype: db/+;	phenotype: lean non-diabetic,ctrl
control HMEC,ctrl
Human colon biopsies from non-inflammatory control,ctrl
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: Vehicle Only;	treatment time: 3 Days,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.72329,pert
Brain (Inferior Olivary Nucleus)_control subject_#1,ctrl
human fibroblasts overexpressing progerin,pert
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage _3",ctrl
"DBA/2J Chronic morphine treated, biological replicate 2",pert
female;	33 yr old;	White,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 72h",pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
Dysf -/- TA mouse muscle,pert
PBMC normal sample RNA,ctrl
MPM tumor specimen 14,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 72,pert
"Patient  C, lesion, 2 week",pert
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 58;	dfs-event: 0;	distant metastasis: 0",pert
"cell line HCT-116, Ki-RAS-mutation, DNMT1 knockout, DMSO-treated",pert
"RNA from Cell line SLM2, mutant status WT, condition Treated with Sorafenib",pert
genotype: Tsc1-deficient;	cell type: CD8 naive cells;	genetic background: C57BL\6,pert
Liver_experimental mouse,pert
Age: 54;	Cycle: NA;	BRCA1/2 mutation: BRCA1;	Family History: Yes,pert
Backskin_Get1_e18,ctrl
Patient: M;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
"Ishikawa cell line, BPA, 1pM, 48hr",pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 1;	Exposures: 3,ctrl
control IgG,ctrl
patient E1566,ctrl
Neurointermediate lobe _control,ctrl
Disease_status: Healthy control;	Age (years): 55;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
27 weeks female,pert
strain: Gata4tm1.1Sad/J;	infection: Nuclear β-galactosidase;	culture: Growth medium,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
CD4+CD8+ double positive (DP) thymocytes 3h Dexamethasone(DEX) (final concentration 1E-07 M) treated,pert
mutant testis at 17dpp,pert
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 5 months;	genotype: Wild type,ctrl
human promyelocytic leukemia cells,ctrl
17beta estradiol: 30 pM,pert
patient: 801B;	disease state: LGSC;	component: Borderline,ctrl
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 6h;	gender: Female;	age: 5 months,pert
ID4+/+TCL1-tg spleen CD19+ B cells,ctrl
No_drug_#4870,ctrl
56 Day Mouse Diaphragm muscle,pert
patient: 249;	current medication: Azathioprine 150mg Salazopyrine;	birth date: 1/12/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/90;	diagnosis date: 3/24/90;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/8/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 4/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
normal liver tissue,pert
"14B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
E18.5 Embryonic Liver,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,pert
strain: mixed C57BL6;	genotype/variation: Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,ctrl
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
A VIS _B069,pert
c48 is a clonal Nurr1 stably-expressing stem cell line,pert
treatment: baseline;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
race: caucasian;	age (years): unknown;	stage: IC;	grade: 2;	histology: endometrioid,pert
PBMC sample from healthy volunteer,ctrl
EB_6_19d_310_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
EB_07_8d_143_HCHO_Nasal_Rat230_2_CIIT05024,pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
hepatocytes,ctrl
tissue: white blood cells;	age: 15;	Sex: male,ctrl
Dermal fibroblasts from healthy individual,ctrl
b-catenin deficient BxPC3 clone 111,pert
age: 55;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Human cutaneous T cell lymphoma HuT-102 cells, vector control",ctrl
multiple sclerosis_3,pert
CHF - LV15,pert
HMEC_50,ctrl
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr",pert
human lung,ctrl
"liver, STZ-treated fed 0.1% quercetin diet for 14 days",pert
cell line: HL60;	disease state: promyelocytic leukemia,ctrl
genotype: PML Knockout;	treatment: Low Fat Diet;	gender: male;	tissue: liver,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 17;	disease state: Lesional,pert
age: 60;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
transduced NIH-3T3 cellline,ctrl
12 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxi;24728,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 2, 48h",pert
Karyotype: inv(14)(q11q32);	Age: 72 years;	Gender: male,pert
Human umbilical vein endothelial cells (HUVEC),pert
"Sv129/C57B6 intercrossed hybrid strain, 12 week old male",pert
"Control, replicate 8",ctrl
1% dmso batch 1,ctrl
female_alcoholic,pert
timepoint: Post-Cediranib treatment,pert
Mature mice skeletal muscle sample from the hind limb,ctrl
cell line: RT112;	transduced: FGFR3 shRNA 2-4;	doxycycline treatment: no,ctrl
"Cervical cancer cell line, CaSki",pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: none;	time: 72hr,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell line: MDA-MB231;	treatment: none;	cell type: metastatic breast cancer cells,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 3;	psoriasis duration: 37.0;	age of psoriasis onset: 11,pert
"NALT infected with 90-226att, 24h, biological rep1",pert
MCF-7_TOX3 expression,pert
sample type: HeLa-LAMP3siRNA-4d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 4d interferon alpha;	treatment: interferon alpha,pert
tissue: Liver;	genotype/variation: Hmgn1+/+;	treatment: injection of 10 µg/g body weight of saline,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 1",pert
"Diagnosis:AML M2;	Age: 66y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: INV9, INV14;	FLT3 ITD: No Data;	FLT3 TKD: No Data",pert
strain: C57BL/6;	genotype: Wild Type;	replicate: 3,ctrl
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: E2;	time: 4h,pert
"transfection: pRTS-GFP;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",ctrl
treatment: DMNQ;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,pert
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P14,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 24;	gender: male,ctrl
A39 WT2	F5/53	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 1,pert
cell type: T cell;	treatment: 37C;	genotype: HSF1-/-;	genetic background: mixed 129Sv.BALB/c background,pert
genotype/variation: control mice treated with tamoxifen for 1 week;	tumour stage: Benign tumour,ctrl
whole splenic B-cells from adult Xid mice,pert
MS brain lesion (following demyelination-active inflammation),pert
"liver, PPAR KO_ctr_118",pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-1502;	gender: female;	passage: P55;	clone: C32,ctrl
cell line: neuro 2A (N2A);	cell type: neuroblastoma cell line;	genotype/variation: transiently transfected with Pou3f3 knockdown construct,pert
cell line: OVCAR-10;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 3,pert
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD8+ T-cells,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#108,pert
"Patient  J, lesion, 2 week",pert
"female Spargue-Dawley rats, diet only for 7 days,  tissue: mammary gland",ctrl
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection;	vector: pLKO.1;	activation: 2 h 100 ng/ml TNP-BSA,ctrl
hepatoma cells,ctrl
strain: Myd88 KO;	gender: n/a;	age: 4 month;	weight: 25-30g;	tissue: trachea,pert
"blood, -LPS",ctrl
CON - R22,ctrl
Patient: F;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-10 shRNA),pert
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: wild type,ctrl
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C16,ctrl
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,pert
Disease_status: Down syndrome;	Age (years): 61;	Gender: Female;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
"BALB/c, Female, Control",ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,ctrl
S4B Sporadic-cerebellum,ctrl
Cervical cancer_CC207,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 27,pert
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 97;	Usage number: 5;	Exposures: 3,pert
B6C3F1 male,pert
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,pert
patient: 1;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"control colon tissue, biological rep3",ctrl
A HID U_B015,pert
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,pert
Cochleae from wild type mice at P60,ctrl
CD34+ cells of CML patient before therapy,ctrl
"Mouse liver, MAT1A knockout, steatosis, 3 months",pert
confluent HUVECs stimulated with Angiopoietin for 1 hour,pert
Genotype: NHE3-/-;	Age: 6-8 weeks,pert
ATCC CRL-1555,pert
HEK cell lines expressing mutant channel,ctrl
Total RNA from MDA-MB-231 cells infected with a lentivirus shControl,ctrl
Postmenopausal female. Tibolone treated. Patient 6.;	Replicate,pert
genetic background: C57BL/6;	tissue: liver;	genotype: wt;	gender: female;	age: 3 mo,ctrl
Strain: C57BL/6; Tissue: liver,ctrl
EB_2_5d_215_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
mouse intestine pLagl2 wild type 4,ctrl
"BMDM, IFNgamma treated, KO Vdr -/-",pert
RNA from whole tissue section of case 1045 labeled with Cy5,ctrl
Age: 48;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
Brain from 84 days Npc1-/- mouse1,pert
"LCL GM19238, Kd WHSC1, 72hrs",pert
cell type: Embrionic stem cell line;	genotype: HPRT -/-: GTF2I +/-,pert
Karyotype: no inv(14)(q11q32);	Age: 62 years;	Gender: male,pert
B-CLL PB P155,pert
tMLL05,ctrl
gender: male;	age (years): 34;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
phenotype: alcoholic;	gender: male;	case_id: 210;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 27;	brain ph at time of freezing: 5.58;	labeling_batch: 1,pert
individual: patient1;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
normal mouse embryonic kidney day 12.5,ctrl
Dissociated dorsal root ganglia treated for 30 min with DMSO,ctrl
patient id: T127;	tissue: Normal cortex;	gender: Male;	age: 35;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: LPS;	tissue: liver,pert
34A;pretreatment;female;breast tumor,ctrl
braak stage: CTRL;	rin: 74;	tissue: substantia nigra;	disease state: control,ctrl
P4 Ovary cultured for 48 hours with no treatment,ctrl
gender: female;	age (years): 34;	evolution time (years): 14;	disease extension: Pancolitis;	treatment: Azathioprine,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 20.57534,pert
"treatment: control;	batch: 3;	donor: 29;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
strain: C57BL/6;	genotype: Klhl40 knock out;	age: 0 days;	tissue: muscle;	muscle type: Quadriceps,pert
diseased cells stimulated,pert
FCHL patient #98-1056,pert
CD11b+Gr1+ cell sample_2 (derived from IL17RC Knock out mouse),pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.68219,pert
NFIA P16WT1,ctrl
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: gastrocnemius,ctrl
cell line: SU8686;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: PGC1a shRNA 66,pert
Tumor,pert
Placenta_nl1 with Cy5,ctrl
Strain : 100% C57BL/6;	Gender: Female;	Age: 9 weeks (Moderate stage);	Transgene: Mutant ataxin-7,pert
"mouse skin, Tcfap2 mutant",pert
gender: male;	age: 6 months old;	genotype: Pdx1flox/flox;VilCre (KO);	litter: brother of the same litter,pert
"Biceps, FSHD, cohort 21, subject 21B",pert
cell line: HEK293;	sirna: hCdc73;	condition: sparse,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,ctrl
cell line: non-clonal BMSC cultures;	transfection: siTERC-RNA (siTERC) construct,pert
LP50 cells treated with vehicle and control shRNA,ctrl
cell line: HCT116;	shRNA: CDK8;	treatment: untreated,pert
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, Harlan Teklad TD03045 diet, liver",pert
tissue: Frontal cortex;	age: 77;	Sex: M,ctrl
pLenti transduced cell lines Mock (empty vector),ctrl
Patient: G;	Time: 0;	Group: responder;	Condition: lesional,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.2;	colon weight (mg): 159;	colon ratio (mg/mm): 2.56;	myeloperoxidase activity (u/mg): 0.391;	tissue: colon;	treatment: 5% DSS,pert
cell line: AGS;	tissue origin: stomach;	cell type: human gastric carcinoma cells;	treated with: none (control),ctrl
reference: whole mouse total RNA,pert
parental HeLa cells,ctrl
cervical spinal cord,pert
"10 days old prosaposin knockout mice, cerebrum",pert
Subtype: RA;	Karyotype: normal,pert
BALB/DBA F1 mouse treated with pristane for 3 days,pert
SKI-DLCL cells treated with Aplidin (3nM) for 24h. Total RNA was extracted.,pert
type_of_rx: AFG;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,pert
"t20, surgically resected from patient of gastric cancer.",pert
PBMC from T cell Large granular lymphocyte leukemia patient#1375,pert
tissue: oropharyngeal carcinoma KB,pert
206_SIO,pert
"mouse lung, tamoxifen-treated Tmem1002loxP/2loxP;ROSA26+/CreER",pert
cell line: HEK293 human embryonic kidney cell line;	protocol: control (untreated),ctrl
cell type: peripheral blood mononuclear cells;	disease state: multiple sclerosis,pert
cell line: IEC-6;	tissue: colon epithelium,ctrl
FVB 129 mice used as bone marrow donors,pert
"Neurod1 KO, 129 mouse pineal glands from postnatal day zero.",pert
"LCL GM19238, Kd CREBBP, 72hrs",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Jejunum",pert
"Cell type: endothelial, age:45, gender:male, diagnostic group: schizophrenia, PMI:18h",pert
"brain, lateral and medial ganglionic eminences",ctrl
Tissue:tumor; Gender:male; Age:56; Tumor stage:T4N0M1,pert
"BOEC, not_at_risk 4",pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 5,ctrl
Skin biopsy from upper nates taken 96 hours after exposure to 5% nickel sulfate,ctrl
A HID U_B054,pert
no_18,ctrl
HLA risk: Medium;	Height: 162.5 cm;	Weight: 53.4 kg;	BMI: 20.2;	Age: 13.03 years;	Gender: Female;	Race: White;	Glucose: 81 mg/dl;	HbA1c: 7.8%,pert
Healthy-7 baseline,ctrl
41wk FVB(97%)/CF-1 (3%) mammary gland,ctrl
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-3,pert
tissue: Temporal cortex;	age: 91;	Sex: F,pert
AT2 E/R positive leukemia cell line,pert
"Patient  D, lesion, 1 week",pert
lung_myd88_mock_repA,pert
mixed reference (CRG+ FR),pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.85;	choa: 184;	fata: 69;	eea: 2080;	wtkg: 109.2;	perfat: 30.1;	lbm: 68.9;	fat_mass: 3286.92,ctrl
RNA from microdissected breast cancer cells from case 871 labeled with Cy5,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: B;	experimental sample name: PC8-R,pert
scan batch: Batch 2;	group: autism;	subject age: 14;	paternal age: 30;	maternal age: 32,pert
Bone marrow CD34+ cells,ctrl
control_16hr,ctrl
DU145/NC siRNA,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 42 yr;	population: white;	dsm-iv: 295.3;	age of onset: 18 yr,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, 12h",pert
lateral hypothalamus,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
wild type mammary stroma,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, T1 (treated with resveratrol)",pert
56 Day Mouse leg muscle,ctrl
WT AA 4,ctrl
"Human Umbilical Vein Endothelial Cell, Single Donor, Passage_3",pert
A11,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 35, stage IB1, HPV 18, HPV 45",pert
Gender: Male;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
subject: 37;	disease: CP;	muscle: GR;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 7.7;	colon weight (mg): 169;	colon ratio (mg/mm): 2.19;	myeloperoxidase activity (u/mg): 0.039;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 10",pert
fully differentiated (day 6) myotubes,pert
DBTRG untreated,ctrl
tissue: skin;	individual: Patient P3;	condition: ANL;	eczema severity: SCORAD: 0,pert
"Sample Type: human cellular RNA, Cell Line: primary airway epithelial cells, Cell Type: tracheobronchial",ctrl
"Male, 32 years old, HIV infection of >2 years",pert
strain background: Sprague Dawley;	gender: male;	diet: Lieber-DeCarlie diet containg EtOH for 6 wk;	sample group: Alcohol ingestion;	cell type: Alveolar type 2 cells,pert
individual: Control3;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
"biopsies from healthy individuals undergoing colonoscopic examination, snap-frozen immediately, stored at -80ºC",ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: SALL4 knockdown,pert
"Tsc2 wildtype mouse, cerebellum",ctrl
Thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
"n03, surgically resected from patient of gastric cancer.",ctrl
Th17 cells,ctrl
Endometrium-Normal 8,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: n/a;	maternal age: 27,pert
"lymphoblastoid cell line from T3.02, one out of seven of insensitive group, 50*10e6 cells",pert
treatment: baseline;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
"Primary aortic endothelial cells, transgenic_PPARG_V290M",pert
E2F2 Null,pert
age_years: 43;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
RNA from whole tissue section of case 319 labeled with Cy5,pert
"Control fetal heart (vehicle treated with corn oil via oral gavage on gd14.5, collected on gd17.5)",ctrl
mixed reference,ctrl
"hMSC-Tert, RNF40 siRNA, 2 days adipocyte differentiation",pert
Gallbladder-leptin treated,ctrl
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 1, clone 2",pert
Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: None,ctrl
AGS_Celecoxib treated,pert
tissue: temporal lobe;	strain: 129SV;	genotype: WFS1 KO,pert
"BOEC, normal 20",ctrl
cell line: HEK293T;	transfection: si-TNIK;	induction agent: Wnt3A;	induction time: 7 hours,pert
"human embryonic stem (hES) cells line VUB01, biological replicate  2",ctrl
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle,ctrl
mouse spinal cord,pert
cell line: U87;	treatment: 20 uM Temozolomide;	cell type: glioblastoma cancer cell line,pert
"100-200 motor neurons, sacral spinal cord, 60 days post injury",pert
"liver,6weeks,WT",ctrl
gender: female;	age (years): 41;	evolution time (years): 7;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,pert
vastus lateralis biopsy,pert
tissue: Biceps muscle;	patient: C.b.7;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 3m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
iFGFR1 mammary gland 8 hr AP20187,pert
MCF7,ctrl
"fatty (fa/fa), liver, Rosiglitazone",pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: Wt;	tissue: Skeletal muscle (quadriceps),pert
cell type: Normal human primary hepatocytes isolated from non-transplantable donor tissue;	time point: 6 h;	dose: 0.1 μM;	agent: VX (O-ethyl S-[2-(diisopropylamino)ethyl] methylphosphonothiolate),pert
tissue: secondary brain tumor;	cell type: glioblastoma;	age: 40;	gender: female;	tumor grade: IV,pert
cell line: JoMa1;	cell type: neural crest precursor cells;	transfectant: GFP control,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: untreated;	normal donor 5,ctrl
APP_R6,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 43;	gender: male,ctrl
HL-60 cell line infected with scrambled control shRNA,pert
cell type: Immortalized lung epithelial cells,ctrl
heart tissue,pert
LSK cells SRF wt 3,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with Wy14643 for 6h,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T26,pert
whole blood,ctrl
HCT 116 cells transfected with siControl,ctrl
control participant P350 (human CD3 positive T cells),ctrl
C2C12 MYOTUBES STARVED 4 DAYS,pert
phenotype: alcoholic;	gender: male;	case_id: 290;	age: 51;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 46;	brain ph at time of freezing: 6.35;	labeling_batch: 1,pert
T141,pert
"lateral prostate, PTEN+/- epithelium, 12 months",ctrl
Human normal prostate tissue,ctrl
"fetal liver, wild type",ctrl
Human peripheral blood mononuclear cells,pert
G93A mouse 801,pert
cell line: SA-01;	treatment: with X5050 (100 µM final),pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,ctrl
Liver experimental mouse,pert
A61 NES 142Q TG1	F6/13	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
NORMAL #99-0583,ctrl
batch: A;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#2,ctrl
"wild-type control (littermates) of ""P32_exPKO_pancreas""; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: WT;	rb: WT,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
Squamous cell lung cancer patient 42,ctrl
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: Tfam+/-,pert
disease state: Healthy Control;	gender: Female,ctrl
"Brain tissue from Fisher 344 male rat, Animal #261, 50mg/kg D-Serine",pert
Strain: B6129;	Gender: male;	Age: 12 weeks;	Tissue: liver;	Developmental stage: adult,pert
cell line: U937;	replicate: Replicate1;	treatment: shSYK_2,pert
nTreg cells Foxo1KO,pert
trained wt,ctrl
Gata3 overexpression line,ctrl
NK_cell_pool_melanoma_M01+M02,pert
4A;pretreatment;female;breast tumor,ctrl
"A3_tumor, lung tissue",pert
Rb Mouse spleen Ter19+CD71high sorted cells,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Group B Strep,pert
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",pert
sex: Male;	family: 4;	age: 12;	disease status: Affected;	tissue: Muscle: Biceps,pert
FCHL patient #99-0308,pert
Mouse Reference,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with vehicle for 6h,pert
Endometrium-Normal 1,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
race: caucasian;	age (years): 55;	stage: IB;	grade: 1;	histology: endometrioid,pert
treatment: siRNA LMG4,pert
HT29RC PLX4720 resistant cell line,pert
patient id: T166;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: mutant;	pbrm1 status: wild type;	vhl status: mutant,pert
cell type: E9.0 embryonic cardiac progenitors,pert
"Semitendinosus Muscle, Cerebral Palsy",pert
"Epididymal fat, knockout",pert
wild-type male mice angiotensin II treated,pert
background strain: C57Bl6;	genotype: wildtype,ctrl
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 5,ctrl
"17B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
genotype/variation: Ghrh-KO;	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,pert
Esophagus cell line OE33 siRNA,pert
3T3-L1 20uM troglitazone,pert
EB_0_6_322_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 67;	baseline tumor size (cm): 9x7;	patient id (to identify the 2 chips from the same patient): 12791332,pert
MPM tumor specimen 4,pert
"Sample Type: human cellular RNA, Cell Line: primary airway epithelial cells, Cell Type: tracheobronchial",pert
Ebola-infected macrophages harvested at 6h post-treatment from donor 3,pert
KO 1 Quadriceps,pert
cell line: OVCAR-8;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
White matter from age-matched healthy controls,ctrl
cell line: A549;	agent: decitabine;	dose: 3 uM,pert
"LY2 cell line, SRC-1 scrambled treated 120min,  biological rep3",ctrl
KO_72_O3_4,pert
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 54 yr;	population: white;	dsm-iv: 296.89;	age of onset: 45 yr,pert
"Control rat liver, snap frozen",ctrl
Gene expression profiling of normal cortex of patient 260,ctrl
Pre-Frontal cortex of naïve AChE-R mice,pert
condition: Normal;	patient: N_AJ1;	tissue: Normal skin biopsy;	kit: Ovation,ctrl
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
AGS_control,ctrl
Sex: male;	Age: adult (11-12 weeks),pert
colon cancer cells,ctrl
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: I;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N0;	er: 0;	pgr: NA;	dfs-month: 18;	dfs-event: 0;	distant metastasis: 0",pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
agent: ConA;	time point: 3 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 204,ctrl
"CA1, SOX7 expressing HESC - clone1",pert
cell line: SCC25;	tissue: tongue;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
Prostate,pert
RV63.09_CHF_day19,pert
PancreaticSample24-Tumor,pert
B3_saline_overexpressor_422,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.01644,ctrl
"Tibialis Anterior Muscle, Wildtype, Adult",ctrl
genotype/variation: Vax2-/-;	age: E16.5;	tissue: Whole eye,pert
"Normal cervix epithelium, microdissected, Age 44",ctrl
Differentiation of hES cells line SA01 towards neural rosettes;	Neural precursor phenotype,ctrl
"eye, retina",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 2,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 230min;	race: White;	sex: Female,pert
"Deltoid, control, cohort 13, subject 13U",ctrl
"Lung, Sporadic Idiopathic Interstitial Pneumonia (S-IIP), Usual Interstitial Pneumonia (UIP)",pert
Whole testis from Ing2 -/- littermate,pert
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: E14,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
Trasnsformed Lymphocytes Bipolar Disorder Affected (Affected pateint of MZ twin pair 2),pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep4",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 4h,pert
"Pancreatic islets, control, 02",ctrl
Patient: H;	Time: 0;	Group: responder;	Condition: lesional,ctrl
cell line: BL2;	transfection: LEF siRNA;	batch: 1,pert
"Embryonic stem cells, HERVH shRNA",pert
Strain: C57BL/6 wildtype;	P7,ctrl
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Rosiglitazone,pert
WT Non stim 2,ctrl
"Rat pups treated with saline, spinal cord",ctrl
chip number: 23;	transfection plate: 3A;	target gene: SP3;	kd level: 0.59;	rin: 9.4;	transfection date: 2012-03-26,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14532;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: liver;	age: 14 months,pert
age_years: 55;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Control,ctrl
cell line: DAOY;	cell type: medulloblastoma;	genetic modification: none (wildtype),ctrl
NSCLC cell line H157. Transfected with scrambeled control non-targetting oligomer siRNA - #1,ctrl
ApoE-/- mouse infected wtih an adenovirus expressing dominant negative cJun,pert
"Animal id 543, left retina, 8 months, female, DBA/2J",pert
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: untreated,ctrl
wildtype resting B-Cells,ctrl
"cell line: F348, WBS, skin fibroblasts;	microdeletion: del(7q11.23);	gender: female;	age at biopsy: 3 years",pert
24 weeks male,pert
cell type: HUVEC;	treatment: RAF1 S259A,pert
"Deltoid, FSHD, cohort 15, subject 15A",pert
Age: 57;	Cycle: NA;	BRCA1/2 mutation: Unknown;	Family History: No,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 3,ctrl
tissue: Pancreas;	cell line: Panc-1;	treatment group: TGFβ Treated 48 hr,pert
ExtendedOligo,pert
Extract:LOX-1:113402;	Extract Description:GFP_Untreated_12hr:113402;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.48;	Quality: Background Mean Dev.:0.18;	Quality: Absent (%):59.48;	Quality: Absent (%) Dev.:0.95;	Quality: Scaling Factor:0.7;	Quality: Scaling Factor Dev.:0.72;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113402;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295723,ctrl
cell type: Primary hepatocytes;	donor: 2;	agent: Wy14643;	time: 24h;	gender: Male;	age: 44 years old,pert
Commercial RNA from normal cervix,ctrl
chip number: 14;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.84;	rin: 9.6;	transfection date: 2012-03-26,pert
T152,pert
DP (CD4+/8+) cells from Notch1-IC over-expressing peripheral tumor (thymoma),pert
"HL-60 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
Heart of 10 weeks old mice,pert
patient: 1;	disease state: hypertension;	tissue: Atheroma plaque,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 9.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 34;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#1,pert
cell type: dental pulp cells,ctrl
Choriocarcinoma,pert
"skin, no treatment",ctrl
Trib1 #1 Wild-type macrphages were treated with LPS,ctrl
age: 24 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
RNA from whole tissue section of case 1368 labeled with Cy5,ctrl
Monocyte derived dendritic cells,ctrl
histology: chronice active plaque;	disease state: multiple sclerosis following demyelination-active inflammation;	tissue: multiple sclerosis brain lesion,pert
DA rat colon control,ctrl
"vector control cells, biological rep2",ctrl
patient id: 111;	tissue: Normal cortex;	gender: Female;	age: 72;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
genotype: wildtype;	diet: high fat;	muscle hypertrophy: none;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,ctrl
Yy1_siRNA,pert
"fatty (fa/fa), skeletal muscle (gastrocnemius), Pioglitazone",pert
hepatocytes treated with 625 μM BZP,pert
affection: ADHD;	treatment: untreated;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 4;	Exposures: 3,pert
Reference RNA e17.5 embryo,pert
age_years: 32;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
genotype/variation: GATA3 KO;	cell type: Tregs,pert
patient: 51628;	sample: tumor,pert
H4-II-E-C3 cells exposed to 29 µM CoCl2 for 24 h,pert
chip number: 21;	transfection plate: 3B;	target gene: EP300;	kd level: 0.73;	rin: 9.1;	transfection date: 2012-03-26,pert
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; 1h EGF,pert
"MaF pre-iPSC9P2, Vc treated, lysed on D3",pert
cell line: MCF7;	treatment: control,ctrl
liver; fasted 18h,ctrl
Bone Marrow.,pert
Endometrium-Normal 4,ctrl
"affected status (disease state): IS patient;	gender: female;	age-at-examination: 70;	age-at-onset: 69;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,pert
disease state: paediatric glioblastoma;	age: 13;	gender: M;	h3.3_status: G34R,pert
NTera-2 cells transfected with Ambion Silencer Select SOX2 siRNA,pert
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
Heart sample6,ctrl
Patient: M;	Time: 0;	Group: responder;	Condition: lesional,ctrl
genotype: Oga knockout;	gender: Female;	cell type: MEF,pert
INS-1 cell line #1a with non-induced HNF1b,ctrl
strain: wt;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,ctrl
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: DMSO (control);	dose: n/a;	time: 3 hr,ctrl
"vector control cells, biological rep1",ctrl
Patient: K;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"LSK (Lin-, Sca-1+, c-Kit+) cells sorted from Lkb1 WT bone marrow cells",ctrl
B-CLL PB P137,pert
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 1",pert
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 29,ctrl
"testis with regular spermatogenesis from orchiectomy cases due to prostate carcinoma, patient age: 67y",ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
MCF7 silenced Estrogen receptor alpha (PII),pert
Whole body,pert
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 96 hrs,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Epithelial Cell,ctrl
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14454;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
Atrioventricular canal,ctrl
chip number: 21;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
"knock out, lung",pert
PBMC from T cell Large granular lymphocyte leukemia patient#112,pert
tissue: Melanoma Lymph node Metastasis;	cell line: WM164;	treatment: DMSO,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 24 hours,pert
G93A non transgenic littermate 803,ctrl
bone marrow macrophages from 1 female and 2 male wild type Balb/c mice,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
age_years: 41;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 72h,pert
"Extensor digitorum longus, healthy control",ctrl
dental pulp cells obtained from milk teeth,pert
Human CD34+ cord blood cells expressing the empty MIG control vector,ctrl
"Control at ZT20, pineal gland",ctrl
pooled reference mRNA from 4 harvests of HME-CC cells,pert
RNA from microdissected breast cancer cells from case 319 labeled with Cy5,pert
"PC from MM patient, isolated using CD38-APC.",pert
"C57BL/6J Saline treated, biological replicate 1",ctrl
strain: C57BL/6J;	genotype: Homozygous Wild-type;	developmental stage: P15,ctrl
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: metastasis to lung;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
tissue: spleen Ter19+CD71high sorted cells;	genotype: E2f8 KO;	age: 3-month,pert
strain: C57BL/6 * 129;	age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
tissue: Frontal cortex;	age: 84;	Sex: F,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 39;	age of psoriasis onset: 7,pert
Whole adrenal RNA from Crem-/- mouse #77 at 0h,pert
PBMCs from normal control subject J,ctrl
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 60;	ld: HCV;	creatnine: 1.3;	mdrd: 57;	gfr: 50;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: neg;	hcv: POS;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 11;	ana: UN;	gp: ATN, mild IFTA, moderate arterisclerosis;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 0;	c: 0;	empe: 3;	bmwid: 0;	bmd: 0;	edd: 0;	no of glomeruli: 12;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: moderate intimal fibrois;	if: IGG+IGA+;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
wild type proximal tubules of mouse kidney,ctrl
"Wild type mouse striatum, postnatal day 0",ctrl
3T3-L1 Day 0 (passage 19) 24h after siControl transfection,ctrl
race: caucasian;	age (years): 83;	stage: IB;	grade: 3;	histology: endometrioid,pert
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit and Sca1 (LSK) positive expressing bone marrow progenitors",pert
"Patient  G, lesion, 1 week",pert
age: 15;	sex: M;	disease status: control subject;	Filter number: 82;	Usage number: 1;	Exposures: 3,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
cell line: MCF-7;	sirna knockdown: siLRH-1_#3,pert
Murine bone marrow from C57bl/6 mice,ctrl
HCC_11T,pert
Tissue: Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use:  Yes,ctrl
"Mouse organ of Corti from cochlea, apical half, littermate control",ctrl
A3,pert
Kidney from mice treated with 7 daily iv injections of vancomycin at 200 mg/kg,pert
"lymphoblastoid cell line from P910, one out of seven of sensitive group, 50*10e6 cells",ctrl
Sample Group: control; Gender: female; Age: 30; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
Septic shock;	gender: Male;	Survivor;	organism: Adenovirus;	organism class: Viral,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep3",ctrl
MCF7 - MTDH_WT_KD,pert
cell line: HeLa;	cell type: human Cervical Carcinoma;	genotype/variation: parental,ctrl
cell line: MDA-MB-231;	cell type: Breast cancer cells;	group: Control group,ctrl
"Postnatal day 11 Cerebellum, wildtype; replicate 3",ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle. Galgt2 Transgenic",pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 24 hour",ctrl
"Age: 37;	Sex: F;	Ancestry: African;	Smoking status: smoker, 23 pack-years",pert
Nrg4 KO mouse liver,pert
cell type: WAO9 human embryonic stem cells;	genotype/variation: shRNA-mediated HNF4a knockdown;	growth protocol: subjected to a hepatic differentiation protocol;	time: d20,pert
AA_SLE_CD8,pert
tissue: Brain;	genotype: Npc1-/-;	age: 37 days;	subject: Mouse1;	genetic background: BALB/c,pert
"Gender: Female, Age: 28, BMI: 34, Tissue: luteinized cumulus cells",ctrl
Vector expression/control suppression,ctrl
pre-iPSC- siRNA to Cbx3- biological replicate3,pert
Tet1 KD mouse ES cells,pert
MCF7 fulvestrant-resistant cell line transfected by antisense hsa-miR-222,pert
MC3T3 cell line,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 1;	gender: male,pert
ATF2 Genotype: WT,ctrl
Patient identifyier: L;	Sex: male;	Age of patient: 34 years;	Duration of psoriasis: 22 years;	Body surface area: 10 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Tissue: normal thyroid; Gender:female; Age:65,ctrl
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
Septic shock;	gender: Male;	Survivor;	organism: None;	organism class: None,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 47;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
subject: 12U;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 24;	Sex: F;	batch: Batch_3,ctrl
bone marrow derived mast cells,ctrl
30 with Cy5,pert
"BOEC, normal 18",ctrl
parental cell line: WA;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
"Mouse, WT, colon, DSS, rep1",ctrl
patient: 17;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
LNCaP-LM xenograft with Hes6 overexpression,pert
strain: C57BL/6J;	tissue: E13.5 embryonic fibroblasts;	genotype/variation: wild type,ctrl
HepG2_HIF-1α knockdown,pert
"D3_non-transgenic mice, lung tissue",ctrl
patient: 14;	disease state: hypertension;	tissue: Atheroma plaque,pert
cell line: KARPAS-231;	cell type: diffuse large B-cell lymphoma (DLBCL) cells;	treatment: non-targeting siRNA,ctrl
gender: male;	age: adult;	tissue: liver;	genotype: Rictor floxed;	treatment: fasted 16hr then given ad libitum access to food for 3 hr,pert
"Kidney, AGTR1A-KO mice, control",pert
"Cell type: endothelial, age:19, gender:male, diagnostic group: schizophrenia, PMI:28h",pert
GC resistant clone C7H2-R10E7 treated for 6 hours with EtOH,ctrl
"Lymphoblastoid cell lines derived from family 1724, member 1",pert
Mouse_Klf5 KO_ES_clone 1,pert
original diagnosis: PolyRF-;	cell type: Peripheral blood mononuclear cells,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 49 yr;	population: white;	dsm-iv: 296.54;	age of onset: 20 yr,pert
cell line: D3;	genotype/variation: PRMT1 knockdown (siPRMT);	cell type: undifferentiated embryonic stem cells,pert
age: 49;	sex: M;	disease status: Marfan subject;	Filter number: 92;	Usage number: 5;	Exposures: 3,pert
26 weeks female,pert
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep4,pert
"heart, QH2, 14 months",pert
Genetic background: mixed 129 and C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: Scd1 -/-.,pert
"macrophages, 4 days post SeV inoculation",pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,ctrl
Monocyte derived dendritic cells were generated by culturing human monocytes isolated from buffy coats using CD14 microbeads (Miltenyi),ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 68;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
Normal cervix_05-5007,ctrl
"liver, control, 14 months",ctrl
patient: 250;	current medication: Asacol 2.4g/d;	birth date: 1/27/58;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 1/1/94;	diagnosis date: 5/30/94;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/29/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 4/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
treatment: baseline;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: 0.8 uM INCB18424 for 4 wks (Persistent);	treated with: 0.8 uM INCB18424 for 4 hrs;	sample type: persistent,pert
56 y/o male,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
Mouse C2C12 Myotubes treated with Palmitate for 16 hours,pert
Myd88 KO control tissue  2,pert
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,ctrl
Isolated PBMCs from diabetic male patient_Grape extract group_6 months,ctrl
agent: ConA;	time point: 6 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 3",pert
Total RNA from bone marrow derived macrophage from C3H/ARC mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 35;	sex: M,ctrl
treatment: shVEGFR-2;	cell line: U138MG,pert
prefrontal cortex (BA10);	depression,pert
Primary hepatocytes isolated from Donor 1 treated with Wy14643 for 24h,pert
"MCF-10A cells, shRNA targetting p63 DBD",pert
tissue: Temporal cortex;	age: 89;	Sex: M,ctrl
WT fed  regular chow,ctrl
age: 7;	sex: M;	disease status: Marfan subject;	Filter number: 36;	Usage number: 4;	Exposures: 3,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: DMSO for 48h,ctrl
Hep G2 treated with Cadmium chloride 2.5-hydrate,pert
scan batch: Batch 1;	group: autism;	subject age: 9;	paternal age: 27;	maternal age: 28,pert
cell line: MCF7;	treatment: Control,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 31;	maternal age: 29,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 168;	colon ratio (mg/mm): 2.82;	myeloperoxidase activity (u/mg): 1.157;	tissue: colon;	treatment: 5% DSS,pert
MMP-8 KO control mouse,pert
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr",ctrl
"Heart, MAT1 control, 2 wk, sample 2",ctrl
HL-60 cell line infected with GSK3B Construct 1 shRNA,pert
Th17 cells,pert
cell line: COV434;	transfection: empty vector,ctrl
E16.5 top2b-/- brain,pert
Jurkat cells with LEDGF transcript knockdown (PSIP1 gene),pert
patient: 31;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
source tissue: umbilical cord blood;	cell type: CD34+/CD38- Lin- cells;	treatment: knockdown control,ctrl
Gfi1b overexpressed,pert
"NRK-52E cells (DeLarco and Todaro, 1978) (ATCC, CRL-1571)",ctrl
"SRC-2 null mouse, liver",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 95min;	race: White;	sex: Female,ctrl
Cell culture of Melanoma Cell Line - A375,pert
PBMC;	Age: day 4,pert
KO_24A_1c,pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Endometrium/Ovary-Disease 5,pert
cell line: U87;	tumor tissue source: Cell line established;	tumor organ site: Brain;	pathological diagonosis: Glioma,pert
genotype/variation: mutant ThPOK,pert
cell type: kidney epithelial proximal tubule cells;	cell line: NRK-52E;	genotype: Osborne-Mendel;	treatment: DMSO 24 hr,ctrl
Wildtype H9 hESC derived NSC 2,ctrl
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,ctrl
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
INS-1 cell line #3b with induced HNF1b mutant A263insGG,pert
HTH83 cell lines,ctrl
HeLa cells were transfected with siRNA specific for optineurin mRNA,pert
Surgical sample,ctrl
TTF=156min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
tissue: full-thickness skin;	age: newborn (P0);	genotype/variation: Krt1+/+;	strain: C57BL/6,ctrl
gender: female;	age (years): 50;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"twin pair: #3;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,ctrl
PancreaticSample13-Tumor,pert
phenotype: control;	gender: male;	case_id: 211;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 29;	brain ph at time of freezing: 6.68;	labeling_batch: 2,ctrl
cell line: FOXO WT,ctrl
strain: C57BL/6J;	cell type: KLS;	genotype/varation: ∆Hmga2,pert
Kidney tissues from lean rats on diet with rosiglitazone,pert
tissue: white blood cells;	age: 12;	Sex: male,ctrl
"Ls174T, dominant-negative Tcf4, uninduced",ctrl
TIG3 embryonic diploid fibroblasts,ctrl
brain microvessels,ctrl
Total RNA from bone marrow derived macrophage from C3H/HeJ mice after 10ug/ml LPS (S. minnesota) stimulation for 21 hours,pert
tissue: Peripheral blood;	disease status: patient without recurrent events,pert
Brain area 8/9 from two 8 year-old girls suffering from Rett Syndrome.,pert
"cerebellum,18month,WT",ctrl
scc_06,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.265;	OD280: 1.203;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 144;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
treatment: shRNA against DBC1 (shDBC1);	cell line: MDA-MB-231,pert
Unaffected MZ twin pair 4 (Unaffected patient of MZ twin pair CCN4),ctrl
gender: male;	individual: patient 2;	treatment: control,ctrl
E.8 DBA-C57BL/6 whole embryo,pert
monocytes_T0,ctrl
cell line: SK-N-SH;	lentivirus: eGFP,ctrl
BL Ramos cell line,pert
age: 7 weeks old;	strain: C57Bl/6;	phenotype markers: CD4+ Foxp3+ CD25+;	separation method: FACSAria;	Sex: Female,pert
sample: #13;	subject: PD case #1;	brain: T-1982;	age: 79;	sex: Male;	region: Dorsal motor nucleus of the vagus,pert
colon from macrophage-specific PPARg-deficient mouse,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 47,pert
"Frontal cerebrocortex, deltamethrin (1 mg/kg), 6 hours",pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 24 hrs Solvent,pert
explanted neonatal cardiomyocyte,ctrl
Whole testis RNA from Crem-/- mouse #76 at 0h,pert
subject id: c3;	infection: control;	status: control;	tissue: whole blood,ctrl
Murine skeletal muscle (gas),ctrl
patient: EUR12;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
visceral_fat_Akt1+/-_female_8wk_rep2,pert
"Jurkat cells stably transfected with shRNA constructs (si1340) against LEDGF transcript (PSIP1 gene), derived from Jurkat si1340JK Cl-2 which was established and described in LLano et al. (2004). J. Virol. 78 (17):9524-9537.",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu1,pert
GM8923,pert
microdissected epithelial cells from invasive cancer originating in IPMN 2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),ctrl
tissue: retina;	age: postnatal day 8;	genotype: wild type,ctrl
"Strain: D3, mouse embryonic stem cell",ctrl
Sex: female;	Age: 12;	SL: 5.31;	House: 6;	Severity: SM;	Ashworth: 3;	Zancolli: 2A;	PEFF: 85;	PESF: 85;	AEFF: 55,pert
gender: female;	age (years): 30;	evolution time (years): 3;	disease extension: Pancolitis;	treatment: Systemic steroids,pert
cell type: embryonic stem cells;	genotype/variation: transfected with yy1-specific siRNA,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L003,ctrl
gender: male;	strain: SV129;	tissue: heart;	genotype: PKCZ -/-;	age: 32 weeks,ctrl
A61 WT2	F6/21	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
T116,pert
EB_2_6h_209_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
primary normal lung tissue 3370,ctrl
"Lymphoblastoid cell lines derived from family 1724, member 2",pert
HOX424 Control Day0,ctrl
"brain, Q10, 14 months",pert
"liver, fed 0.1% quercetin diet for 14 days",pert
human fibroblasts overexpressing prelamin A,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
strain: C57 BL6NCr;	tissue: Distal colon,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month, 2x1h exposure per day",ctrl
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
HeLa-Ctrl-siRNA-4d,ctrl
medium to late response after cadmium treatment,pert
disease state: healthy;	group: baseline,ctrl
Runx1 wild-type,ctrl
Age: 36;	Sex: M;	Ancestry: European;	Smoking status: non-smoker,ctrl
cell line: KYSE220;	cell type: squamous cell carcinoma,pert
CD8_Tcells_non_severe_asthma,pert
strain background: B6/C3H;	genotype/variation: Brwd1 mutant;	developmental stage: germinal vesicle (GV) stage;	tissue: oocytes (100 cells),pert
Squamous cell lung cancer patient 33,pert
BMM,pert
Pool Eu_P30,ctrl
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: wildtype,ctrl
PS-/- cerebrum at 20 days,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.,pert
race: caucasian;	age (years): 85;	stage: IB;	grade: 3;	histology: endometrioid,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
tMLL06,ctrl
"sebocyte cell line, SV-40 immortalized, 13-cis retinoic acid treated",pert
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 7,ctrl
PS-/- cerebrum at 10 days,pert
PDAC_T_138,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,pert
"HeLa, epithelial cells, adenocarcinoma (CCL-2; American Tissue Culture Collection ATCC, Manassas, VA, USA)",ctrl
non tumorigenic human breast epithelial MCF10A cell line: SFN_rep2,pert
Gfp purified cell,pert
Striatum of 8-10 week old DBA/2J mice,pert
"MaF pre-iPSC9P2, Vc untreated, lysed on D5",ctrl
WT S49 Cells 6h treatment with cAMP,ctrl
patient: 40975;	sample: normal,ctrl
genetic modification:;	tissue: breast adenocarcinoma,ctrl
HepG2_Vehicle_24hr,ctrl
E2F WT,pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
cell line: AT2 E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
"patient: 212;	current medication: Pred 10mg, AZA150mg, ADCAL D3;	birth date: 8/3/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/97;	diagnosis date: 9/1/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 11/9/04;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 12;	octn1: 11;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/9/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/16/04;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
B_cell_pool_healthy_H09+H10,ctrl
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  1",pert
disease state: tibial muscular dystrophy (TMD);	tissue: gastrocnemius medialis;	age at biopsy: 62;	Sex: male,pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 -/-;	tissue type: renal tissue",pert
human normal breast tissue RNA,ctrl
"Deltoid, control, cohort 21, subject 21U",ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 30;	gender: male,ctrl
Extract:LOX-1:213102;	Extract Description:LOX1_0hr:213102;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.58;	Quality: Background Mean Dev.:1.4;	Quality: Absent (%):59.09;	Quality: Absent (%) Dev.:0.65;	Quality: Scaling Factor:0.6;	Quality: Scaling Factor Dev.:0.13;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295453,pert
Knockout liver DEN-injected 12weeks repl1,pert
Megacaryocyte-Erythrocyte Progenitors,pert
Cervical cancer_98-04T,pert
chip number: 19;	transfection plate: 3A;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2012-03-26,ctrl
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
"BOEC, at_risk 9",pert
genotype: control;	strain: inbred 129;	cell line: E14;	cell type: embryonbic stem cells,ctrl
"BOEC, not_at_risk 5",pert
cell type: Mouse embryonic fibroblasts;	genotype: MLL1 KO;	time: CT30,pert
cell line: HEK293;	sirna: hCdc73;	condition: confluent cell density,pert
cell line: mNB-A1;	strain/background: mixed C57BL/6 x 129X1/SvJ;	cell type: MYCN-driven neuroblastoma;	treatment: MLN8237,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 15,ctrl
EE_IB_3_cauc_lcm,pert
"Wt mouse, cerebellum, old, nicotinamide riboside treatment",pert
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,ctrl
genotype/variation: WT;	cell type: Tregs,ctrl
"male, healthy, no medicamentation",ctrl
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Ovol1 KO;	treatment: calcium,pert
T-ALL cell line treated with DMSO,ctrl
Fourth day of N2B27 differentiation,ctrl
Wildtype liver DEN-injected 12weeks repl3,ctrl
8 week old wild type mice spleen,ctrl
cell line: HepG2,ctrl
WT_d00_eX,ctrl
subcutaneous fat,ctrl
"S100a10 cells, p11 KO, cortex, TRAP RNA, VEH treated",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.315;	OD280: 0.668;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 312;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"mouse strain: C57B/SV129;	genotype: Nrf2 wt;	tissue: mouse liver, 10 weeks",pert
"SKO-transduced MEFs, Vc untreated, lysed on D10",ctrl
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,pert
unstimulated CD3+ T-cells from Itk knockout C57BL/6 mice,pert
A HID U_B084,pert
8 wk old male mdx5cv soleus,pert
H157 siMOCK,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/giant cell;	matched/unmatched: unmatched,pert
left hippocampus,ctrl
n3_hi_12,pert
Supraoptic nucleus_3d dehydrated,pert
affected status (disease state): control;	gender: male;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	lifestyle characteristics: ever smoker,ctrl
"12-week-old spontaneously hypertensive rats (SHR), male, brain microvessels, treated with vehicle for 4 weeks subcutaneously by osmotic minipump.",pert
tissue: skin;	individual: Patient P3;	condition: AL;	eczema severity: SCORAD: 81,pert
patient: 40741;	sample: tumor,pert
Lung tissue sample from lung transplant patient,ctrl
Flexor carpi ulnaris from cerebral palsy patient,ctrl
wt testis at 17dpp,ctrl
cell line: SC263;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",ctrl
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.123;	Ratio: 2.13,pert
adipocytes expressing spliced XBP1,pert
patient: 263;	current medication: Azathioprine 75mg Fosomax 70mg;	birth date: 11/9/58;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/00;	diagnosis date: 6/1/00;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 7/8/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/8/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"HCT116 cells, control siRNA",ctrl
Untreated Y79 cells,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 6,ctrl
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: ACBP-/- (KO),pert
genetic background: C57BL/6;	gender: male;	cell type: primary murine fibroblast-like synoviocytes (FLS);	genotype: human TNF transgenic and knockout in Rsk2 gene (Rsk2-/y FLS);	flow cytometric cell sorting: CD90.2pos/VCAM1pos/CD11bneg,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 159;	colon ratio (mg/mm): 2.607;	myeloperoxidase activity (u/mg): 0.477;	tissue: colon;	treatment: 5% DSS,pert
Rybp#10 (OHT+)_4d,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: High fat diet,pert
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 3,pert
CUTLL1 MigR1 GSIwash4h,pert
Heart ventricle,ctrl
Normal Adrenal Gland,ctrl
cell line: HEK293 cells;	transgene: NPAP1/C15orf2;	treatment: uninduced,ctrl
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: c-Met KO,pert
Oral Squamous Cell Epithelium Tissue,ctrl
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 3;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
pSuper vector control 2,ctrl
SV589_8DayKD_SerumStarved->1hr EGF,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,ctrl
"heart, subendocardial left ventricle",ctrl
injection: IP 8hr 1 mg/kg Dexamethasone in saline;	diet: AIN-76A,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: kidney;	age: 14 months,ctrl
"Transgenic, snap frozen, extensor digitorum longus muscle, 10 month age animal",pert
Brain from 25 days Npc1+/+ mouse1,ctrl
mouse intestine pLagl2 wild type 3,ctrl
NORMAL #99-0834,ctrl
"SKI-DLCL cells untreated, cultured for 24h, total RNA was isolated using RNeasy kit",ctrl
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
A SIT_B099,pert
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
"age at diagnosis: 71;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1c;	er: 1;	pgr: 1;	dfs-month: 36;	dfs-event: 0;	distant metastasis: 0",pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
race: caucasian;	age (years): 60-65;	stage: n/a;	grade: n/a;	histology: atrophic endometrium,ctrl
"NCI-H69 xenografts, PDT treated and control untreated",ctrl
"Male, 36 years old, HIV infection of >1 year",pert
clone type: AtT20 clone types treated with control siRNA rep 1,ctrl
strain: C57BL/6;	genotype/variation: WT;	cell type: Peritoneal MF,ctrl
disease state: Multiple sclerosis;	cell type: CD4+T;	twin: R,pert
Jurkat T-cells non transfected,ctrl
Nonirradiated-ATM-KO Replicative2,pert
homozygous_TGFb_4hr_2,pert
"coronary smooth muscle cells (hcaSMC), treated with metoprolol for 72 hours",pert
"Male, Wistar, 6hrs/day access to cocaine, lateral hypothalamus",pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 37.0;	age of psoriasis onset: 24,pert
"Gender: female, Age: 54 years, Tissue: normal vulva,",ctrl
Jurkat cell line,pert
EB_400_6_365_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
primary normal lung tissue 1361,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:45;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=poorly differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=diffuse type",pert
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: shRNA targeting TMEM88;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,pert
scan batch: Batch 1;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: n/a,pert
tissue: prefrontal cortex from adult APP knock-out mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,pert
"Adherent lung cancer cell line, control siRNA",ctrl
"NRVM, Fibronectin-coated plates",pert
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.7;	colon weight (mg): 168;	colon ratio (mg/mm): 2.51;	myeloperoxidase activity (u/mg): 0.474;	tissue: colon;	treatment: 5% DSS,ctrl
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 1,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,ctrl
agent: EFNA4-Fc conjugate;	time: 1h,pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
mucosa collected and archived within 30 mins after surgery,pert
strain: C57BL/6;	gender: Female;	age: 7 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 35;	maternal age: 32,ctrl
C57BL/6J-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,ctrl
cell line: Colo205 parental cell line;	cell type: colon cancer,ctrl
"SBC-5 cells, siEGFP (control), 48 hr after siRNA, duplicate sample 2",ctrl
"Gata4_S105Amut, PE treated whole heart",pert
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 wild type,ctrl
Disease_status: Down syndrome;	Age (years): 52;	Gender: Male;	Post mortem interval (hours): 24;	Braak stage: VI;	Cause of death: Bronchopnuemonia,pert
A673 cell line that has been treated with DMSO vehicle control for 3 days.,ctrl
"Mouse wt heart ventricular tissue at E17.5, pool of 3",pert
Human LRRK2 (G2019S) homozygous patient fibroblast,pert
Human skeletal muscle biopsy sample;	Patient #164 with PM,pert
EB_2_19d_232_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 49;	age-at-onset: 47;	geographical origin: Mirandela;	lifestyle characteristics: ever smoker, ever drinker",pert
231/ARF-1_3,pert
cell type: primary p53-null neural stem cells;	retroviral expression: PlagL2,pert
ES cell RNA,ctrl
tetracycline inducible Ngn3 ESC differentiated for 3 days without feeder cells or LIF and with doxycycline,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 44 yr;	population: white;	dsm-iv: 296.74;	age of onset: 26 yr,pert
SNB19 GBM cell line,pert
Kin- S49 Cells 24h cAMP treatment,pert
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
MLL_00110,ctrl
cell type: PBMC;	disease state: Convalescence,pert
Left ventricle,ctrl
adult male,pert
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: cancer, homogenized",pert
Atrioventricular canal,pert
Sprague-Dawley Rat (male),pert
Z138-shControl,ctrl
cell line: H1299;	agent: azacitidine;	dose: 3 uM,pert
age: 50;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Aquaporin-11-/-_mouse P7 kidney #2-3,pert
cell type: ESC;	genotype/variation: Snai1 knockout,pert
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group",ctrl
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: UNMUT,ctrl
"primary cortical neurons, NLGN3 shRNA",pert
"wild-type control (littermate) of ""P16_exPKO_pancreas""; mixed genetic background; postnatal day 16; total pancreas; replicate mouse #1.",ctrl
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
siRNA-2-COLLAGEN,pert
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
genotype/variation: wildtype;	strain: C57Bl/6;	gender: female;	cell type: skin melanocytes,ctrl
disease state: paediatric glioblastoma;	age: 7;	gender: F;	h3.3_status: wt,ctrl
CON - R20,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ and Rosiglitazone,pert
A549 cultured cell,pert
chip number: 15;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.72;	rin: 9.7;	transfection date: 2012-03-26,pert
age_years: 50;	sex: M;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
"primary fibroblasts expressing a control shRNA construct, clone 2",ctrl
tissue biopsy of non-lesional skin from CIU patient,ctrl
"Biceps muscle, Control patient",ctrl
PBMC sample from hepatocellular carcinoma patient,pert
patient: 255;	current medication: Asacol 800mg BD;	birth date: 3/14/77;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/31/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/01;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.809;	OD280: 0.918;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 8.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 156;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell line: ARPE-19;	clone: 23;	genotype: Wild type,ctrl
pre-iPSC- siRNA to luciferase- biological replicate2,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
Vehicle-Control;	Vehicle-Control 24 hours set 2,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 6,pert
tissue: atria;	genotype: Myh6-cre; COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1tetO-Nanog/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,pert
"Infected with H37Rv, replicate 1",ctrl
"patient 13, baseline",ctrl
infected BALB/cByJ fibroblasts (9 h post inf),pert
protocol: control,ctrl
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: Trnp1 knockdown,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#6,pert
human pluripotent cells,ctrl
PancreaticSample53-Normal,ctrl
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep5",ctrl
subject: 31;	disease: TD;	muscle: GR;	gender: M;	age: 14;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Calf muscle complex,pert
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,ctrl
tissue: PBMCs;	treatment: before IFNb-1a in-vivo treatment,ctrl
liver sample group: : Control,ctrl
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14474;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
Patient: E;	Time: 0;	Group: responder;	Condition: lesional,ctrl
"Sodium arsenite added to food: None; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: 10 ppb, 5wk",pert
pool of thyroids from 6 months old RET-PTC transgenic mice,pert
tissue: prostate;	normal/tumor: normal,ctrl
chip number: 23;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.53;	rin: 9.8;	transfection date: 2011-10-17,pert
"liver,12weeks,WT",ctrl
"Gata6-KO heart, CRE, biological rep1",pert
"Wild type, brain hemisphere",ctrl
tissue: glomeruli of human kidney;	disease state: control,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 25.68219,ctrl
tissue: Biceps muscle;	patient: C.b.4;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Kidney from mice treated with 7 daily iv injections of vancomycin at 50 mg/kg,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 1,ctrl
Brown Norway DPA-Treated Liver,pert
"56B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: Embryonic kidney cell line HEK;	genotype/variation: WT channel;	agent: tetracycline,ctrl
Celecoxib_#4867,pert
"DHL4, R406, 2h",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.32329,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 63 yr;	population: white;	dsm-iv: 296.89;	age of onset: 43 yr,pert
cell line: U-87MG;	treatment: parkin,pert
E14.5 fetal liver TER119+ wildtype,ctrl
genotype/variation: ACTL6a knock down,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 2 days adipocyte differentiation,ctrl
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: vehicle control,ctrl
"strain: FVB;	transduction: transformed by v-src gene;	tissue: Primary prostate epithelial cell culture, oncogene-transduced",pert
lymphocytes,ctrl
tissue: retina;	disease state: Diabetes,pert
23 weeks female,pert
Disease_status: Bipolar disorder;	Age (years): 31;	Gender: Male;	Age of onset (years): 21;	Duration of illness (years): 10;	Brain pH: 6.3;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 6,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 41, stage IIIB, HPV 16",pert
Ileum,ctrl
surgical specimen,ctrl
Mouse Spleen CD8 T cells,ctrl
Sample ID:DCBD2.1;	Twin Pair ID:TP7 ;	Clinical Status:BD1 with psychotic features ;	Age of Onset:19 ;	Age at interview & blood sampling:20 ;	Current Age (2007):24;	Sex: Male ;	Medication at interview (duration) :lithium & olanzapine (64 weeks),pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 297B;	age-at-biopsy-years: 46,pert
gender: Male;	age (y): N/A;	tissue: normal pituitary,ctrl
D425,ctrl
"Entire small intestine, wild type, control",ctrl
"differentiated U937 cells, ROS exposed, 1uM curcumin treated, 18h",pert
genotype/variation: control,ctrl
"Liver, Nrf2 deficient",ctrl
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 1",pert
mouse spinal cord,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T144,ctrl
"cell line: MCF7;	disease state: Breast adenocarcinoma, estrogen receptor-positive;	genotype/variation: MTDH WT KD",pert
SLE patient blood,pert
cell line: COLO829 melanoma cell line;	genotype/variation: control;	agent: control,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: spleen;	sample name: 4-sp2,pert
Universal Human Reference RNA,pert
subject: 15A;	cohort: 15;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 28kb;	age (y): 66;	Sex: M;	batch: Batch_5,pert
heart of 1 week control male mouse,ctrl
quadriceps_muscle_Akt1+/-_female_35wk_rep4,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD4+ T-cells",pert
race: caucasian;	age (years): 64;	stage: IC;	grade: 1;	histology: endometrioid,pert
"suprarenal aorta, aneurysm, Ang II treated 14d",pert
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
cell type: prostate cancer cell;	cell line: LNCaP;	transfection: empty vector,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 33.0;	age of psoriasis onset: 26,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 47 yr;	population: white,pert
"A549 human adenocarcinoma cell line, cisplatin-treated",pert
"NIH3T3, FGF 4 h",pert
Strain: C57BL/6;	Gender:male;	Tissue:liver,ctrl
C2,ctrl
EE_IC_3_cauc_lcm,pert
age: 55;	gender: female;	ejection fraction: 31;	left ventricular end diastolic diameter: 61;	inflammation/PVB19: positive,pert
"Undifferentiated C2C12 myoblasts, passage #11;	",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Male,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 41.25205,pert
age_years: 54;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 3,pert
genotype: Male;	age: 15 years adolescent male,ctrl
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"TNFa-OMe siRNA-B, replicate 5",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.417;	OD280: 1.217;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 337;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: lymphoblastic leukemia;	gc resistant: TRUE;	treatment: GC,pert
siZMPSTE24-treated A549,pert
microdissected epithelial cells from normal main pancreatic duct 3,ctrl
"FVB/N genetic background. 4-month old;	virgin female mice were used, mice were kept on a 12-hour;	light/dark cycle with ad libitum access to chow and water",ctrl
rat distal colon,ctrl
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,ctrl
quadriceps_muscle_Wt_female_35wk_rep1,ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD4+ T-cells",pert
S3_sham_overexpressor_12,pert
PS-NA cerebellum at new born,pert
MLL_00117,ctrl
RNA from NCCIT human cells depleted of TET2 by siRNA,pert
PBMC sample from healthy patient,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
"Cultured ovarian cancer cell line A2780, untreated",ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 2;	psoriasis duration: 7.0;	age of psoriasis onset: 41,pert
patient: 2;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
1834 cells with Tet1-expression,pert
normal liver,ctrl
Calu-3_SIN3A siRNA,pert
"8B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
RNA prepared from fibroblast cell lines treated with 10% serum for 90 min followed by 0.5 µg/ml actinomycin D for 60 minutes,pert
N11B Normal-cerebellum,ctrl
Cultured human trabecular meshwork cells,ctrl
PS_IA_2_aa_lcm,pert
genotype: Wild Type;	stimulation: stimulated with LPS and mouse recombinant IL-4 (day 2);	cell type: B cells,ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,ctrl
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
genotype variation: Nrf+/+;	treatment: air;	developmental stage: neonate,ctrl
genotype: Emu-myc;Suv39h1-/-;	transduction: Bcl2;	cell type: primary lymphoma cells from lymph nodes;	treatment: Adriamycin (ADR),pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,ctrl
XBP1s_B_cells_spleen_20_weeks,pert
Extract:LOX-1:113102;	Extract Description:GFP_0hr:113102;	Quality: Classification:Medium;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.62;	Quality: Background Mean Dev.:0.83;	Quality: Absent (%):60.38;	Quality: Absent (%) Dev.:1.65;	Quality: Scaling Factor:0.75;	Quality: Scaling Factor Dev.:1.2;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113102;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295423,ctrl
parental cell line: WA;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
WT1-null mouse embryonic fibroblasts,pert
"39B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"SRF silenced, treated with EtOH, biological rep 1",pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: F,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N16,pert
sample description: pool of total RNA from 10 human cell lines,pert
XBP1s_Tumor,pert
Brwd1 mutant_GV-stage_oocytes,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 8week,ctrl
tissue: white blood cells;	age: 7.88;	Sex: male,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 3,ctrl
"genetic background: B6/129;	genotype: Tet2 KO;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor Low CD34 positive expressing bone marrow progenitors CMP",pert
Wistar rat liver tissue following animal no exposure to orotic acid  (control),ctrl
E10.5 embryo yolk sacs,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 20;	maternal age: 19,ctrl
induced pluripotent stem cells obtained from dental pulp cells,ctrl
Cbfb-deficient Treg,ctrl
"liver, STZ-treated fed AIN93G diet for 14 days",ctrl
"liver, untreated",ctrl
age_years: 66;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
Female - caucasian - N-02-G,ctrl
"Rat pups treated with saline, sciatic nerve",ctrl
"Lymphoblastoid cell lines derived from family 1733, member 2",pert
Primary hepatocytes isolated from Donor 4 treated with Wy14643 for 24h,pert
liver_SHP-/-,pert
Brg1 mutant 2 cell embryo rep4,pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: PTD-DRBD-mediated siRNA delivery;	time: 12hr,pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp3,pert
Mouse Retina at P7,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.25205,pert
genetic background: 129/SVE;	genotype: Des(-/-);	tissue: tibialis anterior;	age: 7-9 wk;	strain: Des(-/-)/129/SVE;	treatment: 50 eccentric contractions 12 hours,pert
age: 6 weeks postnatal;	tissue: midbrain;	genotype/variation: Pink1 knockout,pert
tissue: white blood cells;	age: 13;	Sex: female,ctrl
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3 (control vector),ctrl
Time:4 day; condition:ctr;,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.74521,pert
human head and neck cancer,pert
Septic shock;	gender: Male;	Non survivor;	organism: None;	organism class: None,pert
treatment: atRA + cycloheximide;	genotype: WT;	cell line: F9,pert
"male,17,Caucasian",pert
ErbB3 DOX-KO,ctrl
"metastasis: metastatic recurrence;	Stage: 3c;	tissue: normal, homogenized",ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_287,ctrl
strain: C57BL/6;	treatment: Cebpa knockdown;	cell type: lineage-negative marrow progenitors,pert
RNA from microdissected breast cancer cells from case 655 labeled with Cy5,ctrl
spleens from mice on C57/Bl6 x 129 Sv background,ctrl
patient: 236;	current medication: None;	birth date: 11/20/53;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 15;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 2/18/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: 1/1/71;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
patient E2644,pert
strain: MBT/Pas;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
MDA-MB-231,pert
"Cervical cancer cell line, HeLa, adenocarcinoma",pert
background mouse strain: C57BL/6;	source: white adipose tissue;	genotype: Rap1 knockout,pert
strain: HNF4LoxP/- no Cre;	age: 1 month;	tissue: small intestine;	sex: male,ctrl
"age: Embryonic day 14.5;	genotype: wild type (WT);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",ctrl
patient code: 117;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: PMA,ctrl
tissue type: Lesional skin;	time: Week12_etanercept,pert
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: DMSO control,ctrl
CUTLL1 DNMAML1 GSI,ctrl
tissue: prefrontal cortex from adult wild-type mouse;	genetic background: back-crossed to C57BL/6 for 6 generations;	gender: male,ctrl
C8,ctrl
"patient 13, right arm treated with pimecrolimus until day 22",pert
age	69;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	8.2;	leukocyte count (/nl)	9;	hemoglobin (g/dl)	14.3;	platelet count (/nl)	283,pert
cell line: BL2;	transfection: LEF siRNA;	batch: 3,pert
AF cell free mRNA from 2nd trimester euploid fetus,ctrl
Female - caucasian - N-08-G,ctrl
"HSCs from female mice treated with E2, replicate 3",pert
Postmenopausal female. Estradiol treated. Patient 8.,pert
"affected status (disease state): control;	gender: male;	age-at-examination: 52;	age-at-onset: n/a;	geographical origin: Vila-Real;	clinical characteristics: Hypertension, hypercholesterolemia;	lifestyle characteristics: ever drinker",ctrl
tissue: whole blood;	disease state: global developmental delay and autistic features,pert
"RWPE1 cells treated for 48 hours with 100 nM 1,25(OH)2D",pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 10 nM;	treatment time: 24 hours,pert
cell lines HUVEC (human umbilical vein EC),pert
optic nerve head astrocyte,ctrl
Dot1l -/- day 5 after transduction with cre,pert
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD2,pert
hematopoietic stem cells transduced with Cre,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 65 years,ctrl
Septic shock;	gender: Female;	Non survivor;	organism: Staph aureus,pert
PS-NA cerebellum at 4 weeks,pert
"Gastrocnemius muscle, Smad4 KO mouse",pert
cRNA;	postnatal day 16;	NFIA deficient,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; no EGF,pert
E14.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Palate,pert
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: cancer, homogenized",pert
pre-iPSC- siRNA to Cbx3- biological replicate1,pert
Cultured hESC H1,ctrl
cDeaf,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
MPM tumor specimen 13,pert
Liver from C57BL/6NTac mouse,pert
disease state: healthy;	tissue: soleus;	age at biopsy: 76;	Sex: male;	individual identifier: 1,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 33;	sex: M,ctrl
Patient: F;	Time: 0;	Group: non-responder;	Condition: lesional,ctrl
E14 cells_control RNAi,ctrl
Mouse testicular Sertoli cell line TTE3,pert
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4-/-,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 30.0411,pert
Psoriasis-4 baseline,pert
Cervical cancer_CC128,pert
renal tissue from Nrf2 KO mice,pert
primary dermal fibroblasts treated,pert
X50 NLS 18Q TG2	F2/35	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
CON-1-PLASTIC,pert
"Brain tissue from Fisher 344 male rat, Animal #254, 200mg/kg D-Serine",pert
U2OS_siHic5_2_0h,pert
subject id: 41;	infection: DENV;	status: DF;	tissue: whole blood,pert
U2OS control shRNA_pLenti_2007,ctrl
30 day LAD ligated heart from C57BL/6 strain,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.442;	Ratio: 2.08,pert
tissue: heart;	genotype: WT;	genetic background: C57BL/6,ctrl
tissue: brain;	genotype: mutant Ndel ko/cko;	age: P0,pert
PancreaticSample11-Normal,ctrl
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: ALK inhibitor CEP-14083,pert
35/1-22 - Dox_1,ctrl
heterozygot FH P276 (human CD3 positive T cells),pert
"Patient  L, lesion, 2 week",pert
"cerebellum, wild type, 3 month",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.899;	OD280: 1.476;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 56;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 2,ctrl
Subtype: RARS;	Karyotype: other,pert
agent: ConA;	time point: 3 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"liver, genetic control, Nrf2(+/+)",ctrl
hOB695_shEV_0hr,ctrl
Endometrium/Ovary-Disease 9,pert
"Uninfected, replicate 3",ctrl
age: 53;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 5;	Exposures: 3,pert
NTG mouse heart left ventricl,ctrl
HEL cell line_Control shRNA (Luc),ctrl
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: SRC-2 knockout (KO);	tissue: heart;	age: 10-12 weeks old,pert
control participant P328wh (human CD3 positive T cells),ctrl
RV63.04_CONTROL_day19,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 36.89315,pert
"Liposarcoma culture from tumor 401, doxorubicin treated",pert
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing induced Tet1,pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 knock out mouse, chow diet, liver",pert
HEK293 F5 WTX inducible,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 214,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: naïve,ctrl
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",pert
"T1.5 fetal heart (treated on gd1.45 via oral gavage, collected on gd17.5)",pert
subject: 5;	disease: TD;	muscle: GR;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 46.39726,pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 23;	maternal age: 24,pert
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
"Whole blood - mental retardation or developmental delay, Female",pert
Flexor carpi ulnaris from cerebral palsy patient,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 3,pert
HeLa cells transduced LKO control lentivirus.,ctrl
"Mouse liver, MAT1A knockout, non-alcoholic steatohepatitis, 8 months",pert
Gender:male,pert
ATCC HTB-30,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.45479,pert
Strain: C57BL/6 wildtype P7,ctrl
Array Type: HG-U133A_2;	Ratio: 1.96;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Wild-type mice following nicotine-induced seizures,pert
Disease_status: Healthy control;	Age (years): 52;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
melanoma cell line,ctrl
"Only sedentary male subjects were recruited. Patients with type 2 diabetes were either treated by diet alone or in combination with sulphonylurea or metformin, which were withdrawn one week prior to the study. The patients were all GAD65 antibody negative and without signs of diabetic retinopathy, nephropathy, neuropathy or macrovascular complications.",pert
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro technologies;	Cause of Death: Hypoxia;	Tobacco Use: None,ctrl
"fetal sex: female;	karyotype: 46,XX",ctrl
Cochleae from a9 null mice at P60,pert
Genotype: MMTV-c-myc/Hunk WT; Gender: Female; Tissue: Mammary gland tumors; Strain: FVB,ctrl
strain: C57BL6/J;	genotype/variation: wildtype;	age: 8wks;	developmental stage: adult;	gender: male;	agent: vehicle (saline);	tissue: liver,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 150min;	race: Caucasian/White;	sex: Female;	group: Con;	prototype: N,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 17;	maternal age: n/a,ctrl
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 2 Days,ctrl
cell line: HT144;	transfection: siRNA targeting CITED1,pert
Vehicle 24 hours_3,ctrl
"wild type Treg, replicate 1",ctrl
Human Umbilical Vein Endothelial Cells (HUVEC),ctrl
CON - R18,ctrl
skin,pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14440;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
"pancreas, control diet, sham injected",ctrl
Ovarian cancer cell line,ctrl
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
patient code: 138;	gender: Male;	age: 50;	tumor grade: 2;	t-stage: 2;	n-stage: 1;	ajcc classif. (2002): 2b,pert
cell line: PC-3;	treatment: siAgo1,pert
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: sphingosine-1-phosphate (S1P) lyase knock-out,pert
"T1.5 fetal heart (treated on gd14.5 via oral gavage, collected on gd 17.5)",pert
ex vivo cultivated melanocytes,ctrl
Female - caucasian - N-06-G,ctrl
strain: C57/BL6;	genotype/variation: wild type;	gender: male;	age: 8-9 weeks;	tissue: liver,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 72;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
Female - caucasian - N-03-G,pert
wild type,ctrl
pooled reference mRNA from 4 harvests of MCF-7 cells,ctrl
Human prostate cancer tissue,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	sex: Male,pert
NIH3T3,ctrl
RNA from whole tissue section of case 829 labeled with Cy5,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 33;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
neurectoderm derived from embryonic stem cells,pert
Whole blood,pert
"GV oocyte, Rnf2 mutant",pert
Heart sample3,ctrl
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: Cre adenovirus",pert
Dysf +/+ control mouse muscle,ctrl
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep4,ctrl
"U937 cell line, transduced with shSYK_2 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
laminin alpha 2 chain deficient mouse,pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-WT;	agent: aflatoxin B1 (AFB1),ctrl
"liver, SCD+/+",ctrl
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
peripheral blood CD8 T cells,ctrl
FCHL patient #98-1174,pert
Gfp purified photoreceptors,pert
Supraoptic nucleus_1d Dehydrated,pert
human skeletal muscle from insulin sensitive individuals after insulin therapy,pert
"Mouse, WT, colon, UT, rep2",ctrl
MDA-MB231 control shRNA cells,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T2, N2, M0, G4",pert
strain CD-1 mouse. RV was isolated by laser capture microdissection.,ctrl
"Cnr1-/-/Cnr2-/- female number 3, 2 months old, whole ear tissue, untreated control ear",pert
Bach2 KO Thymus,pert
Macrophages obtained from a contralateral lung segment challenged with saline,ctrl
PancreaticSample20-Tumor,pert
"whole-blood leukocytes, etanercept, 4hr",pert
"gender: Female;	age: 67;	post-mortem delay: 3.5h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 48 yr;	population: white;	dsm-iv: 296.53;	age of onset: 31 yr,pert
Cy5 labeled Liver RNA,pert
cell type: Mouse embryonic fibroblasts;	genotype: wild type;	time: CT18,ctrl
cell type: Primary hepatocytes;	strain: BL6;	agent: Wy14643;	time: 24h;	gender: Male;	age: 2 months,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 39;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
gender: female;	genotype: Wild type for TWIST2;	ethnicity: Puerto Rican,ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: P14,pert
gonadal white adipose tissue_Sfrp5 KO_8 weeks of high-fat diet,pert
treatment: si221;	cell line: MCF7-FR,pert
chip number: 17;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.67;	rin: 8.7;	transfection date: 2011-10-17,pert
primary normal lung tissue 1074,ctrl
EB_2_8d_222_HCHO_Nasal_Rat230_2_CIIT05024,pert
"skin fibroblasts, passages #3 and 5",pert
male;	38 yr old;	White,pert
"Mmp10-/- epithelium, uninfected, 0h",pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 71;	tissue: Blood,pert
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 2",pert
"150 pos, CD 48 neg, Lin neg Sca and c-kit pos BM cells",pert
cell line: SV589;	knockdown (days): 15;	treatment: no treatment,ctrl
"BOEC, not_at_risk 7",pert
Mouse female ES cells PGK12.1 after double RNAi treatment of Kdm6a siRNAs. Kdm6a RNAi experiment-2 in PGK12.1.,pert
treatment: siYAP RNA #2 transfected;	cell type: Primary cell line,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 10,pert
hNHEPS human hepatocytes not exposed to VX at 6 h,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 1;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 46 yr;	population: white;	dsm-iv: 295.9;	age of onset: 22 yr,pert
"mortality: alive;	ethnicity: White;	gender: M;	age (yrs): 38;	ld: ETOH;	creatnine: 1.4;	mdrd: 60;	gfr: 57;	protein: 0;	hematuria: 0;	c3: 1;	c4: 0;	rf: 30;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.2;	meld: 11;	ana: NEG;	gp: normal parenchyma by LM and IF, limited sample;	mm (mesangial matrix expansion): 0;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 0;	as (arteiosclerosis): 0;	igg: 0;	iga: 0;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: P;	no of glomeruli: 3;	glomerulosclerosis: 0;	intact t: 1;	arteries: normal;	if: IGM+ mesangial;	mesangium ig: M;	tissue: Kidney_Biopsy_Liver_disease",pert
"Cell type: endothelial, age:47, gender:female, diagnostic group: schizophrenia, PMI:30h",pert
"Huh7 cells, JFH-1 Infected, 24 hours.",pert
"B cells, wild type, unstimulated",ctrl
RNA: whole lung;	strain: C57BL/6;	genotyp: myd88 -/-;	infected: no;	replicate: B,pert
Lung of hemorrhaged animal 72h,pert
EB_400_6_372_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
KO_lung_PBS_control,ctrl
"ME180 cells, 10μM ATRA, 1 hour",pert
Age: 47;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
cell line: SV589;	knockdown (days): 8;	treatment: Serum Starved; no EGF,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: corn oil,ctrl
treatment: 1 ug/ml doxycyline;	time: 53 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE] ",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Heterozygote,ctrl
E14.5 top2b-/- brain,pert
agent: Cadmium 0.2 µM,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep6",ctrl
"Fibroblasts from UIP histology lung tissue, IPF-20",pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: 2 h 100 ng/ml TNP-BSA,pert
cell line: HeLa cervical carcinoma,pert
Anterior tibialis,pert
prefrontal cortex (BA10);	control,ctrl
Tissue: primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 48h,pert
"brain, motor cortex, fast spiking interneurons, Mecp2 null",pert
"D3T treated rat liver, snap frozen",pert
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
GFP+ cells from Sox9-EGFP Mus Musculus pancreas at p23,pert
gender: Male;	tissue: Tendon;Patellar;	age: 41;	donor: 10;	disease state: Lesional,pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_1,pert
Ebola-infected macrophages harvested at 1h post-treatment from donor 1,pert
Placenta_PE(LO)4 with Cy5,pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 12 hour",ctrl
chip number: 6;	transfection plate: 1;	target gene: E2F1;	kd level: 0.8;	rin: 9.6;	transfection date: 2011-03-29,pert
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 8",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 216,pert
skin: normal,ctrl
"frontal cortex, schizophrenia",pert
ApoE-/- mouse infected with a control adenovirus expressing GFP,ctrl
56 Day Mouse extraocular muscle,pert
8 wk old male C57BL10 diaphragm,ctrl
ESCs_pCIP siRNA 2,pert
MCF7 Control cells Array 2,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
wild-type male mice non-treated,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIIA, HPV 16",pert
Ileum epithelials cells,ctrl
age_years: 34;	sex: F;	ethnicity: Black;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
cell type: T cell;	disease state: control participant,ctrl
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 10;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
Paclitaxel-sensitive,ctrl
skeletal muscle myoblast_OE_day0,pert
Celecoxib_#4873,pert
"Morphology: epithelial, Organ: lung, Disease: adenocarcinoma (pleural effusion), Gender: male, Ethnicity: caucasian",ctrl
cell type: pre-iPSCs;	sirna mediated knockdown: Cbx3 (HP1gamma),pert
28 Day Mouse extraocular muscle,ctrl
"liver, conditional Keap1 knockout, Alb-Cre::Keap1(flox/-)",pert
"t10, surgically resected from patient of gastric cancer.",pert
cell line: prostate cancer cell line VCaP;	genotype/variation: negative control siRNA,ctrl
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous neoplasm (IPMN),pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: HIGH;	genome/variation: KIT mutation detected,pert
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 100pmol/ml",pert
Endometrium-Normal 3,ctrl
Control treated with WY14643,pert
strain: mixed background;	age: 4 months;	genotype: wildtype;	tissue: jejunum;	sample type: control littermate,ctrl
mouse NB N1E-115 cell lines,pert
"Normal testis, donor with no known history of cancer",ctrl
PC3 cells treated with Wee1inhibitorII,pert
Du145-PCAT1 cells transfected with non-targeting siRNA,ctrl
"Control mouse for dy/dy, 8 week",ctrl
migratory cells only found in diseased OA tissue with stem cell characteristics,pert
C57BL/6J-ob/ob;	Pancreatic islets;	Age: 14 weeks;	Gender: Male,ctrl
cell line: PC-3;	treatment: siControl,ctrl
"Proximal, Small Intestine 21 days old",pert
control_bronchial biopsies,ctrl
CD11b+Gr1+ cell sample_5 (derived from IL17RC Knock out mouse),pert
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
NL_aa_lcm,ctrl
mouse wild-type lung 8 h after cecal ligation and puncture surgery,ctrl
"disease group: Atopic Dermatitis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 4.5;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 100;	ige (kiu/l): normal (0-48.5 kIU/L): 36;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
human umbilical vein endothelial cells,ctrl
treatment: transfected with Ambion Silencer Select Negative Control #1;	cell type: embryonal carcinoma;	cell line: 2102Ep;	passage: 35-50,ctrl
9_2_MOE_430A_HE,pert
age: 72;	sex: M;	disease status: control subject;	Filter number: 94;	Usage number: 4;	Exposures: 3,ctrl
subject: 19A;	cohort: 19;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 22kb;	age (y): 65;	Sex: M;	batch: Batch_4,pert
"lung adenocarcinoma, cell line",ctrl
diseased cells unstimulated,ctrl
AF cell free mRNA from 2nd trimester Turners syndrome fetus,pert
"TNFa-OMe siRNA-B, replicate 1",pert
amygdala,pert
Rat liver,pert
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	treatment: Pyrazinamide;	time: 42 dpi,pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 3",ctrl
"Csbm/m mouse, cerebellum, standard diet supplemented with resveratrol ad lib",pert
"Cell type: endothelial, age:44, gender:female, diagnostic group: control, PMI:10h",ctrl
Emx2 KO mouse,pert
"Cell type: neuronal, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24729,pert
imr-32,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.386;	OD280: 0.669;	Ratio: 2.01;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 308;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Strain: C57BL/6J;	Gender: M;	Age: 9 weeks;	Treatment: untreated,ctrl
Pooled total RNAs from lymphoblastoid cells of 14 individuals,ctrl
Testicular seminoma,pert
Rat eft ventricle,pert
alveolar macrophages from bronchoalveolar lavage,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.86027,pert
"lymphoblastoid cell line from F23.05, one out of seven of insensitive group, 50*10e6 cells",pert
cell line: SW1736;	time point: 48h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 48 h,pert
Y VIS _B030,ctrl
Tendon;Biceps_Non-lesional,ctrl
"Male, 39 years old, HIV infection of 2 years",pert
strain: C57BL/6;	tissue: liver;	genotype/variation: Nrg4 knockout;	diet: high-fat diet fed starting at 3 months of age for eight weeks.,pert
Sample ID: TP25;	Twin Pair ID: CCN4.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
CON-3-COLLAGEN,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 101,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: High-fat diet,ctrl
patient id: 1524;	tissue: Normal cortex;	gender: Male;	age: 70;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
scan batch: Batch 2;	group: control;	subject age: 7;	paternal age: 35;	maternal age: 28,ctrl
Gender: female;	Age: 63;	Source: left lower leg,pert
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 1",ctrl
Mus musculus liver - wildtype,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 1;	Exposures: 3,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 39.88219,pert
chip number: 19;	transfection plate: 4;	target gene: RDBP;	kd level: 0.73;	rin: 9.1;	transfection date: 2011-10-17,pert
Primary brain tumor tissue,ctrl
patient: 40726;	sample: normal,ctrl
infection: seasaonal H1N1 Influenza virus;	cell type: cultured primary human lung epithelial cells,pert
pancreatic beta-cells,pert
MCF-7 cells treated with E2 for 3h.,pert
diagnosis: COP;	fvc-group: FVC3;	tissue: lung,pert
"37B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
affected status (disease state): control;	gender: male;	age-at-examination: 72;	age-at-onset: n/a;	geographical origin: Vila-Real;	lifestyle characteristics: ever drinker,ctrl
cell line: SCOV3,ctrl
Mouse Left Ventricle,ctrl
"metastasis: none;	Stage: 2a;	tissue: normal, homogenized",ctrl
"Trained mice, time point 5 week",ctrl
Extract:LOX-1:213203;	Extract Description:LOX1_Untreated_2hr:213203;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.76;	Quality: Background Mean Dev.:0.44;	Quality: Absent (%):57.87;	Quality: Absent (%) Dev.:0.3;	Quality: Scaling Factor:0.58;	Quality: Scaling Factor Dev.:0.29;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213203;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295553,pert
T cells,pert
"genotype: wild type (Wutz et al., 2000);	cell line: ES",ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 44.2600958247776;	age of psoriasis onset: 8,pert
"Patient  C, lesion, 4 week",pert
gender: Female;	age: 89;	post-mortem delay: 5h;	ph: 6.5,ctrl
tissue: arterial;	status: normal,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 998;	treatment: BETAFERON;	time: 24 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
CML cell line: KU-812,ctrl
"HSCs from female mice treated with oil, replicate 2",ctrl
sample 1:;	age: 46;	gender: male;	sample 2;	age: unknown;	gender: unknown,ctrl
race: caucasian;	age (years): 57;	stage: IA;	grade: 1;	histology: endometrioid,pert
multiple sclerosis_8,pert
"wt, no doxycycline",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 41;	maternal age: 39,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
race: caucasian;	age (years): 58;	stage: IC;	grade: 3;	histology: endometrioid,pert
cell type: hepatocytes,pert
"Human lung adenocarcinoma A549 cells treated with TNFα, in presence of control siRNA",ctrl
patient: 7;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"Patient  A, lesion, time: 0",ctrl
WT_laser captured Paneth cells,ctrl
FCHL patient #99-0712,pert
Adipose tissue from male Casp1-/- animal (C57/Bl6 background),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.749;	OD280: 0.86;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 220;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 3,ctrl
chip number: 13;	transfection plate: 5;	target gene: RELA;	kd level: 0.62;	rin: 9.3;	transfection date: 2011-10-17,pert
induced pluripotent stem cells obtained from dental pulp cells,pert
Cbfb-deficient Treg,pert
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT6,ctrl
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: lapatinib,pert
P28 testes Dhh Cre,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: Schistosoma japonicum;	time point: 7 weeks post infection 20 cercariae,pert
breast epithelium from reduction mammoplasty,ctrl
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",pert
Superior Frontal Gyrus from a 5 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
cell line: NOMO-1;	genotype: ZFX wild type,ctrl
MCF-7 Control,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 49.07945,pert
Total RNA from Ph+ ALL (C57Bl6 and Bach2 -/- background),pert
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Bone Marrow CD34+ progenitors cells,ctrl
"NOD islets, non-transgenic",ctrl
Gene expression profiling of normal cortex of patient 111,ctrl
HUVEC cell culture,ctrl
Disease_status: Healthy control;	Age (years): 54;	Gender: Male;	Post mortem interval (hours): 10;	Braak stage: II;	Cause of death: Aortic aneurysm,ctrl
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
"Female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
normal skin from controls,ctrl
"cell type: PBMCs;	disease state: acutely admitted, severely psychotic schizophrenia patient;	gender: male",pert
Mock infected macrophages harvested at 6h post-treatment from donor 3,ctrl
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 31;	maternal age: 30,ctrl
type_of_rx: AF;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,pert
sex: Male;	family: 2;	age: 66;	disease status: Asymptomatic;	tissue: Muscle: Deltoid,pert
"female Spargue-Dawley rats, Targretin, 60 mg/kg BW gavage for 7 days, tissue: lung",pert
SCLC cell line SBC-3,pert
lumbar spinal cord,ctrl
"Mouse Sciatic Nerve, Control Rosi",ctrl
"pancreas, control diet, male Wistar rat",ctrl
"Male, Wistar, 6hrs/day access to cocaine, amygdala",pert
cell line: E14;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
8 weeks cardiac muscle,ctrl
cell line: THP-1,ctrl
strain: F1 generation of CBA x C57BL/6J;	tissue: Mouse testis;	time: 15days;	genotype/variation: WT,ctrl
PBMC RNA from a healthy control,ctrl
cell line: H1993;	tissue: Lung adenocarcinoma,ctrl
tibialis anterior muscle,ctrl
pool,pert
siSox2,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.21096,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 3,pert
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,pert
Whole body,ctrl
"lymphoblastoid cell line from R, one out of seven of sensitive group, 50*10e6 cells",pert
rtTA-Dmrt5 day 7 +Dox,pert
genotype: DTG;	diet: high fat;	muscle hypertrophy: +;	sex: male;	tissue: liver;	treatment: doxycycline 3wks,pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 4,ctrl
"fatty (fa/fa), adipose tissue (epididymal), Troglitazone",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",pert
nfia E18KO2,pert
cell line: U20S;	tissue type: osteosarcoma,pert
SHEP-SF neuroblastom,ctrl
MPM tumor specimen 1,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 48 yr;	population: white,ctrl
disease state: healthy control;	tissue: epidermis;	age: 33;	gender: female;	treatment: untreated;	time: control,ctrl
"Fmr1 knockout mouse, cerebellum",pert
Homogenized lung tissue,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.442;	OD280: 1.248;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 205;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 72h,pert
gender: female;	agent: E2;	cell type: Hematopoietic stem cells,pert
genetic background: CD1;	genotype: WT;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,ctrl
subjects: patient with AAA undergoing open surgery to treat AAA;	tissue type: non-aneurysmal AAA neck tissue,pert
strain: C57BL/6;	gender: male;	cell type: ESC-like cells;	genotype/variation: Prdm14 Knockout;	culture conditions: 2i,pert
cell line: MCF-7;	cell type: Breast Cancer Cells,ctrl
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: saline,ctrl
subject: 34;	disease: CP;	muscle: GR;	gender: M;	age: 15.2;	gmfcs: 2;	popliteal angle: 120,pert
strain: C57BL/6;	genotype: Myd88 null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
sarcoma tissue,pert
RNA from whole tissue section of case 843 labeled with Cy5,pert
treatment: control siRNA;	cell line: PC3,ctrl
S10B Sporadic-cerebellum,ctrl
Wt CD9+ trophoblasts,ctrl
Aquaporin-11-/-_mouse P7 kidney #1-2,pert
"BOEC, normal 15",ctrl
Strain: Inbred C57BL/6J;;	 Gender: male;;	 Age: day of life 3;;	 Tissue: liver,ctrl
CHF - R10,pert
Primary brain tumor tissue,pert
No_drug_#4860,ctrl
liver from control mouse,ctrl
agent: EphB2-Fc conjugate;	time: 1h,pert
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 63 dpi,pert
tissue: white blood cells;	age: 16.02;	Sex: male,pert
tissue: Frontal cortex;	age: 92;	Sex: F,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 5.3;	colon weight (mg): 149;	colon ratio (mg/mm): 2.811;	myeloperoxidase activity (u/mg): 0.208;	tissue: colon;	treatment: 5% DSS,pert
knockdown: Control;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 7.7;	colon weight (mg): 157;	colon ratio (mg/mm): 2.04;	myeloperoxidase activity (u/mg): 0.038;	tissue: colon;	treatment: 5% DSS,ctrl
small_intestine_complete_24h_fasted,ctrl
treatment: Sirt1 siRNA Knockdown 1;	cell line: Caco-2,pert
primary osteoblasts treated,pert
"age at diagnosis: 67;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1bi;	er: 1;	pgr: 1;	dfs-month: 29;	dfs-event: 1;	distant metastasis: 1",pert
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 24 months;	genotype: Wild type,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,ctrl
cell line: BL2;	transfection: scrb siRNA;	batch: 3,ctrl
pancreatic cancer cell line MiaPaCa2 containing AGR2 overexpressing vector pCEP4 -AGR2,pert
patient id: 26;	tissue: Normal cortex;	gender: Female;	age: 77;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 66,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 310;	age-at-biopsy-years: 60,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.042;	OD280: 1.079;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 216;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
WT V6.5 ESCs on day 0,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 27;	Duration of illness (years): 21;	Brain pH: 6.1;	Post mortem interval (hours): 13;	Side of brain: Right;	Fluphenazine mg. Equivalents: 200;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
Striatum of 8-10 week old SWR/J mice,pert
CD19 selected B-cells,ctrl
wild type; BMDM; not treated,ctrl
Human hepatocellular carcinoma cell line,pert
"Pou4f1+/+ cells, transduced with control virus",ctrl
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 96;	Usage number: 4;	Exposures: 3,pert
treatment group: inorganic arsenic 0.1 uM;	cell line: TK6 cells,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 23.6137,pert
wildtype (GFP-negative) kidney cells,ctrl
ICR MEF infected  with pMX-jhdm1b retrovirus,ctrl
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Moderate-responder).,pert
Gender: female;	Age: 10 weeks,ctrl
MC3T3 cell line,ctrl
TTF=135min;	Race=Black or African American;	Sex=Female;	Group=B;	Prototype_N,pert
knockdown: control;	cell line: MCF7,ctrl
Airway epithelial cells,ctrl
Kyoto Rat liver tissue following animal exposure to orotic acid for 14 days,pert
alveolar epithelial cells exposed to cyclic stretch 20% elongation,pert
race: asian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
Extract:LOX-1:213403;	Extract Description:LOX1_Untreated_12hr:213403;	Quality: Classification:Good;	Quality: Gradient Severity:0.1;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.79;	Quality: Background Mean Dev.:0.74;	Quality: Absent (%):59.36;	Quality: Absent (%) Dev.:0.86;	Quality: Scaling Factor:0.66;	Quality: Scaling Factor Dev.:0.42;	Pretreatment [C]:LOX1;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_12hr;	RNA extraction source key [A]:282295793,pert
transfection: shPARP-2 transfected,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: pre-UV,pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: PAX3 siRNA,pert
COLO829 cells with shMITF knockdown and PLX4032 treatment,pert
Rb-/- prostate epithelial cell line,pert
MLL_PTD12,pert
"LCL GM19238, Kd IRF5, 72hrs",pert
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1953348007;	hybridization batch: III,ctrl
"BOEC, normal 19",ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,ctrl
adult hearts,ctrl
genotype/variation: C57BL/KLS-leprdb/leprdb (db/db),pert
Affected,pert
TK6 cells,ctrl
chip number: 3;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.4;	transfection date: 2011-03-29,pert
RNA from microdissected breast cancer cells from case 1093 labeled with Cy5,ctrl
treated Murine 3T3-L1 cells,pert
strain background: Sprague Dawley;	gender: male;	diet: isocaloric control diet without EtOH for 6wks;	sample group: Control;	cell type: Alveolar type 2 cells,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 3",pert
Disease_status: Healthy control;	Age (years): 46;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 31;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 23;	Brain pH: 6.2;	Post mortem interval (hours): 19;	Side of brain: Left;	Fluphenazine mg. Equivalents: 60000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: Bmal1 KO,pert
cell line: Breast carcinoma cell line Cal51;	genotype/variation: IPMK depletion;	agent: MMC,pert
NORMAL LIVER,pert
model: Fischer 344;	gender: Male;	age: 21 to 22 months old,pert
genotype: p300+/-;	replicate: 3;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
patient: 30162;	sample: normal,ctrl
CRG,ctrl
sirna: Claudin 1;	treated with tnfα: YES,pert
RNA: whole lung;	strain: C57BL/6;	genotyp: wt;	infected: no;	replicate: A,ctrl
EB_07_8d_144_HCHO_Nasal_Rat230_2_CIIT05024,pert
Insig1 ∆/∆ /Insig2 -/-,pert
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 3 Days,pert
"male;	CABG patient, atrial tissue, sevoflurane anesthesia, after CABG surgery",pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 46;	maternal age: 42,pert
cell line: H1993;	tissue: Lung adenocarcinoma,pert
cell type: MCF-7;	sirna: SPDEF,pert
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b retrovirus,pert
Differentiation of hES cells line VUB01 towards neural rosettes;	Neural precursor phenotype,ctrl
strain: FVB/N;	tissue: forebrain,ctrl
25 weeks female,pert
"Patient #4, Untreated",pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,pert
"Human lung adenocarcinoma A549 cells treated without TNFα, in presence of Claudin 1 siRNA",pert
"tissue: kidney;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: monuron 72 hr",pert
Primary hepatocytes isolated from Donor 3 treated with DMSO for 6h,ctrl
disease state: normal skin,ctrl
chip number: 14;	transfection plate: 4;	target gene: HCST;	kd level: 0.87;	rin: 9.6;	transfection date: 2011-10-17,pert
genotype: WT;	tissue: brown adipose;	genetic background: 129,ctrl
Squamous cell lung cancer patient 35,pert
genotype/variation: Fbn1 wild-type;	tgfbr2 status: conditional disruption of Tgfbr2;	tissue: ascending aorta;	age: 6 weeks,pert
CD4+YFP+Ly5.2+ from Foxp3delta,pert
PancreaticSample16-Tumor,pert
Neurointermediate lobe _3d dehydration,pert
disease status: autism;	tissue (brain region): Temporal cortex,pert
Patient identifyier: D;	Sex: male;	Age of patient: 61 years;	Duration of psoriasis: 21 years;	Body surface area: 12 percent;	Overall erythema: mild;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#1,ctrl
Cervical carcinoma,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 52;	age-at-onset: 48;	geographical origin: Mirandela;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever smoker, ever drinker",pert
"Cells: U2OS, Treatment: infected with PRC shRNA4_pLenti, blasticidin selection",pert
T21.01,pert
SKGT4 cell line,ctrl
"NALT infected with 90-226att, 24h, biological rep2",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 69,pert
"muscle, knock out",pert
"129 Wildtype mice, pineal glands taken at postnatal day zero",ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M0;	flt3 status: WT,pert
Normal cervix_03-5657,ctrl
"Csbm/m mouse, cerebellum, old, nicotinamide riboside treatment",pert
P5A Progranulin-frontal,pert
WT_Regulatory T-cells CD4+CD25+,ctrl
hOB1705_shEV_24hr_IR,pert
A673 cell line that has been treated with Doxorubicin for 5 days with concentration of 119.76 nM (2 x EC50).,pert
ID: MLL_00117;	cell type: PBMC;	disease state: control,ctrl
"Gastrin Knockout, 2 month old male mice parietal cell",pert
rat heart ventricle,ctrl
HepG2_vehicle_24hr,ctrl
"MCF10A cells, HER2 over-expression",pert
COLO829 cells with shMITF knockdown and DMSO treatment,ctrl
sciatic nerve of P60 Pmp22 knockout mice,pert
genotype/variation: wt;	age: E12.5;	tissue: whole eye,ctrl
cell line: NB4;	genotype: wild-type;	treatment: untreated;	biological replicate: 1,ctrl
A HID B_B043,pert
gender: male;	dietary group: grape extract (B);	time point: 6 months;	cell type: Isolated peripheral blood mononuclear cells (PBMCs),ctrl
Sex: male;	Age at operation: 76 years;	Site: thigh;	Size in cm: 3.5x3x3;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: non-recombinant clone 24 (STAG2 wild-type),ctrl
cell line HCT-116,pert
"hMSC-Tert, control siRNA, 5 days osteoblast differentiation",ctrl
"SBC-5 cells, siEGFP (control), 48 hr after siRNA, duplicate sample 1",ctrl
individual: patient9;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"ID: MLL_00248;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
"18 weeks old normal mice, cerebellum",ctrl
Hdh mutant (111/111-polyQ) 3,pert
Human medulloblastoma DAOY cell line,ctrl
Strain: B6SJL;	Age: 110 days;	,ctrl
"Neural precursor cells derived from hES cells line VUB03_DM1, biological replicate  3",pert
subject: 12B;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
whole kidney from WT mice,ctrl
strain: C57BL/6J;	Sex: male;	expression: sh-PRDM16;	agent: rosiglitazone at 1uM,pert
"Huh7 cells, Mock Infected, 48 hours.",ctrl
8 wk old male mdx quad,pert
Adult WT mouse whole brain,ctrl
RNA from microdissected breast cancer cells from case 1260 labeled with Cy5,ctrl
Y SIT_B074,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 146;	time: 0;	batch: 3,ctrl
6 h-control (EtOH),ctrl
"Strain: Mixed genetic background, predominantly (>87.5%) C56BL/6 with some CD1. Genotype: Mx1-Cre negative: PTENfx/+. Sex: Female;	Age: eight and a half weeks (at tissue isolation). Tissue: Small Intestine (jejunum/ileum region). ",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 83;	Sex: male;	region: M1;	age: 38;	genotype: Y/X;YFPH/-,ctrl
subject: 09U;	cohort: 9;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
strain: C57BL/6J;	genotype/variation: WT;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),ctrl
sex: male;	tissue: liver,ctrl
"HSCs from male mice treated with oil, replicate 2",ctrl
MEFs,pert
tissue: Temporal cortex;	age: 54;	Sex: F,ctrl
tMLL10,ctrl
cell line: prostate cancer cell line VCaP;	genotype/variation: MYB siRNA,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 38.0;	age of psoriasis onset: 7,pert
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/16;	differentiation status: undifferentiated;	cell line: Q20,pert
cell line: CUTLL1 (T lymphoblastic leukemia / lymphoma),pert
"Strain: C57BL/6, ADNP+/- Gender: mixed Age:E9 Tissue: whole embryonic body;	Please refer to: Activity-dependent neuroprotective protein: a novel gene essential for brain formation.;	Brain Res Dev Brain Res. 2003 Aug 12;144(1):83-90. ;	PMID: 12888219 [PubMed - indexed for MEDLINE]",pert
"maternal exposure to dioxin, HypM",pert
Mouse spleen at 4 month,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 44 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
"Mouse brain, Adult, 4hr post Saline ip injection",ctrl
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: prenatal stress,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 352;	age-at-biopsy-years: 41,ctrl
adult hearts,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
cell type: induced pluripotent stem cells,pert
"FACS-sorted cones, P90 C-DGCR8 KO mice",pert
MGHU3 Cells_Control siRNA + PD173074,ctrl
Strain: RPE65-/-;	Age: 4 months;	Tissue: retina,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: sigenome non-targeting siRNA;	genotype/variation: negative control,ctrl
microdissected epithelial cells from IPMA 3,pert
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 29;	maternal age: 37,pert
"new born normal mice, cerebellum",ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: untreated,pert
"Ishikawa cell line, BPA, 10nM, 24hr",pert
"brain, locus coeruleus neurons, Mecp2 null",pert
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,ctrl
"disease state: Nasopharyngeal carcinoma;	stage: III, T3, N2, M0, G4",pert
Healthy controls; individual=CJ; time=2; beverage=alcohol,pert
tissue: cell line: MDA-MB-231;	transfection: pcDNA6/V5-His plasmid,pert
microdissected epithelial cells from IPMC 5,pert
cell line: MCF-7 breast cancer cells,ctrl
"SWR/J Chronic morphine treated, biological replicate 2",pert
"Well-differentiated human lung epithelial cells, infected with BN/59 (seasonal H1N1) for 36h",pert
clone type: AtT20 clone types overexpressing NSBP1SE protein rep2,pert
"Hippocampus, soman, 96h",pert
RNA from microdissected breast cancer cells from case 605 labeled with Cy5,ctrl
primary human monocyte-derived macrophages,ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: IFNβ,ctrl
"Age: 59;	Sex: M;	Ancestry: European;	Smoking status: smoker, 60 pack-years",pert
tissue: inner ear;	genotype/variation: Wild-type;	age: E10,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.631;	OD280: 0.833;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 146;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: embryonic stem cell;	genetic background: C57BL/6;	genotype: Prdm14 knockout,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 2,pert
"patient 16, baseline",ctrl
Cultured trabecular meshwork cells,ctrl
gender: Male;	tissue: Tendon;Quadriceps;	age: 41;	donor: 10;	disease state: Non-lesional,ctrl
A HID U_B089,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 73;	gender: f;	treatment: -,ctrl
Rarb null mammary stroma,pert
disease: Down syndrome;	gender: female;	age: 6 months;	tissue: thymus,pert
sampleID: SAM630130;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
"Liposarcoma culture from tumor 393, untreated",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: pineal gland;	time: ZT20,ctrl
MPM tumor specimen 19,pert
Sample Group: HD patient; Gender: female; Age: 61; Tissue: lymphocytes (blood); IT15 CAG repeats: 19/44,pert
phytohemagglutinin-activated PBMCs from normal control subject J,ctrl
"age at diagnosis: 25;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T3;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 25;	dfs-event: 1;	distant metastasis: 1",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 59.49589,pert
Brain from 62 days Npc1-/- mouse1,pert
HCC_36N,ctrl
cell type: Embryonic Stem Cell;	genotype: wild type;	strain: C57BL/6,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 43 yr;	population: white;	dsm-iv: 296.64;	age of onset: 25 yr,pert
race: african american;	age (years): 55-60;	stage: n/a;	grade: n/a;	histology: inactive endometrium,ctrl
U937 cell line infected with GSK3B Construct 2 shRNA,pert
"mental retardation or developmental delay, Female",pert
"heart, middle septum",pert
treatment: progesterone;	genotype: wild type;	treatement time: 4 hours,ctrl
Human heart,ctrl
HCC_19T,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 81,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 33;	gender: male,ctrl
"Lymphoblastoid cell lines derived from family 1725, member 2",ctrl
cell line: H1299;	agent: decitabine;	dose: 3 uM,pert
subject: 12V;	cohort: 12;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: >112kb;	age (y): 45;	Sex: F;	batch: Batch_3,ctrl
Sample ID: TP40;	Twin Pair ID: CCE4.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-10.5;	Age at interview & blood sampling: 31;	Current Age (2007): 34;	Sex: MALE;	Medication at blood sampling : Epilim,pert
12 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratox;24730,pert
"Sham NALT (PBS), biological replicate 4",ctrl
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 9,ctrl
microdissected muscle fibers,ctrl
Gender: Male;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: YES,pert
"Patient #6, Untreated",pert
age: 21 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),ctrl
strain: FVB/NCrIBR;	tissue type: ear skin,pert
Mouse C2C12 Myotubes treated with BSA for 16 hours,ctrl
Brain tissue from glioma patient,pert
cell type: HaCaT cells at day 12 of calcium induced in-vitro differentiation;	shRNA transfection: ZNF750 gene silencing,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.929;	OD280: 1.018;	Ratio: 1.86;	Dilution: 1:5;	RNA Integrity Number: 8.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 233;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
wild-type macrophages stimulated with MALP-2 for 2 h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.607;	OD280: 0.846;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 213;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
scan batch: Batch 1;	group: control;	subject age: 8;	paternal age: 24;	maternal age: 25,ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
DN4 cells sorted from mouse n°131 (Cre-),ctrl
mouse TMJ-cartilage from DDR-1-KO mouse KO_Tal2,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep4",pert
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",pert
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; 3h EGF,pert
"gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
strain background: mixed;	tissue: retina;	Stage: E14;	onecut genotype: WT,ctrl
Diagnosis: MDS/AML;	Age: 79y ;	Gender: Male;	Blast %: 87;	Source: PB;	Cyto: Normal;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 3,pert
Patient 4 appendix,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 54;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Mouse colonic epithelial cell line MCE301,pert
"Control #9, Untreated",ctrl
strain background: C57/129S;	genotype/variation: Fra-1-/-: Fra-1 KO;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,ctrl
tissue: Whole pancreas;	genotype: WT;	background: C57BL/6;	age: 8 weeks,ctrl
tissue: gastrointestinal stromal tumor (GIST);	cell type: freshly sorted tumor associated macrophages (TAMs),pert
Kyoto Rat liver tissue following animal exposure to orotic acid for 3 days,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
HT29 cell line,ctrl
"WT mouse cortex, P29",ctrl
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
HLA risk: Low;	Height: 157.3 cm;	Weight: 54.4 kg;	BMI: 21.9;	Age: 24.43 years;	Gender: Female;	Race: White;	Glucose: 95 mg/dl;	HbA1c: NA,ctrl
Left ventricular myocardium in patients with Dilated cardiomyopathty,pert
infection: Un-infected control;	cell type: cultured primary human lung epithelial cells,ctrl
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: mild;	Induration: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
CP Pool,ctrl
"new born PS-NA mice, cerebrum",pert
chip number: 12;	transfection plate: 5;	target gene: SREBF2;	kd level: 0.8;	rin: 9.2;	transfection date: 2011-10-17,pert
A HID I_B047,pert
age_years: 35;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
retina at age PN40,pert
biopsy of undifferentiated NPC,pert
subject id: 49;	infection: DENV;	status: DHF;	tissue: whole blood,pert
ak_12,pert
MPM tumor specimen 10,pert
Colon 17 days old,ctrl
brown adipose tissue,pert
"dy/dy mouse, 8 week",pert
condition: Normal;	patient: N_LJ_7;	tissue: Normal skin biopsy;	kit: Affy,ctrl
ventral prostate,pert
cell type: hRPE;	disease state: 24h post-infection with WNV;	gender: male,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Colon",ctrl
cell type: sorted LSK cells;	strain: C57BL/6;	genotype/variation: SRF wt,ctrl
Brg1 mutant 2 cell embryo rep3,pert
"WM 266.4 metastatic melanoma cell line, siCTR",ctrl
A39 WT1	F5/50	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
"human embryonic stem (hES) cells line VUB01, biological replicate  3",ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticle",ctrl
kidney biopsy from patient with NSC,pert
Mannitol control treated A549 human lung cancer cell cultures replicate B,ctrl
LIRKO liver sample 2,pert
Intestinal Epithelial Cells (IECs),pert
Placenta_nl4 with Cy5,ctrl
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks;	Tissue: thymus,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 64;	donor: 23;	disease state: Lesional,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 2;	psoriasis duration: 0.770020533880903;	age of psoriasis onset: 39,pert
strain: C57BL/6;	gender: male;	develpmental stage: embryonic day E15.5;	genotype/variation: Ing1-/-;	cell type: mouse embryonic fibroblasts (MEF cells),pert
PBMC from T cell Large granular lymphocyte leukemia patient#129,pert
construct: HDAC1 A3 shRNA;	cell type: Primary human erythroid progenitor cells,pert
"RT4D6 Schwannoma cells, treated with mutant siRNA for Sox 10, 48 hours",ctrl
mouse fetal liver at E14.5,ctrl
ST045849 24 hours_3,pert
"Age: 8 months, Sex: Female, Retina: left, Final IOP (mm Hg): 25.3, Strain:DBA/2J",pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu1,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 1,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 75,pert
"D1_non-transgenic mice, lung tissue",ctrl
cell lines HUVEC (human umbilical vein EC),ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
cell line: MDA-MB-231;	cell line origin: Breast cancer;	genotype/variation: ZMPSTE24 silencing,pert
Mouse brown preadipocyte cell line,ctrl
Wild type_VMH,ctrl
gallbladder -saline treated,ctrl
Strain: C57BL/6J;	Gender: Male;	Age: 16 weeks;	Tissue: testis,ctrl
patient E1566,pert
subject: 07A;	cohort: 7;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
"Gastrocnemius medialis, TMD",pert
F23.05,ctrl
skin derived melanocyte cell line_21day NRG1 treated,pert
Granulocyte-Macrophage Progenitors,pert
cell line: SF539;	transfection: PARK2 siRNA#1,pert
Tissue:tumor; Gender:female; Age:65  Tumor stage:T2NxMx,pert
"Tsc2 +/- mouse, cerebellum",pert
Kidney from mice treated with 7 daily ip injections of vancomycin at 50 mg/kg,pert
Mouse male ES cells WD44 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-2 in WD44.,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.9;	choa: 195;	fata: 28;	eea: 1310;	wtkg: 64.5;	perfat: 27;	lbm: 44.9;	fat_mass: 1741.5,ctrl
age: 14;	sex: M;	disease status: control subject;	Filter number: 86;	Usage number: 1;	Exposures: 3,ctrl
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 2",ctrl
cell line: M24met melanoma cell-line;	genotype/variation: wild type;	treatment: control,ctrl
"Gender: male;	Age: 75;	Source: skin, left heel",pert
"Soleus, TMD",pert
RWPE1 cells treated for 24 hours with vehicle (0.1% ethanol),ctrl
8 wk old male mdx5cv quad,pert
A549 cells exposed to cyclic stretch 20% elongation for a total of 4hrs experiemnt performed on Nov 21 2002,pert
patient E1610,pert
tissue: Brain;	genotype: Npc1+/+;	age: 60 days;	subject: Mouse2;	genetic background: BALB/c,ctrl
pancreatic cancer cell line FA6 transiently transfected with AGR2 siRNA,pert
Gender: male;	Age: 46;	Source: back,pert
tissue: Hippocampus;	age: 80;	Sex: M,ctrl
"Age: 45;	Sex: M;	Ancestry: African;	Smoking status: smoker, 70 pack-years",pert
cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
cell line: NCI-H1299;	cell type: lung cancer cells;	transfected with: shPTK7 (PTK7 knockdown),pert
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
age: 40;	sex: F;	disease status: control subject;	Filter number: 93;	Usage number: 4;	Exposures: 1,ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 1,pert
cell line: HeyA8;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
"seminoma specimen, pT1, patient age: 31y",pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 3",pert
Prostate,ctrl
subject: 30;	disease: CP;	muscle: ST;	gender: M;	age: 4.1;	gmfcs: 2;	popliteal angle: 125,pert
patient id: T22;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 67;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3N0M0;	Stage: III;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
cell line: prostate cancer cell line PC-3M;	genotype/variation: negative control siRNA,ctrl
splenocytes,ctrl
tissue: Brain;	genotype: Npc1+/+;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
tissue: skin;	individual: Patient P12;	condition: AL;	eczema severity: SCORAD: 91.1,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14465;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
strain: C57BL/6J;	genotype: wild type;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,ctrl
MLL_PTD14,pert
HTH83 cell lines,pert
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: esophagus,ctrl
EB_6_24h_289_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341073;	sentrix position: D;	experimental sample name: PC13-R,pert
cell line: HL-60;	replicate: Replicate1;	treatment: shSYK_1,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/FGFR1;	biological replicate: 2,pert
cell type: Endothelial cells;	strain: C57Bl/6;	genotype/variation: wild type,ctrl
"18 weeks old PS-NA mice, cerebellum",pert
chip number: 21;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.75;	rin: 9.5;	transfection date: 2012-03-26,pert
"pooled adult mouse intestine, kidney, and liver plus fetus tissue",pert
MDA-MB-231 - MTDH_WT_KD,pert
brownfat,ctrl
treatment: baseline;	gender: M;	age (y): 44;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: 3 days in N2B27,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 10;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 42;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: DMSO for 72h,ctrl
Hdh mutant (111/111-polyQ) 2,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: Wy14643;	time: 24h;	gender: Female;	age: 5 months,pert
MRF control littermate cultured oligodendrocytes,ctrl
Liver_WT_Vehicle,ctrl
"lymphoblastoid cell line from T6.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
67 y/o female,ctrl
"age at diagnosis: 48;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 1;	dfs-month: 34;	dfs-event: 0;	distant metastasis: 0",pert
Mesenchymal derived mouse cell line,ctrl
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Nonspecific Interstitial Pneumonia,pert
EB_07_6h_129_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2+/+;	genotype: Gastrocnemius and Soleus muscles,ctrl
"Patient  D, lesion, time: 0",ctrl
gender: Male;	tissue: Tendon;ECRB;	age: 52;	donor: 30;	disease state: Lesional,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep1",ctrl
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
Rybp#15 (OHT-)_12d,ctrl
"mouse genome informatics (mgi) strains: Dicer1tm1Bdh (MGI:3589208) X Tg(Atoh1-cre)1Bfri (MGI:3775845);	genotype: Dicer1 conditional knockout, Atoh1-Cre;Dicer1(flox/flox);	tissue: organ of Corti from cochlea, basal half;	age: postnatal day 16",pert
Tissue: normal thyroid; Gender:male; Age:36,ctrl
cell line: WA-09;	passage: 30-45;	induction: NPTX1 shRNA;	time point: Day 0,pert
Macrophages,ctrl
"liver,12weeks,KO",pert
Against CDK8-2 transfected HeLa S3 cell,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 34.13425,pert
cell line: H4-II-E-C3,ctrl
"Strain: C57BL/6;	Gender: Male;	Age: 2 to 4 months;	Tissue: Heart, left ventrical",pert
"Lung tissue of CD-1 wildtype mouse, control group",ctrl
DA rat stomach treated 1 h,pert
"Mouse jejunum, PND30",ctrl
MLL_00114,ctrl
"Strain: SPARC-null, C57Bl/6 background;	Gender: male;	Age: 28 days;	Eye: Left",pert
"Human lung adenocarcinoma A549 cells treated with TNFα, in presence of Claudin 1 siRNA",pert
"cardiac muscle, left ventricle",ctrl
Gene expression profiling of normal cortex of patient 233,ctrl
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,pert
"treatment: control;	batch: 2;	donor: 28;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of vehicle treated rat,ctrl
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Pioglitazone,pert
patient: 2;	disease state: hypertension;	tissue: Atheroma plaque,pert
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",pert
patient: 30057;	sample: normal,ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.3;	colon weight (mg): 195;	colon ratio (mg/mm): 3.1;	myeloperoxidase activity (u/mg): 0.703;	tissue: colon;	treatment: 5% DSS,pert
cell line: HCT116;	cell type: colon cancer;	sirna: CD44,pert
Age: 42;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 5382insC;	Family History: Yes,ctrl
OVCAR-3/mock cell line,ctrl
HT29 methotrexate-sensitive cells,ctrl
chip number: 16;	transfection plate: 4;	target gene: NS;	kd level: NA;	rin: 9.3;	transfection date: 2011-10-17,ctrl
CFU-PreB colonies Hspa9+/-,pert
S3B Sporadic-cerebellum,ctrl
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 retrovirus,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
Strain: Fischer 344;	Gender: Male;	Age: 6;	Tissue: Liver of vehicle treated rat,ctrl
Bladder cancer cells,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: B;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
liver_NEMO_KO,pert
gender: male;	individual: patient 4;	treatment: control,ctrl
gonadal white adipose tissue_wild-type_8 weeks of high-fat diet,ctrl
race: caucasian;	age (years): 46;	stage: IB;	grade: 1;	histology: endometrioid,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 4h,pert
"IFNAR2-/- BMMC, uninfected",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.9;	age of onset: 15 yr,pert
patient id: T144;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T2N1M0;	Stage: III;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
"age at diagnosis: 42;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 26;	dfs-event: 1;	distant metastasis: 0",pert
"skin, 1 week isotretinoin treatment",pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
"MCF7/BUS cells, human breast adenocarcinoma cell line, estrogen receptor-positive",pert
strain: FVB/NHsd;	tissue type: back skin,pert
E14.5 Tgfbr2 Wildtype Mouse Model Tongue,ctrl
RNA from whole tissue section of case 68 labeled with Cy5,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
"Patient  I, lesion, 1 week",pert
disease status: controls;	tissue (brain region): Frontal cortex,ctrl
Heart,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD4+ T-cells",pert
striatum_6 month,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 60,pert
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,pert
"ADIPOSE TISSUE, CR, Before",ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: Native American;	dsm-iv: 296.53;	age of onset: 22 yr,pert
HeLa cells transiently transfected with control siRNA,pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shSYK_2,pert
tissue: neocortex;	developmental stage: E14.5;	genotype: Eomes WT;	genetic background: C57BL\6,ctrl
"Lymphoblastoid cell lines derived from family 1744, member 1",ctrl
tissue: Temporal cortex;	age: 80;	Sex: M,ctrl
tissue: breast cancer;	cell line: MDA-MB-231,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 3x1h exposure per day",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.232;	OD280: 0.618;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 230;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
BATF_KO_P14_D3_Effector,pert
CD46+/STAT1-KO hippo - Untreated-C,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 1 day,pert
Postmenopausal female. Untreated control. nr 37.,ctrl
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/Flox Mx1-Cre+ (LRF homozygous knockout);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,pert
"AZ521 dnSox2 cells, uninduced, 12h",ctrl
"65 y/o male 46,XY",pert
TOV112D cells_untreated,ctrl
quadriceps_muscle_Akt1+/-_female_35wk_rep2,pert
IRAK2 KO macrophages unstimulated,pert
EB_0_6_323_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
tissue: brain;	genotype: WT mix background B;	age: P0,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,pert
Igf1 -/- mouse vestibular organs 15day old (P15),pert
chip number: 20;	transfection plate: 3B;	target gene: NFE2L1;	kd level: 0.71;	rin: 9.8;	transfection date: 2012-03-26,pert
quadriceps_muscle_Wt_female_8wk_rep3,ctrl
disease state: paediatric glioblastoma;	age: 10;	gender: M;	h3.3_status: K27M,pert
"tissue: lung, upper lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 67",pert
cell type: MaF pre-induced pluripotent stem cells;	treatment: none;	time: Day 3,ctrl
Cervical cancer_CC205,pert
age: 29;	sex: F;	disease status: Marfan subject;	Filter number: 90;	Usage number: 5;	Exposures: 3,pert
strain: 170;	Disorder: normal;	Condition: no hydrocortisone,ctrl
"metastasis: metastasis;	Stage: 4;	tissue: cancer, homogenized",pert
WT mix background B,ctrl
"hMSC-Tert, RNF40 siRNA, 5 days adipocyte differentiation",pert
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: heart left ventricle,ctrl
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: Cd4-Cre_C57BL6-STAT3<tm1Dlv> (STAT3KO);	treatment: stimulated for 3 hours with medium alone,pert
PBS Treated Cells 3,ctrl
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 24h;	gender: Male;	age: 6 months,ctrl
"glioma cell line U373, MAML1-dn expressing",pert
lung_wt_mock_repB,ctrl
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,ctrl
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
Panc1 cell line,ctrl
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_6;	fev1 (% predicted): 55;	fvc (% predicted): 69;	medication: Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd;	cell type: CD8+ T-cells",pert
"Sodium arsenite added to food: 10 ppb, 5wk; Injection: None; Diet: AIN-76A; Sodium arsenite added to drinking water: None",pert
A375 melanoma cells treated with vemurafenib,pert
17beta estradiol: 100 pM,pert
disease state: normal;	biopsy type: surgical;	tissue: lung,ctrl
gender: female;	age (years): 34;	evolution time (years): 13;	disease extension: Pancolitis;	treatment: 5-ASA,pert
Patient: D;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
8 week old extraocular muscle,ctrl
strain/background: mix of 129Sv and C57BL/6;	genotype: control;	tissue: back skin;	age: 10 days,ctrl
extensor digitorum longus muscle,pert
age: 6 month postnatal;	tissue: striatum;	genotype: SNCA knockout,ctrl
passage: 10;	cell type: fibroblast;	cell line: GM00038,ctrl
chip number: 22;	transfection plate: 3A;	target gene: BATF;	kd level: 0.64;	rin: 9.8;	transfection date: 2012-03-26,pert
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p30;	strain: E14,ctrl
Karyotype: inv(14)(q11q32);	Age: 90 years;	Gender: female,pert
genotype: wild type;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,ctrl
Mus musculus embryonic stem cells derived from wild type embryos,ctrl
"Biceps, control, cohort 19, subject 19U",ctrl
Sprague-Dawley rat diaphyseal femoral callus,ctrl
"SiRNA-scrambled, replicate 1",ctrl
WT thymocytes,ctrl
Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: None,ctrl
WT_72_O3_3c,ctrl
female,pert
A HID I_B008,pert
"conditional Keap1 knockout Alb-Cre:Keap1(flox/-), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",pert
disease state: control;	patient: 1,ctrl
Gender:M;	Age:33;	Tissue: Mucosa,pert
RWPE-PCAT1 cells transfected with non-targeting siRNA,ctrl
"Skin biopsy, lesional",pert
patient E1584,pert
strain CD-1,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 1",ctrl
NK_cell_pool_melanoma_M05+M06,pert
subject: 2824 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
age: 65;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Sample ID: TP31;	Twin Pair ID: CCE2.1;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-4.5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
Scrambled 24 hours_3,ctrl
Control A549 cell,ctrl
"BMDM, LPS 0 hr",ctrl
RNA from microdissected breast cancer cells from case 280 labeled with Cy5,pert
"Normal, biological rep 2",ctrl
P5C Progranulin-hippocampus,pert
cell line: HEK293E,ctrl
"Liposarcoma culture from tumor 387, doxorubicin treated",pert
tissue: synovial biopsies;	disease: Systemic lupus erythematosus;	age: 31;	gender: f;	treatment: -,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 71 years,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 135min;	race: White;	sex: Female,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: Klf3 KO,pert
Mouse female ES cells PGK12.1 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-3 in PGK12.1.,ctrl
Human skeletal muscle,ctrl
tissue type: hepatocellular carcinoma,pert
"transfection: pRTS-CA-IKK2;	cell type: human Burkitt lymphoma;	dsmz no.: ACC 603;	origin: established from the ascitic fluid of a 3-year-old boy with American-type Burkitt lymphoma in 1972; cells were described to be EBV-negative but EBV infectible, to carry the (8;14) translocation and p53 mutations",pert
"NCI-H460, control, 2 hr",ctrl
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
Embryonic lung at E18.5 days from an Hmga2 KO mice,pert
HLA risk: High;	Height: 170.2 cm;	Weight: 63.9 kg;	BMI: 21.8;	Age: 30.94 years;	Gender: Female;	Race: White;	Glucose: 93 mg/dl;	HbA1c: NA,ctrl
"SIRT1 LKO liver, ad lib, 4:00pm",pert
cell type: late passage (LP50) LNCaP,ctrl
background: C57BL/6x129Sv/B6 hybrid;	genotype: Prkaca+/-;	age: 9 months;	tissue: caudal vertebral bone,pert
Treated with 5% mannitol for 4 hrs -- replicate #3,ctrl
Genetic background: C57BL/6J; Age: 6 weeks old; Gender: female; Diet: chow; Non-fasted; Genetic modification: None (Scd1 +/+; wide type control).,ctrl
aortic biopsy,pert
Normal cervix_05-446,ctrl
Tissue: brain (frontal cortex);	Disease State: HIVE,pert
"Human LIMA artery from patient 1, treatment: paclitaxel-eluting stent",pert
FCHL #98-1176,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.78;	myeloperoxidase activity (u/mg): 0.056;	tissue: colon;	treatment: 5% DSS,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 79,ctrl
Control osteoblastic lineage cells 5-6 weeks post doxycylin withdrawal,ctrl
nucleus accumbens,ctrl
HCC_21T,pert
Dot1l -/- day 7 after transduction with cre,pert
MDA-MB-231ER+ Breast Cancer Cells,pert
Gender: Male;	Age: 34;	Ethnicity: White,pert
Extract:LOX-1:213201;	Extract Description:LOX1_Untreated_2hr:213201;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.67;	Quality: Background Mean Dev.:0.2;	Quality: Absent (%):57.28;	Quality: Absent (%) Dev.:0.75;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.59;	Pretreatment [C]:LOX1;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213201;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_Untreated_2hr;	RNA extraction source key [A]:282295533,pert
Scrambled 24 hours_1,ctrl
"Frontal cerebrocortex, deltamethrin (0.3 mg/kg), 6 hours",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.88;	choa: 240;	fata: 58;	eea: 1750;	wtkg: 85.6;	perfat: 23.1;	lbm: 58.3;	fat_mass: 1977.36,ctrl
F3-WT-2nd,ctrl
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
cell line: AST13;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: SNCA triplication,pert
subject: 9;	disease: CP;	muscle: ST;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
E14.5 fetal liver TER119- Klf3 KO,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 29;	maternal age: 24,ctrl
"E14 embryonic stem cells, untreated",ctrl
human breast tumor tissue RNA,pert
Concordant for Epilepsy twin pair 3 (Affected patient of MZ twin pair CCE3),pert
individual: patient4;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
patient: 15;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
S25 WT1	F4/27	S25	wild type	Mouse	3 months	Cerebellum	Male,ctrl
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_287,pert
RNA from whole tissue section of case 297 labeled with Cy5,ctrl
Diagnosis: MDS/AML;	Age: 45y ;	Gender: Male;	Blast %: 85;	Source: PB;	Cyto: Complex;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 61;	donor: 16;	disease state: Lesional,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: 16 hrs AP20187,pert
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 72 hr,pert
Brain from 81 days Npc1+/- mouse1,ctrl
dental pulp stem cells extracted from deciduos tooth,ctrl
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,ctrl
APLP2_R6,pert
"C57BL/6 female, fasted 18h (overnight), age 4-5 months",pert
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 18h,pert
cell line: sh3293 T47D;	sherbb3: +,pert
cell line: PC-3;	treatment: luteolin;	treatment duration: 24h,pert
Dysf -/- QF mouse muscle,pert
Neocortex E14.5 mouse Eomes WT,ctrl
S46 NLS 142Q TG3	F5/10	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 5. Replicate B,ctrl
A39 WT4	F25/17	A39	wild type	Mouse	4 months	Cerebellum	Female,ctrl
(ca)erbB-2_1,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 57;	baseline tumor size (cm): 5x5;	patient id (to identify the 2 chips from the same patient): 19101935,ctrl
con-11,ctrl
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD4-FITC;	cell type: CD4 positive T cells,pert
cell line: um-uc-3 (atcc# crl-1749);	cell type: bladder cancer cells;	genotype/variation: transfected with gfp,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.79452,pert
"BOEC, normal 11",ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 2,pert
treatment: 12 weeks of RTX therapy;	gender: M;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
multiple sclerosis_6,pert
"Wild type, snap frozen, gastrocnemus muscle, 7month age animal",ctrl
retinal,ctrl
Strain: J1 Cell type: mouse embryonic stem culture,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 2 (untreated with resveratrol)",ctrl
braak stage: CTRL;	rin: 81;	tissue: substantia nigra;	disease state: control,ctrl
Strain: C57BL/6J;	Gender: Male;	age: 3days;	genotype:KO;	tissue: brown fat,pert
health control_4,ctrl
28 Day Mouse Diaphragm muscle,pert
"23B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"MCF-7 cells, siERK2 treatment 60h, 10 nM E2 for 24h",pert
Tet cells with Tetracycline-repressible WT1(-KTS) expression,ctrl
Age: 66 yrs Gender: Female  Ethnicity: Caucasian,ctrl
tissue: Primary human lung fibroblasts;	treatment: None;	patient: 1;	time: Baseline,ctrl
1000uM H2O2,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 33 yr;	population: white;	dsm-iv: 295.9;	age of onset: 19 yr,pert
treatment: Control siRNA Vehicle;	cell line: MCF7,ctrl
tissue: muscle;	sample group: resveratrol;	treatment: before;	gender: Female,ctrl
homozygous_TGFb_24hr_2,pert
"Transgenic, snap frozen, plantaris muscle, 7month age animal",pert
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS;	,ctrl
"TGCT cell line NTera2/clone D1, treated 3 days with retinoic acid, differentiated",pert
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
BMMs_untreated control_ko,pert
Patient identifyier: N;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 20 years;	Body surface area: 25 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Endometrium-Normal 1,pert
tissue: white blood cells;	age: 16.53;	Sex: female,pert
age: 49;	gender: female,pert
"Patient  D, lesion, 12 week",pert
Untreated diabetic,ctrl
Insm1 mutant #4_pituitary gland,pert
Sample Group: control; Gender: female; Age: 51; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
patient: 222;	current medication: Prednisolone 20mg Balsalazide;	birth date: 4/13/52;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 9/1/85;	diagnosis date: 6/20/86;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 9;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Endometrium/Ovary-Disease 6,pert
Normal Lung,ctrl
Paraquat Human-ApoD transgenic gain of function mutant,pert
EB_0_6_356_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
Myd88 KO control tissue  4,pert
Kidney HEK293 cells,ctrl
tissue type: Lesional skin;	time: Pre-dose,ctrl
Murine cell culture,ctrl
mouse CD4+ T cells,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 1,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#4,ctrl
sampleID: SAM630135;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
chip number: 13;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.5;	transfection date: 2012-03-26,pert
con-52,ctrl
cells: spleen follicular B cells;	genotype: WT;	genetic background: C57BL/6J,ctrl
skin total,pert
strain: SW129/C57BL/6J  cells;	genotype/variation: wild type;	cell type: B-lymphoid,pert
developmental stage: E14.5;	genotype: Pax2Cre/+;PtenloxP/loxP,pert
FCHL patient #98-1103,pert
"strain:BALB/c WT, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",ctrl
A HID I_B051,pert
"differentiated U937 cells, untreated, 4h",ctrl
"ID:11-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Patient  E, lesion, 4 week",pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 3",ctrl
Array Type: HG-U133A_2;	Ratio: 1.97;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
"Oral Squamous cell epithelium tissue;	Patient code:OSCC-2;	Age:58;	Sex:F;	TNM:T2N0M0;	;	ABBREVIATION:TNM,TUMOR-NODE-METASTASIS",pert
Mus Musculus Kidney,pert
"K562, 250nM1R-Chl, 24hrs, rep3",pert
"triceps, control mouse",ctrl
TAF4b knockout,pert
HCC SNU-398_SALL4 knockdown,pert
strain: C57BL/6;	tissue: cerebral cortex;	age: E14;	gender: not determined;	genotype: WT,ctrl
"Femal C57BL/6, ovariectomized",pert
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 83;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/Mecp2-;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: brain;	age: 6 months,ctrl
Against CDK8-1 transfected HeLa S3 cell,pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 3,pert
subject: 9;	disease: CP;	muscle: GR;	gender: M;	age: 11.2;	gmfcs: 2;	popliteal angle: 110,pert
cell type: Embryonic stem cells;	genotype: Bmpr1a-/-;	culture condition: ESC media,pert
Control;	Survivor;	gender: Male,ctrl
"SiRNA-scrambled, replicate 4",ctrl
CD8+ cells isolated from spleen,pert
MDA-MB-231ER+ Breast Cancer Cells,ctrl
WT striatum,ctrl
HdhQ111/HdhQ111 cerebellum at 3~10 weeks biological rep 4,pert
IDH2 R140Q mutant mice,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q,pert
scan batch: Batch 2;	group: control;	subject age: 8;	paternal age: 34;	maternal age: n/a,ctrl
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 79;	Usage number: 4;	Exposures: 2,pert
Bone marrow.,pert
tissue: Frontal cortex;	age: 77;	Sex: F,ctrl
"Brain tissue from Fisher 344 male rat, Animal #244, control (0mg/kg) D-Serine",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp2,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 24h,pert
"Healthy control mice, time point 1 week",ctrl
synovial fluid macrophages,pert
race: caucasian;	age (years): 88;	stage: IC;	grade: 3;	histology: endometrioid,pert
background strain: CD1;	age: p23;	tissue: pancreas;	genotype/variation: Sox9-EGFP;	facs: GFP+,pert
strain: C57Bl/6;	genotype: wt;	treatment: Freshly isolated cells,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 58 yr;	population: white;	dsm-iv: 296.54;	age of onset: 27 yr,pert
WT mouse heart under basal conditions,ctrl
genotype/variation: wildtype;	strain: C57/Bl6;	age: newborn 0-6 h;	tissue: Lung,ctrl
protocol: control;	cells: Human Neural Stem Cell Line F3,ctrl
Wildtype liver,ctrl
WT Liver - Pooled -Cy5,ctrl
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
E9.0 embryo yolk sacs,ctrl
"Animal id 552, right retina, 8 months, female, DBA/2J",pert
tissue: atria;	genotype: COUP-TFIIflox/flox;	age: 2 months;	genetic background: C57BL/6,ctrl
patient: 40892;	sample: normal,ctrl
"brain, adrenal medulla",pert
cell line: H1299 lung cancer cell line;	genotype/variation: control;	shRNA: scramble,ctrl
Embryonic lung at E18.5 days WT,ctrl
gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3,pert
Pancreatic islets,pert
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: wild-type,ctrl
Y YOKE_B059,ctrl
Age: 47;	Cycle: Follicular;	BRCA1/2 mutation: BRCA2 6174delT;	Family History: Yes,ctrl
Placenta_PE(EO)3 with Cy5,pert
Vastus lateralis muscle,pert
Healthy controls; individual=JR; time=2; beverage=alcohol,pert
GFAP-negative lamina cribrosa cells,ctrl
3T3-L1 1uM rosiglitazone,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 39 yr;	population: white;	dsm-iv: 295.3;	age of onset: 17 yr,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 24 h after intravenous endotoxin challenge""",pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#4,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 23 yr,pert
Tissue: brain (frontal cortex);	Disease state: HIVE-control,ctrl
tissue: dorsal skin;	genotype/variation: GR-/-;	strain: B6D2/F1;	age: E18.5,pert
"LCL GM19238, Kd RAD21, 72hrs",pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: Calcitonin,pert
Array Type; Affymetrix Mouse 430_2;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7,pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 2,ctrl
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 24h,pert
Cervical cancer_88-04T,pert
BT-20 cell line,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 72h,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: del5q plus monosomy7/del7q plus other,pert
SK-N-SH cell line infected with eGFP lenti,ctrl
"LY2 cell line, SRC-1 scrambled treated 120min, biological rep1",ctrl
CD11b+Gr1- cell sample_1 (derived from wild type mouse),ctrl
Lung of hemorrhaged animal 6h,pert
"DBA/2J Acute morphine treated, biological replicate 1",pert
wild-type,ctrl
"human embryonic stem (hES) cells line VUB03_DM1, biological replicate  3",pert
hTNFtg;Rsk2-/y FLS,pert
"Adherent lung cancer cell line, anti-Evi1 siRNA",pert
Acute samples,ctrl
tissue: isolated from spleen;	cell type: memory CD8 T cells;	strain: C57/BL6;	genome/variation: wild type;	age: over 80 days after infection,ctrl
patient E1520,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: WT CTNNB1,ctrl
uterus - Proliferative endometrium from patient with  endometriosis,pert
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.2;	colon weight (mg): 154;	colon ratio (mg/mm): 2.14;	myeloperoxidase activity (u/mg): 0.019;	tissue: colon;	treatment: 5% DSS,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.652;	OD280: 0.857;	Ratio: 1.92;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 215;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Csbm/m mouse, cerebellum, old, saline treatment",ctrl
race: african american;	age (years): 50;	stage: IA;	grade: 1;	histology: endometrioid,pert
"WT BMMC, uninfected",ctrl
"BMDM, LPS 5hr",ctrl
BMMs_untreated control_da,pert
tissue: brain,ctrl
lymphoblast cell line,pert
14A;pretreatment;female;breast tumor,ctrl
"LCL GM19238, Kd ZHX2, 72hrs",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 42;	gender: m;	treatment: -,ctrl
IKK2 KO tumor,pert
foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: none,pert
Whole adrenal RNA from WT mouse #80 at 0h,ctrl
patient: 34208;	disease state: LGSC;	component: Borderline,ctrl
"male;	CABG patient, atrial tissue, propofol anesthesia, after CABG surgery",pert
Disease_status: Down syndrome;	Age (years): 63;	Gender: Male;	Post mortem interval (hours): Unknown;	Braak stage: Unknown;	Cause of death: Unknown,pert
"Control #2, Untreated",ctrl
14 Day Mouse Diaphragm muscle,ctrl
tissue: skeletal muscle;	disease status: inclusion body myositis,pert
"cell type: Normal human diploid WI-38 lung fibroblasts, CCL-75(TM), passage 7-12.",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.908;	OD280: 1.959;	Ratio: 1.96;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 356;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
cell line: cervical cancer (HeLa) cells;	agent: Cas II-gly,pert
Pancreas,pert
mouse TMJ-cartilage from wild type mouse WT_Tal4,ctrl
microdissected epithelial cells from IPMA 2,pert
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor conditional knockout,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 36, stage IIB, HPV 16",pert
Embryonic day 14.5 pancreas,pert
P2A Progranulin-frontal,pert
"BMDM, LPS 1hr",ctrl
liver tissue from 21 days old mice,ctrl
Biopsy 4 from cystectomy 16,pert
Hep G2 treated with Phenol,pert
"patient: 108;	current medication: Asacol 400mg BD;	birth date: 8/30/33;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: Altered bowel habbit, ? UC 1974, never on Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
nasopharyngeal carcinoma;	WHO histology: IIB;	Tumor Stage: T2N2,pert
EB_0_24h_56_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
A HID I_B050,pert
GM8921A,ctrl
PS-/- cerebrum at new born,pert
MCF10A 9days,ctrl
Sprague-Dawley diaphyseal femur,ctrl
Macrophages,pert
human neurons isolated from postmortem dorsolateral prefrontal cortex,ctrl
"Patient  B, lesion, 4 week",pert
rat liver,pert
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 35;	maternal age: 34,ctrl
HCT 116 cells transfected with siChe-1,pert
"control colon tissue, biological rep2",ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Mesenchymal Cell,pert
"MCF-7 breast cancer cell, transfected, pcDNA3.2",ctrl
"Whole blood - Autism no regression, Male",pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 36;	maternal age: 36,pert
COV434,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 26.040;	Ratio: 2.11,pert
female heart 10 days post cvb3 injection,pert
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,ctrl
Non failing,ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
56 Day Mouse leg muscle,pert
Murine Lung,ctrl
"Control, replicate 6",ctrl
cell type: embryonic stem cells;	genotype/variation: transfected with scrampled-control siRNA,ctrl
28dpp Ubb knockout testis,pert
Sex: female;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
cell line: lymphoblastoid cell line;	family id: 1724;	coriell cell line repository identifier: GM14475;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
"primary cortical neurons, MeCP2 shRNA",pert
tissue: Biceps muscle;	patient: C.b.8;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Strain: 129S2/SvPasCrlf;	Genotype: Wildtype,ctrl
age_years: 46;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
"Control at ZT6, pineal gland",ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Male,pert
subject: 13U;	cohort: 13;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
treatment protocol: GSK-3 inhibitor (SB216763) treated for 20 hours,pert
WT.DMSO.1,ctrl
"seminoma specimen, pT1, patient age: 25y",pert
HCC_30T,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 4h,pert
disease state: heterozygous Nxnl1 null;	strain: BALB/c AJ,pert
8 week old Nix null mice (Nix-/-) spleen,pert
HCC_22N,ctrl
Strain: C57BL/6J;	Gender: female;	Age: 7 days;	Tissue: kidney,pert
neocortex,pert
Tissue: lung;;	Genetics: Sporadic IIP;;	Histology: Usual Interstitial Pneumonia,pert
"kidney, control, 14 months",ctrl
Tendon;Patellar_Lesional,pert
Leukemic mice 3 weeks after birth,pert
agent: control (untreated);	time: 48h,ctrl
Wildtype mouse embryonic fibroblasts,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 1,pert
c57/BL,ctrl
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
mouse ventral prostate,ctrl
S46 WT6	F5/54	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
Gender:M;	Age:35;	Tissue: Mucosa,ctrl
E12.5 heart,pert
cell line: THP-1;	shRNA construct: GSK3A Construct 5,pert
Bronchial biopsies from lung tissue,pert
cell line: HEK293 cells WTX inducible clone F18;	agent: control,pert
"C26, whole heart",pert
ak 04,pert
patient: 244;	current medication: Seratide Bricanyl BFZ;	birth date: 1/29/55;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/16/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/29/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 6/1/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 15-24;	other illnesses: Asthma Hypertension;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
normal human salivary gland,ctrl
Systemic,pert
scan batch: Batch 2;	group: control;	subject age: 5;	paternal age: 30;	maternal age: 27,ctrl
wt_2,ctrl
cell type: Oct4-GiP ES cells,ctrl
sampleID: SAM630140;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 211,ctrl
Dissociated dorsal root ganglia treated for 30 min with capsaicin,pert
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
Parkinson's disease,pert
wild-type E18.5,ctrl
genotype: TAF4b knockout,pert
HLA risk: Medium;	Height: 166.3 cm;	Weight: 64.5 kg;	BMI: 23.2;	Age: 18.16 years;	Gender: Female;	Race: Other;	Glucose: 114 mg/dl;	HbA1c: 7.4%,pert
Human PBMC,pert
LIRKO liver sample 1,pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 62;	donor: 13;	disease state: Non-lesional,ctrl
siZMPSTE24-treated SCC-2,pert
Small intestine,ctrl
Alpha7 nAChR subunit L250T heterozygous mice without treatment,ctrl
"SWR/J Acute morphine treated, biological replicate 2",pert
WT mouse skin treated once with TPA and collected 24 hr later,ctrl
IRAK2 KO macrophages stimulated with MALP-2 for 4 h,pert
tissue: bone marrow;	cell type: macrophage;	genotype/variation: IFNAR2-/-;	infection: uninfected,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 55.27671,pert
short-hairpin rna: shCDK8;	cell line: HCT116,pert
muscle,pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep2",pert
age_years: 60;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
T134,pert
BV2_rep3,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 35.01096,pert
Total RNA from Monkey PBMC labeled with cyanine-5 (red),pert
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: control,ctrl
"Cultured HepG2 cells,  ATCC# HB-8065",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.783;	Ratio: 2.13,ctrl
sex: Male;	Age: 8 months;	additional patient information found in Series supplementary file,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.592;	OD280: 1.273;	Ratio: 2.03;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 341;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
MCF-7 cells from ATCC,pert
MMA heterozygote,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.308;	Ratio: 2.12,pert
"Setd2 wild type mESCs, biological rep3",ctrl
patient: 120;	current medication: Minicycline;	birth date: 5/6/54;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
Human-ApoD transgenic gain of function mutant,pert
Extract:LOX-1:213103;	Extract Description:LOX1_0hr:213103;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.03;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.32;	Quality: Absent (%):58.85;	Quality: Absent (%) Dev.:0.46;	Quality: Scaling Factor:0.54;	Quality: Scaling Factor Dev.:0.6;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213103;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295463,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,pert
Pancreas,ctrl
phenotype: control;	gender: male;	case_id: 190;	age: 68;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 16.75;	brain ph at time of freezing: 6.59;	labeling_batch: 1,ctrl
tissue: leukemia;	genotype: Sh2b3-/- ΔE-NOTCH1,pert
Adipose Tissue,ctrl
"Rat liver, left lateral lobe",ctrl
WT hippocampus PDE10i,pert
Whole blood from children with septic shock.,pert
"BMMC, NTAL KD, activated",pert
CTRL,ctrl
embryonic fibroblasts from female wild type Balb/c mice,ctrl
Superior Frontal Gyrus from 2 and 4 year-old girls suffering from Rett Syndrome.,pert
hOB695_shRB1383_16hr_IR,pert
Diagnosis: AML M1;	Age: 54y ;	Gender: Female;	Blast %: 89;	Source: PB;	Cyto: Normal;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
"seminoma specimen, pT2, patient age: 31y",pert
tissue: testis;	gestational age: 22 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: abiraterone,pert
genotype: ILKS343D Tg;	tissue: Heart;	strain: C57BL/6;	age: 8-9 weeks;	gender: Female,pert
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: tamoxifen for 120 min,pert
RNA from microdissected breast cancer cells from case 297 labeled with Cy5,ctrl
NOMO-1 cells infected with ZFX shRNA SH1,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.615;	OD280: 0.851;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 73;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
Fibroblasts isolated from mouse mammary glands with Pten deletion in fibroblasts,pert
cell type: Primary human epidermal melanocytes (neonatal),pert
Lung; nmMLCK-/-; VILI,pert
A HID U_B042,pert
"Lymphoblastoid cell lines derived from family 1717, member 2",ctrl
"Ulcerative colitis patient, biopsy taken from the descending colon, no macroscopic signs of inflammation.",pert
"Control, replicate 7",ctrl
"TNFa siRNA-A, replicate 4",pert
Splenic T1 cells,pert
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",pert
ploidy: euploid;	tissue: cerebellum;	developmental stage: P0 postnatal stage,ctrl
pLenti transduced cell lines overexpressing canonical CDH1,pert
"BOEC, normal 22",ctrl
chip number: 7;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2011-03-29,ctrl
Lung tissue from male control mice,ctrl
medicated bipolar patient,pert
age: 67;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: dexamethasone for 4 hr,pert
"Liposarcoma culture from tumor 314, untreated",ctrl
"Cultured ovarian cancer cell line TYK-nu, untreated",ctrl
patient id: T142;	tissue: Normal cortex;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
patient id: 83;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 85;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1N0M0;	Stage: I;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: loss;	vhl status: mutant,pert
"LY2 cell line, SRC-1 scrambled treated 120min,  biological rep3",pert
strain: Sprague-Dawley;	tissue: spinal cord (ipsilateral dorsal horn);	developmental stage: Adult (8-12wks);	treatment group: sham,ctrl
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep4",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#1352,pert
tissue: brain;	genotype: mutant 14-3-3 ko/ko;	age: E14,pert
"10B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: WT,ctrl
sample type: fvb control;	strain: fvb/nj;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Nondiabetic,ctrl
GIST882 Cell line,pert
tissue: Biceps muscle;	patient: C.b.9;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 2y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
condition: Normal;	patient: N_LJ_6;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 2),ctrl
"C57BL/6, Female, Contol",ctrl
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 4hr,pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,pert
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
strain:C57BL/6; VillinCRE-HNF4loxp; female; tissue colon; control,ctrl
Array Type: HG-U133A_2;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: excellent;	Sample Preservation: -70C,ctrl
lumbar spinal cord,pert
"Mouse Sciatic Nerve, Control Rosi",pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 35;	Usage number: 1;	Exposures: 4,pert
treatment: untreated;	cell type: CLL B-cells,ctrl
112 Day Mouse extraocular muscle,pert
MCF-7_trans-retinoic acid_12hr,pert
RNA from microdissected breast cancer cells from case 289 labeled with Cy5,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 202,ctrl
cell line: MCF-10A,ctrl
"tissue sample from Bellevue Hospital, NY",ctrl
MCF10A 3days,ctrl
age: 3 wk;	tissue: whole heart;	genotype: Pitx2 Flox/Flox,ctrl
"A pool of RNA from lung from three female mice, raised at Denver altitude (nearly normoxic), with SM22-rtTA x tetO7-BMPR2delx4+ transgene activated for 8 weeks",pert
cell type: E14 murine embryonic stem cells;	genotype: Mock knock-down cells,ctrl
age_years: 51;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
cell line: L428-PAX5;	treatment: Mifepristone (M);	duration of treatment: 5 days,ctrl
"genetic control Alb-Cre:Keap1(flox/+), gender- male, age- 9 weeks, n = 1, # of tissue = 1 tissue: Liver",ctrl
tissue: white blood cells;	age: 9.66;	Sex: male,pert
patient: 124;	current medication: OCP;	birth date: 6/25/77;	gender: F;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
patient: 428;	disease state: LGSC;	component: Borderline,ctrl
"Embryoid bodies, 12h,Plus Dox",pert
immortalized cells derived from brown fat tissue of mouse of mixed background.;	passage number: 4,ctrl
Glomeruli from diabetic male OVE26 mouse sacrificed at 8 weeks,pert
"TG male mice, water",pert
Rap1 mutant mouse embryonic fibroblasts,pert
tissue: testis;	genotype: wt;	age: 14dpp,ctrl
cell line: C13;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
"Gender: female, Age: 32 years, Tissue: VIN 3",pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 0.5, Units of Harvest Time Point: hr",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 39;	Usage number: 4;	Exposures: 3,pert
Diagnosis: AML M1;	Age: 52y ;	Gender: Female;	Blast %: 88;	Source: BM;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
hTNFtg FLS,ctrl
"Patient  E, lesion, time: 0",ctrl
tissue: whole blood;	disease state: healthy,ctrl
tissue: resected liver tumor;	genotype: major [rs8099917 TT],ctrl
tisue: cleared mammary fat pad;	genotype: Rarb +/+;	age: four weeks,ctrl
primary normal lung tissue 1546,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 4;	psoriasis duration: 18.009582477755;	age of psoriasis onset: 20,pert
colonoscopic biopsy from adult with affected colon from adult with UC,pert
PDAC_P_138,ctrl
source: JAX stock # 005823;	strain: B6.129P2-Lrp5tm1Dgen/J;	tissue: retina;	age: P8;	genotype: Lrp5 KO,pert
heart left ventricle,ctrl
sirna: NR2F2 knockdown;	cell line: TOV112D;	cell type: Ovarian cancer cell line,pert
50A;pretreatment;female;breast tumor,ctrl
MPM tumor specimen 37,pert
RCC patient,pert
"mouse embryonic fibroblasts derived from FHL2-/- mice, FHL2mutH",pert
"brain, ethanol-treated P70  male",pert
"A1_tumor, lung tissue",pert
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: wild type;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,ctrl
"tissue: whole lung;	strain: SPC(+)Cre(-), Dox E6.5-12.5, PN15;	genotype/variation: wildtype, control",ctrl
Gender:M;	Age:28;	Tissue: Mucosa,ctrl
"fetal testis sample 23L, 20 weeks gestation",ctrl
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, DMSO-treated",ctrl
"gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
individual: Control4;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
cell line: BxPC3;	cell type: pancreatic cancer;	transfected vector: control,ctrl
tissue: GV oocyte;	strain: mixed 129/Sv and C57BL/6J;	genotype/variation: Ring1+/+Rnf2F/F (control),ctrl
HeLa cells treated with RENT1 siRNA,pert
patient id: T183;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxM1;	Stage: IV;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379045;	hybridization batch: IV,ctrl
H295R adrenocortical carcinoma cells,ctrl
Human melanoma cell lines,pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 84;	Usage number: 4;	Exposures: 3,pert
white blood cells,pert
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Male;	Age of onset (years): 33;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 19;	Side of brain: Right;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells prior to (baseline - 0 h) intravenous saline challenge""",ctrl
"A549 cells (lung epithelial cells, a common cell line used in IFN assays)",ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 6x5;	patient id (to identify the 2 chips from the same patient): 16821717,ctrl
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2-/-;	agent: IFNβ,pert
Healthy controls; individual=IF; time=2; beverage=alcohol,pert
cell line: NG4;	cell type: embryonic stem cells;	transfection: siDdb1,pert
heart tissue from KD mouse,pert
cell type: Embryonic Stem Cells;	genotype/variation: WT,ctrl
condition: Normal;	patient: N_LJ_2;	tissue: Normal skin biopsy;	kit: Affy,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T158,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.469;	OD280: 0.766;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 139;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: PGC;	genotype/variation: control,ctrl
total RNA from testis,ctrl
strain: C57/Bl6;	genotype/variation: ASC1 null;	gender: male;	tissue: epididymal white adipose tissue,pert
"wildype 129 mice, pineal glands disected at postnatal day zero.",ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: HIGH;	genome/variation: PDGFRA mutation detected,pert
"ventricular myocardium, A2AR knockout, saline, 24h",pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: EPZ004777;	time: day 4;	biological rep: 3,pert
A HID U_B004,pert
genotype: tg/g;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,ctrl
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 54;	age-at-onset: 53;	geographical origin: Mirandela;	clinical characteristics: Diabetes, hypercholesterolemia;	lifestyle characteristics: ever drinker",pert
"female Spargue-Dawley rats, 4-hydroxyphenylretinamide, 782 mg/kg diet for 7 days, tissue: liver",pert
cell line: HL-60;	replicate: Replicate3;	treatment: shLuciferase,ctrl
Gallbladder- leptin treated,pert
7 Day Mouse Diaphragm muscle,ctrl
treatment: PLX4720;	time: Day10;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
strain: 21;	Disorder: normal;	Condition: no hydrocortisone,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 42;	gender: male,ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 48;	gender: male,pert
"Knee articular cartilage, 4 weeks following OA surgery",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Obese, rep4",ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 1 (untreated with resveratrol)",ctrl
Tumor_Pdk1 knock out,pert
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: sham surgery,ctrl
race: african american;	age (years): unknown;	stage: IA;	grade: 3;	histology: papillary serous,pert
human peripheral blood mononuclear cells (healthy subject),ctrl
cell line: MDA-LM2-shTARBP2;	transfection: shControl,ctrl
"Fetal lung, CD-1 background",pert
"Lung, Familial Idiopathic Interstitial Pneumonia (F-IIP), Usual Interstitial Pneumonia (UIP)",pert
Old neocortex,pert
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
Sample ID: TP32;	Twin Pair ID: CCE2.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-5;	Age at interview & blood sampling: 34;	Current Age (2007): 36;	Sex: FEMALE;	Medication at blood sampling : None,pert
small_intestine_complete,ctrl
S5_sham_overexpressor_12,pert
Aire KO,pert
patient: 9;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
strain: C57BL/6J;	genotype: non-transgenic;	tissue: aorta;	age: 32-34 weeks,ctrl
ATF2 Genotype: KO,pert
Concordant for Epilepsy twin pair 1 (Affected patient of MZ twin pair CCE1),pert
"SKO-transduced MEFs, Vc treated, lysed on D10",pert
SKI-DLCL cells,pert
PKCZ -/- male mice non-treated,ctrl
coc-10,pert
"Oct4-Gip ES cells, Panct1 RNAi, 72h post transfection",pert
cell line: LNCaP-abl;	transfection: siHIPK2,pert
strain: C57BL/6J;	day: 1;	drug: Heroin;	phase: Drug treatment;	tissue: striatum;	replicate: 1,pert
tissue: Whole pancreas;	genotype: Rkip-1 KO;	background: C57BL/6;	age: 8 weeks,pert
Disease_status: Bipolar disorder;	Age (years): 56;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 42;	Brain pH: 6.58;	Post mortem interval (hours): 26;	Side of brain: Left;	Fluphenazine mg. Equivalents: 25000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.0274,pert
X50 WT2	F2/9	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
cell line: MCF7;	condition: siRNA Smc3,pert
"Liver, fasted, phenobarbital",ctrl
ID4+/-TCL1-tg spleen CD19+ B cells,pert
Frontal cortex of AD brain,pert
"in vivo,2 cell stage, embryo",ctrl
"ID:9-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure",ctrl
Retina of 6 month old C57BL/6 mouse,ctrl
"Cell type: neuronal, age:39, gender:female, diagnostic group: control, PMI:58h",ctrl
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 1,pert
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
PancreaticSample24-Normal,ctrl
C,ctrl
Brain tissue from epilepsy patient,ctrl
"Liposarcoma culture from tumor 377, untreated",ctrl
#1_Wt-C-3,ctrl
"Patient  O, lesion, 12 week",pert
WM1205 cell line,pert
homozygous_1,pert
"Rat Schwannoma cell line that express genes associated with glial characteristics including Sox10, p75, GFAP, and S100.  For additional information please see: Hai, M., Muja, N., DeVries, G.H., Quarles, R.H. and Patel, P.I.;	(2002) Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies. J Neurosci Res 69:497–.508.",pert
human fibroblasts overexpressing prelamin A treated with FTI,pert
disease state: Control;	gender: Female,ctrl
Nfkbiz-/- peritonial macrophages,pert
"Control subject, biopsy taken from the sigmoideum, no macroscopic signs of inflammation.",ctrl
E14.5 WT 3,ctrl
EB_07_8d_146_HCHO_Nasal_Rat230_2_CIIT05024,pert
Skin removed from back region of embryonic day 16.5 mouse,ctrl
"gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
tissue: skin;	individual: Patient N-1;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
placebo treated ipsilateral to stroke replicate,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: vehicle control;	treatment time: 48 hours,ctrl
"BOEC, normal 25",ctrl
Postmortem human substantia nigra,ctrl
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP,pert
tissue: Biceps muscle;	patient: P.b.6;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 4m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
"HSCs from male mice treated with E2, replicate 2",pert
Yolk sac tumor,pert
sex: Male;	Age: 108 months;	additional patient information found in Series supplementary file,ctrl
tissue: xenograft tumor,ctrl
cell line: HEK293,ctrl
tissue: tumor;	disease state: DCIS,pert
cell type: Primary hepatocytes;	donor: 2;	agent: control;	time: 24h;	gender: Male;	age: 44 years old,ctrl
tissue: skin;	individual: Patient P9;	condition: AL;	eczema severity: SCORAD: 55,pert
tissue: lung;	strain: CD-1;	age: 20 week;	genotype: Wild type,ctrl
BE,pert
B5_pseudomonas_overexpressor_422,pert
phenotype: control;	gender: male;	case_id: 510;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 21.5;	brain ph at time of freezing: 6.66;	labeling_batch: 1,ctrl
"strain: Swiss;	tissue: adult mouse intestine, kidney, and liver plus fetus tissue",ctrl
IKK2 WT cell line,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#5,pert
strain: FVB;	genotype/variation: ErbB3 DOX-KO;	tissue: Mammary epithelial organoids;	treatment: control,ctrl
gender: Male;	age: 83;	post-mortem delay: 11.5h;	ph: 6.1,pert
oculomotor nucleus,ctrl
"tissue: neurectoderm derived from embryonic stem cells;	treatment: control, shRNAmir #11;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",ctrl
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Stromal Cell,pert
"ID:13-2, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
cell line: MOLM-14;	shRNA construct: GSK3A Construct 5,pert
WT.DMSO.3,ctrl
c42 is aclonal Nurr1 stably-expressing stem cell line,ctrl
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
chip number: 18;	transfection plate: 3B;	target gene: DIP2B;	kd level: 0.83;	rin: 9.5;	transfection date: 2012-03-26,pert
"BOEC, at_risk 8",pert
"Healthy control mice, time point 5 week",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 33;	gender: male,pert
cell type: fibroblast;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: 0;	clone: 0,ctrl
Time:4 day; condition:LaminA ko;,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 70;	gender: male,pert
"t11, surgically resected from patient of gastric cancer.",pert
"WT cells, replicate 5",ctrl
Mouse WT memory CD8 T cells,ctrl
OTT1 knock out,pert
A61 WT4	F24/5	A61	wild type	Mouse	8 months	Cerebellum	Female,ctrl
cell type: placental trophoblast;	developmental stage: E12.5;	genotype/variation: wild type,ctrl
gender: female;	cell type: peritoneal macrophages;	strain: Nfkbiz-/-,pert
TLR4 knockout normoxia,pert
PancreaticSample54-Tumor,pert
"wildtype MEFs with cisplatin treatment (16microM, 24hrs)",pert
MPM tumor specimen 17,pert
KO_48A_2c,pert
patient: 216;	current medication: NONE;	birth date: 5/10/36;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/19/66;	diagnosis date: 8/20/66;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 11;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/18/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: NONE;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"A4_tumor, lung tissue",pert
"60B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
LP50 cells treated with vehicle and AR-shRNA,pert
"ID:6-4, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
tissue: lesional skin;	urticaria status: affected;	patient: 7,pert
gender: male;	age (years): 40;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
sample: #17;	subject: PD case #3;	brain: T-3321;	age: 77;	sex: Female;	region: Dorsal motor nucleus of the vagus,pert
ID: MLL_00118;	cell type: PBMC;	disease state: control,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: 16 hrs AP20187,pert
Healthy,ctrl
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Mock,ctrl
"female,20,Caucasian",ctrl
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Extract:LOX-1:113302;	Extract Description:GFP_Untreated_6hr:113302;	Quality: Classification:Medium;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.43;	Quality: Background Mean Dev.:1.03;	Quality: Absent (%):59.24;	Quality: Absent (%) Dev.:0.77;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.23;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113302;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295603,ctrl
Genotype: wild type;	Strain: C57BL/6J;	Age: 8-weeks,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/111;	differentiation status: undifferentiated;	cell line: Q111,pert
no_19,ctrl
25A;pretreatment;female;breast tumor,ctrl
Tendon;Subscapularis_Non-lesional,ctrl
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: control,ctrl
"seminoma specimen, pT1, patient age: 35y",pert
"Patient  A, lesion, 1 week",pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 65;	gender: f;	treatment: NSAIDs,ctrl
Sample ID:TP5;	Twin Pair ID:DCBD1.1;	Clinical Status:BD1 with psychotic features;	Age of Onset:19;	Age at interview & blood sampling:55;	Current Age (2007):58;	Sex: Female;	Medication at interview (duration) :lithium & citalopram (22.5 years),pert
Patient: A;	Time: 1 week;	Group: responder;	Condition: lesional,pert
CD4+YFP+Ly5.2+ from Foxp3+,ctrl
cell line: HL-60;	shRNA construct: GSK3A Construct 5,pert
MLL_00252,pert
CD4+ T cells derived by negative selection from leukopheresed blood sample,pert
"UM-UC-3 bladder cancer cells, stably transfected with GFP (control), biological replicate A",ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 41;	sex: M,ctrl
wild type control tissue  4,ctrl
cell type: NPC 5-8F cells;	genotype/variation: NESG1 overexpression,pert
"MDA-MB-231 (human, Caucasian, breast, adenocarcinoma)",pert
cell line: NB4;	genotype: TG2 knockout;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 2,pert
231/NS (nonsilence),ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: cervical carcinoma, Separation Type: Trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",pert
NCI-H69 human small cell lung cancer,ctrl
patient: 104;	current medication: None;	birth date: 1/2/72;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"Hippocampus, soman, 1h",pert
sex: Male;	Age: 11 months;	additional patient information found in Series supplementary file,pert
race: african american;	age (years): 79;	stage: IA;	grade: 2;	histology: endometrioid,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339032,ctrl
subject: 13U;	cohort: 13;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 63;	Sex: F;	batch: Batch_3,ctrl
"vehicle treatment, 24 hour time point, biological replicate 3",ctrl
Insm1 mutant #5_pituitary gland,pert
patient code: 105;	gender: Male;	age: 68;	tumor grade: 3;	t-stage: 2;	n-stage: 0;	ajcc classif. (2002): 1b,ctrl
"rat hippocampus (combined dorsal and ventral aspects), aged PIO, subject 4",pert
subject: 22A;	cohort: 22;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
patient with sepsis only,ctrl
Whole brain hemispheres,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 22.0;	age of psoriasis onset: 23,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 217,pert
Human lung adenocarcinoma cells_Non targeting (NS) siRNA transfected,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D5",pert
subject: 2;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
subject: 5;	disease: TD;	muscle: ST;	gender: F;	age: 12.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
U87 10 uM Y15,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 101;	Usage number: 4;	Exposures: 3,pert
HeLa cells transiently transfected with SON siRNA,ctrl
Region of the left ventricle [lv] above the LAD artery of a sham operated mouse,ctrl
T144,pert
"Cell type: endothelial, age:37, gender:male, diagnostic group: schizophrenia, PMI:30h",pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD8+ T-cells,pert
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,ctrl
"BT474 breast cancer cell line, DMSO",ctrl
MCF7 cells,ctrl
"Kidney, wild type mice, control",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 3,pert
A HID B_B086,pert
Murine Heart Apex,ctrl
"Biceps, FSHD, cohort 15, subject 15A",pert
strain: Balb/C;	Sex: female;	tissue: pancreas;	age: 30 days old;	maternal diet: Control diet;	treatment: sham,ctrl
cell line: NAS9;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
whole lung E18 sftpc-nmyc,pert
chip number: 22;	transfection plate: 3B;	target gene: NS;	kd level: NA;	rin: 9.7;	transfection date: 2012-03-26,ctrl
NET1 knockdown AGS cells,pert
strain: 129/Sv;	genotype/variation: DDR-1-KO;	tissue: madibular condyle cartilage,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: 90min;	race: White;	sex: Female,ctrl
Neonatal mouse ovaries cultured in DMSO (0.1%),ctrl
"cell line: HEK293 human embryonic kidney cell line;	protocol: MIF depletion, siRNA-mediated;	siRNA concentration = 50pmol/ml",pert
Diabetic Male Wistar rat  after 28 days of diabetes induced with streptozotocin,pert
cell line: derived from JoMa1-MYCN-induced tumor,pert
cell line: HEK293,pert
cell type: iPSC;	genotype: CCALD patient,pert
Cochleae from a9 null mice at P3,pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,pert
Kidney from mice treated with 7 daily ip injections of saline,ctrl
WT V6.5 ESCs on day 7,ctrl
EGFR+EGF_3,pert
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR KO;	treatment: control,pert
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
"Liver, untreated, rep3, knockout mouse",pert
gender: Male;	strain: C57BL/6;	genotype/variation: B1-/-;	tissue: Epididymal fat;	age: 3 month-old,pert
LRRK2 mutant knockin H9 hESC derived NSC 2,pert
treatment group: air;	tissue: left lung lobe;	gender: Male;	strain: C3H/HeJ,pert
gender: male;	age (years): 51;	evolution time (years): 2;	disease extension: Pancolitis;	treatment: Azathioprine,pert
"strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 4 months;	treatment: daily injections of NR (500 mg/kg/d, ip) for one week",pert
"Cells: U2OS, Treatment: infected with PRC shRNA1_pLenti, blasticidin selection",pert
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 4hr,ctrl
3 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24718,pert
human liver,pert
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post saline ip.,ctrl
cell type: Heptaocellular carcinoma cell line with HIF-1alpha knockdown,pert
Strain: C57BL/6 Rs1h knockout P7,pert
phenotype: control;	gender: female;	case_id: 270;	age: 60;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 21;	brain ph at time of freezing: 6.8;	labeling_batch: 1,ctrl
The placenta (E 10.5) of a congenic adra2B-/- mouse embryo (maternal genotype Adra2b+/-) was rapidly dissected and flash frozen.,pert
subject: 20U;	cohort: 20;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 39kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
treatment: EtOH + cycloheximide;	genotype: WT;	cell line: F9,ctrl
cell: Cultured oligodendrocytes;	genotype: Myelin-gene Regulatory Factor control littermate,ctrl
Normal prostate stroma,ctrl
N-BMSCs were transfected with siTERC-RNA (siTERC) construct,pert
"SKO-transduced MEFs, Vc untreated, lysed on D6",ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
patient: 40728;	sample: tumor,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 61,pert
Sex: male;	Age at operation: 38 years;	Site: knee;	Size in cm: 8.3x4x7;	Histological Subtype: myxoid liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: primary tumor;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
Wild-type control 2,ctrl
strain: HNF4LoxP/+  Villin Cre;	age: 1 month;	tissue: small intestine;	sex: female,ctrl
"cerebellum,24weeks,WT",ctrl
"H1 hESCs, NANOG shRNA",pert
"20 days normal mice, cerebrum",ctrl
age_years: 40;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
gender: female;	cell type: peritoneal macrophages;	strain: C57Bl/6,ctrl
agent: ConA;	time point: 1 hr;	replicate: 3;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
Control PB C106,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: tetracycline,ctrl
EB_07_8d_145_HCHO_Nasal_Rat230_2_CIIT05024,pert
sciatic nerve of P4 wild type mouse,ctrl
RNA from whole tissue section of case 1205 labeled with Cy5,ctrl
tissue: white blood cells;	age: 16.13;	Sex: male,pert
Epidermal keratinocytes treated with EFNA4 for 48h,pert
tissue: blood;	patient: 4;	gender: female;	age: 28,pert
T161,pert
healthy donor,ctrl
"differentiated U937 cells, ROS exposed, 18h",ctrl
cell line: SCC-40;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
Female - caucasian - E-02-M,pert
phenotype: control;	gender: female;	case_id: 393;	age: 71;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.2;	labeling_batch: 2,ctrl
protocol: Non-silencing control siRNA;	cell line: MCF7,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 58;	tissue: Blood,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 63,pert
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",ctrl
"LCL GM19238, Kd KLF13, 72hrs",pert
"Gender: female, Age: 44 years, Tissue: VIN 3",pert
cell line: A2058;	treatment: Control siRNA,ctrl
"Normal cervix, commercial_BioChain",ctrl
cell line: bj-fib_2: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-4;	Primary Site:Floor of the mouth;	Age:60;	Sex:M;	TNM:T4N1M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
HCC_4N,ctrl
tissue: Pancreas;	cell line: Panc-1;	treatment group: Untreated Control,ctrl
gender: male;	age: 7.5 mo +/-2.5 weeks;	genotype/variation: PPAR WT;	treatment: control,ctrl
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 1",pert
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6.4,pert
C10,ctrl
Sex: female;	Age: 13;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
human liver; normal liver tissue,ctrl
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 24h;	gender: Female;	age: 3 months,ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 144;	time: 0;	batch: 1,pert
braak stage: CTRL;	rin: 60;	tissue: substantia nigra;	disease state: control,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 46;	tissue: Blood,pert
timepoint: 2h;	drug: Saline;	group no.: 37;	large batch: Y;	plate: 4164379020;	hybridization batch: IV,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 168 h after intravenous endotoxin challenge""",pert
Patient: G;	Time: 1 week;	Group: responder;	Condition: lesional,pert
cell line: HEK293T,ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte;	treatment: doxorubicin,pert
chip number: 12;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.81;	rin: 9.2;	transfection date: 2011-10-17,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
tissue: white blood cells;	age: 14.58;	Sex: male,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 7,ctrl
age: 35;	sex: F;	disease status: control subject;	Filter number: 97;	Usage number: 4;	Exposures: 3,ctrl
Extract:LOX-1:113101;	Extract Description:GFP_0hr:113101;	Quality: Classification:Bad;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.12;	Quality: Defective Area (%):0.08;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.61;	Quality: Background Mean Dev.:6.14;	Quality: Absent (%):61.21;	Quality: Absent (%) Dev.:2.29;	Quality: Scaling Factor:0.45;	Quality: Scaling Factor Dev.:1.4;	Pretreatment [C]:GFP;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_0hr;	RNA extraction source key [A]:282295413,ctrl
Postmenopausal female. Estradiol treated. Patient 3.,pert
strain: C57BL/6J;	cell type: KLS;	genotype/varation: wildtype,ctrl
human liver; very early HCC,pert
primary normal lung tissue 1050,ctrl
Insm1 mutant #3_pituitary gland,pert
Genotype: Mdr2-KO heterozygous mouse;	Age: 12 month,ctrl
Postmenopausal female. Untreated control. nr 22.,ctrl
genotype/variation: Control (wild-type);	tissue: liver;	gender: male;	strain: mixed C57BL6 and 129SV,ctrl
Alveolar epithelial cell line A549,ctrl
SW480 cells,ctrl
RNA from whole tissue section of case 849 labeled with Cy5,pert
disease state: paediatric glioblastoma;	age: 9;	gender: F;	h3.3_status: wt,ctrl
Disease_status: Healthy control;	Age (years): 38;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.00;	Post mortem interval (hours): 33;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting GFP,ctrl
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 16;	Duration of illness (years): 29;	Brain pH: 6.03;	Post mortem interval (hours): 35;	Side of brain: Left;	Fluphenazine mg. Equivalents: 20000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"affected status (disease state): IS patient;	gender: male;	age-at-examination: 71;	age-at-onset: 65;	geographical origin: Porto;	clinical characteristics: Hypertension;	lifestyle characteristics: ever smoker, ever drinker",pert
Brain from 25 days Npc1+/- mouse1,ctrl
Macroscopically intact carotid tissue adjacent to the atheroma plaque,ctrl
PBMC sample from gastric cancer patient,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 81;	Usage number: 5;	Exposures: 3,pert
S4A Sporadic-frontal,ctrl
n3_hi_10,pert
strain: C57BL6  X 129sv mixed;	tissue: liver;	genotype: WT,ctrl
"spinal cord, ventral spinal cord",pert
"Gift Prof Dr Olivier De Wever, Ghent University Hospital, Ghent, Belgium)",ctrl
WT_embryonic brain_posterior,ctrl
cell line: NCI-H716;	treatment: YAP mutant vector,pert
CH 2,ctrl
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,pert
DLBCL_FOXP1 overexpression,ctrl
Human skeletal muscle biopsy sample;	Patient #175 with PM,pert
LOX1_Untreated_12hr,pert
strain: B6/129;	gender: male;	age: 6 months;	tissue: dorsal prostate;	genotype: Klf5-/-; Pten-/-;PB-Cre4,pert
Wild type mouse embryonic stem cells,ctrl
"Animal id 1025, left retina, 3 months, female, DBA/2J",ctrl
Unaffected MZ twin pair 1 (Unaffected patient of MZ twin pair CCN1),ctrl
Strain: Long-Evans;	Gender: Male;	Age: Adult (PND62-PND64);	Tissue:  Cerebrocortex,ctrl
tissue: thymus;	genotype: E2Aflox/flox Cd4-cre+;	age: 8 weeks,pert
age (days old): 10;	genotype: SC-RbKO,pert
cell line: Panc1;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
ploidy: Ts1Cje (segmental trisomy of chromosome 16);	tissue: cerebellum;	developmental stage: P15 postnatal stage,pert
Gallbladder-leptin treated,pert
Mouse lungs infected with Mtb for 42 days,pert
genotype: p300+/-;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
patient: 122;	current medication: Venlafaxine;	birth date: 7/10/61;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
Mammary cell line,ctrl
CONTROL;	Age = 21;	Sex = F,ctrl
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI beta,pert
lung_myd88_mock_repB,pert
GM9023,ctrl
wild-type macrophages stimulated with MALP-2 for 4 h,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: trisomy8,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,pert
"patient 10, baseline",ctrl
subject: 09A;	cohort: 9;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
treatment: PLX4720;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
injury stage: Spinal 21 days;	gender: male;	strain: Wistar,pert
"Peripheral blood was obtained by venipuncture from healthy adult volunteers. Blood samples from umbilical cords of the placentas of healthy, full-term infants after scheduled caesarean section or vaginal delivery were obtained by puncture of the cord immediately after delivery",ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 49.34795,ctrl
Female - caucasian - E-02-G,pert
MCF-7 cells treated with vehicle for 3h.,ctrl
Y YOKE_B023,ctrl
gender: male;	age (years): 33;	evolution time (years): 8;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
patient: 21;	disease state: hypertension;	tissue: Atheroma plaque,pert
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 24h;	gender: Male;	age: 4 months,ctrl
MGP melanoma,pert
cell type: splenic CD11c+ dendritic cells;	strain: C57Bl/6strain: C57Bl/6;	genotype/variation: WT;	treatment: tamoxifen,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 60 years,ctrl
"2 month old, double transgenic (InsMycER+,RIP-BclXL+)",pert
age: 6 month postnatal;	tissue: cerebellum;	genotype: wild type (129S6/SvEvTac),pert
cell line: Calu-3;	cell type: airway epithelia cells;	treated with: SIN3A siRNA,pert
C57/BL6 murine Liver RNA- 6 hours post-injection with PBS,ctrl
WT 1 1508,ctrl
Caco-2 ZNF658 siRNA 1,pert
disease state: cocaine addiction;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: cocaine related,pert
strain: C57BL/6;	cell type: Lineagelow Sca1+cKit high Cells;	genotype/variation: mutant JAK2V617F (heterozygous),pert
cell line: LICR HN2;	treatment: PBS,ctrl
cell type: Sarcoma cell line;	strain: C57BL6/J;	genotype/variation: Dicer Null,pert
HCC_31N,ctrl
cell line: U937;	replicate: Replicate2;	treatment: shSYK_2,pert
A673 cell line that has been treated with DMSO vehicle control for 5 days.,ctrl
cell line: NALM1;	tissue: Human B cell precursor leukemia,pert
"Pancreatic tumor cells, replicate 4",pert
condition: Psoriasis;	patient: PS-O;	tissue: LS skin biopsy;	kit: Affy,pert
chip number: 11;	transfection plate: 6;	target gene: USF1;	kd level: 0.77;	rin: 9.3;	transfection date: 2012-03-26,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 76;	time: 0;	batch: 4,pert
"gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
"Lymphoblastoid cell lines derived from family 1717, member 1",ctrl
RNA from microdissected breast cancer cells from case 1085 labeled with Cy5,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 4.08;	OD280: 2.003;	Ratio: 2.01;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 325;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
braf status: BRAFmutant;	tissue: PTC with a BRAF mutation,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M0;	flt3 status: WT,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: MIG control;	biological replicate: 2,ctrl
age_years: 31;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
human skeletal muscle,ctrl
"Gata4-KO heart, CRE, biological rep2",pert
patient: 30;	disease state: hypertension;	tissue: Atheroma plaque,pert
con-56,ctrl
Eed KO E14 ESCs on day 0,pert
disease: psoriasis;	skin: non-lesional,pert
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T3N2,pert
age: 21 month postnatal;	tissue: cerebellum;	genotype: SNCA knockout,pert
patient: 51681;	sample: tumor,pert
"Brain tissue from Fisher 344 male rat, Animal #267, 5mg/kg D-Serine",pert
"40B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
HCT116 with Bgal knockdown,ctrl
cell line: Medulloblastoma cell line D425;	protocol: control;	time: 8 hrs,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 2,ctrl
"Human mononuclear cells were isolated by Ficoll-Paque centrifugation in a discontinuous gradient from buffy coats from healthy blood donors. Cells were differentiated in macrophage-SFM medium supplemented with 70 U/ml human granulocyte macrophage colony-stimulating factor. After 3 days, the medium was changed to macrophage-SFM without GM-CSF and cells were cultured up to 8 days",ctrl
"ID:c 2-2, Genotype=(C57BL/6J), Treatment= none",pert
"ID:8-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
S46 NLS 142Q TG6	F4/2	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
Squamous cell lung cancer patient 31,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 58,ctrl
EB_0_8d_64_HCHO_Nasal_Rat230_2_CIIT05024,ctrl
"Human breast, pre AF treatment",ctrl
cell line: SKBR3 resistant;	treatment: basal conditions,ctrl
Strain: DBA/2J Sex: Male Age: 8-10 weeks Treatment: Fluoxetine,pert
"primary fibroblasts expressing a control shRNA construct, clone 1",ctrl
Brain hemisphere,pert
"Cervical cancer cell line, SiHa",pert
Gfp+ photoreceptor cells,ctrl
EB_2_6h_205_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
SCLC cell line SBC-5,pert
B_cell_pool_melanoma_M07+M08,pert
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.80;	Post mortem interval (hours): 47;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"BOEC, normal 23",ctrl
"Wt Gata4, Wt Gata6, heart, CRE transgenic, biological rep1",ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 24.37534,pert
full differentiated 3T3F422A adipocyte,ctrl
DBTRG 10 uM Y15,pert
cell line: HT29 parental cell line;	cell type: colon cancer,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 120min;	race: White;	sex: Female,pert
"Right brain hemisphere ,C57BL male mouse,Un-treated Control,12 weeks",ctrl
Y YOKE_B058,ctrl
T6.01,pert
MH1C1 cells exposed to 160 µM CoCl2 for 24 h,pert
uterus - Proliferative endometrium from normal patient,ctrl
parental Ainv15 undifferentiated ESC,ctrl
hepatocellular carcinoma cell line,pert
6 weeks old,ctrl
race: african american;	age (years): 71;	stage: IA;	grade: 1;	histology: endometrioid,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 3,pert
sex: Female;	family: 1;	age: 69;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
strain background: C57/129S;	genotype/variation: Fra-1+/+; wild type;	gender: female;	age: 2 months;	treated with: 30 µl of PBS for 5 days;	tissue: lung,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: control; biological replicate: 3,ctrl
Heart,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.468;	OD280: 1.278;	Ratio: 1.88;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 57;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
LOX1_Untreated_6hr,pert
Gender:F;	Age:44;	Tissue: Mucosa,pert
tissue: Biceps muscle;	patient: P.b.3;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 7m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
age: 63;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
human subcultured chondrocytes (passage 2) from normal donors maintained for 14 days in scaffold culture,ctrl
whole lung E18 normal,ctrl
tissue: white blood cells;	age: 14.94;	Sex: male,pert
braak stage: BR12;	rin: 58;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
Murine lymph node,ctrl
Old neocortex,ctrl
B-CLL PB P143,pert
MPM tumor specimen 20,pert
A673 cell line that has been treated with DMSO vehicle control for 24 hours.,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 72;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 12961346,pert
tissue: leukemia;	genotype: Sh2b3 wild type ΔE-NOTCH1;	strain: C57BL6,ctrl
Patient: O;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
frozen surgical tissue,ctrl
8 weeks cardiac muscle,pert
patient: 257;	current medication: 6MP 50mg;	birth date: 5/16/64;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/2/05;	indictation for procedure: ;	ucss: 7;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/2/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 9/14/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 2/1/05;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
T73,pert
"Frontal Cerebrocortex, vehicle control (corn oil), 6 hours",ctrl
"adult male mouse colon, Hnf4a mutant",pert
A673 cell line that has been treated with Doxorubicin for 3 days with concentration of 119.76 nM (2 x EC50).,pert
EB_0_19d_75_Formaldehyde_Nasal_Rat230_2_CIIT05024,ctrl
3 ERRg WT E18.5 male cadiac ventricles,ctrl
hESC transduced with mutant miR-122-expressing lentiviral vector,ctrl
"ID:6-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
treatment: AMN107 (Nilotinib);	cell line: K562,pert
strain: C57BL/6;	genotype: Ager null;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,pert
Macro-dissected renal epithelial tissue from wild-type littermate controls,ctrl
"YAP-overexpressing cells, biological rep1",pert
21dpp wild type testis,ctrl
"AML blasts from bone marrow (at diagnosis), mutated NPM",pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 360;	age-at-biopsy-years: 36,ctrl
Extract:LOX-1:113501;	Extract Description:GFP_Untreated_24hr:113501;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.09;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.38;	Quality: Absent (%):56.87;	Quality: Absent (%) Dev.:1.07;	Quality: Scaling Factor:0.52;	Quality: Scaling Factor Dev.:0.75;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113501;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295833,ctrl
tissue: Frontal cortex;	age: 87;	Sex: F,ctrl
BL6CBDL,pert
tissue: Brain;	genotype: Npc1-/-;	age: 62 days;	subject: Mouse1;	genetic background: BALB/c,pert
Human synovial biopsies from the knee of a patients with RA prior to (T0) or after (T12) RTX therapy (EULAR Poor-responder).,ctrl
Primary hepatocytes isolated from FVB mouse strain treated with Wy14643 for 6h,pert
Age: 41;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.28767,pert
Diagnosis: AML M5;	Age: 62y ;	Gender: Male;	Blast %: 96;	Sourc: PB;	Cyto: No Data;	FLT3 ITD: 1;	FLT3 TKD: 0,pert
ePuro,ctrl
Sex: male;	genotype: sst -/-;	tissue: liver;	genetic background: C57BL/6,pert
"seminoma specimen, pT2, pN1, patient age: 43y",pert
breast precancerous tissue,pert
type_of_rx: AFG;	pre_or_post_treatment: pre;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,ctrl
disease: type 1 diabetes;	gender: male;	cell type: endothelial progenitor cell,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: exogenous SNF5 overexpression,pert
Adam10 knockout mouse,pert
"Liposarcoma culture from tumor 398, doxorubicin treated",pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 2,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 2",pert
Mouse lungs infected with Mtb for 63days,ctrl
Y VIS _B065,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 31 yr;	population: white,ctrl
strain: BALB/c;	genotype/variation: Rag1-deficient;	treatment: WT nTreg + WT iTreg;	cell type (sorted): ex-iTreg,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Ileum",ctrl
Knockout liver_saline-injected 12weeks repl2,pert
Skin biopsy from upper nates no nickel exposure,ctrl
phenotype: control;	gender: female;	case_id: 460;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: ?;	post-mortem-interval (hrs): 15;	brain ph at time of freezing: 6.93;	labeling_batch: 2,ctrl
B lymphocytes,ctrl
cell type: embryonic stem cells;	genotype/variation: Trim71 KD,pert
"Control pancreas, sample 1",ctrl
diaphram muscle,ctrl
sampleID: SAM630134;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
strain: C57BL/6J;	day: 18;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
cell line: GIST882;	agent: Imatinib;	dose: 1μM;	replicate: Rep2,pert
parental cell line: HEK 293 Flp-In T-REx;	construct stably transfected into cell line: Ero1α-WT;	overexpression induced with doxycline: No,ctrl
3T3-L1 Day 0 (passage 21) 48h after siControl transfection,ctrl
"Patient  B, lesion, 1 week",pert
"SBC-5 cells, siEGR4 (target), 72 hr after siRNA, duplicate sample 1",pert
31wk FVB(87.5%)/CF-1 (12.5%) mammary gland,ctrl
Strain: RPE65-/-;	Age: 2 months;	Tissue: retina,pert
"Trim28 conditional KO mice naïve CD4 positive cell, unstimulated, replicate 3",pert
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 41;	Usage number: 1;	Exposures: 3,pert
RNA from whole tissue section of case 1125 labeled with Cy5,ctrl
normal tissue from mastectomy specimen from postmenopausal patient with invasive lobular carcinoma (ILC),ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 4;	psoriasis duration: 4;	age of psoriasis onset: 24,pert
"airway epithelium, small airways, obtained by bronchoscopy and brushing",ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: EPZ004777;	time: day 6;	biological rep: 1,pert
Cultured cell line,pert
PancreaticSample21-Tumor,pert
duration of untreated disease in month:30.6;	age at onset:1.0,pert
cell line: lymphoblastoid cell line;	family id: 1757;	coriell cell line repository identifier: GM14584;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"FACS purified YFP+ muscle stem cells, harvest immediately after isolation",pert
"cerebellum, knock out, 3 month",pert
mouse fetal liver at E14.5,pert
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
genotype: wild-type;	cell type: naive CD4 T cells;	genetic background: C57BL\6,ctrl
Gender: Male;	Age: 38;	Ethnicity: Black,pert
tissue: lesional skin;	urticaria status: affected;	patient: 1,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: kidney;	age: 12 weeks,pert
"ID:10-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
phenotype: alcoholic;	gender: male;	case_id: 252;	age: 59;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.57;	labeling_batch: 1,pert
cell line: ARPE-19;	clone: 30;	genotype: Knockout,pert
Kin- S49 Cells 2h cAMP treatment,pert
Primary neonatal keratinocytes,pert
"Lymphoblastoid cell lines derived from family 1720, member 1",ctrl
"cell line: hgps-ipsc_1: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository and reprogrammed using the protocol below",pert
"Proximal, Small Intestine 17 days old",ctrl
patient: 51104;	disease state: LGSC;	component: Invasive,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.023;	OD280: 1.564;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 322;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
tissue: Epididymal adipose;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 686,ctrl
F9 WT treated 8hr with EtOH,ctrl
mouse ventral prostate,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 41 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
HLA risk: High;	Height: 157.7 cm;	Weight: 54.5 kg;	BMI: 21.9;	Age: 57.96 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: NA,ctrl
Whole Blood of healthy control,ctrl
H2009_shPTK7,pert
C57/BL6 murine Liver RNA- 6 hours post-injection with 200ul PBS (Mock),ctrl
condition: Discoid Lupus;	patient: L1;	tissue: LS skin biopsy;	kit: Ovation,pert
Mouse hypothalamus,pert
PBMC sample from pancreatic cancer patient,pert
GC resistant clone C7H2-R19E5 treated for 6 hours with GC,pert
Array Type: HG-U133A_2;	Ratio: 2.02;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
siOGT 12 hours_1,pert
patient id: T142;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 56;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
Mutant right atria,pert
Ctrl PGC rep1,ctrl
"BOEC, normal 16",ctrl
"ID:13-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
"Heart, wild type2",ctrl
mouse embryonic fibroblasts,ctrl
"Brain tissue from Fisher 344 male rat, Animal #262, 20mg/kg D-Serine",pert
strain: Gata4tm1.1Sad/J;	infection: Cre recombinase;	culture: Differentiation medium for 3 days,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 216,pert
Patient skin sample-Acne Lesion,pert
"SW480, colon cancer cell",pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,ctrl
hOB695_shRB1383_0hr,ctrl
FVB 129 mice were used as bone marrow donors,ctrl
Blood,pert
"Patient  O, lesion, 1 week",pert
patient: 219;	current medication: Sulphasalazine 1.2g Colifoam;	birth date: 1/5/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/81;	diagnosis date: 1/1/81;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/7/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 48 hrs;	time course: 3,pert
"Epidermal keratinocytes untreated control, 24h",ctrl
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 2;	time: 0;	batch: 2,pert
gender: Male;	age: 91;	post-mortem delay: 9.5h;	ph: 6.3,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 57;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
sciatic nerve of P60 wild type mice,ctrl
ICL670 10uM for 16hs,pert
strain: C57BL/6;	tissue: heart;	genotype/variation: KO;	age: 6-weeks old,pert
"seminoma specimen, pT2, patient age: 28y",pert
Brain from 59 days Npc1-/- mouse1,pert
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
"C57BL/6N, adult, female",pert
HepG2_HIF-2α knockdown,pert
"BMDM, LPS 0hr",pert
sample type: no history of asthma;	tissue: smooth muscle cells;	treatment: none,ctrl
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: SNF5 shRNA infenction,pert
9A;pretreatment;female;breast tumor,ctrl
SKI-DLCL cells treated with Aplidin 3.0nM for 24h. Total RNA was isolated using RNeasy kit.,pert
NK_cell_pool_melanoma_M07+M08,pert
PBMC from T cell Large granular lymphocyte leukemia patient#117,pert
cell line: MOLM-14;	replicate: Replicate1;	treatment: shLuciferase,ctrl
PBMCs from CIS patient before IFNb-1a in-vivo treatment,ctrl
Liver from a 5 month old wild type mouse,ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Primary palate mesenchyme;	age: E13.5  + P2,ctrl
Mouse Liver,ctrl
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 23,ctrl
sample 1:;	age: 69;	gender: female;	sample 2: ;	age: 64;	gender: male;	sample 3:;	age: 75;	gender: male;	sample 4:;	age: 58;	gender: male,ctrl
E2F1 Null,pert
tissue: murine embryonic stem cells;	genotype: knockout;	strain: 129SV/C57BL/6,pert
N/A,pert
Whole skin tissue,ctrl
cell line: Y79;	passage: 27;	cell type: Retinoblastoma,ctrl
Primary MEF from 13.5 dpc E2F4 null mouse,pert
"gender: Male;	age: 25;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
RNA from microdissected breast cancer cells from case 1437 labeled with Cy5,ctrl
Teratoma,pert
MMA mutant,pert
Disease_status: Bipolar disorder;	Age (years): 48;	Gender: Male;	Age of onset (years): 31;	Duration of illness (years): 17;	Brain pH: 6.90;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
Skeletal muscle,ctrl
Array Type: HG-U133A_2;	Ratio: 2.03;	RNA Integrity Number: 9.3;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Sample ID: TP36;	Twin Pair ID: CCE3.2;	Clinical Status: Childhood Absence Epilepsy;	Age of Onset:-7;	Age at interview & blood sampling: 57;	Current Age (2007): 60;	Sex: MALE;	Medication at blood sampling : None,pert
"disease state: Nasopharyngeal carcinoma;	stage: IIB, T1, N1, M0, G4",pert
age: 47;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"cerebellum,18month,KO",pert
cell line: lymphoblastoid cell line;	family id: 1712;	coriell cell line repository identifier: GM14439;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
embryonic stage: E14;	cell type: embryonic stem cells;	genotype/variation: Trip12 mut/mut,pert
Peripheral blood,ctrl
Adam10 wildtype mouse,ctrl
untreated_24hr,ctrl
"Mouse jejunum, PND30",pert
phenotype: no or early glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
control_32hr,ctrl
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: NLGN1 shRNA,pert
strain: C57BL/6J;	genotype/variation: Rsk2-KO,pert
patient: 234;	current medication: Aza 150mg Atenolol Atorvastatin BFZ Clopidogril;	birth date: 9/29/46;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/1/88;	diagnosis date: 9/29/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 2/3/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 2/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: IHD Angina;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
gender: Female;	age: 75;	post-mortem delay: 3h;	ph: 6,pert
strain: mixed background of C57BL/6;	genotype: Ezh2f/f;	tissue: heart;	developmental stage: adult,ctrl
c17.2 mouse neural stem cell line,ctrl
mutant Dcx ko/Y,pert
F3-WT-1st,ctrl
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 KO;	stress: control",pert
RNA from NCCIT human cells depleted of TET1 by siRNA,pert
"wild-type control (littermates) of ""P19_exPKO_pancreas""; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.",ctrl
RNA from microdissected breast cancer cells from case 1037 labeled with Cy5,ctrl
patient: 18;	disease state: hypertension;	tissue: Atheroma plaque,pert
Array Type: HG-U133A_2;	RNA Integrity Number: 9.2;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
Mammary Gland,ctrl
Bone Marrow Mononuclear Cells;	35y Male,ctrl
G93A non transgenic littermate 800,ctrl
cell line: SKBR3 parental;	treatment: 0.1uM Lapatinib,pert
"Cultured ovarian cancer cell line IGROV-1, Cisplatin treated",pert
Gene expression profiling of normal cortex of patient 265,ctrl
NSCLC adenocarcinoma cell line,ctrl
Disease_status: Healthy control;	Age (years): 49;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 46;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
chip number: 14;	transfection plate: 5;	target gene: ZHX2;	kd level: 0.51;	rin: 9.2;	transfection date: 2011-10-17,pert
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Wild-type,ctrl
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
1000uM H2O2 rep 4,pert
"Sorted erythroblasts, Sod2+/+",ctrl
strain: C57BL/6J;	genotype: Tgfbr2 fl/fl;	tissue: Posterior Palate;	age: E15.5;	gender: Not determined,ctrl
cell line: PC3;	treatment: none,ctrl
Osteoblasts_Lrp5_Control_Day7,ctrl
"ME180 cells, 10μM ATRA, 6 hours",pert
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 3",ctrl
patient: 238;	current medication: Enalapril Zantac;	birth date: 9/27/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 9/25/03;	diagnosis date: 1/14/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: NEW;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: Hypertension Diverticular disease;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"breast tumor, control",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 4,ctrl
disease state:DM;,pert
chip number: 14;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.7;	rin: 9.7;	transfection date: 2012-03-26,pert
cell type: tumor-derived cell line;	ikk2 status: IKK2 -/-,pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,pert
HCC_31T,pert
"HCT116 shCDK19, normal growth",pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 278;	age-at-biopsy-years: 44,ctrl
MCF 7 parental cell line,ctrl
"adult female mouse colon, Hnf4a mutant",pert
"ID:7-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
Blood,ctrl
"paraventricular nucleus of the hypothalamus, saline, 1 hour",ctrl
CD4_T_cell_pool_healthy_H09+H10,ctrl
wild type 2 cell embryo rep4,ctrl
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.7;	colon weight (mg): 172;	colon ratio (mg/mm): 3.02;	myeloperoxidase activity (u/mg): 0.932;	tissue: colon;	treatment: 5% DSS,pert
tissue: Brain;	genotype: Npc1+/+;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
HeLa cells transduced shYY2 control lentivirus.,pert
"Gender: Female, Age: 28, BMI: 17, Tissue: luteinized cumulus cells",ctrl
Wildtype H9 hESC derived NSC 1,ctrl
"Cultured ovarian cancer cell line OVCA420, Cisplatin treated",pert
age	40;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	9.5;	leukocyte count (/nl)	129;	hemoglobin (g/dl)	9.4;	platelet count (/nl)	261,pert
scan batch: Batch 1;	group: control;	subject age: 11;	paternal age: 32;	maternal age: 27,ctrl
10uM H2O2 rep 3,pert
Patient: B;	Time: 2 weeks;	Group: non-responder;	Condition: lesional,pert
MDA-MB-231 cells transfected with negative control siRNA,ctrl
healthy chondrocytes,ctrl
HCT116,pert
Patient: C;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
cell line: L-540;	cell type: Human Hodgkin Lymphoma;	treatment: 10 µM Perifosine for 24hrs,pert
chip number: 21;	transfection plate: 3A;	target gene: BATF;	kd level: 0.5;	rin: 9.8;	transfection date: 2012-03-26,pert
intestinal crypt cells isolated by laser capture microdissection,ctrl
Gender:F;	Age:33;	Tissue:Mucosa,pert
cell line: SKMEL28;	time point: 0h;	mutation: BRAFV600E;	treatment: untreated,ctrl
2830 WT,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 50 yr;	population: white;	dsm-iv: 296.54;	age of onset: 25 yr,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: SAMPLE-6A,pert
patient E1542,ctrl
status: Control;	gender: Male;	age: 47;	tissue: Blood,ctrl
MDA-MB-231+ERalpha-WT,ctrl
tissue: liver;	treatment: CCl4;	strain: A/J,ctrl
A HID B_B021,pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
strain: Swiss;	tissue: Ovary;	agent: Control (0.1% DMSO);	replicate: 2;	age: Post natal day 3-5,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 6hr.",ctrl
heart left ventricle,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,pert
trypsin-2 overexpressing HSC-3 cell line,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 43;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
Peripheral blood mononuclear cells;	ttf: 120min;	race: White;	sex: Male,pert
background strain: Derived from blastcysts from a 129 female crossed to a (129 X PGK)F1 male.;	cell line: PGK12.1;	cell type: ES cell;	passage: 14-18,pert
gender: Female;	tissue: Tendon;Subscapularis;	age: 63;	donor: 20;	disease state: Non-lesional,ctrl
Irradiated-ATM-WT Replicative1,ctrl
Region of the left ventricle above the LAD artery of a sham operated mouse,ctrl
Trasnsformed Lymphocytes Unaffected (Unaffected pateint of MZ twin pair 3),ctrl
Lung Adenocarcinomas of c-Myc-Transgenic Female Mice,pert
sirna: control;	plate: collagen coated;	cell line: MCF10A,pert
ESCs_pCIP siRNA 1,pert
"disease state: Nasopharyngeal carcinoma;	stage: II, T2, N0, M0, G4",pert
RNA from microdissected breast cancer cells from case 763 labeled with Cy5,ctrl
wild type control tissue  1,ctrl
"gender: male;	batch: 2;	age (years): 23;	patient id: Non_severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 98;	medication: Becotide, Ventolin;	cell type: CD4+ T-cells",pert
tissue: Frontal cortex;	age: 84;	Sex: M,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Hypoxia;	Tobacco Use: No,ctrl
Pooled healthy pulpal tissue,ctrl
cell line: U937;	replicate: Replicate2;	treatment: shLuciferase,ctrl
"Gender: female, Age: 33 years, Tissue: normal vulva,",ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: spleen;	sample name: 3-sp1,pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M4;	flt3 status: WT,ctrl
treatment: baseline;	gender: F;	age (y): 21;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
T cells,ctrl
Panc0403 cell line,pert
cell line: U937;	replicate: Replicate1;	treatment: shSYK_1,pert
cell line: MLL-AF9 AML cell line 10950 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
"ID:c 2-3, Genotype=(C57BL/6J), Treatment= none",pert
Sprague-Dawley rat femoral diaphysis,ctrl
"gender: male;	batch: 1;	age (years): 32;	patient id: Severe_3;	fev1 (% predicted): 98;	fvc (% predicted): 113;	medication: prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od;	cell type: CD8+ T-cells",pert
affection: unaffected;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 6 unaffected controls,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous endotoxin challenge""",pert
Strain: C57BL6;	Transgenic ATF6-MER;	Gender: male;	Age: 40 weeks;	Tissue: left ventricle;	Treatment: tamoxifen,pert
"Strain : 75% C57BL/6, 25% CBAJ;	Gender: Male;	Age: 9 weeks (Moderate stage);	WILD TYPE",ctrl
Brain from wild-type E18.5 mouse embryo,ctrl
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 30;	maternal age: 29,ctrl
Adipose from a 5 month old Myc heterozygous mouse,pert
gender: female;	age (years): 22;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
"Strain: Sprague-Dawley, Gender: male, Weight: 350 g",ctrl
tissue: liver;	genotype: p14 WT;	genetic background: C57BL/6,ctrl
diagnosis: HP;	fvc-group: FVC2;	tissue: lung,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): EtOH vehicle,ctrl
"medulloblastoma, wt",ctrl
"HL-60 cell line, transduced with a control luciferase and selected with  1 µg/ml puromycin 48 hours post-infection",ctrl
pool of wild type thyroids from 2 months old wild type mice,ctrl
RKO colon cancer cells,ctrl
cell line: MOLM-13;	cell line description: acute myeloid leukemia (MLL-AF9 rearrangement);	growth conditions: RPMI with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
E.8 DBA-C57BL/6 whole embryo,ctrl
Raji cells transfected with miR-142-3p mimic at 24 hours,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 5;	gender: male,pert
"ID: MLL_00259;	cell type: PBMC;	disease state: Multilineage dysplasia, acute myeloid leukemia, biallelic",pert
construct: HDAC1 G10 shRNA;	cell type: Primary human erythroid progenitor cells,pert
sample type: Sample;	cell line: H1;	cell type: embryonic stem cell;	protocol: OCT4 knockdown;	time: 2 Days,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 7;	gender: male,pert
cell type: R1/E ESC;	RNAi: Rad21,pert
initial tumor increase/(-)decrease: n/a;	kit mutation: wildtype;	tissue: GIST Tumor,pert
cell line: CH1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
FCHL patient #98-1281,pert
"LCL GM19238, Kd BCL3, 72hrs",pert
Strain: C57BL/6; Tissue: quadricpes muscle,ctrl
subject id: 54;	infection: DENV;	status: DF;	tissue: whole blood,pert
tissue: rectal mucosal epithelia;	genotype: CFTR D508,pert
"MUSCLE, RES, After",pert
colon cancer cells,pert
mixed reference (FR + CRG),ctrl
"SPC-c-raf transgenic mice, 6 month old, male, unaltered",pert
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,pert
scan batch: Batch 1;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 8,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: sh53BP1-1,pert
human peripheral blood mononuclear cells (healthy subject),pert
tissue: Biceps muscle;	patient: P.b.9;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,ctrl
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,ctrl
Human skeletal muscle biopsy sample;	Patient #193 with NORM,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 44;	ld: HCV;	creatnine: 2.8;	mdrd: 26;	gfr: 30;	protein: 0.3;	hematuria: 1;	c3: 0;	c4: 0;	rf: 29;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 5.9;	meld: 16;	ana: NEG;	gp: Mesangial GN+ 2nd FSGS;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 1;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 1;	empe: 1;	bmwid: 1;	bmd: 0;	edd: 1;	no of glomeruli: 16;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: normal;	if: IGG+IGM+IGA++C3+ mesangial;	mesangium ig: AMC;	tissue: Kidney_Biopsy_Liver_disease,pert
siRNA Control1 scanned on 07/21/10,ctrl
23 weeks female,ctrl
thorax from embryo of OTT1 knockout E18.5 mouse,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 55;	Sex: male;	region: M1;	age: 40;	genotype: Y/X;YFPH/-,ctrl
glaucoma: glaucoma;	phenotype: no or early glaucoma;	radiation: No radiation treatment;	strain: DBA/2J;	gender: Female;	age (mos): 10.5,pert
disease state: non-alcoholic steatohepatitis (NASH);	tissue: liver,pert
cell type: Primary hepatocytes;	donor: 3;	agent: Wy14643;	time: 6h;	gender: Female;	age: 70 years old,pert
estrogen treated ipsilateral to stroke,pert
"DBA/2J Acute morphine treated, biological replicate 2",pert
"69B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
age: 14dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
7dpp wild type testis,ctrl
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 7.8;	colon weight (mg): 172;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.076;	tissue: colon;	treatment: 5% DSS,ctrl
"Diabetic mice, time point 5 week",pert
strain: C57BL/6;	age: 1 year old;	tissue: liver,pert
Normal Uninflamed terminal ileum,ctrl
MCF10A cells,ctrl
Flp-In™ T-REx™ 293,pert
"SWR/J Chronic morphine treated, biological replicate 1",pert
hur status: WT;	rna subtype: nuclear RNA after HnRNPA1 Immunoprecipitation,ctrl
mIMCD3 cells,pert
6 h-apra-2 nM;HT-29;colorectal adenocarcinoma;apratoxin;24721,pert
gender: Male;	age: 63;	post-mortem delay: 30h;	ph: 6.5,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: Foxd3 conditional knockout cells treated with Tamoxifen,pert
UC Inflamed descending colon,pert
Normal skin from Stat3c_control mouse,ctrl
231/ARF-1_2,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: Wy14643;	time: 24h;	gender: Male;	age: 6 months,pert
age: 65;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 12.21;	Ratio: 2.08,pert
"Benign, Pooled, prostate tissue",ctrl
"liver, PPAR WT_ctr_55",ctrl
"fatty (fa/fa), skeletal muscle (gastrocnemius), Troglitazone",pert
MCF7 Argyrin A treated 12h,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 4,ctrl
"BOEC, normal 13",ctrl
miR122-WT,ctrl
"seminoma specimen, pT2, pN2, pM1, patient age: 37y",pert
E2F WT,ctrl
Control Mouse Lungs,ctrl
tissue: rectal mucosal epithelia;	genotype: non-CF,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: White;	sex: Female,pert
"Gender: female, Age: 38 years, Tissue: normal vulva,",ctrl
B-CLL PB P254,pert
"-Rosi, +PPAR, 2hrs",pert
male,ctrl
strain: C57BL/6;	gender: male;	genotype/variation: WT;	treatment: phenobarbital;	tissue: liver,ctrl
Sample ID: TP14;	Twin Pair ID: CCN1.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2R** ,ctrl
patient: 134;	current medication: None;	birth date: 12/21/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/12/05;	indictation for procedure: Abdominal pain;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
Insm1 control #6_pituitary gland,ctrl
C2C12 myotubes,pert
S46 NLS 142Q TG2	F5/9	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
WT_cerebellum at P30,pert
subject: 39;	disease: CP;	muscle: GR;	gender: M;	age: 15.3;	gmfcs: 2;	popliteal angle: 120,pert
A549 non-small cell lung cancer (NSCLC) cell line,ctrl
cell type: Bone marrow cells;	genotype: MSI2-inducible mice;	strain: C57BL/6,pert
age: 15;	sex: F;	disease status: control subject;	Filter number: 102;	Usage number: 1;	Exposures: 3,ctrl
tissue: Hippocampus;	age: 100;	Sex: F,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: severe stress + saline vehicle,pert
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 59;	donor: 34;	disease state: Lesional,pert
Wild-type ES cells,ctrl
CD8 KLF13 WT,ctrl
Normal mouse,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 6,pert
cell type: Pancreatic ductal adenocarcinoma;	cell line: CAPAN2;	transfection: control lentivirus,ctrl
Epidermal keratinocytes treated with EphB2 for 1h,pert
scan batch: Batch 2;	group: control;	subject age: 4;	paternal age: 32;	maternal age: 38,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 24hr,pert
frozen surgical tissue,pert
"patient: 210;	current medication: Mesalazine 800mg B, Prednisolone Supps;	birth date: 6/28/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/73;	diagnosis date: 1/10/74;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/19/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/14/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Scarlet Fever 1964;	disease: UC;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",pert
cell line: U-87MG;	treatment: vector,ctrl
RNA from whole tissue section of case 638 labeled with Cy5,ctrl
EB_2_8d_221_HCHO_Nasal_Rat230_2_CIIT05024,pert
"Normal cervix, commercial_Stratagene",ctrl
37A;pretreatment;female;breast tumor,ctrl
OCI-Ly7 NTsiRNA,ctrl
Sprague-Dawley rat femoral diaphysis,pert
Posterior_wild type,ctrl
Pool Ts1Cje_P0,pert
EB_07_6h_127_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
HeLa cells transduced shYY1 control lentivirus.,pert
"Neuroblastoma SH-SY5Y cells, stably transfected with RNAi against DJ-1",ctrl
CD11b+Gr-1+ myeloid cells sorted from the colon tumors of HDC-EGFP/HDC-KO transgenic mice induced with AOM/DSS,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: wild-type,ctrl
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
RNA from whole tissue section of case 289 labeled with Cy5,pert
disease state: paediatric glioblastoma;	age: 11;	gender: M;	h3.3_status: K27M,pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 2 hours,ctrl
cell type: hepatoma cells;	cell line: Huh-7;	transfection: IRF1,pert
RV64.11_CHF_day25,pert
Tissue: lung;;	Genetics: Familial IIP;;	Histology: Usual Interstitial Pneumonia,pert
ST045849 12 hours_3,pert
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 30 (P30);	tissue: cerebellum,pert
strain: C57BL/6 (B6);	genotype: WT;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,ctrl
"Brown adipose tissue, WT",ctrl
Ramos cells,pert
RV16;	Age = 20;	Sex = M,pert
"wild type Treg, replicate 2",ctrl
Mouse heart at 6-weeks old,pert
"Cervical cancer cell line, C-33A",pert
tissue: esophageal squamous cell carcinoma,pert
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC;	Vehicle Treated 0.1N KOH (equivalent volume to treated) in cell culture media,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 44;	sex: M,ctrl
undifferentiated,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: retina;	time: ZT20,pert
strain: C57BL6/J;	age: 12 weeks;	gender: female,pert
HCC_38T,pert
R,ctrl
cell line: U373;	cell type: glioma;	vector: MAML1 dominant-negative,pert
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of miR-142-3p mimic;	treatment duration: 24 hrs,pert
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
quadriceps_muscle_Akt1+/-_female_35wk_rep1,pert
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/8,ctrl
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 12h",pert
"SPC-c-raf transgenic mice, 12 month old, female, tumor",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day7,pert
U2OS_siNS_4h,ctrl
X50 NLS 18Q TG3	F2/49	X50	NLS Htt exon 1 18Q	Mouse	16 months	Cerebellum	Male,pert
"HeLa cells, 72 hs after transfection",pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L221,ctrl
Patient: N;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
Strain: B6SJL;	Age: 75 days,ctrl
human_hepatocyte_400uM_ciprofloxacin_prep1,pert
Cell line established from CA1 HESC using pClip vector,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 43, stage IIB, HPV 16",pert
cell line: MiaPaCa2;	cell type: dasatinib-resistant pancreatic cancer cell line,ctrl
Whole testis,ctrl
"Liposarcoma culture from tumor 385, untreated",ctrl
subject: 10;	disease: TD;	muscle: ST;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 47.31781,pert
tissue: Biceps muscle;	patient: C.b.1;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 2m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
VGP melanoma,pert
ESVJ (+/+ parental of Abca1 +/-),ctrl
"age at diagnosis: 75;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 0;	pgr: 0;	dfs-month: 28;	dfs-event: 1;	distant metastasis: 1",pert
"heart, QH2, 6 months",pert
Laser-capture microdissected non-malignant FTE from normal control patient,ctrl
treatment: baseline;	gender: F;	age (y): 51;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,ctrl
"SRF silenced, treated with R1881, biological rep 1",pert
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
NSC_FOXO_NULL-2,pert
tissue: brain;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
Disease_status: Healthy control;	Age (years): 29;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 42;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
23 weeks male,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 24hr.",pert
tissue: Brain;	genotype: Npc1+/-;	age: 55 days;	subject: Mouse4;	genetic background: BALB/c,ctrl
CF CFTR unexposed,pert
strain: C57BL/6J;	day: 6;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
"NCI-H69 xenografts, PDT treated and control untreated",pert
genetic background: C57Bl/6;	genotype: Calcr-/-;	cell type: Osteoclasts;	treatment: untreated,ctrl
"Whole brain hemispheres, harvested at 8 weeks",ctrl
cell line: KU-812;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
OV1002 Control Day7,ctrl
sorted CML CD34+CD38- cells cultured without exposure to drugs (controls),ctrl
diagnosis: RB-ILD;	fvc-group: FVC3;	tissue: lung,pert
Leukemai,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: FMR1 shRNA,pert
"skeletal muscle, quadriceps",ctrl
"E14 molar teeth, TCDD exposure",pert
RNA from microdissected breast cancer cells from case 633 labeled with Cy5,pert
sampleID: SAM630145;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
genotype: SIRT3 KO;	tissue: brown adipose;	genetic background: 129,pert
unaffectd brother,ctrl
"BN strain, male, age 21 weeks, treated with the synthetic estrogen diethylstilbestrol (DES) for 12 weeks",pert
cell type: hepatoma cells;	cell line: Huh7,ctrl
patient id: T79;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 59;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM0;	Stage: n/a;	fuhrman grade: 4;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: JAK2 knockdown (Jak2-9 shRNA),pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK1;	agent: EtOH;	time: 4h,ctrl
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: CC10-rtTA-IL13 transgenic (TG);	age: 6-10 weeks old mouse,pert
"HCT116 shControl, low glucose",ctrl
"strain background: C57BL/6;	genotype/variation: wild type; Cdh1+, P53+;	age: 2 months;	gender: female;	tissue: uterus",ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l -/-;	days after transduction: 7,pert
Mouse C57/bl6,ctrl
PancreaticSample29-Tumor,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.",ctrl
"Tumor sample from patient with p53 mutant, replicate 1",pert
subject: 28;	disease: TD;	muscle: GR;	gender: M;	age: 14.8;	gmfcs: N/A;	popliteal angle: N/A,ctrl
control participant P316 (human CD3 positive T cells),ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes,pert
Patient: C;	Time: 1 week;	Group: responder;	Condition: lesional,pert
tissue: lung adenocarcinoma;	cell line: A549;	transfection: pcDNA-MYC (control),ctrl
genotype: PIK3CA.H1047R;	agent: DMSO,pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: none;	time: Day 8",ctrl
cell type: R1 mouse embryonic stem cells stably transfected with Pcl2 shRNA sequence,pert
RV16;	Age = 20;	Sex = F,pert
Disease_status: Healthy control;	Age (years): 44;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.59;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
tissue: muscle;	sample group: resveratrol;	treatment: after;	gender: Female,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 70min;	race: White;	sex: Male,ctrl
primary leukemic cells purified from peripheral blood,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.36986,pert
Emx2 KO mouse,ctrl
human preadipocytes+oligo1_day0_rep2,pert
cell type: granulocytes;	group: Healthy control;	patient treatment: not applicable,ctrl
patient: 28;	disease state: hypertension;	tissue: Atheroma plaque,pert
Intima media,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month;	treatment: fresh air, treatment over 5 month, 4x1h exposure per day",ctrl
cell line: OVCAR3;	transfection: eukaryotic expression vector pcDNA3.1 containing the full-length cDNA for CD157,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 52.78082,pert
patient E1635,ctrl
"BMDC, Asc-/-",pert
"Biceps, control, cohort 20, subject 20U",ctrl
"Strain: C57BL/6 X SV129, Age: Embryonic Day 17.5, Tissue: Heart Venticlee",pert
abl cells transfected with control siRNA under hormone depleted conditions,ctrl
MEFs,ctrl
cell type: MaF pre-induced pluripotent stem cells;	treatment: vitamin C;	time: Day 6,pert
cell line: BL2;	transfection: LEF siRNA;	batch: 2,pert
cell line: SBC-5 cells;	treatment: siEGFP (control);	time: 72 hr,ctrl
sample type: Primary culture of type II cells collected from SPC KO lung adult;	age: adult;	cell type: type II lung epithelial;	genotype: Surfactant Proteiin C KO;	genetic background: 129S6/SvEvTac,pert
G93A non transgenic littermate 1264,ctrl
siZMPSTE24-treated MDA-MB-231,pert
normal donor,ctrl
HEK293 F5 WTX inducible,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 12 weeks,ctrl
Flp-In™ 293 T-Rex,ctrl
"Transgenic, snap frozen, diaphragm muscle, 10 month age animal",pert
E2F1 Null,ctrl
Brain from 60 days Npc1+/+ mouse1,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.092;	OD280: 0.567;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 284;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
NB87,ctrl
"seminoma specimen, pT1, patient age: 56y",pert
OCUBM,pert
EB_0_6_321_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
"DSS colon tissue, biological rep3",pert
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD8+ T-cells",pert
Mouse embryo fibroblast,ctrl
placenta (E 10.5),pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.132;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 50;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, peritumoral tissue;	disease status: hepatocellular carcinoma",pert
"38B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Retina of 6 month old RPE65 -/- mouse,pert
patient: 10;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
subject: 20A;	cohort: 20;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 28;	Sex: M;	batch: Batch_5,pert
"Ulcerative colitis patient, biopsy taken from the descending colon, macroscopic inflammation vissible",pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 1,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
"T1.5 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
A HID B_B009,pert
treatment: progesterone;	genotype: progesterone receptor knockout;	treatement time: 4 hours,pert
UC Uninflamed descending colon,pert
HCC_12T,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.03;	RNA Integrity Number: 9.6;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,pert
"BOEC, normal 21",ctrl
C57/BL,pert
tissue: Pancreas;	strain: C57BL/6;	genotype: Mist1Cre-ER/Cre-ER;	age: 8 weeks,pert
"Trained diabetic mice, time point 5 week",pert
"Nrl-ko, purified Gfp+ photoreceptor cell",pert
cell line: T47D;	treatment: Telpristone [1µM],pert
"HSCs from female mice treated with oil, replicate 1",ctrl
Patient: F;	Time: 4 weeks;	Group: non-responder;	Condition: lesional,pert
Female - caucasian - N-03-G,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 131,ctrl
"Ishikawa cell line, BPA, 100pM, 48hr",pert
agent: untreated;	time point: 0 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,ctrl
Both ventricles of heart,pert
"Heart, wild type3",ctrl
cell line: U87MG;	treatment: control siRNA,ctrl
HCT116 human colon cancer cells with PTEN -/-,ctrl
patient: 265;	current medication: Pentaza 500mg TDS;	birth date: 8/17/71;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 2/5/04;	diagnosis date: 3/22/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/19/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/19/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 0-4;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
SCLC cells,ctrl
"twin pair: #10;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
MDA-LM2-shTARBP2,pert
tissue: skin;	individual: Patient N-2;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 113;	treatment: REBIF;	time: 24 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
hur status: WT;	rna subtype: nuclear RNA,ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siPsmd14,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siCtrl;	agent: EtOH;	time: 24h,ctrl
Female - caucasian - N-02-M,ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 3",pert
cell line: MOLM-14;	replicate: Replicate2;	treatment: shLuciferase,ctrl
"cell type: HVS-transformed T cells;	genotype/variation: ITK R335W mutant , homozygous",pert
patient: 11;	disease state: hypertension;	tissue: Atheroma plaque,pert
colorectum,pert
Neuroretina 8-week old db/db mouse: BKS.Cg- + Leprdb/+ Leprdb/OlaHsd,pert
iFGFR1 mammary gland 16 hrs AP20187,pert
strain background: FVB;	genotype/variation: wild type;	tissue: whole skin,ctrl
subject: 2826 TG;	type: transgenic;	tissue: Mouse skeletal muscle,pert
cell line: THP-1,pert
genotype/variation: Usp2-KO;	strain: C57BL6/N,pert
Normal Uninflamed sigmoid colon,ctrl
Insm1 control #10_pituitary gland,ctrl
agent: resveratrol_150mM;	tissue: mammary epithelium adenocarcinoma;	cell line: MCF7,pert
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: 4-hydroxytamoxifen;	dose: 500 nM,pert
LRRK2 mutant knockin H9 hESC derived NSC 1,pert
cell line: Panc0403;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
Peripheral blood mononuclear cells;	TTF=95min;	Race=White;	Sex=Male,pert
G93A mouse 1261,pert
-DOX/+E2 48h_2,pert
Colonic mucosal endoscopic pinch biopsy,ctrl
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,ctrl
RWPE-PCAT1 cells transfected with cMyc siRNA #4,pert
colonoscopic biopsy from normal adult,ctrl
"PDAC, sample 1",pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 33;	maternal age: 32,pert
lung tissue,pert
strain: C57BL/6;	tissue: small intestine;	genotype: wild type;	treatment: lubiprostone,pert
patient E1635,pert
"Male, Wistar, 6hrs/day access to cocaine, nucleus accumbens",pert
Whole testis RNA from Crem-/- mouse #151 at 0h,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M2;	flt3 status: WT,ctrl
"Bicalutamide treated LNCaP cells not stimulated with DHT, biological replicate 1",pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T4, N3, M0, G4",pert
WT BMDCs tumor-derived DNA stimulation,ctrl
coc-38,pert
Universal Human Reference RNA - Cy3,pert
Control AGS cells (transduced with non targetting shRNA),ctrl
DA rat jejunum treated 1 h,pert
8_2,pert
tissue: normal skin;	urticaria status: non-afffected;	patient: 14,ctrl
control normoxia,ctrl
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,pert
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Rectosigmoid;	Drug Treatment: NO,ctrl
age: 31;	gender: female;	ejection fraction: 56;	left ventricular end diastolic diameter: 71;	inflammation/PVB19: positive,pert
MiaPaCa2 cell line,ctrl
cell line: BT474;	cell type: breast cancer;	lapatinib sensitivity: lapatinib-sensitive;	her2 status: HER2-positive;	treatment: lapatinib,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: multiple gunshot wounds,ctrl
HLA risk: High;	Height: 171.8 cm;	Weight: 82.4 kg;	BMI: 28;	Age: 57.67 years;	Gender: Female;	Race: White;	Glucose: 78 mg/dl;	HbA1c: NA,ctrl
disease state: sarcoidosis;	biopsy type: transbronchial;	tissue: lung,pert
chip number: 4;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.84;	rin: 9.1;	transfection date: 2011-03-29,pert
Postmenopausal female. Tibolone treated. Patient 11.,pert
68A;pretreatment;female;breast tumor,ctrl
RNA from microdissected breast cancer cells from case 140 labeled with Cy5,pert
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 32+26=58;	Sex: male;	region: M1;	age: 47,48;	genotype: Y/Mecp2-;G42/-",pert
age: 6 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
Bone Marrow Mononuclear Cells;	22y Male,ctrl
SKM-1 acute myeloid leukemia cells,pert
A61 WT3	F24/2	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 120min;	race: UK;	sex: Female,ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 2hr,ctrl
cell line: LNCaP;	overexpression vector: FOXA1,pert
genetic background: C57BL/6-129Sv hybrid background;	genotype: Setdb1 2lox/1lox/Cre;	treatment: tamoxifen;	cell type: embryonic stem cell,pert
strain: C57BL/6J;	day: 6;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
subject: 10;	disease: TD;	muscle: GR;	gender: M;	age: 14.9;	gmfcs: N/A;	popliteal angle: N/A,ctrl
heart of male mouse subjected 4 week to chronic intermittent hypoxia.,pert
"age at diagnosis: 56;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1biii;	er: 0;	pgr: 0;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 2",ctrl
tissue: white blood cells;	age: 16.28;	Sex: male,pert
cell line: GIST882;	agent: DMSO (control);	replicate: Rep3,ctrl
H1 hESCs,ctrl
"Skin removed from back region of embryonic day 16.5 mouse, Tcfap2c mutation",pert
White portion of the gastrocnemius muscle,pert
NORMAL #00-0386,ctrl
strain background: C57BL/6J;129S5/Brd mixed hybrid;	genotype/variation: wild type control;	tissue: uterine;	age: 15 days,ctrl
Strain: C57BL/6 Gender: mixed Age:E9 Tissue: whole embryonic body;	,ctrl
Peripheral blood mononuclear cells;	TTF=92min;	Race=White;	Sex=Female,pert
strain: C57BL/6J;	cell type: embryonic fibroblasts;	genotype/variation: Ulk1/2+/+;	agent: untreated,ctrl
MDA-MB-231 breast cancer cell line,ctrl
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing myc-tagged Hes1 and GFP,pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.53973,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day0,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: M,ctrl
21A;pretreatment;female;breast tumor,ctrl
"BMDC, wt",ctrl
"patient 10, right arm treated with pimecrolimus until day 22",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 48.13151,pert
gender: male;	age: 2-3 months;	tissue: kidney;	genotype: ERRa KO,pert
mixed background e18.5 male cardiac ventricle,pert
U2OS_siNS_0h,ctrl
Epidermal keratinocytes treated with EphB2 for 48h,pert
cell type: Human melanoma cell line;	cell line: M249;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
MPM tumor specimen 33,pert
age	26;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.1;	hemoglobin (g/dl)	14.6;	platelet count (/nl)	217,ctrl
individual: patient5;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Eed KO E14 ESCs on day 7,pert
astrocyte,ctrl
"Cultured ovarian cancer cell line OVCAR-8, Cisplatin treated",pert
cell type: Dorsal skin Basal IFE epidermal stem cells;	genotype: wild type,ctrl
strain background: C57BL;	genotype/variation: SHP knockout; SHP-/-;	tissue: liver,pert
"-Rosi, -PPAR, 72hrs",ctrl
Superior Frontal Gyrus from 10 year-old normal girl,ctrl
cPuro,ctrl
Adipose tissue from male ASC-/- animal (C57/Bl6 background),pert
Murine Cells (Macrophages),pert
protocol: control;	cells: Neural Neural Stem Cell Line F3,ctrl
Strain: C57BL/6;	Age: 6 months;	Tissue: retina,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: Liver;	age: 5 months;	genotype: Wild type,ctrl
WT mESC,ctrl
Patient: N;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
"ATP7B -/- Ko mice, 6 weeks old",pert
"BOEC, at_risk 10",pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient D;	treatment: Vemurafenib 1000 nM for 48h,pert
cell line: H295R adrenocortical carcinoma cells;	tissue: Cells derived from Adrenal gland;	agent: angiotensin II;	dose: 100 nM;	time: 3 hr,pert
Heart dissected from wildtype E12.5 fetus.,ctrl
gender: Male;	age: 74;	post-mortem delay: 4.5h;	ph: 6,pert
vulva biopsy of normal tissue,ctrl
tissue: Temporal cortex;	age: 95;	Sex: F,pert
A2058 CT16 siRNA,pert
status: Control;	gender: Male;	age: 49;	tissue: Blood,ctrl
Endometrium-Normal 3,pert
race: caucasian;	age (years): 66;	stage: IB;	grade: 1;	histology: endometrioid,pert
tissue: Frontal cortex;	age: 90;	Sex: M,pert
cell type: Primary neonatal keratinocytes,ctrl
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days.  The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
scram_lo_2,ctrl
tissue: muscle;	genotype: WT;	genetic background: C57BL/6,ctrl
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,pert
"ID:6-2, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
"Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: 10 ppb, 5wk",pert
isolated keratinocytes from mouse skin,ctrl
race: caucasian;	age (years): 62;	stage: IB;	grade: 1;	histology: endometrioid,pert
"midbrain,24weeks,KO",pert
"Female (age range 33-49), skin biopsy taken from upper nates 96 hours after nickel exposure",ctrl
subject id: 38;	infection: DENV;	status: DHF;	tissue: whole blood,pert
race: african american;	age (years): unknown;	stage: IA;	grade: 2;	histology: papillary serous,pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with vehicle for 6h,ctrl
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 8",pert
gender: male;	genotype: Alb-Cre/ TAK1 flox;	strain: C57BL/6;	tissue: liver;	age: 4 wk,pert
subject: 33;	disease: TD;	muscle: GR;	gender: M;	age: 13;	gmfcs: N/A;	popliteal angle: N/A,ctrl
T162,pert
"age: Embryonic day 14.5;	genotype: Zfp36l2 knockout (KO);	tissue type: fetal liver;	strain: b6, 129 mixed background strain",pert
race: african american;	age (years): 73;	stage: IB;	grade: 3;	histology: papillary serous,pert
"Biceps, FSHD, cohort 12, subject 12A",pert
tissue: skin;	cell line: NZM15;	tumour stage: metastatic melanoma;	tumour site: neck nodule;	treatment: media-only control,ctrl
human_hepatocyte_gatifloxacin_24hr,pert
S3star_Sham_wildtype_8,ctrl
tissue: white blood cells;	age: 14.5;	Sex: male,pert
Flp-In™ T-REx™ 293,ctrl
MCF10A cells,pert
Extract:LOX-1:113403;	Extract Description:GFP_Untreated_12hr:113403;	Quality: Classification:Good;	Quality: Gradient Severity:0.05;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.04;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.7;	Quality: Background Mean Dev.:1.04;	Quality: Absent (%):57.99;	Quality: Absent (%) Dev.:0.2;	Quality: Scaling Factor:0.48;	Quality: Scaling Factor Dev.:1.14;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113403;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295733,ctrl
HEK293-cells,ctrl
Sciatic nerves from GNMT-KO mice,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 75,pert
THP-1 cell line infected with GSK3B Construct 2 shRNA,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD4+ T-cells,ctrl
cell type: Human melanoma cell line;	cell line: M238;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
Immortilised monocyte cell line,ctrl
12A;pretreatment;female;breast tumor,ctrl
KO_48A_1c,pert
"Human male subjects with familial combined hyperlipidemia (FCH), peripheral blood monocytes",pert
1833 cells with HMGA2-depletion,pert
placenta,ctrl
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 2,pert
tibialis anterior Muscle control,ctrl
HDC-expressing CD11b+Gr-1+ myeloid cells sorted from the bone marrow of HDC-EGFP transgenic mice,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,pert
"SKI-DLCL cells, not treated and cultured for 24h. Total RNA was isolated using RNeasy kit",ctrl
1% dmso batch 3,ctrl
human normal cell lines airway with 24 hours of DMNQ treatment,pert
cell line: MDA-MB231;	treatment: G9a knockdown;	cell type: less metastatic breast cancer cells,pert
chip number: 14;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.65;	rin: 9.8;	transfection date: 2012-03-26,pert
background mouse strain: C57BL/6;	source: liver;	genotype: Rap1 knockout,pert
"Liposarcoma culture from tumor 389, doxorubicin treated",pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 4,pert
disease state: Healthy;	cell type: CD4+T;	twin: R,ctrl
mouse E12.5 embryonic kidney isolated from wild-type pregnant female,ctrl
"Gender: Female, Age: 32, BMI: 25, Tissue: luteinized cumulus cells",pert
"midbrain,18month,KO",pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 1 (RAEB1);	genome/variation: normal,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
"genotype: Ring1B mutant generated by gene targeting (Leeb et al., 2007);	cell line: ES",pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5b;	flt3 status: internal tandem duplication (ITD)/D835 mutation,pert
CD71+ bone marrow cells from CD70TG (clone F13) mouse 1,pert
Brain from 20 days Npc1+/+ mouse1,ctrl
"cultured human airway smooth muscle, 24 hour dex treatment, replicate 3",pert
Epithelial prostate primary cells from fresh tumor explant.,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 64, stage IIB, HPV 18",pert
gender: male;	individual: patient 5;	treatment: paclitaxel-eluting stent,pert
strain: SW129/C57BL/6J  cells;	genotype/variation: c-jun knock out;	cell type: B-lymphoid,pert
strain: Des(-/-)/129/SVE;	genetic background: 129/SVE;	tissue: tibialis anterior;	age: 12-14 mo,pert
wild-type Jurkat cells,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 104min;	race: White;	sex: Female,ctrl
P4A Progranulin-frontal,pert
gender: male;	batch: 1;	age (years): 46;	patient id: Control_4;	fev1 (% predicted): 92;	fvc (% predicted): 105;	medication: None;	cell type: CD8+ T-cells,ctrl
"wild type, embryonic stem cells",ctrl
gender: male;	strain: C57B/6Jx129Sv;	genotype/variation: wild type;	tissue: heart;	age: 10-12 weeks old,ctrl
Muscle_mutation,pert
Background: mixed genetic backgroud of C57Bl/6 and 129/SvJ;	Genotype: IRF6 wt;	Age: Embryonic day 17.5,ctrl
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, bone marrow;;	disease: (severe) aplastic anemia (SAA) post therapy / in hematological remission",pert
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed",ctrl
monocyte derived DCs,pert
MDA cells resistant to paclitaxel were treated with 30 nM Paclitaxel,pert
patient: 29;	disease state: hypertension;	tissue: Atheroma plaque,pert
disease state: healthy control;	tissue: epidermis;	age: 74;	gender: female;	treatment: untreated;	time: control,ctrl
Pre-Frontal contex of naïve AChE-S mice,pert
B lymphocytes,pert
mouse B6xCF-1  Non-transgenic (control-3),ctrl
cell type: AML blasts;	fab classification: M2,ctrl
HUVEC monolayer,ctrl
transgene: FTO;	treatment: noninduced,ctrl
Cell line established from CA2 HESC using pClip vector,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 59;	donor: 17;	disease state: Non-lesional,ctrl
tissue: white blood cells;	age: 14.51;	Sex: female,pert
affected status (disease state): control;	gender: female;	age-at-examination: 45;	age-at-onset: n/a;	geographical origin: Mirandela,ctrl
HEK 293,pert
HepG2_wild type,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.549;	OD280: 0.803;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 7.9;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 63;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",pert
background strain: mixed (C57BL6/6J and 129);	genotype: Dmrt1 flox/flox with Dhh-cre;	gender: male;	tissue: testis;	age: postnatal day 28 (P28),pert
disease state: paediatric glioblastoma;	age: 14;	gender: F;	h3.3_status: wt,ctrl
Cell line: NALM1,ctrl
Adipose from a 24 month old Myc heterozygous mouse,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 5,ctrl
"liver,fasted,refed, 3hr",pert
Brain area 8/9 from 6 year-old RTT girl,pert
cell line: TOV112D;	cell type: epithelial ovarian cancer cell;	treatment: Untreated,ctrl
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,pert
tissue: Brain;	genotype: Npc1-/-;	age: 40 days;	subject: Mouse2;	genetic background: BALB/c,pert
EB_400_6_369_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,pert
cell line: HT29;	cell type: colon cancer;	methotrexate sensitivity: resistant,pert
Endometrium/Ovary-Disease 8,pert
N8C Normal-hippocampus,ctrl
scan batch: Batch 2;	group: control;	subject age: 10;	paternal age: 23;	maternal age: n/a,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 73;	gender: female;	years of disease: Unknown;	treatment: phototherapy;	time: pre-UV,pert
n3_hi_11,pert
Extract:LOX-1:113202;	Extract Description:GFP_Untreated_2hr:113202;	Quality: Classification:Medium;	Quality: Gradient Severity:0.06;	Quality: Distortion Severity:0.07;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0;	Quality: 3'/5' Mean:1.75;	Quality: Background Mean Dev.:2.27;	Quality: Absent (%):59.11;	Quality: Absent (%) Dev.:0.67;	Quality: Scaling Factor:0.55;	Quality: Scaling Factor Dev.:0.5;	Pretreatment [C]:GFP;	Time point [C]:2 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113202;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_2hr;	RNA extraction source key [A]:282295483,ctrl
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: Eed KO;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+CD48-CD150+,pert
MEF cells from female  WT embryo (D12.5),ctrl
Whole Blood of Dengue infected patient at acute infection time point,pert
"Cell type: neuronal, age:46, gender:male, diagnostic group: control, PMI:31h",ctrl
ICR MEF infected  with pMX-Oct4 retrovirus,pert
"Distal, Small Intestine 21 days old",pert
Extract:LOX-1:113503;	Extract Description:GFP_Untreated_24hr:113503;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.04;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.04;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.36;	Quality: Absent (%):58.28;	Quality: Absent (%) Dev.:0.02;	Quality: Scaling Factor:0.65;	Quality: Scaling Factor Dev.:0.34;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113503;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295853,ctrl
agent: pristane;	time: 3 days;	strain: BALB/DBA F1 hybrid;	tissue: mesentery,pert
treatment: PLX4720;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,pert
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,pert
tissue: Hippocampus;	age: 99;	Sex: M,pert
"mNB-A1, MLN8237",pert
Whole adrenal RNA from WT mouse #146 at 0h,ctrl
"seminoma specimen, pT1, patient age: 55y",pert
"RET-PTC, 2 months",pert
sampleID: SAM630147;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
18.5 dpc mouse small intestine pLagl2 knockout,pert
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Jun delta mu,pert
EB_07_19d_156_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
tissue: T cells;	genotype: CTLA-4 KO 5C.C7;	background mouse strain: B10.A,pert
APLP2_R1,pert
TET-on Human lung carcinoma H1299,ctrl
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
CHARACTERISTICS;	Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Paraventricular nucleus,pert
PC-3 cell  control mir,ctrl
RNA from microdissected breast cancer cells from case 260 labeled with Cy5,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 27;	disease state: Lesional,pert
HUVEC infected by retroviral vectors bearing a control scramble sequence,ctrl
RNA from microdissected breast cancer cells from case 1304 labeled with Cy5,pert
"RWPE1 cells treated for 24 hours with 100 nM 1,25(OH)2D",pert
gender: Male;	age: 60;	post-mortem delay: 16h;	ph: 6.9,ctrl
tissue: Breast adenocarcinoma,ctrl
strain: Wistar;	gender: male;	tissue: spinal cord;	treatment: saline,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 70",pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 42.93699,pert
cell line: HeyC2;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
Sample ID: TP13;	Twin Pair ID: CCN1.1;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.1R** ,ctrl
"endometrial stromal cell - Jag1 retrovirus infected1, 3 days post infection",pert
Hec50co human endometrial cancer cells with MTDH knocked down using ShRNA,pert
chip number: 20;	transfection plate: 3B;	target gene: E2F6;	kd level: 0.65;	rin: 9.5;	transfection date: 2012-03-26,pert
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: Notch3 knockout;	age: 2 months,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
cell type: Primary hepatocytes;	strain: BalbC;	agent: control;	time: 6h;	gender: Male;	age: 6 months,ctrl
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: moderate;	Tumor Site: Ascending;	Drug Treatment: YES,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 4",pert
"cell type: MEF;	transduction: SKO (sox2, klf4 and oct4);	treatment: vitamin C;	time: Day 6",pert
"C57BL/6N, adult, female",ctrl
runx1-null luminal mammary epithelial cells,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 45 yr;	population: white;	dsm-iv: 295.3;	age of onset: 34 yr,pert
BV2_Curcumin_rep3,pert
"BL from CLL patient, isolated using CD19-PE and CD5-APC",pert
"A673 cell line, a human EWS/FLI translocated Ewing sarcoma cell line.",ctrl
braak stage: BR34;	rin: 62;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
hur status: KO;	rna subtype: nuclear RNA,pert
"NOD islets, RIP-Aire27 transgenic",pert
"patient 11, baseline",ctrl
cell line: NOMO-1,pert
"CD3+ T cells, peripheral blood derived, SAA patients",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 51,pert
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: retina;	age: 10.5 months,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.898;	OD280: 0.49;	Ratio: 1.84;	Dilution: 1:5;	RNA Integrity Number: 7.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 209;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Whole adrenal RNA from Crem-/- mouse #144 at 0h,pert
Large PreB,ctrl
NHEK_MLL2 siRNA_1.8mM Ca_48hr,pert
SV589_3Day KD,ctrl
RNA from whole tissue section of case 420 labeled with Cy5,pert
MCF-10A_sh53BP1-1,pert
siUbr5,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 36.00274,pert
"metastasis: none;	Stage: 1;	tissue: cancer, homogenized",pert
Wild type fully-grown GV oocyte from transgenic mice,ctrl
genotype: C57BL/6 WT,ctrl
Tissue:tumor; Gender:male; Age:36; Tumor stage:T4aN1aM1,pert
age: 36;	gender: male;	ejection fraction: 64;	left ventricular end diastolic diameter: 50;	inflammation/PVB19: negative,ctrl
"Embryoid bodies, 24h,Plus Dox",pert
"liver,6weeks,KO",pert
background strain: B6/129;	genotype/variation: wild type;	age: 11 Month;	tissue type: Liver,ctrl
"FACS-sorted cones, P90 wild type mice",ctrl
braak stage: CTRL;	rin: 65;	tissue: substantia nigra;	disease state: control,ctrl
tissue: Spleen;	cell type: B lymphocytes;	gfpmyc status: positive,pert
Untransfected Jurkat cell line,ctrl
mutant testis at 14dpp,pert
Squamous cell lung cancer patient 36,ctrl
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject J,ctrl
Genotype: wildtype MEFs;	Primary mouse embryonic fibroblasts (MEFs) generated from embryos at E13.5,ctrl
cell line: JURL-MK1;	tissue: Myeloid leukemia cells;	agent: untreated,ctrl
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 4,pert
A39 NES 142Q TG6	F1/4	A39	NES Htt exon 1 142Q	Mouse	10.5 months	Cerebellum	Female,pert
"endometrial stromal cell - Jag1 retrovirus infected3, 3 days post infection",pert
"Lymphoblastoid cell lines derived from family 1720, member 2",pert
"ID:c 4-5, Genotype=(C57BL/6J), Treatment= none",pert
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Control;	time point: 5-6 weeks post doxycylcin withdrawal,ctrl
cell line: HCT 116;	treatment: control,ctrl
"BALB/c, Male, Contol",ctrl
genotype/variation: Zfx wt/y CreER;	treatment: infected with control retrovirus with GFP selectable marker,ctrl
"sebocytes cultured from M, 55, normal preauricular sebaceous glands and SV-40 immortalized",ctrl
patient: 7;	disease state: hypertension;	tissue: Atheroma plaque,pert
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,pert
Disease_status: Healthy control;	Age (years): 50;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.75;	Post mortem interval (hours): 49;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 50,ctrl
age: 20;	sex: M;	disease status: Marfan subject;	Filter number: 89;	Usage number: 4;	Exposures: 3,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14504;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
patient id: T158;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Female;	age: 82;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T3NxM1;	Stage: IV;	fuhrman grade: 3;	bap1 status: wild type;	pbrm1 status: mutant;	vhl status: mutant,pert
untreated,ctrl
EB_2_5d_216_HCHO_Nasal_Rat230_2_CIIT05024,pert
EB_07_6h_131_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
"Heart, MAT1 CKO, 4 wk, sample 3",pert
"Primary culture of dermal fibroblasts from normal scar, treated with 1.5uM hydrocortisone",pert
cultured human melanoma cancer cell BL,pert
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",pert
M AA S37C,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 15b;	treatment: with vehicle for 6h,pert
cell line: SKMEL28;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
disease state: healthy control;	tissue: epidermis;	age: 28;	gender: female;	treatment: untreated;	time: control,ctrl
Lesional skin from K5-Tie2 mouse,pert
"DHL4, R406, 48h",pert
background strain: C57Bl/6;	genotype/variation: Notch1 wild type,ctrl
"BOEC, normal 2",ctrl
gender: female;	age (years): 60;	evolution time (years): 22;	disease extension: Left-sided colitis;	treatment: 5-ASA,pert
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Ly5.1+,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 58, stage IIA, HPV 16",pert
RNA from NCCIT human cells depleted of TET3 by siRNA,pert
wild type MEF,ctrl
"Knock-out Nrf2 mice, liver sample",pert
cell line: mda-mb-231;	transfectant: siRNA for LacZ,ctrl
cell line: IEC-6;	tissue: colon epithelium,pert
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: ZMYM2/FGFR1;	biological replicate: 1,pert
hOB695_shEV_4hr_IR,ctrl
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Post mortem interval (hours): 29;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
cell line: mda-mb-231;	transfectant: siRNA for Pin1,pert
"Rat liver, left lateral lobe",pert
Hippocampus,pert
gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9,ctrl
"Strain: Polg+/+ mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",ctrl
tissue: embryonic fibroblasts,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 2x1h exposure per day",ctrl
Embryonal carcinoma,pert
"Lymphoblastoid cell lines derived from family 1757, member 2",pert
RNA from 3 MCF7 cell culture plates treated with 250 mM of resveratrol (SIGMA St. Louis MO),pert
"89 y/o female. 46,XX",pert
wild type; BMDM; IFNgamma treated,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.448;	OD280: 0.781;	Ratio: 1.85;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 309;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
cell type: Oct4-Gip ES;	RNAi: Panct1;	treatment time: 72h,pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a control siRNA.",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 165;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/16;	hybridization date: 09/06/30;	colon length (mm): 6.6;	colon weight (mg): 160;	colon ratio (mg/mm): 2.42;	myeloperoxidase activity (u/mg): 0.423;	tissue: colon;	treatment: 5% DSS,pert
T9.01,ctrl
genotype: Wild type;	strain: C57BL6,pert
"CD8 DC, WT",ctrl
cell type: primary human monocyte-derived macrophages;	differentiation factor: MCSF,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 10.008;	Ratio: 2.11,pert
gender: Female;	age: 65;	post-mortem delay: 3h;	ph: 6.1,pert
cell type: embryonic stem cells;	genetic modification: WT,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 35 yr;	population: white;	dsm-iv: 295.3;	age of onset: 14 yr,pert
HMEC,ctrl
patient: 40836;	sample: tumor,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 3 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
EB_6_5d_296_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
Age (mean +- SE),ctrl
"paraventricular nucleus of the hypothalamus, saline, 3 hour",ctrl
"LY2 cell line, SRC-1 siRNA untreated, biological rep2",ctrl
Primary MEF from 13.5 dpc wild type mouse,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 68 years,ctrl
transfection: Rif1 shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,pert
"foxp3 expression: NO;	cell type: CD4+/CD25- T effector cell;	disease state: IPEX disease carrier;	genotype: FOXP3 2T>C(mut);	gender: female;	treatment: anti-CD3, anti-CD28 for 72 h",pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 90,pert
gender: Male;	age: 41;	post-mortem delay: 8h;	ph: 6.3,pert
"K562, NoTreatmentControl, 24hrs, rep3",ctrl
infection: GFP protein (control),ctrl
DN4 cells sorted from mouse n°129 (Cre+),pert
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with vehicle for 6h,ctrl
Heart left ventricle,ctrl
tissue: kidney;	protocol: intravenous;	agent: saline;	dose: 0 mg/kg,ctrl
sample: #24;	subject: PD case #6;	brain: T-227;	age: 76;	sex: Female;	region: Inferior olivary nucleus,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
Normal Pleura 2,ctrl
Breast Cancer Cell Line,ctrl
PancreaticSample6-Tumor,pert
PancreaticSample37-Tumor,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 1, mock (24h post-infection)",ctrl
"brain, cochlea",ctrl
BaF3 cell line transduced MPLW515L3 mutant,pert
EGFR+EGF_1,pert
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
HCC_30N,ctrl
Snai1 knock out ESCs,pert
diagnosis: UIP/IPF;	fvc-group: FVC1;	tissue: lung,pert
"129P3/J Acute morphine treated, biological replicate 1",pert
"gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Sample Group: control; Gender: female; Age: 60; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
MS brain lesion (after inflammation has subsided -late stage),pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 2 hrs;	Drug: No Rosiglitazone present,pert
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: siRNA targeting FOXP1;	genotype/variation: siRNA-mediated FOXP1 knockdown,pert
"LY2 cell line, SRC-1 siRNA treated 120mins, biological rep1",pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.57;	Post mortem interval (hours): 36;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: AZD6244 MEK inhibitor 100mg/kg for 4 days,pert
"Embryoid bodies, 24h,Min Dox",ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 50;	sex: F,ctrl
CD4_T_cell_pool_healthy_H03+H04,ctrl
PancreaticSample12-Tumor,pert
Fourth day of N2B27 differentiation,pert
ICL670 treated K562 cells (10uM for 16hrs),pert
gender: male;	strain: BALB/c;	tissue: liver;	diet: AIN93G with 1.0% quercetin diet for 14 days,pert
Whole lung tissue_healthy donor lung,ctrl
Ebola-infected macrophages harvested at 1h post-treatment from donor 3,pert
gender: female;	age (years): 38;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
PancreaticSample38-Tumor,pert
The RNA samples from DHT 4hr treated LNCaP cells,pert
MLL_00255,pert
PDAC_P_123,ctrl
A YOKE_B061,pert
no_21,ctrl
whole splenic B-cells from adult CBA mice,ctrl
"age at diagnosis: 38;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
chip number: 12;	transfection plate: 6;	target gene: RAD21;	kd level: 0.89;	rin: 9.3;	transfection date: 2012-03-26,pert
gallbladder saline treated,pert
heterozygot FH P283 (human CD3 positive T cells),pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
aorta of Tgfbr2 knockout mice,pert
NBD inhibitory peptide-treated KOPT-K 100mM 16h,pert
RUES2_shRNA TMEM88,pert
patient: 20;	disease state: hypertension;	tissue: Atheroma plaque,pert
EB_15_6_341_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
subject: 21A;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
"Fibroblasts from normal histology lung tissue, NL-6",ctrl
Peripheral Blood Mononuclear Cells,ctrl
HEK293 cell line #4 with induced HNF1alpha,pert
ak_09+15,pert
F16.01,ctrl
CTL made from wild type splenocytes,ctrl
Normal Pleura 5,ctrl
"CA1, parental control SOX7 HESC- clone2",ctrl
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 93;	Usage number: 4;	Exposures: 2,pert
"LCL GM19238, Kd STAT6, 72hrs",pert
Cell line: BV-173,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 20.0;	age of psoriasis onset: 19,pert
pre-iPSC- siRNA to Cbx3- biological replicate2,pert
human frontal cortex,pert
Total RNA from LM2 cells labeled with Cyanine-5 (red).,ctrl
"Cell type: neuronal, age:48, gender:male, diagnostic group: bipolar disorder, PMI:23h",pert
"Male, Wistar, 0 access to cocaine, lateral hypothalamus",ctrl
"Patient  C, lesion, 12 week",pert
"AZ521 dnSox2 cells, uninduced, 24h",ctrl
cell type: HeLa cells,pert
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
HepG2 cells,ctrl
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",pert
chip number: 15;	transfection plate: 3B;	target gene: TCF12;	kd level: 0.85;	rin: 9.4;	transfection date: 2012-03-26,pert
Cav3KO 1504,pert
CD8_T_cell_pool_healthy_H07+H08,ctrl
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing,ctrl
P4C Progranulin-hippocampus,pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: CTNNB1 mutation (T41A),pert
cell line: Colo205RC PLX4720 resistant cell line;	cell type: colon cancer,pert
HT29 derived clone with vector expressing GFP directed shRNA,ctrl
cell line: H69;	treatment: none,ctrl
cell line: SW1736;	time point: 1h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 1 h,pert
gender: male;	strain: CBA/C57BL/6;	genotype/variation: IL8 transgenic;	tissue: colon cancer tumor,pert
Total RNA from bone marrow derived macrophage from BalbC mice,ctrl
race: caucasian;	age (years): unknown;	stage: IA;	grade: 2;	histology: endometrioid,pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 5 months;	genotype: Myc heterozygous,pert
Directly ex vivo brain CD8 T cells,pert
"A549 human adenocarcinoma cell line, control",ctrl
T145,pert
HUVEC,pert
APPsa_R6,pert
quadriceps_muscle_Akt1+/-_female_35wk_rep3,pert
Strain: a mixed C57BL6/129 genetic background,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 59;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,pert
gender: Male;	age: 72;	post-mortem delay: 20h;	ph: 6.6,pert
"Cultured ovarian cancer cell line C13, untreated",ctrl
renal vesicle from E12.5 wild type kidney,ctrl
transplanted heart,pert
"HEK293 cell, siRNA-mediated MIF knockdown",pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L017,pert
"strain/background: C57B6SJL;	genotype/variation: MAT1A knockout;	age: 15 months;	tissue: liver, tumoral tissue;	disease status: hepatocellular carcinoma",pert
Male wild-type BALB/c,ctrl
tissue: liver;	genotype: WT;	genetic background: C57BL/6,pert
Early Secretory Phase Endometriosis,pert
Human prostate tumor tissue,pert
Lesional ear skin from K14-Areg mouse,pert
B-CLL PB P250,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.782;	OD280: 1.422;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 54;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Strain: Wistar, Sex: male",pert
cell type: granulosa cells;	disease: normal,ctrl
Mouse forebrain primary cell cultue of astrocytes,pert
Celecoxib_#4877,pert
Spleen & Lymph Node,pert
RNA from whole tissue section of case 1507 labeled with Cy5,ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, 1.25uM sapphyrin PCI-2050 (1.25uM final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
Disease_status: Bipolar disorder;	Age (years): 61;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 43;	Brain pH: 6.5;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 40000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: Yes (5 treatments);	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
tissue: Frontal cortex;	age: 99;	Sex: M,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.01;	RNA Integrity Number: 10;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
"G392E, 2 ug/ml doxycycline",pert
individual: patient15;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 2,ctrl
"liver, ABCA1-TG",pert
race: caucasian;	age (years): unknown;	stage: IA;	grade: 3;	histology: endometrioid,pert
age: 24 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
Bmpr1a-/-  ESCs cultured 3 days in N2B27,pert
tissue: Cop1-null embryos,pert
ATCC CRL-2868,pert
"cell line: SW480-Snail, Snail expressing stable line",pert
LNCaP cells treated with vehicle and ELK1-shRNA,pert
hippocampal tissue from wild-type mice (standard cage),ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 165min;	race: Caucasian/White;	sex: Female;	group: A;	prototype: Y,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	1st technical replicate,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep1",pert
23 Day Mouse Diaphragm muscle,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 54.90137,pert
IRAK4-KD-MEFs_unstimulated_4hours_rep2,pert
"genetic modification: cells stably expressing the oncogenes c-myc and Ha-ras under the control of the Tet-off regulatable promoter, konstitutive expression of the estradiol activatabel IRF-1hER fusion protein;	tissue: fibroblast",pert
human epithelial colorectal adenocarcinoma cells (Caco-2),ctrl
CD11b+Gr1- cell sample_4 (derived from wild type mouse),ctrl
age: adult;	gender: female;	tissue: lung,ctrl
strain: FVB/N;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Fibroblasts;	genotype: Fsp-cre; PtenloxP/loxP,pert
"Brain tissue from Fisher 344 male rat, Animal #245, control (0mg/kg) D-Serine",ctrl
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: Control construct,ctrl
8 Month FORKO Ovary_02,pert
Sample ID:TP9;	Twin Pair ID:DCBD3.1;	Clinical Status:BD1 with psychotic features ;	Age of Onset:18 ;	Age at interview & blood sampling:35 ;	Current Age (2007):38 ;	Sex: Female ;	Medication at interview (duration) :sodium valproate (5 years),pert
patient E1520,ctrl
Mammary cell line,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T22,ctrl
cell type: embryonic stem cells;	genotype/variation: Satb1 overexpression,pert
Mouse T cells,pert
strain/background: C57BL6J;	tissue: jejunum;	gender: male;	age: 8 weeks;	treatment: cholestatic intestinal injury,pert
cell line: H1;	cell type: human embryonic stem cells (hESCs);	treatment: OE-NANOG,pert
"Liposarcoma culture from tumor 398, untreated",ctrl
S46 WT7	F5/55	S46	wild type	Mouse	10 months	Cerebellum	Female,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 44.58082,pert
"striatum,24weeks,WT",ctrl
Endometrium from untreated postmenopausal woman,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 85min;	race: White;	sex: Female,pert
E14.5 fetal liver TER119+ Klf3 KO,pert
cell line: LNCap;	sirna transfection: siRNA Control1,ctrl
phenotype: control;	gender: male;	case_id: 257;	age: 58;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 12;	brain ph at time of freezing: 6.46;	labeling_batch: 2,ctrl
"control colon tissue, biological rep1",ctrl
sMPNST cells treated with 500 nM JQ1,pert
"Right brain hemisphere ,C57BL male mouse,Un-treated Control,4 weeks",ctrl
strain: HNF4 loxP/- villin cre;	age: 1 month;	tissue: small intestine;	sex: male,pert
strain: v6.5;	cell_type: ES cells;	transfection protocol: Tet1 shRNA transfected;	culture media: ES,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia (RA);	genome/variation: del5q plus monosomy7/del7q plus other,pert
chip number: 17;	transfection plate: 3B;	target gene: WHSC1;	kd level: 0.73;	rin: 9.7;	transfection date: 2012-03-26,pert
tissue: prefrontal cortex from adult APLP2 knock-out mouse with mixed genetic background;	genetic background: back-crossed to C57BL/6 for 1 generation;	gender: male,pert
injury stage: Sham 21 days;	gender: male;	strain: Wistar,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.131;	Ratio: 2.11,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch2",pert
Murine osteoclasts,ctrl
Human Embryonic Stem Cells,pert
S46 NLS 142Q TG7	F4/3	S46	NLS Htt exon 1 142Q	Mouse	10 months	Cerebellum	Female,pert
HLA risk: Low;	Height: 160 cm;	Weight: 53.4 kg;	BMI: 20.7;	Age: 22.84 years;	Gender: Female;	Race: White;	Glucose: 88 mg/dl;	HbA1c: NA,ctrl
cell line: KCL-22;	tissue: Myeloid leukemia cells;	agent: Imatinib,pert
Bone Marrow Mononuclear Cells;	26y Female,ctrl
"n23, surgically resected from patient of gastric cancer.",ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: unmatched,pert
patient: 19;	disease state: hypertension;	tissue: Atheroma plaque,pert
treatment: BCL-3 vector;	cell line: HaCaT;	tissue: Immortalized keratinocytes;	cell type: Immortalized cell line,pert
"D890, WBS, skin fibroblasts",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/15/07;	# cells: 60;	Sex: male;	region: CB (cerebellum);	genotype: Y/X;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,ctrl
"brain, forebrain",ctrl
Healthy controls; individual=IF; time=2; beverage=water,ctrl
Normal cervix_05-15,ctrl
"MCF-7 cells, siERK2 treatment 60h, 0.1%EtOH for 24h",ctrl
"FACS-sorted cones, P60 wild type mice",ctrl
subjectid: 5269;	imatinib: IM;	lbh589: NoLBH,pert
LNCaP prostate cancer epithelial cell line,pert
HLA risk: High;	Height: 184.1 cm;	Weight: 77 kg;	BMI: 22.7;	Age: 17.16 years;	Gender: Male;	Race: White;	Glucose: 260 mg/dl;	HbA1c: 6.3%,pert
"Cultured ovarian cancer cell line FU-OV-1, untreated",ctrl
olfactory epithelium,ctrl
race: caucasian;	age (years): 85-90;	stage: n/a;	grade: n/a;	histology: cystic atrophy with sessile polyp,ctrl
"D4_non-transgenic mice, lung tissue",ctrl
Celecoxib_#4859,pert
hNHEPS human hepatocytes not exposed to VX at the beginning of experiment,ctrl
prefrontal cortex (BA46);	control,ctrl
"t06, surgically resected from patient of gastric cancer.",pert
HLA risk: Low;	Height: 157 cm;	Weight: 52 kg;	BMI: 21.1;	Age: 27.24 years;	Gender: Female;	Race: White;	Glucose: 79 mg/dl;	HbA1c: NA,ctrl
Subtype: RAEB1;	Karyotype: del(5q),pert
Strain: NMRI mouse;	Age: 14 day embryo;	Tissue: molar tooth germ,pert
cell type: Follicular (FO) B cells;	age: 8-12 weeks;	strain: C57/bl6-129sv;	genotype/variation: KAP1 KO,pert
small_intestine_complete_24h_fasted,pert
Regulatory T-cells CD4+CD25+ from HDAC6 knock out mice,pert
PBMC SE T0,ctrl
HEK293 F18 WTX inducible,ctrl
subject: 12A;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2-,ctrl
subject: 07A;	cohort: 7;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 29kb;	age (y): 18;	Sex: F;	batch: Batch_2,pert
Gender: Female;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: fresh air, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
Mouse spleen at 1 month,ctrl
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 2",pert
"whole liver, treated with saline (control)",ctrl
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Control;	condition: -Dox,ctrl
Alb73 mutant mouse,pert
HGF patient gingiva tissue,pert
patient E1603,pert
COLO829 cells with shScrambled knockdown and PLX4032 treatment,pert
hESC transduced with WT miR-122-expressing lentiviral vector,pert
Paraquat ApoD knock-out,pert
tissue: Frontal cortex;	age: 86;	Sex: F,ctrl
Cell line expressing inducible wt-GFP-lamin A. Induction: day 0. Replicate B,ctrl
"cultured human airway smooth muscle, no treatment, replicate 3",ctrl
age: 10-week old;	sex: male;	strain: C57BL6;	tissue: liver,pert
double positive thymocytes,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 90;	ige (kiu/l): normal (0-48.5 kIU/L): 70.8;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
CUTLL1 DNMAML1 GSIwash2h,pert
ICR MEF infected  with pMX-Oct4 retrovirus,ctrl
Transgenic male mouse 60 day old,pert
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: control;	transduction 2: control,ctrl
RV82.03_CONTROL_day10,ctrl
hOB695_shRB1383_8hr_IR,pert
1uM H2O2 rep2,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 19;	maternal age: 19,pert
neurectoderm derived from embryonic stem cells,ctrl
RNA from whole tissue section of case 356 labeled with Cy5,pert
cell type: Oct4-GiP ES cells,pert
"36B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep2",pert
Treated with 10uM Motexafin gadolinium for 4 hrs -- replicate #1,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 65;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
age: 6 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
CD11b+Gr1- cell sample_5 (derived from IL17RC Knock out mouse),pert
CD8_T_cell_pool_melanoma_M09+M10,pert
HL-60 cell line infected with GSK3B Construct 2 shRNA,pert
Retina of 2 month old C57BL/6 mouse,ctrl
"Patient  M, lesion, time: 0",ctrl
"SPC(+)Cre(-), Dox E6.5-12.5, PN15; knockout",pert
Diagnosis: MDS/AML;	Age: 51y ;	Gender: Female;	Blast %: 72;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
Human prostate cancer cell line,pert
disease state: Healthy;	cell type: CD4+T;	twin: P,ctrl
tissue: white blood cells;	age: 17.45;	Sex: female,pert
Primary hepatocytes isolated from Donor 1 treated with DMSO for 6h,ctrl
treatment: Mepenzolate;	time: 7,pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: tumor;	sample name: 6-tu2,pert
db/db mice (stock 000642 Jackson lab),ctrl
normal lung tissue,ctrl
lymphocytes (blood),pert
Bone Marrow Mononuclear Cells;	31y Male,ctrl
"LCL GM19238, Kd DIP2B, 72hrs",pert
day: d00;	strain: C57BL/6;	genotype: WT;	experimental run: e0,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 27.56164,ctrl
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 102;	Usage number: 4;	Exposures: 3,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 19 yr;	population: white;	dsm-iv: 295.9;	age of onset: 18 yr,pert
Female - caucasian - E-05-G,pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 35 yr;	population: white;	dsm-iv: 296.54;	age of onset: 19 yr,pert
condition: Discoid Lupus;	patient: L9;	tissue: LS skin biopsy;	kit: Ovation,pert
gender: Male;	tissue: Tendon;Flexor-Pronator;	age: 45;	donor: 19;	disease state: Lesional,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G52,pert
strain background: CD1;	genotype/variation: Raldh2 null mutant; Raldh2 -/-;	tissue: embryonic brain;	tissue region: Rostral/Anterior;	developmental stage: 14 somite stage,pert
treatment: atRA + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
"wild type naïve CD4 positive cell, unstimulated, replicate 3",ctrl
cell line: U87;	treatment: untreated;	cell type: glioblastoma cancer cell line,ctrl
patient: TLW18;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Lung; nmMLCK-/-; spontaneous breathing,pert
HMEC -EGF for 2days,ctrl
T5.02,ctrl
"tissue: lung, upper lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 54",pert
"t12, surgically resected from patient of gastric cancer.",pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 49,pert
"mouse, liver (CCl4) (week 18)",ctrl
"peripheral ganglion, unknown",pert
25 weeks male,ctrl
NET1 knockdown AGS cells,ctrl
RNA from microdissected breast cancer cells from case 1507 labeled with Cy5,ctrl
"SKO-transduced MEFs, Vc treated, lysed on D3",pert
Strain: 129Sv/C57BL/6,ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,ctrl
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: no mutation detected,ctrl
subject: 12;	disease: TD;	muscle: ST;	gender: M;	age: 15.6;	gmfcs: N/A;	popliteal angle: N/A,ctrl
Primary hepatocytes isolated from Donor 5 treated with Wy14643 for 24h,pert
Cervical cancer_CC214,pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Liver",ctrl
cell line: Melanoma Cell Line - A375;	treatment: DMSO Control;	time: 1hr,ctrl
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: Control",ctrl
cell line: U937;	replicate: Replicate3;	treatment: shLuciferase,ctrl
Murine prostate,ctrl
Disease_status: Bipolar disorder;	Age (years): 35;	Gender: Male;	Age of onset (years): 19;	Duration of illness (years): 16;	Brain pH: 6.30;	Post mortem interval (hours): 35;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: Yes;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
112 Day Mouse leg muscle,pert
"Cervical cancer cell line, MS751",pert
"DSS + L-Arg colon tissue, biological rep1",pert
Cochleae from a9 null mice at P7,pert
mouse: 4;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
Splenic CD11b+Gr-1 high cell populations,pert
Klf9 mutant (Klf9KO) mice jejunum; Age: PND 30,pert
HLA risk: Low;	Height: 170 cm;	Weight: 61.2 kg;	BMI: 21.1;	Age: 14.9 years;	Gender: Female;	Race: White;	Glucose: 86 mg/dl;	HbA1c: NA,ctrl
Murine bone marrow from C57bl/6 mice,pert
"whole ear tissue, untreated control ear",pert
age_years: 57;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: untreated,ctrl
"129P3/J Chronic morphine treated, biological replicate 2",pert
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: D,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IIIB, HPV 16",pert
HT29 parental cell line,ctrl
strain: C57BL/6;	tissue: mouse bone marrow;	genotype: E-FABP knockout;	treatment: 1x10^6 cells in a 12-well plate co-cultured overnight with 1x10^6 E0771 tumor cells in an sterile insert,pert
"Mouse liver peritumoral tissue, MAT1A knockout, hepatocellular carcinoma, 15 months",pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate pre-treatment;	subject: A235_L112,ctrl
Mus musculus embryo E8.5 wild-type,ctrl
siOGT 12 hours_2,pert
"human embryonic stem (hES) cells line SA01, biological replicate  2",ctrl
Extract:LOX-1:113303;	Extract Description:GFP_Untreated_6hr:113303;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.66;	Quality: Background Mean Dev.:0.13;	Quality: Absent (%):58.09;	Quality: Absent (%) Dev.:0.13;	Quality: Scaling Factor:0.63;	Quality: Scaling Factor Dev.:0.14;	Pretreatment [C]:GFP;	Time point [C]:6 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113303;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_6hr;	RNA extraction source key [A]:282295613,ctrl
"airway epithelium, small airways, obtained by bronchoscopy and brushing",pert
status: Control;	gender: Female;	age: 48;	tissue: Blood,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 43;	gender: female;	tumor grade: IV,pert
PBMC from T cell Large granular lymphocyte leukemia patient#114,pert
tumor,pert
Primary hepatocytes isolated from Donor 3 treated with Wy14643 for 24h,pert
ID: MLL_00107;	cell type: PBMC;	disease state: control,ctrl
tissue: mouse lung upper left lobe;	strain: C57BL/6;	genotype/variation: wildtype;	age: 6-10 weeks old mouse,ctrl
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",ctrl
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: captopril;	treatment time: 7 months;	age: 32-34 weeks,pert
strain: C57BL/6;	tissue: small intestine;	genotype: cftr-tm1Unc (cftr null);	treatment: lubiprostone,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Neurointermediate lobe of the Pituitary,ctrl
disease state: wild type;	strain: BALB/c AJ,ctrl
XBP1s_B_cells_spleen,pert
RV64.10_CHF_day25,pert
Patient: G;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
MLL_00230,pert
13A;pretreatment;female;breast tumor,ctrl
patient code: 104;	gender: Female;	age: 72;	tumor grade: 3;	t-stage: 3;	n-stage: 1;	ajcc classif. (2002): 2b,ctrl
tissue: peripheral blood;	subject: Control;	rna prep: PAXgene Globin reduced;	molecule: Globin-depleted RNA,ctrl
strain: Swiss Webster;	treatment: 10mg/kg MPH;	tissue: substantia nigra,pert
Beta4 nAChR subunit null mice without treatment,ctrl
"brain, QH2, 14 months",pert
EB_2_24h_213_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
bone marrow derived mast cells,pert
REST shRNA KD 2,pert
age: 54;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP/HDC-KO;	age: 3-4 months;	tissue: bone marrow;	cell type: bone marrow CD11b+Gr-1+ myeloid cells,pert
E14Tg2a ES Cells,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: corn oil,pert
Prdm14(-/-) ESC-like cells,pert
LIRKO liver sample 3,pert
Embryonic Stem Cell,ctrl
8 wk old male mdx5cv EDL,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: healthy;	Sex: M;	age: 58,ctrl
U2OS_shControl,ctrl
phenotype: severe glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
cell line: MCF10A;	transduction: HER3,pert
"t03, surgically resected from patient of gastric cancer.",pert
0-day rat ovary cultured 2 days,pert
E14 cells in ESC media,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 33;	maternal age: 36,ctrl
chip number: 15;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.5;	transfection date: 2011-10-17,pert
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Mediastinal lymph node B cell;	Influenza A/Mem71 48h;		,pert
"Strain: mixed genetic background, predominantly (>87.5%) C57BL/6 with some CD1. Genotype: PTEN mutant = Mx1-Cre positive: PTENfx/fx. Sex: Male. Age: Eight and a half weeks (at tissue isolation). Tissue: Intestinal Polyp (from jejunun/ileum).",pert
Disease_status: Healthy control;	Age (years): 32;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 7.03;	Post mortem interval (hours): 24;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
"cell line: ME180;	tissue: cervix; derived from metastatic site: omentum;	disease: epidermoid carcinoma;	organism: Homo sapiens, human;	drug treatment: 10μM ATRA;	treatment time: 3 hours",pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	tissue: Liver;	age: 2 Month,pert
pooled reference mRNA from 4 harvests of ME16C cells,ctrl
T9.01,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	target lesion score (peasi): 6;	peasi reduction [%]: 0,ctrl
tissue: Frontal cortex;	age: 80;	Sex: F,ctrl
biopsy specimen,ctrl
G93A non transgenic littermate 1263,ctrl
WILDTYPE cerebrum at 20 days,ctrl
cell type: Melanoma cell line;	cell line name: A375P;	expression: Control shGFP,ctrl
tissue: leukocytes from whole blood;	genotype: control subject;	age: 25;	gender: male,ctrl
tissue: testis;	gender: male;	age: 2-3 months;	genotype: wild-type,ctrl
RV16;	Age = 22;	Sex = F,pert
"liver,24weeks,KO",pert
"Gastrocnemius, 2 months old",pert
HeLa cells infected with shLSD2 retrovirus,ctrl
benign tissue,ctrl
H295R adrenocortical carcinoma cell line,ctrl
age: 26;	gender: female;	ejection fraction: 74;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
strain: C57BL/6J;	gender: male,ctrl
"C57Bl/6, CD-1",ctrl
HCT116 human colon cancer cells with PTEn -/-,ctrl
v-src retroviral vector-infected immortalized mouse embryonic fibroblasts,pert
"Heart, MAT1 control, 4 wk, sample 2",ctrl
tissue: freshly isolated human monocyte;	gender:male; age: 47 yr; weight: 80 kg,ctrl
treatment: DMSO;	time: Day8;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,ctrl
WT AA 1,ctrl
KrasG12D PDEC,ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: ErbB2,pert
"skeletal muscle, short duration",pert
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 8 hour",ctrl
"mortality: alive;	ethnicity: Hispanic;	gender: M;	age (yrs): 48;	ld: ETOH;	creatnine: 1.9;	mdrd: 38;	gfr: 63;	protein: 1.2;	hematuria: 1;	c3: 1;	c4: 1;	rf: 52;	hcv: NEG;	htn: 0;	dm: NEG;	hba1c: 5.1;	meld: 19;	ana: POS;	gp: Mesangial Immune complex deposit, lupus class II;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 2;	igm: 1;	c: 2;	empe: NA;	bmwid: NA;	bmd: NA;	edd: P;	no of glomeruli: 7;	glomerulosclerosis: 0;	intact t: 0.95;	arteries: intimal fibrosis, thickening;	if: IGM+IGG+IGA++C3++C1Q+mesangial;	mesangium ig: ACMG;	tissue: Kidney_Biopsy_Liver_disease",pert
gender: female;	age (years): 62;	evolution time (years): 4;	disease extension: Pancolitis;	treatment: Azathioprine,pert
hNHEPS human hepatocytes exposed to 0.1 μM VX 6 h after exposure,pert
"striatum,6weeks,KO",pert
mouse skin,ctrl
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 52;	ld: HCV;	creatnine: 1.5;	mdrd: 39;	gfr: UN;	protein: 0;	hematuria: 0;	c3: 0;	c4: 0;	rf: neg;	hcv: NEG;	htn: 0;	dm: POS;	hba1c: 7;	meld: 23;	ana: NEG;	gp: arterisclerosis, mild mesangial expansion;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 0;	bm (basement membrane thickening): 0;	ta (tubular atrophy): 1;	if (interstital fibrosis): 1;	as (arteiosclerosis): 0;	igg: NA;	iga: NA;	igm: NA;	c: NA;	empe: NA;	bmwid: NA;	bmd: P;	edd: P;	no of glomeruli: 1;	glomerulosclerosis: 0;	intact t: 0.7;	arteries: intimal duplication/fibrosis;	if: not submitted;	tissue: Kidney_Biopsy_Liver_disease",pert
cell line: HL-60;	shRNA construct: Scrambled Control,ctrl
"BT474-J4 breast cancer cell line, foretinib",pert
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
gender: female;	batch: 1;	age (years): 31;	patient id: Control_7;	fev1 (% predicted): 85;	fvc (% predicted): 96;	medication: None;	cell type: CD8+ T-cells,ctrl
strain: C57BL6;	genotype: WT;	tissue: hippocampus;	treatment: PDE10i,pert
tissue: LNCaP-LM NSG xenografts;	expression: Hes6 overexpression,pert
cell line: lymphoblastoid cell line;	family id: 1720;	coriell cell line repository identifier: GM14464;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: cardiac muscle",pert
"Control small intestine 1, polyI:C, 30 days",ctrl
RNA from whole tissue section of case 763 labeled with Cy5,ctrl
whole lungs overexpressing an nmyc-gfp fusion protein via the lung surfactant c promoter,pert
disease: Down syndrome;	gender: male;	age: 1 year and 2 months;	tissue: thymus,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 2",pert
36M2 cell line from ovarian serous carcinoma cells,ctrl
subject: 35;	disease: CP;	muscle: GR;	gender: M;	age: 5.9;	gmfcs: 5;	popliteal angle: 130,pert
Lesional skin from K5-Tgfbeta mouse,pert
"SBC-5 cells, siEGFP (control), 72 hr after siRNA, duplicate sample 2",ctrl
background strain: B6/129;	genotype/variation: WT;	tissue: Liver;	age: 2 Month,ctrl
HCT116 human colon cancer cells with intact PTEN,ctrl
G93A non transgenic littermate 1265,ctrl
ESC Cultured in 15% KO + LIF without feeders,ctrl
patient: 13;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
tissue: peripheral blood;	subject: sickle-cell patient;	rna prep: PBMC;	molecule: RNA extracted from PBMC,pert
HCC_23N,ctrl
Aquaporin-11+/+_mouse P7 kidney #5-1,ctrl
patient: 24;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"breast adenocarcinoma, cell line",ctrl
tissue: skin;	individual: Patient P5;	condition: ANL;	eczema severity: SCORAD: 0,pert
cell type: hepatocytes,ctrl
subject id: 574328;	infection: DENV;	status: DHF;	tissue: whole blood,pert
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 3",ctrl
MPM tumor specimen 16,pert
"A pool of two pure subsets of peripheral blood B cells (CD19+ CD3- CD4- CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched stage IV (American Joint Committee on Cancer) melanoma patients.",pert
gemcitabine resistant Calu3 derivative generated from the parental Calu3 line by consecutive treatments with 50 nM gemcitabine over a period of 3 months,pert
age: 12 weeks postnatal;	tissue: striatum;	genotype/variation: Pink1 knockout,pert
tMLL02,ctrl
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: male;	age: 26 weeks;	genotype/variation: control",ctrl
"cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: 100 nM 1,25(OH)2D;	time point: 24 hours",pert
"brain, control, 14 months",ctrl
MCF-10A_shControl,ctrl
Caudate-Putamen of naive AChE-R mice,pert
"heart tissue, ad lib feeding, 10-12 weeks old",pert
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate A,ctrl
"BOEC, normal 7",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 64 years,ctrl
strain: 129/Sv;	group: knock-in;	genotype (hdh cag repeat length): 7/45;	differentiation status: undifferentiated;	cell line: Q50,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,ctrl
"Liposarcoma culture from tumor 401, untreated",ctrl
Pooled mouse tissue,ctrl
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 82;	Usage number: 5;	Exposures: 3,pert
PancreaticSample33-Tumor,pert
phenotype: control;	gender: male;	case_id: 329;	age: 48;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.73;	labeling_batch: 1,ctrl
A1,pert
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:64;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
strain: C57B6;	genotype: Tgfbr2fl/fl;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,ctrl
Heart sample4,pert
tissue: white blood cells;	age: 13.07;	Sex: male,pert
"HeLa cells, 72 hs after transfection",ctrl
VPA treated MC3T3 mice,pert
gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 71,pert
tissue: Hippocampus;	age: 55;	Sex: M,ctrl
cell line: BT474-J4;	cell type: breast cancer;	lapatinib sensitivity: acquired lapatinib-resistant;	her2 status: HER2-positive;	treatment: DMSO,ctrl
gender: Female;	tissue: Tendon;Suspraspinatus;	age: 62;	donor: 13;	disease state: Lesional,pert
brown adipose tissue,ctrl
tissue: blood;	control: 3;	gender: female;	age: 38,ctrl
adrenergic-deficient,pert
Pcgf6_1_shRNA1+dox,pert
2827 TG,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 55,pert
splenic CD11c+ dendritic cells,ctrl
N14B Normal-cerebellum,ctrl
INS-1 cell line #6a with induced HNF1b mutant P328L329del,pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 4051964045;	hybridization batch: II,pert
P4B Progranulin-cerebellum,pert
PMVEC isolated from mice carrying immortomouse and Rosa26-rtTA transgenes,ctrl
"47, XY, +21",pert
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 176-day-old male;	70 mg liver used for RNA extraction",pert
gender: Male;	tissue: Tendon;Patellar;	age: 32;	donor: 15;	disease state: Non-lesional,ctrl
"Infected with H37Rv, replicate 3",ctrl
3T3-L1 Day 0 (passage 19) 24h after siLSD1 transfection,pert
"ID:7-3, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
braak stage: BR56;	rin: 72;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
strain/background: C57BL/6;	genotype/variation: C-DGCR8 KO (D4-cre/DGCR8 KO/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 30,pert
strain: C57BL/6J;	day: 1;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 2,ctrl
"patient: 106;	current medication: None;	birth date: 5/29/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/18/04;	indictation for procedure: Abdominal pain, upper GI symptoms.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
primary normal lung tissue 1090,ctrl
cell line: Hep3B;	treatment: transfection with nonsense siRNA,ctrl
tissue: brain;	genotype: mutant Ndel ko/+;	age: P0,pert
cell line: SV589;	knockdown (days): 0;	treatment: no treatment,ctrl
cell line: MDA-MB-231 1833;	cell type: breast cancer cells,ctrl
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PR;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 87;	baseline tumor size (cm): 5x3;	patient id (to identify the 2 chips from the same patient): 19301950,pert
whole heart,pert
laser-captured pancreatic islets,ctrl
Jurkat T-cells transfected with siRNA #2 for Sp3 for 48 hours,pert
Mouse soleus,pert
Genotype: wild type;	not differentiated,ctrl
LSK cells SRF wt 1,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 1",pert
tissue: white blood cells;	age: 4;	Sex: male,ctrl
"villin-creERT2:beta-catenin+/lox, induced by tamoxifen for 2days",ctrl
cell line: OVCA429;	cell type: ovarian cancer cell line;	treatment: none;	batch: 1,ctrl
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
A61 WT1	F6/20	A61	wild type	Mouse	8 months	Cerebellum	Male,ctrl
The Caco-2 cell line is derived from a male Caucasian with a colon tumor,ctrl
tissue: prostate tumor;	genotype: Pb-Cre+;PtenL/W;K-rasG12D/W;	age: older than 20 weeks,ctrl
cell type: MCF-7;	sirna: control non-targeting pool,ctrl
strain: FVB;	cell type: 6 DIV cultured hippocampal neurons;	transfected with: Sindbis virus expressing GFP alone,ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 35;	maternal age: 30,pert
Male mice from fiona transgenic line (dystrophin-deficient with a transgene expressing high level of full length utrophin) were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction. Biological Replicate 1.,pert
"SW480, colon cancer cells",ctrl
P4 Ovary cultured for 48 hours with NT3,pert
mouse adipose tissue,ctrl
strain: C57BL/6;	cell type: MEFs;	genotype/variation: Cebpg-/-,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 74,ctrl
Human sorted B cells,ctrl
Patient 5 appendix,pert
gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3,pert
patient id: T163;	tissue: Normal cortex;	gender: Male;	age: 52;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 180;	colon ratio (mg/mm): 2.95;	myeloperoxidase activity (u/mg): 0.27;	tissue: colon;	treatment: 5% DSS,ctrl
Tissue:tumor; Gender: male; Age:43; Tumor stage:T2NxMx,pert
diagnosis: FU;	fvc-group: FVC1;	tissue: lung,pert
Pool Eu_P0,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His plasmid, cell culture 2",ctrl
heart of male mouse subjected 1 week to chronic constant hypoxia (C1BM),pert
"TNFa-OMe-P siRNA-C, replicate 1",pert
"Mouse liver, wild type, healthy, 8 months",ctrl
A5,pert
oculomotor nucleus,pert
"Retina, 42 days old wildtype mice",ctrl
NB69,ctrl
age: 8 month;	strain: FVB/N;	genotype: wide type;	tissue: normal urothelium,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: mid-UV,pert
H1299 cells,ctrl
sex: Male;	Age: 36 months;	additional patient information found in Series supplementary file,ctrl
tissue: Adrenocortical adenoma;	tumor secretion profile: Aldosterone;	genotype: WT CTNNB1,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
"Patient  G, lesion, 12 week",pert
sex: Male;	family: 4;	age: 54;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
Normal Uninflamed descending colon,ctrl
patient: 8;	disease state: hypertension;	tissue: Atheroma plaque,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks;	tissue: Spleen;	infection/agent: none,ctrl
Wild-type mouse embryonic stem cell,ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),ctrl
Human hepatoma cell line (HepG2),pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 63;	gender: male,pert
"kidney, Q10, 14 months",pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: normal chow,ctrl
Tissue: lung;	Genetics: Sporadic IIP;	Histology: Usual Interstitial Pneumonia,pert
cell type: fibroblast;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P7;	clone: 0,pert
HUVEC transfected with anti-miR-210-LNA,pert
patient: 232;	current medication: Pentaza 2g BD;	birth date: 1/9/63;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/95;	diagnosis date: 1/1/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/31/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 1/31/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
CD8 T cells isolated from spleen,pert
unstimulated CD8+ T-cells from Itk knockout C57BL/6 mice,pert
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Good-responder;	tissue: synovium,pert
heterozygot FH P250 (human CD3 positive T cells),pert
J1 mouse embryonic stem cell,pert
wild-type placenta embryonic day 12.5,pert
Disease_status: Healthy control;	Age (years): 58;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.0;	Post mortem interval (hours): 27;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.945;	Ratio: 2.12,pert
Type II cells from Nrf2+/+ mouse.,ctrl
strain/background: C57BL/6;	genotype/variation: Zbtb7a Flox/+ Mx1-Cre+ (LRF heterozygous);	age: 4 weeks;	cell type: FACS-sorted LT-HSCs (LSK IL7Ra-Flt3-CD150+CD48-);	time point: 9 days after 1st pIpC injection,ctrl
"Neuroblastoma SH-SY5Y cells, transfected with scramble control",ctrl
tissue: Temporal cortex;	age: 72;	Sex: F,ctrl
Pooled mouse tissue,pert
sidroshaB-transfected sample,pert
Mus Musculus Kidney,ctrl
thymic tumor IKL/L mouse,pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. vehicle (ethanol) + 1 uM vehicle (ethanol) for 24hr;	batch: 2,ctrl
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treatment: not treated,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.1;	colon weight (mg): 183;	colon ratio (mg/mm): 3;	myeloperoxidase activity (u/mg): 0.298;	tissue: colon;	treatment: 5% DSS,ctrl
C4_CLP_overexpressor_12,pert
"ID:c 2-1, Genotype=(C57BL/6J), Treatment= none",pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.87;	choa: 154;	fata: 45;	eea: 1280;	wtkg: 79.3;	perfat: 44.9;	lbm: 40.9;	fat_mass: 3560.57,ctrl
sex: Male;	Age: 14 months;	additional patient information found in Series supplementary file,pert
29A;pretreatment;female;breast tumor,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: LPA,pert
"LCL GM19238, Kd IKZF3, 72hrs",pert
"HEK293T human embryonic kidney cells, CM, si-control",ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: SAMPLE-1B,ctrl
"male;	CABG patient, atrial tissue, ;	baseline before CABG surgery",ctrl
pancreatic islets,pert
"LCL GM19238, Kd JUND, 72hrs",pert
PCOS Endometrial Biopsy,pert
"Primary, Prostate cancer, localized",pert
cell line: V6.5;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 3,ctrl
cell line: TF-1;	gender: male;	age: 35 years;	disease: erythroleukemia (AML M6);	sirna: anti-Evi1,pert
EE_IB_3_aa_lcm,pert
Intracranial arterial aneurysm (unruptured),pert
thyroid sample containing normal cells,ctrl
3T3-L1 Day 0 (passage 21) 48h after siControl transfection,pert
"BOEC, normal 3",ctrl
status: Control;	gender: Male;	age: 66;	tissue: Blood,ctrl
Pcgf6_3_shRNA2+dox,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.977;	OD280: 0.478;	Ratio: 1.99;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 300;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"hMSC-Tert, RNF40 siRNA, 5 days osteoblast differentiation",pert
treated with TGF-beta,ctrl
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
age_years: 70;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 2,ctrl
53A;pretreatment;female;breast tumor,ctrl
Endometrium/Ovary-Disease 1,pert
TOtal RNA,ctrl
WT_72_O3_2,ctrl
cell line: MCF-7;	cell type: Breast tumor cell line;	transfected with: pcDNA3-Pit-1 overexpression vector,pert
0810A-01_clone 2-1,pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 73,ctrl
chip number: 20;	transfection plate: 5;	target gene: NS;	kd level: NA;	rin: 9.2;	transfection date: 2011-10-17,ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 35week,pert
PS-NA cerebrum at 4 weeks,pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 74 years,pert
subject id: c9;	infection: control;	status: control;	tissue: whole blood,ctrl
"Liver, fasted, PBS",ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
CH 4,ctrl
B2_saline_overexpressor_48,pert
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: normal,pert
tissue: skin;	individual: Patient P13;	condition: ANL;	eczema severity: SCORAD: 0,pert
agent: ConA;	time point: 6 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
cell line: J1;	genotype/variation: Eed KO;	cell type: embryonic stem cells;	days of differentiation: 0,pert
SV589_15Day KD_Serum Starved,pert
Gene expression profiling of normal cortex of patient 131,ctrl
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: SRF Silencing;	agent (treatment): R1881,pert
HeLa-LAMP3siRNA-3d,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 68;	gender: male;	tumor grade: IV,pert
Healthy controls; individual=MB; time=2; beverage=alcohol,pert
Disease_status: Healthy control;	Age (years): 45;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
cell line: SF539;	transfection: PARK2 siRNA#2,pert
OVCAR-3/CD157 cell line,pert
No abuse,ctrl
colonoscopic biopsy from adult with unaffected colon from adult with UC,pert
tissue: Frontal cortex;	age: 89;	Sex: M,ctrl
DH 4,pert
tissue type: Bone Marrow;	cell type: Monoclonal Gammopathy of Undetermined Significance (MGUS) plasma cells,pert
strain background: Mixed background;	genotype/variation: Otx2 k.o.;	developmental stage: E13;	gender: not determined,pert
strain: C57BL/6J;	day: 18;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
22A;pretreatment;female;breast tumor,ctrl
age: 43;	sex: M;	disease status: control subject;	Filter number: 95;	Usage number: 4;	Exposures: 3,ctrl
"female Spargue-Dawley rats, diet only for 7 days,  tissue: liver",ctrl
race: caucasian;	age (years): 77;	stage: IA;	grade: 2;	histology: endometrioid,pert
cell line: LICR HN2;	treatment: Cetuximab 15 nm Cetuximab for 13 hours,pert
cell line: M24met melanoma cell-line;	genotype/variation: Wnt-1 overexpressing;	treatment: control,pert
Male mice from mdx (C57BL/10ScSn-Dmdmdx/J) line were sacrificed by asphyxiation with carbon dioxide at 56 days old. Skeletal muscle tibialis anterior (TA) were dissected bilaterally and pooled. Tissue samples were flash-frozen in liquid N2 and stored at -80ºC until RNA extraction.,pert
subject id: 37;	infection: DENV;	status: DF;	tissue: whole blood,pert
Liver GPR120KO ND,pert
"Cardiac, ventricular tissue",pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 74;	gender: female;	years of disease: 2 y;	treatment: phototherapy;	time: mid-UV,pert
"liver, genetic control Alb-Cre:Keap1(flox/+)",ctrl
tissue: cardiac biventricle;	genotype/variation: PGC-1a KO/PGC-1b KO,pert
"Transgenic, snap frozen, diaphragm muscle, 7 month age animal",pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 31 yr;	population: white;	dsm-iv: 295.3;	age of onset: 22 yr,pert
HepG2 cells treated with 5-aza-dC,pert
HeLa cells nucleofacted with Dharmacon control siRNA,ctrl
cell: MCF-7;	treatment: FoxA1 siRNA and vehicle (control),pert
tissue: pancreatic ductal adenocarcinoma tumor;	genotype: Pdx1-Cre; Ink4a/Arffl/fl; LSL-KrasG12D;	gender: Male;	age: 10 weeks-old,pert
6-month mouse dorsal prostate,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: No;	1st technical replicate,pert
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: control,ctrl
SK-N-SH cell line infected with MECP2_e1 lenti,pert
WT S49 Cells,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 45;	gender: m;	treatment: NSAIDs,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with TNKS inhibitor for 16h,pert
cell line: DAOY M2.1;	cell type: medulloblastoma;	genetic modification: siRNA cMYC silenced,pert
control,ctrl
"Primary culture of dermal fibroblasts from normal scar, no hydrocortisone treatment",ctrl
N1B Normal-cerebellum,ctrl
"n16, surgically resected from patient of gastric cancer.",ctrl
"NeuroD1 cKO at ZT20, retina",pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 59, stage IIB, HPV 18",pert
RV16;	Age = 19;	Sex = F,pert
braak stage: BR34;	rin: 77;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Human skeletal muscle biopsy sample;	Patient #197 with PM,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 1hr,pert
background strain: B6/129;	genotype/variation: wild type;	age: 14 Month;	tissue type: Liver,ctrl
Strain: C57BL/6J;	Gender: M;	Age: 7 weeks;	Treatment: untreated,pert
Mouse Liver,pert
mature Ly-6G+ thioglycollate-elicited peritoneal neutrophils,ctrl
"Gata4-KO heart, CRE, biological rep3",pert
cell line: HeLa;	cell type: human Cervical Carcinoma;	transfected with: siRNA directed against Sp1 mRNA (siSp1),pert
microdissected epithelial cells from normal main pancreatic duct 1,ctrl
H6PDH WT,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L014,ctrl
strain: B6129;	cell type: MLL-AF9 leukemia cells;	genotype: Dot1l flox/flox;	days after transduction: 7,ctrl
"epidermis, healthy control",ctrl
subject: 13B;	cohort: 13;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
"patient: 121;	current medication: Cp-tenedone, Enalapril, Loperamide.;	birth date: 4/8/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/1/05;	indictation for procedure: Diarrhoea, Blastocytitis on stool cultures.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
gender: female;	age (years): 41;	evolution time (years): 15;	disease extension: Pancolitis;	treatment: 5-ASA,pert
Hippocampus of of non-AD brain,ctrl
Basal IFE cells isolated from 1 year old WT mice,ctrl
gender: male;	genetic background: C57BL/6x129;	age: 6.5 months;	tissue: Crhr2-/-;	genotype: Gastrocnemius and Soleus muscles,pert
cell line: OCI-Ly1;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
Transfected MCF-7 cell line (control non-targeting pool),ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 21.753;	Ratio: 2.10,pert
cell type: Human melanoma cell line;	cell line: M238_R1;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
phenotype: alcoholic;	gender: male;	case_id: 212;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 24;	brain ph at time of freezing: 6.59;	labeling_batch: 2,pert
Asthmatic after Flovent,pert
ARPE-19,ctrl
strain: FVB;	genotype: wild-type;	tissue: mammary gland tumor,ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,pert
C57BL/6 BMDM infected with WA(pYV),pert
ATCC HTB-30,pert
Colo205 parental cell line,ctrl
strain: BALB/C;	age: 8-10 weeks;	treatment: CVB3;	gender: Female;	time: 10 dpi;	tissue: heart,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: DMSO;	time: 4 hours,ctrl
cell type: BMDM;	strain: C57BL/6;	genotype: wild-type;	infection status: uninfected,ctrl
11_3_MOE_430A_HE,pert
sampleID: SAM630148;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: IL17RC Knock out,pert
age: 6 month postnatal;	tissue: striatum;	genotype: wild type (129S6/SvEvTac),pert
RNA from whole tissue section of case 342 labeled with Cy5,pert
cell line: lymphoblastoid cell line;	family id: 1734;	coriell cell line repository identifier: GM14503;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Mouse Left Ventricle,pert
cell line: CL1-0;	gender: male,ctrl
tissue: Biceps muscle;	patient: P.b.8;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: F;	age at baseline: 1y 5m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
tissue: glomeruli of human kidney;	disease state: nephrosclerosis,pert
Monocyte human familial combined hyperlipidemia (FCH) sample,ctrl
"Pancreatic islets, control, 03",ctrl
B6C3F1 male,ctrl
"Liposarcoma culture from tumor 400, doxorubicin treated",pert
"52B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Normal ear skin from control mouse,ctrl
disease group: osteoarthritis;	cell type: chondrocytes;	cell culture: monolayer,pert
MPM tumor specimen 36,pert
Disease_status: Healthy control;	Age (years): 31;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.13;	Post mortem interval (hours): 11;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 1;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 67;	Sex: male;	region: LC;	age: 40;	genotype: Y/X;TH/-,ctrl
genotype/variation: Vax2-/-;	age: E10.5;	tissue: whole eye,pert
MIST1-null pancreatic RNA with inducible MIST1 transgene 36 hours post-tamoxifen,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 204,ctrl
RNA from whole tissue section of case 1304 labeled with Cy5,pert
GM9013,pert
strain: CD-1;	genotype/variation: wild-type;	developmental stage: embryo;	age: E17.5;	tissue: kidney,ctrl
A673 cell line that has been treated with Doxorubicin for 24 hours with concentration of 59.88 nM (EC50).,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 96 hrs;	time course: 1,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.811;	OD280: 0.9;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 372;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Tissue: peripheral blood, Subject:Sickle cell patient",pert
GM8830,pert
Brain (Inferior Olivary Nucleus)_control subject_#3,ctrl
NK_cell_pool_healthy_H01+H02,ctrl
A549 alveolar epithelial cell line,ctrl
B-CLL PB P138,pert
"LNCaP cells, treated with EtOH, biological rep 2",ctrl
"Patient  H, lesion, 1 week",pert
PancreaticSample25-Tumor,pert
HCC_33T,pert
"urogenital ridge epithelium, E10.5, -/-",pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 27;	sex: F,ctrl
scan batch: Batch 2;	group: autism;	subject age: 3;	paternal age: 41;	maternal age: 32,pert
lox67 control mouse,ctrl
Sex: male;	Age at operation: 70 years;	Site: thigh;	Size in cm: 9x3x6;	Histological Subtype: atypical lipoma;	Responder type: medium;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
tissue: blood;	control: 6;	gender: female;	age: 40,ctrl
subject: 21A;	cohort: 21;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 82;	Sex: F;	batch: Batch_5,pert
Unaffected MZ twin pair 5 (Unaffected patient of MZ twin pair CCN5),ctrl
Brain from 55 days Npc1-/- mouse1,pert
fluorescent activated cell sorter (FACS)-selected cells,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.326;	OD280: 0.691;	Ratio: 1.83;	Dilution: 1:5;	RNA Integrity Number: 8.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 292;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
WT S49 T-lymphoma cells,ctrl
H441 lung cancer cells,pert
braak stage: BR56;	rin: 69;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
tissue: skin;	individual: Patient P2;	condition: ANL;	eczema severity: SCORAD: 0,pert
Strain:J1 Cell type: mouse embryonic stem cell,ctrl
tissue: white blood cells;	age: 10.88;	Sex: male,pert
Brain from 82 days Npc1+/- mouse1,ctrl
MPM tumor specimen 29,pert
Primary human lung fibroblasts,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339033,pert
Strain: C3H/HeN;	Gender: female;	Age: 4 weeks,ctrl
mouse strain: C57BL/6J;	genotype/variation: normal control,ctrl
cell line: MH1C1,pert
Regulatory T-cells CD4+CD25+ from wild type mice,ctrl
strain: Mixed;	genotype/variation: Nrf1 CKO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
iPSC derived from CCALD patient dermal fibroblast,pert
HeLa cells were transfected with siRNA specific for optineurin mRNA,ctrl
neonatal cord blood mononunclear cells without LPS-treatment,ctrl
patient E1521,pert
"Control pancreas, sample 3",ctrl
treatment: control;	time: 0 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,ctrl
reference: whole mouse total RNA,ctrl
"Liposarcoma culture from tumor 340, doxorubicin treated",pert
health control_1,ctrl
patient: 226;	current medication: Azathioprine 150mg Asacol 1.6g Ca Vit D B12;	birth date: 6/15/74;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/89;	diagnosis date: 1/1/89;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: TRUE;	procedure date: 1/11/05;	indictation for procedure: ;	ucss: 8;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/11/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
RNA from whole tissue section of case 180 labeled with Cy5,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 145min;	race: White;	sex: Female,ctrl
race: caucasian;	age (years): 63;	stage: IC;	grade: 1;	histology: endometrioid,pert
genotype: p300+/-;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,pert
MDA-MB-231 cells transfected with precursor of miR-148b were analyzed 48h after transfection,pert
gender: Male;	age: 82;	post-mortem delay: 11h;	ph: 6,pert
tissue: Temporal cortex;	age: 83;	Sex: M,ctrl
wild type mammary gland,ctrl
strain: BALB/c;	cell type: CD8 T;	genotype/variation: KLF13 KO,pert
"MCF-7 human cell line, siControl",ctrl
EB_6_8d_299_HCHO_Nasal_Rat230_2_CIIT05024,pert
tissue: white adipose tissue (WAT);	gender: Male;	age: 18-weeks old;	diet: Regular chow diet,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 44;	donor: 33;	disease state: Lesional,pert
tissue: Temporal cortex;	age: 75;	Sex: F,ctrl
Strain: C57BL;	Gender: male;	Age: 9-10 weeks;	Tissue: liver;	Developmental stage: adult;	Cell type: Primary hepatocytes,pert
clone type: AtT20 clone types treated with control siRNA rep 3,ctrl
E12 embryo proper,ctrl
RPMI8226_shKDM3A#2,pert
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 2,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: post-UV,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 4;	biological rep: 1,ctrl
thyroid cancer cell line,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 70;	gender: male;	tumor grade: IV,pert
microdissected epithelial cells from normal main pancreatic duct 7,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis posterior;	age at biopsy: 52;	Sex: male,pert
"Nickel allergic female (age range 33-49), skin biopsy from upper nates. No nickel exposure.",pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,ctrl
"Cultured ovarian cancer cell line A2008, untreated",ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug.  At four hours prior to RNA isolation, actinomycin D (5 ug/mL final concentration) was added to the culture.  After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
"Age: 40;	Sex: M;	Ancestry: African;	Smoking status: smoker, 24 pack-years",pert
"Heart, MAT1 control, 2 wk, sample 1",ctrl
retina at age PN40,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 31;	sex: M,ctrl
B3_saline_overexpressor_48,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P7;	clone: C11,ctrl
HCC_17T,pert
"Brain tissue from Fisher 344 male rat, Animal #258, 50mg/kg D-Serine",pert
Primary hepatocytes isolated from BL6 mouse strain treated with Wy14643 for 24h,pert
"Mouse embryonic fibroblasts, Bptf KO",pert
SUDHL-1 cell line teated by ALK inhibitor,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 27.0;	age of psoriasis onset: 24,pert
mouse B6xCF-1  Non-transgenic (control-1),ctrl
parental cell line: WB;	vector: pBabe-human v-src (v-src vector);	replicate: 2,pert
tissue: Brain;	genotype: Npc1-/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,pert
chip number: 22;	transfection plate: 4;	target gene: NR3C1;	kd level: 0.63;	rin: 9.1;	transfection date: 2011-10-17,pert
mouse hippocampus,ctrl
"genotype: wild-type;	strain: C57BL/6;	gender: male;	age: 8 weeks, 3 days;	tissue: colon",ctrl
Healthy controls; individual=JL; time=2; beverage=water,ctrl
RNA from whole tissue section of case 1343 labeled with Cy5,pert
cell type: epithelial cells,pert
Gender: Male; Tissue: Prostate.,ctrl
batch: A;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 60.6137,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 105min;	race: White;	sex: Female,ctrl
"CCM3 shRNA cells, passage 7",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ptpn2;	tissue: tumor;	sample name: 4-tu2,pert
cell line: IGROV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 3,ctrl
Genotype: HtrA2 wild type,ctrl
wt_TGFb_24hr_1,ctrl
OSE4 cells,ctrl
primary normal lung tissue 2841,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 28.81096,ctrl
E2f8 KO Mouse spleen Ter19+CD71high sorted cells,pert
cell line: CL1-0;	gender: male,pert
"Patient SE, stable renal transplant recipients, male, 31 years old, T0 (time of enrollment)",ctrl
strain background: C57Bl/6J;	gender: male;	strain background: wild type;	age: adult;	tissue: whole brain,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 145min;	race: White;	sex: Female,pert
con-7,ctrl
A673 cell line that has been treated with Puromycin for 24 hours with concentration of 0.09 uM (EC50).,pert
knockdown: TNFa siRNA-A;	amplification date: 09/06/16;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 167;	colon ratio (mg/mm): 2.783;	myeloperoxidase activity (u/mg): 0.199;	tissue: colon;	treatment: 5% DSS,pert
Melanoma cells,pert
Human skeletal muscle biopsy sample;	Patient #45 with NORM,ctrl
Cell line: NALM1,pert
"LKR13, knockdown of K-ras by shRNA",pert
skeletal muscle myoblast_WT_day3,ctrl
"liver, fed Western diet containing 0.05% quercetin for 20 weeks",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 61 years,ctrl
S3A Sporadic-frontal,ctrl
Age: 40;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
CD4_T_cell_pool_melanoma_M01+M02,pert
Trabecular meshwork tissue from POAG donor A. 59y/male/caucasian. Cause of death: Renal failure. Othe ocular diseases: cataracts. IOP: 17-28. Drug therapy: Xalatan,pert
microdissected ovarian tumor,ctrl
EpiAdip wildtype ND,ctrl
knockdown: Control;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 7.5;	colon weight (mg): 166;	colon ratio (mg/mm): 2.21;	myeloperoxidase activity (u/mg): 0.009;	tissue: colon;	treatment: 5% DSS,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 84,pert
"Strain: C57BL/6; PGC1beta mutant mopuse, Tissue: quadriceps muscle",pert
transgene: FTO;	treatment: 48h after induced espression of integrated copy of the FTO gene,pert
gender: male;	tissue: heart;	tissue: Transmural sample taken from near the apex of the left ventricle,pert
Primary hepatocytes isolated from FVB mouse strain treated with Wy14643 for 24h,pert
Y HID_B003,ctrl
Brain from 37 days Npc1-/- mouse1,pert
strain: C57BL/6J;	day: 12;	drug: Methamphetamine;	phase: Drug treatment;	tissue: striatum;	replicate: 2,pert
"murine kidney, cystic epithelial tissue,  Fh1 knockout mouse",pert
"Liver, fasted",pert
"sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta, non-dissected aneurysm;	agent: Ang II;	time: 7d",pert
"PDAC, sample 2",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.606;	OD280: 0.744;	Ratio: 2.12;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 145;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
patient with Acute Lung Injury,pert
Caco-2 ZNF658 siRNA 2,pert
CONTROL;	Age = 19;	Sex = M,ctrl
full thickness aortic wall biopsy,pert
Normal patient platelets,ctrl
patient: 30277;	sample: normal,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 63;	gender: male;	tumor grade: AIII,pert
"mortality: dead;	ethnicity: Hispanic;	gender: F;	age (yrs): 59;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 38;	protein: 0;	hematuria: 1;	c3: 1;	c4: 1;	rf: 96;	hcv: POS;	htn: 0;	dm: POS;	hba1c: 6.4;	meld: 14;	ana: POS;	gp: Nodular glomerulosclerosis, Diabetic Nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 1;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 0;	if (interstital fibrosis): 1;	as (arteiosclerosis): 1;	igg: 1;	iga: 1;	igm: 2;	c: 1;	empe: P;	bmwid: P;	bmd: P;	edd: P;	no of glomeruli: 6;	glomerulosclerosis: 0;	intact t: 0.9;	arteries: duplication;	if: IGG+IGM++IGA+C3+C1q+ capillary wall linear;	mesangium ig: O;	tissue: Kidney_Biopsy_Liver_disease",pert
14 Day Mouse leg muscle,pert
"male,17,Caucasian",ctrl
Strain: In-house BALB/c mice; Gender: Male; Age: 22 months old; Tissue: Brain; Treatment: 4 hours post LPS 0.33mg/kg BW ip.,pert
Panc-1_Control,ctrl
subject: 12A;	cohort: 12;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 22;	Sex: F;	batch: Batch_3,pert
"Gender: female, Age: 41 years, Tissue: normal vulva,",ctrl
"A549 human lung cancer cells (1X10^5 per T-25 flask in 7 mL complete RPMI 1640 medium) were seeded eights days prior to treatment of non-cycling plateau phase cultures with drug. At four hours prior to RNA isolation, 2.5uM sapphyrin PCI-2050 (final concentration) was added to the culture. After incubation for four hours, the culture was washed twice with HBSS supplemented with 0.5% BSA and total RNA was isolated.",pert
cell type: mouse embryonic fibroblasts (MEF);	phase: cycling,pert
breast adenocarcinoma from 69yr old female caucasian,pert
Strain: C57BL/6J;	Gender: female;	Age: 6 weeks;	Tissue: whole brain,ctrl
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
KO_d00_eX,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 68;	baseline tumor size (cm): 8x8;	patient id (to identify the 2 chips from the same patient): 12781328,pert
Mouse T cells,ctrl
ANL,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: 5,pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 3,ctrl
"Primary aortic endothelial cells, Non_transgenic_control",ctrl
cell line: U-87 MG;	cell type: glioma,ctrl
strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E18.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 flox/null Tg-Mx1cre,pert
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: wt,ctrl
M24met melanoma cell-line,ctrl
none provided,pert
"Strain:Wistar, Gender: male, Tissue: cirrhotic liver, Induction of cirrhosis: CCl4",pert
gender: male;	age (years): 41;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
chip number: 23;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.84;	rin: 9.7;	transfection date: 2012-03-26,pert
Cardiacmyocyte,ctrl
patient: 221;	current medication: Prednisolone 7mg Asacol Adcal Seretide Fe SO4;	birth date: 1/29/86;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 12/10/01;	diagnosis date: 12/10/01;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/14/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Asthma Eczema;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: LPA,pert
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Complete Freunds adjuvant,ctrl
Alpha7 L250T heterozygous mice following nicotine-induced seizures,pert
15d control,ctrl
tissue: white blood cells;	age: 10.6;	Sex: male,pert
individual: patient6;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
miR122-KO,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.848;	OD280: 0.434;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 207;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"SiRNA-scrambled, replicate 7",ctrl
"HEK cells transfected with scrambled siRNA, 24h after transfection",ctrl
genotype/variation: Tpl2 deficient;	treatment: unstimulated,pert
Pool Ts1Cje_P30,pert
affected brother,pert
cell line: CL-0;	transfection: vector control,ctrl
sciatic nerve of P60 Trembler mice,pert
Disease_status: Healthy control;	Age (years): 40;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.67;	Post mortem interval (hours): 38;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
C1_CLP_wildtype_8,ctrl
subject: 22A;	cohort: 22;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 27kb;	age (y): 71;	Sex: F;	batch: Batch_5,pert
Tissue: whole retina,ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 28,ctrl
"Cervical cancer cell line, ME-180",pert
Strain: C57BL/6; Tissue: quadriceps muscle,ctrl
Diagnosis: AML M5;	Age: 68y ;	Gender: Male;	Blast %: 69;	Source: BM;	Cyto: tris8;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
tissue: testis;	genotype: ClpP KO;	genetic background: C57BL/6,ctrl
34 with Cy5,pert
"Cryptosporidium parvum-infected HCT-8 cells, time course 3, 6h",pert
WT_72_O3_1,ctrl
"Control, replicate 5",ctrl
HeLa cells treated with Cas-II-gly,pert
genotype: E-mu-BRD2;	cell-type: lymphoma_marginal;	splenomegaly: marginal;	Ig clonality: oligoclonal,pert
HEK293T cell line,pert
Sample ID: TP16;	Twin Pair ID: CCN1.2R;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 37;	Current Age (2007): 40;	Sex: MALE;	Medication at blood sampling : None;	**Note this sample has a Biological replicate- Blood was taken from this patient on two separate occasions and two different transformed lymphocytes were arrayed. The matching sample is CCN1.2**,ctrl
strain: C57BL/6J;	day: 18;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
2008-Ets1 stable inducible (tetracycline) ovarian cancer cells,pert
cell type: mouse embryonic fibroblasts (MEFs);	genotype: KSR1 -/-;	expression: GFP;	background strain: DBA,pert
Du145-PCAT1 cells transfected with cMyc siRNA #3,pert
"t09, surgically resected from patient of gastric cancer.",pert
92.1 cells,pert
H1299_shLUC,ctrl
"Heart, MAT1 control, 4 wk, sample 3",ctrl
NORMAL #00-0267,ctrl
"striatum,12weeks,KO",pert
genotype: Villin-Cre - / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 88,ctrl
Primary epithelial cell culture from esophageal biopsies,ctrl
"Lymphoblastoid cell lines derived from family 1744, member 2",ctrl
CD46+ hippo - Untreated-C,ctrl
RNA from whole tissue section of case 1047 labeled with Cy5,ctrl
Retina severe glaucoma,pert
WI-38 cells exposed to 0.5 uM BPDE for 24 h,pert
cell line: E14;	cell type: embryonic stem cells (ESCs);	treatment: valproic acid (VPA);	treatment time: 16 hours,pert
Gastrocnemius and Soleus muscles,pert
strain: C57BL/6J;129S5/SvEvBrd;	genome/variation: Inha-/-;	cell type: granulosa cell;	treatment group: 44-46hr PMSG,pert
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 30;	maternal age: 29,pert
renal tissue from WT mice,ctrl
"twin pair: #9;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
NFIA P16KO1,pert
Livers of WT mice sacrificed at 4 weeks,ctrl
REST shRNA KD 1,pert
CD3+ T cells from patients with sarcoidosis,pert
"20 days old normal mice, cerebellum",ctrl
"ES cells: E14 (129P2/OlaHsd background), Genotype: Wild (Phgdh+/+), C57BL/6J background, Gestation: 13.5 days, Tissue: head",ctrl
6-KO_RD3b,pert
NK_cell_pool_healthy_H03+H04,ctrl
Lmx1b -/- E11.5 129Sv,pert
P0 Whole Brain,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: n/a;	maternal age: n/a,pert
primary normal lung tissue 3208,ctrl
MDA-MB-231 parental cells,ctrl
56A;pretreatment;female;breast tumor,ctrl
human preadipocytes+siCtrl_day6_rep1,ctrl
RA patient,pert
J1 mouse embryonic stem cell,ctrl
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 100min;	race: White;	sex: Male,pert
"midbrain,6weeks,WT",ctrl
Healthy controls; individual=JL; time=2; beverage=alcohol,pert
patient: 30582;	sample: tumor,pert
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic.",ctrl
R1 ES cells expressing human Gata3 T2ER fusion,ctrl
RWPE-PCAT1 cells transfected with cMyc siRNA #3,pert
con-41,ctrl
"HEK cells transfected with TDP-43 siRNA, 24h after transfection",pert
Age: 41;	Cycle: NA;	BRCA1/2 mutation: Negative;	Family History: No,pert
"thymus, control",ctrl
terminal end buds from mice,ctrl
age: adult;	gender: male;	tissue: lung,ctrl
CD3-purified cells from T-PLL peripheral blood sample. >95% purity,pert
kidney tissues from obese rats on diet with rosiglitazone,pert
Transfected MCF-7 cell line (siRNA targeting SPDEF),pert
Wildtype liver_saline-injected 12weeks repl3,ctrl
"Ishikawa cell line, BPA, 100pM, 8hr",pert
human skeletal muscle from diabetic individuals before insulin therapy,ctrl
Fetal liver CD-1 background,pert
Stratagene reference,ctrl
age: 44;	gender: female,pert
Bone marrow derive macrophage,ctrl
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 pM;	treatment time: 24 hours,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 35;	gender: female;	tumor grade: IV,pert
MDA-MB231 PIAS1 shRNA cells,pert
"Wt mouse, cerebellum, standard diet ad lib",ctrl
Tumor from MYF-5 CRE/SSM2 mouse,pert
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp3,pert
"gender: Female;	age: 78;	post-mortem delay: 8h;	ph: 6.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
genotype: Wild type;	strain: C57BL6,ctrl
"gender: Male;	age: 79;	post-mortem delay: 4h;	ph: 6.2;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=Black/African American;	Sex=Male,pert
GATA-1deltaN mutant E12.5 fetal liver derived megakaryocytes,pert
coMCF-7_3,ctrl
patient: CLS14;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 4,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 2,pert
"Hunk Knock-Out, Mammary gland",pert
"liver, knock out",pert
"Bone Marrow sorted Zfx-flox HSC (Lin-, Sca1+, c-Kit+)",ctrl
patient: 135;	current medication: none;	birth date: 8/14/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/28/05;	indictation for procedure: bloody diahorrea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
subject: 21B;	cohort: 21;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 26kb;	age (y): 59;	Sex: F;	batch: Batch_5,pert
"SKO-transduced MEFs, Vc untreated, lysed on D5",ctrl
"SiRNA-scrambled, replicate 5",ctrl
strain: FVB/N;	genotype/variation: wildtype;	age: embryonic day 9.5;	cell type: erythroid cells,ctrl
"MCF-7 cells, siERK5 treatment 72h, 10 nM E2 for 24h",pert
HCC_37T,pert
strain: C57BL/6;	tissue: Lung;	agent: saline;	genotype/variation: FIZZ2 knockout,ctrl
Superior Frontal Gyrus from a 10 year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
"Gender: female;	Age: 25;	Source: skin, left thigh",ctrl
NZM12 metastatic melanoma cells media-only control,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Carbo;	time: day1,pert
age_years: 45;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6aKO;	treatment: DSS for 3 days,pert
"Mouse wt heart ventricular tissue at E17.5, pool of 2",ctrl
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 24h,ctrl
tissue: blood;	patient: 6;	gender: male;	age: 46,pert
Human skeletal muscle biopsy sample;	Patient #17 with PM,pert
disease state: Mantle Cell Lymphoma;	cell type: B cell lymphocyte;	ighv status: MUT,pert
"t22, surgically resected from patient of gastric cancer.",pert
cells origin: subcutaneous white adipose tissue;	individual characteristics: Non-obese individual,ctrl
Mouse Tibialis Anterior 4 weeks post birth,pert
WILDTYPE cerebrum at 4 weeks,ctrl
tissue: large intestine;	genotype: HDAC3FF;	strain: C57BL/6,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
KO 3 Quadriceps,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (Luc),ctrl
"U2OS cell line(osteosarcoma;female),Tetracycline-repressible WT1(-KTS) expression, time-course induction of WT1(-KTS) expression.",pert
Disease_status: Healthy control;	Age (years): 34;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.48;	Post mortem interval (hours): 22;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
placebo treated ipsilateral to stroke,ctrl
cell line: HEK293 cells WTX inducible clone F18;	agent: control,ctrl
Gastrocnemius muscle from transgenic mouse overexpressing PPARalpha,pert
Tissue: striatum;	Age: 6 months;	Gender: F,pert
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 3,ctrl
"Patient #1, Untreated",pert
Disease_status: Bipolar disorder;	Age (years): 54;	Gender: Male;	Age of onset (years): 45;	Duration of illness (years): 9;	Brain pH: 6.50;	Post mortem interval (hours): 44;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,pert
unstimulated sparse HUVECs,ctrl
cell source: Human CD34+ cells isolated from umbilical cord blood;	agent: BCR/ABL1;	biological replicate: 1,pert
protocol: AP-2 gamma targetting siRNA 3;	cell line: MCF7,pert
age_years: 63;	sex: F;	ethnicity: Latino;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 1,pert
Age: 37;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Unknown,ctrl
heterozygot FH P278 (human CD3 positive T cells),pert
Patient: K;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
Peripheral blood mononuclear cells;	TTF=65min;	Race=White;	Sex=Female,pert
cell line: BV-173;	tissue: Human B cell precursor leukemia,ctrl
RNA from RAW 264.7 Cells,pert
wt testis at 14dpp,ctrl
"genetic background: Cebpa-Cre;R26-LSL-Eyfp;Dicer1wt/fl/Dicer1fl/fl (donror), C57BL/6 (recipient);	genotype: Dicer wild type;	cell type: YFP-positive  granulocyte-macrophage progenitor",ctrl
patient: 14;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
liver,ctrl
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
cell type: Primary hepatocytes;	strain: DBA;	agent: control;	time: 6h;	gender: Female;	age: 3 months,ctrl
"Heart, MAT1 CKO, 4wk, sample 2",pert
"strain: C57BL6/J;	pooled: Yes;	amplification batch: 07/15/05;	# cells: 11+16=27;	Sex: male;	region: M1;	age: 37,40;	genotype: Y/Mecp2-;G42/-",pert
MPM tumor specimen 21,pert
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: wild type (WT),ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 180min;	race: Black/African American;	sex: Female,pert
"H1299 treated with PBS buffer, 12hr",ctrl
Male C57Bl/6  Mice were 10.5 weeks old at time of sacrifice.,ctrl
patient: 51628;	sample: normal,ctrl
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 135min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 176,pert
Strain: C57BL/6J;	Gender: F;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 100 pM;	treatment time: 24 hours,pert
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day14,ctrl
siOGT 24 hours_3,pert
Dorsal Skin_SKO,pert
Cortex,ctrl
"150 pos, CD 48 neg, Lin neg Sca and c-kit pos BM cells",ctrl
Control Treg,pert
diagnosis: UIP/IPF;	fvc-group: FVC2;	tissue: lung,pert
patient: 211;	current medication: Predfoam Adcal D3 Alendronate;	birth date: 11/10/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 6/7/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/5/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/5/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Coeliac disease 1991;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
status: Rapid;	age: 68;	gender: male;	tissue: cultured human fibroblasts,pert
"INS-1 cell line, clone #5-3.19",ctrl
Skeletal muscle tibialis anterior (TA) from mdx line,ctrl
"Mouse, ATF6aKO, colon, DSS, rep1",pert
cell type: CD8 T cells;	transduction: shRNA targeting Ppp2r2d;	tissue: spleen;	sample name: 2-sp1,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 1,pert
"Human LIMA artery from patient 2, control (unstented)",ctrl
Diagnosis: MDS/AML;	Age: 76y ;	Gender: Female;	Blast %: 96;	Source: PB;	Cyto: No Data;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
"ACI strain, male, age 21 weeks",ctrl
Brain from 82 days Npc1-/- mouse1,pert
Carboplatin;	Carboplatin 36 hours set 2,pert
Thymus,ctrl
Total RNA was extracted from omental adipose tissue from a control subject,ctrl
murine medullary thymic epithelial cells,ctrl
human preadipocytes+oligo1_day6_rep1,pert
Wildtype liver_saline-injected 12weeks repl2,ctrl
hiPSC-derived 6-week-old neurons,pert
MLL_00106,ctrl
HEK293 cell line #5 with uninduced HNF1beta mutant A263insGG,ctrl
Scrambled 12 hours_2,ctrl
Wistar rat liver tissue following animal exposure to orotic acid for 14 days,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N3, G4",pert
HEK cell lines expressing WT channel,ctrl
"blood, +Q10H2, +LPS",pert
"patient: 114;	current medication: None;	birth date: 6/27/36;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Altered bowel habit, Alcohol excess;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: trisomy8,pert
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype N/A;	matched/unmatched: unmatched,pert
strain background: F2 of C57BL/6J and DBA;	gender: female;	genotype/variation: wild type;	age: 3 months;	tissue: hippocampus,ctrl
strain: C57BL/6J;	day: 24;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 3,ctrl
chip number: 22;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.82;	rin: 9.3;	transfection date: 2011-10-17,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 55;	sex: M,ctrl
"PTEN mutant 3 intestinal polyp, polyI:C, 30 days",pert
patient: 30364;	sample: tumor,pert
nebivolol treated muscle cells,pert
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,ctrl
Old heart,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 429,pert
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,pert
tissue: normal adjacent esophageal tissue,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.03;	RNA Integrity Number: 8.3;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
cell type: DN4,ctrl
Strain: Fischer 344;	Gender: Male ;	Age: 6 ;	Tissue: Liver of D3T treated rat,pert
tissue: liver;	genotype: WT;	genetic background: C57BL/6,ctrl
E15.5 Tgfbr2 Wildtype Mouse Model,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,pert
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14536;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
FVB 129 mice were used as bone marrow donors,pert
cell line: HEK293 cells WTX inducible clone F18;	agent: doxycycline,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 48;	age-at-onset: n/a;	geographical origin: Lisboa;	clinical characteristics: Hypercholesterolemia;	lifestyle characteristics: ever drinker,ctrl
advanced HCC,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.536;	OD280: 0.766;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 299;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
HL60 AML cells,ctrl
"Animal id 1024, left retina, 3 months, female, DBA/2J",ctrl
pool of 3 normal E12.5 kidneys,ctrl
age: 71;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cell line: HT144;	transfection: negative control non-targeting siRNA,ctrl
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: histone methyltransferase ESET KO;	genetic background: C57BL\6,pert
cell type: leukemic spleen cells;	genotype: CBFb-SMMHCd179-221 chimera,pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,ctrl
"gender: Female;	age: 90;	post-mortem delay: 12.5h;	ph: 5.7;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
disease state: endometrioma;	patient: M1,pert
Knockout liver DEN-injected 12weeks repl2,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 2, Units of Harvest Time Point: hr",ctrl
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: E,ctrl
sex: Male;	family: 1;	age: 49;	disease status: Affected;	tissue: Muscle: Biceps,pert
"Huh7 cells, Mock Infected, 12 hours.",ctrl
The caudate nucleus from a neurologically normal Jpanese male (aged 60 yr).,ctrl
Total RNA from MDA-MB-231 cells infected with a lentivirus shLOXL2,ctrl
EB_2_6h_206_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: siHic5_2;	treated with: dexamethasone (Dex) for 0h,pert
NFIA P16KO2,pert
WILDTYPE cerebrum at 10 days,ctrl
condition: Psoriasis;	patient: PS-G;	tissue: LS skin biopsy;	kit: Affy,pert
chip number: 18;	transfection plate: 3B;	target gene: PAX5;	kd level: 0.82;	rin: 9.5;	transfection date: 2012-03-26,pert
"patient: 119;	current medication: Salubtamol, Bricanyl;	birth date: 9/30/70;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/27/05;	indictation for procedure: FH Colon Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
treatment: siCFIm68;	cell line: HeLa,pert
"RKO colon carcinoma cells (ATCC #CRL-2577), cultured in DMEM (Invitrogen Catalog#10569) containing 10% FBS (Atlas Biologicals)",pert
short term cultures of epidermal melanocytes,ctrl
siGFP-transfected sample 2,ctrl
A VIS _B068,pert
Sex: male;	Age at operation: 60 years;	Site: upper arm;	Size in cm: 9.9x7x7;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
"glioma cell line U373, DTX1 over-expressing",pert
strain: 129/Ola;	cell type: embryonic stem cells,pert
Diagnosis: AML M2;	Age: 41y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Normal;	FLT3 ITD: No Data;	FLT3 TKD: No Data,pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.86;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/wt, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",ctrl
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 37;	gender: male,pert
Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,ctrl
"midbrain,24weeks,WT",ctrl
cell line: MV4-11;	cell line description: biphenotypic B myelomonocytic leukemia (MLL-AF4 rearragenment);	growth conditions: IMDM with 10% FBS;	agent: Vehicle;	time: day 6;	biological rep: 1,ctrl
race: caucasian;	age (years): 67;	stage: IC;	grade: 1;	histology: endometrioid,pert
gender: Female;	age: 53;	cell type: PBMC;	individual: Patient 4;	treatment: BETAFERON;	time: 3 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-D1a,ctrl
strain: 129P2 (formerly called 129/Ola);	tissue: embryoid bodies;	treatment: Day2 EBs induced with doxycycline and cultured for another 24h,pert
"new born prosaposin knockout mice, cerebrum",pert
"tissue sample from Bellevue Hospital, NY",pert
CD3+ T cells from healthy volunteers,ctrl
"gender: Male;	age: 77;	post-mortem delay: 3h;	ph: 6.1;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"control, untreated muscle cells",ctrl
Monocytes from buffy coat preparation,pert
293T cells with scramble shRNA (control cell line).,ctrl
bipolar disorder,pert
GC resistant clone C7H2-R10E7 treated for 6 hours with GC,pert
"SRF silenced, treated with EtOH, biological rep 1",ctrl
strain: C57BL/6J;	genotype: Cmah KO;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
cell line: Panc0504;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
"seminoma specimen, pT1, patient age: 40y",pert
prefrontal cortex (collagen),pert
normal skin,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 16.9158110882957;	age of psoriasis onset: 18,pert
Normal cervix_05-4602,ctrl
human glioblastoma cell line,ctrl
race: caucasian;	age (years): 58;	stage: IB;	grade: 1;	histology: endometrioid,pert
Whole lung tissue_advanced IPF_explant,pert
age	31;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	8.3;	hemoglobin (g/dl)	14.9;	platelet count (/nl)	269,ctrl
Sca+ SP (side population) bone marrow cells,pert
RKO colon cancer cells,pert
Lin- Rosa26rtTA cells transduced with pRRL.TET.EVI1.IRES.EGFP,pert
"adult mouse jejunum, hnf1alpha control",ctrl
race: caucasian;	age (years): 50-55;	stage: n/a;	grade: n/a;	histology: secretory endometrium,ctrl
cell line: H1299 lung cancer cell line;	genotype/variation: RBP2 depletion;	shRNA: RBP2 KD1,pert
patient: CEM11;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Untreated-Control, Period of treatment: 4 weeks, Method of sacrificing: cervical dislocation.",ctrl
"LNCaP cells, treated with R1881, biological rep 3",ctrl
cell line: E14;	treatment: REST knockdown,pert
boen marrow-derived macrophages,pert
"lymphoblastoid cell line from F16.01, one out of seven of insensitive group, 50*10e6 cells",ctrl
strain: C57BL/6J;	age: 4 months;	gender: male;	tissue: lung;	genotype/variation: Ifitm1 k.o.,pert
Carboplatin;	Carboplatin 30 hours set 1,pert
cell line: KM-H2;	treatment: CIITA-BX648577 knockdown,pert
Human Embryonic Stem Cells,ctrl
dorsal mouse skin,pert
genotype/variation: Vax2-/-;	age: P60;	tissue: Whole eye,pert
hOB695_shEV_16hr_IR,ctrl
"t02, surgically resected from patient of gastric cancer.",pert
"Femal C57BL/6, ovariectomized",ctrl
S1C Sporadic-hippocampus,ctrl
epithelium from colon of control mouse no.3,ctrl
"cultured human airway smooth muscle, 4 hour dex treatment, replicate 2",pert
"Normal cervix, Age 56",ctrl
Disease_status: Bipolar disorder;	Age (years): 44;	Gender: Female;	Age of onset (years): 26;	Duration of illness (years): 18;	Brain pH: 6.37;	Post mortem interval (hours): 37;	Side of brain: Right;	Fluphenazine mg. Equivalents: 30000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
"cerebellum,24weeks,KO",pert
PBMC from T cell Large granular lymphocyte leukemia patient#123,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: male;	age: 5 Month old;	tissue: White adipose tissue (WAT);	diet: 35% Fat Diet (High Fat Diet; HFD),ctrl
SKI-DLCL cells were treated with AraC alone in concentration 20nM for 24h. Total RNA was extracted,pert
"twin pair: #1;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; Pten+/loxP,pert
H2009_shLUC,ctrl
T56,pert
"Frontal Cerebrocortex, permethrin (1 mg/kg), 6 hours",pert
Patient: M;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
chip number: 20;	transfection plate: 5;	target gene: RELA;	kd level: 0.79;	rin: 7.9;	transfection date: 2011-10-17,pert
Normal Cervix,ctrl
cell type: AML blasts;	fab classification: M4,ctrl
"TGCT cell line NTera2/clone D1, untreated, undifferentiated and pluripotent",pert
plantaris muscle,pert
"C57BL/6J Saline treated, biological replicate 3",ctrl
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 5,pert
CD8_T_cell_pool_healthy_H11+H12,ctrl
tissue: whole Gastrocnemius;	gender: adult male;	strain: CD1,pert
100uM H2O2 rep 2,pert
very early HCC,pert
Capan2 cells transduced with lentivirus carrying shRNAs targeting LLGL1 transcript,pert
Celecoxib_#4880,pert
age: 71;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 1h;	donor: 3,pert
patient E1589,ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 4,pert
age: 17;	sex: M;	disease status: Marfan subject;	Filter number: 34;	Usage number: 4;	Exposures: 2,pert
cell line: RT112;	transduced: FGFR3 shRNA 4-1;	doxycycline treatment: no,pert
"Patient  K, lesion, 2 week",pert
tissue: Liver;	genotype: wild-type;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 687,ctrl
double positive thymocytes,pert
siRNA-1-PLASTIC,pert
C57/BL6 murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
Human wildtype fibroblast,ctrl
strain: Swiss;	tissue: Ovary;	agent: 4-Vinylcyclohexene Diepoxide (50uM);	replicate: 3;	age: Post natal day 3-9,pert
INS-1 cell line #1 with non-induced HNF4a2,ctrl
bone marrow,ctrl
tissue: blood;	control: 1;	gender: male;	age: 41,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.77534,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: ATF6bKO;	treatment: untreated,pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep3",ctrl
"WT cells, replicate 3",ctrl
COLO829 cells with shScrambled knockdown and DMSO treatment,ctrl
Eed KO E14 ESCs on day 3,pert
Untransduced Wild Type DAOY Cells;	,ctrl
genotype/variation: GSK-3b-/-;	cell type: embryonic stem cells,pert
T175,pert
"T3 fetal heart (treated on gd 14.5 via oral gavage, collected on gd17.5)",pert
sample type: ove26 mice;	strain: fvb(cg)-tg(ins2-calm1)26ove tg(cryaa-tag)1ove/pnej;	gender: Male;	age: 8 weeks;	tissue: glomerulus;	disease state: Diabetic,pert
H1299_shGFP,ctrl
SV589_3Day KD_Serum Starved -> 3hr EGF,pert
10uM H2O2 rep 4,pert
skin_tissue,ctrl
genetic background: CD1;	genotype: A2AR KO;	Sex: male;	age: 14 weeks;	tissue: ventricular myocardium;	treatment: saline,pert
"Control #7, Untreated",ctrl
H1299 cells,pert
REST shRNA KD 3,pert
Melanoma allograft_AZD6244 100mg/kg 4 days,pert
age: 77;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
strain/background: C57BL/6;	genotype/variation: wild type (D4-cre/Ai9 tdTomato);	tissue: retina;	cell type: cone photoreceptors;	age: postnatal day 60,ctrl
tissue: ankle joint;	genotype/variation: MMP-8 KO;	strain: C57BL/6,pert
Percutaneous biopsies of vastus lateralis,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.0;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 32;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
cell line: Hep G2;	genotype: wild-type THRA and;	treatment: with 100 nM T3 for 6h,pert
HLA risk: Low;	Height: 178.5 cm;	Weight: 71.2 kg;	BMI: 22.4;	Age: 25.25 years;	Gender: Female;	Race: White;	Glucose: 80 mg/dl;	HbA1c: NA,ctrl
patient: 116;	current medication: Clomiprimine;	birth date: 1/19/56;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: FH Colon cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
healthy,ctrl
cell line: A549;	agent: decitabine;	dose: 0.3 uM,pert
treatment: 1 ug/ml doxycyline;	time: 36 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
RNA from microdissected breast cancer cells from case 1405 labeled with Cy5,ctrl
CUTLL1 MigR1 GSI,ctrl
"Neuroblastoma SH-SY5Y cells, stably transfected with RNAi against DJ-1",pert
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
K562 cell line,pert
"7B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 25.208;	Ratio: 2.10,pert
disease affected colon of an adult with Crohn's disease (CD).,pert
gender: M;	age at blood draw: 58;	tissue: whole blood,ctrl
disease status: CML chronic phase (CP);	cell source: bone marrow (BM);	cell type: CD34+ mononuclear cells,pert
"PC-3 cells, before treatment (0h)",ctrl
Actinomycin D treated A549 human lung cancer cell cultures replicate A,pert
Cardiacmyocyte,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Male;	batch: 4;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.683;	OD280: 0.839;	Ratio: 1.98;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 294;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
allergic_asthmatic_bronchial biopsies,pert
cell type: Melanoma cell line;	cell line: A375,pert
"kidney, control, 6 months",ctrl
RKO human colorectal carcinoma cells,pert
"ID:3-1, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",ctrl
Y SIT_B070,ctrl
gender: Male;	age (y): 48;	tissue: prolactinoma,pert
gender: male;	age: 8 weeks;	strain: Sprague Dawley rats;	tissue: lumbar dorsal root ganglia,pert
Total Prefrontal cortex RNA,pert
cell type: MEFs;	genotype/variation: p27KO,pert
disease-state: normal (reduction mammoplasty);	tissue-type: breast epithlieum;	patient-id: 314;	age-at-biopsy-years: 49,ctrl
strain/background: C57B6SJL;	genotype/variation: wild type;	age: 15 months;	tissue: liver;	disease status: healthy,ctrl
sample: #9;	subject: Control case #4;	brain: T-779;	age: 76;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
H157 siDJ-1 #1,pert
scan batch: Batch 1;	group: control;	subject age: 7;	paternal age: 32;	maternal age: 38,ctrl
cell type: Normal Human Epidermal Keratinocytes (NHEK);	transfected with: MLL2 siRNA,pert
"patient: 101;	current medication: Paracetamol;	birth date: 10/5/63;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/2/04;	indictation for procedure: Weight loss, altered bowel habbit.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
SCLC cell line Lu-130,pert
tissue: Frontal cortex;	age: 83;	Sex: M,ctrl
Placenta_PE(LO)2 with Cy5,pert
age: 34;	sex: M;	disease status: Marfan subject;	Filter number: 77;	Usage number: 1;	Exposures: 4,pert
strain: C57BL/6;	cell type: hepatocytes;	genotype/variation: GNMT-KO;	agent: aflatoxin B1 (AFB1),pert
B cells - wildtype mice - not infected,ctrl
"Lymphoblastoid cell lines derived from family 1736, member 1",ctrl
strain background: C57Bl/6;	genotype/variation: Lrp5+/+;	cell type: primary calvarial osteoblasts;	time point: day 7 of differentiation,ctrl
"primary cortical neurons, NLGN1 shRNA",pert
"patient 14, right arm treated with pimecrolimus until day 22",pert
Patient: E;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
SPC WT lung (adult),ctrl
Jurkat T-cells non-transfected,ctrl
age: 42;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
agent: EphB2-Fc conjugate;	time: 4h,pert
mouse B6xCF-1 RNAi transgenic,pert
Monocyte derived dendritic cells,pert
cell line: A549;	agent: azacitidine;	dose: 3 uM,pert
treatment: Vehicle;	time: 25,ctrl
Cervical cancer_1798T,pert
individual: patient11;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"Lymphoblastoid cell lines derived from family 1744, member 2",pert
PancreaticSample17-Tumor,pert
human preadipocytes+siCtrl_day0_rep1,ctrl
cell line: Reh;	transfection: IKKb(EE);	malignancy: non-Hodgkin lymphoma,pert
Human muscle (vastus laterlis),ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.7;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 53;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 56.76164,ctrl
Hep G2 treated with Arsenic (III) oxide,pert
"H1299 treated with PTD-DRBD GAPDH siRNA, 12hr",pert
NBD inhibitory peptide-treated T-ALL1 100mM 16h,pert
Strain:  B6.V-Lep ob;	Gender: female;	Age:  12 weeks;	Tissue:  gallbladder,pert
sex: female;	tissue: liver,pert
Un-stimulated CD4+CD25+high regulatory T cells from PBMCs,ctrl
Mouse brown preadipocyte cell line,pert
cell type: Lin- Sca-1+ c-Kit+ (LSK);	age: six weeks old;	genotype/variation: Ott1 wild type,ctrl
siRNA-2-PLASTIC,pert
untreated AML blasts,ctrl
cell line: E14;	treatment: control,ctrl
A HID I_B083,pert
Gallbladder - leptin treated,pert
"age at diagnosis: 55;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1b;	er: EV;	pgr: EV;	dfs-month: 22;	dfs-event: 0;	distant metastasis: 0",pert
Mouse forebrain primary cell cultue of astrocytes,ctrl
Spleen & Lymph Node,ctrl
duration of untreated disease in month: 63.5;	age at onset: 5.1,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
SK-MEL-2 cells,pert
liver; fasted 18h,pert
T6.01,ctrl
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: wildtype,ctrl
tissue: white blood cells;	age: 15.59;	Sex: male,pert
"lymphoblastoid cell line from F6.04, one out of seven of sensitive group, 50*10e6 cells",pert
"rat hippocampus (combined dorsal and ventral aspects), young control, subject 8",ctrl
"TGCT cell line NTera2/clone D1, treated 7 days with retinoic acid, differentiated",pert
cell line: HL-60;	shRNA construct: GSK3A Construct 5,ctrl
human liver; early HCC,pert
EB_2_24h_211_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
strain: C57BL/6J;	tissue: WAT;	genotype/variation: wild-type;	gender: male;	age: 3 month,ctrl
Embryoid body formation (10 days) of Bmi1 transduced embryonic stem cells (CCE ES cells).,pert
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
mortality: alive;	ethnicity: Asian;	gender: M;	age (yrs): 33;	tissue: Normal_Kidney_Biopsy,ctrl
"Human LIMA artery from patient 4, treatment: paclitaxel-eluting stent",pert
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
condition: control;	tissue: decidous teeth dental pulp;	gender: female,ctrl
A HID B_B011,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient B;	treatment: Vemurafenib 1000 nM for 48h,pert
"Gata6-KO heart, CRE, biological rep3",pert
"t19, surgically resected from patient of gastric cancer.",pert
subject id: c1;	infection: control;	status: control;	tissue: whole blood,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 44;	gender: male;	tumor grade: IV,pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: E2;	time: 24h,pert
disease state: paediatric glioblastoma;	age: 15;	gender: M;	h3.3_status: G34R,pert
condition: Psoriasis;	patient: PS-C;	tissue: LS skin biopsy;	kit: Affy,pert
"Lung tissue of Nrf2 knock-out mouse, smoke treated",pert
age: 34;	sex: F;	disease status: Marfan subject;	Filter number: 72;	Usage number: 1;	Exposures: 4,pert
Aquaporin-11-/-_mouse P7 kidney #5-2,pert
Sex: female;	Age at operation: 57 years;	Site: thorax;	Size in cm: 4.9x4x3;	Histological Subtype: pleomorphic liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: local recurrence;	Previous radiation: no;	Previous chemotherapy: no,pert
HVS-CD4-ITK-R335W_unstim,pert
scan batch: Batch 1;	group: control;	subject age: 4;	paternal age: 35;	maternal age: 33,ctrl
strain: C57/Bl6;	gender: N/A;	age: 4 months;	weight: 25-30g;	tissue: whole trachea,ctrl
strain: C57BL/6;	genotype: PTEN+/- (epithelium);	age: 12 months;	tissue: lateral prostate,ctrl
"age at diagnosis: 60;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIC;	t (extent of primary tumor): T2;	n (lymph node metastasis): N3a;	er: 0;	pgr: 0;	dfs-month: 19;	dfs-event: 1;	distant metastasis: 1",pert
age: 6 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
Lung of hemorrhaged animal 1h,pert
subject id: 60;	infection: DENV;	status: DHF;	tissue: whole blood,pert
CON-3-PLASTIC,pert
Region of the left ventricle above the infarction (above the LAD artery),pert
genotype: Bcl6 knock-out;	cell type: FoxP3+ Treg,pert
cell line: KGN;	transfection: FOXL2 stealth RNAi,pert
A HID B_B046,pert
retina,ctrl
"MCF7 cells stably transfected with XBP1, passage 6",pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 18.378;	Ratio: 2.09,ctrl
"BMMC, WT, activated,",ctrl
Zucker rats,pert
"SPC-c-raf transgenic mice, 10 month old, female, tumor",pert
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: Alk2 cKO,pert
cell line: H1;	cell type: embryonic stem cells;	shRNA: HERVH,pert
"INS-1 cell line, clone #5-3.14",ctrl
Septic shock;	gender: Male;	Non survivor;	organism: None,pert
strain background: C57Bl/6;	genotype/variation: P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,ctrl
subject: 03A;	cohort: 3;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
Brg1 deficient,pert
age_years: 62;	sex: F;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 3,ctrl
IMR90 cells stably expressing H-RasV12 treated with Metformin,pert
batch: A;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
cell type: Osteoblastic lineage cell;	strain: C57BL/6;	phenotype: Scl-tTA::TRE-BCR/ABL;	time point: 5-6 weeks post doxycylcin withdrawal,pert
knockdown: TNFa-OMe-P siRNA-C;	amplification date: 09/06/22;	hybridization date: 09/06/29;	colon length (mm): 7.1;	colon weight (mg): 151;	colon ratio (mg/mm): 2.127;	myeloperoxidase activity (u/mg): 0.082;	tissue: colon;	treatment: 5% DSS,pert
"8 wk old BALB/c (or BALB-RAG) mice were sensitized to ovalbumin (or PBS)]on days 1 and 7, and challenged with aerosolized ovalbumin (or PBS) on days 15-21, and samples harvested on day 22",pert
"gender: female;	age: juvenile, 8 weeks (P59);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
treatment: naïve;	transgenic variant: AChE-S;	tissue: Caudate-Putamen;	genetic background: FVB/N,pert
CD8_T_cell_pool_melanoma_M11+M12,pert
Mock,ctrl
"cell population of MDA-MB-231 stably transfected with pcDNA6/V5-His-ZNF217 plasmid, cell culture 2",ctrl
NSC_FOXO_WT-3,ctrl
"Spleen, CD4+CD25hi Tregs, wildtype",ctrl
"Amniocytes, trisomy 21, 1575",pert
cell type: monocyte;	disease state: homozygote FH,pert
tissue: prostate;	normal/tumor: tumor,pert
"HEK001, siNCSTN",pert
quadriceps_muscle_Akt1+/-_female_8wk_rep3,pert
S46 WT1	F5/3	S46	wild type	Mouse	3.5 months	Cerebellum	Male,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 6;	gender: male,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: GTE6;	ttf: 70min;	race: White;	Sex: Male;	fstl-1 (ng/ml): 248,pert
race: caucasian;	age (years): 43;	stage: IB;	grade: 3;	histology: endometrioid,pert
tissue: primary brain tumor;	cell type: oligodendrioglioma;	age: 45;	gender: male;	tumor grade: OGIII,pert
WT_48A_4,ctrl
"Mouse embryonic fibroblasts, control",ctrl
sampleID: SAM630142;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
treatment: baseline;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,ctrl
knockdown: TNFa siRNA-A;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6.4;	colon weight (mg): 171;	colon ratio (mg/mm): 2.672;	myeloperoxidase activity (u/mg): 0.204;	tissue: colon;	treatment: 5% DSS,pert
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 40;	maternal age: 40,pert
tissue: liver;	gender: male;	disease status: type 2 diabetes,pert
Nonirradiated-ATM-KO Replicative1,pert
tissue: Hippocampus;	age: 95;	Sex: F,pert
Hippocampus pool from three SHA rats,ctrl
age: 35;	sex: M;	disease status: control subject;	Filter number: 79;	Usage number: 1;	Exposures: 3,ctrl
cell type: MEFs;	genotype/variation: wild type,ctrl
Mature mice skeletal muscle sample from the forelimb,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Male;	Source: In Vitro Technologies;	Cause of Death: Anoxia;	Tobacco Use: No;	1st technical replicate,pert
cell type: mammary epithelial cells;	gender: female;	age: 8 weeks;	myc: WT;	p53: KO;	rb: WT,pert
RNA from microdissected breast cancer cells from case 68 labeled with Cy5,pert
Dysf +/+ TA control mouse muscle,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 0.918;	OD280: 0.454;	Ratio: 1.99;	Dilution: 1:5;	RNA Integrity Number: 7.7;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 301;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
sciatic nerve,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 21.40548,pert
subject id: c6;	infection: control;	status: control;	tissue: whole blood,ctrl
NORMAL #00-0504,ctrl
disease state: endometrioma;	patient: 2,pert
subject: 13B;	cohort: 13;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 16kb;	age (y): 42;	Sex: F;	batch: Batch_3,pert
E9.5 KLF1-/- erythroid-6,pert
patient: 266;	current medication: Prednisolone ciproxin mesalazine fosomax Fe SO4;	birth date: 8/12/40;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/93;	diagnosis date: 1/1/93;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/22/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 700;	esr: 0;	crp: 20;	hb: 93;	wcc: 17;	neutrophils: 16;	albumin: 23;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 0;	igr2198: 11;	igr2230: 11;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 7/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: COPD-Previous severe pneumonia;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
cell line: MCF10A;	treatment protocol: Vehicle,ctrl
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: female;	age: 68",pert
liver_knockout,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 220,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient C;	treatment: Vemurafenib 1000 nM for 48h,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 24hr,pert
strain: Wistar;	gender: male;	tissue: sciatic nerve;	treatment: acrylamide,pert
phenotype: alcoholic;	gender: female;	case_id: 443;	age: 49;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: No;	post-mortem-interval (hrs): 56;	brain ph at time of freezing: 6.11;	labeling_batch: 1,pert
cell type: Primary hepatocytes;	strain: FVB;	agent: control;	time: 24h;	gender: Female;	age: 5 months,ctrl
WT V6.5 ESCs on day 3,ctrl
Patient: C;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
"Amniocytes, trisomy 21, 1551",pert
cell line ATCC,pert
tissue: Hippocampus;	age: 2-3 months;	genotype/variation: IκBαfl/-;Nestin-Cre,pert
E9.5 KLF1-/- erythroid-5,pert
age: 40;	sex: F;	disease status: control subject;	Filter number: 90;	Usage number: 1;	Exposures: 2,ctrl
strain background: mixed 129Sv/C57BL6;	genotype/variation: Col1a1+/+;Rosa26rtTA/+;	gender: male;	age: 8 months;	tissue: liver,ctrl
"lymphoblastoid cell line from F6.01, one out of seven of sensitive group, 50*10e6 cells",pert
C57BL/6J Mouse Female Kidney,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 6",pert
Peripheral blood mononuclear cells;	TTF=125min;	Race=White;	Sex=Male,pert
gender: female;	batch: 2;	age (years): 23;	patient id: Non_severe_4;	fev1 (% predicted): 84;	fvc (% predicted): 81;	medication: Salbutamol;	cell type: CD4+ T-cells,pert
Placenta_nl3 with Cy5,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 57 years,ctrl
cell line: HEK001,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: G;	transfectant type: stably transfected with RNAi against DJ-1,ctrl
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 17.7488021902806;	age of psoriasis onset: 21,pert
wild-type prostate epithelial cell line,ctrl
sciatic nerve of PMP22 knockout mice at P4,pert
age: 49;	sex: M;	disease status: control subject;	Filter number: 84;	Usage number: 5;	Exposures: 3,ctrl
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p27;	strain: E14,pert
age: 36;	sex: M;	disease status: control subject;	Filter number: 98;	Usage number: 5;	Exposures: 3,ctrl
strain: mixed C57BL6;	genotype/variation: Rptrflox/flox;Pax7CreER/+;Rosa26REYFP/+;	age: 3-5 months old;	treatment: noninjured;	tissue: hindlimb muscle;	cell type: QSC;	time: control,pert
3_3_MOE_430A_WT,ctrl
age	43;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.8;	hemoglobin (g/dl)	14;	platelet count (/nl)	311,ctrl
Brain from 20 days Npc1+/- mouse1,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: B;	genotype/variation: NET1 present;	agent: no LPA (control),ctrl
"gender: Male;	age: 38;	post-mortem delay: 6h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.57808,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 2h;	culture batch: 2;	bead chip array sentrix code: 4421339046,ctrl
scan batch: Batch 1;	group: autism;	subject age: 5;	paternal age: 36;	maternal age: 27,pert
"Sham NALT (PBS), biological replicate 2",ctrl
U87 untreated,ctrl
cell line: NAS2;	cell type: induced pluripotent stem cells (iPSCs);	genotype/variation: wild-type,ctrl
"pancreas, ethanol diet, male Wistar rat",pert
"BOEC, normal 4",ctrl
U2OS osteosarcoma cell line transfected with an shControl construct,ctrl
cell line: HEK293T,pert
EB_2_24h_214_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell type: PBMC;	responder: Not ACR70;	treatment: Methotrexate post-treatment;	subject: A235_L027,pert
strain: C57BL/6;	tissue: cerebellum;	genotype/variation: Cxcr4 null,pert
cell type: HeLa;	genotype/variation: Transfected with wild type Neuroserpin,ctrl
Liver from a 24 month old wild type mouse,ctrl
PancreaticSample38-Normal,ctrl
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 6h;	gender: Male;	age: 2 months,ctrl
Sex: female;	Age at operation: 58 years;	Site: pelvis retroperitoneal;	Size in cm: 4x7x9;	Histological Subtype: myxoid/roundcell liposarcoma;	Responder type: high;	Grading: G3;	Specimen character: metastasis;	Previous radiation: no;	Previous chemotherapy: no,ctrl
MEF cells from female  Oga knock out embryo (D12.5),pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 31;	maternal age: 28,pert
tissue: skin;	individual: Patient P8;	condition: ANL;	eczema severity: SCORAD: 0,pert
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
"LCL GM19238, Kd TCF12, 72hrs",pert
day: d00;	strain: C57BL/6;	genotype: KO;	experimental run: eX,pert
"Hunk WT, Mammary gland",ctrl
"MaF pre-iPSC9P2, Vc treated, lysed on D6",pert
Extract:LOX-1:113502;	Extract Description:GFP_Untreated_24hr:113502;	Quality: Classification:Medium;	Quality: Gradient Severity:0.12;	Quality: Distortion Severity:0.08;	Quality: Defective Area (%):0.01;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.46;	Quality: Background Mean Dev.:0.06;	Quality: Absent (%):60.04;	Quality: Absent (%) Dev.:1.38;	Quality: Scaling Factor:0.87;	Quality: Scaling Factor Dev.:2.22;	Pretreatment [C]:GFP;	Time point [C]:24 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113502;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_24hr;	RNA extraction source key [A]:282295843,ctrl
Low pH stimulated SKGT4 cells,pert
"Ls174T, β-catenin siRNA, induced",pert
liver_Wt_female_35wk_rep4,ctrl
Tissue: Spleen;	Type: Saline;	Strain: C57BL/6;	Batch: 4/22,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 6,ctrl
"strain: C57BL/6J;	genotype: Tmod3-/-;	phenotype: small fetal liver, anemia",pert
"fatty (fa/fa), liver, Pioglitazone",pert
cell line: PC-3;	transfection: control miR,ctrl
"MCF-7 human cell line, siLRH-1_#2",pert
Strain: C57BL/6;	Gender: female;	Age: 110 days;	Tissue: mammary tumor;	Days after tumor onset: 14 days,ctrl
cell line: PA-1;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
17A;pretreatment;female;breast tumor,ctrl
Sex: female;	Age: 12;	SL: 4.56;	House: 3;	Severity: SS;	Ashworth: 3;	Zancolli: 2B;	PEFF: 50;	PESF: 45;	AEFF: -90,pert
tissue: white blood cells;	age: 10.37;	Sex: male,pert
Rosi-treated diabetic,pert
G93A-SOD1 mouse,pert
Beta4 nAChR subunit null mice following nicotine-induced seizures,pert
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: Vemurafenib 1000 nM for 48h,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shControl,ctrl
tissue: primary brain tumor;	cell type: glioblastoma;	age: 40;	gender: male;	tumor grade: IV,pert
heart of male mouse subjected 2 week to chronic constant hypoxia,pert
Nasal Epithelium,ctrl
33 with Cy5,pert
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD8+ T-cells",pert
QK-knockdown U87 transduced with a scrambled non-targeting microRNA (miR-NT),ctrl
Liver,pert
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Wild-type;	treatment: Imatinib (2uM for 16h),pert
"patient 8, left arm treated with pimecrolimus until day 22",pert
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,ctrl
patient: 30617;	sample: tumor,pert
strain: C57BL6;	genotype: PDE10A KO;	tissue: hippocampus;	treatment: vehicle control,pert
HaCaT cells at day 12 of in-vitro calcium induced differentiation,pert
"sirna: Sense Control siRNA (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",ctrl
murine neural crest,pert
"age at diagnosis: 46;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): TX;	n (lymph node metastasis): N2;	er: 1;	pgr: 1;	dfs-month: 60;	dfs-event: 0;	distant metastasis: 0",pert
"SPC-c-raf transgenic mice, 10 month old, male, tumor",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/09/07;	# cells: 58;	Sex: male;	region: CB (cerebellum);	genotype: Y/Mecp2-;G42/-;	cell type: G42 GFP labeled Purkinje neurons from the cerebellum,pert
normal control,ctrl
2828 WT,ctrl
"male sprague-dawley rat, 21 days olanzapine",pert
Human colon cancer cell line Caco-2,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 28;	gender: male,ctrl
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 200 mg/kg,pert
"age at diagnosis: 47;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1;	er: 0;	pgr: NA;	dfs-month: 13;	dfs-event: 0;	distant metastasis: 0",pert
strain: B6/C3H F1 hybrid;	gender: male;	age: 30-month-old,pert
NFIA P16WT2,ctrl
Mock infected macrophages harvested at 1h post-treatment from donor 3,ctrl
Placenta_PE(EO)5 with Cy5,pert
8 Month Wild Type Ovary_02,ctrl
age: 62;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
Female - caucasian - E-06-M,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6.2;	colon weight (mg): 170;	colon ratio (mg/mm): 2.742;	myeloperoxidase activity (u/mg): 0.643;	tissue: colon;	treatment: 5% DSS,pert
human preadipocytes+oligo2_day6_rep1,pert
human preadipocytes+oligo1_day0_rep1,pert
cell line: LNCaP,pert
cell line: bj-fib_1: BJ (CRL-2522) fibroblasts were purchased from ATCC.,ctrl
patient: 261;	current medication: Asacol 800mg BD;	birth date: 1/7/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/98;	diagnosis date: 1/1/98;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/14/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/14/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G63,pert
N2A Normal-frontal,ctrl
"skin fibroblasts, passages #14 and 15",ctrl
Cell line: BV-173,ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: no LPA (control),pert
"Male, 34 years old, HIV infection of 9 years",pert
RNA from microdissected breast cancer cells from case 1419 labeled with Cy5,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 24 hrs;	time course: 3,pert
10uM H2O2 rep 2,pert
19A;pretreatment;female;breast tumor,ctrl
"BMDM, LPS 1hr",pert
condition: Normal;	patient: N_LJ_4;	tissue: Normal skin biopsy;	kit: Affy,ctrl
8 week old control mouse diaphragm,ctrl
HCC_10T,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 47, stage IIB, HPV 16",pert
cell type: Primary hepatocytes;	donor: 5;	agent: control;	time: 24h;	gender: Male;	age: 73 years old,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/19;	hybridization date: 09/06/29;	colon length (mm): 6;	colon weight (mg): 155;	colon ratio (mg/mm): 2.58;	myeloperoxidase activity (u/mg): 1.35;	tissue: colon;	treatment: 5% DSS,ctrl
disease unaffected colon of a adult with ulcerative colitis (UC).,pert
"age at diagnosis: 35;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet + 7mg quercetin from B.S & S.,;	Tissue: Liver",pert
Neural progenitor cells,ctrl
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N3b;	er: 1;	pgr: 0;	dfs-month: 65;	dfs-event: 0;	distant metastasis: 0",pert
"Lymphoblastoid cell lines derived from family 1727, member 1",pert
source tissue: lung;	strain: Insig1 flox/flox /Insig2 -/- ( AT2 cells obtained from 2 months old SpC-rTTA / Otet-CRE / Insig1 flox/flox / Insig2-/- mice treated with doxycycline from E6.5 to E12.5. Control animals lacked either SpC-rtTA or Otet-CRE);	cell type: Alveolar Type II,ctrl
tissue: Epididymal adipose;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 719,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shCHK1-4,pert
chip number: 4;	transfection plate: 1;	target gene: E2F1;	kd level: 0.77;	rin: 9.8;	transfection date: 2011-03-29,pert
WT_T. gondii-infected_5dpi_ileum,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 4 hour",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 8.5;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 45;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
"Metastatic, prostate cancer",pert
Weight:High;	CFstatus:knockout;	Sex:Male,pert
"A pool of two pure subsets of peripheral blood CD8+ T cells (CD19- CD3+ CD4- CD8+ CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
heart fasted,pert
gender: female;	age (years): 60;	evolution time (years): 29;	disease extension: Pancolitis;	treatment: 5-ASA,pert
"immortalized cells derived from brown fat tissue of PGC-1alpha KO mouse (mixed background), expressing a siRNA specific for PGC-1beta knockdown.",pert
U2-OS-ERa,pert
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: vehicle;	genotype/variation: fl,ctrl
tissue: white blood cells;	age: 5;	Sex: male,ctrl
1000uM H2O2 rep3,pert
type_of_rx: AF;	pre_or_post_treatment: pre;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,ctrl
tissue: Hippocampus;	age: 77;	Sex: M,ctrl
cell line: bj-ipsc_1: BJ normal human fibroblasts (CRL-2522) were from ATCC and reprogrammed to iPSC with the protocol defined below,ctrl
"wild-type Nrf2 mice, liver sample",ctrl
Sex: male;	Age: 13;	SL: 6.36;	House: 1;	Severity: SS;	Ashworth: 4;	Zancolli: 3;	PEFF: -5;	PESF: -90;	AEFF: -70,pert
"metastasis: none;	Stage: 1;	tissue: normal, homogenized",ctrl
Tissue: HepG2 Cells;	Gender: Male;	Source: ATCC,pert
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: Rybp-KO,pert
EB_2_5d_218_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"Gender: female, Age: 43 years, Tissue: normal vulva,",ctrl
Klf9 wild type (Klf9WT) mice jejunum; Age: PND 30,ctrl
Hdh+/Hdh+ cerebellum at 3~10 weeks biological rep 4,ctrl
"Patient  H, lesion, 12 week",pert
strain: C57BL/6J;	day: 15;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 1,pert
olfactory bulb,ctrl
CD11b+Gr1+ cell sample_4 (derived from IL17RC Knock out mouse),pert
C6star_CLP_wildtype_8,ctrl
Mouse liver tissue,ctrl
231/ARF-2_2,pert
"Age: 56;	Sex: M;	Ancestry: African;	Smoking status: smoker, 80 pack-years",pert
Rybp#15 (OHT+)_12d,pert
phenotype: moderate glaucoma;	gender: female;	strain: DBA/2J;	tissue: optic nerve head;	age: 10.5 months,pert
RNA from whole tissue section of case 280 labeled with Cy5,pert
tissue: testis;	gestational age: 20 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: corn oil vehicle,pert
"Biceps, FSHD, cohort 21, subject 21A",pert
ventricular tissue,ctrl
cell line: lymphoblastoid cell line;	family id: 1727;	coriell cell line repository identifier: GM14481;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
genetic modification:;	tissue: breast adenocarcinoma,pert
phenotype: control;	gender: male;	case_id: 366;	age: 69;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 16;	brain ph at time of freezing: 6.6;	labeling_batch: 2,ctrl
"primary mucosal tissue,  colon",ctrl
cell line: NG4;	cell type: embryonic stem cells;	transfection: siUbr5,pert
Patient: L;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
"disease group: Psoriasis;	Sex: f;	age: 30s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 6.6;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 140;	ige (kiu/l): normal (0-48.5 kIU/L): 18.2;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.13;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
E12.5 heart,ctrl
original diagnosis: Psoriatic;	cell type: Peripheral blood mononuclear cells,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 2 month;	treatment: fresh air, treatment over 2 month, 4x1h exposure per day",pert
"tissue: neurectoderm derived from embryonic stem cells;	treatment: Geminin knockdown, shRNAmir #9;	cell line origin: derivative of ES-E14TG2a (ATCC);	genetic background: 129P2 (formerly 129/Ola)",pert
systolic heart failure due to ischemic cardiomyopathy,pert
cell type: HUVEC;	treatment: RAF1 WT,ctrl
Insm1 mutant #6_pituitary gland,pert
agent: Control,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: SOX2 shRNA;	time: day 3,pert
subject id: 42;	infection: DENV;	status: DF;	tissue: whole blood,pert
"General population, Male",ctrl
strain: C57BL/6;	tissue: Skin;	cell type: keratinocyte;	gender: female;	age: E18.5;	genotype/variation: Control;	treatment: calcium,ctrl
Convalescence samples,pert
"Cultured ovarian cancer cell line TYK-nu, Cisplatin treated",pert
scan batch: Batch 1;	group: autism;	subject age: 3;	paternal age: 26;	maternal age: 24,pert
gender: Male;	tissue: Tendon;ECRB;	age: 48;	donor: 9;	disease state: Lesional,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Female,ctrl
age: 66;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"Organism: Homo sapiens (human) Morphology: lymphoblast;	Source: Organ: bone marrow;	Disease: chronic myelogenous leukemia (CML) ;	Age: 53 years ;	Gender: female ;	Cytogenetic Analysis: The stemline chromosome number is triploid with the 2S component occurring at 4.2%. Fifteen markers (M1 and M(15)) occurred in nearly all S metaphases. Spontaneous non-specific dicentrics occurred, but rarely. Unstable markers were also rarely seen. The X was disomic, and N9 was nullisomic. ",ctrl
"Liver, wt control",ctrl
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 145;	time: 0;	batch: 4,ctrl
"Tibialis anterior, TMD",pert
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 50.55616,pert
Brain,ctrl
strain: C57BL/6J;	genotype: HDC-EGFP;	age: 7 months;	tissue: colon tumor;	cell type: CD11b+Gr-1+ myeloid cells in the tumor stroma,ctrl
disease state: healthy (non EBS);	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,ctrl
"heart, atrial tissue, baseline",ctrl
Patient identifyier: P;	Sex: male;	Age of patient: 76 years;	Duration of psoriasis: 56 years;	Body surface area: 15 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: minimal (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
age: 62;	gender: male;	ejection fraction: 51;	left ventricular end diastolic diameter: 73;	inflammation/PVB19: positive,pert
3 day LAD ligated heart from MRL/MpJ strain,pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: 64;	gender: male,ctrl
mononuclear cells isolated from bone marrow,ctrl
"Mouse organ of Corti from cochlea, basal half, Dicer1 conditional knockout",pert
Normal gastrocnemius,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 24 yr;	population: white;	dsm-iv: 295.9;	age of onset: 20 yr,pert
PBMC from T cell Large granular lymphocyte leukemia patient#110,pert
"gender: Male;	age: 75;	post-mortem delay: 9h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 1,ctrl
strain background: 129/B6 hybrid;	cell type: embryonic stem cells;	genotype/variation: wild-type control,ctrl
mouse NB N1E-115 cell line,pert
subject id: 6;	infection: DENV;	status: DF;	tissue: whole blood,pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Male;	Age of onset (years): 17;	Duration of illness (years): 12;	Brain pH: 6.70;	Post mortem interval (hours): 60;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
"Distal, Small Intestine 21 days old",ctrl
"Age: 44;	Sex: M;	Ancestry: European;	Smoking status: smoker, 45 pack-years",pert
Hep G2 treated with Nickel (II) chloride hexahydrate,pert
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days adipocyte differentiation,pert
EB_6_6h_287_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
EB_6_8d_300_HCHO_Nasal_Rat230_2_CIIT05024,pert
background mouse strain: C57BL/6;	source: mouse embryonic fibroblast;	genotype: Rap1 knockout,pert
"H1 hESCs, control",ctrl
"LY2 cell line, SRC-1 scrambled untreated, biological rep3",ctrl
cell line: BaF3;	infected with: MPLW515L3;	pretreated with: normal condition (Naïve);	treated with: DMSO for 4 hrs;	sample type: control,ctrl
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 400 mg/kg,pert
"female Spargue-Dawley rats, 9-cis-retinoic-acid, 100 mg/kg diet for 7 days,  tissue: liver",pert
"differentiated U937 cells, 1uM curcumin treated, 18h",pert
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD8+ T-cells,ctrl
Pre-Frontal cortex of naïve AChE-S mice,pert
strain: 129S6 x CBA/CaJ;	tissue: cochlea;	genotype: wild type;	age: P60,ctrl
Mouse Retina at P7,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 40;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: post-UV,pert
BM CD34 CELLS,ctrl
Retina,ctrl
cell line: Reh;	transfection: control shRNA;	malignancy: non-Hodgkin lymphoma,ctrl
age: 91;	post-mortem delay: 4.5h;	ph: 6.3,ctrl
RAW 264.7 macrophage cell line,ctrl
sex: Male;	Age: 6 months;	additional patient information found in Series supplementary file,pert
Psoriasis-9 baseline,pert
"gender: female;	batch: 1;	age (years): 55;	patient id: Severe_1;	fev1 (% predicted): 82;	fvc (% predicted): 105;	medication: Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd;	cell type: CD8+ T-cells",pert
DH 3,pert
Cadmium_00hr,pert
cell line: HL-60;	replicate: Replicate2;	treatment: shLuciferase,ctrl
cell line: Lung Epithelial Cell Line MLE15;	genotype/variation: Grhl2 knockdown,pert
"NB4 cell line, TG2 knockout, untreated",ctrl
Zmpste24-/- mouse embryonic fibroblasts (P3),pert
"liver, fed 1% quercetin diet for 14 days",pert
tissue: Biceps muscle;	patient: P.b.4;	diagnosis: Pompe;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 10m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,pert
knockdown: Control;	cell line: 92.1,ctrl
8 wk old male mdx gastroc,pert
Gender: Female;	AJCC Stage: III;	Pathological T: 3;	Pathological N: 1;	Pathological M: 0;	Grade: poor;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 68;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
HCC_12N,ctrl
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b retrovirus,ctrl
quadriceps_muscle_Wt_female_35wk_rep3,ctrl
strain: FVB;	genotype: E2F2 null;	tissue: mammary gland tumor,pert
CD11b+Gr1+ cell sample_4 (derived from wild type mouse),ctrl
monocytes,ctrl
"24hr Hic-5 siRNA, 16hr vehicle treatment replicate 2",pert
Knock-out postnatal day 10,pert
multiple sclerosis_1,pert
cell line: SKBR3 resistant;	treatment: 1uM Lapatinib,pert
strain: C57BL6/J;	genotype/variation: Sfrp5 KO (Q27Stop);	gender: male;	age: 12 weeks;	diet: 8 wks of high-fat diet;	tissue: gonadal white adipose tissue (WAT),pert
"metastatic, prostate cancer",pert
"Cell type: endothelial, age:42, gender:male, diagnostic group: schizophrenia, PMI:19h",pert
mouse intestine pLagl2 wild type 1,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 25 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
mortality: alive;	ethnicity: African American;	gender: M;	age (yrs): 24;	tissue: Normal_Kidney_Biopsy,ctrl
"fatty (fa/fa), liver",ctrl
Tendon;Teres minor_Non-lesional,ctrl
b-catenin deficient BxPC3 clone 4,pert
"endometrial stromal cell - Jag1 retrovirus infected2, 3 days post infection",pert
17beta estradiol: 60 pM,pert
patient liver biopsy,pert
disease state: healthy;	tissue: tibialis anterior;	age at biopsy: 80;	Sex: male;	individual identifier: 2,ctrl
chip number: 16;	transfection plate: 3B;	target gene: EP300;	kd level: 0.72;	rin: 9.5;	transfection date: 2012-03-26,pert
tissue: breast;	normal/tumor: tumor,pert
human subcultured chondrocytes (passage 2) from OA donors maintained for 14 days in scaffold culture,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: tumor;	sample name: 1-tu2,ctrl
tissue: Hodgkin lymphoma;	cell line: KM-H2,pert
"MCF-10A cells, shRNA vector control",ctrl
cell line: SUM149,pert
"ID:5-3, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",ctrl
"Pancreatic tumor cells, replicate 5",pert
tissue: Frontal cortex;	age: 80;	Sex: M,ctrl
Ebs at Day2.5 were treated with Activin for 2 h,pert
NB4 PROMYELOCYTIC CELLS,ctrl
"affected status (disease state): control;	gender: female;	age-at-examination: 65;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
EE_IB_1_his_lcm,pert
Subtype: RARS;	Karyotype: normal,pert
"C5_transgenic but unaltered, lung tissue",pert
age: 48;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
gender: Male;	age (y): 36;	tissue: prolactinoma,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 62, stage IIIB, HPV 45",pert
Gender: Male;	AJCC Stage: I;	Pathological T: 2;	Pathological N: 0;	Pathological M: 0;	Grade: moderate;	Tumor Site: Cecum;	Drug Treatment: NO,ctrl
patient: 32054;	disease state: LGSC;	component: Invasive,pert
Healthy-10 baseline,ctrl
HepG2 human hepatocellular carcinoma cell line,pert
"wild type naïve CD4 positive cell, unstimulated, replicate 2",ctrl
affected sister,pert
"Ctip2 knockout mouse striatum, postnatal day 0",pert
Time:0 day; condition:LaminA ko;,pert
age: 68;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
strain: C57BL/6;	Sex: Female;	age: 3-weeks old;	genotype: CF,pert
Strain: BALB/c;	Age: postnatal day 0;	Genotype: Ctip2 null mutant,pert
strain: C57BL/6J;	day: 15;	drug: Saline;	phase: Withdrawal;	tissue: striatum;	replicate: 2,ctrl
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of N-nitrosodiethylamine,pert
unused donor heart with normal LV function,ctrl
PBMC CCo T0,ctrl
"PCOS, biological rep 4",pert
subset: HDAC2 siRNA subset;	cell line: HCC cell line Huh7;	treatment: HDAC2 siRNA,pert
"tissue: lung, lower lobe;	lung source: explant;	phenotype: advanced idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 64",pert
At Risk: +;	Age: 18;	Sex: M,pert
"129P3/J Saline treated, biological replicate 3",ctrl
Scrambled 12 hours_3,ctrl
Vector expression uninfected,ctrl
"Quadriceps muscle, control mouse",ctrl
cell line: HCT116;	clone: 28;	genotype: Knockout,pert
"breast, flash-frozen, microdissected ductal tumor cells",pert
strain: 131;	Disorder: normal;	Condition: no hydrocortisone,ctrl
Differentiation of hES cells line VUB03_DM1 towards neural rosettes;	Neural precursor phenotype,pert
cell type: colorectal cancer cells;	cell line: HCT116 cells;	genotype: STAG2 knockout clone 21 (STAG2 deficient),pert
subject: 2;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
"RNA from 3 MCF7 cell culture plates treated with vehicle (ethanol 0,3%).",ctrl
"Female (age range 33-49), skin biopsy taken from upper nates no nickel exposure",ctrl
genotype/variation: wildtype;	strain: C57BL/6;	age: newborn,ctrl
cell line: H1299;	agent: decitabine;	dose: 1 uM,pert
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: wild-type;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),ctrl
cell type: peripheral blood mononuclear cells;	disease state: healthy control,ctrl
siRNA COP1 scanned on 07/21/10,pert
Pool stratagene human,pert
phenotype: alcoholic;	gender: male;	case_id: 322;	age: 56;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 30;	brain ph at time of freezing: 6.13;	labeling_batch: 1,pert
Gender: Female;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 2;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: NO,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: RNF40;	differentiation state: 2 days osteoblast differentiation,pert
alveolar macrophages from bronchoalveolar lavage,ctrl
"Deltoid, FSHD, cohort 19, subject 19A",pert
Prostate cancer cell line,pert
SV589 15 Day KD Serum Starved-> 1hr EGF,pert
lung from Cmah KO mouse,pert
Bone marrow,pert
PBMCs from CIS patient after IFNb-1a in-vivo treatment,pert
Strain: C57BL/6J;	Gender: female;	Age: 7 weeks;	Tissue: whole brain,ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 63;	sex: F,ctrl
patient: 25;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
genotype: WT;	agent: DMSO,ctrl
patient: 30277;	sample: tumor,pert
subject id: 43;	infection: DENV;	status: DF;	tissue: whole blood,pert
Universal Human Reference RNA - Cy3,ctrl
hOB695_shRB1383_4hr_IR,pert
"WT mice, 6 weeks old",ctrl
Disease_status: Healthy control;	Age (years): 49;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.72;	Post mortem interval (hours): 45;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
untreated untrMurine 3T3-L1 cells,ctrl
testis,pert
braak stage: BR34;	rin: 75;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
"Mybf/w Cd4-Cre Tcra-/- DP, biological rep3",pert
Flp-InTMT-RExTM-293 (Invitrogen) cell line derived from the human embryonic kidney cell line HEK293 carrying tetracycline inducible transgene,pert
"patient: 111;	current medication: Paracetamol;	birth date: 9/5/82;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: FH of CD, Path Increased lymphiod in TI Bx.;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
PolyRF-,pert
"MCF-10A cells, overexpression vector control",ctrl
strain background: C57BL/6;	genotype/variation: WT;	cell type: sorted Ter119+CD71+ bone marrow cells,ctrl
Stroma associated to prostate invasive tumor,pert
Karyotype: normal;	Age: unknown;	Gender: unknown,ctrl
purified Gfp+ photoreceptor cells,ctrl
quadriceps_muscle_Wt_female_8wk_rep2,ctrl
Neonatal mouse ovaries cultured in Methoxychlor (50uM),pert
IMR-32,ctrl
MLL_PTD11,pert
cell type: induced pluripotent stem cells,ctrl
Substantia nigra,pert
"FACS-sorted Lin-, c-kit+, Sca-1+ HSC from the bone marrow of PU.1 knockdown mice with targeted disruption of the distal enhancer (URE) –14kb upstream of the PU.1 gene.",pert
E1 clone infected with control retrovirus.,ctrl
"Liver, untreated, rep3",ctrl
Murine prostate,pert
Peripheral blood mononuclear cells;	TTF=105min;	Race=White;	Sex=Female,pert
SV589 NoKD Serum Starved-> 1hr EGF,pert
sample 1;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male,ctrl
SK-MEL-2 melanoma cell line,pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/+;	tissue type: renal tissue",ctrl
EA_Control_CD20,ctrl
T-ALL Cell line,ctrl
"44B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"Patient  L, lesion, 1 week",pert
2-3 month old animal with brain-specific IκBα deletion ( IκBαfl/-;Nestin-Cre),pert
"t16, surgically resected from patient of gastric cancer.",pert
H1 hESCs,pert
cell type: E14 murine embryonic stem cells;	genotype: Zfp322a Knock-down cells,pert
cell line: H69;	treatment: TGX221,pert
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: Treg;	treatment: unstimulated;	genotype: WT,ctrl
"9837, control, skin fibroblasts",ctrl
tissue: Biceps muscle;	patient: C.b.2;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 1y 11m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
Endometrium-Normal 10,ctrl
"cultured human airway smooth muscle, no treatment, replicate 4",ctrl
T4,pert
"WT mouse embryonic fibroblasts, unstimulated, 4 hours",ctrl
"disease group: Nonatopic Control;	Sex: f;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: YES;	eosinophil level (cells/ml): normal (120-300 cells/ml): 50;	ige (kiu/l): normal (0-48.5 kIU/L): 2.5;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
"BOEC, normal 8",ctrl
"TF-1 cells, pLKO, d2.5",ctrl
cell type: PBMC;	group: Patient;	patient treatment: Mtx,pert
patient: 267;	current medication: Mesalazine 800mg TDS;	birth date: 8/16/74;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/05;	diagnosis date: 5/10/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 8/15/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 9/20/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 9/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 5/1/03;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: ascending colon;	inflammation_status: Inflamed,pert
mouse B6xCF-1  RNAi transgenic,pert
"Gastrocnemius, Cmah KO, 2 months old",pert
status: Control;	gender: Male;	age: 67;	tissue: Blood,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 46;	donor: 29;	disease state: Lesional,pert
S6_Sham_wildtype_8,ctrl
"patient 12, left arm treated with pimecrolimus until day 22",pert
cerebellum_6 month,pert
"genetic background: B6;	genotype/variation: wildtype;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",ctrl
tissue: Frontal cortex;	age: 100;	Sex: F,pert
gender: male;	age (years): 20;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
status: Control;	gender: Female;	age: 55;	tissue: Blood,ctrl
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",ctrl
"C57BL/6, Female, CF",pert
"Deltoid, control, cohort 18, subject 18U",ctrl
"Human Umbilical Vein Endothelial Cell, Control, 0 hours",ctrl
early HCC,pert
"Distal and Proximal Large Intestine, 8week old mouse",pert
Wild type,ctrl
strain background: C57BL/6N;	genotype/variation: Stat1 delta alpha (da);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
Primary hepatocytes isolated from BalbC mouse strain treated with DMSO for 6h,ctrl
EB_0_6h_52_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,ctrl
HCC_18N,ctrl
cell line ATCC,ctrl
2i/LIF maintained Embryonic Stem Cell,ctrl
"gender: Female;	age: 94;	post-mortem delay: 9.5h;	ph: 6.3;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
gender: Male;	strain: C57BL/10;	genotype: WT;	tissue: Kidney;	surgery: Sham;	reperfusion time: 4hr,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient F;	treatment: DMSO for 48h,ctrl
gender: male;	strain: BL6/C57;	genotype/variation: A2BAR-/-;	age: 12 weeks,pert
GM9017,ctrl
mouse model: 3xTG-AD;	gender: female;	age: 14 months old,ctrl
strain: C57Bl6;	age: 4 weeks;	cell type: BCR-ABL1 transformed pre-B cells;	disease state: BCR-ABL1-driven ALL;	genotype/variation: Bach2 knockout,pert
WT S49 Cells 24h cAMP treatment,ctrl
"mouse aorta cross strain comparison, times 0, 4, 10, 24, 40 weeks",ctrl
human skeletal muscle from diabetic individuals after insulin therapy,pert
Genotype: wild-type;	Age: 6-8 weeks,ctrl
transgenic (LH-overexpressing) mammary gland,pert
HLA risk: High;	Height: 147 cm;	Weight: 58.9 kg;	BMI: 27.3;	Age: 9.9 years;	Gender: Male;	Race: White;	Glucose: 94 mg/dl;	HbA1c: NA,ctrl
tissue: Frontal cortex;	age: 55;	Sex: M,ctrl
Human skeletal muscle biopsy sample;	Patient #218 with NORM,ctrl
Age: 35;	Sex: M;	Ancestry: African;	Smoking status: non-smoker,ctrl
treatment: Vamp7 knockdown siRNA;	cell line: NTERA2/D1,pert
tissue: white blood cells;	age: 10.58;	Sex: female,pert
mRNA of substantia nigra from saline-treated mouse,ctrl
Ileum,pert
Mouse Spleen CD8 T cells,pert
A673 cell line that has been treated with cytarabine (ARA-C) for 24 hours with concentration of 0.34 uM (2 x EC50).,pert
"Wild type, snap frozen, diaphragm muscle, 7month age animal",ctrl
cell type: HVS-transformed T cells;	genotype/variation: ITK wild type,ctrl
"maternal exposure to vehicle, pitM",ctrl
"CA1, SOX7 expressing HESC - clone2",pert
cell line: RT112;	transduced: FGFR3 shRNA 6-16;	doxycycline treatment: no,pert
"vehicle treatment, 24 hour time point, biological replicate 1",ctrl
"CCM3 shRNA cells, passage 11",pert
"RET-PTC, 6 months",pert
kidney_colistin_treated,pert
HEK293-cells,pert
pooled reference mRNA from 4 harvests of ME16C cells,pert
batch: B;	knock-in: Twist-WT;	cell line: MycCap prostate cancer cells,ctrl
cell type: embryonic stem cell;	strain: 129/Ola;	developmental stage: E14;	genotype/variation: EGFP,ctrl
PBMCs from Ulcerative Colitis subject,pert
CD11b+Gr1- cell sample_2 (derived from wild type mouse),ctrl
35A;pretreatment;female;breast tumor,ctrl
Hodgkin lymphoma cell line KM-H2,ctrl
"gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
Intima media; control subject,ctrl
NHEK_scrambled siRNA_1.8mM Ca_48hr,ctrl
Epithelials cells isolated from mouse mammary glands with PtenF341V expression,pert
cell type: embryonic stem cells;	shRNA: shKdm2b;	shRNA sequence: CGCTGTGGAAATATCTGTCAT;	passages: p29;	strain: E14,pert
"C57BL/6J female number 1, 2 months old , whole ear tissue, untreated control ear",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 43;	maternal age: 36,pert
Strain: J1 Cell type: mouse embryonis stem cell,ctrl
strain: ICR/B6D2;	tissue type: back skin,ctrl
ancestral background: European-American (EA);	gender: Female;	subject condition: Systemic lupus erythematosus (SLE) patient;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,pert
treatment: EtOH + cycloheximide;	genotype: RARaKO;	cell line: F9,pert
tissue: Testis;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 143;	time: 0;	batch: 2,pert
"ID:12-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
timepoint: 2h;	drug: Saline;	group no.: 16;	large batch: X;	plate: 1957998115;	hybridization batch: I,ctrl
race: caucasian;	age (years): 51;	stage: IA;	grade: 1;	histology: endometrioid,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: gun shot wound,ctrl
Mouse otic vesicle at E10 mut,pert
tracheal tissue,pert
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal),ctrl
"Distal, Small Intestine 17 days old",ctrl
38A;pretreatment;female;breast tumor,ctrl
age_years: 53;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
"CD1, E15 pregant mouse",pert
p53R2 attenuated,pert
"brain, lateral and medial ganglionic eminences",pert
"Gender: Female, Age: 27, BMI: 21, Tissue: luteinized cumulus cells",ctrl
"Gender: female, Age: 16 years, Tissue: normal vulva,",ctrl
"age at diagnosis: 59;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N1a;	er: 1;	pgr: 0;	dfs-month: 25;	dfs-event: 0;	distant metastasis: 0",pert
"Patient #2, Untreated",pert
Characteristics:;	Organism: Rattus norvegicus;	Strain: Brown Norway;	Weight: 150-170 grams;	Tissue: liver;	Gender: male;	Sacrifice Time: 6 hours,ctrl
M833,pert
tissue: inner ear;	genotype/variation: Wild-type;	age: E10.5,ctrl
Patient: N;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: D3, mouse embryonic stem cell",pert
braak stage: CTRL;	rin: 72;	tissue: substantia nigra;	disease state: control,ctrl
Sample Group: HD patient; Gender: female; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,pert
NeuroD1 transgenic animals die very shortly after birth.,pert
LSK cells SRF KO 2,pert
sample type: test;	gender: male;	strain: ApoE-/-;	tissue: suprarenal aorta;	agent: control (saline);	time: 14d,ctrl
PBMC;	Age: day 3,pert
60A;pretreatment;female;breast tumor,ctrl
treatment: 12 weeks of RTX therapy;	gender: F;	age (y): 77;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Moderate-responder;	tissue: synovium,pert
"A pool of RNA from lung from three female mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks.",ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 70, stage IIB, HPV negative",pert
nTreg,ctrl
Epithelials cells isolated from mouse mammary glands with Wild-type Pten expression,ctrl
agent: untreated;	time point: 0 hr;	replicate: 2;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,ctrl
"liver, PPAR KO_ctr_115",pert
RPMI8226_shKDM3A#1,pert
"DBA/2J Saline treated, biological replicate 3",ctrl
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: colistin at 16 mg/kg/day in 2 divided doses;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: D;	experimental sample name: PC9-R,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M1;	flt3 status: internal tandem duplication (ITD),pert
CD8+CD28low regulatory T cells,pert
braak stage: BR12;	rin: 51;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
"vehicle treatment, 72 hour time point, biological replicate 3",ctrl
"patient: 213;	current medication: PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI;	birth date: 11/1/43;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/82;	diagnosis date: 2/2/83;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/12/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/12/04;	followup rectum: COLONOSCOPIC;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/74;	smoking amount: unknown;	other illnesses: ISCHEAMIC HEART DISEASE;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",pert
"Gastrocnemius muscle, WT mouse",ctrl
disease: cardiopathy;	gender: male;	age: 2 years;	tissue: thymus,ctrl
PC-3 human prostate cancer cell line,pert
patient: 128;	current medication: Pentaza;	birth date: 3/19/81;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 4/1/05;	indictation for procedure: IBS Type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
C1 clone infected with control retrovirus.,ctrl
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",ctrl
patient: 25;	disease state: hypertension;	tissue: Atheroma plaque,pert
age	34;	gender	male;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	6.3;	hemoglobin (g/dl)	14.5;	platelet count (/nl)	293,ctrl
skin total,ctrl
Errb mutant mouse stria vascularis,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,ctrl
alveolar macrophage from bronchoalveolar lavage,pert
PBMC CCa T1,pert
cell type: mouse embryonic stem cells 3x passaged without feeder cells;	genotype: TRPM7-/-;	genetic background: C57BL/6,pert
8- to 10-week-old male balb/c mice. tissue: whole liver,ctrl
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N2a;	er: 0;	pgr: 0;	dfs-month: 52;	dfs-event: 0;	distant metastasis: 0",pert
"H1299 treated with PBS buffer, 24hr",ctrl
42A;pretreatment;female;breast tumor,ctrl
Cervical cancer_892T,pert
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#5,pert
cell type: lineage depleted cord blood cells;	culture: liquid culture day 11;	transduction 1: BCR-ABL1;	transduction 2: control,pert
type_of_rx: AF;	pre_or_post_treatment: post;	response: SD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 56;	baseline tumor size (cm): 8x7;	patient id (to identify the 2 chips from the same patient): 16281659,pert
cell line: MLL-AF9 AML cell line 10980 (Zfx wt);	treatment protocol: vehicle;	genotype/variation: wt,ctrl
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: female;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,pert
"Mesodermal Precursor Cells derived from hES cells line VUB03_DM1, biological replicate 1",pert
tissue: Murine small intestine (jejunum);	genotype/variation: VillinCreERT2+_Brg1fl/fl,pert
"Gastrocnemius, mdx, 2 months old",pert
SV589_3Day KD_Serum Starved,pert
normal tissue,ctrl
INS-1 cell line #4a with induced HNF1b mutant A263insGG,pert
Psoriatic,pert
patient: 40892;	sample: tumor,pert
14-week-old Trim24-/- liver_411M,pert
age: adult;	gender: female;	tissue: lung,pert
Age: 36;	Cycle: Luteal;	BRCA1/2 mutation: NA;	Family History: No,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: DMSO for 72h,ctrl
Disease_status: Healthy control;	Age (years): 39;	Gender: Female;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.46;	Post mortem interval (hours): 58;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
umbilical cord tissue; low gestational age,ctrl
"Pancreatic tumor cells, replicate 3",pert
cell type: endometrial stromal cells;	growth phase: early passage,pert
Cell line: SUP-B15,pert
ICR MEF infected  with pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,pert
cell line: RWPE-1-PCAT-1 (CRL-11609);	age: < 20 cell passages from derivation,pert
"Strain: PolgD257A/D257A mice;	Gender: male;	Age: 9 month-old ;	Tissue: cochlea;	For additional details about the strain used please refer to the following reference:;	Kujoth, G.C. et al. (2005) Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309, 481-4.",pert
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 119;	genotype/variation: WT;	age: 8 weeks,ctrl
Dot1l flox/flox day 5 after transduction with control,ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Typical antipsychotic Haloperidol, Dose: 1.6mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking Water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#3,ctrl
"Pancreatic tumor cells, replicate 2",pert
tissue: neonatal foreskin;	cell type: primary dermal fibroblasts;	shRNA transfection: shKDM4C construct 2,pert
OV1002 Carbo Day2,pert
15d Dicer cKO,pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 32; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
"patient: 113;	current medication: OCP;	birth date: 8/17/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/14/04;	indictation for procedure: Recurrant abcess, ?IBD;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",ctrl
MLL_PTD01,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 29.04384,pert
"Spleen homogenate, uninfected",ctrl
"mouse embryonic fibroblasts, unstimulated, 4 hours",ctrl
age: 24 weeks postnatal;	tissue: cerebellum;	genotype/variation: Pink1 knockout,pert
genotype: wildtype;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,ctrl
chip number: 7;	transfection plate: 1;	target gene: ARNTL2;	kd level: 0.84;	rin: 9.7;	transfection date: 2011-03-29,pert
subject: 21U;	cohort: 21;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 63kb;	age (y): 48;	Sex: F;	batch: Batch_5,ctrl
2.5uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate C,pert
"strain background: 129/B6 mixed;	cell type: Ada3FL/FL MEF, immortalized;	infected with: control adenovirus",ctrl
gender: Male;	age: 56;	post-mortem delay: 16.5h;	ph: 6.4,pert
"Control #6, Untreated",ctrl
HdhQ111/HdhQ111 striatum at 3~10 weeks biological rep 2,pert
K562 cell line,ctrl
"MCF-7 cells, siGL3 treatment 72h, 10 nM E2 for 24h",ctrl
"MUSCLE, PLC, Before",ctrl
Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 24h,pert
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 1",ctrl
anterior pituitary,ctrl
E14.5 cKO 2,pert
eDeaf,pert
female;	29 yr old;	Hispanic,ctrl
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenloxP/loxP,pert
HL-60 cell line infected with GSK3A Construct 6 shRNA,ctrl
U2OS_shCHK1-4,pert
duration of untreated disease in month:6.6;	age at onset:6.1,pert
Sex: female;	Age at operation: 76 years;	Site: thigh;	Size in cm: 38.5x17.5x6;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,ctrl
cell line: shEGFP T47D;	sherbb3: -;	sample type: control,ctrl
cell line: THP-1;	shRNA construct: GSK3A Construct 6,pert
Cy3: Human Common Reference,pert
"Total RNA purchased from ADMET Technologies (Durham, NC), extracted from healthy liver tissue.",ctrl
"NALT infected with wild type 90-226, biological rep4",pert
Cervical carcinoma,pert
CD4_T_cell_pool_melanoma_M05+M06,pert
Transgenic ATF6-MER mouse;	Strain: C57 BL/6;	Gender: male;	Age: ~30wk;	Tissue: heart LV;	treatment: tamoxifen,pert
"Myeloid cell line, anti-Evi1 siRNA",pert
cells: Differentiated macrophages;	disease state: Ebola infected;	post-treatment: 6h;	donor: 2,pert
A39 NES 142Q TG4	F7/5	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 2,pert
"Distal, Small Intestine 17 days old",pert
pancreatic cancer cell line MiaPaCa2 stabley transfected with AGR2 overexpressing vector pCEP4 -AGR2,pert
"Control, replicate 4",ctrl
Skin biopsy from upper nates taken 48 hours after exposure to 5% nickel sulfate,ctrl
T47D breast cancer cells,ctrl
"Infected with H37Rv and treated with 1,25D, replicate 3",pert
"suprarenal aorta, non-dissected aneurysm, Ang II treated 7d",pert
"Female (age range 33-49), skin biopsy from upper nates taken 7 hours after nickel exposure",ctrl
clone type: AtT20 clone types overexpressing NSBP1SE protein rep3,pert
"D2_non-transgenic mice, lung tissue",ctrl
cell line: gastric adenocarcinoma AGS cells;	shRNA: 63 shRNA;	replicate: B;	genotype/variation: NET1 knockdown;	agent: no LPA (control),ctrl
Strain: C57BL/6;	Gender: Male;	Age: 8 weeks;	Tissue: Large Intestine (Distal and Proximal);	C57BL/6 Winnie G9492A,pert
resected non-tumor liver tissue,ctrl
cell type: embryonic stem cells;	shRNA: shScrambled;	shRNA sequence: CCTAAGGTTAAGTCGCCCTCG;	passages: p29;	strain: E14,ctrl
IkL/L mouse thymic tumor,pert
CTCF-depleted fully-grown GV oocyte from transgenic mice,pert
Insm1 control #1_pituitary gland,ctrl
patient: 110;	current medication: None;	birth date: 3/13/54;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/2/04;	indictation for procedure: Diarrhoea;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 6-2-01;	anatomic_location: terminal ileum;	inflammation_status: Uninflamed,ctrl
"Cell type: neuronal, age:32, gender:male, diagnostic group: control, PMI:13h",ctrl
Human CD34+ cord blood cells expressing BCR/FGFR1,pert
"age at diagnosis: 37;	diagnosis: Adenocarcinoma of breast, ductal, medullary features;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0 (i-);	er: 0;	pgr: 0;	dfs-month: 51;	dfs-event: 0;	distant metastasis: 0",pert
Female - caucasian - N-06-M,ctrl
A HID I_B048,pert
chip number: 18;	transfection plate: 4;	target gene: NFKB2;	kd level: 0.9;	rin: 9.4;	transfection date: 2011-10-17,pert
Kidney from mice treated with 7 daily iv injections of saline,ctrl
tissue: brain;	genotype: WT mix background B;	age: P14,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 110min;	race: Black/African American;	Sex: Male;	fstl-1 (ng/ml): 222,pert
race: caucasian;	age (years): unknown;	stage: IB;	grade: 3;	histology: papillary serous,pert
patient: 460A;	disease state: LGSC;	component: Invasive,pert
disease status: autism;	tissue (brain region): Cerebellum,pert
"Nrl-ko-Gfp, Gfp+ photoreceptor cells",pert
NPCs derived from healthy control subject,ctrl
cell line: rtTA-Dmrt5;	differentiation: 9 days;	treatment: -Dox,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 1,ctrl
phytohemagglutinin-activated PBMCs enriched for CD8+ cells from normal control subject K,ctrl
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
CD34+ cells of CML patient after 7 days of Glivec therapy,pert
cell line: A549;	agent: azacitidine;	dose: 1 uM,pert
Mock-treated A549,ctrl
"Human LIMA artery from patient 4, control (unstented)",ctrl
Cervical cancer_2035T,pert
PancreaticSample4-Tumor,pert
"female Spargue-Dawley rats, diet only for 7 days,  tissue: lung",ctrl
cell type: E9.0 embryonic cardiac progenitors,ctrl
cell line: Embryonic kidney cell line HEK;	genotype/variation: mutant channel;	agent: untreated,pert
colonoscopic biopsy from adult with affected colon with Crohn's disease,pert
"LCL GM19238, Kd NFKB2, 72hrs",pert
patient: 41027;	sample: normal,ctrl
siRNA-2-PLASTIC,ctrl
"Mdr2-KO homozygous mouse, 3 month old mouse, liver sample",pert
treatment: DMSO;	time: Day3;	cell line: Colo-205;	tissue: Colon cancer cell line;	array id: 9259561012,ctrl
"C57BL/6, CD-1",ctrl
race: african american;	age (years): 65;	stage: IC;	grade: 2;	histology: endometrioid,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 3",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 221,pert
"gender: female;	age: juvenile, 8 weeks (P58);	strain: Sv129 / C57BL/6N mixed background;	genotype/variation: Cldn16 +/-;	tissue type: renal tissue",pert
Normal_Kidney,ctrl
EE_IC_2_cauc_lcm,pert
cell line: ARPE-19;	clone: 25;	genotype: Knockout,pert
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: undifferentiated,ctrl
"LNCaP cells, treated with EtOH, biological rep 1",ctrl
Liver from 1 year old- TAK1 KO mice,pert
pancreas,pert
strain background: 129/SvEv;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,ctrl
patient: 51722;	sample: tumor,pert
"Patient GM, stable renal transplant recipients, female, 53 years old, T0 (time of enrollment)",ctrl
8- to 10-week-old male balb/c mice. tissue: whole liver,pert
"Extensor digitorum longus, TMD",pert
mutant Ndel ko/cko,pert
fibroblast,pert
Laser Capture Microdissection (LCM) to isolate tissue sections of the hippocampus area of Rasgrf1 knockout mice brains,pert
Wt MEF cycling cells,ctrl
strain: C57BL/6;	genotype/variation: RORasg/sg;	gender: male;	age: 5 Month old;	tissue: Liver;	diet: 35% Fat Diet (High Fat Diet; HFD),pert
"Normal cervix epithelium, microdissected, Age 43",ctrl
patient: 205;	current medication: Pentaza 3g/d;	birth date: 6/8/79;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/03;	diagnosis date: 8/30/04;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 4;	calprotectin: 0;	esr: 15;	crp: 19;	hb: 110;	wcc: 5;	neutrophils: 3;	albumin: 43;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: NEW;	smoking status: ex;	smoking start date: 1/1/85;	smoking stop date: 3/1/03;	smoking amount: 15-24;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,pert
age_years: 56;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
7 Day Mouse Diaphragm muscle,pert
RNA from microdissected breast cancer cells from case 317 labeled with Cy5,pert
agent: pristane;	time: 18 days;	strain: BALB/c;	tissue: mesentery,pert
cell type: Primary hepatocytes;	donor: 4;	agent: control;	time: 6h;	gender: Female;	age: 54 years old,ctrl
background strain: C57Bl6;	genotype/variation: Gata4_S105A_homozygous mutant;	age: 9 weeks old;	tissue: whole heart ventricle,pert
tissue: primary brain tumor;	cell type: glioblastoma;	age: 69;	gender: female;	tumor grade: IV,pert
A HID I_B044,pert
Disease_status: Healthy control;	Age (years): 47;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.81;	Post mortem interval (hours): 21;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"brain, motor cortex, fast spiking interneurons, wild type",ctrl
MGHU3 Cells_TAK1 siRNA + PD173074,pert
Parp-2 KO_bone marrow cells,pert
cultured human melanoma cancer cell 224,pert
Five-week-old C3H/HeN female mice liver,ctrl
WT mouse lung,ctrl
biopsy of Barrett's esophagus from the same patient as a matched normal esophagus biposy,pert
Actinomycin D treated A549 human lung cancer cell cultures replicate C,pert
"male,15,Caucasian",ctrl
"Tissue: Forebrain (left hemisphere), Strain: C57BL, Gender: Male, Age: 4weeks, Drug treatment: Atypical antipsychotic Clozapine, Dose: 12mg/kg/day, Route of treatment: Oral treatment-Drug added to drinking water, Period of treatment: 12 weeks, Method of sacrificing: cervical dislocation.",pert
patient: 225;	current medication: Asacol;	birth date: 5/30/76;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/03;	diagnosis date: 6/2/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/99;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
R3_saline_wildtype_48,ctrl
EE_IA_1_aa_lcm,pert
homozygous_TGFb_4hr_1,pert
PKCZ -/- male mice non-treated,pert
cell line: WM-266;	pir knock-down: yes,pert
"Patient #8, Untreated",pert
482 cells scrambledshRNA rep2,ctrl
Cochleae from wild type mice at P3,ctrl
A61 NES 142Q TG4	F5/1	A61	NES Htt exon 1 142Q	Mouse	8 months	Cerebellum	Male,pert
disease state: paediatric glioblastoma;	age: NA;	gender: NA;	h3.3_status: wt,ctrl
"human hepatoma cell line, Hep G2",ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: mCAR knockout;	ligand: phenobarbitol,pert
ES cell RNA,pert
liver endothelial cells,ctrl
L4/L5 dorsal root ganglia from adult rats (2 months old) 7 days after SNI surgery,pert
"rat hippocampus (combined dorsal and ventral aspects), young PIO, subject 5",pert
"strain: C57BL/6;	tissue: heart, left ventricle;	gender: male;	genotype/variation: Hsp22 WT;	stress: control",ctrl
HEL cell line_JAK2 knockdown (Jak2-10 shRNA),pert
treatment: PLX4720;	time: Day3;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
ATCC CRL-1555,ctrl
Myc(F/F);CreER CD8 T cells,pert
"MCF-7 cells, siGL3 treatment 72h, 10 nM E2 for 24h",pert
tissue: skin;	individual: Patient P7;	condition: ANL;	eczema severity: SCORAD: 0,pert
"LY2 cell line, SRC-1 siRNA untreated, biological rep2",pert
wt LSK,ctrl
EB_0_5d_61_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
dorsal skin from GR+/+ E18.5 embryo,ctrl
Strain: Btk KO/CBA were created by back-crossing Btk KO/SW129 mice on CBA background strain for 9 generations,pert
"ES cells: E14 (129P2/OlaHsd background),;	Genotype: Wild (Phgdh+/+), C57BL/6J background,;	Gestation: 13.5 days,;	Tissue: head",ctrl
Head RNA of Phgdh KO@E13.5 No.1,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 1,pert
gender: M;	age at blood draw: 32;	tissue: whole blood,ctrl
cadmium_16hr,pert
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ WT ES cells,ctrl
"whole right lung, 3 weeks after a bleomycin dose of 100mg/kg, given by osmotic minipump.",pert
NB4 PROMYELOCYTIC CELLS,pert
patient: 40875;	sample: tumor,pert
"LCL GM19238, Kd ARNTL2, 72hrs",pert
age at diagnosis: NA;	diagnosis: Within normal limits;	tumor grade: NA;	mininal stage grouping: NA;	t (extent of primary tumor): NA;	n (lymph node metastasis): NA;	er: NA;	pgr: NA;	dfs-month: NA;	dfs-event: NA;	distant metastasis: NA,ctrl
Anaplastic Thyroid Carcinoma,pert
age: 18 month postnatal;	tissue: cerebellum;	genotype/variation: Pink1 wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 208,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day1,pert
gender: male;	individual: patient 2;	treatment: paclitaxel-eluting stent,pert
cell line: AINV15;	strain background: 129P2/OlaHsd;	genotype/variation: Aurka;	condition: -Dox,ctrl
"RT4D6 Schwannoma cells, treated with wild type siRNA for Sox 10, 48 hours",pert
At Risk: +;	Age: 10;	Sex: F,pert
mouse embryonic stem cells,ctrl
Calreticulin knockout of mouse embryonic stem cell line,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 05/07/06;	# cells: 60;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
"striatum,18month,WT",ctrl
"male,23,Caucasian",pert
tissue: kidney;	protocol: intraperitoneal;	agent: vancomycin;	dose: 400 mg/kg,pert
Unaffected MZ twin pair 1 Repeat (Unaffected patient of MZ twin pair CCN1),ctrl
"Strain: SPARC-null, C57Bl/6 background;	Gender: female;	Age: 28 days;	Eye: Left",pert
"Ishikawa cell line, BPA, 1uM, 8hr",pert
minor salivary gland,ctrl
infection status: stably expressing shRNA directed against YAP;	cell type: human ccRCC cell line,pert
"Postnatal day 11 Cerebellum, wildtype",ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 62 years,ctrl
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: wild type,ctrl
Epithelials cells isolated from mouse mammary glands with Pten deletions,pert
Disease_status: Healthy control;	Age (years): 37;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.50;	Post mortem interval (hours): 13;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,ctrl
"T47D, sh2608",pert
"129/B6 background, 6-10 weeks",ctrl
Monocytes from buffy coat preparation,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.626;	OD280: 0.845;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 75;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
MPM tumor specimen 31,pert
primary leukemic cells purified from peripheral blood,pert
Post Transduction:12 hr; treatment:Mut;,pert
postmortem brain tissue,pert
"All mice (C57BL/6) were free of Helicobacter species, housed in a specific pathogen free facility with 12-h light/dark cycles with free access to standard food and water.",pert
subject: 09U;	cohort: 9;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 47kb;	age (y): 57;	Sex: F;	batch: Batch_2,ctrl
BTBR-ob/ob;	Liver ;	Age: 14 weeks;	Gender: Male,pert
DMSO treated MC3T3 mice,ctrl
PDAC_P_91,ctrl
NTG mouse heart left ventricle,ctrl
RV16;	Age = 18;	Sex = M,pert
disease state: healthy control;	tissue: epidermis;	age: 26;	gender: male;	treatment: untreated;	time: control,ctrl
human_hepatocyte_400uM_Ciprofloxacin_24hr,pert
Genotype: B6.Pdss2loxP/loxP;	Age: 213-day-old male;	40 mg liver used for RNA extraction,ctrl
Diagnosis: AML M0;	Age: 61y ;	Gender: Female;	Blast %: 94;	Source: PB;	Cyto: tris4;	FLT3 ITD: 0;	FLT3 TKD: 0,pert
OV1002 Control Day1,ctrl
gender: Male;	age: 82;	post-mortem delay: 5h;	ph: 6.2,pert
genotype: Villin-Cre + / Runx1-floxed;	strain: C57BL/6 background;	gender: male;	age (days): 81,pert
"Rat pups treated with acrylamide, sciatic nerve",pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
Rap1 knockout mouse embryonic fibroblasts,pert
Carotid atheroma plaque obtained from endarterectomy,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 3;	psoriasis duration: 3.8507871321013;	age of psoriasis onset: 30,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.678;	OD280: 1.857;	Ratio: 1.95;	Dilution: 1:5;	RNA Integrity Number: 7.5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 352;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
gender: Male;	cell type: hESC H1 cells;	genotype/variation: B2M KO,pert
"Lung, Familial Idiopathic Interstitial Pneumonia (F-IIP), Nonspecific Interstitial Pneumonia (NSIP)",pert
Skin biopsy from upper nates taken 96 hours after exposure to 5% nickel sulfate,pert
Sex: female;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 2;	psoriasis duration: 18.0;	age of psoriasis onset: 29,pert
cell type: Endothelial cell;	agent: ethanol;	dose: 0.1%,ctrl
"hMSC-Tert, control siRNA, undifferentiated",ctrl
batch: A;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
subject: 6;	disease: TD;	muscle: ST;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 12hr,ctrl
Ebs at Day2.5 were treated with SB431542 for 2 h,pert
gender: Male;	age: 54;	post-mortem delay: 12h;	ph: 6.6,ctrl
cell line: T47D;	sherbb3: -;	sample type: control,ctrl
tissue: Temporal cortex;	age: 87;	Sex: F,ctrl
strain: ICR;	agent: saline/distilled water;	time point (week end): 2;	disease state: normal,ctrl
KPL4 + Medi5117,pert
cell line: Melanoma Cell Line - A375;	treatment: 650nM MLN4924;	time: 8hr,pert
MGHU3 Cells_TAK1 siRNA,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep3",pert
phenotype: control;	gender: male;	case_id: 277;	age: 50;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Ex;	post-mortem-interval (hrs): 19;	brain ph at time of freezing: 6.26;	labeling_batch: 2,ctrl
duration of untreated disease in month:2.6;	age at onset:8.8,pert
patient: 30308;	sample: tumor,pert
strain: C57BL/6;	genotype/variation: KLF5 KO;	cell type: LSK BM cells,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 13 days;	treatment: fresh air, treatment over 5 month + 15 days recovery, 4x1h exposure per day",ctrl
PancreaticSample33-Normal,ctrl
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,ctrl
type_of_rx: AF;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 76;	baseline tumor size (cm): 7x8;	patient id (to identify the 2 chips from the same patient): 13491389,pert
gastric biopsies,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 35;	gender: male,pert
"liver, knock out",ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 45 yr;	population: white;	dsm-iv: 296.44;	age of onset: 35 yr,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.2;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 33;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 265,pert
PancreaticSample25-Normal,ctrl
cell line: NCI-H2009;	cell type: lung cancer cells;	transfected with: control hairpins targeting luciferase,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M2;	flt3 status: WT,pert
"Fibroblasts from UIP histology lung tissue, IPF-22",pert
sirt7 allele: wild-type,ctrl
sex: Male;	Age: 12 months;	additional patient information found in Series supplementary file,pert
strain: C57BL/6;	tissue: liver;	gender: female;	age: 35week,pert
"BOEC, at_risk 12",pert
"muscle, wild type",ctrl
Peripheral blood mononuclear cells;	TTF=120min;	Race=White;	Sex=Male,pert
Skin biopsy from upper nates taken 7 hours after exposure to 5% nickel sulfate,ctrl
Dysf +/+ control TA mouse muscle,ctrl
"liver, QH2, 14 months",pert
Human Sperm from an infertile male with a consistent severe teratozoospermia,pert
Brown Norway Control Liver,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",ctrl
normal donors,ctrl
"whole right lung, when moribund after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
cell line: Hep G2;	genotype: HCC-THRA mutant bN;	treatment: with 100 nM T3 for 6h,pert
strain: CD1;	tissue type: back skin,pert
cell line: U2OS;	cell type: osteosarcoma cells;	transfected with: nonspecific siRNA (SiNS);	treated with: dexamethasone (Dex) for 2h,ctrl
"genotype/variation: wildtype;	strain: mixed background (Gebuhr TC, Kovalev GI, Bultman S, Godfrey V, Su L, Magnuson T. The role of Brg1, a catalytic subunit of mammalian chromatin-remodeling complexes, in T cell development. J Exp Med. 2003 Dec 15;198(12):1937-49.);	age: P1",ctrl
Megacaryocyte-Erythrocyte Progenitors,ctrl
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
"Normal cervix, age 27 years, micordissected squamous epitheilium",ctrl
Proximal hindlimb bud tissue (~500um from base of limb bud) pooled from 3 embryos (6 limbs total).,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu3,pert
patient: 32;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
"SWR/J Acute morphine treated, biological replicate 3",pert
Primary hepatocytes isolated from Donor 4 treated with DMSO for 6h,ctrl
Gene expression profiling of normal cortex of patient T127,ctrl
HCT116 with NFX1-91 knockdown,pert
batch: B;	knock-in: VEC;	cell line: MycCap prostate cancer cells,ctrl
Wildtype white adipose tissue,ctrl
mutant_embryonic brain_posterior,pert
whole right lung,ctrl
primary normal lung tissue 1144,ctrl
patient: 18;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: P15;	genotype: Igf1 +/+,ctrl
strain: C57BL/6J;	day: 12;	drug: Saline;	phase: Drug treatment;	tissue: striatum;	replicate: 1,ctrl
HCT116 colon cancer cells,ctrl
E9.5 FVB/N erythroid cells-4,ctrl
splenocytes,pert
Human myeloid leukemia cell line,ctrl
HCC_2N,ctrl
Gender: Female;	AJCC Stage: II;	Pathological T: 3;	Pathological N: 0;	Pathological M: 0;	Grade: well;	Tumor Site: Ascending;	Drug Treatment: NO,ctrl
race: caucasian;	age (years): 60;	stage: IB;	grade: 1;	histology: endometrioid,pert
iFGFR2 mammary gland 8 hrs AP20187,pert
"Mouse organ of Corti from cochlea, basal half, littermate control",ctrl
"Autism no regression, Female",pert
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep1",pert
"H1 hESCs, OE-SOX2",pert
Human skin biopsy from psoriatic patient (uninvolved skin),ctrl
Septic shock;	gender: Female;	Survivor;	organism: None;	update,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 28;	gender: female;	years of disease: > 10y;	treatment: phototherapy;	time: post-UV,pert
"jejunum, control, 2",ctrl
A HID B_B014,pert
Rybp#15 (OHT+)_4d,pert
Strain:C57BL/6J;	Gender: male;	Age:2-3 months;	Tissue:heart,ctrl
disease: Down syndrome;	gender: female;	age: 1 year and 2 months;	tissue: thymus,pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 0 hours;	individual identifier: 211,ctrl
strain: C57BL/6x129Sv;	gender: female;	genotype: wild-type;	ligand: phenobarbitol,ctrl
Tiam1 silenced Y79 cells,pert
"t13, surgically resected from patient of gastric cancer.",pert
individual: Control2;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
EB_07_19d_155_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"cerebellum,6weeks,WT",ctrl
patient: 40741;	sample: normal,ctrl
treatment: Arid3a overexpression pool;	cell line: J1 ES cells;	sample type: pool,pert
control participant P318 (human CD3 positive T cells),ctrl
"29B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
untreated_6hr,ctrl
KO 2 Quadriceps,pert
age: 36;	sex: M;	disease status: control subject;	Filter number: 99;	Usage number: 5;	Exposures: 3,ctrl
Embryonic day 14.5 wild type (WT) mouse fetal liver,ctrl
tissue: primary skin cells;	genotype/variation: Adam10 wildtype,ctrl
strain: C57Bl/6;	cell type: Regulatory T-cells CD4+CD25+;	genotype/variation: Foxp3cre control,ctrl
Corl51 SCLC cel line,pert
cell type: human neuroblastoma cells;	cell line: SH-SY5Y;	clone: M;	transfectant type: stably transfected with scramble control,ctrl
cell line: SCC-2;	cell line origin: Oral cancer;	genotype/variation: ZMPSTE24 silencing,pert
"Total RNA, Tet2 KO CMP",pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 0 hrs;	time course: 3,pert
Gene expression profiling of normal cortex of patient 83,ctrl
"peripheral white blood cells, baseline",pert
"Bone marrow-derived macrophages, MyD88 -/-, Zymosan stimulated, 120 minutes",pert
cell line: non-small cell lung carcinoma cell line H1299;	protocol: Lipofection-mediated siRNA delivery;	time: 12hr,pert
tissue: white blood cells;	age: 8.38;	Sex: male,pert
Whole testis RNA from Crem-/- mouse #143 at 0h,pert
Strain: C57BL/6J;	Gender: M;	Age: 8 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,pert
strain: BALB/cByJ;	cell type: mouse embryonic fibroblasts (MEFs);	rift valley fever virus: infected,pert
sex: Male;	Age: 28 months;	additional patient information found in Series supplementary file,pert
sex: Female;	family: 5;	age: 57;	disease status: Asymptomatic;	tissue: Muscle: Biceps,pert
"Lymphoblastoid cell lines derived from family 1724, member 1",ctrl
Mannitol control treated A549 human lung cancer cell cultures replicate C,ctrl
"cell line: HeTH-4;	genotype/variation: THOC1-depletion;	comments: HeLa cell line with inducible THOC1-depletion, induced",pert
treatment: control esiRNA;	cell line: HeLa,ctrl
age: 35;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 4;	Exposures: 2,pert
disease affected colon of an adult with Crohn's disease (CD). Replicate-1,pert
cell line: Huh7.5.1;	tissue: liver;	agent: PBS,ctrl
CD3-stimulated CD4+ T-cells from Wt C57BL/6 mice,ctrl
Tissue: normal thyroid; Gender:male; Age:56,ctrl
Tissue: Spleen;	Type: Sham;	Strain: C57BL/6;	Batch: 12/1/03,pert
"sirna: siRNA1 (Ambion);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
"Granulosa Cell, 44-46hr PMSG",pert
"genotype Cldn16 +/+, renal tissue",ctrl
disease state: endometrioma;	patient: M4,pert
"24B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
primary CD4+ T cells from spleen and lymph nodes,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 3,ctrl
"age at diagnosis: 57;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIB;	t (extent of primary tumor): T2;	n (lymph node metastasis): N1a;	er: 0;	pgr: 0;	dfs-month: 1;	dfs-event: 1;	distant metastasis: 1",pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 2",ctrl
2008 ovarian cancer cells,ctrl
cell line: MCF7 breast cancer cells;	genotype/variation: estrogen receptor alpha (ESR1) knockdown,pert
cell line: SA-01;	treatment: with DMSO (0.1 % final),ctrl
chip number: 17;	transfection plate: 3B;	target gene: CREBBP;	kd level: 0.74;	rin: 9.2;	transfection date: 2012-03-26,pert
"Cultured ovarian cancer cell line HeyA8, untreated",ctrl
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue:	white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 25.86575,pert
age_years: 63;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
No_drug_#4876,ctrl
Ctrl PGC rep2,ctrl
"control + L-Arg colon tissue, biological rep2",ctrl
PC-3 cells,ctrl
SKI-DLCL cells were treated with Aplidin at concentration 3nM for 24h. Total RNA was extracted.,pert
"BOEC, normal 24",ctrl
"ID:8-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
"Proximal, Small Intestine 17 days old",pert
"primary fibroblasts expressing a shRNA construct targeting KDM4C, construct 2, clone 2",pert
gender: Males;	strain: C57/B6;	age: 3 months old;	tissue: Brain,pert
"SKO-transduced MEFs, Vc treated, lysed on D6",pert
"Cultured ovarian cancer cell line IGROV-1, untreated",ctrl
Aquaporin-11-/-_mouse P7 kidney #3-2,pert
Kidney from mice treated with 7 daily ip injections of vancomycin at 400 mg/kg,pert
gender: female;	age (years): 40;	evolution time (years): 13;	disease extension: Left-sided colitis;	treatment: Azathioprine,pert
CHF - R14,pert
male;	42 yr old;	Black,pert
tissue: colon;	genotype/variation: HDAC2 KO,pert
E12.5 Lim1 mutant renal vesicles isolated by laser capture microdissection.,pert
"MOLM-14 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
age: 69;	gender: male;	ejection fraction: 35;	left ventricular end diastolic diameter: 60;	inflammation/PVB19: positive,pert
gender: male;	batch: 1;	age (years): 39;	patient id: Control_1;	fev1 (% predicted): 78;	fvc (% predicted): 76;	medication: None;	cell type: CD8+ T-cells,ctrl
Y YOKE_B024,ctrl
HepG2 cell line from ATCC at 8th generation after 24 hours of PCB77 treatment.,pert
Peripheral Blood Mononuclear Cell (PBMC),ctrl
patient: 40899;	sample: normal,ctrl
28A;pretreatment;female;breast tumor,ctrl
Spleen and lymph nodes,ctrl
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 55;	gender: m;	treatment: NSAIDs/colchicine,ctrl
"Line A39 transgenic cerebellum, mouse, male, 10 months",pert
CD11b+Gr1+ cell sample_1 (derived from wild type mouse),ctrl
"DSS + L-Arg colon tissue, biological rep3",pert
RNA from microdissected breast cancer cells from case 868 labeled with Cy5,ctrl
"cell line: MDA-MB-231;	disease state: Breast adenocarcinoma, estrogen receptor-negative;	genotype/variation: MTDH_WT_KD",pert
"Female (age range 33-49), skin biopsy taken from upper nates 7 hours after nickel exposure",ctrl
Slow progressing fibrosis,pert
Primary hepatocytes isolated from BL6 mouse strain treated with Wy14643 for 6h,pert
cell type: induced pluripotent stem cell;	disease state: normal;	cell line: CRL-2429;	gender: male;	passage: P55;	clone: C11,ctrl
Postmenopausal female. Estradiol treated. Patient 23.,pert
Normal Uninflamed ascending colon,ctrl
cell line: Y79;	passage: 29;	cell type: Retinoblastoma,pert
iPSC derived from healthy control dermal fibroblast,ctrl
Strain:  B6.V-Lep ob;	Gender:  Female;	Age: 12 weeks;	Tissue:  Gallbladder,pert
"83 y/o male 46,XY",pert
age: 21 month postnatal;	tissue: striatum;	genotype: SNCA knockout,pert
patient: 105;	current medication: None;	birth date: 7/29/84;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/15/04;	indictation for procedure: IBS type symptoms;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
Sample ID: TP26;	Twin Pair ID: CCN4.2;	Clinical Status: Unaffected;	Age of Onset:-N/A;	Age at interview & blood sampling: 29;	Current Age (2007): 32;	Sex: FEMALE;	Medication at blood sampling : None,ctrl
initial tumor increase/(-)decrease: n/a;	kit mutation: exon 9;	tissue: GIST Tumor,pert
subjectid: 5278;	imatinib: NoIM;	lbh589: NoLBH,ctrl
disease state: paediatric glioblastoma;	age: 8;	gender: F;	h3.3_status: K27M,pert
"Patient  G, lesion, 2 week",pert
chip number: 1;	transfection plate: 1;	target gene: CEBPG;	kd level: 0.78;	rin: 9.8;	transfection date: 2011-03-29,pert
cell line: HEK293;	sirna: control;	condition: confluent cell density,ctrl
MCF10A-HER2(+) 3days,pert
GIST Tumor,ctrl
Normal Human Sperm,ctrl
scan batch: Batch 2;	group: autism;	subject age: n/a;	paternal age: 36;	maternal age: 38,pert
RNA from whole tissue section of case 140 labeled with Cy5,pert
strain: C57BL/6;	genotype: Cmah knockout;	tissue: heart;	age: 12 weeks,pert
"Soleus muscle, basal state, Ts65Dn",pert
"Patient CV, stable renal transplant recipients, male, 58 years old, T0 (time of enrollment)",ctrl
Muscle from a 5 month old wild type mouse,ctrl
cell line: SUDHL-1 Cells derived from the a patient with Anaplastic Large Cell Lymphoma;	agent: control,ctrl
Normal cervix_05-1352,ctrl
Cav1 knockout,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 3;	gender: male,pert
chip number: 16;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.66;	rin: 9.5;	transfection date: 2012-03-26,pert
MH1C1 cells untreated,ctrl
"SW480, control RNAi, luciferase",ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 72 hour time point,  biological rep 5",pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/10/05;	# cells: 93;	Sex: male;	region: M1;	age: 39;	genotype: Y/Mecp2-;YFPH/-,pert
rtTA-Dmrt5 day 9 +Dox,pert
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 51;	gender: f;	treatment: NSAIDs,ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 48 hours;	biological replicate: 1,ctrl
undifferentiated,pert
agent: Nickel 140 µM,pert
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.2;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 2;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 2,ctrl
caudate nucleus,pert
Normal cervix epithelium_CaCx4,ctrl
age: 28dpp;	genotype/variation: Ubb knockout;	tissue: testis,pert
Disease_status: Bipolar disorder;	Age (years): 29;	Gender: Female;	Age of onset (years): 18;	Duration of illness (years): 11;	Brain pH: 6.74;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
C1 clone infected with Deaf-1-expressing retrovirus.,pert
genotype: E-mu-BRD2;	cell-type: resting;	splenomegaly: none;	Ig clonality: polyclonal,pert
"NB4 cell line, wild-type, ATRA, 72hr",pert
bladder epithelial cells,ctrl
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 4",pert
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Ipsilateral,pert
"A pool of two pure subsets of peripheral blood CD4+ T cells (CD19- CD3+ CD4+ CD8- CD16- CD56-), stringently sorted by flow cytometry, from two age and gender matched healthy donors.",ctrl
triplicate 3 of S. aureus infected HepG2 nt cells,ctrl
Sprague-Dawley rat diaphyseal femoral fracture callus,pert
"Soleus, healthy control",ctrl
strain: C57BL/6;	cell type: MACS-purified mature B cells;	genotype: irf4+/+,ctrl
Skeletal muscle,pert
Retina,pert
"NALT infected with wild type 90-226, biological rep1",pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,pert
Sample Group: control; Gender: female; Age: 39; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
"TF-1 cells, shTRAF6, d2.5",pert
Superior Frontal Gyrus from a 2year-old girl not suffering from Rett Syndrome and therefore considered as a normal subject.,ctrl
"vertebral bone, WT",ctrl
tissue: resected non-tumor liver tissue;	genotype: major [rs8099917 TT],pert
"strain: C57BL6/10J;	genotype: Cmah KO, mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle",pert
sample: #3;	subject: Control case #2;	brain: T-346;	age: 84;	sex: Male;	region: Dorsal motor nucleus of the vagus,ctrl
Patient 7 appendix,pert
scram_hi_7,ctrl
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: Rosiglitazone,pert
strain: C57BL/6J;	day: 24;	drug: Heroin;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
P3A Progranulin-frontal,pert
EB_6_19d_308_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
"GV oocyte, control",ctrl
Rat spinal dorsal horn,pert
WA09 human embryonic stem cells,pert
peripheral blood from E12.5 Cbfb-/-  embryos,pert
"LCL GM19238, Kd RXRA, 72hrs",pert
patient: 223;	current medication: Prednisolone 20mg Asacol 2.4g;	birth date: 1/18/44;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 3/1/04;	diagnosis date: 3/15/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/16/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/16/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
race: caucasian;	age (years): 60;	stage: IA;	grade: 3;	histology: endometrioid,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT3B knockout, U0126-treated",pert
KGN,pert
strain: C57BL/6;	tissue: cerebral microvascular fragments;	genotype/variation: wildtype;	age: 2 months,ctrl
normal mammary tissue,pert
"Skin biopsy, normal",ctrl
5091212024_G,pert
Strain: C57BL/6JNIA;	Age: 15 months;	Gender: Male;	Tissue: Whole hippocampus,pert
cell line: MOLM-14;	replicate: Replicate2;	treatment: shSYK_2,pert
Strain: FVB;	Genotype: iFGFR1;	Gender: Female;	Age: 6 weeks;	Tissue: Mammary gland;	Treament: not treated,ctrl
cell line: H1299;	agent: azacitidine;	dose: 0.3 uM,pert
"Untreated LNCaP cells not stimulated with DHT, biological replicate 1",ctrl
PGC1-a KO striatum,pert
Wistar rat liver following animal exposure to orotic acid for 14 days,pert
mouse intestine pLagl2 wild type 2,ctrl
DS fibroblast,pert
cell line: MCF-7 breast cancer cell line;	sirna: control (scrambled siRNA);	agent: control (vehicle);	dose: n/a,ctrl
tissue: dorsal skin;	genotype/variation: GR+/+;	strain: B6D2/F1;	age: E18.5,ctrl
3T3 cells from cyclin D1KO mice infected with MSCV-D1a,ctrl
patient: 240;	current medication: Asacol 800mg BD;	birth date: 1/10/59;	gender: M;	ethnicity: ASIAN;	symptoms onset date: 8/2/04;	diagnosis date: 12/14/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/3/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/3/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
disease status: controls;	tissue (brain region): Temporal cortex,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M4;	flt3 status: internal tandem duplication (ITD),pert
Basal IFE cells isolated from 1 year old KO mice,pert
patient: 112;	current medication: None;	birth date: 7/5/81;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/7/04;	indictation for procedure: Altered bowel habit;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed,ctrl
"13B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
"metastasis: none;	Stage: 3b;	tissue: normal, homogenized",ctrl
sex: Female;	family: 3;	age: 35;	disease status: Control;	tissue: Muscle: Deltoid,ctrl
Whole pancreas,pert
EB_6_6h_283_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.708;	OD280: 0.892;	Ratio: 1.89;	Dilution: 1:5;	RNA Integrity Number: 7.8;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 298;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
Control siRNA transfected HeLa S3 cell,ctrl
subject id: c4;	infection: control;	status: control;	tissue: whole blood,ctrl
"C57BL/6J female number 3, 2 months old, whole ear tissue, untreated control ear",ctrl
IKK2 WT tumor,ctrl
"Patient  M, lesion, 12 week",pert
Strain: C57BL/6;	Age: E14;	Retrovirus: MSCV-GFP control,pert
strain: C57BL/6;	gender: male;	age: 10 weeks;	treated with: 0.1% saline twice daily;	tissue: kidney;	sentrix id: 8324341086;	sentrix position: C;	experimental sample name: PC5-R,ctrl
strain: C57/Bl6;	gender: male;	genotype: Egr-1 knock-out;	age: 42 days;	tissue: retina,pert
EB_07_24h_132_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
tissue: temporal lobe;	strain: C57;	genotype: WFS1 KO,pert
bladder cancer cells treated 48 hr,ctrl
patient E1614,ctrl
siRNA-1-COLLAGEN,pert
EB_6_19d_312_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
patient: 40728;	sample: normal,ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 41;	donor: 28;	disease state: Non-lesional,ctrl
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Stromal Cell,ctrl
age: 18 month postnatal;	tissue: striatum;	genotype/variation: Pink1 wild type,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Arhgap5;	tissue: spleen;	sample name: 5-sp1,pert
cell type: Primary hepatocytes;	donor: 4;	agent: Wy14643;	time: 6h;	gender: Female;	age: 54 years old,pert
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: depleted of EZH2;	treatment protocol: under hormone depleted conditions,pert
"Uninfected, replicate 1",ctrl
aorta of wildtype mice,ctrl
P5B Progranulin-cerebellum,pert
MCF10A-HER2(+) 1.5days,pert
Primary human erythroid progenitor cells expressing HDAC1 A3 shRNA,pert
Strain: C57BL/6J;	Gender: male	;	Age: day3;	Genotype: KO;	Tissue: brown fat ,pert
"NIH3T3, 0 h",ctrl
Gender: Female;	AJCC Stage: IV;	Pathological T: 4;	Pathological N: 0;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
"Pool of two samples (n=2);;	gender: one female/one male;;	age: 70/64 years old;;	cells: CD3+ T cells, peripheral blood;;	disease: (severe) aplastic anemia (SAA)",pert
CSTB KO_cerebellum at P30,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Supraoptic nucleus,pert
"SiRNA-scrambled, replicate 2",ctrl
E13.5 Wnt1-Cre;Tgfbr2 Conditional Knockout Mouse Model Primary Palate Mesenchyme collected after 2 passages in culture,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 52;	gender: male,ctrl
control E14,ctrl
strain: C57BL/6;	genotype: Wild Type;	replicate: 2,ctrl
HLA risk: High;	Height: 183 cm;	Weight: 93.5 kg;	BMI: 27.8;	Age: 57.76 years;	Gender: Male;	Race: White;	Glucose: 104 mg/dl;	HbA1c: NA,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: internal tandem duplication (ITD),pert
8 with Cy5,pert
hepatocytes treated with 0.1% DMSO,ctrl
"-Rosi, -PPAR, 2hrs",ctrl
"Sodium arsenite added to food: None; Injection: None; Diet: LRD-5001; Sodium arsenite added to drinking water: 100 ppb, 5wk",pert
"24hr Hic5 siRNA, 16hr 10nM DHT treatment replicate 1",pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATM-1,pert
Sex: Male;	strain: C57Bl/6;	tissue: Skeletal muscle;	age: 24 months;	genotype: Myc heterozygous,pert
scc_11,pert
diagnosis: UIP/IPF;	fvc-group: FVC3;	tissue: lung,pert
cell type: HUVEC;	treatment: empty lentiviral vector pLVX-IRES-puro,ctrl
"Liposarcoma culture from tumor 392, untreated",ctrl
"mouse embryonic fibroblasts derived from WT mice, I",ctrl
HEL cell line_JAK2 knockdown (Jak2-9 shRNA),pert
An XDP Filipino (aged 52 yr),pert
patient: 51572;	sample: tumor,pert
cell line: SV589;	knockdown (days): 3;	treatment: Serum Starved; 3h EGF,pert
MCF7 cells treated with 2uM Doxorubicin for 24 hours Array 2,pert
OCUBM,ctrl
duration of untreated disease in month:13.6;	age at onset:2.5,pert
embryonic stem cell,pert
strain: F1 littermate of TCL1 (C3H/B6) and ID4+/+ (CD1) mice;	genotype/variation: ID4+/+TCL1-tg;	tissue type: spleen;	cell type: CD19+ B;	age of the mice: 1 month old,ctrl
strain: C57Bl/6;	genotype/variation: Notch2 KO;	cell type: cDC;	cell type subset: CD11b+,pert
HeLa cell,pert
"""female subject, 18-45 yrs, peripheral blood mononuclear cells 30 min after intravenous endotoxin challenge""",pert
Abca1 +/- mouse liver,pert
"twin pair: #4;	individual: healthy;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",ctrl
"Postnatal day 11 Cerebellum, wildtype; replicate 2",ctrl
race: caucasian;	age (years): 53;	stage: IC;	grade: 3;	histology: endometrioid,pert
Aortas isolated from atherosclerotic APOE-deficient mice,ctrl
"42B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tetracycline inducible Ngn3 ESC differentiated for 3 days as EB without doxycycline,pert
"BT474-J4 breast cancer cell line, DMSO",ctrl
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 30;	maternal age: 29,ctrl
cell line: KJD;	transformation: SV40 virus transformed;	cell type: epidermal keratinocyte,ctrl
OVSAYO ovarian cancer cell line,pert
cell type: Primary human epidermal melanocytes (neonatal),ctrl
"ERRa ko ventricle, baseline",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.644;	OD280: 1.383;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.2;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 68;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 12 hour",pert
race: caucasian;	age (years): 57;	stage: IC;	grade: 2;	histology: endometrioid,pert
8 wk old male C57BL10 quad,ctrl
subject: 09A;	cohort: 9;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 25kb;	age (y): 31;	Sex: F;	batch: Batch_2,pert
cell line: REH E/R positive leukemia;	treatment: treated with specific E/R targeting shRNA,pert
Age: 46;	Cycle: Luteal;	BRCA1/2 mutation: BRCA2 C5910G;	Family History: Yes,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 52 yr;	population: white;	dsm-iv: 295.1;	age of onset: 28 yr,pert
PBMC CV T0,ctrl
WT_P14_D3_Effector,ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 siRNA;	treatment: tamoxifen for 120 min,pert
subject: 37;	disease: CP;	muscle: ST;	gender: M;	age: 8.7;	gmfcs: 2;	popliteal angle: 95,pert
WT_cerebellum at P7,ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: OCT4 shRNA;	time: day 4,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
"strain: C57BL/Ka-CD45.2:Thy-1.1;	genotype: wild-type;	tissue: bone marrow from femoral and tibial bones;	cell type: LSK (Lin-, Sca-1+, c-Kit+) cells",ctrl
"disease state: Nasopharyngeal carcinoma;	stage: IVA, T4, N2b, M0, G4",pert
"epidermoid carcinoma, cell line",ctrl
Strain: 129Sv (PPARalpha knockout);	Gender: male;	Age: 14 weeks;	Tissue: small intestine,pert
"Human hepatoma cell line (HepG2), grown for 6 or 12 hours, and then total RNA harvested with Trizol and Qiagen Rneasy kit.",pert
chip number: 12;	transfection plate: 4;	target gene: IRF3;	kd level: 0.91;	rin: 9.5;	transfection date: 2011-10-17,pert
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 2",pert
gender: female;	age (years): 60;	evolution time (years): --;	disease extension: --;	treatment: --,ctrl
human subcultured chondrocytes (passage 2) from OA donors,pert
Bone Marrow,ctrl
non tumorigenic human breast epithelial MCF10A cell line: Vehicle_rep3,ctrl
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 2;	gender: male,ctrl
"Biceps, control, cohort 09, subject 09U",ctrl
MLL_00268,pert
U-87MG,ctrl
Placenta_PE(LO)3 with Cy5,pert
PDAC_T_104,pert
strain/background: C57BL/6;	gender: male;	age: postnatal day 9;	tissue: right hippocampus;	treatment: mild stress + saline vehicle,pert
tissue: pancreas;	cell type: epithelial cells;	disease status: intraductal papillary-mucinous carcinoma (IPMC),pert
Neural progenitor cells,pert
"male, 275-300g",ctrl
Postmenopausal female. Untreated control. nr 12.,ctrl
tissue: kidney;	protocol: intravenous;	agent: vancomycin;	dose: 50 mg/kg,pert
cell type: CD8 T cells;	transduction: shRNA targeting Egr2;	tissue: tumor;	sample name: 3-tu2,pert
"age: 41;	sex: M;	ancestry: African;	smoking status: smoker, 20 pack-years",pert
"Control, replicate 9",ctrl
15A;pretreatment;female;breast tumor,ctrl
NET1 knockdown AGS cells treated with 10 microM LPA for 4 hr,pert
lesional skin bioposy obtained from patient after 3 days of treatment,pert
sMPNST cells with Brd4 shRNA induction,pert
splenic CD11c+ dendritic cells,pert
EB_6_8d_298_HCHO_Nasal_Rat230_2_CIIT05024,pert
strain: Hnf4LoxP/+AlfpCre;	age: E18.5;	tissue: Fetal Liver,ctrl
Age: 39;	Cycle: Luteal;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
"ID:14-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
"Fibroblasts from UIP histology lung tissue, IPF-19",pert
QK-knockdown U87 transduced with miR-20a,pert
"CBP, p300, CH1, TAZ1, hypoxia, MEF",ctrl
cell line: MGHU3;	cell type: malignant urothelial cells;	genotype/variation: FGFR3 Y375C mutation;	transfected with: 5ug TAK1 siRNA,pert
cell type: bone marrow derived mast cells;	genotype: NTAL wild type;	genetic background: C57BL/6;	treatment: lentiviral infection - NTAL knock down;	vector: pLKO.1/TRCN0000127243;	activation: none,pert
pSuper vector control 1,ctrl
genotype: Pxr knockout;	Sex: Male;	tissue: Liver;	compound: Vehicle;	route: IP;	dose: 0 mg/kg,pert
MEF,pert
tissue: retina;	age: postnatal day 8;	genotype: rd1,pert
"Patient  H, lesion, 4 week",pert
treatment: control,ctrl
batch: B;	knock-in: Twist-AQA;	cell line: MycCap prostate cancer cells,pert
cell line: HT1080;	clone: 8;	genotype: Knockout,pert
disease status: CML chronic phase (CP);	cell source: leukapheresis products (LP);	cell type: CD34+ mononuclear cells,pert
"LCL GM19238, Kd HCST, 72hrs",pert
normal skin sample,pert
condition: Psoriasis;	patient: 292;	tissue: LS skin biopsy;	kit: Ovation,pert
Wt,ctrl
wild type mouse retina at age postnatal day 6,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 76 years,ctrl
human bronchial smooth muscle cell_vehicle_24h,ctrl
strain: ICR;	agent: AOM/DSS;	time point (week end): 20;	disease state: colorectal adenocarcinoma,pert
"LKR13, knockdown of Wt1 by shRNA",pert
tissue: kidney;	protocol: intraperitoneal;	agent: saline;	dose: 0 mg/kg,ctrl
"diet: AIN-76A;	sodium arsenite added to drinking water: 10 ppb, 5wk",pert
age: 48;	sex: F;	disease status: Marfan subject;	Filter number: 33;	Usage number: 1;	Exposures: 4,pert
HEK cell lines non-expressing WT channel,pert
"G392E, no doxycycline",pert
lung Endothelial cells,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 220,pert
embryonic stem cells,ctrl
12h control (2);HT-29;colon:carcinoma;NONE;42995,ctrl
passage: 10;	cell type: fibroblast;	treatment: overexpressing prelamin A treated with FTI;	cell line: GM00038,pert
hOB695_shRB1383_24hr_IR,pert
age_years: 44;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 2,pert
Endometrium-Normal 5,ctrl
Stratagene Human Universal Reference Pool,pert
Mus musculus liver - wildtype,pert
"striatum,12weeks,WT",ctrl
cell type: CD43+/41+/235+ progenitors generated from Trisomy 21 iPSCs,pert
Strain: 129Sv/C57BL/6,pert
treatment: 1 ug/ml doxycyline;	time: 72 h;	cell line: A673;	transgene: doxycyclin  inducible EWS-FLI1 knockdown;	sample type: Asp14 Clone of Ewing's sarcoma A673 cell line with doxycyclin  inducible EWS-FLI1 knockdown construct,pert
Wt1f/f MEFs were infected with adenoviral Cre to knockout Wt1,pert
cell type: embryonic stem cells;	genotype/variation: Satb2 overexpression,pert
"""male subject, 18-45 yrs, peripheral blood mononuclear cells 6 h after intravenous saline challenge""",ctrl
wild type mouse stria vascularis,ctrl
"Calu3 human non-small lung cancer cells, gemcitabine resistant (Ligand)",pert
age	42;	gender	female;	disease	CML;	disease phase	chronic phase;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	5.4;	leukocyte count (/nl)	180;	hemoglobin (g/dl)	12.1;	platelet count (/nl)	476,pert
Cav3KO 1506,pert
Mouse wt palatal shelf tissue at E14.5,ctrl
tissue: Liver;	genotype: GPR120 KO;	treatment: high fat diet HFD;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 427,pert
cell line: DHL6;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 2h,pert
cell line: MOLM-14;	shRNA construct: GSK3B Construct 2,pert
mutant mouse embryonic kidney day 12.5,pert
Striatum of 8-10 week old 129P3/J mice,pert
"mortality: alive;	ethnicity: Hispanic;	gender: F;	age (yrs): 58;	ld: HCV;	creatnine: 1.4;	mdrd: 41;	gfr: 39;	protein: 0;	hematuria: 0;	c3: 1;	c4: 1;	rf: 102;	hcv: POS;	htn: 1;	dm: POS;	hba1c: 7;	meld: 15;	ana: NEG;	gp: MESANGAIL PROLIFEATION,Ig A nephropathy;	mm (mesangial matrix expansion): 1;	mc (mesangial cell increase): 0;	ii (interstitial inflammation): 0;	podocyte: 1;	bm (basement membrane thickening): 1;	ta (tubular atrophy): 2;	if (interstital fibrosis): 2;	as (arteiosclerosis): 2;	igg: 1;	iga: 3;	igm: 2;	c: 0;	empe: 2;	bmwid: 1;	bmd: 0;	edd: 0;	no of glomeruli: 31;	glomerulosclerosis: 0.13;	intact t: 0.5;	arteries: intimal fibrosis,duplication n widening;	if: IGG+IGM+IGA+++C1Q+ mesangial only IgG and focal capillary walls;	mesangium ig: A;	tissue: Kidney_Biopsy_Liver_disease",pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: n/a;	maternal age: n/a,ctrl
"non-transgenic mice, 7 month old, male",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 33.34247,pert
Female - caucasian - N-05-G,ctrl
iFGFR1 mammary gland 24 hr AP20187,pert
MCF7 cells treated with 2uM ARC for 24 hours Array 1,pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 69;	gender: m;	treatment: NSAIDs,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 11/13/06;	# cells: 124;	Sex: male;	region: LC;	age: 39;	genotype: Y/Mecp2-;TH/-,pert
lung_myd88_mock_repC,pert
cell line: HCC1954 cells;	subtype: HER2 Positive;	treatment type: TBK1 inhibitor II;	treatment time: 3 Days,pert
patient: 259;	current medication: pentaza 2g D;	birth date: 9/20/78;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 8/1/03;	diagnosis date: 1/13/04;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/7/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/7/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/03;	smoking amount: 5-14;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
patient E1709,pert
treatment: control;	cell line: CuFi;	genotype: Cystic Fibrosis deltaF508 mutation,ctrl
SV589_8Day KD_Serum Starved -> 3hr EGF,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 95min;	race: Asian;	sex: Female,pert
"HtrA2 KO mouse cortex, P29",pert
cell type: peripheral blood mononuclear;	disease state: multiple sclerosis,pert
WM35 cell line,pert
"peripheral white blood cells, matched control",ctrl
58A;pretreatment;female;breast tumor,ctrl
Murine liver,pert
cell line: HEK293;	sirna: control;	condition: sparse,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 72;	tissue: Blood,pert
S46 NLS 142Q TG4	F5/12	S46	NLS Htt exon 1 142Q	Mouse	3.5 months	Cerebellum	Female,pert
strain: C57BL/6;	tissue: colon;	genotype: PPAR g fl/fl; Lysozyme M cre+;	phenotype: PPAR gamma deficient;	treatment: dextran sodium sulfate (DSS),pert
Extract:LOX-1:113401;	Extract Description:GFP_Untreated_12hr:113401;	Quality: Classification:Good;	Quality: Gradient Severity:0.03;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.56;	Quality: Background Mean Dev.:0.03;	Quality: Absent (%):57.6;	Quality: Absent (%) Dev.:0.5;	Quality: Scaling Factor:0.61;	Quality: Scaling Factor Dev.:0;	Pretreatment [C]:GFP;	Time point [C]:12 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:113401;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:GFP_Untreated_12hr;	RNA extraction source key [A]:282295713,ctrl
lineage: colorectal;	cell line: SW480;	treatment: none,ctrl
"Patient  J, lesion, 1 week",pert
age: 24;	sex: M;	disease status: Marfan subject;	Filter number: 98;	Usage number: 4;	Exposures: 3,pert
EB_0_6_352_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 51 yr;	population: white;	dsm-iv: 296.44;	age of onset: 23 yr,pert
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 15.0;	age of psoriasis onset: 32,pert
Normal cervix epithelium_03-4986,ctrl
UC Uninflamed terminal ileum,pert
"UM-UC-3 bladder cancer cells, stably transfected with GFP-tagged RhoGDI2, biological replicate B",pert
age: 43;	sex: M;	disease status: control subject;	Filter number: 80;	Usage number: 4;	Exposures: 3,ctrl
Septic shock;	gender: Female;	Survivor;	organism: Staph aureus,pert
"Sv129/C57B6 hybrid strain, 12 week old male",ctrl
pLenti transduced cell lines overexpressing CDH1a,ctrl
Whole adrenal RNA from WT mouse #145 at 0h,ctrl
Epidermal keratinocytes treated with EphB2 for 24h,pert
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 54,pert
patient: KPW13;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,pert
Wistar rat liver tissue following animal exposure to orotic acid for 3 days,pert
Gastrocnemius muscle PPARalpha overexpressing transgenic mouse,pert
Gender:male,ctrl
MCF-7cells treated with 100 nM 4-hydroxytamoxifen and scrambled siRNA,pert
parental cell line: WC;	vector: pBabe-human v-src (v-src vector);	replicate: 3,pert
Strain: C57BL/6J;	Gender: male;	Age: 9 weeks;	Tissue: whole brain,ctrl
cerebellum,pert
transitional E-mu-BRD2 mediated lymphoma,pert
cell line: HEK001,ctrl
"0.5 mg/kg/ml Isoproterenol treatment, 24 hour time point,  biological rep 3",pert
iFGFR1 mammary gland 8 hrs AP20187,pert
genotype/variation: Pou4f1-/-;	agent: control virus;	tissue type: fetal liver,pert
sample: #1;	subject: Control case #1;	brain: T-199;	age: 82;	sex: Female;	region: Dorsal motor nucleus of the vagus,ctrl
Normal,ctrl
Embryonic Stem Cell,pert
Gene expression profiling of normal cortex of patient T166,ctrl
KO MEF,pert
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: C57BL6-STAT1<tm1Dlv> (STAT1KO);	treatment: stimulated for 3 hours with medium alone,pert
strain: C57BL/6;	cell type: bone marrow-derived mast cells;	treatment: interleukin 3,ctrl
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 13 days;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 15 days recovery, 3x1h exposure per day",pert
"Lymphoblastoid cell lines derived from family 1733, member 1",pert
KSL cells from Runx1-knockout mice (Runx1floxed/floxedMxCre+/-),pert
Human Fresh Bronchial Epithelial cells,pert
Testis,pert
"Liver, untreated, rep2",ctrl
iFGFR1 mammary gland 24 hrs AP20187,pert
Notch2 f/f CD11c-cre C57Bl/6,pert
Panc-1 Pancreatic Cancer Cells,ctrl
"seminoma specimen, pT1, patient age: 29y",pert
"suprarenal aorta, control, saline treated 14d",ctrl
"Frontal cerebrocortex, deltamethrin (3 mg/kg), 6 hours",pert
Whole brain,ctrl
Chemically-induced skin papillomas in K14CREER:SOX2fl/fl mice treated with tamoxifen for 1 week,pert
1% dmso batch 2,ctrl
SUDHL-1 cell line,ctrl
placenta,pert
Du145-PCAT1 cells transfected with cMyc siRNA #4,pert
c-Kit + MA9 AML Zfx fl,ctrl
Lung Normal,ctrl
Biopsy 7 from cystectomy 15,pert
cell line: HEK293T;	transfection: si-control;	induction agent: Wnt3A;	induction time: 7 hours,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,ctrl
UC Uninflamed sigmoid colon,pert
Human Neural Stem cell line(Maternal transcript),ctrl
Primary chondrocytes; Wt; total RNA,ctrl
Jejunum,pert
MCF10A cells in 3-D culture,pert
"patient 8, baseline",ctrl
HL-60 cell line infected with GSK3A Construct 6 shRNA,pert
cell line: Z138;	cell type: mantle cell lymphoma (MCL) cells;	shRNA: shSOX11.1,pert
"C57BL/6N, adult, male",ctrl
cell line: Reh;	transfection: CBFA2T3 shRNA;	malignancy: non-Hodgkin lymphoma,pert
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#2,pert
Primary human monocytes,pert
age: 36;	gender: female;	ejection fraction: 68;	left ventricular end diastolic diameter: 47;	inflammation/PVB19: negative,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: ascending colon;	inflammation_status: Uninflamed",ctrl
"Gender: male;	Age: 74;	Source: skin, left ear",pert
LNCaP-control,ctrl
strain/background: C57BL/6;	genotype/variation: Csbm/m;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: a SD supplemented with 100 mg/kgchow resveratrol ad libitum,pert
"gender: female;	batch: 1;	age (years): 54;	patient id: Severe_5;	fev1 (% predicted): 44;	fvc (% predicted): 61;	medication: Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn;	cell type: CD8+ T-cells",pert
1uM H2O2,pert
Sample Group: control; Gender: male; Age: 50; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
genotype: wildtype;	strain: C57Bl/6;	cell type: HSC,ctrl
NONE_72,ctrl
Psoriasis-6 baseline,pert
strain: C57BL/6;	gender: male;	genotype/variation: CCRPKO;	treatment: phenobarbital;	tissue: liver,pert
cell line: PC-3;	transfection: pre-miR-221,pert
Peripheral blood mononuclear cells;	TTF=135min;	Race=White;	Sex=Male,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M2;	flt3 status: D835 mutation,pert
sirna: control;	plate: plastic;	cell line: MCF10A,ctrl
23 Day Mouse Diaphragm muscle,pert
206_DMSO,ctrl
Heart of 10 weeks old mice,ctrl
"Human breast, pre AFI treatment",ctrl
cell line: SNU-398;	cell type: Hepatocellular carcinoma (HCC);	genotype/variation: scrambled control,ctrl
strain: C57BL/6J;	cell type: bone marrow derived macrophage,ctrl
No_drug_#4882,ctrl
"WT male mice, water",ctrl
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with osteoarthritis",ctrl
30 day LAD ligated heart from MRL/MpJ strain,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 12h;	culture batch: 1;	bead chip array sentrix code: 4421339032,ctrl
strain: CD-1;	age: 20 week;	genotype: Wild type;	tissue: lung,ctrl
strain: C57BL/6;	tissue: quadriceps_muscle;	gender: female;	age: 8week,pert
treatment: Untreated,ctrl
status: Rheumatoid Arthritis Patient;	gender: Male;	age: 49;	tissue: Blood,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 2;	psoriasis duration: 13.2375085557837;	age of psoriasis onset: 8,pert
Bone marrow from naive C57BL/6 mice,pert
"Cervical cancer, adenocarcinoma, microdissected, age 46, stage IB2, HPV 16",pert
Normal skin from Tgfbeta_control mouse,ctrl
PBMC GM T0,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Control;	time: day1,ctrl
control_00hr,ctrl
"MDA-MB231 cells, control",ctrl
HCT116 human colon cancer cells with intact PTEN,pert
tissue: freshly isolated human monocyte;	gender:female; age: 19 yr; weight: 65 kg,ctrl
"n09, surgically resected from patient of gastric cancer.",ctrl
background strain: C57Bl6;	genotype: Polgtm1Lrsn-/-;	tissue: Mouse bone marrow;	age: 32 weeks;	gender: female,pert
"glioma cell line U373, EGFP expressing",ctrl
patient: 127;	current medication: Prednisolone 10mg Heparin Questran Gabapentin FA;	birth date: 9/9/36;	gender: M;	ethnicity: JEWISH;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/29/05;	indictation for procedure: Pseudomembranous Colitis;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
MLL_00107,ctrl
Skeletal muscle tibialis anterior (TA) from Normal wild-type mice,ctrl
age: 69;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
"twin pair: #2;	individual: diseased individual, inflamed;	tissue: primary mucosal tissue,  colon;	mean age: 31.5",pert
Reference RNA e17.5 embryo,ctrl
"whole right lung, when moribund after a bleomycin dose of 100mg/kg, given by osmotic minipump.",pert
Adolescent mouse tumor sample,pert
NSC_FOXO_NULL-3,pert
MOLM-13 cells,ctrl
hOB695_shEV_2hr_IR,ctrl
CD34+ cells isolated from the bone marrow of an MDS patient,pert
patient: 23;	disease state: hypertension;	tissue: Atheroma plaque,pert
Old Control;	male,ctrl
RNA from microdissected breast cancer cells from case 342 labeled with Cy5,pert
subject: 18A;	cohort: 18;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 21kb;	age (y): 36;	Sex: F;	batch: Batch_4,pert
"HSCs from female mice treated with oil, replicate 3",ctrl
cell line: NB4;	genotype: wild-type;	treatment: all-trans-retinoic acid (ATRA);	time: 72 hours;	biological replicate: 2,ctrl
"Primary, localized, prostate cancer",pert
patient: 217;	current medication: Asacol 1.2g daily;	birth date: 2/9/57;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/10/79;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/26/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 11;	octn2: 11;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 11/26/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
tissue: skin;	individual: Patient P13;	condition: AL;	eczema severity: SCORAD: 51,pert
46A;pretreatment;female;breast tumor,ctrl
tissue: Biceps muscle;	patient: C.b.10.MELAS;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 9m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
"BOEC, at_risk 11",pert
Strain: Top2b+/+ in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,ctrl
"TNFa-OMe siRNA-B, replicate 4",pert
treatment: Oct4 knockdown;	cell line: J1 ES cells,pert
atopic dermatitis: mild-to-moderate AD;	tissue: skin biopsy;	peasi reduction [%]: 33,pert
agent: Cadmium 0.55 µM,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 40;	maternal age: 38,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient A;	treatment: Vemurafenib 1000 nM for 48h,pert
developmental stage: embryonic day E14.5;	strain: FVB/NJ;	tissue: fetal liver;	cell type: TER119-;	genotype/variation: wildtype,ctrl
"Brain tissue from Fisher 344 male rat, Animal #270, 5mg/kg D-Serine",pert
siRNA-3-COLLAGEN,ctrl
IKK2 -/- cell line,pert
murine colon epithelium,pert
sirna: Syk siRNA knockdown;	plate: plastic;	cell line: MCF10A,pert
hTERT-immortalized human skin fibroblasts,pert
AJCBDL,pert
1uM H2O2 rep 3,pert
"LCL GM19238, Kd ZBTB38, 72hrs",pert
disease state: Breast adenocarcinoma;	cell line: MCF-7;	sirna: siERK2;	agent: EtOH;	time: 24h,pert
>95% CD3+ T cells negatively isolated with Dynal kit,pert
"Strain: B6CF1 x C57BL/6, Tissue: Bone marrow, Age: 7 weeks",pert
"SBC-5 cells, siEGR4 (target), 24 hr after siRNA, duplicate sample 1",pert
Testis,ctrl
BV2_rep2,ctrl
strain: C57BL/6;	cell type: mononuclear bone marrow cells;	treatment protocol: Evi1 retroviral transduction,pert
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5a;	flt3 status: WT,pert
"Lymphoblastoid cell lines derived from family 1717, member 2",pert
Cell line: TOM-1,pert
Mc3T3 cells_treated with AA_5 days,pert
"Frontal cerebrocortex, permethrin (10 mg/kg), 6 hours",pert
"MCF10A cells, Her2 and Myc over-expression",pert
ethnic background: Caucasian;	gender: male;	age: 45-65 years;	tissue: vastus lateralis muscle,ctrl
Lineagelow Sca1+cKit high Cells,pert
scan batch: Batch 1;	group: control;	subject age: 9;	paternal age: 26;	maternal age: 33,ctrl
"gender: female;	batch: 1;	age (years): 42;	patient id: Severe_8;	fev1 (% predicted): 33;	fvc (% predicted): 94;	medication: Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium;	cell type: CD4+ T-cells",pert
"array type: Affymetrix Mouse 430_2,;	amount: 5ug;	bioanalyzer results: Good;	cell type: RAW 264.7",ctrl
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
strain: C57BL/6x129Sv;	gender: female;	genotype: hCAR transgenic in mCAR knockout background;	ligand: corn oil,pert
strain: C57BL/6;	cell type: cytotoxic T-lymphocytes (CTL);	genotype/variation: PDK1 null,pert
Head RNA of Phgdh Knockout@E13.5 No.4,pert
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.09 uM (EC50).,pert
Patient: I;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
Male BALB/c deficient in Il1rn,pert
Alveolar type 2 cells_Alcohol ingestion,pert
"31B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
background strain: B6/129;	genotype/variation: mir-122 knockout;	age: 14 Month;	tissue type: Tumor,pert
phenotype: alcoholic;	gender: male;	case_id: 313;	age: 70;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 62;	brain ph at time of freezing: 6.82;	labeling_batch: 2,pert
con-37,ctrl
GFP_Untreated_2hr,ctrl
Mouse Tibialis Anterior 4 weeks post birth,ctrl
"brain, cerebellum, Purkinje cells, Mecp2 null",pert
30A;pretreatment;female;breast tumor,ctrl
cell line: RUES2;	cell type: human embryonic stem cells;	transduced with: control shRNA;	time point: Day 5 of cardiac differentiation; cardiovascular progenitor cell stage,ctrl
Primary lung tumor,pert
"Patient  N, lesion, 2 week",pert
"Mus musculus (backcrossed to C57BL/6J mice for 5+ generations);	Scd1 wild type mouse, chow diet, liver",ctrl
mammary epithelial cells,pert
"MCF7 cells stably transfected with pCDNA3.1, passage 2",ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:60;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
strain: C57BL/6;	genotype: Ppif-/- (global gene knockout);	tissue: heart;	age: 8 weeks,pert
Diagnosis: AML M4;	Age: 67y ;	Gender: Male;	Blast %: 75;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: No data,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 47 yr;	population: white,ctrl
strain: 129/Sv,ctrl
"Setd2 knockout mESCs, biological rep1",pert
cell type: AML blasts from bone marrow;	set: training;	npm status: wild-type;	fab classification: M2;	flt3 status: internal tandem duplication (ITD),ctrl
duration of untreated disease in month:1.1;	age at onset:6.8,pert
individual: patient8;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 6",ctrl
"male,23,Caucasian",ctrl
coc-8,pert
HeLa cells transiently transfected with control siRNA,ctrl
human prolactinoma,pert
Human fibroblast,ctrl
"Wildtype, 129 mouse pineal glands from postnatal day zero.",ctrl
tissue: breast cancer;	cell line: MDA-MB-231,pert
MCF-7 cells,ctrl
"C57BL/6J Acute morphine treated, biological replicate 2",pert
strain: C57BL/6;	genotype: WT;	gender: male;	age: 10-12 weeks;	tissue: liver;	resection_percent: 85%;	time_after_resection: 2 hours,ctrl
strain: C57BL/6;	cell type: MEFs;	genotype/variation: wild type,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 0 hours;	individual identifier: 218,pert
rat heart ventricle,pert
Cav1KO 1762,pert
cell line: lymphoblastoid cell line;	family id: 1743;	coriell cell line repository identifier: GM14533;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
strain background: 129/SvEv;	genotype/variation: STING knockout;	cell type: bone marrow derived dendritic cells (BMDCs);	stimulated with: purified tumor-cell derived DNA,pert
patient: 40975;	sample: tumor,pert
YFP-pos GMPs,ctrl
tissue type: normal thyroid;	matched/unmatched: unmatched,ctrl
WT CD80hi mTEC sample1,ctrl
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P0,pert
Hdh knock-in mice striatal cells,ctrl
liver,pert
MDA-231 cells,pert
RNA from whole tissue section of case 1206 labeled with Cy5,pert
patient: 51176;	sample: normal,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 10. Replicate A,pert
Disease_status: Healthy control;	Age (years): 51;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.70;	Post mortem interval (hours): 31;	Side of brain: Right;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,pert
27 weeks male,ctrl
tissue: whole blood;	condition: Unaffected control;	gender: Female;	batch: 2;	psoriasis duration: n/a;	age of psoriasis onset: n/a,ctrl
patient: 241;	current medication: Asacol 800mg bd Azathioprine 100mg;	birth date: 6/25/62;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 11/1/90;	diagnosis date: 11/11/91;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/10/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 22;	igr2198: 22;	igr2230: 22;	octn1: 22;	octn2: 22;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 3/10/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 5/30/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
Diagnosis: ET/AML;	Age: 51y ;	Gender: Male;	Blast %: 70;	Source: PB;	Cyto: Complex;	FLT3 ITD: 0;	FLT3 TKD: No data,pert
disease state: Normal,ctrl
chip number: 16;	transfection plate: 6;	target gene: USF1;	kd level: 0.79;	rin: 9.4;	transfection date: 2012-03-26,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 53;	sex: F,ctrl
wild-type double positive cells sorted from thymus of 8 week old mouse,ctrl
"Frontal cerebrocortex, permethrin (1 mg/kg), 6 hours",pert
age_years: 43;	sex: M;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 1,pert
age: 72;	sex: M;	disease status: control subject;	Filter number: 103;	Usage number: 4;	Exposures: 3,ctrl
cell line: RWPE-1;	cell type: Immortalized normal prostate epithelial cells.;	treatment: Vehicle (0.1% ethanol);	time point: 6 hours,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.808;	OD280: 0.956;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 77;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 46;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
B cells -  wildtype mice - influenza-infected,ctrl
tissue: peripheral blood;	cell type: primary leukemic cells;	individual: patient E;	treatment: Vemurafenib 1000 nM for 48h,pert
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
K562 cells CREB Knock-out,pert
patient: 34208;	disease state: LGSC;	component: Invasive,pert
cell line: KYSE70;	cell type: squamous cell carcinoma,pert
tissue: lung;	genotype/variation: Tmem1002loxP/2loxp,ctrl
Psoriasis-1 baseline,pert
strain: BALB/c;	gender: female;	type: TSG-6 knockout;	treatment: none,pert
wild type E12.5 fetal liver derived megakaryocytes,ctrl
cell type: granulosa cells;	disease: Polycystic ovary Syndrome,pert
treatment: PLX4720;	time: Day1;	cell line: HT29;	tissue: Colon cancer cell line;	array id: 9270006077,pert
primary dermal fibroblasts untreated,ctrl
rd1 mouse retina at age postnatal day 6,pert
Head RNA of Phgdh Knockout@E13.5 No.3,pert
Adipose from a 5 month old wild type mouse,ctrl
WT 2 Quadriceps,ctrl
"Reh, transient knockdown of CBFA2T3",pert
source: JAX stock # 000664;	strain: C57BL/6J;	tissue: retina;	age: P8;	genotype: wild type,ctrl
10A;pretreatment;female;breast tumor,ctrl
tissue: Lung;	strain: B6D2F1;	infection: Mtb;	time: 42 dpi,pert
mutant Ndel ko/+ mix background,pert
murine lymph node,ctrl
"RNA was prepared from papilomas of 2-3 mice (2 for WT and 3 for Knockout) and this was pooled to perform the array. Each pooled sample was run in triplicates.   The mice were treated once with DMBA, followed by TPA application for 30 wks.",pert
mortality: alive;	ethnicity: Asian;	gender: F;	age (yrs): 26;	tissue: Normal_Kidney_Biopsy,ctrl
cell line: non-small cell lung carcinoma cell line H1299;	protocol: control;	time: 24hr,ctrl
tissue: ankle joint;	genotype/variation: MMP-8 wild type;	strain: C57BL/6,ctrl
EB_2_5d_219_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
disease state: psoriasis;	group: baseline,pert
Cal51 cells,ctrl
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 75 years,pert
gastrocnemius muscle wild-type mouse,ctrl
empty retroviral vector-infected immortalized mouse embryonic fibroblasts,ctrl
IMR90 cells stably expressing H-RasV12 treated with vehicle,ctrl
cell type: Primary hepatocytes;	strain: NMRI;	agent: control;	time: 6h;	gender: Male;	age: 4 months,ctrl
cell line: U937;	cell type: histiocytic lymphoma;	genotype/variation: control;	agent: vehicle,ctrl
cell line: BxPC3;	genotype: wild type;	beta-catenin gene (ctnnb1): wild type,ctrl
Breast cancer,ctrl
White portion of the gastrocnemius muscle,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle/squamoid cell;	matched/unmatched: unmatched,pert
Untreated Myd88 knockout,pert
"Liposarcoma culture from tumor 394, untreated",ctrl
Strain: 129SV/EV;	Gender: Female;	Age: 8-12weeks;	Tissue: Lymph node B cell;	Noninfected;		,ctrl
Human skeletal muscle biopsy sample;	Patient #110 with NORM,ctrl
age: 29;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
WT fed  High Fat Diet,ctrl
Peripheral blood mononuclear cells;	TTF=85min;	Race=White;	Sex=Male,pert
MEFs carrying a tet-inducible Pten transgene,pert
tissue: liver tissue;	disease state: hepatocellular carcinoma tumor,pert
"tissue: lung tissue;	genotype: CD-1_Nrf2 -/-;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",pert
strain: B6.V-Lep ob;	gender: female;	age: 12 weeks;	tissue: gallbladder,pert
"ID:13-4, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",ctrl
A HID B_B090,pert
microdissected ovarian tumor,pert
"Inducible stable HEK 293 Flp-In T-REx Ero1alpha-C104A/C131A cells, expression induced with doxycycline for 24 h",pert
mouse full-thickness skin,ctrl
Tissue: lung,ctrl
strain: HNF4LoxP/LoxP AlfpCre;	age: E18.5;	tissue: Fetal Liver,pert
tissue: Liver;	genotype: GPR120 KO;	treatment: normal diet ND;	genetic background: mixed 129/Sv and C57BL/6;	subject: mouse 720,pert
Strain: C57BL/6; Tissue: liver;,ctrl
tissue: brain;	genotype: mutant Lis1 ko/cko;	age: P14,pert
SW480 cells,pert
U2-OS-ERb,pert
pooled reference mRNA from 4 harvests of MCF-7 cells,pert
Human glioblastoma cell line U87MG treated with a siRNA against CASP2,pert
"human ES cells line from AZ-VUB laboratory, Belgium; derived from normal embryos;	Karyotype: X,Y",ctrl
gender: Female;	age: 33;	cell type: PBMC;	individual: Patient 108;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
Bone Marrow,pert
cell line: LNCaP-abl (abl) prostate cancer cells;	genotype/variation: transfected with control siRNA;	treatment protocol: under hormone depleted conditions,ctrl
condition: Psoriasis;	patient: PS-J;	tissue: LS skin biopsy;	kit: Affy,pert
disease state: control;	organ: Brain;	tissue: Ventral midbrain;	sample type: Postmortem;	Cause of death: hypertensive cardiomyopathy,ctrl
"K562, NoTreatmentControl, 24hrs, rep2",ctrl
MLL_PTD05,pert
patient: 51315;	sample: normal,ctrl
Sample Group: control; Gender: female; Age: 68; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 1,ctrl
"gender: female;	batch: 1;	age (years): 45;	patient id: Severe_7;	fev1 (% predicted): 71;	fvc (% predicted): 105;	medication: Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline;	cell type: CD4+ T-cells",pert
cell type: Embryonic Stem Cells;	genotype/variation: Suz12KO,pert
NB64,ctrl
PancreaticSample7-Tumor,pert
individual: Control10;	disease state: control;	tissue: blood;	cell type: Sorted B cell,ctrl
cell line: MCF10A;	genome/variation: HER2 overexpression;	treatment group: untreated;	length of treatment (days): 1.5,pert
"4 weeks old PS-NA mice, cerebellum",pert
Normal liver control,ctrl
cell type: dermal fibroblast;	genotype: healthy control,ctrl
kidney_saline_control,ctrl
Primary hepatocytes isolated from Donor 6 treated with DMSO for 24h,ctrl
cell type: myoblast;	transduction: lentiDUX4short,pert
sex: Male;	Age: 7 months;	additional patient information found in Series supplementary file,ctrl
"Nuclear RNA, HuR WT MEFs",ctrl
Rat skeletal muscle (gas),pert
OV1002 Carbo Day7,pert
2.5-4.5 month old ovarioectomized female mouse,pert
Mouse RSK2 mutant mandibular molar,pert
"disease state: Nasopharyngeal carcinoma;	stage: IVB, T3, N2, M0, G4",pert
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: BETAFERON;	time: 12 month of BETAFERON;	disease state: multiple sclerosis;	nab status: NAB+,pert
Braf 2,pert
tissue type: gastrointestinal stromal tumor;	gender: Female;	kit expression: MEDIUM;	genome/variation: PDGFRA mutation detected,pert
SV589_3DKD,ctrl
liver_Wt_female_35wk_rep3,ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 67;	gender: male;	years of disease: < 1 y;	treatment: phototherapy;	time: mid-UV,pert
MCF7 cells treated with 2uM Sangivamycin for 24 hours Array 2,pert
"patient: 126;	current medication: None;	birth date: 4/4/87;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/1/05;	indictation for procedure: FH of Crohn's disease, Symtom free at procedure;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: TRUE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
Ribavirin Treated Cells 1,pert
"MCF7 cells, shRNA targetting PDEF",pert
phenotype: no glaucoma;	gender: female;	strain: D2-Gpnmb+;	tissue: retina;	age: 10.5 months,ctrl
"Control 2 small intestine, 30 days",ctrl
original diagnosis: ERA;	cell type: Peripheral blood mononuclear cells,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,ctrl
tissue: brain (frontal cortex);	disease state: healthy control;	age: 40 yr;	population: white,ctrl
cell line: M12;	treatment: control,ctrl
"TNFa-OMe-P siRNA-C, replicate 7",pert
race: caucasian;	age (years): 61;	stage: IC;	grade: 2;	histology: endometrioid,pert
Mouse_WT_ES_clone 1,ctrl
B-CLL PB P86,pert
tissue: leukocytes from whole blood;	genotype: bipolar patient;	age: 23;	gender: male,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:wildtype,Treatment:cornoil,Batch:Batch1",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: control;	time: day 3,ctrl
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 80;	Usage number: 5;	Exposures: 3,pert
Cell line expressing inducible GFP-progerin. Induction: day 5. Replicate A,pert
Mouse Megakaryocytes,pert
CHF - R12,pert
strain: C57BL/6;	tissue type: back skin,ctrl
cell line: D3;	treatment: siPRMT8,pert
organ: Liver;	age: 14-week-old;	genotype: Wild-Type,ctrl
8 week old H3f3b KO,pert
tissue: Frontal cortex;	age: 78;	Sex: F,ctrl
protocol: AP-2 gamma targetting siRNA 2;	cell line: MCF7,pert
"peripheral blood leukocytes, untreated",ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: air at 2hrs;	replicate: 3,ctrl
cell type: AML blasts from bone marrow;	set: training;	npm status: mutated;	fab classification: M5b;	flt3 status: D835 mutation,pert
wt_TGFb_4hr_1,ctrl
Gene expression profiling of normal cortex of patient T163,ctrl
sample 1:;	age: 45;	gender: female;	sample 2;	age: 46;	gender: female;	sample 3:;	age: 64;	gender: male,pert
condition: Psoriasis;	patient: PS-N;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: cervical cancer cell line HeLa,pert
Transgenic male mouse 120 day old,pert
5A;pretreatment;female;breast tumor,ctrl
sciatic nerve of Pmp22 knockout mice,pert
strain: C57BL/6J;	genotype: APOE-deficient;	tissue: aorta;	treatment: none;	disease: atherosclerosis;	age: 32-34 weeks,pert
strain: 129SV;	gender: male;	age: 6 months;	tissue: right ventricle;	genotype: plakoglobin (+/-),pert
HLA risk: High;	Height: 170.4 cm;	Weight: 51.5 kg;	BMI: 17.6;	Age: 13.88 years;	Gender: Male;	Race: White;	Glucose: 196 mg/dl;	HbA1c: 6.2%,pert
tissue: skin;	individual: Patient N-6;	condition: Normal;	eczema severity: SCORAD: 0,ctrl
Superior Frontal Gyrus from 2year-old normal girl,ctrl
"Wt mouse, cerebellum, young, nicotinamide riboside treatment",pert
"BOEC, at_risk 4",pert
"Cell type: neuronal, age:52, gender:male, diagnostic group: schizophrenia, PMI:16h",pert
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S37C),pert
sex: Female;	family: 3;	age: 14;	disease status: Affected;	tissue: Muscle: Deltoid,pert
INS-1 cell line #6a with non-induced HNF1b mutant P328L329del,ctrl
cell line: A549;	cell type: adenocarcinomic human alveolar basal epithelial cells;	transfected with: siRNA against STAT3,pert
parental cell line: WB;	vector: pBabe-puro (empty vector);	replicate: 1,ctrl
patient: 260;	current medication: asacol 800mg TDS Asprin coproxamol;	birth date: 1/1/54;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/79;	joint problems: FALSE;	uc flare up: TRUE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 6/9/05;	indictation for procedure: ;	ucss: 12;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/9/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: DISEASE IN REMISSION;	smoking status: current;	smoking start date: ;	smoking stop date: ;	smoking amount: 5-14;	other illnesses: Arthritis Depression Alcohol excess;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 2",ctrl
Nod2-/-_laser captured Paneth cells,pert
"Background:C57BL/6J,Gender:Male,Age:15 weeks,Tissue:liver,AHR:knockout,Treatment:cornoil,Batch:Batch1",pert
patient: 30617;	sample: normal,ctrl
"reference, mock treated sample",pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.00;	RNA Integrity Number: 8.4;	Bioanalyzer Results: good;	Strain or Line: Fischer;	Individual: 44;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,pert
age: 13.5 day;	strain: 129;	genotype/variation: Chsy-1 knockout,pert
"mNSC nucleofected with miR-128l, replicate",pert
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp3,pert
Supraoptic nucleus_3d Dehydration,pert
"Gender: Female, Age: 27, BMI: 29, Tissue: luteinized cumulus cells",pert
WT mix background A,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-10;	Primary Site:Tongue;	Age:64;	Sex:M;	TNM:T4N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis",pert
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14508;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
"treatment: diclofenac;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",pert
Bronchoalveolar lavage cells,ctrl
"Hep G2 treated with 2,3-Dimethoxy-1,4-naphthoquinone",pert
Macrophages obtained from a contralateral lung segment challenged with LPS,pert
1 with Cy5,pert
Whole testis RNA from WT mouse #78 at 0h,ctrl
"Male, 44 years old, HIV infection of 12 years",pert
Array Type: HG-U133A_2;	Ratio: 2.03;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
human preadipocytes+oligo2_day0_rep1,pert
HeLa cells control,ctrl
nfia E18KO3,pert
Endometrium-Normal 2,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 20s;	race: Caucasian;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 130;	ige (kiu/l): normal (0-48.5 kIU/L): 34.7;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: positive;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
8 Month Wild Type Ovary_01,ctrl
disease state: Healthy Control;	gender: Male,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 80min;	race: White;	sex: Female,pert
cell line: Ishikawa;	cell line derivation: 39-year-old parous Japanese female diagnosed with endometrial adenocarcinoma stage 2.;	treatment: bisphenol A;	dose: 1 uM;	treatment time: 48 hours,pert
(ca)MEK_3,pert
cell line,pert
"T3 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
LM2 cells cultured with HMVEC-L and then purified by FACS,ctrl
cell line: lymphoblastoid cell line;	family id: 1717;	coriell cell line repository identifier: GM14455;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
ONH no or early glaucoma,pert
tissue: white blood cells;	age: 15.15;	Sex: male,pert
cell type: Erythroid progenitors on day 6 of differentiation;	genotype/variation: transduced with lentivirus expressing short hairpins against ZBP-89,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 62;	tissue: Blood,pert
Embryonic Cardiac Progenitors - wild type,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.4;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
race: caucasian;	age (years): 47;	stage: IC;	grade: 2;	histology: endometrioid,pert
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 66;	donor: 31;	disease state: Lesional,pert
cell type: Bone marrow cells;	genotype: control rtTA mouse;	strain: C57BL/6,ctrl
Genotype: FGF23 TG on C57Bl strain;	Age: 8 weeks,ctrl
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 8 hrs;	time course: 1,pert
race: caucasian;	age (years): 63;	stage: IC;	grade: 3;	histology: endometrioid,pert
C8161 cell line,pert
strain: C57BL/6;	genotype/variation: Nrf2 Control;	gender: Female;	tissue: Liver;	age: 6weeks,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 24h;	culture batch: 1;	bead chip array sentrix code: 4421339032,pert
THP-1 cell line infected with GSK3A Construct 6 shRNA,pert
cell line: COLO829 melanoma cell line;	genotype/variation: MITF knockdown;	agent: control,ctrl
tissue: skin;	individual: Patient P12;	condition: ANL;	eczema severity: SCORAD: 0,pert
gender: female;	tissue: endometrium;	phase: Proliferative Stage;	cell type: Mesenchymal Cell,ctrl
"Mdr2-KO heterozygous mouse, 3 month old mouse, liver sample",ctrl
strain: C57BL/6;	genotype/variation: Smchd1 null;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: B,pert
MDA-MB-231,ctrl
Patient identifyier: J;	Sex: female;	Age of patient: 54 years;	Duration of psoriasis: 48 years;	Body surface area: 9 percent;	Overall erythema: mild;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
HCC_36T,pert
HSC,pert
Buffy Coat blood of healthy donors,pert
mouse TMJ-cartilage from DDR-1-KO mouse KO_Tal5,pert
cell line: NCCIT;	cell type: embryonic carcinoma;	transfectant: control siRNA,ctrl
"Control, replicate 2",ctrl
Primary hepatocytes isolated from DBA mouse strain treated with Wy14643 for 6h,pert
Hippocampus of 2 months old WT males,ctrl
E9.5 FVB/N erythroid cells-10,ctrl
"10590, WBS, skin fibroblasts",pert
SHEP-SF neuroblastoma,pert
tissue: Brain;	genotype: Npc1+/-;	age: 20 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Patient: N;	Time: 12 weeks;	Group: responder;	Condition: lesional,pert
MCF7 expressing Estrogen receptor alpha,ctrl
MLL_PTD13,pert
tissue type: brown adipose;	gender: male;	genotype/variation: ob/ob;	harvest time: 4 day post injection;	age: 3 months,ctrl
"ID:5-4, Genotype=(C57BKsJ) Lepr db/m, Treatment= none",pert
patient: CAB10;	diagnosis: chronic plaque psoriasis;	tissue type: skin;	phenotype: lesional,ctrl
WT striatum PDE10i,pert
Strain: Sprague Dawley;	Gender: Male;	Age: 10-12 weeks;	Tissue: Hypothalamic Supraoptic nucleus,pert
sampleID: SAM630132;	strain/background: C57BL/6;	experimentid: spr881;	genotype/variation: wild type,ctrl
subject id: 68;	infection: DENV;	status: DF;	tissue: whole blood,pert
subject: 32;	disease: CP;	muscle: GR;	gender: F;	age: 7.9;	gmfcs: 2;	popliteal angle: 95,pert
"H1299 treated with Lipofection GAPDH siRNA, 24hr",pert
cell line: SW1736;	time point: 6h;	mutation: BRAFV600E;	treatment: treated with 2 uM vemurafenib for 6 h,pert
"sirna: siRNA2 (Dhamacon);	cell line: Human epithelial colonic adenocarcinoma, Caco-2",pert
mIMCD3 cells,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate post-treatment;	subject: A235_L009,pert
strain: ICR/B6D2;	tissue type: back skin,pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 21;	sirna: scrambled;	transfection time: 48h,pert
"Heart, Cmah KO, 2 months old",pert
ancestral background: European-American (EA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
EB_2_5d_217_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
disease state: allergic asthmatic;	cell type: Keratinocytes;	tissue origin: skin biopsies with no stimulation,pert
cell line: J1;	genotype/variation: WT;	cell type: embryonic stem cells;	days of differentiation: 0,ctrl
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 2h;	culture batch: 1;	bead chip array sentrix code: 4421339030,pert
"Brain tissue from Fisher 344 male rat, Animal #257, 50mg/kg D-Serine",pert
"LCL GM19238, Kd E2F1, 72hrs",pert
mammary gland,ctrl
tissue: muscle;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
Mock-treated SCC-40,ctrl
subject: 07U;	cohort: 7;	tissue: Biceps;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: Aug-11;	# cells: 63;	Sex: male;	region: LC (locus coeruleus);	age: P22;	genotype: Y/X;TH/-;	tissue: brain;	cell type: tyrosine hydroxylase (TH)-positive locus coeruleus (LC) neurons,ctrl
lung,pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/22,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 26;	gender: male;	years of disease: 1 y;	treatment: phototherapy;	time: pre-UV,pert
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
peripheral blood mononuclear cells,pert
strain background: ICR;	genotype/variation: Pax6 flox alpha-cre;	developmental stage: E12;	tissue: Embryonic retina/optic cup,pert
IRF4-mut_Th17_cells_42hr,pert
"DHL6, R406, 48h",pert
genotype/variation: wt;	age: E16.5;	tissue: Whole eye,ctrl
Mouse testicular Sertoli cell line TTE3,ctrl
Genotype: non-transgenic;	In the non-transgenic control animals no abnormalities in lung tissue was detected with the exception of a single animal which showed a slight focal interstitial mononuclear cell infiltration.,ctrl
"Patient  F, lesion, 4 week",pert
cell line: 3T3-L1;	cell type: preadipocytes;	cell passage number: 19;	sirna: scrambled;	transfection time: 24h,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 3.245;	OD280: 1.679;	Ratio: 1.91;	Dilution: 1:5;	RNA Integrity Number: 7.3;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 321;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,ctrl
"human post-mortem brain tissue, healthy control",pert
healthy control,ctrl
Cervical cancer_1509T,pert
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD8+ T-cells,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 4;	psoriasis duration: 48.0;	age of psoriasis onset: 19,pert
RNA pool from MPH-treated LCLs generated from ADHD patients,pert
transfection: Rif1 shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,pert
The RNA samples from DHT 0hr treated LNCaP cells,ctrl
H4-II-E-C3 cells exposed to 62 µM CoCl2 for 24 h,pert
clone type: AtT20 clone types treated with control siRNA rep 2,ctrl
melanoma in situ,pert
Cervical cancer_CC163,pert
whole skin,pert
Placenta_PE(LO)5 with Cy5,pert
Vehicle-Control;	Vehicle-Control 36 hours set 2,ctrl
Normal Mouse Skeletal Muscle,ctrl
phytohemagglutinin-activated PBMCs from normal control subject C,ctrl
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Male;	Age of onset (years): 22;	Duration of illness (years): 19;	Brain pH: 6.71;	Post mortem interval (hours): 70;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: Yes;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 5,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: post-UV,pert
PTEN Delted Mouse Lungs,pert
"heart, subendocardial left ventricle",pert
hippocampal CA1 tissue,pert
wild type; 6 months,ctrl
Heart sample9,pert
cell line: Hep G2;	genotype: RCCC-THRA mutant 6a;	treatment: with 100 nM T3 for 6h.,pert
NFIA E18WT3,ctrl
CD8-IGF1R Transfected 3T3 cells treated with A-928605 for 24 h,pert
Rat heart ventricle,pert
Strain: C57BL/6J;	Gender: male;	Age: 2-3 months;	Tissue: heart,pert
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 53 yr;	population: white;	dsm-iv: 295.9;	age of onset: 29 yr,pert
visceral_fat_Wt_female_8wk_rep3,ctrl
NZM15 metastatic melanoma cells treated with PAX3 siRNA,pert
Patient identifyier: Z;	Sex: female;	Age of patient: 42 years;	Duration of psoriasis: 36 years;	Body surface area: 5 percent;	Overall erythema: clear;	Induration: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: clear (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),ctrl
age	54;	gender	female;	disease	healthy control;	disease phase	;	previous therapy	no;	bcr-abl/G6PDH ratio (%)	n.a.;	leukocyte count (/nl)	5.1;	hemoglobin (g/dl)	13.8;	platelet count (/nl)	284,ctrl
strain/background: C57BL/6;	genotype/variation: WT;	gender: male;	tissue: cerebellum;	age: 1 year;	treatment: standard AIN-93G diet (SD; carbohydrate:protein:fat ratio of 64:19:17 percent of kcal) ad libitum for 8 months,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures, Control 3 (untreated with resveratrol)",ctrl
gender: Male;	age: 87;	post-mortem delay: 3.5h;	ph: 6,pert
cell line: HM1 embryonic stem cell line;	genotype/variation: Prmt6 overexpression,pert
"striatum,18month,KO",pert
subject: 12B;	cohort: 12;	tissue: Deltoid;	disease state: FSHD;	ecori/blni allele length: 18kb;	age (y): 49;	Sex: M;	batch: Batch_3,pert
"DEX-treated embryonic primary chondrocyte cultures, incubated for 6hr",pert
Female - caucasian - N-01-M,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, stage IIB1, HPV 18, HPV 45",pert
tissue: liver;	genotype: p14 KO;	genetic background: C57BL/6,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 34 yr;	population: white,ctrl
heart of male mouse subjected 1 week to chronic intermittent hypoxia.,pert
EB_07_19d_154_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
genotype/variation: Fmr1 wildtype;	tissue: blood;	gender: Female,ctrl
strain: Balb/c-DBAj hybrid;	age: 10-11 weeks;	tissue: myocardium,ctrl
cell line: MDA-MB-231 breast cancer cells;	protocol: control;	other: FRAG.cRNA-IB,ctrl
RNA from microdissected breast cancer cells from case 1343 labeled with Cy5,pert
strain: B6; gender: mix; age: 0-2d; tissue: dermis; passage #: 4; treatment: control; biological replicate: 3,ctrl
proband-MS,pert
sex: Male;	Age: 20 months;	additional patient information found in Series supplementary file,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: Control;	time: 6h;	culture batch: 1;	bead chip array sentrix code: 4421339033,ctrl
WT_lung_PBS_control,ctrl
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 39;	Usage number: 1;	Exposures: 4,pert
cell line: U937;	replicate: Replicate1;	treatment: shLuciferase,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Lean, rep4",pert
sex: Male;	Age: 22 months;	additional patient information found in Series supplementary file,pert
age: 8 weeks;	genetic background: SV 129/C57BL/6;	genotype: PPAR-beta deletion;	cell type: pancreatic beta-cell,pert
primary chondrocytes untreated,ctrl
Human prostate cancer cell line,ctrl
tissue: primary brain tumor;	cell type: astrocytoma;	age: 39;	gender: male;	tumor grade: AII,pert
"Murine 3T3-L1 progenitor adipocytes cell cultures, T2 (treated with resveratrol)",pert
small_intestine_complete,pert
gender: male;	disease state: non-metastatic prostate cancer;	tissue: peripheral blood;	cell type: white blood cells;	time of wbc and fatigue score collection: baseline;	individual: P2,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.72;	OD280: 0.901;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 8.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 206;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
harmane 1uM batch 2,pert
"strain:BALB/c SCID, gender:male, age:8wks, tissue: whole lung, condition: uninfected control",pert
"breast, flash-frozen, microdissected normal ductal cells",ctrl
bladder cancer cells treated 48 hr,pert
TTF=100min;	Race=Caucasian/White;	Sex=Female;	Group=Con;	Prototype_N,pert
cell line: JCRB0086 [TALL-1];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
mouse,ctrl
LSK cells SRF wt 2,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: PD;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 73;	baseline tumor size (cm): 7x6;	patient id (to identify the 2 chips from the same patient): 15751594,pert
homozygot FH P254 (human CD3 positive T cells),pert
Immortilised monocyte cell line,pert
tissue: Gastrocnemius muscle;	genotype: WT;	age: OLD,ctrl
S9B Sporadic-cerebellum,ctrl
HCC_3N,ctrl
cell type: human immortalized mesenchymal stem cells;	sirna: control;	differentiation state: 5 days adipocyte differentiation,ctrl
strain background: CD1;	genotype/variation: wild type; Raldh2 +/+;	tissue: embryonic brain;	tissue region: posterior;	developmental stage: 4 somite stage,ctrl
"Reh, control",ctrl
epithelium from colon of HDAC2 KO mouse no.2,pert
231/NS (nonsilence)_2,ctrl
n3_lo_6,pert
age_years: 40;	sex: M;	ethnicity: Asian;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
age: 24 weeks postnatal;	tissue: liver;	genotype/variation: Pink1 knockout,pert
tissue: Fallopian tube;	cell type: epithelium;	cell line: OE-E6/E7,pert
"PC from MM patient, isolated using CD38-APC",pert
Gender: Male;	AJCC Stage: IV;	Pathological T: 3;	Pathological N: 1;	Pathological M: 1;	Grade: moderate;	Tumor Site: Sigmoid;	Drug Treatment: YES,pert
cell line: Ls174T;	cell type: intestinal colorectal carcinoma cells;	induction: dominant-negative Tcf4 transgene;	time: 24hr,pert
strain/background: C57B6SJL;	genotype/variation: GNMT knockout;	age: 3 months;	tissue: liver;	disease status: non-alcoholic steatohepatitis,pert
NZM15 metastatic melanoma cells media-only control,ctrl
ERα-positive breast tumors without PIK3CA mutation,ctrl
23 Day Mouse Leg Muscle,ctrl
"UM-UC-3 bladder cancer cells, stably transfected with GFP-tagged RhoGDI2, biological replicate A",pert
disease: AML;	bcor mutation: wild-type;	karyotype: normal karyotype,ctrl
"Biceps, control, cohort 03, subject 03U",ctrl
Normal lung,ctrl
"Patient  A, lesion, 2 week",pert
Whole blood from normal children.,ctrl
"Nickel allergic female (age range 33-49), skin biopsy from upper nates taken 96 hours after nickel exposure",pert
8 week mouse gastrocnemius/soleus muscle,ctrl
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 34;	Duration of illness (years): 16;	Brain pH: 6.1;	Post mortem interval (hours): 18;	Side of brain: Left;	Fluphenazine mg. Equivalents: 12000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 5;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 3,pert
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: JQ1 treated,pert
genetic background: C57Bl/6;	genotype: wildtype;	cell type: Osteoclasts;	treatment: Calcitonin,pert
Labeled microRNA,pert
tissue: adipose tissue;	sample group: calorie restrictive;	treatment: before;	gender: Female,ctrl
disease state: control;	patient: 12,ctrl
Ebola-infected macrophages harvested at 1h post-treatment from donor 2,pert
chip number: 17;	transfection plate: 5;	target gene: STAT2;	kd level: 0.7;	rin: 9.7;	transfection date: 2011-10-17,pert
Human lung adenocarcinoma cell line,pert
T41,pert
condition: Psoriasis;	patient: PS-H;	tissue: LS skin biopsy;	kit: Affy,pert
status: Control;	gender: Female;	age: 54;	tissue: Blood,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 57;	tissue: Blood,pert
CUTLL1 wash4h-CHX,pert
braak stage: BR56;	rin: 78;	tissue: substantia nigra;	disease state: Parkinson's disease,pert
Aire WT,ctrl
sample type: normal breast cell line with stably transfected full-length chimeric human HER2 receptor with FKBP and HA tags;	cell line: MCF10A;	treatment: Heregulin,pert
"Liposarcoma culture from tumor 377, doxorubicin treated",pert
WT Liver - Pooled -Cy3,pert
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-GFP retrovirus,ctrl
Gastrocnemius and Soleus muscles,ctrl
Genotype: Mdr2-KO heterozygous mouse;	Age: 3 month,ctrl
age: 71;	sex: M;	disease status: control subject;	Filter number: 87;	Usage number: 1;	Exposures: 3,ctrl
strain: C57BL/6J;	genotype/variation: Asc -/-;	cell type: bone marrow derived dendritic cells,pert
DLBCL_ctrl siRNA,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Female;	batch: 1;	psoriasis duration: 4.0;	age of psoriasis onset: 69,pert
WildType_lung,ctrl
control peptide-treated KOPT-K 100mM 16h,ctrl
GC resistant clone C7H2-R19E7 treated for 6 hours with GC,pert
MIST1-null pancreatic RNA 36 hours post-tamoxifen,pert
"metastasis: metastatic recurrence;	Stage: 3b;	tissue: normal, homogenized",ctrl
BALB/c mouse treated with pristine for 3 days,pert
C57BL/6J-ob/ob;	Soleus muscle;	Age: 14 weeks;	Gender: Male,ctrl
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 1.99;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 61;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Strain: C57BL/6J;	Gender: F;	Age: 7 weeks;	Treatment: 1 hour following nicotine-induced seizures,pert
HeLa-LAMP3siRNA-4d,pert
"Male Nrf2 wild-type mice, liver sample",ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: lung;	age: 12 weeks,ctrl
"Mature proximal small intestine, first 5 cm immediately adjacent to the pylorus",ctrl
"NTERA2/D1 cells, Vamp7 knockdown siRNA",pert
wild-type macrophages stimulated with MALP-2 for 8 h,ctrl
10 weeks old,ctrl
Array Type: HG-U133A_2;	Ratio: 2.01;	RNA Integrity Number: 9.5;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,ctrl
cell line: SV589;	knockdown (days): 8;	treatment: no treatment,ctrl
parental Ainv15 ESC differentiated as EB for 3 days,ctrl
tissue: blood;	control: 2;	gender: male;	age: 48,ctrl
type_of_rx: AFG;	pre_or_post_treatment: post;	response: CR;	er_status: pos;	pgr_status_: pos;	her_2_status: neg;	baseline age (years): 59;	baseline tumor size (cm): 3x3;	patient id (to identify the 2 chips from the same patient): 16101647,pert
"PC from WM patient, isolated using Kappa or Lambda-fluorescein isothiocyanate, CD10-PE, CD38-PerCPCy5.5,CD19-PE-Cy7, CD34-APC and CD45-APC-Cy7.",pert
rtTA-Dmrt5 day 9 -Dox,ctrl
Early Secretory Phase Normal,ctrl
sex: Male;	Age: 2.5 months;	additional patient information found in Series supplementary file,pert
PBMC RNA from a patient who achieved remission on MTX,pert
EB_2_6h_207_Formaldehyde_RatNasalTissue_CIIT05024_Rat230_2,pert
strain: C57BL/6;	genotype/variation: Smchd1 wildtype;	developmental stage: E17.5;	cell type: preB cells;	beadchip barcode: 6285414089;	beadchip section: C,ctrl
cell type: AML blasts from bone marrow;	set: test;	npm status: mutated;	fab classification: M5;	flt3 status: internal tandem duplication (ITD),pert
"Right brain hemisphere ,C57BL male mouse,Haloperidol treated,Orally,12 weeks",pert
PancreaticSample32-Tumor,pert
wildtype activated B-Cells,ctrl
mouse intestine pLagl2 knockout 2,pert
"Bone Marrow sorted Zfx-cko HSC (Lin-, Sca1+, c-Kit+)",pert
"PC-3, untreated",ctrl
individual: patient14;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
Ficoll/PBMC,pert
EE_IB_2_unkwn_lcm,pert
"Deltoid, FSHD, cohort 03, subject 03A",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 140min;	race: White;	sex: Male,pert
skeletal muscle (quadriceps); fasted 18h,pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 126;	genotype/variation: WT;	age: 8 weeks,ctrl
Primary chondroyctes; Mir140 KO; Ago2-IP,pert
"SPC-c-raf transgenic mice, 5 month old, female, unaltered",pert
Lung Epithelial Cell Line,ctrl
Patient: L;	Time: 1 week;	Group: responder;	Condition: lesional,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/lacZ; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 14.5; Tissue: whole kidneys from 17 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",pert
RNA from whole tissue section of case 823 labeled with Cy5,pert
Aorta control,ctrl
cell line: MDA-MB-231 1833;	cell type: breast cancer cells;	genotype/variation: expressing HMGA2 shRNA,pert
Wild type mouse liver,ctrl
FoxO3 null mutant,pert
Postmenopausal female. Tibolone treated. Patient 1.,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 31.51233,ctrl
"Strain: Wistar, Sex: male",ctrl
strain: C57BL/6;	gender: male;	cell type: ESCs;	genotype/variation: No genetic modification;	culture conditions: 2i,ctrl
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 72 hrs;	Drug: No Rosiglitazone present,ctrl
gender: Male;	tissue: Tendon;Brachialis;	age: 45;	donor: 5;	disease state: Non-lesional,ctrl
cell type: Immortalized human neural stem cell;	cell line: HB-1;	treatment: Nurr1 overexpression,pert
Strain: DBA/2J;	Sex: Male;	Age: 8-10 weeks;	Treatment: Control,ctrl
Sprague-Dawley Rat retina (male),ctrl
postnatal 3 weeks control heart,ctrl
E9.5 FVB/N erythroid cells-12,ctrl
PS-NA cerebrum at 12 weeks,pert
"gender: Male;	age: 81;	post-mortem delay: 5h;	ph: 6.1;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
Superior Frontal Gyrus from two 8 year-old RTT girls,pert
age: 56;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
"DMSO-treated embryonic primary chondrocyte cultures, incubated for 24hr.",ctrl
cell line: OCI-Ly10;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,ctrl
tissue: T cells;	genotype: wild type 5C.C7;	background mouse strain: B10.A,ctrl
Vector Control Transfected 3T3 cells treated with A-928605 for 24 h,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.81;	choa: 112;	fata: 80;	eea: 1440;	wtkg: 99;	perfat: 57.6;	lbm: 38.9;	fat_mass: 5702.4,ctrl
59A;pretreatment;female;breast tumor,ctrl
MDA-LM2-shTARBP2,ctrl
microdissected epithelial cells from IPMA 5,pert
strain: C57 Bk6;	age: 1.5 day;	tissue: forebrain;	cell type: primary cell culture astrocyte;	treatment: HA1077;	time: 12h;	culture batch: 2;	bead chip array sentrix code: 4421339046,pert
"striatum,6weeks,WT",ctrl
strain: C57BL/6;	genotype/variation: Nrf2 KO;	gender: Female;	tissue: Liver;	age: 6weeks,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
WT.DMSO.2,ctrl
HCC_7T,pert
PancreaticSample35-Tumor,pert
"Control, untreated",ctrl
strain: C57BL6/J;	pooled: No;	amplification batch: 07/15/05;	# cells: 38;	Sex: male;	region: M1;	age: 45;	genotype: Y/X;G42/-,ctrl
C57BL/6J Mouse Male Kidney,pert
Control PB C105,ctrl
Weight:Low;	CFstatus:knockout;	Sex:Female,pert
cell type: tumor nodule cells;	ikk2 status: WT,ctrl
Striatum of 8-10 week old 129P3/J mice,ctrl
Sex: male;	Age: 15;	SL: 4.01;	House: 7;	Severity: M;	Ashworth: 2;	Zancolli: 2B;	PEFF: 80;	PESF: 80;	AEFF: -50,pert
genetic background: hybrid C57BL/6J and 129S5/SvEvBrd;	genotype: control,ctrl
strain: C57BL/6;	gender: Female;	age: 6 weeks old;	cell type: CD4 positive T cell;	treatment: TCR-stimulated;	genotype: Trim28CKO,pert
cRNA;	embryonic day 18;	WT,ctrl
Tissue: HepG2 Cells;	Gender: male;	Source: ATCC;	Vehicle Treated 0.1N KOH (at equivalent volume as treated) in media,ctrl
Isolated PBMCs from diabetic male patient_RES-enriched Grape extract_6 months,pert
"MCF-7 cells, siERK5 treatment 72h, 0.1%EtOH for 24h",pert
"Wistar Han;	Crl:Wi(Han), Male, tissue: Heart",pert
CD34+ hemopoietic progenitors purified from peripheral blood of Idiopathic Myelofibrosis (IM) patients,pert
genotype: tg/wt;	treatment: CaNrf2;	gender: female;	background strain: FVB/N/C57BL/6 mixed,pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 226;	age-at-biopsy-years: 61,pert
rear leg muscle,pert
Strain: C57Bl/6; Tissue: liver,ctrl
cell line: AT2 E/R positive leukemia;	treatment: treated with non targeting lacZ shRNA,ctrl
tissue: Whole Brain;	developemental stage: E 18.5;	genotype/variation: Meg3 knock-out,pert
"Age: 8 months, Sex: Female, Retina: right, Final IOP (mm Hg): 26.5, Strain:DBA/2J",pert
WT_bone marrow cells,ctrl
P1A Progranulin-frontal,pert
subject: 6;	disease: TD;	muscle: GR;	gender: F;	age: 15.5;	gmfcs: N/A;	popliteal angle: N/A,ctrl
E10.5 embryo yolk sacs,pert
"metastasis: none;	Stage: 3b;	tissue: cancer, homogenized",pert
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: etanercept;	time: 4 hours;	individual identifier: 219,pert
cell line: OCI-Ly7;	cell type: diffuse large B-cell lymphoma (DLBCL);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L009,ctrl
"hMSC-Tert, control siRNA, 5 days adipocyte differentiation",ctrl
8 week old mouse leg muscle,pert
human esophageal squamous cell carcinoma cell line,pert
condition: Psoriasis;	patient: PS-L;	tissue: LS skin biopsy;	kit: Affy,pert
mouse PPTA knockout lung 8 h after cecal ligation and puncture surgery,pert
N6A Normal-frontal,ctrl
genotype: WT;	cell type: Th17,ctrl
"Histopathological diagnostic: oligodendroglioma, grade 3",pert
pancreatic acinar cell-specific knockout of the Perk gene; mixed genetic background; postnatal day 19; total pancreas; pooled two mouse cDNA samples equally to generate cRNA.,pert
bleomycin injected mouse lung,ctrl
Head RNA of Phgdh Knockout@E13.5 No.2,pert
Jurkat cell line transfected with SIV Nef,pert
Mouse lungs infected with Mtb for 63days,pert
Tissue: normal thyroid; Gender:female; Age:43,ctrl
cell line: MCF-7;	cell line: breast cancer cells;	transfected with: Empty vector,ctrl
race: caucasian;	age (years): 60;	stage: IB;	grade: 2;	histology: endometrioid,pert
"Gastrocnemius-soleus muscles, basal status, wild type mouse",ctrl
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep1",ctrl
"NB4 cell line, TG2 knockout, ATRA, 72hr",pert
"Liposarcoma culture from tumor 379, doxorubicin treated",pert
tissue: Normal Tissue in Pancreatic Cancer Sample;	sex: Male;	age: 68,ctrl
sex: Male;	Age: 18 months;	additional patient information found in Series supplementary file,ctrl
"50B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
disease state: paediatric glioblastoma;	age: 12;	gender: F;	h3.3_status: wt,ctrl
"patient: 115;	current medication: Frusemide, Codine Phosphate;	birth date: 9/14/28;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/21/04;	indictation for procedure: Diarrhoea, Also has Prostate Ca;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",ctrl
26 weeks female,ctrl
"testis with regular spermatogenesis with status after vasectomy, patient age: 34y",ctrl
EB_400_6_374_HCHO_nasal_Rat230_2_EB_HCHO_Rat_Nasal,pert
"cell line: 1104, control, skin fibroblasts;	gender: female;	age at biopsy: 3 years",ctrl
patient code: 91;	gender: Female;	age: 51;	tumor grade: 3;	t-stage: 3;	n-stage: 0;	ajcc classif. (2002): 2a,ctrl
disease group: normal;	cell type: chondrocytes;	cell culture: 3-D,ctrl
NONE_24,ctrl
"mature (CD44+, NK1.1+) thymic natural killer T cells",ctrl
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-Tg;	tissue: Skeletal muscle (quadriceps),ctrl
patient id: 131;	tissue: Normal cortex;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
HUVEC infected by retroviral vectors bearing pre-miR-210 sequence,pert
strain: C57BL/6;	treatment: control;	cell type: lineage-negative marrow progenitors,ctrl
strain: 131;	Disorder: normal scar;	Condition: +hydrocortisone,pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 59;	gender: male;	years of disease: > 20 y;	treatment: phototherapy;	time: mid-UV,pert
"HIV-1 positive male, 18-60 years old, weight loss of 5-15% in preceding 6 months, stable anti-retroviral therapy. CD4+ T-cells >50/ml, HIV copies =< 10,000/ml, free testosterone <50pg/ml.",pert
cell line: V6.5;	cell type: embryonic stem cells;	treatment: shRNA1-dox,ctrl
patient: 262;	current medication: Asacol 2.4g co-codamol;	birth date: 7/17/43;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/87;	diagnosis date: 1/1/87;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: YES;	aza tolerant: TRUE;	aza at present: FALSE;	procedure date: 7/5/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 7/5/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 8/15/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: none;	disease: UC;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
genotype: Wild-type;	replicate: 1;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
cell line: TYK-nu;	cell type: ovarian cancer cell line;	treatment: Cisplatin;	batch: 1,pert
tissue: skeletal muscle;	strain: mixed background (C57Bl/6 and 129);	genotype: Yin Yang 1 (YY1) knockout;	age: 6 months,pert
chip number: 12;	transfection plate: 5;	target gene: TAF1;	kd level: 0.73;	rin: 9;	transfection date: 2011-10-17,pert
KO_72_O3_3,pert
RNA from microdissected breast cancer cells from case 749 labeled with Cy5,ctrl
ancestral background: African-American (AA);	gender: Female;	subject condition: healthy control;	tissue: Peripheral blood;	surface markers used in facs: CD8-PE;	cell type: CD8 positive T cells,ctrl
patient: 229;	current medication: Naproxen;	birth date: 11/27/61;	gender: unknown;	ethnicity: CAUCASIAN;	symptoms onset date: 1/14/05;	diagnosis date: 1/18/05;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/18/05;	indictation for procedure: ;	ucss: 6;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/26/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: NEW;	smoking status: unknown;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 6-2-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,pert
primary MEFs,pert
"cell line HCT-116, Ki-RAS-mutation, DNMT wildtype, U0126-treated",ctrl
cell type: Human melanoma cell line;	cell line: M229;	genotype: V600E BRAF mutant;	treatment group: 1 uM PLX4032 for 6h,pert
"Entire small intestine, wild type, lubiprostone treated",pert
Normal cervix_03-5611,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus monosomy7/del7q plus other,pert
chip number: 15;	transfection plate: 5;	target gene: RXRA;	kd level: 0.78;	rin: 9.6;	transfection date: 2011-10-17,pert
strain: CD-1;	age: 20 week;	tissue: heart left ventricle;	genotype: dominant negative CREB1 driven by cardiomyocyte-specific myosin heavy chain-? promoter,pert
Jurkat cell line,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T166,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: African American;	age: 29;	sex: M,ctrl
OC1-KO embryonic retina at E14,pert
Patient identifyier: F;	Sex: male;	Age of patient: 47 years;	Duration of psoriasis: 28 years;	Body surface area: 15 percent;	Overall erythema: moderate;	Induration: mild (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"gender: female;	batch: 1;	age (years): 21;	patient id: Severe_2;	fev1 (% predicted): 105;	fvc (% predicted): 101;	medication: Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn;	cell type: CD8+ T-cells",pert
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: EtOH,pert
Mouse embryonic kidney,pert
model: Fischer 344;	gender: Male;	age: 7 to 8 months old,ctrl
"SRF silenced, treated with R1881, biological rep 2",pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Female;	batch: 1;	psoriasis duration: 7.97878165639973;	age of psoriasis onset: 47,pert
Extract:LOX-1:213101;	Extract Description:LOX1_0hr:213101;	Quality: Classification:Good;	Quality: Gradient Severity:0.04;	Quality: Distortion Severity:0.02;	Quality: Defective Area (%):0.02;	Quality: Outlier Area (%):0.01;	Quality: 3'/5' Mean:1.53;	Quality: Background Mean Dev.:1.12;	Quality: Absent (%):58.17;	Quality: Absent (%) Dev.:0.07;	Quality: Scaling Factor:0.51;	Quality: Scaling Factor Dev.:0.89;	Pretreatment [C]:LOX1;	Time point [C]:0 hours;	Treatment [C]:(Not applicable);	Genomic ID [C]:213101;	Cell name [C]:HAECT;	Treatment amount [C]:(Not applicable);	Cell type [C]:Endothelial;	Organism species [C]:Human:Homo sapiens;	Cohort name [C]:LOX1_0hr;	RNA extraction source key [A]:282295443,pert
gender: Male;	age: 44;	post-mortem delay: 4h;	ph: 6.3,pert
FCHL patient #98-1479,pert
WT_cerebellum at P30,ctrl
Strain: FVB/N;	Genotype:mCftr+|+,ctrl
3 h-apra-2 nM,ctrl
disease state: tibial muscular dystrophy (TMD);	tissue: tibialis anterior;	age at biopsy: 48;	Sex: male,pert
gender: male;	age (years): 58;	evolution time (years): 10;	disease extension: Left-sided colitis;	treatment: No treatment,pert
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 29;	maternal age: 29,ctrl
"SPC(+)Cre(-), Dox E6.5-12.5, PN15; control",ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.93;	choa: 330;	fata: 22;	eea: 1930;	wtkg: 84.5;	perfat: 35.2;	lbm: 54;	fat_mass: 2974.4,ctrl
HLA risk: High;	Height: 147.8 cm;	Weight: 52.9 kg;	BMI: 24.1;	Age: 12.2 years;	Gender: Female;	Race: White;	Glucose: 83 mg/dl;	HbA1c: 8.1%,pert
patient: 3;	disease state: hypertension;	tissue: Macroscopically intact tissue,ctrl
diet: AIN-76A,ctrl
strain: 116;	Disorder: normal scar;	Condition: +hydrocortisone,pert
8 wk old male C57BL10 EDL,ctrl
nasopharyngeal carcinoma;	WHO histology: IIA;	Tumor Stage: T2N1,pert
gender: male;	age: adult (80±5 days-old);	tissue: cerebellum;	genotype: ApoD knock-out,pert
"Pou4f1-/- cells, transduced with control virus",pert
human fibroblasts overexpressing progerin treated with FTI,pert
Lck LIGHT Tg;	Age: 4-8 wks,pert
tibialis anterior muscle,pert
Whole liver,ctrl
"liver sample of Wistar rat fed for 12 weeks with standard chow diet, after overnight fast",ctrl
"Genotype: B6.Alb/cre,Pdss2loxP/loxP(Liver-conditional knock-out);	Age: 224-day-old male;	40 mg liver used for RNA extraction",pert
"Autism with regression, Female",pert
chip number: 16;	transfection plate: 3B;	target gene: KLF13;	kd level: 0.87;	rin: 9.8;	transfection date: 2012-03-26,pert
"Biceps, control, cohort 12, subject 12U",ctrl
strain: C57BL/6;	genotype/variation: IkkβΔ,pert
age: 57;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
RNA from microdissected breast cancer cells from case 687 labeled with Cy5,ctrl
Livers of TAK1 ko mice sacrificed at 4 weeks,pert
strain: 129-Sv;	cell line: J1;	cell type: embryonic stem;	time: 6 days;	differentiation: differentiated Flk1+ Tal-1-/-  ES cells,pert
neonatal cord blood mononunclear cells after LPS-treatment,pert
OE-E6/E7 cells,pert
left lung lobe,pert
Hec50co human endometrial cancer cells with a control scrambled ShRNA,ctrl
Sex: male;	Age: 10;	SL: 3.37;	House: -;	Severity: C;	Ashworth: 1;	Zancolli: 0;	PEFF: 90;	PESF: 90;	AEFF: 90,ctrl
tissue: brain (frontal cortex);	disease state: schizophrenia;	age: 43 yr;	population: white;	dsm-iv: 295.9;	age of onset: 25 yr,pert
"Strain: 129 / C57BL/6 / SJL/J mixed, Genotype: Lim1flox/+; Rarb2Cretg/+; Gender: mixed; Age: embryonic day 18.5; Tissue: whole kidneys from 14 embryos. (Reference: BMC Nephrol. 7(1):1, 2006, PMID: 16464245)",ctrl
"age at diagnosis: 81;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G2;	mininal stage grouping: IIIC;	t (extent of primary tumor): T1b;	n (lymph node metastasis): N3a;	er: 1;	pgr: 1;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
HCC_37N,ctrl
Liver from a 5 month old Myc heterozygous mouse,pert
lrrk2 genotype: WT / WT,ctrl
scan batch: Batch 1;	group: autism;	subject age: n/a;	paternal age: 26;	maternal age: n/a,pert
"Neural precursor cells derived from hES cells line VUB01, biological replicate  3",ctrl
AIRE ko CD80hi mTEC sample1,pert
U937-derived cell line harboring TRIPZ-shRNAmir TetOn cassette (clone ID: V3THS-381738),pert
F9 WT treated 8hr with atRA,pert
cell line: JAK2V617F-mutant AML cell line HEL;	treatment: Control shRNA (GFP),ctrl
Lung tissue sample from the patient with ILD,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.572;	OD280: 1.326;	Ratio: 1.9;	Dilution: 1:5;	RNA Integrity Number: 8.4;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 369;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"RNA from RAW 264.7 CellsArray Type; Affymetrix Mouse 430_2,",pert
RNA from MLL1-KO MEF (30h after serum shock),pert
treatment: treated with R1881 and ELK1-shRNA;	cell line: LNCaP,pert
chip number: 19;	transfection plate: 3B;	target gene: BCL3;	kd level: 0.6;	rin: 9.2;	transfection date: 2012-03-26,pert
Septic shock;	gender: Male;	Survivor;	organism: Staph aureus,pert
scan batch: Batch 1;	group: autism;	subject age: 7;	paternal age: 33;	maternal age: 29,pert
extensor digitorum longus muscle,ctrl
patient: 51677;	sample: normal,ctrl
subject: 18U;	cohort: 18;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 57kb;	age (y): 37;	Sex: M;	batch: Batch_4,ctrl
cell line: HCT116;	clone: 10;	genotype: Knockout,pert
"C57BL/6J Acute morphine treated, biological replicate 3",pert
Rat heart,pert
strain: 3rd Gen.FVB/N from 129Sv/Ev and Black Swiss mix;	age: 8 Weeks;	tissue: Mammary Gland;	cell type: Epithelial Cells;	genotype: MMTV-cre; PtenF341V/loxP,pert
Strain: C3HeB/FeJ;	Age: 10-12 weeks at the beginning of the feeding regimen,pert
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: M,ctrl
C6_CLP_wildtype_12,ctrl
strain: C57BL/6J;	genotype/variation: Ifng-/-;	tissue: Bone marrow;	cell type: CD71+ cells (MACS-enriched),pert
kidney,ctrl
primary normal lung tissue 1037,ctrl
A375P cells expressing Control shScr,ctrl
gender: Female;	age: 50;	cell type: PBMC;	individual: Patient 999;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB+,ctrl
27A;pretreatment;female;breast tumor,ctrl
strain: C57BL6/J;	genotype/variation: txnrd1 null;	age: 8wks;	developmental stage: adult;	gender: male;	agent: acetaminophen (APAP);	tissue: liver,pert
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 64;	tissue: Blood,pert
visceral_fat_Wt_female_8wk_rep1,ctrl
cells: spleen follicular B cells;	genotype: IRF8 KO;	genetic background: C57BL/6J-lrf8-/- x CD19-Cre,pert
cell type: embryonic stem cells;	genetic modification: Dgcr8 knockout,pert
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: wild-type,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 133min;	race: White;	sex: Male,pert
Brain from 40 days Npc1-/- mouse1,pert
Array Type: HG-U133A_2;	Ratio: 1.98;	RNA Integrity Number: 9.9;	Bioanalyzer Results: Excellent;	Sample Preservation: -70C,pert
treatment: vehicle;	genotype: progesterone receptor knockout;	treatement time: 40 hours,pert
Sample: alpha-TM180;	Replicate: 1;	Pool: NP,pert
strain: C57BL/6J;	Sex: male;	expression: sh-scr;	agent: none,ctrl
gender: male;	batch: 1;	age (years): 56;	patient id: Control_8;	fev1 (% predicted): 111;	fvc (% predicted): 111;	medication: None;	cell type: CD4+ T-cells,ctrl
tissue: testis;	genotype: wt;	age: 17dpp,ctrl
type_of_rx: AF;	pre_or_post_treatment: pre;	response: SD;	er_status: pos;	pgr_status_: neg;	her_2_status: neg;	baseline age (years): 50;	baseline tumor size (cm): missing;	patient id (to identify the 2 chips from the same patient): 22332259,ctrl
genotype: Wild-type;	replicate: 2;	strain: C57BL/6;	gender: female;	age: adult;	tissue: hippocampus,ctrl
Alveolar epithelial Cell Line A549,ctrl
Treated with 50uM Zinc for 4 hrs -- replicate #1,pert
cell line: non-clonal BMSC cultures;	transfection: negative control (siNC) construct,ctrl
gender: male;	batch: 1;	age (years): 33;	patient id: Control_5;	fev1 (% predicted): 78;	fvc (% predicted): 77;	medication: None;	cell type: CD4+ T-cells,ctrl
23 Day Mouse leg muscle,pert
T133,pert
MS-proband,pert
tissue: amnion;	cell type: mesenchymal;	agent: interleukin-1-beta;	time: 1 hr,pert
SIRT4 KO mouse liver after 16 hrs fast,pert
F23.05,pert
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 57.34247,ctrl
Female - caucasian - E-01-M,pert
"ID:11-1, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
M558_KO,pert
Insm1 control #2_pituitary gland,ctrl
genotype/variation: Fbn1 wild-type;	tgfbr2 status: intact TGF-β signaling;	tissue: ascending aorta;	age: 6 weeks,ctrl
"Male, 34 years old",ctrl
tissue type: Primary lung tumor;	histology: SQ,pert
Lesional tail skin from K14-Areg mouse,pert
tissue: whole blood;	condition: Cutaneous psoriasis without arthritis;	gender: Male;	batch: 1;	psoriasis duration: 2.8104038329911;	age of psoriasis onset: 26,pert
mammary epithelial cells,ctrl
multiple sclerosis_4,pert
chip number: 8;	transfection plate: 1;	target gene: NS;	kd level: NA;	rin: 9.8;	transfection date: 2011-03-29,ctrl
"Heart, MAT1 control, 4 wk, sample 1",ctrl
Wild type C2C12 cells,ctrl
"Csbm/m mouse, cerebellum, young, nicotinamide riboside treatment",pert
genotype: E-mu-BRD2;	cell-type: lymphoma_transitional;	splenomegaly: mild;	Ig clonality: oligoclonal,pert
HOX424 Control Day7,ctrl
"BMMC, NTAL KD, nonactivated",pert
TK6 cells,pert
R1 differentiated controls,ctrl
age: adult;	gender: male;	tissue: lung,pert
PBMCs enriched for CD8+ cells from normal control subject K,ctrl
cell line: lymphoblastoid cell line;	family id: 1736;	coriell cell line repository identifier: GM14509;	individual: Twin number 2;	agent: DMSO;	time: 4 hours,ctrl
CD8 T cells isolated from tumor,ctrl
patient E1507,pert
CD71+ bone marrow cells from WT mouse 3,ctrl
"patient 12, baseline",ctrl
"twin pair: #7;	individual: diseased;	tissue: colon, mucosal tissue;	mean age: 31.5 years old",pert
tumor tissue from mastectomy specimen from postmenopausal patient with invasive ductal carcinoma (IDC),pert
Healthy-9 baseline,ctrl
Scrapings of the distal colon mucosa,pert
Mus musculus embryo E8.5 Tcof1+/-,pert
tissue: temporal lobe;	strain: C57;	genotype: WT,ctrl
Thymuse,pert
sample: #14;	subject: PD case #2;	brain: T-1982;	age: 79;	sex: Male;	region: Inferior olivary nucleus,pert
cell line: L8057;	cell type: megakaryocytic cells;	genotype/variation: shRNA-mediated Ring1b knockdown,pert
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E16.5 embryo;;	Gender: female;;	Tissue: whole brain,pert
surgically resected material,pert
gender: male;	strain: C57BL/6;	developmental stage: day 13.5 embryo;	genotype/variation: DUSP5 knockout (KO),pert
tissue: non-lesional skin;	urticaria status: affected;	patient: 2,ctrl
Treated with 25uM Zinc for 4 hrs -- replicate #1,pert
condition: Psoriasis;	patient: PS-D;	tissue: LS skin biopsy;	kit: Affy,pert
tissue: skin;	individual: Patient P7;	condition: AL;	eczema severity: SCORAD: 56,pert
Cervical cancer_841T,pert
Mus musculus liver - txnrd1 null,pert
patient: 6;	disease state: hypertension;	tissue: Atheroma plaque,pert
patient: 22;	disease state: hypertension;	tissue: Atheroma plaque,pert
race: caucasian;	age (years): 63;	stage: IA;	grade: 3;	histology: endometrioid,pert
Bone Marrow Mononuclear Cells;	24y Female,ctrl
OE-E6/E7 cells,ctrl
control liver,ctrl
cell line: HL-60;	shRNA construct: GSK3B Construct 1,pert
strain: mixed 129/Ola-C57BL/6 background;	genotype/variation: Junf/f,ctrl
scc_01,pert
caudate nucleus,ctrl
SU8686 cell line,ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0.5, Units of Harvest Time Point: hr",ctrl
Skeletal muscle tibialis anterior (TA) from fiona transgenic line,pert
MCF10A-HER2(+) 9days,pert
wildtype_GV-stage_oocytes,ctrl
"Normal cervical epithelium, microdissected, Age 30",ctrl
strain: mixed (C57Bl/6:129Sv) background;	gender: female;	tissue: Liver;	sample number: 141;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
PBMC of Rhesus Macaque,ctrl
"PC-3 cells, 60μM luteolin (Lut), 24h",pert
pooled skins,ctrl
scan batch: Batch 2;	group: autism;	subject age: 8;	paternal age: 29;	maternal age: 27,pert
strain: C57BL6/J;	Sex: female;	genotype: WT;	cell type: mouse embryonic fibroblasts,ctrl
subject: 07U;	cohort: 7;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 34kb;	age (y): 49;	Sex: F;	batch: Batch_2,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b retrovirus,ctrl
patient: 136;	current medication: metranidazole 400mg TDS Prednisolone;	birth date: 5/21/51;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 7/20/05;	indictation for procedure: Diarrhoea PR bleeding;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 11-15-01;	anatomic_location: sigmoid colon;	inflammation_status: Inflamed,ctrl
Primary hepatocytes isolated from Donor 5 treated with DMSO for 6h,ctrl
tissue: heart;	gender: male;	genotype: VAChT KD;	age: 3 months;	strain: C57BL/6,pert
multiple sclerosis_2,pert
gender: female;	tissue: endometrium;	phase: PCOS;	cell type: Endothelial Cell,pert
cell type: Primary hepatocytes;	strain: BL6;	agent: control;	time: 24h;	gender: Male;	age: 2 months,ctrl
strain: C57BL/6;	genotype/variation: Zmpste24+/+;	cell type: mouse embryonic fibroblasts,ctrl
lineage: colorectal;	cell line: SW480;	treatment: treated with MEK inhibitor for 4h,pert
E9.5 FVB/N erythroid cells-11,ctrl
cell type: monocytes;	disease state: healthy,ctrl
"TNFa-OMe siRNA-B, replicate 2",pert
Regulatory T-cells CD4+CD25+ from HDAC6 knock out mice,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with excess blasts 2 (RAEB2);	genome/variation: del5q plus other,pert
EB_6_19d_309_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
CONTROL;	Age = 20;	Sex = F,ctrl
"Whole blood - General population, Female",ctrl
Strain: C57BL/6J;	Gender: M;	Age: 6 weeks;	Treatment: untreated,ctrl
Patient identifyier: G;	Sex: male;	Age of patient: 40 years;	Duration of psoriasis: 19 years;	Body surface area: 12 percent;	Overall erythema: moderate;	Induration: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
"Deltoid, control, cohort 12, subject 12U",ctrl
"cultured human airway smooth muscle, no treatment, replicate 2",ctrl
Proliferative Phase Normal,ctrl
strain: Sprague-Dawley;	tissue: Dorsal root ganglia;	postnatal age: 2 months;	surgery type: Spare nerve injury;	experimetal group: Adult Contralateral,pert
"breast adenocarcinoma, cell line",pert
strain: 21;	Disorder: normal scar;	Condition: +hydrocortisone,pert
chip number: 6;	transfection plate: 1;	target gene: CLOCK;	kd level: 0.83;	rin: 9.1;	transfection date: 2011-03-29,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.83;	choa: 148;	fata: 78;	eea: 1590;	wtkg: 84.3;	perfat: 20.7;	lbm: 62.7;	fat_mass: 1745.01,ctrl
sex: female;	tissue: liver,ctrl
E12.5 Whisker pad Trps1 mutant,pert
patient: 30068;	sample: tumor,pert
HCT116-Neo124 human colon cancer cells with intact PTEN,ctrl
HEK293_hCdc73siRNAConfluent_rep1,pert
Brain BA10 post-mortem control,ctrl
background strain: C57BL/6J;	cell type: Lin- hematopoietic progenitors,ctrl
Mock infected macrophages harvested at 1h post-treatment from donor 1,ctrl
age: 66;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
cell line: HuT-102;	cell type: human cutaneous T cell lymphoma cells;	transfection vector: shRNA expression vector against Luc,ctrl
total cellular RNA from Jurkat T cells,pert
tissue: Biceps muscle;	patient: C.b.3;	diagnosis: Control;	treatment: None;	treatment time (rhgaa): --;	gender: M;	age at baseline: 2y 1m;	motor status (52 weeks treatment): --;	change in glycogen content (52 weeks treatment): --;	response: --,ctrl
"Mesodermal Precursor Cells derived from hES cells line SA01, biological replicate 1",ctrl
strain: C57Bl6;	gender: female;	age: 6 months;	tissue: white adipose tissue;	genotype: WT,ctrl
"cell type: peripheral CD4+CD25hi cells;	mouse genotype: Cbfb-flox/flox, Foxp3-ires-Cre;	gender: male;	age: 5 weeks;	tissue: purified CD4+CD25hi cells from spleen and lymph nodes",pert
disease status: allergic asthmatic subjects;	tissue: bronchial biopsies,pert
status: autism,pert
scan batch: Batch 2;	group: autism;	subject age: 10;	paternal age: 26;	maternal age: 24,pert
cultured LNCaP cells;	refer to ATTC,ctrl
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 41 yr;	population: white;	dsm-iv: 296.72;	age of onset: 14 yr,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 40.17808,pert
"mouse aorta cross strain comparison, times 0, 4, 10, 24, 40 weeks",pert
Cell line: MDA-MB-231,pert
Whole pancreas,ctrl
Heart sample8,ctrl
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14476;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
MMP-8 wild type control mouse,ctrl
strain: C57BL/6;	genotype/variation: B6.Sle1a.1;	gender: female;	sample type: experimental,pert
cell line: MLL-AF9 AML cell line 10949 (Zfx fl);	treatment protocol: +OHT;	genotype/variation: cko,pert
genotype: Smad3-/-;	strain: mixed strains of C57BL/6 and NIH Black Swiss females (Taconic);	treatment: regular diet,pert
cell line: ACC483 [HPB-ALL];	cell type: human T-ALL cell line;	agent: IKKγ Nemo binding domain (NBD) inhibitory peptide,pert
TTF=140min;	Race=Caucasian/White;	Sex=Female;	Group=B;	Prototype_N,pert
"strain: C57BL/6;	genotype variation: Il10+/+;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 24 hours;	agent: air;	exposure dose: 0 ppm O3",ctrl
At Risk: -;	Age: 17;	Sex: M,pert
cell type: bone marrow mesenchymal stromal cells (BM-MSCs);	disease state: multiple myeloma;	mm stage: IIIa;	Sex: F;	age: 56,pert
age (days old): 10;	genotype: wild type,ctrl
cell line: lymphoblastoid cell line;	family id: 1725;	coriell cell line repository identifier: GM14477;	individual: Twin number 2;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
Cells:U-33 cells stably transfected with an empty vector control (U-33/c cells);	Time: 2 hrs;	Drug: Rosiglitazone present,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: CREMKO;	animal: 1;	time: 0;	batch: 1,pert
Cell bank no: RCB1648;	Cell name: Hep G2 ;	Sex: male ;	Age of sampling: 15 years ;	Tissue derived: liver ;	Case history: hepatocyte carcinoma ;	Life span: infinite ;	Classification: Transformed,ctrl
Irradiated-ATM-WT Replicative2,ctrl
patient: 51681;	sample: normal,ctrl
chip number: 20;	transfection plate: 3A;	target gene: IKZF3;	kd level: 0.59;	rin: 9.8;	transfection date: 2012-03-26,pert
Human synovial biopsies from the knee of a patient with severe rheumatoid arthritis,ctrl
Patient: E;	Time: 4 weeks;	Group: responder;	Condition: lesional,pert
"Lymphoblastoid cell lines derived from family 1743, member 1",ctrl
Disease_status: Healthy control;	Age (years): 53;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.40;	Post mortem interval (hours): 9;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
"Trim28 conditional KO mice Treg cell, replicate 1",pert
braak stage: BR12;	rin: 66;	tissue: substantia nigra;	disease state: incidental Lewy body disease,pert
tissue: primary skin cells;	genotype/variation: Adam10 knockout,pert
prefrontal cortex (BA10);	bipolar disorder,pert
subject: 03A;	cohort: 3;	tissue: Biceps;	disease state: FSHD;	ecori/blni allele length: 20kb;	age (y): 40;	Sex: F;	batch: Batch_1,pert
cell line: A549;	cell line origin: Lung cancer;	genotype/variation: control,ctrl
uterus,pert
"peripheral ganglion, unknown",ctrl
cultured skin fibroblasts from Marfan subjects,pert
strain: C57/Bl6J;	days in vitro: 16;	tissue: E16 embryonic cortex;	treatment: PTEN shRNA,pert
SV589_NoKD_Serum Starved,pert
"Brain tissue from Fisher 344 male rat, Animal #249, 500mg/kg D-Serine",pert
"PTEN mutant 1 intestinal polyp, 30 days post polyI:C",pert
cell line: WA-09;	passage: 30-45;	induction: Control;	time point: Day 3,ctrl
sciatic nerve of P4 wild type mice,ctrl
N/A,ctrl
HCC_19N,ctrl
Disease_status: Bipolar disorder;	Age (years): 45;	Gender: Male;	Age of onset (years): 35;	Duration of illness (years): 10;	Brain pH: 6.35;	Post mortem interval (hours): 28;	Side of brain: Right;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: Yes;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): Unknown,pert
cell line: 344SQ lung cancer cell line;	genotype.variation: PIK3CA knockdown,pert
day16 ES derived neuron,pert
"Human LIMA artery from patient 1, control (unstented)",ctrl
cell line: LY2;	phenotype: Tamoxifen resistant;	knockdown: SRC-1 scrambled;	treatment: untreated,ctrl
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 58",pert
mouse pituitary gland cells,pert
cell type: hRPE;	disease state: uninfected;	gender: male,ctrl
Subtype: RAEB1;	Karyotype: other,pert
cell line: THP-1;	shRNA construct: Scrambled Control,ctrl
treatment: baseline;	gender: M;	age (y): 64;	sample type: synovial knee biopsy;	disease state: rheumatoid arthritis;	response: EULAR Poor-responder;	tissue: synovium,ctrl
TL3 cell lines,ctrl
genotype: C57BL/6 Ptenfl/flFoxp3-Cre,pert
ex-iTreg,pert
SV589_15Day KD_Serum Starved -> 3hr EGF,pert
genotype: Atxn1L-null;	strain: C57Bl/6;	cell type: HSC,pert
human_hepatocyte_clinafloxacin_24hr,pert
Weight:High;	CFstatus:control;	Sex:Male,ctrl
E9.5 FVB/N erythroid cells-1,ctrl
"Gastrocnemius, Cmah KO, mdx, 2 months old",pert
tissue: primary unilateral non-metastatic postmenopausal ERα-positive breast tumor;	gender: woman;	age: 79 years,pert
sample 1:;	age: 58;	gender: male;	sample 2;	age: 58;	gender: male;	sample 3:;	age: 57;	gender: male;	sample 4;	age: unknown;	gender: unknown,ctrl
MCF-7_E2_ethanol,pert
5091212024_D,pert
EB_2_8d_223_HCHO_Nasal_Rat230_2_CIIT05024,pert
rear leg muscle,ctrl
c17.2 mouse neural stem cell line,pert
control participant P306wdh (human CD3 positive T cells),ctrl
treatment protocol: depleted BRCA1,pert
cell line: COV434;	transfection: Mutant,pert
patient id: 131;	tissue: Clear-cell renal cell carcinoma (ccRCC) tumor;	gender: Male;	age: 51;	disease state: Clear-cell renal cell carcinoma;	pathologic tnm staging: T1NxMx;	Stage: n/a;	fuhrman grade: 2;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: mutant,ctrl
genotype/variation: Derived from Nf1-/- P53-/- SKPs;	cell type: spindle cell malignant peripheral nerve sheath tumor cell (SMPNST);	treatment: Vehicle treated,ctrl
disease state: Control;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 26.55342,ctrl
cell type: induced pluripotent stem cell;	disease state: Down's Syndrome;	cell line: CCL54;	gender: male;	passage: P55;	clone: C18,pert
"Control subject, biopsy taken from the colon, no macroscopic signs of inflammation.",ctrl
tissue: colon;	genotype/variation: control,ctrl
"PC-3, AA treated 2hr",pert
"35B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
tissue: synovial biopsies;	disease: Rheumatoid arthritis;	age: 43;	gender: f;	treatment: -,ctrl
RNA from microdissected breast cancer cells from case 878 labeled with Cy5,ctrl
Brain (Inferior Olivary Nucleus)_Parkinson's disease subject_#3,pert
EB_6_5d_293_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell line: HepG2;	cell type: Human hepatocellular liver carcinoma cells;	genotype/variation: HIF-1α knockdown;	cell subtype: 10 days old tumor spheroids,pert
phenotype: alcoholic;	gender: male;	case_id: 466;	age: 57;	tissue: postmortem hippocampus;	cirrhosis: Y;	smoker: Yes;	post-mortem-interval (hrs): 43;	brain ph at time of freezing: 6.46;	labeling_batch: 2,pert
E14.5 Top2b+/+ brain,ctrl
Endometrium/Ovary-Disease 2,pert
tissue: blood;	patient: 3;	gender: male;	age: 59,pert
Healthy control,ctrl
cell line: MCF10A;	gender: female;	tissue: breast;	expression: none,ctrl
cell type: alveolar macrophage;	treatment: LPS;	individual: Subject 2;	gender: male,pert
gender: Male;	strain: C57BL/6;	genotype/variation: B1+/+;	tissue: Epididymal fat;	age: 3 month-old,ctrl
chip number: 23;	transfection plate: 3B;	target gene: POU2F1;	kd level: 0.74;	rin: 9.6;	transfection date: 2012-03-26,pert
MLL_00109,ctrl
PBMC CV T1,pert
strain: FVB/N;	age: 13.5 days;	tissue: whole body;	cell type: Fibroblasts;	genotype: Pten+/+,ctrl
cell type: whole-blood leukocytes;	gender: male;	disease status: healthy;	treatment: placebo;	time: 4 hours;	individual identifier: 208,ctrl
human neurons isolated from postmortem dorsolateral prefrontal cortex,pert
strain: Fisher 344;	gender: male;	age: 18 months;	tissue: hippocampal CA1 brain;	treament group: sham,ctrl
strain background: Mixed; mostly C57BL/6 with some 129S/SvImJ (from CJ7 ES cells).;	genotype/variation: wild type;	age: 9-day old;	tissue: bone marrow;	cell type: long-term hematopoietic stem cells (LT-HSC);	cell type: Lin-Sca1+Kit+CD48-CD150+,ctrl
tissue type: bone marrow;	cell type: CD34+ hematopoietic stem cells (HSC);	disease status: myelodysplastic syndromes (MDS);	disease subtype: refractory anemia with ringed sideroblasts (RARS);	genome/variation: other,pert
"eye, retina",pert
timepoint: 2h;	drug: Morphine;	group no.: 4;	large batch: X;	plate: 1953348002;	hybridization batch: III,pert
"Fetal liver, CD-1 background",pert
ICR MEF infected  with pMX-GFP retrovirus,pert
transfection: control shRNA;	cell line: J1 ES Cells;	background strain: 129S4/SvJae,ctrl
Liver tumor,pert
Primary CLL cells (treated with 0.1 μM CDKI-73 for 4h),pert
NSC_FOXO_NULL-1,pert
Primary hepatocytes isolated from NMRI mouse strain treated with Wy14643 for 24h,pert
Sample: nontransgenic control (NTG);	Replicate: 2;	Pool: NP,ctrl
Age: 37;	Sex: F;	Ancestry: African;	Smoking status: non-smoker,ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 1,pert
gender: F;	age at blood draw: 48;	tissue: whole blood,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 46.16712,pert
"patient 15, baseline",ctrl
strain background: (BALB/c x C57BL/6J) F1 obtained by breeding heterozygote mice(+/-) with a C57BL/6J and BALB/cA background;	genotype/variation: Shn2 deficient;	age: adult;	gender: male;	tissue: hippocampus,pert
Peripheral blood mononuclear cells;	TTF=117min;	Race=White;	Sex=Male,pert
tissue: blood;	control: 7;	gender: female;	age: 35,ctrl
control peptide-treated T-ALL1 100mM 16h,ctrl
anterior pituitary,pert
"Biceps muscle, Pompe patient",pert
HCC_38N,ctrl
N1C Normal-hippocampus,ctrl
patient E1589,pert
C57/BL6 C3KO murine Liver RNA- 6 hours post-injection with a 1st generation (E1-E3-CMVLacZ) vector.,pert
Brain from 20 days Npc1-/- mouse1,pert
CD43+/41+/235+ progenitors generated from euploid iPSCs,ctrl
strain: C57BL/6;	genotype/variation: KLF5 WT;	cell type: LSK BM cells,ctrl
genotype: wild-type;	cell type: naive CD8 T cells;	genetic background: C57BL\6,ctrl
SKI-DLCL cells cultured for 24h,ctrl
"cell type: epithelial cells (keratinocytes);	genotype: hTERT-immortalized, non-transformed;	genotype/variation: STR-pGIPZ scramble;	treatment: Ca 0.6mM, 72 h",ctrl
RNA from whole tissue section of case 469 labeled with Cy5,ctrl
Patient identifyier: C;	Sex: male;	Age of patient: 32 years;	Duration of psoriasis: 17 years;	Body surface area: 8 percent;	Overall erythema: moderate;	Induration: severe (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe);	Scaling: moderate (classified by the investigators according to the following six grades: clear  -  minimal  -  mild  -  moderate  -  severe  -  very severe),pert
Placenta_PE(EO)4 with Cy5,pert
SCLC cell line COR-L88,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 41 yr;	population: white,ctrl
cell type: PBMCs;	disease state: healthy control;	gender: male,ctrl
ID: MLL_00110;	cell type: PBMC;	disease state: control,ctrl
Hep G2 treated with Potassium dichromate,pert
"NTERA2/D1 cells, control siRNA",ctrl
patient: 40843;	sample: tumor,pert
tissue: brain;	genotype: mutant Dcx ko/Y;	age: E14,pert
"Gender: Female, Age: 29, BMI: 22, Tissue: luteinized cumulus cells",ctrl
embryons of mice at 14.5 days.,pert
Skin biopsy from upper nates taken 48 hours after exposure to 5% nickel sulfate,pert
T47D breast cancer cells,pert
Stratagene Human Universal Reference Pool,ctrl
mixed reference (CRG + FR),pert
age: 11;	sex: F;	disease status: control subject;	Filter number: 94;	Usage number: 1;	Exposures: 3,ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 8 hour",pert
Gender: male;	Age: 31;	Ethnicity: White,ctrl
Cdk4 +/- ES cell line,pert
cell line: MCF10A;	genome/variation: wild type;	treatment group: untreated;	length of treatment (days): 1.5,ctrl
KO MEF cycling cells,pert
"INS-1 cell line, clone #1-1.2",ctrl
subject id: 3;	infection: DENV;	status: DF;	tissue: whole blood,pert
"46B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
MCF-7 cells,pert
"Gender: female, Age: 45 years, Tissue: VIN 3",pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.681;	OD280: 0.848;	Ratio: 1.97;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 219;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
B5_Pseudomonas_overexpressor_48,pert
cell line: HCT116;	clone: 20;	genotype: Wild type,ctrl
agent: ConA;	time point: 3 hr;	replicate: 1;	age: 8- to 10-week-old;	gender: male;	strain: Balb/c;	tissue: whole liver,pert
"LCL GM19238, Kd STAT2, 72hrs",pert
treatment: control knockdown;	cell line: J1 ES cells,ctrl
host strain: nude mice;	injected with: iNRAS-475 mouse melanoma cells;	tissue: Melanoma allograft;	treated with: vehicle,ctrl
tissue: minor salivary gland;	disease status: early SS,pert
mouse: 6;	strain: C57Bl/6;	genotype/variation: STAT6 KO;	cell type: bone marrow-derived macrophage;	activation: Control;	treatment: Control;	time: 10 days,pert
peripheral blood,ctrl
No_drug_#4863,ctrl
"E17.5 preB cells, Smchd1 null",pert
disease state: Ovarian cancer;	xenograft from ovarian cancer model: OV1002;	agent: Control;	time: day0,ctrl
"seminoma specimen, pT2, patient age: 37y",pert
Female - caucasian - E-08-G,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: LT6;	ttf: UKmin;	race: White;	sex: Male,ctrl
Human skeletal muscle biopsy sample;	Patient #128 with NORM,ctrl
"gender: Female;	age: 28;	post-mortem delay: 11h;	ph: 6.3;	disease state: schizophrenic;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",pert
strain: v6.5;	cell_type: ES cells;	transfection protocol: GFP shRNA transfected;	culture media: ES,ctrl
patient: 206;	current medication: Asacol 800mg BD;	birth date: 9/10/59;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/79;	diagnosis date: 1/1/80;	joint problems: FALSE;	uc flare up: FALSE;	family history: TRUE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 10/8/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 2;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 10/8/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/94;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
A9,pert
"Heart, MAT1 CKO, 4 wk, sample 1",pert
strain: mixed (C57Bl/6:129Sv) background;	gender: male;	tissue: Liver;	sample number: 114;	genotype/variation: JAK2 KO;	age: 8 weeks,pert
Ovarian Cancer xenograft,ctrl
"Heart, WT, 2 months old",ctrl
human liver; very advanced HCC,pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	RNA Integrity Number: 9.7;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 31,pert
"heart tissue, ad lib feeding, 10-12 weeks old",ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 258;	age-at-biopsy-years: 65,pert
"Pou4f1+/+ cells, transduced with MSCV-Pou4f1 virus",pert
CD46+ hippo - Untreated-D,ctrl
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: GATA3 and GFP;	rep: 3,pert
E9.5 FVB/N erythroid cells-9,ctrl
tissue: testis;	genotype: WT;	genetic background: C57BL/6,ctrl
mixed reference (FR + CRG),pert
strain/background: C57BL/6;	genotype/variation: wild type;	tissue: lung;	treatment: PBS control,ctrl
Sex: Male;	strain: C57Bl/6;	tissue: White adipose;	age: 24 months;	genotype: Myc heterozygous,pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 53 yr;	population: white,ctrl
metastatic melanoma culture,pert
chip number: 21;	transfection plate: 4;	target gene: IRF9;	kd level: 0.7;	rin: 9.5;	transfection date: 2011-10-17,pert
"CA2, parental control SOX17 HESC- clone1",ctrl
pB  is a clonal control (puromycin resitant) stably-expressing stem cell line,ctrl
CD8+ cells isolated from spleen,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 60;	tissue: Blood,pert
cell type: Peripheral blood leukocytes;	strain: DBA/2,pert
"Biceps, control, cohort 07, subject 07U",ctrl
14-week-old Trim24-/- liver_463M,pert
Macrophages derived from pheripheral blood,pert
gender: F;	age at blood draw: 37;	tissue: whole blood,ctrl
Tissue:  Primary human hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: CVA;	Tobacco Use: Yes,ctrl
U2-OS-ERa,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
scan batch: Batch 2;	group: control;	subject age: 9;	paternal age: 29;	maternal age: 35,ctrl
Cell line expressing inducible GFP-progerin. Induction: day 0. Replicate B,pert
"H1 hESCs, EF1a-control",ctrl
Gender: Male;	Age: 25;	Ethnicity: White,pert
"Mouse, ATF6aKO, colon, UT, rep2",pert
Caudate-Putamen of naive AChE-S mice,pert
RNA from whole tissue section of case 260 labeled with Cy5,pert
subject: 19U;	cohort: 19;	tissue: Deltoid;	disease state: control;	ecori/blni allele length: 79kb;	age (y): 41;	Sex: F;	batch: Batch_4,ctrl
strain background: C57BL/6J;	genotype/variation: Nod2-/-;	age: 8 weeks;	tissue: small intestine;	cell type: laser captured Paneth cells,pert
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 43;	Usage number: 1;	Exposures: 3,pert
"Heart, MAT1 control, 2 wk, sample 3",ctrl
RV64.09_CHF_day25,pert
"Uninfected, replicate 2",ctrl
"Other: Equal quantities of total RNA from each cell line (brain, breast, B-lymphocyte, cervix, liver, liposarcoma, macrophages, skin, testis, Y-lymphocyte) were pooled together.",ctrl
scan batch: Batch 1;	group: control;	subject age: 5;	paternal age: 32;	maternal age: n/a,ctrl
1.25uM sapphyrin PCI-2050 treated A549 human lung cancer cell cultures replicate A,pert
A HID B_B041,pert
subjectid: 5258;	imatinib: IM;	lbh589: NoLBH,pert
At Risk: +;	Age: 19;	Sex: F,pert
patient E1603,ctrl
patient: 220;	current medication: Asacol 800mg BFZ 2.5mg Metformin Simvastatin;	birth date: 6/28/48;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 1/10/95;	diagnosis date: 3/25/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/10/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 12/10/04;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 3/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/90;	smoking amount: 5-14;	other illnesses: Type 2 DM.;	disease: UC;	run_date: 5-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
Normal skin from Tie2_control mouse,ctrl
"58B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
age_years: 47;	sex: F;	ethnicity: Black;	diagnosis: Sarcoidosis;	dx: sarc_high_lung_fx;	array_batch: 3,pert
patient: 215;	current medication: Prednisolone 5ng Balsalazide Lansoperazole;	birth date: 5/6/60;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 5/1/02;	diagnosis date: 8/16/02;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/16/04;	indictation for procedure: ;	ucss: 3;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: unknown;	last followup date: 11/16/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/31/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/03;	smoking stop date: 1/1/04;	smoking amount: 5-14;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
Ovarian Surface Epithelia,ctrl
tissue: Brain;	genotype: Npc1+/-;	age: 67 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
Human Leukemia cell line RS4.11,ctrl
"Frontal cerebrocortex, permethrin 100 mg/kg, 6 hours",pert
Omental adipose tissue,pert
brown fat cells differentiated for seven days,pert
strain background: 129SvJ;	genotype/variation: cystatin B (CSTB)-deficient (Cstb-/-);	gender: male;	developmental stage: P5+2 DIV;	tissue: cerebellar granule cells,pert
strain: C57BL/6;	tissue: Lung;	agent: bleomycin;	genotype/variation: FIZZ2 knockout,pert
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 0, Units of Harvest Time Point: hr",ctrl
Mouse otic vesicle at E10 wt,ctrl
MCF-7cells treated with vehicle and ER siRNA,pert
"tissue: liver;	genotype: Male, Wistar-derived-Liverpool John Moores University rats;	age: 7-9 weeks of age;	treatment: control 72 hr",ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.29041,pert
"Peripheral blood, patient without recurrent events",pert
Primary hepatocytes isolated from BalbC mouse strain treated with Wy14643 for 6h,pert
subject id: c7;	infection: control;	status: control;	tissue: whole blood,ctrl
Sciatic nerves from GNMT-WT mice,pert
"Normal cervix epithelium, Age 41",ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype squamoid/giant cell;	matched/unmatched: unmatched,pert
"Spleen, SRBC immunized mouse, 12 days post-immunization",pert
Tissue: Spleen;	Type: Pseudomonas aeruginosa;	Strain: C57BL/6;	Batch: 4/8,ctrl
normal superficial temporal artery,ctrl
"Male, 43 years old",ctrl
cell type: blood outgrowth endothelial cell;	status: normal;	race: Caucasian;	age: 29;	sex: F,ctrl
NSCLC cell line H157. Transfected with Oligofectamine (Invitrogen) without RNA,ctrl
scan batch: Batch 2;	group: control;	subject age: n/a;	paternal age: n/a;	maternal age: n/a,ctrl
Brain from 67 days Npc1+/- mouse1,ctrl
Mtb infected mouse lungs treated with PZA-42 days post infection,pert
age: 33;	sex: F;	disease status: Marfan subject;	Filter number: 74;	Usage number: 1;	Exposures: 4,pert
cell line: LNCaP androgen-sensitive human prostate  adenocarcinoma cell line;	sirna transfection protocol: control siRNA;	agent (treatment): R1881,pert
"Mouse brain, Aged, 4hr post LPS ip injection",pert
age: 42;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
treatment: transfected with Ambion Silencer Select SOX2 siRNA;	cell type: embryonal carcinoma;	cell line: NTera-2;	passage: 40-50,pert
epithelium from colon of control mouse no.1,ctrl
HT144 melanoma cell line,pert
B cell lymphocytes from MCL patient,pert
hOB695_shRB1383_0hr,pert
Sample Group: control; Gender: male; Age: 38; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
race: caucasian;	age (years): 57;	stage: IB;	grade: 2;	histology: endometrioid,pert
"liver RNA, ATP 7B KO mouse (first described Hum. Mol. Genet. (1999) 8:1665-1671)",pert
Strain: B6.V-lep ob;	Gender:  Female;	Age:  12 weeks;	Tissue:  Gallbladder,ctrl
"HCT116 cells, CD44 siRNA",pert
sciatic nerve of P4 Pmp22 transgenic mice,pert
Common Myeloid Progenitors,ctrl
RNA from 3 MCF7 cell culture plates treated with 150 mM of resveratrol (SIGMA St. Louis MO),pert
Disease_status: Healthy control;	Age (years): 42;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.91;	Post mortem interval (hours): 37;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 3;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,ctrl
"t08, surgically resected from patient of gastric cancer.",pert
vastus lateralis biopsy,ctrl
Human umbilical vein endothelial cells (HUVEC),ctrl
"Heart, KO3",pert
EB_07_5d_138_Formaldehyde_RatNasal_Rat230_2_CIIT05024,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 260,ctrl
mutant_embryonic brain_rostral,pert
lung fibroblasts from a patient (FASSc2) with fibrosing alveolitis associated with systemic sclerosis,pert
Age: 50;	Cycle: Follicular;	BRCA1/2 mutation: NA;	Family History: No,ctrl
"Biceps, FSHD, cohort 07, subject 07A",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-11;	Primary Site:Tongue;	Age:32;	Sex:M;	TNM:T3N2bM0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
age: 45;	sex: F;	disease status: Marfan subject;	Filter number: 40;	Usage number: 4;	Exposures: 2,pert
immortalized mouse brown preadipocyte,ctrl
Carboplatin;	Carboplatin 24 hours set 1,pert
cerebellar total RNA,pert
"MCF10A cells, vector control",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#132,pert
cell type: CD8 T cells;	transduction: shRNA targeting Lacz;	tissue: spleen;	sample name: 1-sp1,ctrl
gender: Male;	tissue: Tendon;Suspraspinatus;	age: 50;	donor: 24;	disease state: Lesional,pert
TTF=120min;	Race=Asian;	Sex=Female;	Group=A;	Prototype_N,pert
"disease model: Conditional beta cell specific KO mouse model using RIP2-Cre and Vhlh(fl/fl);	citations: Herrera PL (2000), Haase VH et al. (2001);	gender: female;	age: 20 weeks;	genotype/variation: control",ctrl
"cell line: hgps-fib_2: Human HGPS fibroblasts AG01972, AG11498, AG06297, and normal fibroblasts GM00038 (9 year), AG05247 (87 year), AG09602 (92 year) were purchased from Coriell Cell Repository",pert
Wild type MEFs from 13.5 day embryos,ctrl
tissue: heart;	genotype: Gata4_KO;	age: 8 week adult mice,pert
sciatic nerve of P4 Trembler mice,pert
disease state: paediatric glioblastoma;	age: 17;	gender: M;	h3.3_status: wt,ctrl
tissue: tumor tissue from cancer patients;	genotype: p53 wild type;	disease state: Microsatellite Stable Stage III Colorectal adenocarcinoma,ctrl
tissue: testis;	gestational age: 16 weeks;	xenografted into host: castrated male athymic nude mouse hosts;	host treatment: DBP,pert
individual: patient3;	disease state: Systemic lupus erythematosous (SLE);	tissue: blood;	cell type: Sorted B cell,pert
12 h-apra-2 nM,pert
"Wild type, snap frozen, gastrocnemus muscle, 10 month age animal",ctrl
strain: Swiss;	tissue: Ovary;	agent: Methoxychlor (50uM);	replicate: 1;	age: Post natal day 3-10,pert
(ca)MEK_2,pert
T123,pert
Mesangial Cells,ctrl
agent: pristane;	time: 3 days;	strain: BALB/c;	tissue: mesentery,pert
chip number: 18;	transfection plate: 4;	target gene: GTF2B;	kd level: 0.55;	rin: 9.3;	transfection date: 2011-10-17,pert
"gender: Male;	age: 72;	post-mortem delay: 12h;	ph: 6.8;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
"Brain tissue from Fisher 344 male rat, Animal #251, 500mg/kg D-Serine",pert
cell line: NCI-H460;	cell type: human lung large cell carcinoma cells;	treatment: control (none);	timepoint: 24 hours,ctrl
cell line: OV90;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
patient: 107;	current medication: None;	birth date: 07/28/1060;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: ;	diagnosis date: ;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: ;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 11/25/04;	indictation for procedure: FH Colon Cancer;	ucss: 0;	calprotectin: ;	esr: ;	crp: ;	hb: ;	wcc: ;	neutrophils: ;	albumin: ;	blood obtained: FALSE;	ibd affected relatives: ;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: unknown;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: ;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: ;	category: 0;	smoking status: ;	smoking start date: ;	smoking stop date: ;	smoking amount: ;	other illnesses: ;	disease: Normal;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,ctrl
EB_07_5d_140_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
treatment: DMNQ;	cell line: NuLi;	genotype: no-Cystic Fibrosis deltaF508 mutation,pert
Atopic eczema,ctrl
Brain (Dorsal Motor Nucleus of the Vagus)_Parkinson's disease subject_#6,pert
tissue type: gastrointestinal stromal tumor;	gender: Male;	kit expression: LOW;	genome/variation: PDGFRA mutation detected,pert
Strain: DBA/2J;	Tissue: Peripheral Nerve (sciatic);	Treatment: STZ,ctrl
G93A mouse 799,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 22.31507,pert
RNA from WT MEF (30h after serum shock),ctrl
"Animal id 1026, left retina, 3 months, female, DBA/2J",ctrl
strain background: C57Bl/6;	genotype/variation: BATF-/- P14 TCR transgenic C57Bl/6;	cell state: Day 0 Naïve CD8+ T cells,pert
"NRVM, Uncoated plates",ctrl
genotype: wild type;	cell type: colon epithelial cells;	gender: male;	treatment: water,ctrl
Pre-frontal cortex from male C57Bl/6 mice 31 d after i.d. injection of Type II collagen in Complete Freunds adjuvant,pert
cell line: SV589;	knockdown (days): 15;	treatment: Serum Starved; no EGF,pert
B4_pseudomonas_overexpressor_422,pert
strain: 129Sv;	tissue: liver;	genotype/variation: SIRT3WT;	age: 12 weeks;	nutrient state: 24h fasted;	diet: Standard diet,ctrl
RNA from whole tissue section of case 1363 labeled with Cy5,ctrl
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed",pert
sex: Male;	Age: 33 months;	additional patient information found in Series supplementary file,ctrl
cell line: MOLM-14;	shRNA construct: GSK3A Construct 6,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T163,pert
"gender: Male;	age: 25;	post-mortem delay: 17h;	ph: 6.9;	disease state: control;	tissue: superior temporal cortex (Brodmann Area 22, BA22)",ctrl
infection: MIR517A and GFP protein,pert
cell line: HEK293T;	transfection: si-control;	induction agent: CM;	induction time: 4 hours,ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#124,pert
"Mesodermal Precursor Cells derived from hES cells line VUB01, biological replicate 1",ctrl
strain: FVB;	developmental stage: adult (3-month-old);	tissue: hippocampus;	genotype/variation: Prnp0/0,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: non targetting shRNA (control);	replicate: A;	genotype/variation: NET1 present;	agent: LPA,pert
age: 10;	sex: M;	disease status: Marfan subject;	Filter number: 40;	Usage number: 1;	Exposures: 3,pert
"Deltoid, control, cohort 03, subject 03U",ctrl
6 h-apra-10 nM;HT-29;colorectal adenocarcinoma;apratoxi;24724,pert
ANCR knockdown,pert
cell line: ACC525 [DND41];	cell type: human T-ALL cell line;	agent: control,ctrl
cell type: CD8 T cells;	transduction: shRNA targeting Alk;	tissue: spleen;	sample name: 6-sp1,pert
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	2nd technical replicate,pert
"Control maternal diet, wildtype",ctrl
murine adult bone marrow,pert
"treatment: control;	batch: 5;	donor: 5;	tissue: Human liver slices (diameter 4 mm, thickness 250 µm)",ctrl
patient: 242;	current medication: Salazopyrin Folic acid;	birth date: 10/18/39;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/75;	diagnosis date: 1/1/75;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 3/22/05;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 3/22/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 7/7/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: ;	smoking stop date: 1/1/95;	smoking amount: 0-4;	other illnesses: None;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: GTE6;	ttf: 225min;	race: White;	sex: Male,pert
gender: male;	tissue: gastrocnemius muscle;	age: 7.5 months;	genotype: Mstn ko,pert
cell type: alveolar macrophage;	treatment: saline;	individual: Subject 7;	gender: male,ctrl
human pancreatic cancer cell line BxPC3 transfected with vector expressing shJMJD3,pert
phenotype: alcoholic;	gender: male;	case_id: 351;	age: 42;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 41;	brain ph at time of freezing: 6.5;	labeling_batch: 2,pert
"Spleen, SRBC immunized mouse, 12 days post-immunization",ctrl
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 30,pert
AA_Control_CD8,ctrl
Ribavirin Treated Cells 2,pert
HEK293_ControlsiRNAConfluent_rep1,ctrl
"genetic background: B6;	genotype/variation: Xbp1 knockout;	age: 8 weeks;	Sex: female;	tissue: spleen;	cell type: regulatory T cells (Tregs);	phenotype markers: CD4+CD25hi;	exclusion markers: CD19, CD8a, CD11b, CD11c, NK1.1;	separation method: MoFlo Sorter",pert
cell line: Raji;	cell type: human Burkitt's lymphoma;	gender: male;	treatment: expression of control mimic;	treatment duration: 24 hrs,ctrl
status: Normal;	age: 75;	gender: male;	tissue: cultured human fibroblasts,ctrl
HCT116 colon cancer cells,pert
"Primary, localized, pooled, prostate cancer",pert
Human fibroblast,pert
patient E1535,pert
Cultured hESC H1 B2M KO,pert
"male, 275-300g",pert
"age at diagnosis: 76;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G1;	mininal stage grouping: IIIB;	t (extent of primary tumor): T4;	n (lymph node metastasis): N1a;	er: NA;	pgr: NA;	dfs-month: 48;	dfs-event: 0;	distant metastasis: 0",pert
genotype/variation: Tsc2 +/- mouse;	tissue: cerebellum;	gender: Female,pert
strain: FVB/NCrIBR;	tissue type: tail skin,ctrl
SKI-DLCL cells,ctrl
"Lung, Sporadic Idiopathic Interstitial Pneumonia (S-IIP), Nonspecific Interstitial Pneumonia (NSIP)",pert
"SWR/J Saline treated, biological replicate 2",ctrl
Mouse heart with no DOX treatmeant,pert
Aquaporin-11+/+_mouse P7 kidney #4-1,ctrl
"brain, brainstem",ctrl
Primary hepatocytes isolated from FVB mouse strain treated with DMSO for 6h,ctrl
Infergen_24hr,pert
"ATP7B -/- KO mice, 6 weeks old",pert
Strain CD-1,ctrl
Tissue: Primary Human Hepatocyte;	Gender: Female;	Source: In Vitro Technologies;	Cause of Death: Celebral Vascular Accident;	Tobacco Use: Yes;	1st technical replicate,pert
whole brain,pert
PBMCs from Normal subject,ctrl
gender: Female;	age: 35;	cell type: PBMC;	individual: Patient 112;	treatment: REBIF;	time: 12 month of REBIF;	disease state: multiple sclerosis;	nab status: NAB-,pert
BL6SHAM,ctrl
E8.5 embryo proper,ctrl
brain microvessels,pert
gender: female;	strain: C3H/HeN;	genotype/variation: WT;	tissue: liver;	age: Five-weeks-old;	agent: control,ctrl
"metastasis: none;	Stage: 2a;	tissue: cancer, homogenized",pert
patient: 237;	current medication: Omep 20mg Losartan 50mg Bisoprolol 5mg Prav 40mg;	birth date: 11/12/28;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 10/1/95;	diagnosis date: 11/13/95;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 2/18/05;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 6/5/03;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 5/30/05;	category: DISEASE IN REMISSION;	smoking status: ex;	smoking start date: 1/1/50;	smoking stop date: 1/1/52;	smoking amount: 0-4;	other illnesses: Hypercholesteremia Prev CABG;	disease: UC;	run_date: 8-9-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
cell line: HCT116;	shRNA: CDK19;	treatment: untreated,pert
disease state: healthy control;	tissue: epidermis;	age: 59;	gender: male;	treatment: untreated;	time: control,ctrl
"Oral Squamous cell Epithelium Tissue-Normal;	Patient Code:OSCC-2;	Primary Site:Floor of Mouth;	Age:58;	Sex:F;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",ctrl
subject: 2825 WT;	type: wild type;	tissue: Mouse skeletal muscle,ctrl
"Lymphoblastoid cell lines derived from family 1734, member 2",pert
"luteinized human cumulus cells, cultured 48h, nonPCOS, Lean, rep2",ctrl
peripheral blood CD4 T cells,ctrl
liver-AHRKO-cornoil,pert
"Cervical cancer cell line, HeLa",pert
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-12;	Primary Site:Maxilla;	Age:46;	Sex:Male;	TNM:T4N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	;	",pert
hTERT-immortalized skin fibroblast cell line,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.84;	choa: 41.3;	fata: 38;	eea: 1290;	wtkg: 70.3;	perfat: 35.5;	lbm: 42.7;	fat_mass: 2495.65,ctrl
20A;pretreatment;female;breast tumor,ctrl
tissue: whole blood;	condition: Psoriatic arthritis;	gender: Male;	batch: 3;	psoriasis duration: 13.0;	age of psoriasis onset: 30,pert
Patient: D;	Time: 2 weeks;	Group: responder;	Condition: lesional,pert
DBA/2J hippocampus-Control,ctrl
gender: female;	age (years): 36;	evolution time (years): 0;	disease extension: Left-sided colitis;	treatment: No treatment,ctrl
"Trim28 conditional KO mice Treg cell, replicate 2",pert
DLBCL cell line KARPAS-231 transfected with a LITAF-specific siRNA,pert
"MCF7 cells stably transfected with XBP1, passage 2",pert
hdh genotype: Q111/Q111;	tissue: cerebellum;	age: 3~10 weeks,pert
11_1_MOE_430A_WT,ctrl
disease state: Ovarian cancer;	xenograft from ovarian cancer model: HOX424;	agent: Carbo;	time: day7,pert
Brain (Dorsal Motor Nucleus of the Vagus)_control subject_#5,pert
CLDN18_KnockOut_lung,pert
cell line: MCF7 breast cancer;	treatment: RL silenced and LIF-stimulated,ctrl
cell line: MCF7;	treatment: PDEF knockdown,pert
Mock infected macrophages harvested at 1h post-treatment from donor 2,ctrl
cell type: monocytes;	disease state: renal cell carcinoma (RCC),pert
"Synovial biopsies (n = 4 to 6), obtained by needle arthroscopy from the swollen knee of a patient with microcrystalline arthritis",ctrl
sample type: HeLa-LAMP3siRNA-3d;	cell line: HeLa;	knockdown: LAMP-3 siRNA;	time: 3d interferon alpha;	treatment: interferon alpha,pert
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 1h;	donor: 3,ctrl
Glomeruli from nondiabetic male FVB mouse sacrificed at 8 weeks,ctrl
Subtype: RARS;	Karyotype: del(5q),pert
quadriceps_muscle_Wt_female_35wk_rep4,ctrl
"Epithelial prostate primary cells from fresh explant of controlateral normal tissue characterized by the presence of few areas of ""PIN"" (Prostatic In Situ Neoplasia)",ctrl
tissue: Liver;	genotype/variation: Hmgn1-/-;	treatment: injection of 10 µg/g body weight of saline,pert
WT S49 cells 24h cAMP treatment,ctrl
"Oral Squamous cell Epithelium Tissue-Tumor;	Patient Code:OSCC-9;	Primary Site:Tongue;	Age:66;	Sex:M;	TNM:T2N0M0;	;	Abbreviation:TNM,Tumor-node-metastasis;	",pert
NCI-H1650 + Medi5117,pert
"Mouse Sciatic Nerve, Non-diabetic Vehicle",ctrl
"Lymphoblastoid cell lines derived from family 1743, member 2",ctrl
tissue type: Bone Marrow;	cell type: Smoldering Multiple Myeloma (SMM) plasma cells,pert
Insm1 control #5_pituitary gland,ctrl
"Gata4_S105Amut, untreated whole heart",pert
tissue: brain (frontal cortex);	disease state: healthy control;	age: 39 yr;	population: white,ctrl
wt_1,ctrl
"24hr non-specific siRNA, 16hr 10nM DHT treatment replicate 3",ctrl
"BOEC, at_risk 2",pert
"age at diagnosis: 69;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIIA;	t (extent of primary tumor): T1c;	n (lymph node metastasis): N2a;	er: 1;	pgr: 0;	dfs-month: 31;	dfs-event: 1;	distant metastasis: 1",pert
cell line: DHL4;	cell type: diffuse large B-cell lymphoma cells;	treatment: R406;	treatment duration: 6h,pert
"testis, knock out",pert
"C57BL/6 BMDM infected with WA(pTTS,pP60)",pert
Embryonic day 14.5 Zfp36l2 knockout (KO) mouse fetal liver,pert
subject id: 4;	infection: DENV;	status: DF;	tissue: whole blood,pert
tissue: Frontal cortex;	age: 100;	Sex: F,ctrl
Postmenopausal female. Untreated control. nr 12.;	Replicate,ctrl
Primary hepatocytes isolated from BalbC mouse strain treated with DMSO for 24h,ctrl
colon,pert
A673 cell line that has been treated with Puromycin for 3 days with concentration of 0.18 uM (2 x EC50).,pert
tissue: white blood cells;	age: 16.61;	Sex: female,pert
CUTLL1 wash2h-CHX,pert
"Gender: female;	Age: 51;	Source: skin, neck",pert
strain: 129SvEv;	developmental stage: E11.5;	tissue: ventricle,ctrl
HeLa Cells,ctrl
"Control at ZT20, retina",ctrl
Sex: female;	Age at operation: 67 years;	Site: thigh;	Size in cm: 35x15x12;	Histological Subtype: atypical lipoma;	Responder type: low;	Grading: G1;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
strain: C57BL/6;	genotype/variation: wild type;	gender: female;	sample type: control,ctrl
age: 0.33;	sex: F;	disease status: Marfan subject;	Filter number: 45;	Usage number: 1;	Exposures: 3,pert
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age and pooled before synthesis of cDNA,pert
tissue: synovial biopsies;	disease: Microcrystalline arthritis;	age: 72;	gender: f;	treatment: -,ctrl
482 cells Sox2shRNA-rep2,pert
genetic background: C57BL/6;	gender: female;	tissue: left hippocampus;	age: P100;	genotype: wild type;	treatment: control,ctrl
"Gender: Female, Age: 33, BMI: 33, Tissue: luteinized cumulus cells",ctrl
100uM H2O2 rep 4,pert
T50,pert
Gender:M;	Age:41;	Tissue: Mucosa,ctrl
"Cell type: neuronal, age:47, gender:male, diagnostic group: control, PMI:11h",ctrl
whole uterus,pert
cell line: MCF-10A,pert
"Myd88 null C57BL/6 mice, liver, 10-12 weeks old, sacrificed 2 hours after 85% liver resection",pert
TTF=120min;	Race=Black or African American;	Sex=Female;	Group=A;	Prototype_Y,pert
"Lymphoblastoid cell lines derived from family 1733, member 1",ctrl
strain: C57BL/6J;	day: 24;	drug: Methamphetamine;	phase: Withdrawal;	tissue: striatum;	replicate: 3,pert
cell line: MDA-MB-231 breast cancer cells;	protocol: cadherin-11 knockdown;	other: RNAi-4A,pert
"NB4 cell line, wild-type, untreated",ctrl
"BL from healthy donors, isolated using CD19-PE-Cy7.",ctrl
Whole liver,pert
tissue: liver;	gender: female;	disease status: normal glucose tolerance,ctrl
"SBC-5 cells, siEGFP (control), 24 hr after siRNA, duplicate sample 1",ctrl
"liver, QH2, 6 months",pert
Hodgkin lymphoma cell line KM-H2,pert
"A673 cell line, a human EWS/FLI translocated Ewing sarcoma cell line.",pert
C3_CLP_overexpressor_12,pert
"brain, adrenal medulla",ctrl
"Wild type, snap frozen, extensor digitorum longus muscle, 10 month age animal",ctrl
brownfat,pert
Y HID_B002,ctrl
CD8+ T cells derived by negative selection from leukopheresed blood sample,pert
cell line: MCF-7;	expression: Control,ctrl
CEMC1 cells treated with 10 nm rapamycin for 3 hours,pert
Jejunum,ctrl
strain: CBA,ctrl
status: Control;	gender: Male;	age: 45;	tissue: Blood,ctrl
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,pert
genotype/variation: Wildtype_XY;	tissue: gonads;	age: E11.5,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 274;	age-at-biopsy-years: 49,pert
Colon,pert
MCF7 untreated,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 29.26301,pert
"C2 corrected_A2_tumor, lung tissue",pert
Disease_status: Bipolar disorder;	Age (years): 43;	Gender: Female;	Age of onset (years): 29;	Duration of illness (years): 14;	Brain pH: 5.92;	Post mortem interval (hours): 57;	Side of brain: Left;	Fluphenazine mg. Equivalents: 10000;	Lithium treatment: No;	Valproate treatment: No;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
gender: Female;	age: 36;	cell type: PBMC;	individual: Patient 116;	treatment: baseline;	time: baseline;	disease state: multiple sclerosis;	nab status: NAB-,ctrl
Total Prefrontal cortex RNA,ctrl
treatment: vehicle;	genotype: wild type;	treatement time: 40 hours,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 33, stage IIB, HPV 16",pert
"Strain: C57BL/6,;	Sex: Male,;	Age: between 6-8 weeks,;	Diet: RM3 (E) 801710 Soya-free powdered diet from B.S & S.,;	Tissue: Jejunum",ctrl
"FACS-sorted cones, P40 wild type mice",ctrl
"Patient  A, lesion, 12 week",pert
"Lung tissue of Nrf2 knock-out mouse, control group",pert
T21.01,ctrl
cell line: FU-OV-1;	cell type: ovarian cancer cell line;	treatment: none;	batch: 2,ctrl
"cell line: prostate cancer, PPC1",ctrl
"Patient  B, lesion, time: 0",ctrl
Postmenopausal female. Untreated control. nr 38.,ctrl
cell line: SNB19;	transfection: Scramble siRNA,ctrl
"NALT infected with 90-226 deltaM, 24h, biological rep4",pert
3T3-L1 Day 0 (passage 19) 24h after siControl transfection,pert
GATA-1deltaN mutant E12.5 fetal liver derived megakaryocyte progenitors,pert
HCC_8N,ctrl
scan batch: Batch 2;	group: autism;	subject age: 4;	paternal age: 32;	maternal age: 31,pert
EGFP control KD mouse embryonic stem cells,ctrl
cell type: human peripheral blood memory B cells (MBCs);	transduced with: LZRS-FOXP1-IRES-YFP;	genotype/variation: FOXP1 overexpression,pert
age: 5;	sex: F;	disease status: control subject;	Filter number: 105;	Usage number: 1;	Exposures: 3,ctrl
cell type: epithelial cells,ctrl
X50 WT3	F2/33	X50	wild type	Mouse	16 months	Cerebellum	Male,ctrl
HeLa,pert
cell line: MCF-10A;	cell type: mammary epithelial cells;	transfected with: shATR-4,pert
tissue: Adrenal gland;	strain: 129Pas x C57Bl/J;	genotype/variation: WT;	animal: 80;	time: 0;	batch: 3,ctrl
gender: female;	batch: 1;	age (years): 33;	patient id: Control_6;	fev1 (% predicted): 116;	fvc (% predicted): 115;	medication: None;	cell type: CD4+ T-cells,ctrl
"affected status (disease state): control;	gender: female;	age-at-examination: 73;	age-at-onset: n/a;	geographical origin: Porto;	clinical characteristics: Hypertension, hypercholesterolemia",ctrl
chip number: 15;	transfection plate: 4;	target gene: IRF8;	kd level: 0.65;	rin: 9.3;	transfection date: 2011-10-17,pert
"Huh7 cells, Mock Infected, 18 hours",ctrl
Pre-Frontal cortex of naïve FVB/N mice,ctrl
NFIA P16WT3,ctrl
tissue: bone marrow;	cell type: macrophage;	genotype/variation: WT;	infection: uninfected,ctrl
background mouse strain: C57B16;	genotype: Jak2VF;	treatment: Vehicle,pert
status: Normal;	age: 64;	gender: female;	tissue: cultured human fibroblasts,ctrl
Muscle from a 24 month old wild type mouse,ctrl
wildtype MEFs,ctrl
treatment: no vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-Oct4 and pMX-jhdm1b(jmjc) retrovirus,ctrl
control cerebral microvascular fragments,ctrl
Lung,ctrl
Head RNA of littermate wild@E13.5 No.1,ctrl
immortalized cells derived from brown fat of PGC-1alpha KO mouse (mixed background). passage number: 4.,pert
HepG2_100uM_Trovafloxacin_24hr,pert
Myc(F/F) CD8 T cells,ctrl
"Mouse Sciatic Nerve, Non-diabetic Vehicle",pert
"Liver, fasting",ctrl
231/ARF-2,pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T79,pert
"colon from floxed mouse, wild-type phenotype",ctrl
Thioglycollate-elicited PPARg KO macrophages,pert
cell line: Panc1005;	cell type: dasatinib-sensitive pancreatic cancer cell line,pert
"Lymphoblastoid cell lines derived from family 1720, member 1",pert
CD43+/41+/235+ progenitors generated from Trisomy 21 iPSCs,pert
Y HID_B038,ctrl
tissue: Brain;	genotype: Npc1-/-;	age: 54 days;	subject: Mouse5;	genetic background: BALB/c,pert
HCC_8T,pert
mouse NB N1E-115 cell line,ctrl
N2A cells_non-targeting vector,ctrl
medial gastrocnemius,pert
"Trim28 conditional KO mice naïve CD4 positive cell, TCR-stimulated, replicate 2",pert
"metastasis: metastasis;	Stage: 4;	tissue: normal, homogenized",ctrl
"Wt mouse, cerebellum, old, saline treatment",ctrl
"Retina, 30 days old homozygous Egr-1 knock-out mice",pert
Gastrocnemius muscle wild-type mouse - control mouse for PPARalpha overexpressing -rep 2,ctrl
genotype: Fog2flox/delta;	treatment: no Cre;	age: 6-7 wks old;	gender: male;	tissue: heart,ctrl
Irradiated-ATM-WT Replicative3,ctrl
"WT cells, replicate 4",ctrl
Murine Cells (Macrophages),ctrl
T118,pert
cell line: gastric adenocarcinoma AGS cells;	shRNA: 65 shRNA;	replicate: A;	genotype/variation: NET1 knockdown;	agent: LPA,pert
background: C57BL/6x129Sv/B6 hybrid;	genotype: WT;	age: 9 months;	tissue: caudal vertebral bone,ctrl
S2B Sporadic-cerebellum,ctrl
IkL/L thymocytes,ctrl
-DOX/-E2_2,ctrl
Primary hepatocytes isolated from NMRI mouse strain treated with DMSO for 6h,ctrl
"strain: B6.129P2-Il10tmlCgn/J;	genotype variation: Il10-/-;	age: 6-8 weeks;	Sex: Male;	tissue: Left lung;	supplier: Jackson Labs, Bar Harbor, ME;	exposure time: 48 hours;	agent: air;	exposure dose: 0 ppm O3",pert
status: Control;	gender: Female;	age: 47;	tissue: Blood,ctrl
"BOEC, not_at_risk 6",pert
patient id: T144;	tissue: Normal cortex;	gender: Male;	age: 74;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
sample type: Negative control;	cell line: H1;	cell type: embryonic stem cell;	protocol: control;	time: 3 Days,ctrl
HLA risk: Medium;	Height: 175 cm;	Weight: 70 kg;	BMI: 22.9;	Age: 24.4 years;	Gender: Male;	Race: White;	Glucose: 288 mg/dl;	HbA1c: 8.8%,pert
WT MEF,ctrl
cell type: embryonic fibroblasts (MEFs);	genotype: FIH null,pert
murine medullary thymic epithelial cells,pert
23A;pretreatment;female;breast tumor,ctrl
"wild-type, lung",ctrl
CD4+/CD25- T effector cells in resting phase,pert
hOB1705_shEV_16hr_IR,pert
strain: C57B6;	genotype: Tgfbr2fl/fl;Wnt1-Cre;	tissue: Secondary palate;	age: E14.5;	gender: Not determined,pert
"Cell type: endothelial, age:54, gender:female, diagnostic group: schizophrenia, PMI:42h",pert
Thioglycollate-elicited PPARg WT macrophages,ctrl
tissue: skeletal muscle;	status: diabetic;	agent: insulin,pert
tissue: leukocytes from whole blood;	genotype: control subject;	age: 36;	gender: male,ctrl
BALB/c mouse untreated control,ctrl
Aquaporin-11-/-_mouse P7 kidney #4-3,pert
"NB4 cell line, TG2 knockout, untreated",pert
Patient: I;	Time: 0;	Group: responder;	Condition: lesional,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: GTE6;	ttf: 120min;	race: White;	sex: Male,pert
age: 52;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Gender:M;	Age:41;	Tissue: Mucosa,pert
Bone Marrow Mononuclear Cells;	24y Male,ctrl
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: DMEM,pert
MDA-MB-231 - Control,ctrl
WT_P14_Naive,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.242;	OD280: 1.1;	Ratio: 1.97;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 288;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"Lens epithelium, SPARC knock-out mouse",pert
"in vivo,2 cell stage, embryo",pert
cell line: MCF-7;	cell type: human breast adenocarcinoma cells;	treated with: 1 nM final conc. E2 + 1 uM vehicle (ethanol) for 24hr;	batch: 3,pert
Gene expression profiling of normal cortex of patient 209,ctrl
U2OS osteosarcoma cell line transfected with shBAP1 #1 construct,pert
skin,ctrl
tissue: skin;	individual: Patient P14;	condition: AL;	eczema severity: SCORAD: 33,pert
"Control fetal heart (vehicle treated with corn oil on gd14.5 via oral gavage, collected on gd17.5)",ctrl
Pfeiffer BCL6siRNA,pert
tissue: Temporal cortex;	age: 84;	Sex: F,ctrl
"Murine 3T3-L1 progenitor adipocytes cell cultures,T3 (treated with resveratrol)",pert
tissue: liver;	strain: C57BL/6JBomTac;	genotype/variation: wildtype,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 23.741;	Ratio: 2.11,pert
gender: Male;	age: 71;	post-mortem delay: 6.5h;	ph: 6,pert
cell line: Medulloblastoma cell line D425;	protocol: doxycyline inducible shRNA against OTX2;	time: 16 hrs;	time course: 2,pert
"testis, wild type",ctrl
control participant P330 (human CD3 positive T cells),ctrl
Mouse embryonic stem cell line E14,ctrl
cell line: SBC-5 cells;	treatment: siEGR4 (target);	time: 24 hr,pert
neocortex,ctrl
"MaF pre-iPSC9P2, Vc untreated, lysed on D4",ctrl
"Sample Type: cells, Cell Line: ATCC 16Lu, Cell Type: human lung fibroblasts, Harvest Time Point: 1 hour",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 232;	age-at-biopsy-years: 59,pert
"11B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
strain: C57BL/6J;	tissue: WAT;	genotype/variation: Fsp27 knockout;	gender: male;	age: 3 month,pert
age: E14.5;	gender: male;	tissue: dorsal telencephalon;	genotype: wt;	genetic background: C57BL\6,ctrl
diseased_media,ctrl
NIH3T3,pert
"HCT116 shControl, normal growth",ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient T127,ctrl
phenotype: control;	gender: female;	case_id: 410;	age: 78;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: No;	post-mortem-interval (hrs): 11;	brain ph at time of freezing: 6.3;	labeling_batch: 1,ctrl
age_years: 59;	sex: M;	ethnicity: White;	diagnosis: Healthy;	dx: health;	array_batch: 1,ctrl
age_years: 37;	sex: F;	ethnicity: White;	diagnosis: Sarcoidosis;	dx: sarc_low_lung_fx;	array_batch: 2,pert
"Strain: C57BL/10J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle Treated with AAV carrying Galgt2, Deficient in Dystrophin",pert
chip number: 14;	transfection plate: 4;	target gene: IRF8;	kd level: 0.66;	rin: 9.3;	transfection date: 2011-10-17,pert
Gene expression profiling of normal cortex of patient T158,ctrl
sciatic nerve of P60 Pmp22 transgenic mice,pert
tissue: Frontal cortex;	age: 89;	Sex: M,pert
strain: FVB/NCrIBR;	tissue type: ear skin,ctrl
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 1 day;	treatment: fresh air, treatment over 1 day, 3x1h exposure per day",ctrl
RNA from whole tissue section of case 1218 labeled with Cy5,pert
gender: female;	strain: Senescence accelerated mice prone 1;	tissue: heart;	age: 14 months,pert
"Lesional skin biopsy from psoriasis patient, Week12_etanercept",pert
Sorted Zfx ko myeloid progenitors overexpressing only GFP selectable marker,pert
patient id: T166;	tissue: Normal cortex;	gender: Male;	age: 56;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 55.22192,pert
tissue: adenoid cystic carcinoma grown as xenograft tumor;	original tumor status: primary;	organ site at which tumor arose: oral cavity;	donor sex: male,pert
Array Type: Rat230_2;	Amount to Core: 10;	Units of Amount: ug;	Ratio: 2.01;	RNA Integrity Number: 9.8;	Bioanalyzer Results: excellent;	Strain or Line: Fischer;	Individual: 60;	Sacrifice Method: CO2;	Age: 28;	Units of Age: PND,ctrl
Strain:C57BL/6;	Gender:male;	Age:8 weeks,ctrl
tissue: lesional skin;	urticaria status: affected;	patient: 2,pert
iFGFR1 mammary gland 0hr,ctrl
tissue: tumor;	cell line: SK-BR-3;	origin: luminal-like;	transfector: TFPI alpha,pert
disease state: Schizophrenic;	gender: Female,pert
PBMC normal sample RNA for Control,ctrl
Disease_status: Healthy control;	Age (years): 59;	Gender: Male;	Post mortem interval (hours): 47;	Braak stage: Unknown;	Cause of death: Cardiac,ctrl
"age at diagnosis: 63;	diagnosis: Adenocarcinoma of breast, ductal;	tumor grade: G3;	mininal stage grouping: IIA;	t (extent of primary tumor): T2;	n (lymph node metastasis): N0;	er: 1;	pgr: 1;	dfs-month: 12;	dfs-event: 0;	distant metastasis: 0",pert
Disease_status: Healthy control;	Age (years): 48;	Gender: Male;	Age of onset (years): N/A;	Duration of illness (years): N/A;	Brain pH: 6.93;	Post mortem interval (hours): 23;	Side of brain: Left;	Fluphenazine mg. Equivalents: N/A;	Lithium treatment: N/A;	Valproate treatment: N/A;	Electroconvulsive therapy: N/A;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 1,ctrl
microdissected epithelial cells from normal main pancreatic duct 6,ctrl
"C2C12 myoblasts, untreated, replicate 3",ctrl
murine lungs,ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre+/-;	genotype: NeuroD1 cKO;	age: 2 months;	tissue: pineal gland;	time: ZT20,pert
coc-12,pert
A39 NES 142Q TG7	F2/13	A39	NES Htt exon 1 142Q	Mouse	10 months	Cerebellum	Male,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 90min;	race: White;	sex: Female,ctrl
"ERRA KO ventricle, baseline",ctrl
genotype: Wildtype;	tissue: Liver;	genetic background: C57;	Sex: Female,ctrl
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 1524,pert
gender: Female;	age: 46;	post-mortem delay: 4h;	ph: 6.6,ctrl
normal brain tissue,ctrl
Striatum of 8-10 week old C57BL/6J mice,ctrl
Resting CD4 T cells,pert
MLL_00111,ctrl
"Sample Type: Cells, Cell Line: HeLa, ATCC Number: CCL-2, Number of Cells Seeded: 2.20E+05, Cell Type: Cervical Carcinoma, Separation Type: Trypsin, Harvest Time Point: 4, Units of Harvest Time Point: hr",ctrl
LM2 cells,ctrl
cell line: GIST882;	agent: DMSO (control);	replicate: Rep1,ctrl
Lesional skin from K5-Stat3c mouse,pert
mouse intestine pLagl2 knockout 1,pert
cell type: T cell;	disease state: heterozygote FH,pert
Mouse Bone Marrow,pert
strain: C57BL/6J;	gender: male;	tissue: colon;	genotype: WT;	treatment: untreated,ctrl
coMCF-7_1,ctrl
tissue type: anaplastic thyroid carcinoma (ATC);	tissue subtype: subtype spindle cell;	matched/unmatched: matched to N14,pert
"Mybf/f Cd4-Cre Tcra-/- DP, biological rep2",ctrl
strain: C57BL/6J; NeuroD1flox::Crx-Cre-/-;	genotype: control;	age: 2 months;	tissue: retina;	time: ZT6,ctrl
mouse heart,pert
kidney from control mouse,ctrl
"brain, cerebellum",pert
genotype: mcad -/-;	gender: Male;	genetic background: BL6/SV129 mixed;	age: 50-60 days of age;	diet: 12 hrs fasted;	treatment: vehicle;	tissue: liver,pert
cell line: KYSE270;	cell type: squamous cell carcinoma,pert
Sex: female;	Age at operation: 78 years;	Site: thigh;	Size in cm: 13x10x6;	Histological Subtype: atypical lipoma with partly dedifferentiated areas;	Responder type: high;	Grading: G2;	Specimen character: local recurrence;	Previous radiation: yes;	Previous chemotherapy: no,ctrl
Posterior_Shh mutant,pert
tissue: Brain;	genotype: Npc1+/-;	age: 82 days;	subject: Mouse1;	genetic background: BALB/c,ctrl
disease state: paediatric glioblastoma;	age: 5;	gender: M;	h3.3_status: K27M,pert
scan batch: Batch 1;	group: autism;	subject age: 4;	paternal age: 27;	maternal age: 27,ctrl
Strain: 129S2/SvPasCrlf;	Sex: male ;	Genotype: L1CAM knockout (-/Y),pert
C3H10T1/2 cell line,ctrl
"Gender: Female, Age: 35, BMI: 27, Tissue: luteinized cumulus cells",ctrl
scan batch: Batch 2;	group: autism;	subject age: 5;	paternal age: 38;	maternal age: 31,pert
"Biceps, FSHD, cohort 09, subject 09A",pert
"U937 cell line, transduced with shSYK_1 and selected with  1 µg/ml puromycin 48 hours post-infection",pert
"Male, 25 years old, HIV infection of ~2 months",pert
patient id: 265;	tissue: Normal cortex;	gender: Female;	age: 43;	disease state: Clear-cell renal cell carcinoma;	bap1 status: wild type;	pbrm1 status: wild type;	vhl status: wild type,ctrl
8 wk old male C57BL10 soleus,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: systemic JIA;	age_at_onset: LT6;	ttf: 95min;	race: White;	sex: Male,pert
scan batch: Batch 1;	group: control;	subject age: 10;	paternal age: 32;	maternal age: n/a,ctrl
scan batch: Batch 2;	group: control;	subject age: 6;	paternal age: 31;	maternal age: 30,ctrl
"Strain: C57BL/6J, Gender: Male, Age: 2 months, Tissue: Gastrocnemius Muscle",ctrl
cell line: BV2;	treatment: untreated,ctrl
"genetic background/strain: C57BL/6;	genotype: wild type;	cell type: embryonic stem cells;	developmental stage: day 0, undifferentiated;	passage: 8",ctrl
cell line: GIST882;	agent: DMSO (control);	replicate: Rep2,ctrl
Trizol extracted total RNA from uterine fibroid tissue.,pert
chip number: 14;	transfection plate: 6;	target gene: JUND;	kd level: 0.71;	rin: 9.6;	transfection date: 2012-03-26,pert
"A pool of RNA from lung from three male mice with SM22-rtTA transgene on an FVB/N background, raised at Denver altitude (nearly normoxic), fed doxycycline for 8 weeks and sac'd at 12 weeks of age.",ctrl
Cells: HCT116 colon cancer cell line,pert
whole mouse lung homogenate,pert
Scrambled 24 hours_2,ctrl
strain background: 129SvJ;	genotype/variation: wild type;	gender: male;	developmental stage: postnatal day 7 (P7);	tissue: cerebellum,ctrl
disease state: Severe Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 30.47945,pert
Liver from 1 year old- WT mice,ctrl
cell type: Peripheral blood mononuclear cells;	original diagnosis: healthy control;	age_at_onset: GTE6;	ttf: 100min;	race: White;	sex: Female,ctrl
"disease group: Nonatopic Control;	Sex: m;	age: 40s;	race: African American;	easi/pasi: disease severity score, range (0-72). Arbitrarily, we assigned 0 to Controls. EASI is used for Atopic Dermatitis and PASI for Psoriasis: 0;	ar or asthma: YES, subject has history of AR (allergic rhinitis), asthma or both: no;	eosinophil level (cells/ml): normal (120-300 cells/ml): 160;	ige (kiu/l): normal (0-48.5 kIU/L): 2.9;	rast (radioallergosorbent test): detects IgE that reacts specifically with suspected or known allergens: negative;	s. aureus: Skin culture positive or negative for S. Aureus: neg",ctrl
8 hour after cadmium treatment,pert
NOMO-1 cells infected with ZFX shRNA SH3,pert
age: 31;	gender: M;	disease state: hepatocellular carcinoma (HCC);	tissue: tumor,pert
Disease_status: Bipolar disorder;	Age (years): 41;	Gender: Female;	Age of onset (years): 14;	Duration of illness (years): 27;	Brain pH: 6.44;	Post mortem interval (hours): 28;	Side of brain: Left;	Fluphenazine mg. Equivalents: 3000;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): Unknown;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 4,pert
"Patient  L, lesion, 12 week",pert
tissue: skeletal muscle (gastrocnemius);	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
hypothalamus,pert
HeLa-Ctrl-siRNA-3d,ctrl
cell line: JoMa1;	cell type: neural crest precursor cells,ctrl
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 11.938;	Ratio: 2.09,ctrl
CD34+ cells from untreated normal donor,ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 2.434;	OD280: 1.353;	Ratio: 1.88;	Dilution: 1:5;	RNA Integrity Number: 7.6;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 140;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
knockdown: TNFa-OMe siRNA-B;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 6;	colon weight (mg): 172;	colon ratio (mg/mm): 2.87;	myeloperoxidase activity (u/mg): 0.384;	tissue: colon;	treatment: 5% DSS,pert
ATCC CRL-2868,ctrl
tissue: normal skin;	urticaria status: non-afffected;	patient: 11,ctrl
HEK-293,ctrl
knockdown: siRNA-scrambled;	amplification date: 09/06/22;	hybridization date: 09/06/30;	colon length (mm): 5.8;	colon weight (mg): 150;	colon ratio (mg/mm): 2.76;	myeloperoxidase activity (u/mg): 0.393;	tissue: colon;	treatment: 5% DSS,ctrl
Tissue: striatum;	Age: 6 months;	Gender: F,ctrl
BL2,pert
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep6",pert
tissue: Frontal cortex;	age: 84;	Sex: M,pert
cell line: LN229;	expression: Cyr61,pert
patient: 12;	disease state: hypertension;	tissue: Atheroma plaque,pert
"Total RNA, WT GMP",ctrl
"brain, locus coeruleus neurons, wild type",ctrl
SFM,pert
F3-NGN1-2nd,pert
strain: B6; gender: mix; age: 0-2d; tissue: rib cartilage; passage #: 4; treatment: 5-aza-2'-deoxycytidine; biological replicate: 3,pert
"Frontal cerebrocortex, permethrin (1mg/kg), 6 hours",pert
CON-2-COLLAGEN,pert
scan batch: Batch 2;	group: autism;	subject age: 7;	paternal age: 19;	maternal age: n/a,pert
Paraventricular nucleus_3d dehydrated,pert
CML cell line: KCL-22,ctrl
51A;pretreatment;female;breast tumor,ctrl
tissue: Frontal cortex;	age: 94;	Sex: M,pert
cell line: breast cancer cell line MDA-MB-231;	ectopic expression: control GFP;	rep: 2,ctrl
sorted CML CD34+CD38- cells treated with IM,pert
subcutaneous fat,pert
"Patient  K, lesion, 1 week",pert
"Patient  B, lesion, 2 week",pert
Strain: C57BL/6;	Genotype: wild type;	Generation: F5;	Gender: male;	Tissue: white portion of the gastrocnemius muscle;	Feeding condition: fasted,ctrl
gender: M;	age at blood draw: 57;	tissue: whole blood,ctrl
"seminoma specimen, pT1, patient age: 33y",pert
Gender:F;	Age:41;	Tissue: Mucosa,ctrl
tissue: Adrenocortical adenoma;	tumor secretion profile: Cortisol;	genotype: CTNNB1 mutation (S45P),pert
Gene expression profiling of clear-cell renal cell carcinoma (ccRCC) tumor of patient 233,pert
tissue: liver;	gender: male;	strain: Zucker;	genotype/variation: fatty (fa/fa);	pparγ ligand: Troglitazone,pert
SD rat femur,ctrl
S7A Sporadic-frontal,ctrl
"KO, Tumor, 11M",pert
"K562, 250nM1R-Chl, 24hrs, rep1",pert
strain: Sprague-Dawley;	gender: Female;	tissue: ovary;	developmental stage: day P4 cultured for 2 more days,ctrl
GNMT-WT mouse hepatocytes,ctrl
HaCat cells infected with a BCL-3-expressing  lentiviral construct. Replicat 3,pert
"heart tissue, untreated controls",ctrl
INS-1 cell line #1 with induced HNF6,pert
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: female;	age: 20.38904,pert
RPMI8226_shKLF2A#1,pert
Genotype: C57Bl/6 mice;	Age: 8-12 weeks old,ctrl
disease state: Moderate Asthma;	cell type: Fresh Bronchial Epithelial Cells;	gender: male;	age: 24.95342,pert
Nonirradiated-ATM-WT Replicative3,ctrl
"Cultured ovarian cancer cell line FU-OV-1, Cisplatin treated",pert
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.11;	RNA Integrity Number: 9.2;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,pert
patient: 9;	disease state: hypertension;	tissue: Atheroma plaque,pert
WT CFTR unexposed,ctrl
strain: B6EiC3SnF1/J (mix of B6 and C3H background);	genotype: wild-type;	tissue: skeletal muscle;	Sex: male;	age: 5 months,ctrl
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 304B;	age-at-biopsy-years: 49,pert
cell line: HepG2;	genotype/variation: HNF4a knockdown,pert
"Biological Material: Cell line, grown invitro; Tissue derivation: Adenoid cystic carinoma of the parotid gland",ctrl
cell line: lymphoblastoid cell line;	family id: 1744;	coriell cell line repository identifier: GM14535;	individual: Twin number 1;	agent: thapsigargin;	dose: 500nM;	time: 4 hours,pert
murine ES cells overexpressing Satb2,pert
Sample Group: HD patient; Gender: male; Age: 62; Tissue: lymphocytes (blood); IT15 CAG repeats: 17/47,pert
"CD1, E15 pregant mouse",ctrl
"primary cortical neurons, PTEN shRNA",pert
Sex: male;	genotype: sst +/+;	tissue: liver;	genetic background: C57BL/6,ctrl
cell line: CAL27;	treatment: 15 nm Cetuximab for 13 hours,pert
NFIA E18WT2,ctrl
chip number: 9;	transfection plate: 2;	target gene: NS;	kd level: NA;	rin: 9.9;	transfection date: 2011-03-29,ctrl
strain: C57BL/6;	genotype: wildtype;	tissue: heart;	age: 8 weeks,ctrl
Kyoto Rat liver tissue (control),ctrl
control lung fibroblasts,ctrl
Squamous cell lung cancer patient 42,pert
CSTB KO_cerebellar granule cells at P5+2 DIV,pert
"Mouse organ of Corti from cochlea, apical half, Dicer1 conditional knockout",pert
strain: Ts65Dn;	tissue: skeletal muscle;	Sex: male;	age: 5 months,pert
PDAC_T_117,pert
MCF7 breast cancer cells,pert
"diet: LRD-5001;	sodium arsenite added to drinking water: 100 ppb, 5wk",pert
unstimulated HMEC culture experiment 1,ctrl
strain background: BALB/c;	cell line: 4T1.2;	stably transfected with: pMSCV retroviral expression vector system with IRF7;	expressing: IRF7;	tissue: Mammary Tumour,pert
tissue: synovial biopsies;	disease: Seronegative arthritis;	age: 47;	gender: m;	treatment: NSAIDs,ctrl
"cell type: myeloid monocytic cells;	protocol: 24h Q10H2 preincubation, 4h LPS stimulation",pert
strain: C57BL6/10J;	genotype: mdx;	gender: male;	age: 2 months;	tissue: Gastrocnemius muscle,pert
F with Cy5,ctrl
cell line: T47D;	treatment: R5020 [10nM],pert
Rap1 knockout white adipose tissue,pert
INS-1 cell line #4a with non-induced HNF1b mutant A263insGG,ctrl
Cbx2_KO_XX gonads at E11.5,pert
B_cell_pool_melanoma_M01+M02,pert
scan batch: Batch 2;	group: autism;	subject age: 6;	paternal age: 26;	maternal age: 23,pert
cell type: T cell;	treatment: 37C;	genotype: HSF1+/+;	genetic background: mixed 129Sv.BALB/c background,ctrl
A39 NES 142Q TG3	F7/4	A39	NES Htt exon 1 142Q	Mouse	4 months	Cerebellum	Male,pert
Primary hepatocytes isolated from Donor 6 treated with Wy14643 for 6h,pert
Explanted neonatal cardiomyocyte,ctrl
Healthy-2 baseline,ctrl
cell line: AZ521;	genotype/variation: inducible dnSox2;	cell type: gastric cancer cell line;	treatment: doxycycline induced;	time point: 24h,pert
strain: C57BL/6J;	genotype/variation: wild type;	cell type: bone marrow derived dendritic cells,ctrl
Cell line expressing inducible wt-GFP-lamin A. Induction: day 10. Replicate B,ctrl
Brain of BSKO mice,pert
age: 37;	gender: F;	disease state: hepatocellular carcinoma (HCC);	tissue: non-tumor,ctrl
strain background: C57BL/6;	gender: female;	genotype/variation: MMA heterozygote;	tissue: kidney;	diet: high protein diet for 2 months,pert
"TNFa-OMe-P siRNA-C, replicate 4",pert
disease-state: breast cancer;	tissue-type: breast epithlieum;	patient-id: 251;	age-at-biopsy-years: 45,pert
"wild type naïve CD4 positive cell, TCR-stimulated, replicate 1",ctrl
gender: Male;	tissue: Tendon;Biceps;	age: 45;	donor: 5;	disease state: Lesional,pert
IFN_Gamma_24hr,pert
Cells:U-33 cells stably transfected with a PPARg2 expression construct (U-33/g2 cells);	Time: 24 hrs;	Drug: No Rosiglitazone present,pert
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 1,pert
Skin biopsy from upper nates taken 7 hours after exposure to 5% nickel sulfate,pert
Tendon;Biceps_Lesional,pert
cell type: CD4+ T;	strain: C57BL/6J;	genotype/variation: wild type;	treatment: stimulated for 3 hours with medium alone,ctrl
"Macrophage cultures were prepared from C57BL/6J, male, mouse peripheral blood by Optiprep (Accurate Chemical and Scientific, Westbury, NY) gradient centrifugation.",pert
"Sample Type: cells, Cell Line: ATCC 16 Lu , Cell Type: human lung fibroblasts, Harvest Time Point: 12 hours",ctrl
BaF3 cell line transduced MPLW515L3 mutant,ctrl
"Biceps, control, cohort 21, subject 21U",ctrl
"BOEC, normal 5",ctrl
"brain, cochlea",pert
EB_07_19d_152_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
cell line: MDA-MB231;	treatment: PIAS1 shRNA;	media: SCM,ctrl
tissue: skeletal muscle;	status: insulin sensitive;	agent: insulin,pert
Spleen,pert
gender: Female;	age: 71;	post-mortem delay: 13h;	ph: 6.3,ctrl
cells: Differentiated macrophages;	disease state: mock infected;	post-treatment: 6h;	donor: 3,ctrl
"Strain: C57BL/6 Ly5.1+, tissue: CD45.2+ transplanted bone marrow",ctrl
cell type: mammary epithelial cells;	cell line: MCF10A Cells;	genotype/variation: Cas,pert
14 Day Mouse leg muscle,ctrl
"lymphoblastoid cell line from T4.02, one out of seven of insensitive group, 50*10e6 cells",pert
umbilical cord tissue; low gestational age,pert
HeLa cells infected with control retrovirus,pert
PancreaticSample36-Normal,ctrl
HCC_40T,pert
"heart, Q10, 6 months",pert
"SWR/J Saline treated, biological replicate 1",ctrl
"DBA/2J Acute morphine treated, biological replicate 3",pert
Thymuse,ctrl
patient: 253;	current medication: Asacol 800mg BD;	birth date: 3/14/58;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 8/24/97;	diagnosis date: 9/4/97;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: unknown;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 5/24/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 11;	dlg5 133a: 11;	nod 1007 fs: 12;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 5/24/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: BOTH;	followup hep flex: BOTH;	followup total: BOTH;	casenote review date: 8/3/05;	category: FAILURE OF THERAPY;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: None;	disease: UC;	run_date: 11-15-01;	anatomic_location: descending colon;	inflammation_status: Inflamed,pert
strain: C57Bl/6;	gender: male;	age: 4-month-old;	genotype/variation: SKM-KO;	tissue: Skeletal muscle (quadriceps),pert
"BMDM, LPS 5hr",pert
strain background: Mixed;	genotype/variation: wild type;	tissue: ventromedial hypothalamus (VMH),ctrl
subject id: 33;	infection: DENV;	status: DF;	tissue: whole blood,pert
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.475;	OD280: 0.755;	Ratio: 1.93;	Dilution: 1:5;	RNA Integrity Number: 8.1;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 155;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
"tissue: lung tissue;	genotype: CD-1;	age: 13 weeks + 5 month + 1 day;	treatment: 2R4F whole mainstream smoke 750 µg/ml, treatment over 5 month + 1 day recovery, 4x1h exposure per day",ctrl
"LKR13, knockdown of GFP by shRNA",ctrl
patient E1796,ctrl
cell line: U-87 MG;	cell type: glioma,pert
Placenta_PE(LO)1 with Cy5,pert
Mouse colonic epithelial cell line MCE301,ctrl
Total RNA,pert
disease state: Schizophrenic;	gender: Male,pert
Jurkat T-cells 48 hour transfection,ctrl
Postmenopausal female. Tibolone treated. Patient 11.;	Replicate,pert
Wild-type iPSCs,ctrl
Biopsy 4 from cystectomy 10,pert
age: 71;	sex: M;	disease status: control subject;	Filter number: 100;	Usage number: 1;	Exposures: 3,ctrl
Hdh+/Hdh+ striatum at 3~10 weeks biological rep 3,ctrl
"MCF10A cells, Myc over-expression",pert
microdissected epithelial cells from IPMC 6,pert
retina,pert
tissue: 2B1 cell line;	genotype/variation: N/A;	age: 4 days post-differentiation in-vitro,ctrl
Control PB C103,ctrl
tissue: thymus;	genotype: wild-type cd4-cre+;	age: 8 weeks,ctrl
8A;pretreatment;female;breast tumor,ctrl
T147,pert
"T6 fetal heart (treated on gd14.5 via oral gavage, collected on gd17.5)",pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: oligoarticular JIA;	age_at_onset: LT6;	ttf: 165min;	race: White;	sex: Female,pert
strain background: C57BL/6;	gender: male;	tissue: thymus;	cell type: CD4 single-positive thymocytes;	genotype/variation: Bach2 knock out;	genotype/variation: Ly5.1-,pert
transfection: control shRNA;	cell line: Stable F1 Rif1 knockdown ES cells at passage 16;	background strain: C57BL/6xC3H,ctrl
DN4 cells sorted from mouse n°137 (Cre-),ctrl
sMPNST cells with control shRNA induction,ctrl
112 Day Mouse Diaphragm muscle,pert
SKM-Tg,ctrl
tissue: liver tissue;	disease state: adjacent non-tumorous,ctrl
normal;	Adjacent pair of T7,ctrl
8 wk old male mdx TA,pert
cell line: MCF7 breast cancer;	treatment: SIN3A silenced and LIF-stimulated,pert
"disease state: Nasopharyngeal carcinoma;	stage: III, T1, N2, M0, G4",pert
tissue: Frontal cortex;	age: 91;	Sex: F,pert
"53B;female;breast tumor;Letrozole, 2.5mg/day,oral, 10-14 days",pert
Endometrium-Normal 9,ctrl
Healthy-4 baseline,ctrl
Sample Group: HD patient; Gender: male; Age: 55; Tissue: lymphocytes (blood); IT15 CAG repeats: 25/43,pert
"MCF7 cells, SIN3A silenced, NS",pert
tissue: brain (frontal cortex);	disease state: bipolar disorder;	age: 29 yr;	population: white;	dsm-iv: 296.89;	age of onset: 17 yr,pert
"K562 (Iscoves + 10% FCS) and TF-1 (RPMI + 10%FCS + rhGM-CSF.  Cells were cultured at 37oC, 5% CO2 and split every 3 to 4 days. . The CREB specific shRNA sequences were selected and validated based on accepted parameters established by Tuschl et al.",pert
both ventricles of heart,pert
"Neural precursor cells derived from hES cells line VUB01, biological replicate  1",ctrl
"Male, 39 years old, HIV infection of 11 years",pert
"tissue: lung, lower lobe;	lung source: surgical biopsy;	phenotype: early idiopathic pulmonary fibrosis (IPF);	gender: male;	age: 68",pert
"Neural precursor cells derived from hES cells line SA01, biological replicate  3",ctrl
age: 45;	gender: female,pert
gender: female;	agent: control;	cell type: Hematopoietic stem cells,ctrl
age: 65;	gender: female,pert
cell line: MCF10A;	transduction: HER2,pert
"C57BL6J-backcrossed, male",ctrl
genetic background: 129SV;	genotype: WFS1 KO;	tissue: hypothalamus,ctrl
Insig1 flox/flox /Insig2 -/-,ctrl
heart from control mouse,ctrl
strain: E14Tg2A;	cell type: mouse ES cells;	knockdown: control;	overexpression: none,ctrl
"tumor stage: IA, IB, II, IIIA, IIIB, or IV=IA;	age:73;	Sex: female, male:male;	tumor depth: early gastric cancer or advanced gastric cancer=early gastric cancer;	tumor histology: moderately differentiated or poorly differentiated=moderately differentiated;	Lauren's t ype: intestinal type, diffuse type, mixed type, or not determined=intestinal type",pert
Sex: female;	Age at operation: 74 years;	Site: thigh;	Size in cm: 7x6x4;	Histological Subtype: dedifferentiated liposarcoma;	Responder type: medium;	Grading: G2;	Specimen character: primary tumor;	Previous radiation: no;	Previous chemotherapy: no,pert
affection: ADHD;	treatment: MPH;	tissue: EBV-transformed lymphoblastoid cell lines;	pool size: LCLs from 7 ADHD patients,pert
Human colon biopsies from UC patient with active disease (involved mucosa),ctrl
affected status (disease state): control;	gender: female;	age-at-examination: 47;	age-at-onset: n/a;	geographical origin: Mirandela;	clinical characteristics: Hypertension,ctrl
CLL cells,pert
"Gender: female;	Age: 62;	Source: skin, hip",ctrl
triplicate 1 of uninfected HepG2 nt cells,ctrl
"LSK (Lin-, Sca-1+, c-Kit+) cells sorted from Lkb1 KO bone marrow cells",pert
"liver,fasted,refed, 3hr",ctrl
"patient: 202;	current medication: Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118;	birth date: 10/3/50;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/68;	diagnosis date: 1/1/69;	joint problems: TRUE;	uc flare up: TRUE;	family history: FALSE;	aza treated: YES;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 2;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: unknown;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/9/04;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Polymyalgia rheumatica;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed",pert
Age: 39;	Cycle: Follicular;	BRCA1/2 mutation: BRCA1 185delAG;	Family History: Yes,ctrl
"Cervical cancer, squamous cell carcinoma, microdissected, age 45, stage IB2, HPV negative",pert
"age: 8 month;	strain: FVB/N;	genotype: H-ras+/-, p53-/-;	tissue: carcinoma in situ",pert
cell line: MCF7;	treatment: velcade stimulated,pert
S25 WT3	F41/391	S25	wild type	Mouse	2.5 months	Cerebellum	Female,ctrl
pooled reference mRNA from 4 harvests of ZR-75-1 cells,pert
Mouse male ES cells WD44 after single RNAi treatment of negative control siRNAs. Kdm6a RNAi experiment-1 in WD44.,ctrl
tissue: normal esopahgus,ctrl
tissue: white blood cells;	age: 9.78;	Sex: female,pert
"AZ521 dnSox2 cells, induced, 18h",pert
"sodium arsenite added to food: 10 ppb, 5wk;	diet: AIN-76A",pert
Mature mice skeletal muscle sample from the hind limb 2,ctrl
S8C Sporadic-hippocampus,ctrl
"Biceps, FSHD, cohort 12, subject 12B",pert
WT_cerebellar granule cells at P5+2 DIV,ctrl
Gfp purified cell,ctrl
alveolar epithelial cells exposed to cyclic stretch 20% elongation for 1 hr,pert
"MHC class II high thymic medullary epithelial cells, NODaireWT",ctrl
MOLM-14 cell line infected with GSK3B Construct 2 shRNA,pert
Striatum of 8-10 week old DBA/2J mice,ctrl
gender: female;	mean age: 41.3;	mean bmi: 28.9;	depot: abdomen;	type: white adipose tissue;	ethnicity: Caucasian,ctrl
tissue: Tumor Tissue in Pancreatic Cancer Sample;	sex: Female;	age: 59,pert
45A;pretreatment;female;breast tumor,ctrl
plasma;	patient with Acute Lung Injury,pert
patient: 218;	current medication: Sulphasalazine Asprin Metoprolol Atorvastatin;	birth date: 9/27/24;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/58;	diagnosis date: 1/1/58;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 12/3/04;	indictation for procedure: ;	ucss: 0;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: TRUE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 12/3/04;	followup rectum: BOTH;	followup recto sigmoid: unknown;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Breast cancer;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
"Cervical cancer, squamous cell carcinoma, microdissected, age 63, stage IB, HPV 16, HPV 18",pert
"Liposarcoma culture from tumor 337, doxorubicin treated",pert
"genetic background: B6/129;	genotype: WT;	cell type: Lineage negative, c-Kit positive and Sca1 (LSK) negative FCgammaReceptor High CD34 positive expressing bone marrow progenitors GMP",ctrl
cell line: HCT116;	cell type: colon cancer;	sirna: control,ctrl
Mouse_WT_ES_clone 2,ctrl
Hif1a-/- leukemia stem cell,pert
cell line: NCCIT;	cell type: human pluripotent cells;	protocol: Control shRNA infection,ctrl
patient: 51292;	sample: normal,ctrl
condition: Normal;	patient: N_LJ_3;	tissue: Normal skin biopsy;	kit: Affy,ctrl
cell type: hematopoietic progenitor CD34+ cells;	treatment: in vitro TCDD exposure;	normal donor 3,pert
cell type: embryonic stem cells;	cell line: CGR8;	treatment: overexpressed CA-NFATc3,pert
"BMMC, WT pLKO.1, activated",ctrl
Epithelials cells isolated from mouse mammary glands with mono-allelic Pten expression,pert
tissue: skeletal muscle;	status: insulin sensitive;	agent: untreated;	meanrqa: 0.86;	choa: 161;	fata: 49;	eea: 1360;	wtkg: 52;	perfat: 39.5;	lbm: ;	fat_mass: 2054,ctrl
MPM tumor specimen 32,pert
MDA-MB-231 cells transfected with negative control,ctrl
"strain: FVB/C57B6 mixed backgroud;	cell type: primary KrasG12D Pten L/+ pancreatic ductal epithelial cells, P4;	genotype/variation: Pdx1-Cre;LSL-KrasG12D L/+;Pten L/+",pert
marginal E-mu-BRD2 mediated lymphoma,pert
"embryonic stem cells, KD replicate B",ctrl
uterus - Early secretory endometrium from patient with endometriosis,pert
Genotype: FORKO (FSH Recptor Knock Out). FORKO mice was generated by deleting all variants of FSH-Receptor,pert
tissue: brain;	disease status: glioblastoma;	cell type: stem cells G48,pert
control participant P300 (human CD3 positive T cells),ctrl
batch: B;	knock-in: Twist-F191G;	cell line: MycCap prostate cancer cells,pert
"rat hippocampus (combined dorsal and ventral aspects), aged control, subject 7",ctrl
fibroblast cultured from normal esophageal tissue,ctrl
patient: 201;	current medication: None;	birth date: 4/12/56;	gender: M;	ethnicity: CAUCASIAN;	symptoms onset date: 6/19/03;	diagnosis date: 7/4/03;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 9/30/04;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: ;	igr2198: ;	igr2230: ;	octn1: ;	octn2: ;	nod 702: ;	nod 908: ;	dlg5 133a: ;	nod 1007 fs: ;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: BOTH;	diagnosis splen flex: BOTH;	diagnosis hep flex: BOTH;	diagnosis total: BOTH;	last followup date: 9/30/04;	followup rectum: BOTH;	followup recto sigmoid: HISTOLOGICAL;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 12/7/04;	category: FAILURE OF THERAPY;	smoking status: ex;	smoking start date: 1/1/70;	smoking stop date: 1/1/99;	smoking amount: 25+;	other illnesses: None;	disease: UC;	run_date: 1-25-01;	anatomic_location: sigmoid colon;	inflammation_status: Uninflamed,pert
"GI, Duo",ctrl
S2C Sporadic-hippocampus,ctrl
DU145/MYB siRNA,pert
Additional Information: please return the leftover samples to PI.;	Array Type: HG-U133A_2;	Amount to Core: 12;	Units of Amount: ug;	OD260: 29.490;	Ratio: 2.12,ctrl
"luteinized human cumulus cells, cultured 48h, PCOS, Obese, rep5",pert
patient: 32023;	disease state: LGSC;	component: Invasive,pert
genetic modification: Cd19-cre mediated deletion of the SRF Gene;	tissue:  spleen: FACS sorted IgM+IgD+ cells,pert
strain background: C57BL/6N;	genotype/variation: Stat1 delta beta (db);	tissue: Bone marrow derived macrophages (BMMs);	treated with: none (untreated control),pert
disease state: plaque type psoriasis;	tissue: epidermis;	age: 33;	gender: female;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
EE_IA_3_cauc_lcm,pert
"SW480, ezrin RNAi",pert
C57BL6_lung,pert
8 week mouse extraocular muscle,ctrl
strain: BALB/c;	gender: female;	type: Wild-type;	treatment: none,ctrl
cell line: cervical cancer (HeLa) cells;	agent: control,ctrl
tissue: synovial biopsies;	disease: Osteoarthritis;	age: 71;	gender: f;	treatment: NSAIDs,ctrl
patient: 224;	current medication: Salazopyrin BFZ Losartan Thyroxine Doxazosin;	birth date: 2/21/38;	gender: F;	ethnicity: CAUCASIAN;	symptoms onset date: 1/1/77;	diagnosis date: 1/1/77;	joint problems: FALSE;	uc flare up: FALSE;	family history: FALSE;	aza treated: NO;	aza tolerant: FALSE;	aza at present: FALSE;	procedure date: 1/6/05;	indictation for procedure: ;	ucss: 1;	calprotectin: 0;	esr: 0;	crp: 0;	hb: 0;	wcc: 0;	neutrophils: 0;	albumin: 0;	blood obtained: FALSE;	ibd affected relatives: 0;	igr2096: 12;	igr2198: 12;	igr2230: 12;	octn1: 12;	octn2: 12;	nod 702: 11;	nod 908: 12;	dlg5 133a: 11;	nod 1007 fs: 11;	diagnosis rectum: BOTH;	diagnosis recto sigmoid: unknown;	diagnosis splen flex: unknown;	diagnosis hep flex: unknown;	diagnosis total: unknown;	last followup date: 1/6/05;	followup rectum: BOTH;	followup recto sigmoid: BOTH;	followup splen flex: unknown;	followup hep flex: unknown;	followup total: unknown;	casenote review date: 3/4/05;	category: DISEASE IN REMISSION;	smoking status: never;	smoking start date: ;	smoking stop date: ;	smoking amount: unknown;	other illnesses: Hypertension Hashimoto's Thyroditis;	disease: UC;	run_date: 8-9-01;	anatomic_location: descending colon;	inflammation_status: Uninflamed,pert
very advanced HCC,pert
WI-38 cells exposed to 1 uM BPDE for 24 h,pert
Diagnosis: MDS/AML;	Age: 83y ;	Gender: Female;	Blast %: 90;	Source: PB;	Cyto: tris8;	FLT3 ITD: 1;	FLT3 TKD: 1,pert
"vertebral bone, Prkaca+/-",pert
"Control #1, Untreated",ctrl
Colon cancer tumor (control),ctrl
MPM tumor specimen 34,pert
thoracic mammary glands were collected from three virgin F1 CF-1/FVB LH-overexpressing (transgenic) mice at 16 weeks of age; RNA was pooled before synthesis of cDNA,pert
"BOEC, normal 9",ctrl
Array Type: Rat230_2;	Amount to Core: 15;	Units of Amount: ul;	OD260: 1.139;	OD280: 0.58;	Ratio: 1.95;	Dilution: 1:5;	Bioanalyzer Results: Good;	Sample Preservation: Cells resuspended in RNAlater and stored at 4 degrees Centigrade;	Strain or Line: F344/NCrl;	NCBI Taxonomy ID: 10116;	Individual: 154;	Developmental State: Adult;	Sacrifice Method: Deep pentobarbital anesthesia followed by exsanguination;	Sex: Male;	Units of Age: weeks,pert
gender: Male;	age: 79;	post-mortem delay: 4.5h;	ph: 6.1,pert
patient E1532,ctrl
"whole right lung, 6 weeks after a bleomycin dose of 125mg/kg, given by osmotic minipump.",pert
"Gender: Female, Age: 30, BMI: 24, Tissue: luteinized cumulus cells",ctrl
cell line: H1;	cell type: human embyronic stem cells (hESCs);	treatment: NANOG shRNA;	time: day 6,pert
patient: 460A;	disease state: LGSC;	component: Borderline,ctrl
cell line: SKM-1,ctrl
cell type: HeLa;	genotype/variation: nucleofacted with CABIN1 siRNA,pert
cell line: THP-1;	shRNA construct: GSK3B Construct 2,pert
Kyoto rat liver tissue following animal exposure to orotic acid for 3 days,pert
subject: 38;	disease: CP;	muscle: ST;	gender: M;	age: 9.4;	gmfcs: 2;	popliteal angle: 100,pert
"Tumor sample from patient with p53 wild type, replicate 2",ctrl
siRNA-3-PLASTIC,pert
Soleus muscles from male BERKO ( estrogen receptor beta knockout),pert
Rybp#10 (OHT-)_12d,ctrl
EB_6_24h_288_Formaldehyde_Nasal_Rat230_2_CIIT05024,pert
MGHU3 Cells_Control siRNA,ctrl
"soleus muscle, young female pathogen-free Wistar rats",pert
adult peripheral blood mononuclear cells after LPS-treatment,pert
Sample Group: control; Gender: male; Age: 46; Tissue: lymphocytes (blood); IT15 CAG repeats: N/A,ctrl
status: Rheumatoid Arthritis Patient;	gender: Female;	age: 52;	tissue: Blood,pert
cell type: Peripheral blood mononuclear cells;	original diagnosis: RF- polyarticular JIA;	age_at_onset: LT6;	ttf: 85min;	race: White;	sex: Female,pert
"Strain: Bl6, Tissue: Bone marrow, Age: 7 weeks",ctrl
Strain: top2b-/- in 129SvEv (minor 129SvJ) background;;	Age: E14.5 embryo;;	Gender: male;;	Tissue: whole brain,pert
strain: C57/Bl6;	gender: N/A;	age: 4 month;	weight: 25-30g;	tissue: whole trachea,ctrl
EB_0_5d_60_Formaldehyde_RatNasal_Rat230_2_CIIT05024,ctrl
strain: Sprague-Dawley;	tissue: tracheal explants;	treatment: dexamethasone at 2hrs;	replicate: 6,pert
"AZ521 dnSox2 cells, induced, 24h",pert
Liver,ctrl
gender: Female;	tissue: Tendon;Subscapularis;	age: 64;	donor: 23;	disease state: Non-lesional,ctrl
Vehicle-Control;	Vehicle-Control 24 hours set 1,ctrl
"Ls174T, β-catenin siRNA, uninduced",ctrl
microdissected epithelial cells from normal main pancreatic duct 2,ctrl
tissue type: normal thyroid;	matched/unmatched: matched to T14,ctrl
"Patient  L, lesion, time: 0",ctrl
THP-1 cell line infected with GSK3A Construct 5 shRNA,pert
treatment: vitamin C;	cell type: MEF;	strain: ICR;	transfection: pMX-jhdm1b retrovirus,pert
P1C Progranulin-hippocampus,pert
tissue: vestibular organ;	genetic background: hybrid Mf1 with 129/sv background;	age: E18.5;	genotype: Igf1 -/-,pert
"Tibialis Anterior Muscle, Desmin Knockout, Adult",pert
phenotype: alcoholic;	gender: male;	case_id: 330;	age: 53;	tissue: postmortem hippocampus;	cirrhosis: N;	smoker: Yes;	post-mortem-interval (hrs): 59.5;	brain ph at time of freezing: 6.75;	labeling_batch: 2,pert
strain: C57BL6/J;	pooled: No;	amplification batch: 10/18/05;	# cells: 65;	Sex: male;	region: M1;	age: 40;	genotype: Y/Mecp2-;YFPH/-,pert
"Cell line:  Fibroblast TTP KO cell line prepared from littermate E14.5 mouse embryos, derived from parental TTP +/- male and TTP +/- female strain 129/B6;  Embryo age:  E14.5, Tissue:  Whole embryo excluding head and organs",ctrl
PBMC from T cell Large granular lymphocyte leukemia patient#107,pert
duration of untreated disease in month:2.2;	age at onset:7.2,pert
Human muscle (vastus laterlis),pert
Splenic T1 cells,ctrl
sex: Male;	Age: 5 months;	additional patient information found in Series supplementary file,ctrl
scan batch: Batch 2;	group: autism;	subject age: 2;	paternal age: 28;	maternal age: 31,pert
Gender:F;	Age:45;	Tissue: Mucosa,ctrl
cell type: PBMC;	responder: ACR-Ped70;	treatment: Methotrexate pre-treatment;	subject: A235_L010,ctrl
sirna: NT control;	cell line: ES2;	cell type: Ovarian cancer cell line,ctrl
"ID:10-5, Genotype=(C57BKsJ) Lepr db/db, Treatment= none",pert
Primary hepatocytes isolated from BL6 mouse strain treated with DMSO for 6h,ctrl
strain: Wistar;	agent (mother exposed to): vehicle;	gender (pup): male;	age (pup): PND70;	tissue (pup): hypothalamus,ctrl
Array Type: HG-U133A_2;	Amount to Core: 20;	Units of Amount: ul;	Ratio: 2.12;	RNA Integrity Number: 9.8;	Sample Preservation: snap frozen;	Pooled from Multiple Samples: Yes,ctrl
liver_Akt1+/-_female_35wk_rep1,pert
strain: C57BL6;	genotype: WT;	tissue: striatum;	treatment: PDE10i,pert
RNA from microdissected breast cancer cells from case 180 labeled with Cy5,ctrl
PKCZ -/- male mice angiotensin II treated,pert
genetic background: 129/SVE;	genotype: wild type;	tissue: tibialis anterior;	age: 12-14 mo;	strain: 129/SVE;	treatment: 50 eccentric contractions 12 hours,ctrl
Disease_status: Bipolar disorder;	Age (years): 50;	Gender: Female;	Age of onset (years): 25;	Duration of illness (years): 25;	Brain pH: 6.3;	Post mortem interval (hours): 62;	Side of brain: Left;	Fluphenazine mg. Equivalents: 0;	Lithium treatment: No;	Valproate treatment: Yes;	Electroconvulsive therapy: No;	Suicide: No;	Drug abuse (ratings scale: 0 (no use) to 5 (heavy use)): 0;	Alcohol abuse (ratings scale: 0 (no use) to 6 (heavy use)): 0,pert
race: african american;	age (years): 47;	stage: IA;	grade: 2;	histology: endometrioid,pert
"Tracheal explants, Control, 2hr",ctrl
"t07, surgically resected from patient of gastric cancer.",pert
PancreaticSample-Tumor,pert
Weight:Low;	CFstatus:knockout;	Sex:Male,pert
"Liver, untreated, rep1",ctrl
Cervical cancer_20-04T,pert
strain: C57BL/6 (B6);	genotype: Hif1a-/-;	cell type: leukemia stem cells (LSCs);	age: 8 weeks,pert
CD4+T cells,pert
Melanoma allograft_vehicle-treated,ctrl
patient: 24;	disease state: hypertension;	tissue: Atheroma plaque,pert
gender: Male;	tissue: Tendon;Subscapularis;	age: 50;	donor: 27;	disease state: Non-lesional,ctrl
"Patient GM, stable renal transplant recipients, female, 53 years old, T1 (3 months after the switching of the therapy)",pert
HOX424 Carbo Day14,pert
Primary human lung fibroblasts,ctrl
NOMO-1 acute myeloid leukemia cells,ctrl
knockdown: Control;	amplification date: 09/06/19;	hybridization date: 09/06/30;	colon length (mm): 7.4;	colon weight (mg): 161;	colon ratio (mg/mm): 2.18;	myeloperoxidase activity (u/mg): 0.014;	tissue: colon;	treatment: 5% DSS,ctrl
"genotype: Gata6-KO;	cell: Peritoneal resident (CD11b-high, MHCII-low/negative) macrophages",pert
"metastasis: none;	Stage: 3c;	tissue: normal, homogenized",ctrl
"transgene: none;	treatment: treated with scrambled siRNA, after 48h",ctrl
disease state: plaque type psoriasis;	tissue: epidermis;	age: 17;	gender: male;	years of disease: > 10 y;	treatment: phototherapy;	time: pre-UV,pert
